,filename,label,label_predict,score,precision_5,precision_10,precision_15
0,Arch_Gynecol_Obstet-2-2-1705528.txt,symptom||day||viral replic||genit herp||full outbreak||recurr genit herp outbreak||patient||single-day treatment||recurr||onset||treatment||progress||patient-initi episod therapi,herp||genit herp||recurr genit herp||recurr herp||genit herp lesion||full genit herp||herp outbreak||famciclovir genit||herp virus||recurr genit herp outbreak||recurr genit herp infect||famciclovir||genit herp drug treatment regimen||genit herp 4 5 14||single-day famciclovir treatment,102.4||85.636||65.504||63.82||58.345||58.182||57.879||56.161||54.285||52.467||52.279||43.452||37.819||34.606||29.831,0.2,0.2,0.13333333333333333
1,Eur_J_Pharmacol-2-1-2258315.txt,serum||studi||reactiv oxygen speci||effect||biolog activ||hepat stellat cell||anti-fibrot agent||hepatocyt injuri||treatment||cell||mice||cell death||liver fibrosi||death||liver||anti-fibrot activ||hepatocyt||fucoidan||hepat fibrosi||fibrosi||result,fucoidan||hepat stellat||hepat||hepat fibrosi||hepat stellat cell||al.||crude fucoidan||pure fucoidan||fibrosi||stellat cell||hepat stellat cell activ||liver fibrosi||hepat stellat cell prolifer||fucoidan-tr hepat stellat cell||hepat stellat cell apoptosi,89.362||64.958||61.443||52.772||48.299||46.902||45.367||45.239||44.102||41.727||37.785||37.367||37.323||37.022||36.938,0.6,0.4,0.3333333333333333
2,Pediatr_Radiol-4-1-2367394.txt,rare tumour||follow-up||soft-tissu sarcoma||protocol||mri||imag||locat||studi||seri||patient||present||child||chemotherapi||transfus||rm||rhabdomyosarcoma||site||paediatr oncologist||bone scintigraphi||cell||treatment||metastat diseas||tumour||intergroup rhabdomyosarcoma studi group||alveolar histolog||case report||prognosi||surgeri||primari site||epssg protocol||primari tumour||group||biopsi||order||bone||malign tumour||pet||BP tumour||diseas||diagnosi||work-up||children,rhabdomyosarcoma||embryon rhabdomyosarcoma||alveolar rhabdomyosarcoma||childhood rhabdomyosarcoma||genitourinari rhabdomyosarcoma||primari rhabdomyosarcoma||metastat rhabdomyosarcoma||nonmetastat rhabdomyosarcoma||bladder rhabdomyosarcoma||pelvic rhabdomyosarcoma||orbit rhabdomyosarcoma||vagin rhabdomyosarcoma||vesico-prostat rhabdomyosarcoma||genital-tract rhabdomyosarcoma||adult rhabdomyosarcoma,231.344||133.292||127.396||124.926||122.036||121.023||120.587||120.386||119.264||118.231||117.818||117.536||117.081||117.081||116.772,0.2,0.1,0.06666666666666667
3,Evid_Based_Complement_Alternat_Med-3-4-1697739.txt,herb||studi||effect||review||articl||cognit impair||clinic trial||dementia||treatment||psycholog symptom||product||research||herbal medicin||melissa||symptom||random clinic trial||drug||formul||trial||diseas||systemat review||result,officinali||melissa||scholey AB melissa officinali||ginkgo biloba M. officinali||dementia||salvia||11 melissa||che-i||herbal medicin||herbal remedi||brasilia||memantin||herbal product||impair dementia||trial,66.074||30.237||25.943||22.104||21.929||16.487||15.988||15.958||15.608||13.357||12.766||12.766||12.74||12.508||12.505,0.4,0.3,0.26666666666666666
4,Bioinformation-2-1-2139988.txt,inform||diabet||medicin plant||databas||antimicrobi properti||literatur||plant,plant||databas||medicin plant||antidiabet plant||diabet||plant research||indigen plant||plant control||web databas||plant product||databas design||diab||antimicrobi effect||bioinform bioinform bioinform||folklor medicin usag,21.978||20.435||17.5||15.487||12.423||12.274||12.247||11.746||11.402||10.989||10.218||9.529||6.791||6.775||6.59,0.8,0.4,0.26666666666666666
5,J_Immunol_Methods-2-1-2225449.txt,glass coverslip||imag analysi softwar||primari human macrophag||method||dapi||lp||analysi||cell line||data||macrophag||nuclear||cell||binari mask,nf-κb||nuclear||nf-κb nuclear transloc||nuclear transloc||nf-κb rel||nf-κb quantit||cytoplasm nf-κb stain||nf-κb assay||nf-κb activ||nuclear roi||nf-κb pathway||nf-κb promot||nf-κb express||nuclear localis||transloc,56.257||52.134||45.33||39.867||37.617||33.85||32.126||30.349||29.831||29.655||28.891||28.128||28.128||27.662||27.6,0.2,0.1,0.06666666666666667
6,Invert_Neurosci-4-1-2257991.txt,cys-loop lgic||subunit||glutam acid||receptor||cys-loop lgic superfamili||ion channel||cation channel||nematod||glutamate-g chlorid channel||gaba||function||group,C. briggsa C. elegan||caenorhabd elegan embo||sattel DB caenorhabd elegan||caenorhabd||glc-1 elegan C. briggsa||dent JA caenorhabd elegan||springer-verlag 2008 caenorhabd elegan C.||1 1 C. elegan C.||C.||note fig. 1 C. elegan C.||lgc-23 lgc-24 lgc-28 C. elegan 2007||C. briggsa 2007 C.||nematod speci caenorhabd briggsa C.||cys-loop lgic||cbr-lgc-28 C.,58.987||58.599||54.196||51.685||49.458||45.189||44.945||41.868||41.446||34.924||31.392||29.5||25.428||22.402||22.386,0.0,0.0,0.06666666666666667
7,Surg_Endosc-4-1-2292805.txt,type||cardin health||urinari tract||data||appendectomi||patient||admiss||risk||present||complex||nim rate||open surgeri||infect||cmi||approach||hospit||insur||analysi||odd||cholecystectomi||respiratori tract||differ||laparoscop||nim||multivari logist regress analys||nosocomi infect||procedur||laparoscop approach||hysterectomi||nosocomi infect risk||result,appendectomi||nim||laparoscop appendectomi||nosocomi infect||laparoscop||laparoscop cholecystectomi||laparoscop hysterectomi||keyword nosocomi laparoscop cholecystectomi appendectomi hysterectomi||infect||cholecystectomi||open appendectomi||nosocomi wound infect||hysterectomi||nosocomi infect risk||nosocomi infect marker,79.531||77.846||68.849||67.666||58.167||54.836||53.54||53.369||53.232||51.504||50.759||49.73||48.912||48.817||46.708,0.8,0.6,0.5333333333333333
8,Exp_Brain_Res-4-1-2373857.txt,vertic||condit||cue||obliqu effect||respons||system||streri||product task||find||exploratori movement||horizont||anisotrop||obliqu orient||studi||hypothesi||stimulu||spatial orient||sensori motor trace||contralater hand||orient||refer frame||haptic||effect||space||process||sagitt plane||reproduct||percept||review||discrimin||plane||test||cognit resourc||adult||visual system||frontal plane||sensori modal||hatwel||haptic modal||frame||haptic discrimin||subjective-refer frame||paramet||cognit level||haptic percept||task||modal||bodi||diagon||gravit cue||rod||refer||visual modal||systemat bia||obliqu||error||gravit forc||hand||angl||gentaz||result,obliqu||haptic||obliqu orient||haptic orient||orient||haptic obliqu effect||haptic percept||orient percept||vertic orient||obliqu effect||obliqu rod||haptic space||haptic spatial||haptic reproduct||haptic explor,254.606||247.881||247.333||243.97||240.059||181.785||178.749||174.838||155.069||148.737||145.102||142.218||141.483||141.445||139.763,0.8,0.6,0.4
9,Breast_Cancer_Res_Treat-3-1-2001225.txt,follow-up||time||contralater breast||letrozol||lymph node-posit breast cancer||breast cancer||elig patient||initi therapi||tamoxifen||studi||year||recurr||distant metastas||risk||exclus criteria||aromatas inhibitor||ai||secondari end point||event||postmenopaus women||treatment||therapi||primari object||random||face trial||analysi||greater clinic benefit||anastrozol||differ||tumor||earli breast cancer||contralater breast cancer,breast cancer||breast cancer breast cancer||cancer||anastrozol||earli breast cancer||contralater breast cancer||invas breast cancer||receptor-posit breast cancer||primari breast cancer||posit breast cancer||breast cancer chemoprevent||early-stag breast cancer||advanc breast cancer||postmenopaus breast cancer women||contralater breast,55.291||55.291||48.975||47.072||42.371||39.853||37.963||37.947||37.591||37.54||37.501||37.319||36.861||36.432||35.293,0.6,0.4,0.3333333333333333
10,Plant_Mol_Biol-3-1-2140092.txt,smallest polypeptid||transit||protein level||dormanc||dormancy-to-growth transit||pea||prb||observ||amino acid sequenc||similar||signal||phosphoryl||cell||gene||transcript||protein||experi||molecular mass||cell cycl||intact plant||cdna||axillari bud||hp-form||retinoblastoma-rel protein||plant||result,psrbr1||psrbr1 psrbr1 psrbr1 psrbr1 gene||psrbr1 35 psrbr1||psrbr1 protein||rb-relat protein psrbr1 psrbr1 cdna||translat psrbr1||psrbr1 0.11||0.2 psrbr1||phosphoryl psrbr1 protein||authent psrbr1 protein||vitro-dephosphoryl psrbr1 protein||non-modifi psrbr1 protein||vivo-dephosphoryl psrbr1 protein||psrbr1 protein undergo||bud,191.881||154.162||127.921||125.94||97.271||95.94||95.94||95.94||95.642||86.07||85.957||84.959||84.959||83.96||81.398,0.0,0.0,0.0
11,J_Hum_Genet-3-1-1915643.txt,effect||risk||snp||femal control||TT genotyp||plasma folat concentr||mother||plasma homocystein||risk factor||spina bifida||studi||pediatr control||children,nos3 nos3 nos3 894g||nos3 nos3 nos3 mthfr 677c||mthfr nos3 nos3 894gt||refer group nos3 nos3||nos3 1999 2003 nos3 2004||keyword nos3 894g||nos3 894tt genotyp||result case-control studi nos3||nos3 locu birth defect||genotyp determin nos3 1999 mbo||refer group nos3 mthfr 677tt genotyp||transmiss disequilibrium test nos3 1993 2003||refer group transmiss disequilibrium test nos3||894g||homocystein,176.923||144.562||124.209||111.818||90.07||87.454||79.233||56.37||56.283||47.981||47.423||40.129||39.9||39.697||31.852,0.0,0.0,0.0
12,Purinergic_Signal-4-1-2246001.txt,rip||anim||oligodendrocyt||endogen progenitor cell||matur oligodendrocyt||spinal cord injuri||function recoveri||section||increas||spinal cord||lesion||astrocyt||cell prolifer||guanosin||treatment||cell||rat||day||myelin||prolifer||function improv||guanin||analysi||remyelin||usa||cord||brdu||open field||number||sci,oligodendrocyt||guanosin||oligodendrocyt progenitor||oligodendrocyt myelin||adult oligodendrocyt||remyelin||matur oligodendrocyt||cord||oligodendrocyt precursor||spinal cord||post-mitot oligodendrocyt||oligodendrocyt process||oligodendrocyt replac||oligodendrocyt progenitor cell||oligodendrocyt develop,96.727||69.366||68.558||64.093||55.905||55.799||55.655||53.809||52.542||50.607||49.686||49.43||49.355||48.928||48.793,0.4,0.6,0.4
13,Matern_Child_Health_J-2-2-1592156.txt,birth||pregnanc||rate||normal immun function||risk||human||listeria||infect||preconcept care||educ||toxoplasmosi||pregnant women||women||age||food||listeriosi||cmv||cytomegaloviru||transmiss||diseas||viru,cytomegaloviru||toxoplasmosi||cytomegaloviru infect||congenit cytomegaloviru infect||congenit toxoplasmosi||infect||cytomegaloviru diseas||primari cytomegaloviru infect||congenit cytomegaloviru diseas||http://www.cdc.gov/ncidod/dpd/parasites/ toxoplasmosi||congenit cytomegaloviru infect pediatr 1985||congenit toxoplasma gondii infect||listeriosi||congenit cmv infect||cytomegaloviru field virolog,96.381||79.967||75.16||63.932||60.722||53.939||51.994||50.107||48.488||41.548||40.327||39.926||37.311||34.72||34.09,0.4,0.3,0.26666666666666666
14,Environ_Manage-4-1-2233706.txt,ecolog investig||flow||histori||snake river||data||model||studi||comparison||compar studi||strategi||river dam||riparian ecosystem||landscap||aerial photograph||veget||spatial comparison||similar||analys||impact||downstream||natur||ecolog consequ||dam||approach||coincident influenc||valley characterist||research||snake||research strategi||hell canyon||sediment||natur variat||multipl reach||river,river||river dam||river canyon||snake river||river flow||salmon river||free-flow river||river ecosystem||river regul||river reach||colorado river||alluvi river||weiser river||river research||river channel,373.625||269.992||257.373||228.116||209.193||205.376||201.732||199.456||197.827||196.928||196.163||194.227||192.545||191.386||190.554,0.6,0.3,0.2
15,Histochem_Cell_Biol-4-1-2386527.txt,role||muscl||eukaryot cell||chromatin||nucleu||larg famili||review||structur||actin||form||nucleocytoplasm traffick||non-muscl cell||cell||gene||arp||transcript||protein||chromatin remodel||activ||jockusch||cytoplasm||nuclear actin||myosin||function,actin||nuclear actin||cytoplasm actin||actin polymer||actin filament||muscl actin||actin exist||actin pioneer||actin antibodi||actin mutant||actin polym||actin bound||RR actin||nuclear actin export||widespread nuclear actin,180.694||112.282||97.137||93.759||92.604||92.473||91.223||91.201||91.025||90.347||90.347||90.347||90.347||77.431||75.211,0.4,0.2,0.13333333333333333
16,Surg_Endosc-3-1-2169271.txt,endoscopist||level||endoscopi||case||time||expert||data||studi||represent||intermedi||colonoscopi||GI mentor II simul||valid||train||GI mentor II||task||simul||group||number||particip||novic||novic endoscopist,colonoscopi||colonoscopi simul||simul||endoscopist||expert endoscopist||expert||colonoscopi simul 2.95||novic endoscopist||VR colonoscopi||realiti simul||simul setup||simul modul||colonoscopi task||expert valid||flexibl endoscopi simul,67.557||67.256||66.955||57.565||55.255||52.944||46.144||42.224||38.525||38.124||36.056||35.879||35.603||35.5||35.223,0.6,0.5,0.3333333333333333
17,Clin_Auton_Res-3-1-1797061.txt,discharg||muscl||respons||experiment anim||paravertebr chain||spinal cord injuri||vasoconstrictor pathway||autonom nervou system||cutan||nerv||increas||spinal transect||natur activ||postganglion neuron||ongo||axon||sympathet nervou system||short burst||signal||vasoconstrict||perivascular nerv||preganglion input||vascular bed||injuri||activ||ganglia||arteri||autonom dysreflexia||vessel||input||transmiss||segment||tail arteri||sympathet ganglia||neurovascular transmiss,sympathet neuron||sympathet preganglion neuron||sympathet vasoconstrictor||sympathet ganglia||sympathet innerv||sympathet discharg||sympathet activ||sympathet axon||spinal cord||preganglion neuron||sympathet inhibit||sympathet vasoconstrictor pathway||gener sympathet vasoconstrictor||singl sympathet vasoconstrictor||reflex sympathet discharg,52.002||49.258||46.895||44.655||39.817||39.159||38.965||38.849||38.841||37.941||37.029||32.43||31.264||31.264||30.537,0.2,0.1,0.06666666666666667
18,J_Abnorm_Child_Psychol-4-1-2268722.txt,computer task||delay||low arous||measur||respons||behavior||mother||affect||pregnanc||problem||comput||inhibitori control||studi||prenat smoke||question||extern behavior||cool EF||exampl||domin hand respons||frustrat||prepot respons||smoke||hyperact||hot||trial delay||button||task||associ||ambigu||conduct problem||prenat||order||trial||signific differ||adhd||particip||score||emot||children,hot||smoke||hot EF||hot EF task||prenat smoke||cool execut||cool EF||execut||task||prenat||EF||keyword prenat smoke hot||hot inhibitori control||hot EF deficit||cognit task,54.669||44.684||44.06||40.781||39.283||36.544||35.549||35.441||34.221||33.883||33.451||33.309||31.642||31.534||30.503,0.6,0.6,0.4
19,Osteoporos_Int-3-1-1820755.txt,program||balanc train program||visual conflict||home-bas exercis program||studi||patient||initi evalu||final evalu||effect||risk||condit 5||walk||test||improv||intervent||signific||fractur||unstabl surfac||eye||fall||control||exercis program||train||women||research||ctsib||mobil||exercis||clinic data||group||differ||osteoporosi||sensori condit||number||adher||firm surfac||balanc||result,balanc||fall||balanc train||balanc exercis||static balanc||static balanc static balanc||balanc consist||enhanc balanc||dynam balanc||balanc deficit||balanc instrument||balanc train program||balanc train programm||fall prevent||fall risk,109.049||85.61||73.736||71.774||61.643||61.643||55.934||55.137||54.525||54.525||54.525||54.392||49.721||45.201||44.723,0.4,0.2,0.2
20,Eur_J_Epidemiol-4-1-2190782.txt,follow-up||diabet||patient||risk differ||year||admiss||mortal||risk||inform||epidemiolog||netherland||long-term mortal||acut myocardi infarct||signific||analys||popul regist||diabet men||day||hospit||women||result||prognosi||gender||coronari heart diseas||death||myocardi infarct||surviv||differ||date||nation hospit discharg regist||diabet mellitu||ami||cardiovascular diseas,diabet||myocardi infarct||diabet mellitu||mortal||acut myocardi infarct||diabet patient||diabet men||ami||acut myocardi infarct patient||diabet mellitu men||diabet women||hospitalis acut myocardi infarct||nondiabet patient||nondiabet men||diabet distribut,52.969||46.09||37.921||37.737||37.209||35.072||34.97||33.336||32.2||30.938||30.799||28.314||27.018||26.917||26.485,1.0,0.7,0.4666666666666667
21,Pediatr_Nephrol-4-1-2214827.txt,chronic kidney diseas||hypertens||ckd||patient||renal diseas||calcium channel antagonist||effect||risk||sympathet hyperactiv||increas||blood pressur||renal||adult||antihypertens treatment||beta blocker||treatment||therapi||control||esrd||end-organ damag||chronic hyperparathyroid||antihypertens drug||fluid||first-lin therapi||import factor||activ||multipl drug therapi||antihypertens therapi||ace||pathophysiolog||import||fluid overload||drug||low sodium dialys||children,hypertens||renal hypertens||hypertens children||renal||renal nerve-depend hypertens||epo-induc hypertens||erythropoietin-induc hypertens||ckd-associ hypertens||renovascular hypertens||hypertens 45:493||hypertens nephrosclerosi||cyclosporine-induc hypertens||mask hypertens||rebound hypertens||hypertens encephalopathi,89.697||71.478||58.176||53.259||48.629||47.781||47.781||46.315||46.315||46.315||46.315||46.076||46.044||45.864||45.44,0.4,0.2,0.13333333333333333
22,Exp_Brain_Res-4-1-2248215.txt,condit||main find||sham condit||subject pain rate score||acut pain percept||time||magnet stimul||experiment session||studi||subject pain percept||effect||left SI||theta burst stimul||tb||amplitud||primari somatosensori cortex||signific effect||pain process||stimul||lep||result||eeg||pain||yag laser stimul||subject||low-intens stimuli||laser-evok potenti||ctb||germani||peak||hand||itb||compon,stimul||tb||transcrani stimul||stimul cortex||pain||somatosensori||transcrani||somatosensori cortex||transcrani magnet stimul||sham stimul||tb stimul 2005||magnet stimul||laser stimul||transcrani magnet stimul primari somatosensori cortex||lep,72.441||63.082||62.46||59.521||59.455||56.598||52.478||51.599||47.527||47.27||46.377||45.051||42.976||42.425||40.099,0.6,0.3,0.3333333333333333
23,Ulster_Med_J-76-3-2075581.txt,standard practic||author||mechan bowel prepar||practic||rate||studi||patient||colorect surgeri||primari anastomosi||anastomot leakag||anastomosi||clinic practic||rectal carcinoma||signific||evid||infect||mbp group||relev journal||elect procedur||small tumour||small sampl size||surgeri||bowel prepar||mbp||medic literatur||pre-op prepar||infecti complic||group||differ||number||trial||randomis||post-op infecti complic||rct||result,mbp||pre-op mbp||mbp group||mbp regim||bowel||elect colorect surgeri||colorect surgeri||surgeri||bowel prepar||elect colon surgeri||prepar||elect left-sid colorect surgeri||mechan bowel prepar||colon surgeri||elect left-sid colorect surgeri brit,149.318||81.47||77.002||76.367||48.905||45.876||44.777||43.825||43.257||37.94||37.609||37.348||33.163||32.874||30.181,0.4,0.5,0.4
24,Environ_Manage-3-1-1866215.txt,weed||time||commun||speci rich||xeric condit||drawdown||year||valu||horsetooth site||remov||water||total cover||colorado||drawdown rate||total||seedl||site||water surfac||veget||recruit||plant||cottonwood||establish||elev||dam||veget colon||dam remov||upland veget||zone||recruit box model||surfac||cover||nativ||sediment||upland||exposur||bare ground||dam construct||number||perenni||speci||plot||horsetooth reservoir||upland plant commun,dam||veget||dam remov||upland veget||rood||reservoir||veget cover||cottonwood||reservoir drawdown||riparian veget||upland||tall dam||shorelin veget||colorado||american dam remov,87.881||79.72||64.789||63.695||56.292||55.439||55.11||52.769||50.238||48.956||47.669||47.055||46.896||46.621||46.102,0.8,0.5,0.4666666666666667
25,Arch_Dermatol_Res-2-2-1705513.txt,condit||inflamm||psoriasi||lipoprotein||atherosclerosi||preval||studi||diseas associ||patient||common inflammatori pathway||effect||mortal||risk||marker||comorbid||common||synthet antimalari drug||treatment||cell||concomit therapi||inflammatori condit||psoriasi patient||popul||methotrex||psoriasi treatment||atop dermat||drug||cardiovascular event||diseas||diagnosi||cardiovascular diseas,psoriasi||psoriasi drug||psoriasi patient||psoriasi treatment||psoriasi Br||psoriasi therapi||trigger’ psoriasi||psoriasi vulgari||drug-induc psoriasi||psoriasi inpati||psoriasi exist||conclus psoriasi||sever psoriasi||psoriasi eur||psoriasi present,175.026||91.529||90.601||90.512||89.766||89.534||88.979||88.946||88.365||88.094||87.513||87.513||87.513||87.513||87.513,0.6,0.3,0.2
26,Ann_Biomed_Eng-2-2-1705482.txt,thermal histori||arrheniu paramet||hr||time||data||studi||valu||signific amount||hold period||increas||optim clinic protocol||total time||rise||pt||temperatur||signific||clinic thermal therapi protocol||hold time||treatment||cell||non-isotherm portion||applic||tissu||heat rate||drop||hold||break point||total number||total treatment time||injuri||min||cell surviv||energi sourc||tumor||surviv||differ||activ energi||data point||thermal therapi||heat||result,thermal injuri||heat||suspend||1||suspend cell||hold||thermal therapi||injuri||thermal damag||thermal applic||thermal histori||thermal dosimetri||thermal threshold||G. thermal||cell,43.294||37.848||33.079||31.237||30.419||30.077||30.022||29.926||29.116||29.011||28.916||28.915||28.331||28.331||27.759,0.2,0.4,0.4
27,Osteoporos_Int-3-1-1766477.txt,signific risk factor||vertebr fractur||grade||deform||preval||studi||vertebr deform||patient||lumbar spine||risk||fractur||bmd||women||multipl||age||popul||mxa||scan||dxa||osteoporosi||normal lumbar spine bmd||hip fractur||normal bmd||vertebr morphometri,vertebr fractur||fractur||vertebr deform||deform fractur||prior vertebr fractur||unrecognis vertebr fractur||preval vertebr fractur||multipl vertebr fractur||vertebr fractur assess||vertebr crush fractur||vertebr fractur statu||addit vertebr fractur||deform||vertebr morphometri||prior vertebr deform,213.532||187.952||187.848||162.268||148.129||147.16||146.388||144.953||143.26||142.935||142.884||142.355||136.584||132.315||131.006,0.6,0.3,0.3333333333333333
28,Law_Hum_Behav-4-1-2175020.txt,eyewit identif||field studi,mecklenburg||lineup||sequenti lineup||sequenti procedur||procedur||blind sequenti procedur||simultan lineup||sequenti double-blind lineup procedur||mecklenburg studi||mecklenburg report||eyewit identif procedur||simultan procedur||non-blind simultan procedur||blind||eyewit identif,41.006||36.405||34.227||30.122||28.195||27.63||26.985||25.562||25.368||25.01||24.362||22.88||22.673||22.646||22.446,0.0,0.0,0.06666666666666667
29,Diabetologia-4-1-2292427.txt,type||diabet patient||level||progress renal impair||glomerular filtrat barrier||diabet||vegf||hypertens||key player||hyperglycaemia||metabol pathway||filtrat rate||permeabl||develop||observ||normal gfb||increas||glomerular endotheli cell||key||direct cellular effect||signific||vascular diseas||podocyt loss||glycocalyx||diabet nephropathi||genet risk||protein||microalbuminuria||albumin||factor||podocyt||import||gfb||risk factor||import contributor||diabet popul||diseas||diabet complic||inflammatori cytokin,microalbuminuria||diabet microalbuminuria||diabet||diabet nephropathi||HH microalbuminuria||2008 microalbuminuria||microalbuminuria reveal||microalbuminuria eur||persist microalbuminuria||glomerular endotheli glycocalyx||glomerular permeabl||glomerular endotheli dysfunct||diabet mellitu||glomerular barrier||diabet milieu,137.04||125.993||114.947||80.055||71.181||68.52||68.52||68.52||68.52||67.371||66.017||64.364||62.224||60.067||59.591,0.6,0.3,0.2
30,Pediatr_Radiol-3-1-1950217.txt,follow-up||level||inhal CS||signific reduct||reduct||growth hormon||low bmd||patient||year||cranial irradi||oral contracept||full bmd recoveri||idiopath short statur||bone miner||correl||normal hormon level||pediatr||lower extrem||increas||matur||nonambulatori||improv||fractur||treatment||therapi||calcium||CS therapi||bmd||lean tissu mass||chronic condit||normal valu||result||low bone mass||short statur||peak bone mass||normal||puberti||LS bmd||factor||height||dxa||osteoporosi||physic activ||bone deposit||hip bmd||abnorm dxa find||diseas||diagnosi||bone diseas||bone miner densiti||children||dxa find,bone||bone miner||bone densiti||bone miner densiti||miner densiti||normal bone miner||bone miner accrual||bone miner metabol||bone miner content||reduc bone miner densiti||abnorm bone miner||inadequ bone miner||low bone miner densiti||bone miner densiti loss||lower bone miner densiti,229.245||203.79||179.171||178.892||153.716||141.863||141.463||140.452||137.966||136.657||136.501||135.86||135.703||134.46||134.169,0.4,0.2,0.13333333333333333
31,Purinergic_Signal-3-4-2072927.txt,role||extracellular concentr||human mesenchym stem cell||releas||data||adenosin||neurotransmiss||atp||effect||increas||cell divis||receptor||evid||inhibit||cell||rat||brain||stimul||hippocampu||action||ischemia||tonic activ||activ||extracellular space||ntpdase||glutam||antagonist||protect,adenosin||adenosin receptor||adenosin a2a receptor||brain adenosin||adenosin releas||extracellular adenosin||adenosin A3 receptor||A3 adenosin receptor||adenosin outflow||adenosin inhibit||adenosin A1||adenosin receptor agonist||A2 adenosin receptor||adenosin A1 receptor||adenosin modul,148.411||113.135||93.692||87.921||83.895||83.4||81.556||81.556||81.139||80.802||79.524||79.007||78.986||78.968||77.98,0.2,0.1,0.06666666666666667
32,Purinergic_Signal-4-2-2377322.txt,muscl||respons||stimulatori effect||releas||human plasma||perfus||atp||activ skelet muscl||potassium channel||effect||purin||bodi exercis||extracellular atp||cell||acetylcholin||hypoxia||solut||tissu||exercis||depolar||identif||erythrocyt||human muscl||bath solut||motor nerv||substanc||serendip||human erythrocyt||procedur||heart||membran,atp||atp releas||releas||forrest||adenosin triphosph releas||triphosph||adenosin triphosph||adenosin||keyword atp releas||atp channel||extracellular atp||schwiebert EM atp||atp content||nucleosid releas||atp expans,45.378||41.568||37.758||34.122||32.277||30.706||29.536||28.367||27.712||27.323||27.056||25.868||23.603||23.519||23.177,0.4,0.2,0.2
33,Sci_Eng_Ethics-4-1-2225997.txt,independ physician||clinic test||case||critic care situat||time||intens care condit||risk-benefit ratio||prospect||efficaci||brain injuri||studi||good clinic practic||patient||agent||inclus||elderli peopl||short therapeut time window||clinic trial||pharmacolog trial||countri||treatment||tbi||defer consent||acut neurolog||specif ethic issu||emerg research||pharmacolog neuroprotect agent||random||sever traumat brain injuri||consent||acut emerg situat||european||proxi||direct||injuri||time window||proxi consent||clinic research||ethic||sever tbi||trial||signific advers side effect||benefit||waiver,consent||defer consent||proxi consent||inform consent||consent patient||consent procedur||prior consent||accur consent||kin proxi consent||D. inform consent||emerg||inform consent procedur||subsequ inform consent||W. surrog consent||hero-2 consent substudi,120.978||74.681||73.669||66.893||62.178||61.458||60.489||60.489||50.793||47.259||47.07||45.242||44.912||44.026||43.961,0.6,0.3,0.2
34,Surg_Endosc-4-1-2358937.txt,blood loss||transect||anim||materi||time||routin blood test||complic||stapl line reinforc||liver resect||surgeri||substanti liver parenchyma||devic||bile leak||addit||liver,stapl||stapl laparoscop||laparoscop||stapl laparoscop liver resect||laparoscop resect||laparoscop liver resect||liver||stapl line||liver resect||resect||stapl metalloptysi||stapl pulmonari resect||surgic stapl||stapl line reinforc||bioabsorb stapl line,60.157||55.218||50.28||44.569||41.969||39.374||34.183||33.995||33.92||33.658||33.281||32.493||31.262||30.867||29.837,0.0,0.2,0.2
35,Skeletal_Radiol-4-1-2271083.txt,bone marrow-stimul agent||case||spine||mri||imag||histori||patholog report||studi||patient||benign||fdg uptak||pet imag||lesion||fractur||neg predict valu||CT find||patholog result||repeat imag||clinic follow-up||uptak||acut benign fractur||report||compress fractur||suv||benign fractur||malign||emiss imag||fdg-pet,benign||benign fractur||benign compress fractur||compress fractur||malign compress fractur||malign||malign fractur||fractur||malign benign fdg-pet||malign vertebr compress fractur||vertebr compress fractur||acut benign fractur||acut compress fractur||fdg-pet||bodi compress fractur,65.714||63.713||63.574||62.504||62.387||62.153||61.933||61.713||56.845||48.588||44.066||43.633||42.827||42.667||42.096,0.6,0.5,0.4666666666666667
36,Brain_Struct_Funct-4-1-2226080.txt,maze test||anim||stereolog||time||revers trial||total neuron number||matern separ||open arm||section||volum||test||anxieti||total||hole||dentat gyru||escap box||behaviour||maze||day||distanc||open field test||paramet||separ||estim||hippocampu||total distanc||mice||neuron||total number||pnd||experiment group||arm||group||open field||number||barn maze||trial||signific differ||box,0.07||0.07 section||maze||femal||anim||barn maze||ellenbroek||maze test||hippocampu||stereolog||0.05||femal pup||radial maze||neurogenesi||barn maze test,128.293||67.801||55.599||40.017||37.41||36.367||32.223||31.608||31.58||29.677||29.284||28.4||27.799||26.851||26.784,0.4,0.6,0.4
37,Appl_Psychophysiol_Biofeedback-4-1-2259255.txt,condit||find||eeg abnorm||delta activ||behavior||eeg biofeedback||depend||problem||data||alpha absolut power||studi||patient||clinic outcom||alpha||state||chronic||function brain activ||cortic area||effect||sud||quantit eeg||frequenc||section||femal||beta||scale||increas||criteria||amplitud||slow-beta coher||abstin||low-voltag background activ||qeeg alter||disord||frontal||evid||mix substanc abus||classif||treatment||therapi||eeg coher||cocain||qeeg techniqu||control||acut||cognit||power||stimul||approach||alcohol||alpha-theta biofeedback||research||biofeedback||result||function connect||theta||qeeg||subject||neurotherapi||neurofeedback||genet factor||activ||heroin user||theta band||eeg characterist||heroin addict||report||group||clinic research||abus||drug||kulkoski||alpha-theta train||mental rehears||erp||alpha activ||techniqu,eeg||eeg biofeedback||alcohol eeg||alcohol eeg journal||biofeedback||eeg alpha||L. eeg biofeedback||A. eeg||M. eeg||eeg biofeedback treatment||G. eeg||H. eeg biofeedback||T. eeg biofeedback||disord eeg||addict,301.047||244.499||234.104||189.459||187.951||182.314||181.302||180.152||178.677||176.333||173.741||172.618||172.318||171.636||170.653,0.4,0.2,0.13333333333333333
38,Diabetologia-3-1-1794135.txt,type 2 diabet||quantit trait||diabet||variant||data||studi||bmi||effect||risk||insulin sensit||receptor||sir cohort||genotyp||evid||adiponectin gene||associ studi||gene||cohort||control||result||analysi||polymorph||popul||associ||report||snp||UK popul||insulin resist||haplotyp||sequenc||adiponectin receptor,adipor1||adipor1 adipor2||adipor2||1 adipor1 adipor2 adipor1 adipor2||adipor1 adipor2 variant||method adipor1 adipor2||result adipor1 adipor2||interpret adipor1 adipor2||13 adipor1 adipor2||adipor1 rs6666089||tabl 1 adipor1 adipor2||tabl 3 adipor1 adipor2||adiponectin||snp||adipor2 adipor2 14 15 13,132.118||125.941||119.764||100.83||86.149||83.961||83.961||83.961||83.961||67.593||63.067||62.971||59.833||49.403||47.906,0.0,0.0,0.06666666666666667
39,J_Med_Internet_Res-7-5-1550689.txt,document||filter||time||system||data||technic perform||inform||total search time||meta-search filter||user||sourc||evid||meta-search engin||wrapper||approach||parallel process||evidence-bas medicin||pubm||small peak||paper||onlin evid retriev method||clinician||standard||unifi respons languag||capabl||search||intern compon||number||diseas||profil||design||search profil||result,search||sourc||sourc queri||queri||search time||search capabl||data sourc||search speed||1662 search||parallel search||1614 search||individu sourc||uql queri||search profil||feder search,86.267||84.888||75.42||65.951||51.664||49.065||48.075||47.358||47.32||46.624||46.54||46.535||46.311||46.068||45.764,0.4,0.2,0.2
40,Eur_Radiol-2-2-1705542.txt,unclear shoulder pain||imag||arthrographi||superior||complex||coron obliqu||lesion||ighl||secondari imping||tear||shoulder disloc||common form||diagnost work-up||magnet reson||labro-ligament complex||acut||labrum||anterior instabl||bankart||diagnost arthroscopi||bicep||injuri||pain athlet shoulder||athlet||normal anatomi||therapeut decis,shoulder||shoulder disloc shoulder||arthrographi||glenohumer instabl||anterior shoulder instabl||shoulder disloc||shoulder ajr||multidirect shoulder instabl||glenoid||anterior glenohumer instabl||shoulder patholog||shoulder joint||shoulder Br||keyword shoulder||domin shoulder,102.288||74.523||74.363||69.667||64.82||60.641||59.201||59.038||54.782||54.302||53.938||52.611||51.825||51.144||51.144,0.2,0.2,0.13333333333333333
41,Knee_Surg_Sports_Traumatol_Arthrosc-4-1-2413120.txt,type||arthroscop view||time||time-disturb analysi||exact sig||disturb||qualiti||turbid||studi||comparison||knee joint||effect||view||arthroscop pump system||straightforward arthroscop knee surgeri||oper||frame||percentag||analysi||group||differ||presenc||arthroscopi||number||loos fibrou tissu||signific differ||result,autom pump||graviti pump||pump system||pump perform||shaver||pump group||arthroscop pump system||graviti pump cyst||fluid pump system||disturb||fm 4 pump||shaver durat||oper||disturb turbid||arthroscop knee oper,41.667||35.476||33.122||32.627||31.74||31.602||30.123||24.112||23.143||22.612||21.739||21.552||21.368||21.141||20.888,0.0,0.2,0.2
42,Purinergic_Signal-4-1-2246000.txt,atp||microglia||propag||microgli cell||wave||work||lane||receptor||astrocyt||releas||site||calcium wave||transmiss||model||diffus substanc||valu||initi||cell||densiti||calcium,mbox||document||mu||documentclass||12pt||amsmath||amsfont||mathrsf||69pt||end||microglia||2||2 2||μ||microglia brain,187.099||144.894||144.488||76.318||76.318||76.318||76.318||76.318||76.318||62.965||51.35||30.463||30.463||30.241||27.049,0.0,0.0,0.06666666666666667
43,Neurochem_Res-4-1-2295255.txt,level||nos-2||patient||control mice||region||astrocyt||infect||brain||day||gfap||glial cell||hippocampu||mice||olfactori bulb||capillari blood vessel||model mous||report||infect mous brain||influenza viru||viru||blood vessel||result,influenza||influenza viru||viru||influenza viru infect||nos-2||33 influenza viru||nw viru||neuroadapt influenza viru||avian influenza viru||influenza viru replic||neurovirul influenza||influenza enceph||viru infect||influenza epidem||human influenza,60.427||52.138||43.85||42.024||38.406||36.475||35.826||35.725||35.325||34.759||34.712||33.786||32.823||30.898||30.213,0.6,0.3,0.2
44,Cancer_Causes_Control-2-2-1705538.txt,posit associ||birth||histori||data||studi||menopaus statu||bmi||densiti||continu form||multivari model||risk||effect||mammogram||clinic assess form||cutpoint||famili histori||patient intak form||analys||breast cancer risk factor||breast cancer risk||breast densiti||pariti||menarch||nhmn record||women||posit effect||age||previou studi||factor||hormon replac therapi||influenc||mammograph breast densiti||interact||larg popul||breast||current visit,breast||breast densiti||breast cancer||breast cancer breast cancer||mammograph breast densiti||densiti||breast cancer risk||histori breast cancer||high breast densiti||breast densiti read||greater breast densiti||higher breast densiti||breast cancer 0.09||denser breast||refer refer refer refer refer,108.603||84.901||77.652||77.652||71.348||61.2||57.19||56.983||56.969||56.601||56.601||56.601||56.053||55.693||54.876,0.6,0.5,0.3333333333333333
45,J_Occup_Rehabil-3-1-2039785.txt,categori||low job satisfact||case||high effort||object instrument||measur||product loss||studi popul||pain intens||studi||dichotom variabl||musculoskelet symptom||select||mous usag||neck||worker||logist regress analys||sick leav||comput worker||presente||analys||psychosoci factor||product||pain||associ||product due||popul||subject||sick absenc||previou research||psychosoci load||respond||intens||factor||symptom||comput usag||descript statist||loss||mous posit||result,symptom||worker||product||product loss||loss||arm symptom product loss||shoulder symptom||arm symptom||hand symptom||comput worker||musculoskelet symptom||product loss associ||symptomat worker||self-report product loss||product loss 16,96.768||94.651||88.391||82.725||77.06||74.26||69.946||65.796||63.07||60.097||59.525||57.96||57.711||56.182||55.15,1.0,0.6,0.4666666666666667
46,Pediatr_Nephrol-4-1-2259256.txt,condit||time||infant||detrusor overact||lower extrem function||abnorm||intraves pressur||myelodysplasia||present||lower urinari tract||lower extrem||increas||spinal cord||lesion||pressur||newborn||bladder||urodynam studi||reflux||cerebr palsi||sphincter||urodynam||assess||dysfunct||renal function||low pressur||injuri||cic||cord||high||anticholinerg medic||sacral agenesi||incontin||complianc||children,bladder||spinal cord||neurogen bladder||spinal dysraph||urodynam||bladder dysfunct||cord||bauer||compliant bladder||spinal cord injuri||spinal cord malform||underact bladder||reflex bladder||bladder function||hyperact bladder,65.811||46.654||44.275||40.83||40.003||37.978||37.06||36.787||36.674||36.104||35.978||35.794||34.911||34.821||34.35,0.6,0.4,0.26666666666666666
47,Virchows_Arch-3-1-2039779.txt,method||ileal mucosa||studi||comparison||patient||lower number||cell kinet||apoptot index||section||affer loop||famili adenomat polyposi||adenoma||investig||increas||tissu section||pouch||cell prolifer||restor proctocolectomi||apoptot rate||cell||prolifer||tissu area||apoptosi||semiquantit||rang||photograph||biopsi||differ||number||fap||signific differ||crypt||index,pouch||ileal pouch||pouch mucosa||ileal||pouch adenoma||ileoan pouch||pelvic ileal pouch||pouch adenocarcinoma||pouch content||ileal prolifer||polyposi||ileal mucosa||ileal pouch anal anastomosi||crypt||ileal loop,140.158||113.048||93.565||85.938||83.909||78.932||75.365||73.56||70.079||67.694||67.278||66.455||60.979||56.232||54.481,0.2,0.1,0.2
48,Diabetologia-4-1-2270365.txt,effect||risk||gene||power||case-control data||loci||joint effect||trio||type 1 diabet||interact||diseas||data||genotyp||hla||supplementari materi||result,ptpn22||ptpn22 ctla4 ptpn22 ctla4||ctla4 ptpn22||ptpn22 ctla4||ptpn22 ptpn22 df ptpn22||ptpn22 ctla4 jo27||ptpn22 ctla4 gene||ptpn22 df||interact ptpn22||ptpn22 1858t||result ptpn22||conclus ptpn22||ptpn22 4 5 ptpn22 df||ctla4 ptpn22 5 8||1 ptpn22 arg620trp,110.31||92.239||92.239||92.239||87.022||67.537||65.046||63.735||59.968||56.666||55.171||55.155||47.556||46.12||43.236,0.0,0.0,0.0
49,Purinergic_Signal-4-2-2377325.txt,role||level||respons||releas||photoreceptor||adenosin||agonist||effect||space||transport||evid||signal||rpe||light-sensit signal||cell||stimuli||stimul||epinephrin||rpe cell||microenviron||membran||subretin space||rod||consist||ectoenzym activ||atp releas||glutam||cftr,pigment||retin pigment||retin pigment epithelium||subretin space||bovin retin pigment||human retin pigment||frog retin pigment epithelium||retin pigment epithelium 1998||chick retin pigment epithelium||subretin purin||rpe||bovin pigment epithelium||subretin microenviron||cultur human retin pigment||subretin inject,81.344||73.786||64.135||52.451||51.404||50.708||48.748||48.576||48.532||48.352||47.702||44.271||39.102||38.841||35.682,0.2,0.1,0.13333333333333333
50,Eur_Radiol-3-1-1914269.txt,percentu width||measur||heart phantom||method||cardiac cycl||tempor resolut||longitudin plane||CT imag||imag||studi||stent||attenu profil||imag qualiti||plane||increas||coronari stent||heart rate||lumen visibl||averag spearman coeffici||highest score||CT attenu||64-slice mdct||coronari arteri||averag decreas||movement||attenu||heart||stent lumen||result,stent||coronari stent||stent lumen||stent imag||coronari stent lumen||coronari arteri stent||stent increas||coronari stent restenosi||coronari stent patenc||drug-elut stent||cypher stent||provision stent||stent diamet||heart||plane,86.474||67.577||55.327||54.394||53.111||51.236||47.877||47.663||47.247||44.627||44.539||44.327||44.025||43.852||42.958,0.6,0.3,0.3333333333333333
51,J_Gastrointest_Surg-3-1-1852377.txt,poor outcom||hepatocellular carcinoma||studi||patient||recurr||liver transplant||signific||microvi||df||present studi||multivari analysi||analysi||microvascular invas||vascular invas||hcc||liver||factor||tumor||surviv||histolog grade||number||liver explant||stage||outcom,hepatocellular||hepatocellular carcinoma||liver||liver transplant||transplant||small hepatocellular carcinoma||hepatocellular carcinoma valid||LT||orthotop liver transplant||microvi||macrovi||liver transplant versu liver resect||liver explant||d'amico DF liver transplant||NL robert JP liver transplant,82.286||61.645||56.988||53.9||50.811||41.458||41.096||38.136||37.985||37.104||37.104||34.376||32.92||29.77||25.581,0.6,0.4,0.3333333333333333
52,Clin_Rheumatol-3-1-1820749.txt,mechan||chronic fatigu syndrom||physiolog mechan||cognit emot sensit||respons||central process||knowledg||pain complaint||studi||theoret background||patient||function brain activ||central nervou system||chronic widespread pain||sensit||investig||spinal cord||pain process||evid||similar||stimuli||brain abnorm||multipl spinal segment||tempor summat||cognit||electr stimul||chronic fatigu||catastroph thought||pain||musculoskelet pain||hyperalgesia||cf||central sensit||chronic pain||allodynia||wind-up||fibromyalgia||central mechan||inhibitori pathway||spatial summat||pathway||hypothesi||result,pain||chronic pain||chronic pain syndrom||musculoskelet pain||widespread pain||pain modul||chronic musculoskelet pain||pain hypervigil||pain complaint||pain patient||pain disabl||chronic widespread pain||non-specific’ pain||myofasci pain||pain pathway,190.289||139.207||111.322||103.691||101.286||98.571||98.502||98.036||98.019||97.957||97.414||96.899||96.59||96.241||96.194,0.6,0.4,0.3333333333333333
53,Environ_Manage-3-1-1914239.txt,legal entiti||skill||case||oper entiti||design oper entiti||cameroon||commun||project||capac||figur||cdm implement||studi||argument||develop||inform||carbon||sustain||project develop||impact||institut arrang||manag||resourc||cost||ngo||bimbia||rule||clean develop mechan project||commun forest||sustain develop||resourc tenur||clean develop mechan||environment impact||biodivers||cdm||reforest||materi||activ||implement||timber exploit||environment servic||impact assess||commun capac||emiss||tinto||requir||capac requir||forest||nation fund||current modal||commun manag||plan||addition||carbon sequestr,forest||commun forest||commun||tinto commun forest||commun forest manag||cdm||commun forestri||forest carbon||bimbia commun||forest manag||90 commun forest||200 commun forest||tinto commun||commun manag||cdm forestri,261.234||242.941||224.648||189.604||185.706||172.157||171.182||169.708||168.508||166.235||161.961||161.961||153.789||147.942||144.937,0.6,0.4,0.3333333333333333
54,Eur_J_Pediatr-3-1-1914268.txt,domain read||find||case||system||children||perinat asphyxia||ambigu result||problem||mild NE||studi||normal rang||young age||school||behavior problem||heterogen group||moder NE||difficulti||criteria||review||abil||behavior consequ||neonat encephalopathi||sever NE||brain||neuropsycholog function||mild||inclus criteria||sarnat||cognit||research||futur research||long-term follow-up||age||educ achiev||gener||group||school age||asphyxia||intellig||healthi peer||area||read||averag rang||addit||score||function||outcom||result,NE||moder NE||mild NE||mild NE moder NE sever NE||sever NE||attent NE||5 NE||control group NE||neonat encephalopathi||13 moder NE||10 moder NE||moder NE form||rang mild NE||vocabulari mild NE||8 mild NE,171.486||103.446||99.599||97.224||88.626||86.907||85.775||72.358||71.464||69.201||68.967||68.964||68.408||66.898||66.646,0.6,0.4,0.26666666666666666
55,Sci_Eng_Ethics-4-1-2413106.txt,futur||fuel||time||main object||justic||line||cfc||fuel cycl||valu||reactor||risk||recycl||period||plutonium||nuclear reactor||ofc||trade-off||addit risk||moral discuss||sustain||countri||short-term||energi||long-term benefit||intergener justic||nea||iaea||prolifer||open||long-term radiolog risk||world||futur gener||product||secur concern||analysi||framework||materi||reprocess||present gener||reason||gener||option||order||wast||natur uranium||public||uranium||radiotox||benefit||nuclear wast||plant||safeti,fuel||wast||nuclear wast||nuclear fuel cycl||fuel cycl||spent nuclear fuel||justic||spent fuel||nuclear energi||reprocess wast||intergener justic||fuel leak||cfc||advanc nuclear fuel cycl||radioact wast,161.202||116.388||111.627||105.865||105.365||97.942||95.284||93.48||88.603||87.149||80.842||80.601||79.492||79.399||75.996,0.8,0.5,0.4666666666666667
56,Evid_Based_Complement_Alternat_Med-4-4-2176145.txt,type||program||health benefit||week||diabet||hypertens||glucos level||studi||session||cholesterol||yoga||overweight||effect||high cholesterol||review||intervent||adult||day||health condit||glucos||chronic diseas||subject||weight||bodi weight||cardiovascular diseas||benefit||systol BP||articl,yoga||yoga program||yoga train||hatha yoga||yoga asana||yoga intervent||yoga lifestyl||yoga postur||yoga session||yoga exercis||yoga review||yoga practic||yoga reduc||yoga sequenc||4-week yoga program,208.208||111.069||110.427||110.404||110.404||108.043||106.983||106.955||106.158||105.962||105.548||105.287||105.225||104.606||74.725,0.2,0.1,0.06666666666666667
57,Ann_Surg_Oncol-4-1-2277451.txt,cancer||adjuv therapi||surgic volum||hospit||volum||surgeon||studi||centr||servic||literatur||poor qualiti||patient||oper||manag||institut||outcom,volum||outcom||volum outcom relationship||hospit volum||surgic volum||cancer outcom||unit volum||procedur volum||keyword cancer volum outcom||surgeon procedur volum||volum low volum ref||outcom relationship||current volum||surgeon||surviv outcom,42.171||32.314||28.226||25.503||24.238||23.75||23.398||22.774||22.418||21.864||21.783||21.254||21.085||20.044||18.506,0.6,0.3,0.26666666666666666
58,Pharm_World_Sci-3-1-2082655.txt,chronic ill experi||find||meta-synthesi||in-depth interview||individu||studi||patient||encount||effect||process||medic||health care practition||theme||interview transcript||medic experi||natur||control||understand||pharmaceut care||research||chronic condit||bodi||practic concept||pharmaceut care practic||practition||sens||ill||particip,medic||medic experi||medic theme||medic practic||chronic medic||patients’ medic experi||neurolept medic||medic condit||experi||patient ’s medic experi||medic experi shoemak sarah||patients’ medic practic||medic ’s benefit||bodili effect medic||jone A. medic,101.056||74.629||61.174||56.403||54.974||52.844||51.456||50.528||48.203||42.123||41.79||40.693||39.272||37.982||33.685,0.4,0.2,0.13333333333333333
59,Bioinformation-1-4-1891668.txt,record||number||diabet||medicin plant||databas||diseas||data||diamedbas||plant,plant||diamedbas||medicin plant||plant part||util diamedbas||plant research||plant speci||specif plant||databas||diabet||bioinform bioinform bioinform||diamedbas alo vera figur 1||medicin valu||diabet literatur databas||valuabl medicin properti,26.622||26.556||20.527||15.558||14.546||13.768||13.311||13.311||10.953||9.302||9.29||8.91||7.786||7.531||6.583,0.6,0.5,0.3333333333333333
60,Biogerontology-3-1-2040177.txt,measur||major gene||individu||rate||sampl||chuvashia||herit||oss measur||effect||correl||biolog age||investig||residu varianc||sex||signific||parsimoni model||segreg analysi||present studi||BA index||livshit||age adjust||gene||women||age||analysi||popul||MG genotyp||genet factor||group||famili||skelet||oss||index||biomark,age||oss||biolog age||age 45 oss||menopaus age||human age||chronolog age||age predict||age adjust||age group||function age||age 45||age rang||age 50||age cohort,73.058||54.013||46.733||42.357||41.49||39.759||38.14||37.379||37.229||37.219||36.539||36.529||36.529||36.529||36.529,0.6,0.4,0.26666666666666666
61,Behav_Genet-3-1-1914288.txt,measur invari||parent rate||boy||sex differ||behavior||adhd index||conner teacher rate scale||data||model||equal||correl||scale||teacher rate||MI criteria||sex||environment influenc||factor structur||item||preval differ||girl||varianc||estim||twin||odd||analysi||parent||genet||teacher||factor||differ||influenc||adhd||children,teacher||girl||boy||conner teacher||teacher rate||AE girl||teacher data||teacher report||adhd||ace||twin||conner teacher rate scale||AE||differ||genet,102.568||80.456||73.999||63.999||61.068||59.039||51.787||51.284||43.488||42.646||40.906||37.98||37.623||35.211||35.069,0.8,0.5,0.6
62,Eur_J_Nucl_Med_Mol_Imaging-4-1-2275773.txt,normal tissu||tumour-specif apoptot respons||respons||protocol||radiat||roi||imag||baselin||studi||patient||earli apoptosi||effect||abil||dose||hnscc||tumour||apoptosi||lymph node||spect||primari tumour||parotid gland||differ||radiat dose||treatment-induc annexin uptak||salivari gland function||scintigraphi||submandibular gland||convent gamma camera||annexin,annexin||gland||annexin uptak||parotid gland annexin uptak||parotid gland||tav||oropharynx||tumour||imrt||radiotherapi annexin||uptak||parotid||treatment-induc annexin uptak||submandibular gland||technetium-99m-hyn annexin,40.489||35.214||31.942||30.554||29.165||27.638||26.071||25.805||24.566||23.631||23.395||23.117||22.712||22.588||21.629,0.4,0.3,0.3333333333333333
63,Naunyn_Schmiedebergs_Arch_Pharmacol-3-1-1915601.txt,mechan||antibodi||sphingosine-1-phosph receptor||membran||luminesc signal||time||fluoresc||BM chemiluminesc blot substrat||hisg-tag||protein||non-radioact method||receptor||fluoresc microscop||internalis||signal||detect method||cell||detect||cell membran||result,receptor||receptor internalis||internalis||adrenerg receptor||1 receptor||sphingosine-1-phosph receptor||receptor ligand||protein-coupl receptor||antibodi||specif receptor antibodi||n-termin hisg-tag receptor||alexafluor||endogen receptor||model receptor||receptor kinas,32.06||29.386||26.711||21.71||20.102||18.783||18.139||17.649||17.115||16.7||16.621||16.263||16.03||16.03||16.03,0.4,0.4,0.26666666666666666
64,Environ_Health_Perspect-114-2-1367850.txt,measur||method||neurolog examin||data||studi||specif aspect||year||seychel island||question||psycholog test||prenat exposur||develop||development effect||effect||inform||review||investig||mehg||consensu||test||development outcom||methylmercuri||mehg exposur||outcom||cognit process||exposur assess||neurobehavior test||research||futur research||assess||age||faro island||associ||subject||literatur||matern hair||report||import||exposur||field||current uncertainti||prenat mehg exposur||development rate scale||systemat review||outcom measur||children||result,methylmercuri||methylmercuri exposur||grandjean||exposur||prenat methylmercuri exposur||al||fetal methylmercuri exposur||1983 methylmercuri exposur||postnat methylmercuri exposur||mehg exposur||prenat exposur||methylmercuri environ||methylmercuri studi||weih||2003 prenat methylmercuri exposur,109.37||94.441||79.875||79.513||78.327||74.69||64.588||63.914||63.72||63.107||62.806||62.642||60.717||60.469||58.875,0.4,0.3,0.26666666666666666
65,Eur_Child_Adolesc_Psychiatry-2-2-1705530.txt,depress symptom||mother||birth||pre-nat smoke||studi||depress||effect||risk||famili risk||child||lbw||variabl||birth-weight||unit increas||analys||coeffici||genet risk||twin||age||social class||associ||standard||weight||birth weight||factor||regress analysi||parent report||gestat||report||influenc||symptom||interact||depress disord||children||result,depress||birth-weight||psyc 157:190||psyc 163:369||psyc 152:833||psyc 155:172||psyc 160:625||psyc 184:446||psyc 179:230||psyc 156:133||psyc 179:116||psyc 179:450||psyc 175:380||psyc 178||adolesc depress,111.96||108.465||77.673||77.673||77.673||77.673||77.673||77.673||77.673||77.673||77.673||77.673||77.673||77.05||72.825,0.4,0.2,0.13333333333333333
66,Appl_Microbiol_Biotechnol-4-1-2266784.txt,jar fermentor||heterolog protein||cultur||signal peptid||product||secret||amino acid||kikuchi||industri product||industri scale protein product,corynebacterium glutamicum||C. glutamicum corynebacterium||C. glutamicum C.||corynebacterium||2005 corynebacterium glutamicum corynebacterium||C. ammoniagen C.||C. glutamicum 2003||2 C. glutamicum C.||C. ammoniagen C. ammoniagen atcc6872||C. ammoniagen atcc6872||12 13 C. glutamicum||8 9 C. glutamicum||10 11 C. glutamicum||18 C. ammoniagen||2008 streptomyc mobaraensi corynebacterium glutamicum brevibacterium,127.999||114.186||108.829||102.629||89.657||87.426||83.178||82.007||75.085||66.568||60.384||60.19||59.982||58.573||54.657,0.0,0.0,0.0
67,Fam_Cancer-4-1-2253650.txt,risk||potenti role||cancer||gene||syndrom||case||women||dgc||mutat carrier||studi||prophylact gastrectomi||lbc||lobular carcinoma||lobular breast cancer||loss||mutat||breast||predict genet test||famili,cdh1||cdh1 mutat||cancer||2007 cdh1 cdh1 mutat||cdh1 cdh1 mutat test||cdh1 gene||cdh1 promot||germlin cdh1 mutat||gastric cancer||breast cancer||e-cadherin||recurr cdh1 mutat||method cdh1 mutat||famili breast cancer breast cancer||cdh1 9 cdh1 42 43,199.045||133.114||121.837||116.517||116.318||103.334||100.426||99.757||93.459||92.329||90.371||89.15||88.745||80.235||79.838,0.2,0.1,0.06666666666666667
68,Diabetologia-3-1-2100429.txt,type 2 diabet||mother||pregnanc||studi||offspr||matern nutrit variabl||newborn||adipos||bodi composit||women||thci||matern nutrit||indian||fat mass||size||folat||risk factor||insulin resist||nutrit measur||mma||children,12||12 12||folat||12 12 concentr||matern folat||12 12 12 12 30 1||nutrit||folat statu 12 12 1 12||insulin||pune||india||insulin resist||erythrocyt folat||matern nutrit||yajnik CS,45.815||45.815||39.447||31.999||30.642||30.588||30.51||30.184||29.605||28.271||26.269||26.227||26.224||26.174||25.935,0.2,0.1,0.2
69,Cancer_Immunol_Immunother-3-1-2082063.txt,antigen process machineri||independ predictor||prognost paramet||apm defect||case||patient||stromal cell||express||erap||df||tumour||human carcinoma||tap||erap1||intern posit control||signific associ||independ prognost paramet||defect express||apm compon||surviv||apm||normal express||cervic cancer||cervic carcinoma||cervic carcinoma patient||loss||clinicopatholog paramet||down-regul||score||compon,class||hla class||erap1||antigen class||erap1 loss||loss||partial hla class||antigen||mhc class||alter hla class||microglobulin hla class||3 hla class||ferron||erap1 down-regul||hla express,53.125||47.247||44.059||43.97||42.87||41.681||37.192||34.815||33.321||33.079||33.064||31.537||31.456||31.007||29.873,0.2,0.2,0.13333333333333333
70,Apoptosis-4-1-2423419.txt,cancer||studi||icad||express level||region||promot||site||express||cell||myc||gene||dna fragment||function import||transcript||apoptosi||activ||human cancer||transcript regul||report||dff||ectop express||icad protein||construct||myc-bind site||result,icad||icad icad||2008 icad icad icad||icad myc icad||icad 5 icad||icad gene icad icad ecor||c-myc icad||myc icad 3 icad icad promot||icad promot||icad gene||icad express||icad protein||icad 39 icad gene regul||n-myc icad promot||icad promot activ,267.428||267.428||200.887||192.232||178.285||162.815||151.914||143.533||142.249||138.418||137.532||134.13||109.991||105.8||96.799,0.2,0.1,0.13333333333333333
71,Neuroradiology-4-1-2275774.txt,follow-up||imag||patient||stent||volum||contrast medium||intracrani stent||rotat acquisit||examin||volum dataset||invas techniqu||intraven administr||brain parenchyma||act||CT angiogram||cta||ica||vessel||cerebrovascular diseas||inject||stent lumen,stent||intracrani stent||stent lumen||nitinol stent||elect stent||coronari stent||stent placement||intracrani stent buhk jan-hendrik||intracrani angioplasti||iv-act||intracrani vessel||intracrani arteri||intracrani aneurysm||tomographi flat-panel cerebrovascular diseas intracrani stent||coronari arteri stent,40.68||34.761||23.947||22.066||21.141||21.038||20.988||19.97||18.072||17.266||16.917||15.778||15.594||15.446||14.931,0.6,0.3,0.2
72,Brain_Struct_Funct-4-1-2248604.txt,condit||function imag||respons||lexic statu||block||gyru||sensori compon||middl posit||roi||posit differenti bold||oddbal block||word deviant||motion||effect||oddbal||speech||posterior auditori cortex||test||sensori mechan||deh||stimuli||day||control||map||bonferroni||result||standard||subject||acoust factor||primari auditori cortex||activ||cognit mechan||anterior||speech stimulu interact||deviant||contrast||middl||standard-devi pair||sound||outlier,deviant||deviant map||non-word deviant||deh||deviant stimuli||deviant stimulu||deviant map deviant control map||word deviant||deviant word||deviant exemplar||deviant control||deviant respons||map||success deviant||physic deviant,129.241||97.08||92.422||91.759||87.436||84.294||79.84||78.845||78.845||71.998||70.061||65.406||64.919||64.62||64.62,0.4,0.3,0.26666666666666666
73,Arch_Orthop_Trauma_Surg-4-1-2228384.txt,delay||signific pain reduct||studi||patient||durat||effect||adant||viscosupplement||infiltr||hh||hyaluronan||non-op treatment||treatment||hyaluron acid||product||hip||pain||prepar||hip osteoarthr||group||differ||signific differ||inject||tha||statist signific differ,hip||viscosupplement hip||hip osteoarthr||hip infiltr||viscosupplement||hyaluron||osteoarthr||hip pain||symptomat hip osteoarthr||hip joint||hip OA||hip arthroplasti||intra-articular hyaluron||hip patient||hip dysplasia,61.325||51.858||49.109||45.943||42.39||39.742||36.892||36.623||34.083||33.643||33.44||32.925||32.688||32.232||31.29,0.6,0.3,0.2
74,Ann_Surg_Oncol-4-1-2234450.txt,superfici lymphat||system||first-tier lymph node||radiograph||intern thorac arteri||sentinel node biopsi||femal||anatom analysi||node||lymph vessel||cross-sect studi||dye||axilla||peritumor inject||thin adult cadav||tissu||neg sentinel node studi||lymph node||previou studi||anterior upper torso||subareolar inject||intern mammari lymphat||sentinel node||lymphat||specimen||germani||cadav||vessel||subareolar plexu||inject||sappey||branch||pathway||breast||sentinel lymph node biopsi||result,lymphat||breast lymphat||node||sentinel node||lymphat anatomi||lymphat vessel||lymph node||sentinel lymph node||sentinel||sentinel lymph||lymph||superfici lymphat||lymphat collector||lymphat drainag||lymphat territori,120.696||89.052||80.202||78.011||76.893||76.793||76.718||76.418||75.82||74.527||73.234||68.646||67.603||65.034||63.067,0.6,0.4,0.3333333333333333
75,Antonie_Van_Leeuwenhoek-3-1-2140094.txt,conidiophor||uniqu||extrolit||ascospor||diam||aerial hypha||cultur||cya||coloni||mea||speci||promin equatori furrow,N.||neosartorya||aspergillu||fumigati N.||neosartorya aspergillu N. indohii N.||N. denticulata||N. assulata||N. galapagensi||diam||N. sublevispora N. takakii N. tsuruta||aspergillu fumigatu||vel||soil||netherland N. pseudofischeri||aspergillu panamensi,102.209||79.328||78.879||78.56||73.745||64.83||64.83||64.83||53.632||53.566||50.358||49.231||47.633||45.7||45.539,0.0,0.1,0.06666666666666667
76,Dig_Dis_Sci-3-1-1914222.txt,bmp||morpholog||level||high-dos dox treatment||epitheli homeostasi||mucos||epitheli||increas||express||villi||dose||differenti||treatment||cell||damag||day||control||sever villu atrophi||prolifer||mice||medium dose||protein||group||decreas||dox||tcf4||length||pathway||crypt||stem cell||wnt pathway||mtx,dox||intestin||crypt||intestin damag||intestin mucos||bmp4||intestin crypt cell||murin intestin crypt||intestin cell||dox treatment||intestin mucosa||bmp4 express||tcf4||intestin lactas||intestin morpholog damag,58.382||56.202||42.849||39.255||36.765||36.287||35.314||33.017||31.547||31.445||30.716||29.951||29.847||29.593||29.466,0.4,0.2,0.2
77,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2367393.txt,posterior capsul||vitreou entrap||case||flare||optic edg||year||natur barrier effect||len epitheli cell||hyaloid||routin procedur||posterior capsul opacif||retin detach||anterior vitrectomi||optic buttonhol||eye||lec||primari posterior capsulorhexi||edg||potenti||intraocular lens||techniqu||after-cataract||pobh||surgeri||ppccc||central posterior capsul||peripher retina||iol||anterior||standard in-the-bag implant||capsular diaphragm||toric iol||optic centrat||after-cataract prevent||ovd||optic rim||optic||regeneratori lec prolifer||fibrosi||barrier,optic||iol optic||capsul||posterior capsul||iol||optic buttonhol||posterior optic buttonhol||posterior||optic edg||optic rim||optic centrat||6-mm iol optic||posterior optic surfac||optic buttoning-in||anterior capsul,179.24||145.549||124.377||114.726||111.858||111.124||109.108||105.076||102.174||101.176||98.22||97.707||96.81||96.787||95.55,0.6,0.6,0.4666666666666667
78,Qual_Life_Res-3-1-1915604.txt,dutch huntington associ||consequ||qualiti||studi||patient||life||amount||durat||ill percept||percept||scale||qol||mental health||spous||analys||huntington||coupl||treatment||control||higher score||total motor score||research||gener health||futur research||social function||subscal||long durat||ill||belief||symptom||patient qol||partner||diseas||vital||result,ill||ill percept||percept||patients’ ill percept||patients’ ill||partners’ ill||ill psycholog||spousal ill percept||ill percept questionnair||ill percept 1||ill percept dimens||partners’ ill percept kaptein||partner||perceiv ill||partners’ percept,112.549||96.754||80.959||78.651||77.496||76.169||73.858||70.985||65.834||64.503||64.503||61.357||60.487||60.442||60.374,0.6,0.3,0.26666666666666666
79,J_Abnorm_Child_Psychol-4-1-2277450.txt,cost diari||anxiou children||anxieti disord||method||inform care||children||preval||data||sever score||studi||year||annual societ cost-of-il||discrimin valid||school||physic problem||converg valid||mental health treatment||anxieti||disord||aim||treatment||childhood anxieti disord||resourc||cost||percentag||parent||psycholog problem||care||gener practition||clinic anxieti disord||reason||famili||group||differ||work||top-down data||cost-of-il||mental disord||diari||gener popul||result,cost||87.21 0.00||cost diari||bottom-up cost||famili cost||societ cost||total cost||out-of-pocket cost||annual cost||prospect cost||indirect cost||cost dairi||anxiety-rel cost||3-week cost||health-car cost,277.398||182.425||167.821||165.857||155.996||149.314||147.462||145.737||143.393||141.494||140.676||140.076||139.806||139.806||139.403,0.4,0.2,0.13333333333333333
80,Mol_Neurobiol-3-1-2039847.txt,AD brain||level||system||AD lesion||protein aggreg||data||apolipoprotein||strategi||hsp||aggreg||human||microgli cell||chaperon||amateur chaperon||profession chaperon||profession||transport||cell||brain||heat shock protein||tpa||gag||heparan sulfat proteoglycan||mice||protein||format||apo||hyperphosphoryl tau||activ||accumul||bind||shsp||earli develop||clearanc||toxic||neurodegen diseas||amyloid||addit||tau||amyloid beta-protein||vivo||result,alzheim||Aβ||alzheim amyloid||Aβ apolipoprotein||alzheim ’s||apolipoprotein||alzheim diseas||amyloid||Aβ aggreg||Aβ fibril||alzheim beta-protein||Aβ clearanc||alzheim ’s diseas||alzheim diseas brain||Aβ serum amyloid,173.591||162.184||135.76||135.557||111.865||108.931||107.615||97.93||96.012||95.678||94.451||92.024||88.457||87.835||87.094,0.0,0.2,0.13333333333333333
81,Purinergic_Signal-2-2-2254478.txt,ntpdase||nervou tissu||platelet||cd39||immunolog||ecto-atpas||vasculatur||ectonucleotidas||liver||apyras,diphosphohydrolas||cd39||triphosph diphosphohydrolas||ecto-atpas||atp diphosphohydrolas||nucleosid triphosph diphosphohydrolas||ecto-nucleosid triphosph diphosphohydrolas||ecto-atpas ntpdase2||sévigni||ecto-nucleotidas cd39||ecto-nucleosid triphosph diphosphohydrolas ntpdase2||ectonucleotidas||ectonucleosid triphosph diphosphohydrolas||triphosph diphosphohydrolas 1||nucleosid,96.729||83.998||81.052||80.831||72.653||71.819||63.139||63.094||60.106||59.609||58.694||58.559||57.064||54.034||53.353,0.4,0.2,0.2
82,Naunyn_Schmiedebergs_Arch_Pharmacol-4-1-2323035.txt,peptid YY||dpp-iv||cd26||diabet||dipeptidyl peptidas IV||glucagon-lik peptide-1,pyy3||36||dpp-iv||dipeptidyl peptidas IV||peripher pyy3||competit dipeptidyl||chronic pyy3||proteas dipeptidyl peptidas IV||peptidas IV||dpp-iv inhibitor||dipeptidyl peptidase-4 inhibitor||keyword dipeptidyl peptidas IV glucagon-lik||cd26||dpp-iv inhibit||36 inject,39.732||30.532||29.796||25.597||21.371||19.877||19.866||19.482||19.087||18.765||18.761||18.136||17.938||16.71||16.507,0.4,0.2,0.2
83,J_Mol_Biol-1-5-1885970.txt,crystal||activ form||catalyt zinc||linker region||matrix metalloproteinas||contact||water molecul||catalyt domain||structur||form||pro-peptid domain||extracellular matrix||domain||region||asymmetr unit||activ enzym||triple-hel collagen||collagen||enzym||residu||hemopexin-lik domain||activ||peptid hydrolysi||hydrogen bond||crystal structur||activ site mutant||interact||water proton,mmp-1||mmp-1 structur||mmp-1 residu||activ mmp-1||mmp-1 interact||human mmp-1||porcin mmp-1||collagenas||metalloproteinas||activ human mmp-1||structur||monom||matrix metalloproteinas||Å||procollagenase-1 structur,78.599||54.992||46.137||44.971||42.758||41.641||40.32||32.897||32.05||31.542||31.386||30.33||28.316||27.87||24.758,0.0,0.0,0.13333333333333333
84,J_Med_Internet_Res-1-1-1761705.txt,grade||author||measur||method||system||internet user||sampl||qualiti||studi||correl||inform||articl||webometr||daili visit||content||updat||inbound link||journal||resourc||websit||evalu||medic websit||averag||citat||internet||rate system||medic matrix||citat analysi||visit||sens||number||world wide web||impact factor||qualiti indic||work||link||index||media||result,websit||link websit||websit evalu||websit editor||medic websit||websit author||pediatr websit||authorit websit||25 websit||valuabl websit||websit characterist||extern websit||institut websit||137 websit||websit visit counter,125.671||76.89||75.072||73.358||71.424||67.235||65.893||65.844||63.989||63.809||63.728||63.458||62.835||62.835||58.834,0.4,0.2,0.13333333333333333
85,Diabetologia-3-1-1975734.txt,anim||lentivir deliveri||long-term transgen express||diabet||diabet mice||studi||gene therapi||lentivir vector||vitro||type 1 diabet||partial hepatectomi||deliveri||normal pancrea||insulin||express||cell||rat||gene||transduct effici||beta cell transcript factor||physiolog glucos control||intraven glucos toler test||ffo||liver||group||hepatocyt||pancreat beta cell||ins-fur||procedur||insulin storag||transduct||vivo,insulin||lentivir transduct||lentivir vector||liver||insulin gene||pdx1||hmd||transduct||ins-fur transduct||ins-fur||furin-cleav insulin||human insulin||vector neurod1||lentivir deliveri||lentivir ipf1 vector,53.992||42.597||42.449||40.894||40.579||40.111||36.161||34.274||33.711||33.147||31.515||29.902||29.737||29.161||29.022,0.6,0.5,0.4
86,Histochem_Cell_Biol-4-1-2323033.txt,mechan||cancer cell||cancer||alpha-hel bundl||form||syncytin||receptor||express||macrophag||placenta||cell||gene||membran microdomain||fusion||host cell||protein||regul||bind||fusogen||tumor||import||mous||cell fusion||molecul||membran,fusion||cell fusion fusion||cell fusion||trophoblast fusion||cancer cell fusion||macrophag fusion||spontan fusion||myoblast fusion||host cell fusion||fusion protein||vitro fusion||cancer-endotheli cell fusion||cell fusion machineri||muscl cell fusion||endotheli cell fusion,123.559||103.266||93.12||71.032||66.67||66.567||65.464||64.993||64.842||64.726||63.527||63.054||62.87||62.843||62.702,0.4,0.2,0.13333333333333333
87,J_Occup_Rehabil-3-1-1915618.txt,measur||capac||fce||pain intens||sampl||studi||patient||function capac||tampa scale||fear avoid belief questionnair||chronic low back pain||test||tsk||high intens perform level||variabl||analys||dynam||high intens lift||weak||rehabilit||relationship||effort||pain||regress equat||activ||intens||clbp||univers medic center groningen||avoid behavior||fabq||perform||fear||lift||hand||result,pain||back pain||pain disabl||chronic pain||pain variabl||pain intens||patient pain||musculoskelet pain||pain manag||pain β||pain symptom||pain expect||chronic pain behavior||chronic musculoskelet pain||pain relat fear relat,113.611||70.794||67.578||64.553||63.805||61.927||57.999||57.808||57.679||56.805||56.805||56.805||45.525||43.704||42.583,0.2,0.2,0.13333333333333333
88,Bioinformation-1-10-1896055.txt,transcriptom||integr analysi||embryo||organ system||sampl||seri||microarray data||probe||express profil||dataset||biolog replic||file||gene||compar bioinformat analysi||annot||analysi||refer collect||mous||number||express data||birth defect||mous embryo,metachip||ciaeasi||metasampl metachip ciaeasi ciaeasi||0.001||metasampl metachip ciaeasi http://systemsanalysis.louisville.edu||432a-u74a metachip||figur 1 metasampl metachip ciaeasi||18 ciaeasi||10 ciaeasi||moe430av2||mg-u74av2||0.001 21||0.001 22||0.001 12||20 metasampl metachip tool,49.101||45.826||42.552||41.043||32.731||26.186||26.18||24.03||23.835||22.908||22.908||21.262||21.037||21.028||20.698,0.0,0.0,0.0
89,Histochem_Cell_Biol-3-1-2137945.txt,mechan||target||retent||method||nuclear architectur||cajal bodi||distinct structur element||releas||rna motion||bind site||motion||transcript factor||chromatin||nucleu||intranuclear traffick||site||fundament question||key||dynam natur||sequestr||dynam||cell||nuclear bodi||gene||transcript||protein||bodi||nucleolu||rapid||nuclear compart||diffus||nuclear environ||interact||nuclear motion||molecul||dynam properti||rna,rna||rna dynam||dynam||nuclear protein||protein dynam||dynam protein||nuclear motion||nuclear compart||nuclear bodi||nuclear target||nucleu||nuclear speckl||nuclear bodi protein||nuclear architectur||dynam traffick,42.233||41.703||41.174||39.591||34.229||34.229||31.374||30.925||30.892||30.489||30.348||29.776||29.689||29.395||29.061,0.4,0.5,0.4666666666666667
90,J_Gastrointest_Surg-3-1-1852389.txt,superior mesenter arteri||follow-up||left renal vein||smv||interposit graft||patient||involv||renal vein||pancreat cancer||creatinin level||superior mesenter vein||venou resect||left gonad||periop morbid||oper||superior border||portal vein||graft||pancreaticoduodenectomi||renal function||primari end-to-end anastomosi||eu||vein||resect||length||addit choic||reconstruct,vein||renal vein||renal vein graft||portal vein||graft||splenic vein||autolog vein||vein involv||femor vein||adren vein||left renal vein graft||autolog vein interposit graft||left renal vein||portal vein reconstruct||portal vein resect,115.109||71.961||69.013||68.935||63.118||63.074||62.653||59.963||58.491||58.26||57.936||57.578||56.209||56.026||53.237,0.8,0.4,0.3333333333333333
91,Med_Biol_Eng_Comput-4-1-2329731.txt,cross-correl||case||deform||matrix remodel||method||imag analysi||time||compact||imag||studi||local deform||standard deviat||matrix element||singl smooth muscl cell||specif cell||consecut imag||tool||cell||analysi||experi||algorithm||pixel||collagen deform||direct CC||coat||decomposit CC||nois||stage||techniqu,matrix||matrix remodel||matrix compact||collagen matrix deform||local collagen matrix||cross-correl||local collagen matrix remodel||matrix reorgan||collagen matrix exp cell||decomposit CC||collagen deform||local matrix remodel||remodel||cell||matrix tissu,39.008||30.413||28.14||27.624||25.993||25.731||24.949||24.617||24.27||22.249||21.932||21.836||21.818||21.803||21.487,0.2,0.3,0.3333333333333333
92,Lipids-3-1-2039812.txt,ara||fatti acid composit||inflamm||fatti acid incorpor||concentr||data||patient||effect||section||human||proport||intervent||express||temperatur||cell||isotype-match control antibodi||protein||cytokin||fatti acid||activ||intestin inflamm||epa||fish oil||caco-2 cell||ibd||medium||vivo||result,ara||fatti acid||caco-2||epa||fatti acid OA||acid||n-3 fatti acid||icam-1||polyunsatur fatti acid||OA||ara versu epa||epa versu ara||fatti acid composit||total fatti acid||fatti acid incorpor,61.781||53.756||50.209||49.612||48.656||47.328||45.477||41.418||39.499||38.456||38.314||38.314||36.735||36.12||35.837,0.6,0.3,0.3333333333333333
93,Mycorrhiza-4-1-2245993.txt,aggreg||effect||plug||chamber||1-octen-3-ol||signific inhibit||bodi||collembola||collembolan||speci||signific effect||methyl cinnam||sawahata,tricholoma matsutak||collembolan||mushroom||collembola||sawahata||proisotoma minuta||tricholoma||1-octen-3-ol tricholoma||2007 tricholoma matsutak proisotoma minuta T.||1-octen-3-ol||collembolan speci||keyword collembola matsutak methyl||wild mushroom||agar mushroom||T. matsutak 1983 1991,52.966||46.338||45.132||38.602||36.405||34.193||33.094||31.439||30.752||29.784||29.145||28.914||27.567||27.064||26.996,0.6,0.4,0.26666666666666666
94,Reprod_Biol_Endocrinol-1-_-153492.txt,regress||structur luteolysi||term||process||progesteron||corpu luteum||luteolysi||speci||molecular mechan||luteal regress||function luteolysi||cell||function,luteal regress||corpu luteum||luteal regress luteolysi||luteolysi corpu luteum||luteolysi||structur luteal regress||regress||rat corpu luteum||luteal involut||function luteal regress||corpu luteum vari||structur luteolysi||luteolysi frontier||function luteolysi||mammalian corpu luteum recent progress,54.288||53.865||53.526||53.244||52.001||39.453||39.225||38.924||38.027||37.166||35.91||30.892||28.105||27.462||22.206,0.6,0.4,0.4
95,Ann_Hematol-2-2-1705486.txt,bone marrow microenviron||patient||cytogenet respons||addit chromosom abnorm||clinic trial||treatment||therapi||cytotox effect||month||complet suppress||complex karyotyp||unexpect effect||normal||myelodysplast syndrom||cytogenet remiss||transfus independ||lenalidomid||metaphas||case studi||hemoglobin||md patient||erythroid respons,lenalidomid||5q||del||lenalidomid respons||lenalidomid treatment||lenalidomid therapi||md||keyword lenalidomid myelodysplast syndrom||md patient||transfusion-depend del||patient||springer-verlag 2006 lenalidomid||lenalidomid clinic trial||isol del||karyotyp,82.888||64.489||54.614||46.484||45.199||41.988||33.329||31.169||31.017||29.74||28.706||28.591||28.123||27.307||26.397,0.2,0.2,0.2
96,Oecologia-3-1-1915602.txt,host||root tissu||qualiti||studi||harvey||effect||root biomass||develop||mortal||indol glucosinol||foliar herbivori||parasitoid||adult||natur enemi||control||herbivor||glucosinol||insect cultur||insect herbivor||interact||root||larva||plant||result,radicum||parasitoid||rapa||insect parasitoid||parasitoid interact||brassica||jersey trybliographa rapa delia radicum||root||trybliographa rapa||radicum 2005 2003||root herbivor||T. rapa D. radicum adult||herbivor||plant root||insect interact trybliographa rapa,126.63||72.408||70.124||56.824||56.216||55.878||50.27||48.635||48.621||48.502||47.241||46.574||45.848||45.019||44.627,0.2,0.2,0.2
97,Crit_Care-8-3-468887.txt,norepinephrin||flow||data||studi||patient||sepsi||splanchnic oxygen consumpt||gastric intramucos pH||effect||lower gastric phi||agent||increas||blood pressur||phi||shock||adrenerg drug||low-dos dopamin||splanchnic haemodynam||inflammatori respons||cardiac output||vasopressin||red blood cell transfus||splanchnic circul||epinephrin||iloprost||min||microcirculatori blood flow||dobutamin||cardiac index||group||fraction splanchnic blood flow||septic shock,septic shock||shock||norepinephrin||septic shock patient||sever septic shock||septic patient||dobutamin||splanchnic oxygen||norepinephrin hsbf||splanchnic haemodynam||splanchnic hemodynam||splanchnic perfus||splanchnic microcircul||splanchnic blood flow||circulatori shock,106.84||91.035||80.971||75.953||71.817||68.412||61.882||60.644||56.574||50.258||49.658||49.33||47.945||47.21||47.142,0.6,0.5,0.3333333333333333
98,Int_J_Biochem_Cell_Biol-1-5-1885942.txt,condit||kd||epiderm growth factor||liver phenotyp||sigma||western||ksfm||transcript factor||assay||de-differenti||GS||express||rt-pcr||dexamethason||day||urea product||liver function||pa||protein||ugt||differenti properti||dex||hepatocyt||keratinocyt serum-fre medium||cultur||rat hepatocyt||car||pituitari gland extract||medium||result,hepatocyt||rat hepatocyt||cultur rat hepatocyt||cultur||differenti hepatocyt||hepatocyt differenti||primari hepatocyt cultur||hepatocyt isol||isol hepatocyt||hepatocyt ureagenesi||kds-cultur hepatocyt||human hepatocyt||hepatocyt monolay||hepatocyt prolifer||kd cultur,115.635||70.112||69.038||66.89||64.75||64.75||63.481||60.635||60.635||59.252||59.252||58.147||57.818||57.818||56.713,0.6,0.3,0.2
99,Arch_Dermatol_Res-3-1-1839867.txt,igg||igg subclass||acantholysi||pathogen||blister-induc potenti||complement||studi||patient||type vii collagen||predomin||autoimmun bullou diseas||subepiderm blister||relev||intracellular||pemphigu||subclass||epidermolysi bullosa acquisita||mice||leukocyt||bullou pemphigoid patient||autoimmun||autoimmun respons||blister format||activ||skin||autoantibodi||bullou pemphigoid||diseas||bullou system lupu erythematosu,autoantibodi||subclass autoantibodi||subclass||igg autoantibodi||bullou pemphigoid autoantibodi||igg4 autoantibodi||igg subclass||igg1 autoantibodi||bullou pemphigoid igg subclass||complement-fix autoantibodi||non-pathogen autoantibodi||predomin autoantibodi||pemphigu foliaceu autoantibodi||igg3 autoantibodi||non-complement-fix autoantibodi,153.121||135.888||118.654||111.804||100.793||99.815||94.571||87.862||84.6||82.507||81.021||80.53||80.402||78.376||78.047,0.4,0.3,0.2
100,Breast_Cancer_Res_Treat-3-1-2001219.txt,orr||first-lin endocrin therapi||respons||postmenopaus||ttf||letrozol||endocrin therapi||breast cancer||studi||patient||tamoxifen||diseas progress||superior||effect||aromatas inhibitor||metastas||earliest date||advanc breast cancer||signific||treatment||advers event||therapi||metastat diseas||random||analysi||first-lin therapi||post-menopaus women||surviv||clinic benefit||trial||diseas||signific improv||progress,tamoxifen||breast cancer||first-lin tamoxifen||tamoxifen versu tamoxifen||metastat breast cancer breast cancer||cancer||metastat breast cancer cancer||advanc breast cancer||metastat breast cancer||versu tamoxifen||letrozol versu tamoxifen||letrozol||first-lin letrozol versu tamoxifen||trial breast cancer||first-lin letrozol,92.834||74.103||73.47||70.074||66.598||66.174||62.74||61.793||61.595||58.694||58.642||58.538||57.508||56.962||56.322,0.4,0.3,0.26666666666666666
101,Med_Biol_Eng_Comput-4-1-2329737.txt,find||respons||myocardi oxygen balanc||adenosine-medi vasodil||adenosin||channel||vasodil||coronari circul||hypertrophi||flow perturb||heart failur||coronari resist vessel||coronari vasoconstrict||receptor||endotheli dysfunct||coronari vasculatur||parasympathet control||LV dysfunct||product||coronari arteriol||dysfunct||exercis||activ||myocardi infarct||decreas||influenc||vasodil influenc||heart||swine||coronari blood flow||vivo,coronari||heart||coronari vasodil||heart failur||coronari circul||merku||vasodil||adenosine-medi coronari vasodil||exercise-induc coronari vasodil||coronari reserv||heart failur circ||coronari arteriol||swine||pacing-induc heart failur||coronari vasculatur,82.608||71.184||66.82||57.986||53.809||52.644||51.032||47.284||45.955||45.83||45.47||44.837||44.722||44.251||43.476,0.6,0.4,0.4666666666666667
102,Arch_Dermatol_Res-4-1-2254657.txt,chronic plaque-typ psoriasi||manifest||report||therapi||psoriasi||case||pustulosi||ppp||indic||treatment||psoriat arthriti||infliximab||patient||infliximab therapi||tnf||gpp||tnf-antagonist||pustular skin lesion||factor,psoriasi||ppp||infliximab||pustular psoriasi||plaque-typ psoriasi||recalcitr pustular psoriasi||plaqu psoriasi||sever pustular psoriasi||infliximab therapi||psoriasi vulgari||psoriasi patient||new-onset psoriasi||moderate-to-sever psoriasi||psoriasi area||activ psoriasi,74.587||66.36||64.825||60.517||48.054||42.17||41.901||40.635||40.118||39.964||39.15||38.563||38.242||37.294||37.294,0.6,0.4,0.26666666666666666
103,Eur_J_Clin_Pharmacol-4-1-2426926.txt,placebo||tablet||level||dacp||time||week||men||plasma||lipoprotein||concentr||baselin||studi||cholesterol||plant stanol||urinalysi||increas||hypercholesterolemia||higher dose||event||dose||treatment||advers event||blood sampl||singl dose||sitostanol||phase||pharmacokinet||subject||placebo group||stanol||phase 2||physic examin||activ||group||decreas||dasp||fm-vp4||plant sterol||stanol-contain product||low-dens lipoprotein cholesterol||dose group||ldl-c||safeti,fm-vp4||day fm-vp4||fm-vp4 tablet||subject||fm-vp4 merit||fm-vp4 safeti pharmacokinet||day||dacp||100 subject||placebo||dasp||hypercholesterolem subject||twenty-f subject||sterol||80 subject,113.593||79.241||66.53||64.289||57.455||50.186||44.888||36.905||36.514||35.827||34.065||33.113||33.009||32.975||32.905,0.4,0.4,0.3333333333333333
104,Eur_Arch_Otorhinolaryngol-4-1-2254469.txt,diagnost protocol||find||clinic sign||aspir||standard endoscopi protocol||ventil||ill patient||oral feed||endoscop assess||fee||studi||patient||oral diet||tracheotomi||risk||liquid bolu||naso-gastr tube||examin||swallow||evalu||deglutit||acut symptom||assess||popul||pharyng||fee find||silent aspir||rapid evalu||procedur||compensatori treatment procedur||decis||clinic studi||icu||percutan endoscop gastrostomi,aspir||fee||tracheotomi||silent aspir||aspir pneumonia||endoscopy-proven aspir||aspir 115||aspir event||aspir 129||aspir statu||fee procedur||initi fee||bedsid fee||fee examin||swallow,86.655||65.542||52.031||48.257||47.055||44.894||44.005||43.328||43.328||43.328||38.4||37.366||37.067||36.786||36.614,0.8,0.4,0.3333333333333333
105,Behav_Brain_Res-2-1-2424131.txt,delay||data||opfc||orbit prefront cortex||effect||lamp||lesion||inter-tempor choic||weber fraction||behaviour||rat||disconnect lesion||delay discount||sham-les group||phase||experi||curv||linear indiffer function||acbc||sucros solut||lever||light||callosotomi group||choic||group||size||callosotomi||signific differ||trial||reinforc||prefer function||result,callosotomi||disconnect||acbc||callosotomi lesion||disconnect lesion||reinforc||core acbc callosotomi||acbc lesion||disconnect callosotomi sham lesion||szabadi||callosotomi group||opfc||bradshaw c.m||fail callosotomi||disconnect group,48.549||42.223||36.409||35.342||32.179||32.047||30.383||29.272||28.54||27.305||26.913||26.305||25.766||24.275||23.75,0.6,0.4,0.4
106,J_Mol_Biol-1-5-2291451.txt,mechan||core||Ig||nativ state||pack||data||mutat||contact||nucleu||tnfn3||structur||fibronectin type iii||domain||fold||greek key topolog||residu||protein||cafn2||strand||loop||immunoglobulin||mutant||oblig||layer||interact||transit state||sheet||fniii,fold||fold nucleu||protein fold||domain fold||ig-lik fold||immunoglobulin fold||fold pathway||fold mechan||ubiquitin fold||fold process||obligatori fold nucleu||conserv fold nucleu||discuss cafn2 fold||fold transit state||obligatori fold posit,174.578||116.746||102.34||100.134||95.039||91.501||89.71||89.369||88.153||87.289||87.169||80.844||76.819||76.308||68.837,0.2,0.1,0.06666666666666667
107,Purinergic_Signal-3-4-2072918.txt,antibodi||entpd||transfect||purinoceptor||immunoprecipit analys||purinerg||genet immun||protein||immun||result||antipeptid antisera||ecto-enzym||antisera||express||western-blot analys||analys||cell||member||monoclon antibodi||famili,purinoceptor||5446 rb 1||7619 rb 1:800 henpp2||ecto-enzym||1:1600 mentpd1||antibodi||entpd famili 5441 rb 1:1600 hentpd2||1:1600 mentpd2||koch-nolt||1:1600 7||p2x purinoceptor||1:1600 metntpd2||7620 rb 1:3200 renpp3||1:1600 4||1:1600 1,25.472||22.542||22.276||21.232||21.213||20.12||19.781||19.581||19.58||18.199||18.045||17.95||17.818||17.812||17.758,0.4,0.3,0.2
108,J_Headache_Pain-4-1-2245992.txt,horizont deviat||horizont plane||cerebellum||cerebellar||neuromuscular junction||studi||cerebellar function||movement||singl fiber emg||nmj||migrain||aura||neuromuscular transmiss||mcd||channel||patient||function||median valu,migrain||migrain headach||schoenen||aura||hemipleg migrain||headach||migrain famili||migrain patient||migrain trust||ambrosini||neuromuscular transmiss||aura ambrosini anna||sfemg||headach pain||typic aura,58.517||44.596||38.014||33.28||32.346||30.676||30.452||29.695||29.258||23.865||19.688||19.676||19.56||17.508||17.505,0.4,0.2,0.2
109,Diabetologia-4-1-2270364.txt,type 2 diabet||level||diabet||studi||pgc-1α||non-diabet donor||insulin secret||oxid phosphoryl||human||insulin releas||dna methyl||express||sirna||human diabet islet||gene||beta cell function||pancreat islet||usa||human islet||GK rat||islet||insulin resist||gene express,ppargc1a||ppargc1a ppargc1a ppargc1a||ppargc1a ppargc1a||ppargc1a ppargc1a ppargc1a ppargc1a ppargc1a express||method ppargc1a ppargc1a ppargc1a ppargc1a||ppargc1a ppargc1a ppargc1a 2||ppargc1a ppargc1a 1 ppargc1a||ppargc1a ppargc1a express||hypothesi ppargc1a ppargc1a ppargc1a ppargc1a express||7 ppargc1a ppargc1a ppargc1a ppargc1a express||1 ppargc1a ppargc1a||interpret ppargc1a ppargc1a||7 ppargc1a ppargc1a||ppargc1a 5 ppargc1a ppargc1a express||ppargc1a ppargc1a 19 ppargc1a gene,336.195||336.195||336.195||281.657||269.12||252.873||252.64||227.119||225.625||225.625||224.788||224.13||224.13||203.51||202.783,0.0,0.0,0.0
110,Mol_Syst_Biol-4-_-2387231.txt,physic complex||set||measur||method||human protein||physic associ||microarray||data||comparison||likelihood||cold aceton||correl||human||tendenc||test||complex||ortholog||valid||ortholog gene||mass spectrometri||gene||control||cce||yeast||annot||protein||pair||analysi||accuraci||associ||nuclear export||distribut||co-express||posit||interact||score,al||cce||cce pair||pair||cce associ||protein pair||associ||protein||al supplementari tabl 1||physic protein associ||physic associ||figur 7D||human protein pair||ortholog pair||protein interact,143.549||54.0||52.56||51.12||48.516||46.579||43.032||42.037||41.616||41.138||40.688||38.614||37.368||37.095||36.683,0.4,0.4,0.3333333333333333
111,Dev_Genes_Evol-4-1-2265772.txt,annelid||worm||glutamin synthetas||myohara||amino acid ident||express||ejg||ovari||sequenc||regener,gs||japonensi||enchytraeu japonensi||gs E. japonensi 2006 E. japonensi||gs gene||gs right-hand||glutamin||glutamin synthetas||xenopu 1995 gs E. japonensi regener||discuss E. japonensi glutamin synthetas||enchytraeu japonensi 1999 E. japonensi 1999||1991 gs C.||glutamin metabol glutamin||E. japonensi 2006 1993||glutamin synthetas gene,139.489||124.702||77.104||76.451||72.176||71.786||66.866||58.693||56.254||54.975||52.558||47.178||45.756||41.069||40.75,0.0,0.1,0.06666666666666667
112,Matern_Child_Health_J-2-2-1592148.txt,chronic hypertens||import opportun||program||etiolog pathway||care coordin||week||infant||hypertens||birth||pregnanc||problem||locat||matern||weight problem||recurr||folic acid||risk assess||effect||internat care||internat visit||nutrit risk||postpartum care||health promot||intervent||content||addit support||psychosoci support||resourc||internat period||health||servic coordin||preconcept care||women||research||preterm birth||clinic intervent||servic||preterm deliveri||famili||import||visit||access||support||six-week postpartum visit||on-go care||oral health servic||children,internat care||internat visit||internat intervent||internat support||internat period||internat care.||subsequ internat care||enhanc internat care||comprehens internat care||internat care model||internat care consist||internat care refer||univers internat care||internat psychosoci intervent||six-week internat visit,166.12||149.169||142.74||123.716||123.519||121.901||115.206||111.979||111.508||110.97||110.746||110.746||110.746||108.592||105.379,0.6,0.3,0.2
113,Immunogenetics-3-1-1914236.txt,gene||snp||result||celiac diseas||appli biosystem||analysi||genet associ||sampl||express||studi||dutch popul||famili,"spink4||spink spink4 spink4 spink4 spink4||spink4 spink4 spink spink4||spink spink4 spink4||spink5||spink spink spink1 2 5 spink4||spink4 rs891671 33,222,271||spink4 sequenc analysi||2 spink tabl 2 spink4 snp||spink5 mutat||1 spink haplotyp||spink spink2 gusb error||fig. 2 spink||spink2||asterisk 1 spink4 4 arrow point",175.633||161.235||157.636||151.637||79.769||73.533||62.796||59.393||48.155||41.287||35.942||35.741||34.622||31.895||29.708,0.0,0.0,0.0
114,Diabetologia-3-1-1914278.txt,vascular vulner||diabet mellitu||diabet||arteri wall||patient||carotid arteri||cimt||type 1 diabet||sex||plasma hyaluronan||hyaluronan||present studi||endotheli glycocalyx||glycocalyx||control||age||subject||plasma hyaluronan level||hyaluronidas||intima-media thick||imag analyst,hyaluronan||diabet||hyaluronidas||cimt||plasma hyaluronan||hyaluronan metabol||serum hyaluronan||0.3 hyaluronan||diabet mellitu||diabet control||diabet 0.008||non-insulin-depend diabet||increas hyaluronan metabol||type 1 diabet||plasma hyaluronan level,65.122||47.686||47.338||42.336||35.05||35.002||33.104||32.561||29.735||25.281||25.215||24.882||24.426||24.241||23.889,1.0,0.6,0.5333333333333333
115,Methods-1-5-1895922.txt,method||indic||concentr||fischer suppli||serial dilut||purifi compound||bacteri strain||microtitr plate||extract||assay||strain||compound||antibiot||resazurin||solut||minimum inhibitori concentr||test materi||mic||bacteri speci||crude extract||antibacteri assay||number||natur product||resazurin method||result,resazurin||mic||resazurin assay||resazurin method||resazurin solut||resazurin plant||modifi resazurin assay||steril resazurin tablet||modifi resazurin method||true’ mic||accur mic||mic-2||mic-1||steril||bacteri concentr,41.241||26.535||25.306||23.983||23.524||20.62||20.128||19.326||19.246||15.979||14.402||13.742||13.742||13.151||12.06,0.6,0.3,0.2
116,Planta-4-1-2270920.txt,cytosol||metabolit||sugar alcohol concentr||peach||non-aqu fraction||siev tube||subcellular distribut||studi||myo-inositol||sugar alcohol||leaf cell||phloem||compart||sourc||mannitol||common plantain||leav||ratio||sucros||leaf||subcellular compart||vacuol||sugar||mesophyl cell||sea plantain||distribut||sorbitol||celeri||apoplast||speci||fructos||activ transport||stroma||plant,phloem||sorbitol||plantain||phloem concentr||sucros||sorbitol concentr||celeri||plantain sea plantain peach celeri||sorbitol transport||mannitol||plantain sorbitol 133||plantain sorbitol 22||phloem sap||phloem load||sucros concentr,116.057||103.712||100.267||82.706||80.732||76.534||76.154||72.581||72.454||68.537||68.359||67.993||66.258||65.315||65.044,0.6,0.5,0.3333333333333333
117,Purinergic_Signal-4-2-2377319.txt,atp||cyclic nucleotid||ideal||synaps||purinerg||nucleotid||tissu||atp releas||receptor||releas||introductori articl||receptor channel||adenosin||nucleosid||microenviron||cell,purinerg||purinerg signal purinerg||purinerg signal||autocrin purinerg||paracrin purinerg||paracrin purinerg signal||microenviron||extracellular purinerg signal||purinerg ligand||intralumin autocrin purinerg||paracrin purinerg biolog||autocrin signal||s11302-007-9091-x editori purinerg||ideal microenviron||activ purinerg ligand,66.79||57.197||52.4||42.21||40.462||39.645||39.559||37.484||35.565||29.811||27.92||27.82||23.882||23.765||23.71,0.2,0.2,0.13333333333333333
118,Bioinformation-1-5-1891680.txt,pfm||sequenc motif||promot||user||web server||sequenc||server||motif||pmsearch||transcript factor,pfm||input pfm||similar pfm||507 pfm||pmsearch||predict bind site||site||server||put bind site||transcript factor bind||site web server||input||sequenc||bind specif||conclus pmsearch,70.359||42.813||37.593||35.97||28.617||23.215||22.347||20.931||18.563||16.524||15.944||15.266||15.024||14.77||14.308,0.4,0.3,0.26666666666666666
119,Dev_Biol-2-1-2098691.txt,anim||endoderm gene express||transgen||depend||sox site||element||tgf-β||effect||direct target||promot element||gfp fluoresc||region||promot||site||lane||veget||express||downstream||gene||endoderm||direct effect||transcript||endoderm differenti||gfp||bind||sox17||vegt||emsa||gastrula||endoderm element||construct||sequenc||network||result,xsox17||xsox17 xsox17||xsox17 clement||endoderm||endoderm network xsox17 xsox17 clement||1999 xsox17 xsox17 clement||xsox17 sinner||xsox17 hudson||2003 xsox17 xsox17 gurdon||xsox17 induct||vegt||xsox17 zhang||xsox17 auto-induct||xsox17 mech||endogen xsox17,184.749||184.749||130.359||120.153||114.226||112.144||109.681||97.89||97.533||97.373||96.561||95.457||95.258||94.578||94.222,0.2,0.1,0.13333333333333333
120,Exp_Brain_Res-3-1-1914230.txt,variat||task constraint||role||trial block||kinemat paramet||heavi||target area||experiment condit||joint action||studi||interperson transfer||joint-act coordin||target region||high speed||effect||observ||action observ||mass||analys||interperson transfer effect||present studi||fitts’ law||experiment task||cylind||task||experi||dyad||repetit||weight||actor||transfer||data analys||size||trial||tabl||movement||particip||area||coordin||object||speed,"cylind||object||actor||transfer cylind||movement||object size||movement speed||cylind ’s||speed||thick cylind||heavi cylind||size 1,13||object weight||fetching-actor||movement speed transfer",68.813||48.692||45.15||43.301||38.569||37.904||37.321||36.262||36.073||35.445||35.433||34.266||33.831||32.541||30.811,0.8,0.5,0.3333333333333333
121,Angiogenesis-4-1-2268723.txt,blood suppli||endotheli cell||vasoprolif respons||host||folkman||effect||develop||neovascular||angiogenesi||evid||cell||growth||day||tissu||mice||judah folkman||activ||factor||tumor||vessel||cam||antiangiogen activ||blood vessel||molecul,folkman||angiogenesi angiogenesi||angiogenesi||tumor angiogenesi||tumor||judah folkman||joms.2002.36063 folkman||angiogenesi inhibit||inhibit angiogenesi||angiogenesi inhibitor||cotran RS folkman||cotran RS tumor angiogenesi||tumor growth||tumor-induc angiogenesi||tumor graft,132.263||99.724||99.724||91.874||84.025||70.547||67.603||60.271||60.271||56.775||51.816||51.733||51.435||51.183||50.194,0.6,0.4,0.26666666666666666
122,J_Biol_Inorg_Chem-3-1-2039866.txt,reaction||bi||attempt||structur||spectrum||sodium pyruv||precipit||solut||complex||chemic||differ fourier map||calc||zinc||signal||reaction mixtur,2 2||2||2 2 2||2 2 2 2 2 2||2 2 2 2||2 2 2 2 2 Pr||2 2 2 2 1 2||2 2 2 1 2||1 2 2 2 2||5 2 2 2 2||2 2 asterisk 2||2 2 2 35||2 2 Pr||sodium pyruv 2 2 2 2||2 2 Ac,512.091||512.091||512.091||512.091||512.091||433.823||427.897||411.059||411.059||409.673||384.811||384.068||355.555||344.831||342.64,0.0,0.0,0.0
123,Health_Qual_Life_Outcomes-2-_-395842.txt,measur||instrument||commun||well-b||rate||qualiti||patient||year||contact||life||cognit rate scale||scale||nurs||dementia||behaviour||sever dementia||item||approach||daili live||assess||mobil||bcr||activ||old-old patient||factor||physician||barthel index||neg affect||life measur||global deterior scale,item||65 item||core item||item level||barthel item 5||barthel item 4||barthel item 3||barthel item 2||barthel item 7||barthel item 8||barthel item 9||barthel item 10||0.08 item 37||nurs barthel item 1||barthel,104.232||54.095||52.116||52.116||49.669||49.581||49.48||49.447||49.447||49.447||49.447||49.447||47.944||47.424||44.108,0.2,0.1,0.06666666666666667
124,Eur_Radiol-2-2-1705470.txt,prospect studi||case||gastric tumor||endolumin RF coil||mri||carcinoma||histopatholog stage||studi||gastric wall||gastric region||gastric wall layer||experiment studi||tumor volum||inform||sensit||cardia||lymphoma||lesion||magnet reson imag||coil concept||suffici imag||suffici detail||serosa||lymph node||opposed-phas sequenc||diffuse-typ gastric carcinoma||factor||tumor||layer||signal intens||imag techniqu||gastric carcinoma||gastric wall differenti||sequenc||intermedi||stage||vivo,gastric tumor||gastric wall||stage||gastric layer||gastric carcinoma||gastric adenocarcinoma||gastric region||gastric malign||gastric cardia||gastric cancer||gastric lymphoma||oper gastric||gastric wall layer||tumor stage||gastric carcinoma specimen,65.42||60.653||60.174||60.172||59.672||52.919||52.253||51.434||51.33||50.89||50.587||49.991||47.613||46.101||41.901,0.8,0.5,0.4
125,Pediatr_Nephrol-4-1-2335291.txt,cathet||dryness||capac||boy||indic||peni||birth||patient||year||risk||overact||pelvic floor||stoma||high detrusor pressur||upper urinari tract||pressur||bladder||approach||girl||age||abdomin approach||subject||surgeri||antimuscarin||renal function||high bladder pressur||cic||suspens||detrusorectomi||bladder neck||urinari contin||incontin||good result||spina bifida||children||result,bladder||sling||stoma||neuropath bladder||bladder autoaugment||neurogen bladder||spina bifida||bladder neck||overact neuropath bladder||low-pressur bladder||bladder capac||overact||detrusor overact||overact detrusor||detrusor,73.486||50.563||48.588||42.333||41.277||40.979||40.524||40.185||39.799||38.016||37.851||34.729||34.456||34.456||34.182,0.4,0.4,0.3333333333333333
126,Cancer_Causes_Control-2-2-1705485.txt,hair||incid rate||ear||melanoma||rate||data||hair cover||femal||neck||site||face||women||age||invas melanoma||incid||chang||australia||differ||younger women||scalp||sun exposur||solar UV exposur||solar ultraviolet radiat||hypothesi,melanoma||ear melanoma||ear||neck melanoma||invas melanoma||cutan melanoma||facial melanoma||melanoma prevent||hair||melanoma incid rate||incid invas melanoma||bare ear||femal ear||hair cover||australia,65.929||57.838||49.747||42.611||38.293||35.951||34.478||32.964||32.812||31.755||31.416||27.108||26.976||26.534||26.27,0.6,0.4,0.4
127,Eur_J_Appl_Physiol-3-1-1782100.txt,efl||control||blood||time||averag 52||debt||limit||recoveri||cardiac output||exercis||data||compon,document||hbox||dot||efl||efl exercis||documentclass||12pt||amsmath||amsfont||mathrsf||69pt||end||exercis||efl control exercis efl exercis||efl exercis test,142.692||115.261||114.94||91.63||76.974||75.217||75.217||75.217||75.217||75.217||75.217||66.941||62.318||62.264||51.316,0.2,0.1,0.13333333333333333
128,Pediatr_Nephrol-4-1-2413095.txt,chronic kidney diseas||ra||ckd||CV abnorm||tissu ra||data||studi||renal diseas||patient||allel||risk||pediatr ckd popul||pediatr||increas||gene polymorph||renal||human genom||genotyp||natur||gene||cytokin||polymorph||popul||associ||whole-genom associ studi||genet||factor||snp||atherosclerot CV abnorm||potenti weak||CV diseas||function||error||diseas||haplotyp||preliminari evid||gene express||progress||kidney||cardiovascular diseas,polymorph||ckd||esrd||gene polymorph||genet polymorph||delet polymorph||kidney||gene polymorph 4G||single-nucleotid polymorph||promot polymorph||ace gene polymorph||taqi polymorph||intragen polymorph||individu polymorph||ckd progress,88.304||59.476||58.277||57.013||55.257||53.133||49.834||47.219||45.893||45.426||45.414||45.344||45.073||44.6||44.362,0.6,0.4,0.26666666666666666
129,Eur_J_Pediatr-3-1-2151776.txt,pertussi control||case||infant||pertussi||strategi||childhood diseas||review||increas||adult||newborn||countri||infect||laboratori diagnosi||immun||vaccin strategi||incid||univers immun||cultur||ill||pcr||adolesc||diseas||diagnosi||laboratori techniqu,pertussi||pertussi infect||acellular pertussi||adult pertussi||prevent pertussi||pertussi incid||pertussi epidemiolog||classic pertussi||pertussi control||pertussi antibodi||pertussi problem||acellular pertussi vaccin||acelluar pertussi vaccin||vaccin strategi pertussi vaccin||bordetella pertussi infect,206.662||118.91||118.351||113.702||107.556||105.543||104.723||104.362||103.94||103.861||103.331||101.671||92.694||87.929||84.494,0.2,0.2,0.13333333333333333
130,Oecologia-4-1-2311384.txt,competit||concentr||studi||valu||hollow||competit abil||effect||water||bog||increas||cover chang||site||northern||mixtur||temperatur||signific interact||treatment||water level||growth||product||posit effect||biomass product||evapor||global warm||northern site||competit advantag||experi||greenhous||bulk densiti||differ||height||height increment||speci||water tabl,S.||S. balticum S.||S. balticum||sphagnum S. balticum S.||S. fuscum S. balticum S.||S. magellanicum S. balticum S.||S. fuscum S.||S. balticum S. magellanicum S. balticum||S. balticum S. fuscum||S. balticum S. magellanicum||S. magellanicum S. balticum||S. fuscum S. balticum S. fuscum||S. balticum S. magellanicum S. cuspidatum||S. fuscum||S. magellanicum,414.466||374.202||354.07||351.158||348.684||347.521||345.094||338.546||332.239||330.784||330.784||324.962||311.874||310.408||307.498,0.0,0.0,0.0
131,Histochem_Cell_Biol-4-1-2248605.txt,type||transport vesicl||imag||endo-lysosom system||studi||endosom||lysosom||cargo||observ||lysosom membran protein||complex||direct pathway||receptor||gga||transport||cell||cd-mpr||enzym||protein||tgn||mannos 6-phosphat receptor||electron microscopi||literatur||escrt||factor||subdomain||specif compart||machineri||acid phosphatas||acid phosphatas activ||function||distinct stage||compon,lysosom||endosom||multivesicular endosom||endosom vacuol||lysosom hydrolas||lysosom protein||lysosom biogenesi||earli endosom||endosom protein||lysosom enzym||lysosom traffick||liver lysosom||late endosom||endosom subdomain||secondari lysosom,151.016||146.877||84.017||83.121||82.583||81.764||80.737||80.279||79.694||79.161||78.439||76.326||75.952||75.629||75.508,0.4,0.2,0.13333333333333333
132,Eur_Child_Adolesc_Psychiatry-3-1-1914287.txt,attent||social commun||high level||level||boy||behavior||infant||sex differ||children||problem||princip compon analysi||sampl||data||studi||young age||develop||pearson correl||social commun problem||stabil||problem behavior||earli age||common||aim||analys||inhibit||item||age||parent||older children||dimens||factor||order||commun sampl||compet||work||total problem score||score||infant develop||result,behavior||behavior problem||problem behavior||problem||uncommon problem behavior||earli problem behavior||develop problem behavior||parent-report problem behavior||intern problem behavior||problem behavior evolv||opposit behavior||behavior dimens||unwant behavior||behavior scale||impuls behavior,91.854||76.869||76.869||61.884||54.22||53.976||53.713||51.991||51.524||51.246||49.838||49.413||47.093||46.797||46.495,0.6,0.3,0.2
133,Eur_Radiol-2-2-1705545.txt,excel||coronari angiographi||low vessel opacif||protocol||diamet||bpm||high preval||imag||interv||studi||patient||data analysi||calcif||imag qualiti||diagnost accuraci||low signal-to-nois ratio||agatston score||extens coronari calcif||heart rate||motion artifact||heart rate control||high pre-test probabl||dsct||signific stenos||data acquisit||accuraci||popul||entir heart||nonenhanc dsct||cad||ica||dual-sourc CT||vessel||coronari arteri||coronari arteri stenosi||segment||score,coronari angiographi||coronari arteri||coronari stenos||tomographi coronari angiographi coronari stenosi||coronari calcif||coronari arteri stenos||dsct||coronari arteri segment||coronari angiographi scan||non-invas coronari angiographi||coronari diseas||noninvas coronari angiographi||coronari lesion||invas coronari angiographi||quantit coronari angiographi,65.195||56.917||56.267||49.866||49.02||45.98||45.767||45.711||45.026||44.836||44.777||44.757||44.213||44.198||43.463,0.4,0.3,0.2
134,Int_Arch_Occup_Environ_Health-3-1-1915645.txt,measur||level||time||higher level||passiv leisur||sampl||qualiti||studi||hypothesi||gener questionnair||home activ||worker||weekend||recoveri||variabl||activ leisur activ||hour||analys||sleep complaint||respect||diari studi||higher score||pleasur||effort||relationship||associ professor||high-effort group||experi||employe||job||activ||home||workday||group||differ||single-item report mark||particip||fatigu||support||partner||neg affect||daili basi||ancova||report mark||result,work||effort||work activ||overtim work||work time||work-rel effort||effort group||work engag||weekend||activ||domest work||work day||work hour||work motiv||work activ particip,149.158||139.151||117.15||102.35||96.636||93.883||86.807||86.37||85.159||85.143||84.212||81.289||80.885||80.732||80.495,0.2,0.3,0.2
135,Pediatr_Radiol-4-1-2292499.txt,csf||find||flow||infant||complic||subarachnoid space||import role||extra-axi fluid collect||doppler||studi||patient||sonographi||brain sulci||mening||bacteri mening||ventricul||brain||evalu||earli abscess||fluid||ventricl||postinfecti hydrocephalu||neurolog find||subdur effus||central nervou system infect||diagnosi||children,mening||bacteri mening||neonat mening||citrobact mening||infantil mening||neonat bacteri mening||pyogen mening||purul mening||mening edema||suspect mening||streptococcu mening||mening thicken||complic bacteri mening||infantil bacteri mening||suspect bacteri mening,144.345||101.244||85.222||80.539||76.637||76.196||76.062||74.687||74.628||74.134||73.906||72.927||71.411||70.473||68.804,0.4,0.2,0.13333333333333333
136,J_Abnorm_Child_Psychol-3-1-1915605.txt,condit||neg evalu outcom||measur||find||pre-adolesc children||higher level||depress symptom||respons||mood||time||cdi||social||self-verif||studi||depress||subsequ||peer||effect||self-verif theori||prefer||failur||adult||control condit||evid||analys||state mood||success||real time||feedback||chang||highest score||contest||lowest total score||interact||particip||feedback prefer||peopl||score||children||neg feedback subsequ,feedback||peer feedback||feedback prefer||neg feedback||feedback valenc||feedback manipul||success feedback||feedback condit||subsequ feedback||posit feedback||failur feedback||unfavor feedback||feedback inform||C. feedback||favor feedback,160.158||108.157||106.806||98.914||88.16||86.901||85.35||85.347||84.844||84.173||83.624||82.68||82.286||81.792||80.865,0.4,0.2,0.13333333333333333
137,Behav_Processes-2-1-2396234.txt,anim||measur||respons||neophilia||time||hole-board||valid measur||studi||central area||frequenc||explor||increas||hole||sex||rodent||head-dip||behaviour||male||rat||head-dip behaviour||research||mice||previou studi||environ||exposur||open field||presenc||trial||apparatu||area||avers condit||object||locomot||result,"head-dip||4,56||head-dip behaviour||hole-board||head-dip behavior||hole-board apparatu||head-dip increas||apparatu||hole-board file||head-dip male 9.3||hole-board behavior||al.||behav||hole||hole-board test",97.403||76.733||62.99||56.067||55.339||50.537||49.106||45.007||36.971||36.095||34.671||33.885||31.412||30.811||30.341,0.6,0.4,0.3333333333333333
138,Eur_Radiol-3-1-2077908.txt,grade||find||time||OA||imag||studi||patient||multipl joint site||total||lesion||womac||cyst||bone marrow edema-lik||anatom locat||pain||associ||chang||bme||decreas||bone||size||knee||total size||diseas||progress,"bme||bme lesion||bme size||1,638 bme lesion||bme fluctuat||unchang bme lesion||327 bme lesion||lesion||knee||total bme score||knee osteoarthr||osteoarthr||keyword knee mri bme womac OA||edema-lik lesion||knee score",85.401||64.091||47.585||45.965||44.159||43.171||43.086||42.782||36.539||34.681||34.098||31.657||26.406||25.947||24.513,0.2,0.3,0.2
139,Eur_J_Epidemiol-4-1-2413078.txt,mortal||immigr||inform||earlier life condit||german pension scheme||germani||pension insur||foreign||death rate||popul||migrant mortal||host popul||data||death||studi||countri||pension||migrant||migrant background,migrant||migrant mortal||mortal||pension||migrant popul||german pension||foreign migrant||migrant mortal advantag||german||mortal statist||underestim mortal||popul||migrant background||migrant health||german pension scheme,49.95||49.497||49.045||40.787||39.243||37.46||37.173||35.039||34.132||33.763||29.604||28.535||28.321||27.263||26.439,0.8,0.4,0.4666666666666667
140,Mol_Immunol-1-5-1995235.txt,role||primer||studi||perfus||specif role||blood contamin||blood cell||analys||spermatozoa||testi||cd59a||gene||absent||tissu||protein||motil||liver||mous||abund express||mac||cd59b||mrna||acrosom||amplif||result,cd59b||cd59a||cd59a cd59b cd59a cd59b primer||cd59b primer||cd59b mrna||cd59b express||cd59b distribut||cd59b protein||cd59b mamm||cd59b ratio||cd59a primer||cd59a mrna||cd59b testi 24.8||mous cd59a||cd59a holt,201.375||150.232||148.275||119.768||115.549||111.376||102.161||101.647||101.529||101.3||94.196||89.978||87.844||84.343||80.615,0.4,0.2,0.13333333333333333
141,J_Med_Internet_Res-8-4-1794003.txt,geriatr medicin||age-specif search term||databas||exp adult||combin||strategi||hand search||age-specif search strategi||mesh term||research assist||sensit||studi particip||three-term strategi||adult||journal||specif||term||clinician||obstetr||absolut decreas||clinic specialti||medlin||medicin||textword||combin term||precis||particip||neonat medicin||year 2000||articl,sensit||sensit search||search||sensit term||search term||specif search||medlin search||term||specif term||specif||age-specif search term||sensit strategi||search strategi||medlin search strategi||medlin,103.986||101.697||99.409||93.83||91.542||90.972||86.339||83.674||83.105||82.535||77.81||77.081||74.792||74.284||73.269,0.2,0.3,0.3333333333333333
142,J_Gastrointest_Surg-3-1-1852385.txt,diverticul||author||case||complic||data||studi||patient||sigmoid diverticul||colon||elect surgeri||recurr episod||signific||diverticular diseas||oper||surgic manag||perfor diverticul||fistula||attack||surgeri||acut diverticul||high rate||surgeon||resect||perfor||procedur||diseas process||diseas||diagnosi,diverticul||sigmoid diverticul||complic diverticul||perfor diverticul||acut diverticul||sever diverticul||mild diverticul sever diverticul||colon||diverticular diseas||diverticular periton||diverticul II recurr||diverticul symptom frequenc||23 24 diverticul||sigmoid diverticular diseas||sigmoid colon,131.706||80.285||72.377||71.789||69.687||66.736||66.294||50.444||49.737||45.129||44.764||44.647||43.902||42.78||39.654,0.8,0.6,0.4
143,Pediatr_Nephrol-4-1-2259257.txt,level||sdn||gfr||control group||studi||year||patient||steroid||rang 2||renal biopsi||treatment||biopsy-proven mcn||csa||studi group||glomerular filtrat rate||drop||remiss||month||renal function||mcn||csa toxic||chronic renal failur||minimal-chang nephrot syndrom||long-term treatment||nephrotox||latest follow-up||function,gfr||csa||nephrot syndrom csa||csa nephrotox||nephrot syndrom||csa therapi||nephrot children||nephrotox csa therapi||csa 136.3||normal gfr||196 gfr||178 gfr||3.4 gfr||186 gfr||long-term csa therapi,71.444||69.603||53.865||48.929||45.997||44.01||39.766||38.759||36.286||36.27||36.245||36.233||36.232||36.212||35.987,0.4,0.2,0.13333333333333333
144,Breast_Cancer_Res_Treat-3-1-2096638.txt,surviv||section||fancd2||prolifer||case||immunohistochemistri||hereditari invas breast cancer||percentag||sporad breast cancer||breast cancer||express||patient||brca1||brca||cell,fancd2||fanconi||fancd2 neg||fancd2 inactiv||fancd2 express||fancd2 protein||fancd2 intens||fancd2 score||fancd2 patient||fanconi anemia||neg fancd2 case||fanconi anaemia||higher fancd2 express||low fancd2 level||fanconi anemia protein,107.593||66.457||57.916||57.567||56.516||55.422||53.797||53.797||53.797||46.719||41.254||39.595||37.677||36.716||32.23,0.2,0.1,0.06666666666666667
145,Int_Urogynecol_J_Pelvic_Floor_Dysfunct-4-1-2335287.txt,uterovagin prolaps||follow-up period||effect size||complic||qualiti||studi||life||anatom outcom||prolaps||domain||bothersom symptom||standard questionnair||symptomat pelvic organ prolaps||urinari leakag||outcom||valid questionnair||urogenit symptom||women||posterior compart||pain||sacrospin ligament||surgeri||recurr cystocel||urinari incontin||sacrospin ligament fixat||sacrospin hysteropexi||symptom||function outcom||follow-up time||procedur||score||pelvic organ prolaps||result,sacrospin||prolaps||sacrospin hysteropexi||uterovagin prolaps||uterin prolaps||sacrospin colpopexi||sacrospin fixat||sacrospin ligament||sacrospin cervicocolpopexi||sacrospin cervico||hysteropexi||vault prolaps||sacrospin hysteropexi show||vagin sacrospin colpopexi||recurr prolaps,130.574||117.135||98.967||79.997||75.451||74.469||72.632||70.592||68.347||68.347||67.36||66.589||65.978||61.663||60.559,0.6,0.4,0.26666666666666666
146,J_Chem_Ecol-4-1-2373414.txt,lima bean||control||odor bind protein||efn secret||compound||lanolin past||signal||heil||plant||voc,volatil||plant||heil||efn||indirect plant defens||bean plant||A. volatil||plant ecolog||attack plant||arabidopsi plant||efn secret||M. 2006. herbivore-induc plant volatil||volatil emiss||lima bean efn||indirect defenc,16.917||16.018||15.316||14.173||11.589||11.129||10.493||9.808||9.602||9.597||9.509||9.116||9.074||8.974||8.932,0.4,0.2,0.2
147,Rev_Endocr_Metab_Disord-3-1-1894829.txt,type||diabet||children||patient||young age||clinic featur||gck||present||test||guidanc||insulin||sulfonylurea||featur||treatment||low dose||gene||glucos||age||young adult||kir6.2||neonat diabet||famili||resist||monogen diabet||lower part||pndm||diagnosi||modi||syndrom||result,diabet||monogen diabet||neonat diabet||diabet mellitu||maturity-onset diabet||famili diabet||insulin||diabet phenotyp||early-onset diabet||very-early-onset diabet||type-ii diabet||late-onset diabet||diabet rang||diabet autoimmun||diabet patient,174.331||114.816||101.214||99.401||93.203||93.112||91.442||89.171||88.743||88.588||88.2||88.002||87.997||87.838||87.696,0.6,0.4,0.26666666666666666
148,Breast_Cancer_Res_Treat-3-1-2096637.txt,ilc||morpholog||author||calcul||find||case||mammographi||lesion size||convent imag||mri||data||studi||seri||valu||addit lesion||patient||dynam curv analysi||non-mass-lik lesion||small studi||correl||sensit||enhanc||lesion||magnet reson imag||mass||surgic manag||treatment||underestim||invas lobular carcinoma||meta-analysi||ultrasound||high variabl||foci||domin mass||addit find||chang||literatur||tumor||size||breast||irregular||detect||result,mri||lobular||ilc||breast mri||invas lobular||lobular carcinoma||breast||invas lobular breast carcinoma||invas lobular carcinoma||breast carcinoma||invas lobular breast cancer||lobular breast cancer||invas lobular carcinoma breast cancer||invas carcinoma||mri find,103.198||101.311||89.076||89.074||82.108||79.422||74.949||74.174||73.916||66.241||61.442||60.955||60.66||60.219||58.265,0.4,0.4,0.26666666666666666
149,Hernia-4-1-2231409.txt,ta||time||method||mesh fixat techniqu||complic||insert||studi||recurr||standard techniqu||crown||laparoscop repair||incision hernia||oper||straightforward repair||oper time||fixat techniqu||puh||studi group||tacker||group||hernia||differ||fixat||lrvih||techniqu,hernia hernia||hernia||ta||ta techniqu||fixat||fixat techniqu||techniqu||hernia repair||tacker fixat techniqu||incision hernia||mesh fixat techniqu||ventral hernia||mesh fixat||laparoscop hernia surgeri||oper techniqu,63.089||63.089||54.698||48.333||44.463||43.215||41.967||39.5||38.659||38.202||35.506||35.327||32.275||31.615||30.367,0.6,0.6,0.4666666666666667
150,Ann_Biomed_Eng-4-1-2239251.txt,shear load||muscl||joint||spinal load||sij stabil||sij||model||sij compress||pelvic floor||increas||slouch||pelvic region||gluteu mediu||present studi||simul model||pelvic floor muscl||sacroiliac joint||vertic sij shear||load||trunk||leg||biomechan analysi||pain||coxal bone||simul||direct||activ||pelvi||bone||pelvic muscl||ligament||postur||trunk load||sij compress forc||maximum muscl stress||sacrum||result,muscl||muscl forc||forc||sij||pelvic muscl||muscl load||trunk muscl||ligament forc||muscl forc vector||muscl forc predict||biomech||M.||joint forc||sij compress forc||sij reaction forc,127.595||117.661||107.727||96.017||86.365||84.795||81.745||80.23||79.282||78.772||76.199||75.824||75.076||72.162||71.828,0.6,0.3,0.26666666666666666
151,Eur_Arch_Otorhinolaryngol-3-1-2099162.txt,tumour||adenocarcinoma||case||neck region||metastas||head||metastat tumour||palatin tonsil||rout||common origin||metastasi||primari adenocarcinoma||patient||oesophagu||tonsil||tumour cell,tonsil||adenocarcinoma||palatin tonsil||tonsillar metastasi||metastasi||palatin||keyword tonsil metastasi adenocarcinoma oesophagu head||gastric adenocarcinoma||primari adenocarcinoma||esophag adenocarcinoma||neck||simultan primari adenocarcinoma||head||metastat tumour||oesophagu,30.176||26.065||24.384||20.072||19.755||18.592||15.721||14.947||14.795||13.777||10.423||10.301||10.234||8.494||8.098,0.8,0.5,0.5333333333333333
152,Pediatr_Nephrol-3-1-1805049.txt,calcif||sodium thiosulf||hu||acut renal failur||week||soft tissu||calcif urem arteriolopathi||hemolyt urem syndrom||patient||calcium,calcif urem arteriolopathi||calcif||urem syndrom||hemolyt urem syndrom||syndrom calcif||calcif ST sodium thiosulf||urem syndrom MC||recess hemolyt urem syndrom||sodium thiosulf||metastat calcif||calciphylaxi||arteriolopathi||vascular calcif||shalev||moe SM urem,18.296||18.069||16.411||15.817||12.519||12.463||12.433||12.302||12.253||11.146||10.965||10.965||10.477||9.965||9.37,0.6,0.4,0.26666666666666666
153,Immunol_Lett-2-1-2430030.txt,murin||present||respons||antigen present||apc||cytokin product||rel pauciti||sampl||express||class II||neutrophil||macrophag||antigen||cell,neutrophil||murin neutrophil||polymorphonuclear neutrophil||human neutrophil||neutrophil gelatinas||neutrophil prepar||neutrophil deplet||neutrophil process||neutrophil sampl||3.3 neutrophil||3.2 murin neutrophil||purifi murin neutrophil||human polymorphonuclear neutrophil||periton polymorphonuclear neutrophil||neutrophil antigen present,115.371||73.601||71.253||59.711||58.689||58.243||58.234||58.146||57.685||57.685||49.771||49.43||48.852||48.679||48.475,0.2,0.1,0.06666666666666667
154,J_Gastrointest_Surg-3-1-1852374.txt,follow-up||perman fecal divers||case||surgic treatment||rate||patient||year||perian abscess||risk||rectal advanc flap||temporari stoma||stoma||perman stoma||fecal divers||fistula||multivari analysi||rectal resect||abscess format||surgeri||factor||abdomin procedur||temporari fecal divers||small bowel resect||fecal incontin,perian||perian crohn ’s||perian crohn ’s diseas||perian fistula||crohn ’s diseas||perian crohn ’s diseas surgeri||perian fistul crohn ’s diseas||complic perian crohn ’s diseas||perian crohn ’s diseas Br||perian abscess||perian crohn ’s diseas world||sever perian crohn ’s diseas||perian crohn ’s diseas int||crohn coliti||perian abscess fistula,128.557||114.462||99.959||98.647||90.427||82.876||82.271||81.8||80.669||80.338||80.332||79.967||79.967||77.406||76.471,0.0,0.1,0.06666666666666667
155,Cardiovasc_Intervent_Radiol-3-1-1914265.txt,endovascular treatment||occlus||abi||complic||procedur||sfa||occlud stent||option||endovascular stent||superfici femor arteri||angiograph result||pier||intervent radiolog||patient||side,stent||occlud stent||subintim stent||endovascular stent||double-barrel stent||self-expand stent||reocclud stent||stent segment||affect stent||addit stent||sfa||endovascular||80.0 mm stent||subintim recan||recan,68.865||49.806||48.073||47.427||39.246||37.254||36.137||35.892||35.411||34.432||31.388||25.989||24.874||23.809||20.336,0.4,0.2,0.2
156,Dig_Dis_Sci-4-1-2292501.txt,pathophysiolog mechan||rate||median age 40 year||studi||patient||maximum toler volum||effect||upper abdomin sensat||test||earli satieti||total||nutrient drink||gastric empti||gastric||daili life||relationship||upper abdomin symptom||upper abdomen||pathophysiolog disord||maximum satieti||age||proxim||stomach||drink test||symptom||nutrient drink test||sever||function dyspepsia,gastric||gastric empti||gastric function||gastric volum||gastric barostat||relax gastric empti||gastric accommod||delay gastric||gastric motor||delay gastric empti||proxim gastric relax||proxim gastric volum||gastric function test||dyspepsia||gastric function question,121.019||87.228||71.508||68.447||67.718||64.197||64.027||62.781||61.057||59.666||55.184||54.43||54.248||50.939||48.12,0.4,0.2,0.13333333333333333
157,Naunyn_Schmiedebergs_Arch_Pharmacol-2-2-1705472.txt,cardiac inotropi||low level||blockad||ang II||flow||mineralocorticoid receptor||aldosteron||effect||eplerenon||blood pressur||heart failur||glucocorticoid||chai||rat||aldosteron level||oxid stress||cardiac tissu||activ||synthesi||arrhythmia||inotropi||cardiac level||antagonist||cortisol,aldosteron||cardiac aldosteron||aldosteron blockad||aldosteron synthas||vascular aldosteron||aldosteron synthesi||blood-deriv aldosteron||plasma aldosteron||aldosteron product||aldosteron level||aldosteron potenti||nongenom aldosteron effect||cardiac aldosteron action||cardiac aldosteron product||aldosteron synthas inhibitor,201.422||116.551||107.831||107.681||103.539||102.661||101.758||101.746||101.662||101.642||100.711||80.959||78.634||78.335||72.357,0.2,0.2,0.13333333333333333
158,Eur_J_Pediatr-4-1-2413082.txt,tubercul pericard||tuberculosi||pericardi fluid||diagnosi||pericard,tubercul pericard||pericard||tubercul pericardi effus||tuberculosi||constrict pericard||pericardi fluid||tuberculin||keyword tuberculosi pericard subxiphoid biopsi corticosteroid||pericardi effusion-mediastin lymph gland||larg pericardi effus bolt roel||15-year-old girl||diagnosi||effus M. tuberculosi dna||girl||anti-tubercul drug,24.894||24.567||16.426||13.723||13.488||10.086||7.461||7.292||6.273||6.044||5.757||5.462||5.428||5.054||4.397,0.6,0.4,0.3333333333333333
159,Pediatr_Radiol-3-1-1805044.txt,find||pretext||siopel||patient||involv||pretext system||risk||pretext stage||criteria||metastas||high risk||current siopel studi||tumour||portal vein||risk stratif||ascit||extrahepat diseas||liver||origin pretext system||biopsi||major branch||hepatoblastoma||medial section||risk factor||hepat vein||revis||diseas||diagnosi||primari malign liver tumour||extrahepat abdomin diseas||children,pretext||hepatoblastoma||tumour||pretext iii tumour||v3a pretext||pretext stage||pretext system||vein||pretext group||metastas||ruptur hepatoblastoma||pretext number||pediatr hepatoblastoma||childhood hepatoblastoma||diffus pretext IV hepatoblastoma,85.643||76.462||56.078||47.795||47.407||46.248||44.751||44.087||43.402||43.29||43.242||42.821||42.82||42.754||42.106,0.6,0.6,0.4
160,Skeletal_Radiol-4-1-2424184.txt,chart review||follow-up||find||time||follow-up period||studi||patient||clinic outcom||bone marrow edema||age differ||review||total||edema||statist analysi||lesion||pattern||cartilag||tka||age||total knee arthroplasti||pain||subject||bandwidth rang||bme||group||function loss||bone||osteoarthrosi||knee||sever||cartilag loss,bme||bme bme||bme pattern||knee||tka||global bme||bme group||bme 23||knee osteoarthrosi||bme result||edema||knee OA||cartilag||tka pattern||global bme 5,103.242||103.242||64.972||64.513||62.061||61.289||55.035||52.512||51.645||51.621||49.036||48.132||45.165||44.381||40.86,0.6,0.3,0.3333333333333333
161,Clin_Rev_Allergy_Immunol-4-1-2243253.txt,antibodi||RA patient||sensit||ccp2 test||test||studi||rheumatoid factor||arthriti||autoantibodi||data||diseas||patient||specif,arthriti||rheumatoid arthriti||acpa||ccp2||anti-ccp2 test||anti-ccp2 antibodi||ccp2 test||ccp2 peptid||anti-ccp test||peptid ccp2 test||autoantibodi||test||RA||anti-ccp antibodi||antibodi test,29.246||18.242||17.216||17.216||16.168||14.651||14.446||12.764||12.724||12.401||12.199||11.676||11.376||11.207||10.159,0.2,0.2,0.26666666666666666
162,Clin_Oral_Investig-4-1-2238785.txt,condit||level||system||indic||sextant||basic structur||studi||eros wear||level score||eros||develop||epidemiolog||bew score sum||tooth wear||manag||examin||basic eros wear examin||research||highest score||bew||surfac||gener dental practition||eros tooth wear||sever||gdp||diagnosi||index||score,eros||eros wear||dental eros||eros tooth wear||bew||sextant||wear||eros indic||basic eros||eros loss||oral dental eros index||tooth wear||eros tooth wear 1||physiolog eros||keyword eros tooth,49.053||39.595||38.709||34.146||33.754||32.817||30.138||28.527||27.834||27.427||27.272||26.693||25.613||24.527||24.1,0.8,0.5,0.4
163,Placenta-1-5-1895600.txt,human pregnanc||gestat age||tunel-posit||sampl||apoptot index||individu cell||increas||express||immunoreact||signific increas||placenta||cell type||cell||stress||murin placenta||hne||oxid stress||gc||apoptosi||ihc||fetal endotheli cell||cyclooxygenas||dual-label||co-localis||mous||glycogen cell||primari antibodi||syncytiotrophoblast,placenta placenta||placenta||hne||murin placenta||cox-1||immunoreact||human placenta||rat placenta||cox-2||placent oxid stress||oxid stress||LZ||syncytiotrophoblast||hne co-localis stain||murin placenta burdon,70.653||70.653||55.023||43.52||40.322||39.399||37.346||35.778||33.729||33.431||33.375||31.523||31.302||30.904||29.842,0.6,0.4,0.4
164,Diabetologia-3-1-1820754.txt,type 2 diabet||respir||muscl||studi||patient||parallel electron input||complex iii||oxid phosphoryl||healthi subject||increas||skelet muscl||insulin||content||evid||present studi||control||uncoupl state||oxid capac||electron transport capac||electron transport||mitochondria||subject||biopsi||citrat synthas activ||result,diabet muscl||muscl||type 2 diabet||skelet muscl||2||2 2 2 2||2 2||type 2||human type 2 diabet||1 2 2 2 2||2 fig. 2 2 2||2max 2 2 2||2 2 flux||mitochondria skelet muscl||diabet complic,45.286||40.62||35.44||34.574||33.325||33.325||33.325||28.183||27.141||27.029||26.66||26.436||26.123||26.015||24.977,0.6,0.3,0.2
165,Biochem_Pharmacol-1-5-1920586.txt,blockad||protocol||concentr||long QT syndrom||data||studi||mutat||effect||current||herg channel||herg||inhibit||fit||control||potenti||short QT syndrom||inactiv||imipramin||extern solut||doxepin||channel pore||mutant||drug,herg||herg channel||herg blockad||herg herg fig. 4||herg inhibit||herg affin||mutant herg||herg measur||herg β||herg channel blockad||herg potassium channel||herg channel inactiv||herg channel block||mutant herg channel||close herg channel,632.981||341.452||332.429||326.504||321.209||318.575||317.894||316.49||316.49||238.26||235.183||232.225||229.761||228.571||228.221,0.4,0.2,0.13333333333333333
166,Int_J_Biochem_Cell_Biol-2-1-2267855.txt,pH depend||mutant||substrat transport||substrat||one-way anova||residu||oocyt||peptid||transport||proton||model||charg pair||substrat bind||wild-typ,meredith||pept1||boyd||1998 meredith||2004 meredith||2000 meredith||meredith david||2005 meredith||boyd c.a.r||1998 meredith D. boyd c.a.r||peptid transport pept1||2000 meredith D. boyd c.a.r||1995 meredith D. boyd c.a.r||oligopeptid transport pept1||cotransport pept1,98.641||66.643||57.98||54.281||52.916||51.229||49.812||49.321||47.27||42.288||41.11||41.067||40.304||38.504||38.485,0.0,0.0,0.0
167,Int_J_Colorectal_Dis-3-1-2077921.txt,dgp||anal manometri||follow-up||case||system||placement||result||artifici bowel sphincter||anal sphincter defect||problem||procedur||data||faecal incontin||studi||implant||treatment||patient||infect||institut,incontin||anal sphincter||ab||trauma||faecal incontin||ruptur||deliveri trauma||ruptur anal repair||fecal incontin||anal repair||ab implant||artifici anal sphincter implant||artifici sphincter||anal sphincter defect||feacal incontin,61.522||51.716||51.486||45.242||43.8||43.234||41.627||40.848||40.223||39.655||36.607||35.99||35.858||35.578||34.017,0.2,0.1,0.13333333333333333
168,Immunogenetics-2-2-1592254.txt,iplitr||detail sequenc analys||molecul||fcrl||domain||cyt||receptor||evid||content||polymorph differ||cell||gene||lrc||genom segment||chir||product||function signific||ident||analysi||catfish||common origin||member||famili||teleost||sequenc analysi||immun receptor||evolut||iplitr sequenc||uniqu composit||inhibitori||lrc-encod receptor||support||lilr||igsf receptor||zflitr||Ig domain||sequenc||membran||kir,iplitr||receptor||iplitr sequenc||Ig||uniqu iplitr||iplitr gene||iplitr D1||iplitr loci||catfish||individu iplitr||iplitr type||iplitr1 Ig||iplitr1 Ig domain iplitr belong||individu iplitr domain||Ig domain,114.053||63.825||62.926||62.593||60.411||59.824||59.696||59.384||58.091||57.941||57.026||50.297||49.27||48.425||45.993,0.6,0.4,0.3333333333333333
169,J_Med_Internet_Res-7-1-1550637.txt,gener theme||mesh||system||databas||patient||concept||consum||clinic||inform||major||broader literatur||servic manag||alli health literatur||scientif||definit||patient care||telemedicin||journal||medic informat||potenti||term||broad rang||applic||ehealth||research||research literatur||commun technolog||analysi||taxonomi||care||internet||medic informat literatur||literatur||clinic data||medic subject head||topic||medlin||order||scientif abstract||field||public||hand||organiz factor||articl,ehealth||ehealth ehealth journal||e-health||e-health e-health||ehealth literatur||ehealth research||term ehealth||search term ehealth ehealth||ehealth system||health||ehealth articl||ehealth scientif||health informat||ehealth tool||ehealth landscap,227.499||154.522||146.988||146.988||121.905||120.768||119.693||119.486||118.548||116.832||116.737||115.949||115.648||114.954||114.862,0.2,0.1,0.06666666666666667
170,Dig_Dis_Sci-3-1-1914242.txt,chapter||central databas||endoscopi||system||code system||find||endobas iii system||complic||databas||descript||comput system||therapeut procedur||structur||investig||get-c||diagnos||text-block||classif||minim standard terminolog||code||intern classif||item||hospit inform system||terminolog||endoscop term||group||report||import||field||comprehens code system||procedur||diseas||endoscop find,code||icd-10 code||get-c code||gastric ulcer||code system||icd-10 code system||gastric||icd-10||specif code||procedur code||origin icd-10 code||accept code||gastrointestin endoscop terminolog code||good code||specif get-c code,102.441||81.644||73.492||71.749||66.853||64.851||61.271||60.847||55.955||54.879||54.808||53.116||52.604||52.283||52.151,0.4,0.2,0.13333333333333333
171,Ann_Biomed_Eng-2-2-1705520.txt,condit||actin cytoskeleton||time||respons||mechan condit||load curv||studi||cell stiff||mechan properti||effect||hold period||frequenc||strain||baselin length||increas||amplitud||forc||cytod||matrix mechan||cell||day||load||collagen||tissu||drop||curv||bioartifici tissu||cell mechan||decreas||incub||matrix||step||larger rang,stretch||cyclic stretch||stretch amplitud||mechan stretch||cyclic stretch amplitud||step stretch||stretch magnitud||stretch length||singl stretch||forc||term stretch||cyclic stretch frequenc||continu cyclic stretch||higher stretch amplitud||5 matrix stretch,235.388||159.319||150.579||128.557||128.136||125.353||121.702||121.386||118.849||118.063||117.694||111.624||107.232||104.408||101.223,0.0,0.1,0.06666666666666667
172,J_Fluoresc-3-1-1915606.txt,measur||time||experiment setup||protein aggreg||sec||dye fluoresc||sampl||irrevers denatur||focal volum||data analysi||aggreg||sensit||increas||temperatur||fluoresc correl spectroscopi||fluoresc intens||denatur protein aggreg||nile red||fluoresc spectroscopi||solut||experiment autocorrel function||protein||experi||normal||light||buffer||sensit detect||analyt detect||fluoresc||room temperatur||peak||heat||size exclus chromatographi,nile||β-galactosidas||nile red||fluoresc||aggreg β-galactosidas||β-galactosidas aggreg||_||fluoresc spectroscopi||β-galactosidas solut||bound nile||time-resolv fluoresc||aggreg||tau _||larg β-galactosidas aggreg||steady-st fluoresc,135.052||108.712||105.92||100.705||84.463||84.463||73.842||72.202||71.515||68.309||62.854||60.215||58.974||58.562||57.814,0.4,0.3,0.26666666666666666
173,Matern_Child_Health_J-2-2-1592247.txt,nation map||program||measur||preconcept risk assess||preconcept||clinic practic strategi||unpublish data||indic||servic provid||public health||project||birth||jurisdict||pregnanc||matern||state||strategi||folic acid||patient||reproduct health||clinic||risk||unit state||perform measur||provid||intervent||preconcept care program||health||preconcept care||educ||health care||women||summit||effort||public polici||father||age||public health practition||popul||abstract||servic||prenat care||ppor||innov strategi||issu||state perform measur||famili plan||prioriti||preconcept health promot||nation summit,preconcept||preconcept health||preconcept care||preconcept health care||health||preconcept health prioriti||preconcept health servic||preconcept health indic||preconcept health promot||preconcept health state titl||preconcept health activ||preconcept care program||preconcept care servic||health care||preconcept counsel,105.283||88.533||73.274||72.777||71.782||71.657||67.625||62.212||61.387||59.692||59.022||57.586||57.453||56.524||56.107,0.6,0.4,0.4
174,Breast_Cancer_Res-5-6-314403.txt,upregul||role||emt||epitheli cell||insert||data||studi||cell cycl control||growth inhibit||total rna||express||treatment||cell||gene||cell growth||analysi||experi||regul||rhob||cdna microarray||hybrid||nmumg cell||data analys||signal intens||pathway||origin data file||time point||gene express||result,tgf-β||tgf-β regul||tgf-β signal||tgf-β play||tgf-β induc||tgf-β respons||ml tgf-β||tgf-β target gene||gene||tgf-β 1||tgf-β treatment||tgf-β effect||tgf-β action||nmumg||tgf-β-regul gene,114.253||68.062||61.7||60.335||58.357||58.233||57.975||57.793||57.701||57.622||57.558||57.128||57.126||40.275||38.918,0.0,0.1,0.06666666666666667
175,Biochem_Pharmacol-2-1-2279149.txt,activ site||breast cancer||arylamin||studi||tamoxifen||model||inter-domain loop||assay||steroid||structur||recombin protein||compound||express||reaction||protein||nat||spectrum||activ||three-dimension structur||mous||substrat||peak||inhibitor,nat2||mous nat2||2.2 nat2 nat2||human nat2||nat2 activ||4 discuss nat2 nat2||nat2 escherichia||mous nat2 structur||unlabel mous nat2||mous nat2 inhibitor||mous nat2 spectrum||mous nat2 model||mous nat2 solut||mous nat2 volum||n-acetyltransferas,160.286||111.901||106.857||86.368||82.591||80.296||80.143||78.744||76.598||76.509||76.241||75.269||74.925||74.91||65.616,0.0,0.0,0.0
176,Cancer_Immunol_Immunother-3-1-2150627.txt,technolog||respons||protocol||panel||assay||frequenc||cimt||pbmc sampl||present||abil||clinic trial||reactiv||cell||elispot reader||percentag||pbmc||phase||analysi||standard||function assay||group||order||cmv||elispot||tetram||intracellular cytokin||posit||number||requir||donor,t-cell||elispot||antigen-specif t-cell||t-cell tetram||t-cell assay||elispot assay||t-cell monitor||t-cell stain||t-cell respons||antigen-specif t-cell respons||elispot panel phase||t-cell immun||t-cell result||ifnγ elispot||influenza-specif t-cell,87.219||75.878||66.548||65.591||64.047||58.376||51.802||49.512||48.627||47.71||46.481||46.42||45.66||45.602||44.994,0.2,0.1,0.06666666666666667
177,Qual_Life_Res-3-1-2039846.txt,person||follow-up||measur||respons||questionnair||practic||util score||hear||studi||patient||standard deviat||dutch tariff||effect||distinct group||follow-up visit||test||life score||econom analys||qali||util||quality-adjust life year||icer||hui||cost||health||aid user||hear aid fit||popul||chang||aid fit||respond||dutch||group||differ||non-applic||visit||attribut||hear complaint||hear loss||score||hrqol||result,hear||eq-5d||hear aid||hui3||util||hear aid fit||tariff||hear complaint||eq-5d dutch tariff||hear loss||C. hear||hear problem||eq-5d UK tariff||hear attribut||hear aid user,144.774||124.203||108.149||91.899||90.602||84.844||80.373||77.92||77.574||74.832||74.311||73.571||73.177||73.075||72.609,0.4,0.5,0.3333333333333333
178,Matern_Child_Health_J-2-2-1592143.txt,social market||time||behavior||pregnanc||patient||pcc||consum||healthi pregnanc||promot||provid||cost||health||preconcept care||product||women||research||health behavior theori||babi||servic||care||market||demand||benefit||outcom,preconcept||preconcept care||market||market preconcept care servic||preconcept care servic||servic||preconcept health care||social market preconcept care servic||pcc servic||care||health care servic||pcc||health care||preconcept health promot||social market,52.646||44.772||43.616||43.313||43.212||40.092||39.806||38.387||37.13||36.897||35.621||34.168||33.386||31.737||31.15,0.4,0.4,0.4
179,Apoptosis-4-1-2311383.txt,role||protein kinas||respons||studi||transcript factor||increas||sirna||phosphoryl||cell||oxid stress||apoptosi||alveolar type II cell||protein||creb||activ||nuclear accumul||pka||import||exposur||creb activ||egfr||oxid||camp||result,2 2 2 2 2 2||2||2 2||2 2 2 2||creb||2008 2 2 2||experi 2 2||2 2 stimul||2 2 2 2 16 17||result 2 2||300 creb 2||2 phosphoryl||2 2 2 hydrogen peroxid||creb phosphoryl||phosphoryl creb,85.152||85.152||85.152||85.152||83.351||64.104||57.638||57.441||56.768||56.768||56.168||52.293||52.06||51.392||51.392,0.2,0.1,0.06666666666666667
180,Surg_Endosc-3-1-2077356.txt,follow-up||enuresi||hospit stay||time||higher enterocol rate||laparoscop procedur||studi||patient||march 1994||adhes obstruct||duhamel procedur||rectum||end point||laparoscop duhamel||open||bowel||postop complic||cosmet result||group||differ||duhamel||adhes bowel obstruct||enuresi rate||signific differ||period||aganglionosi,duhamel||laparoscop duhamel||open duhamel||duhamel procedur||duhamel laparoscop duhamel gender||laparoscop duhamel procedur||laparoscop||open duhamel procedur||LD||laparoscop procedur||bowel||low-anastomosi duhamel procedur result||LD group||rectum||open,48.899||38.359||32.882||32.025||31.404||30.623||27.819||26.972||23.552||21.485||20.125||17.616||16.893||16.887||16.866,0.6,0.4,0.4666666666666667
181,Mol_Genet_Genomics-3-1-2129107.txt,carbon sourc||gene||sucros||inulin||strain||bind||mutant||invertas||unpublish result||transcript||domain||protein||inulinolyt gene||inulinolyt enzym||data||express||extracellular enzym||inur||growth||result,inur||inur inur||A. niger inur inur||pyrg inur inur||inur inur amyr amyr||inur amyr||niger||inur materi||inur protein||inur 1989||5 inur||niger inur A. nidulan||inur A. niger n402 inur materi||fumigatu A. niger A. niger inur||A. niger,288.229||288.229||204.513||202.599||162.846||162.846||161.361||146.081||145.698||145.542||144.145||142.498||138.223||132.07||120.796,0.2,0.1,0.06666666666666667
182,Appl_Microbiol_Biotechnol-3-1-1914294.txt,terpenoid||gene||emiss||iptg||strain||product||isopren||enzym||function||concentr||pathway||express||studi||methylerythritol phosphat pathway||biosynthesi||amount||cell||growth||isopren emiss,subtili||B. subtili||bacillu subtili||1996 bacillu subtili||2 B. subtili B.||isopren||keyword bacillu subtili isopren methylerythritol||B. subtili 1999 2001||fig. 3 B. subtili||B.||bacillu subtili biochem biophi||molecular biotechnolog bacillu subtili||bacteri isopren emiss B. subtili strain||enzym E. coli B. subtili||2 bacillu subtili 600 nm,161.067||107.496||104.452||69.634||67.233||59.598||54.954||54.792||53.97||53.925||52.857||52.723||51.826||50.741||48.177,0.0,0.1,0.06666666666666667
183,Cancer_Causes_Control-3-1-2039842.txt,type||subcohort||cancer||case||fat||mutat||studi||patient||colon||risk||total fat||epidemiolog||linol acid||intak||netherland cohort studi||express||polyunsatur fat||day||rectal tumor||lack||tumor||subcohort member||tabl||rectal cancer||addit||colon tumor||result,apc||apc apc||apc apc apc gene||apc kra||apc apc 1||2 apc apc||kra apc kra apc 25 apc||2 apc apc apc 2||mlh1 apc||fat 3 apc apc||colorect cancer 1 apc apc apc||apc mutat||38 apc kra apc mutat||discuss apc kra apc mutat||apc 2,232.055||232.055||174.501||172.613||154.703||154.703||154.156||139.233||132.195||130.713||127.198||126.272||120.009||119.554||116.027,0.0,0.0,0.0
184,Matern_Child_Health_J-2-2-1592151.txt,respons||questionnair||practic||rate||pregnanc||studi||patient||folic acid||pcc||respons rate||carn||major||counsel||routin care||folic acid supplement||preconcept care||women||posit effect||care||routin exam||factor||group||topic||import||issu||survey||obstetrician-gynecologist||physician,pcc||preconcept care||pcc questionnair||pcc guidelin||pcc 5||care||pcc 3||pcc 2||routin exam||routin care||preconcept counsel||preconcept care guidelin||preconcept care visit||physician||routin offic exam,59.75||37.416||33.719||30.793||30.395||30.187||29.92||29.879||28.437||28.385||27.123||25.556||25.425||24.024||19.635,0.4,0.5,0.4
185,J_Med_Internet_Res-7-3-1550662.txt,type||portal||cancer||categori||health-rel inform||onlin inform||redesign||patient||question||inform||form||search log||clinic trial||onlin||guidelin||cancer inform||health profession||page||websit||cancer patient||averag||result||onlin survey||free-text search||basic search form||feedback||abstract||nci||usabl test||summari||bet||user input||tabl||usabl||specif trial||survey||cancer inform product||internet,nci||nci websit||nci cancernet websit||redesign nci websit||inform||nci site||nci inform product||user inform||inform user||websit||nci staff||current nci websit||nci websit integr||trial inform||2004 nci websit,177.388||134.672||105.964||105.746||105.024||103.602||95.209||92.089||92.089||91.956||91.122||90.101||90.074||89.89||89.812,0.4,0.3,0.2
186,Exp_Brain_Res-4-1-2214825.txt,visual illus||illus||target||time||initi postur||grip select||model||studi||strategi||orient||effect||grip plan||end||percept||present||motor plan||grip type||target object||visual inform||grasp||sequenti object manipul task||frame||visual context||result||rod orient||task||experi||action||clockwis||start postur||rod||postur||end postur||trial||particip||movement||grip||object||plan||switch point,illus||rod||grip||orient illus||grip plan||grasp||visual illus||rod-and-fram illus||rod orient||plan||illus effect||ponzo illus||action plan||lyer illus||ebbinghau illus,97.623||82.227||80.066||69.567||67.263||63.034||63.018||62.048||61.869||54.461||53.486||51.753||51.672||51.364||50.132,0.8,0.8,0.5333333333333333
187,Int_J_Cardiovasc_Imaging-3-1-2048828.txt,tricuspid annulu||measur||RV function||tad||assess||analysi||mri||tad measur||magnet reson imag||taf||studi||patient||TA function||real-tim three-dimension echocardiographi,tricuspid||tricuspid annulu||tricuspid regurgit||mri||rt3de||keyword tricuspid||tricuspid annulu function||mri 2de rt3de mri||tricuspid annular motion||tricuspid annular plane||tricuspid annular veloc||function tricuspid regurgit||2D 3D mri||2D 2D||2D 2D 2D 2D 2D,80.538||52.447||45.99||44.804||43.482||40.269||39.393||39.131||37.331||36.091||36.04||35.089||34.943||33.812||33.812,0.4,0.2,0.13333333333333333
188,Eur_Biophys_J-3-1-2082062.txt,array||chromatin condens||alpha-satellit dna||measur||centromer||repeat number||liquid||gel||chromatin||nucleosom posit||site||internucleosom distanc||dna||nucleosom||afm||atom forc microscopi||nucleosom array||reconstitut||largest fragment||afm measur||distribut||histon||main phase||fraction||posit||agm||number||fragment||peak||kinetochor protein bind||sequenc||result,nucleosom||nucleosom array||nucleosom arrang||cc cc cc cc||cc||nucleosom core||phase nucleosom||nucleosom phase||nucleosom posit||localis nucleosom||nucleosom organis||nucleosom conform||nucleosom height||telomer nucleosom||discuss nucleosom,128.963||73.1||70.353||70.145||70.145||68.123||67.622||67.622||67.587||67.503||66.087||65.879||65.3||65.085||64.481,0.4,0.3,0.2
189,Ann_Surg_Oncol-4-1-2373867.txt,success nerve-preserv surgeri||time||ipss||pelvic autonom nerv||superior hypogastr plexu||studi||patient||preoper baselin data||preserv||femal||nerv||specif sexual problem||erectil function||point likert scale||oper||present studi||femal sexual dysfunct||evalu||inferior mesenter plexu||autonom nerv||intern prostat symptom score||surgeri||sigmoid colon cancer||surgic procedur||item score||rectal cancer||procedur||good||dissect||genitourinari function||function,0||function||iief||sexual function sexual function||sexual function||genitourinari function||autonom nerv||nerv||autonom nerve-preserv surgeri||nerve-preserv surgeri||fsfi||function preserv||pelvic autonom nerv||laparoscop autonom nerve-preserv surgeri||autonom nerve-preserv oper,50.061||37.42||33.917||32.755||32.755||32.581||32.334||32.152||31.656||31.225||30.833||28.943||28.592||27.535||26.999,0.2,0.4,0.3333333333333333
190,Arch_Dermatol_Res-3-1-1914293.txt,skin cell||plasmacytoid dendrit cell||studi||patient||relaps||lichen planu symptom||lesion biopsi||lichen planu lesion||reactiv||treatment||cell||lichen planu||lesion skin||protein||remiss||diseas activ||lymphocyt||skin diseas||biopsi||skin||number||diseas,hhv-7||lichen planu||planu||remiss hhv-7||lichen planu lesion||lichen planu pathogenesi||oral lichen planu||lichen planu symptom||discuss lichen planu||lichen planu episod||hhv-7 reactiv||hhv-7 replic||hhv-7 dna||hhv-7 antigen||pcr hhv-7,101.917||85.981||85.981||63.921||59.115||57.932||57.816||57.766||57.321||57.321||54.671||54.559||53.187||52.66||52.401,0.4,0.3,0.2
191,Clin_Oral_Investig-2-2-1705496.txt,level||neurosensori dysfunct||oral implant||regard||questionnair||object evalu||trigemin nerv injuri||patient||studi||light touch sensat||placement||impress||nerv||complaint||region||sensat||psychophys test||orofaci region||lower jaw||load||age||month||popul||surgeri||test group||physic dysfunct||mental nerv||implant||group||symphysi||procedur||neurosensori disturb||oral caviti||object||area||age 56 year||lower lip,__||__ numb __||__ speak __||__ swallow __||implant||__ temporari __ persist||side __ left __||__ burn __ tickl||hot __ itch __||__ eat __ whistl||__ frozen __ cut __ prurienc||drink __||oral implant||oral||neurosensori disturb,131.046||88.93||88.893||87.72||75.13||67.41||66.625||66.573||66.557||66.537||66.53||66.285||62.612||50.095||49.597,0.2,0.1,0.2
192,Neurosci_Lett-2-1-2271123.txt,habitu||increas||hippocampu||app||stress||brain||elev platform,app||solubl app||stress||app process||amyloid precursor protein||alzheim amyloid precursor protein||alpha-secretase-cleav amyloid precursor protein||amyloid beta precursor protein||neurosci||app band ratio||alter app process||breen k.c||total particul app level||beta-amyloid precursor protein||heuvel C. solubl amyloid precursor,31.214||18.235||18.217||17.211||17.139||16.33||13.675||13.534||13.378||12.407||11.474||11.38||11.153||10.3||10.281,0.4,0.2,0.13333333333333333
193,Mod_Rheumatol-4-1-2275302.txt,rheumatoid arthriti||vector||inflamm||transgen||joint||system deliveri||efficaci||anim model||patient||gene therapi||strategi||gene transfer||effect||angiogenesi||increas||system administr||deliveri||retrovir vector||express||plasmid dna||treatment||cell||therapi||gene transfer vector||success||mice||cytokin||destruct||adenoviru||pannu format||arthriti||inject||deliveri strategi||aav||fibroblast||vivo,arthriti||collagen-induc arthriti||experiment arthriti arthriti||rheumatoid arthriti||plasmid arthriti||arthriti synoviocyt||adjuvant-induc arthriti||antigen-induc arthriti||collagen arthriti||inflammatori arthriti||experiment arthriti||arthrogen-induc arthriti||cii-induc arthriti||murin collagen-induc arthriti||arthriti model,246.783||179.008||165.556||145.502||133.028||132.358||128.959||127.267||125.366||125.008||124.942||124.784||124.784||123.581||123.392,0.4,0.2,0.13333333333333333
194,Histochem_Cell_Biol-4-1-2386534.txt,squamou metaplasia||hair||langbein||diagnost applic||suprabas layer||moll||case||epitheli cell||simpl||mutat||hair follicl||adenocarcinoma||basal||express pattern||marker||pattern||express||schweizer||differenti||cell type||specif||diagnost marker||cell||type II||typic intermedi filament protein||tissu||protein||epitheli type||function signific||tumor||keratin||layer||diseas,keratin||hair keratin||epitheli keratin||keratin express||human keratin||keratin filament||keratinocyt keratin||keratin polypeptid||keratin pattern||epiderm keratin||keratin antibodi||MB keratin||keratin k6hf||corneal keratin||II keratin,446.691||261.824||253.581||251.669||240.223||239.205||236.813||231.798||231.474||230.903||229.0||227.48||227.144||226.865||226.223,0.2,0.1,0.06666666666666667
195,Int_J_Colorectal_Dis-4-1-2386752.txt,tumour||post-op complic||fisi||score||studi||contin||function outcom||tem||procedur||qualiti||local excis||patient||seri||signific||life||rectal tumour||faecal contin||result,tem||transan endoscop microsurgeri||transan endoscop||transan endoscop microsurgeri Br||transan endoscop microsurgeri int||DW transan endoscop microsurgeri excis||tem procedur||tem techniqu||rectum||2008 introduct transan endoscop microsurgeri||tem local excis qualiti||life||qualiti||fisi||rectal tumour,52.321||41.742||38.833||31.972||31.587||28.336||27.244||26.991||26.961||25.505||23.105||21.326||19.823||19.656||18.347,0.2,0.1,0.3333333333333333
196,Virchows_Arch-3-1-2063564.txt,type||grade||intraduct papillari mucin neoplasm||tumor||pancrea||ipmn subtyp||case||intraduct tumor||recent year||ductal adenocarcinoma||prognosi||posit margin||invas||carcinoma||patient||intraduct papillary-mucin neoplasm||recurr||outcom||ipmn,intraduct||intraduct papillari neoplasm||pancrea||intraduct papillari mucin neoplasm||neoplasm||intraduct papillary-mucin neoplasm||papillari neoplasm||intraduct oncocyt papillari neoplasm||papillari mucin neoplasm||intraduct mucin-hypersecret neoplasm||intraduct tubular neoplasm||benign intraduct neoplasm||noninvas intraduct papillari mucin neoplasm||intraduct papillari mucin tumour||intraduct papillari mucin tumor,137.271||98.884||96.209||91.253||84.215||84.122||79.691||79.341||75.913||75.887||75.588||74.422||74.22||71.842||71.581,0.4,0.3,0.2
197,In_Vitro_Cell_Dev_Biol_Anim-4-1-2277440.txt,control group||doxorubicin concentr||hair follicl||effect||assay||signific||temperatur||viabil||cell||damag||human epiderm keratinocyt||doxorubicin exposur||hair loss||group||keratinocyt||scalp cool||differ||decreas||scalp||doxorubicin||signific differ||medium||drug uptak||result,"scalp||doxorubicin||scalp cool||cool||temperatur||vitro doxorubicin||doxorubicin exposur||doxorubicin uptak||doxorubicin concentr||effect scalp||keyword scalp||optim doxorubicin exposur temperatur||local scalp skin temperatur||2,21||exposur temperatur",51.24||50.604||45.547||39.853||38.634||31.026||28.087||27.735||27.555||27.483||25.62||24.214||23.077||22.409||22.102,0.8,0.6,0.4
198,Bioprocess_Biosyst_Eng-2-2-1705532.txt,cool hex||steril inlet feed||pressur drop||flow||lower flowrat||rate||locat||valu||process side||spiral heat exchang||water||air||recycl||effect||process||continu heat treatment||volum||steril||abil||point||pressur||switch||util||temperatur||control||degre||steam||continu steril||ferment||hex||fluid||non-steril side||hot medium||heat treatment||media type||alkalin||acid||loop||resid time||min||fluid densiti||gap||outlet||valv||system outlet||pipe||inlet||steril medium||cooler||media compon||heat transfer||design||heat||media||side,steril||steril inlet||steril temperatur||steril steril medium||steam steril||water steril||steril feed||steril inlet feed||steril side||lpm||steril media||media steril||inlet||inlet temperatur||temperatur,265.067||204.86||204.067||182.458||174.881||164.875||162.45||156.517||153.456||150.504||148.478||148.478||144.652||143.859||143.067,0.2,0.2,0.26666666666666666
199,Biochim_Biophys_Acta-2-1-2396231.txt,upregul||respons||klf express||data||endothelin-1||studi||transcript factor||effect||multipl klf famili member||increas||total rna||gene promot||express||cell type||cell||signific role||cardiac myocyt||gene||krüppel-lik factor||klf||oxid stress||apoptosi||protein||famili||cardiac myocyt hypertrophi||polysom||mrna||pathway||gene express,myocyt||klf||_||klf6||sugden p.h||klf4||klf2||clerk A. sugden p.h||cardiac myocyt||krüppel-lik factor||klf5||klf express||clerk A.||et-1||krüppel-lik famili,54.735||50.403||45.709||44.472||43.726||41.506||40.331||38.362||37.939||37.711||34.462||33.942||32.999||32.61||31.904,0.2,0.3,0.26666666666666666
200,Matern_Child_Health_J-2-2-1592159.txt,infant||birth outcom||mother||birth||pregnanc||data||matern||state||cari||oral health||risk||case-control studi||deliveri||intervent||treatment||dental servic||infect||dental||matern oral health||health||potenti||women||preterm birth||age||care||matern periodont diseas||oral||factor||import||diseas||tooth||children,periodont||periodont health||oral||dental||periodont diseas||oral health||periodont infect||periodont therapi||oral diseas||dental cari||pregnanc||matern periodont diseas||health||oral health care||matern oral health,96.778||71.009||70.268||64.531||60.188||57.754||52.189||48.389||46.933||46.916||46.383||45.622||45.239||44.15||43.999,0.4,0.3,0.4666666666666667
201,J_Gastrointest_Surg-3-1-1852382.txt,tetanu||case||gastrointestin procedur||complic||procedur||surgeri||diffus muscl spasm||patient||clinic present||vulner patient,tetanu||postop tetanu||tetanu bacilli||tetanu case refer||primari tetanu immun||stoddart JC tetanu||springer-verlag 2007 tetanu||trismu||quattlebaum J. postop tetanu||keyword tetanu hemorrhoid surgic procedur||12. murphi KJ tetanu||17. farrar JJ tetanu||aliv||MJ murphi TV tetanu surveil||literatur method tetanu digest system,106.135||59.831||56.114||39.255||37.005||36.364||35.687||34.361||31.633||29.455||27.845||27.143||25.698||22.627||22.046,0.2,0.1,0.06666666666666667
202,Ann_Biomed_Eng-2-2-1705506.txt,scaffold||ecm||si||bioreactor||leaflet||anim model||studi||molecular imag||heart valv||remodel||heart valv tissu||mechan environ||human||polym||bone marrow||extracellular matrix||fibrin gel||decellular||adult||epc||evid||cell||growth factor||properti||applic||matrix protein||tissu||collagen||endotheli||mechan stimul||implant||myofibroblast||valv||field||biodegrad polym||heart||tissu engin||biomark||function||result,valv||valv tissu||heart valv||aortic valv||valv leaflet||bioprosthet valv||valv replac||autolog valv||heart valv tissu||tissu heart valv||cardiac valv||pulmonari valv||mechan valv||mitral valv||nativ valv,256.161||164.98||164.493||142.974||137.145||136.288||134.817||134.28||134.261||134.261||133.222||132.666||130.541||129.966||129.81,0.4,0.3,0.2
203,Pediatr_Nephrol-3-1-1915616.txt,antibodi||hu||shiga-lik toxin||stx||hemolyt urem syndrom||effect||huvec||specif receptor||coincub||toxin||receptor||protein synthesi||temperatur||cell||cytotox effect||experi||temperatur shift||chang||supernat||renal endothelium||target cell||transfer||monocyt||vero cell,monocyt||toxin||stx-load monocyt||human monocyt||shiga toxin||vero toxin||load monocyt||stx||shiga-lik toxin||blood monocyt||unload monocyt||coincub stx2-load monocyt||shiga||supernat stx-load monocyt||shiga toxin b-subunit,62.23||43.141||37.643||36.706||36.0||35.76||33.557||33.35||32.995||32.253||32.049||30.535||28.859||27.371||26.176,0.4,0.4,0.26666666666666666
204,Ann_Biomed_Eng-2-2-1705509.txt,stereoscop movi||infrar rang||blood withdraw||blood vessel||imag||vi||nir||visual rang||inform||percept||depth||shadow||user||enhanc||shutter glass||depth percept||superfici artifact||tissu surfac||tissu||result||devic||wavelength rang||camera||surfac||pixel||crt||contrast||light sourc||mode||reflect||techniqu,nir||vi nir vi||nir imag||vi||nir pixel||vi imag||nir preview||nir view||nir mask||imag||nir transpar||normal nir imag||nir imag size||1 nir||stereoscop,102.233||79.554||77.701||68.214||61.2||60.691||55.362||55.031||54.091||53.169||52.818||52.136||51.8||51.116||44.622,0.4,0.3,0.2
205,Pediatr_Nephrol-4-1-2275772.txt,prevent||proteinuria||measur||antiproteinur||chronic kidney diseas||ra||hypertens||ckd||reduct||efficaci||renal failur||studi||normal rang||patient||effect||risk||therapeut strategi||increas||ckd patient||blood pressur||addit role||chronic inflamm||low-protein diet||adult||ace inhibitor||treatment||oxid stress||antihypertens agent||anemia||renal function||factor||renal replac therapi||kidney function||trial||renal diseas progress||progress||children,kidney||renal diseas||renal failur||renal diseas progress||progress renal diseas||chronic renal diseas||kidney diseas||chronic renal failur||progress renal insuffici||renal function||progress||renal dysfunct||renal outcom||renal tissu||renal injuri,82.421||67.914||65.323||63.242||63.242||57.474||56.989||55.747||54.253||54.063||53.899||53.212||53.139||52.141||52.135,0.4,0.3,0.26666666666666666
206,Ann_Surg_Oncol-4-1-2234448.txt,level||method||sln biopsi procedur||oper procedur||patholog assess||melanoma||sampl||fnb sampl||antimoni concentr||studi||true sln||antimoni||fine-needl biopsi||node||icp-m||fnb specimen||ppb||result||lymph node||ident||analysi||standard||sentinel lymph node||primari cutan melanoma||sln||hydrochlor acid||procedur||patholog||region lymph node||antimoni level||techniqu,node||melanoma||sentinel||sln||sentinel lymph node||lymph node||sentinel lymph||sentinel node biopsi||sentinel lymph node biopsi||node biopsi||antimoni||sentinel lymph node ident||region lymph node melanoma||false-neg sentinel node||true sentinel node,75.451||69.494||69.386||69.097||65.953||64.237||61.204||60.548||58.666||56.128||53.558||50.714||49.995||49.929||49.592,0.8,0.5,0.4
207,Mod_Rheumatol-4-1-2279153.txt,rheumatoid arthriti||younger age||clinic respons||respons||retrospect studi||demograph factor||infliximab||low activ||studi||patient||notabl efficaci||diseas durat||secondari insuffici||discontinu||dose||treatment||advers event||therapi||advers reaction||RA manag group||retrospect clinic studi||diseas activ||remiss||age||respons criteria||factor||crp||japan||eular criteria||clinic efficaci||diseas||infliximab therapi||mtx,infliximab||infliximab therapi||concomit infliximab||infliximab treatment||infliximab therapi variabl||infliximab therapi 12||mtx||infliximab continu rate||initi infliximab infus||das28-crp||infliximab therapi 3 4||eular||arthriti||rheumatoid arthriti||coef,127.763||75.82||69.544||65.255||51.204||50.547||44.699||43.527||43.044||42.878||37.91||35.638||31.798||30.723||30.625,0.4,0.3,0.26666666666666666
208,Pediatr_Nephrol-3-1-2100430.txt,author||inflamm||chronic kidney diseas||import observ||hypertens||ckd||high preval||abnorm||data||renal failur||studi||transplant patient||hyperphosphatemia||patient||gener popul||calcif||cardiac risk factor||mortal||risk||process||diastol dysfunct||increas||ischem heart diseas||chronic inflamm||cardiac morbid||cardiac arrest||adult||treatment||esrd||renal transplant||lvh||young adult||coronari arteri diseas||anemia||valvular diseas||dyslipidemia||death||cvd||transplant||arteri||gener pediatr popul||high rate||doqi||dialysi||chronic hemodialysi||stiff||children||cardiovascular diseas,renal transplant||pediatr||pediatr dialysi||transplant||pediatr renal diseas||children||kidney transplant||dialysi||pediatr ckd||pediatr nephrol pediatr nephrolog||end-stag renal diseas||pediatr kidney transplant recipi||renal transplant 10||renal failur||chronic renal diseas,74.612||74.288||65.641||65.193||62.728||62.214||61.558||56.994||55.323||53.31||52.093||50.776||49.75||49.498||49.081,0.4,0.4,0.3333333333333333
209,Pediatr_Radiol-4-1-2292495.txt,cathet||peripher cannula||line||complic||contrast studi||tip posit||cathet tip||central venou cathet||studi||patient||tip||central venou access devic||thrombu||neck||lumen||contrast jet||contrast medium||site||oper||manag||subsequ manag||tunnel||central||clinic team||malfunct||fibrin sheath||access||initi examin||posit||cvc||inject||children||techniqu,cathet||central venou cathet||cathet malfunct||cathet tip||tunnel cathet||cathet lumen||venou||hemodialysi cathet||haemodialysi cathet||cathet complic||infus cathet venou||infus cathet||double-lumen cathet||cathet salvag||multilumen cathet,249.945||151.862||151.447||142.511||142.393||133.332||131.452||130.615||129.59||129.255||128.979||127.743||127.469||127.231||126.471,0.6,0.3,0.2
210,Med_Biol_Eng_Comput-3-1-2039845.txt,measur||cathet||respons||sampl rate||system||time||valu||tip||thermocoupl||vivo measur||air||frequenc||overshoot||leakag test||increas||transport||temperatur||calibr||signal||airway climat explor||sampl cathet||respons characterist||characterist||order||decreas||humid||sensor hous||central canal||intratrach climat||respons time||heat||step||total assembl||hme,humid||humid sensor||sensor||capacit humid sensor||vaisala humid sensor||humid sensor polym||commerci humid sensor||test humid sensor||heat humid||tracheal humid||humid step||humid measur||temperatur sensor||sensor temperatur||intra-trach humid,186.342||167.549||148.757||112.873||112.665||112.365||112.259||111.7||109.149||100.006||99.851||99.839||98.074||98.074||97.515,0.2,0.1,0.06666666666666667
211,Arch_Microbiol-4-1-2270922.txt,biolog||time||system||rel abund||bioreactor||steadi state||sampl||acet concentr||laboratori||comparison||flask||control cultiv||variabl||pattern||mass||electron donor||cell||growth||optic densiti||protein||proteom||analysi||chemostat cultur||cultiv||acid||shake flask||experi||shake flask cultur||cultur||system biolog||batch||peptid||organ acid||result,oneidensi||shewanella oneidensi||shewanella||flask||shewanella oneidensi mr-1||flask cultur||oneidensi mr-1||cultur||2007 shewanella oneidensi||shake flask cultur||flask cultur replic||shake flask||chemostat cultur||proteom||replic shake flask cultur,62.804||59.434||56.064||51.56||49.159||46.701||45.707||41.842||39.623||36.745||34.518||34.196||32.781||31.455||30.096,0.2,0.3,0.4
212,Pflugers_Arch-3-1-1915652.txt,ino||sampl||effect||increas||express||aminoguanidin||rat||renal proxim tubul||gene||product||renal drug transport||lp||proxim tubul||proxim tubular damag||supplementari materi||nephrotox||endotoxemia||tubul cell||renal abc transport||up-regul||gene express||kidney||import efflux pump,masereeuw||renal ino||ino||aminoguanidin||renal abc transport||abc transport||renal efflux transport||russel FG masereeuw||renal drug transport||renal proxim tubul||bsep||multidrug resist transport||s00424-007-0210-x transport nitric||efflux transport||russel,35.121||32.914||32.173||30.256||28.917||26.548||26.156||25.87||25.092||24.004||23.302||22.659||22.608||22.407||22.403,0.6,0.5,0.3333333333333333
213,Matern_Child_Health_J-2-2-1592251.txt,incom||program||commun health center||preconcept||uninsur||center||public health||pregnanc||state||prevent care||medicaid||major||usual sourc||sourc||health||health coverag||preconcept care||approach||women||health clinic||servic||coverag||feder||fund||opportun||access||famili plan||profession guidelin||waiver||children,health||health care||health coverag||health polici||women health||health care coverag||women health care||medicaid||public health||nation health||health promot||health center||women health polici||health coverag program||health insur,99.875||73.458||72.34||65.454||64.368||63.907||58.593||56.539||56.288||55.412||55.332||53.379||53.256||52.21||51.833,0.4,0.4,0.26666666666666666
214,Arch_Orthop_Trauma_Surg-4-1-2324129.txt,upper ankl joint||follow-up||case||surgic techniqu||lower ankl joint||soft tissu||complic||wire||posterior facet||reduct||joint deviat||disturb||studi||patient||osteiti||clinic||view||lower leg||statist analysi||fractur||close reduct||treatment||intern fixat||calcaneu||intern fixat techniqu||averag||follow-up evalu||surgeri||normal shoe||disloc calcan fractur||good condit||rang||averag follow-up time||zwipp score||compar result||result,calcaneu||calcaneu fractur||fractur||calcan fractur||disloc calcaneu fractur||calcaneu wire||calcan fractur major fractur||disloc calcaneu||intraarticular calcan fractur||disloc calcan fractur||intraarticular fractur||92 calcan fractur||oper calcaneu||100 calcan fractur||intra-articular fractur,93.584||89.402||85.221||71.902||65.01||61.452||57.691||54.904||54.775||53.343||52.871||49.328||48.333||47.935||47.22,0.4,0.3,0.2
215,Sleep_Breath-4-1-2270921.txt,apnea||initi treatment option||linear regress||oral applianc||sleep medicin physician||level||sleep medicin||measur||time||reduct||success treatment outcom||data||model||studi||dental sleep medicin specialist||patient||rdi||upper airway||sleep disord breath||investig||recoveri||posttreat||valid||osa||titrat endpoint||clinic cut-off||sleep||mad||sleep apnea||dentist||obstruct sleep apnea||small sampl size||devic||algorithm||group||correl analysi||cpap therapi||mandibular advanc devic||outcom,sleep||sleep apnea||sleep breath sleep||mad||keyword sleep apnea sleep||obstruct sleep apnea||posttreat||posttreat apnea||sleep medicin||apnea||sleep apnea syndrom||sleep qualiti||sleep 29||sever sleep apnea||complex sleep apnea,106.402||80.477||76.309||67.76||66.839||60.736||60.264||57.408||56.114||54.552||54.324||54.29||54.134||53.994||53.651,0.6,0.7,0.4666666666666667
216,Clin_Oral_Investig-4-1-2238780.txt,level||data||abras||eros||wear||teeth||smith||tooth wear||dentin||adult||evid||term||patholog tooth wear||research||age||popul||attrit||group||adolesc||clinic experi||small proport||hypothesi||progress||children,wear||tooth wear||tooth||palat tooth wear||patholog tooth wear||sever tooth wear||patholog eros tooth wear||gradual wear||wear vari||wear indic||palat tooth||patholog tooth||tooth surfac||eros||keyword eros tooth,131.799||116.214||100.63||80.746||80.399||78.134||73.257||67.427||65.899||65.899||55.22||54.698||53.981||51.834||50.821,0.6,0.3,0.26666666666666666
217,Appl_Microbiol_Biotechnol-3-1-1914249.txt,wastewat||ethanol||reactor||strain||srb||dna||electron donor||specif||cell||gram||oligonucleotid probe||electron acceptor||sulfat||acet||genet divers||singl energi sourc||micro-divers||presenc||substrat||full-scal sulfidogen bioreactor||sulfate-reduc bacteria,analysi desulfovibrio desulfovibrio||sulfate-reduc bacteria||strain desulfovibrio||bacteria||cell hybridis desulfovibrio giga desulfovibrio||reactor||similar sulfate-reduc bacteria||eub338||desulfobacca||srb||probe eub338||desulfovibrio mexicanu sp. nov.||sulfate-reduc bacterium||mesophil sulfate-reduc||sulphate-reduc bacteria,52.731||48.292||47.8||45.518||33.828||33.728||32.194||30.781||29.701||29.034||28.879||28.704||28.462||28.264||27.214,0.2,0.3,0.2
218,Skeletal_Radiol-3-1-2042033.txt,skelet system||diagnost sensit||muscl||case||system||system muscl diseas||fat||high resolut||scanner||mri||imag||muscl diseas||patient||malign diseas||bone marrow||pet-ct||sensit||diagnost accuraci||lesion||magnet reson imag||skelet metastas||multislic CT||muscl dystrophi||patient posit||bone scintigraphi||ms-ct||excel soft tissu contrast||examin||multipl cartilagin exostos||multipl||result||assess||spatial resolut||bodi||multipl myeloma||tumor||destruct||scintigraphi||radiographi||diseas||whole-bodi imag||introduct,whole-bodi mri||whole-bodi imag||bone||whole-bodi mri ajr||mri||bone imag||multi-channel whole-bodi mri||whole-bodi applic||high-resolut whole-bodi||state-of-the-art whole-bodi imag||imag||bone marrow imag||bone marrow||bone metastas||whole-bodi turbo stir,68.365||64.718||54.234||48.232||47.99||47.465||47.425||46.324||44.93||43.832||40.696||40.555||40.484||37.603||36.405,0.4,0.2,0.26666666666666666
219,Crit_Care-8-6-1065076.txt,metabol||effect||control||cardiac surgeri||intens care unit||hyperglycemia||studi||critic ill||hyperglycaemia||intens insulin therapi||ill patient||insulin||tight glucos control||patient,critic||critic ill||icu||glucos control||intens control||tight glucos control||intens care||insulin||tight control||tight blood glucos control||blood glucos||critic ill polyneuropathi||icu mortal||control||intens insulin therapi,22.275||21.554||21.114||19.738||18.935||18.928||18.885||17.287||15.934||15.886||15.838||15.19||14.711||14.56||14.52,0.2,0.3,0.3333333333333333
220,J_Neurooncol-3-1-1915654.txt,von hippel-lindau diseas||hemangioblastoma,hemangioblastoma||radiotherapi||neuro-oncolog||progress hemangioblastoma||von hippel-lindau diseas||von hippel-lindau diseas hans||dissemin hemangioblastomatosi||PO box 5201||PO box 2040||PO box 1350||radiotherapi field||piribau||high-dos total neuraxi radiotherapi||myotom C4||s11060-006-9321-z origin paper hemangioblastomatosi,11.12||7.817||6.903||6.776||6.053||5.549||5.06||4.743||4.536||4.51||4.485||4.039||3.652||3.308||3.306,0.4,0.2,0.13333333333333333
221,Mol_Genet_Genomics-4-1-2413074.txt,cell wall||phylogenet analysi||studi||homologu||present||strain||fungi||express||aspergilli||similar||gene||glucoamylas||alpha-amylas||glucan||starch||enzym||protein||analysi||starch-bind domain||member||group||famili||amyr||maltos||presenc||transfer||agdb||sequenc||function||result,aspergillu niger||A. niger A. niger||A. niger||A. niger aspergillu A. niger||A. niger A.||A. niger 2007 aspergillu A. niger||2 A. niger aspergillu A. niger||niger genom||A. niger amya||amyr||amy A. niger||A. oryza A. niger||21 barker aspergillu niger aspergillu niger||keyword aspergillu niger||4 A. niger,182.228||181.412||181.412||166.953||156.769||139.334||139.134||131.424||127.678||125.605||124.791||122.329||121.876||121.485||120.976,0.0,0.1,0.06666666666666667
222,Bioinformation-2-2-2174422.txt,teck databas||telomer||entri||inform||centromer||chromosom||protein||databas||data||sequenc||cell,teck||teck databas||databas||centromer||teck databas home page||centromer sequenc||protein databas||telomer||comprehens databas||databas gui||sastra||centromer chromosom kinetochor protein||chromosom||centromer pattern||telomeras,30.129||27.856||25.583||21.256||15.811||15.29||15.171||14.639||14.21||14.174||13.215||11.824||11.735||11.477||9.546,0.6,0.4,0.3333333333333333
223,Dev_Genes_Evol-4-1-2292473.txt,insight||insect||constraint||artifact||element||data||organ||breakpoint||region||complex||cluster||express||hox||gene||transcript||beeman||analysi||hox gene||homc||hox cluster||regulatori element||embryon develop||singl imag||sequenc||function||result,tribolium||ptl tc-antp||ptl d60||ptl d60 ptl d60||ptl kt76 ptl d60||tc-antp ptl d60||ptl kt76||dch-3 ptl d60||tc-antp ptl kt76||transcript tribolium tribolium||tc-antp Cx tc-scr ptl d60||tribolium 2005 tribolium||tc-antp tribolium Cx tc-scr||tc-antp||tribolium hox cluster,184.881||176.248||157.77||157.77||145.909||144.182||134.047||128.897||128.367||128.308||124.082||123.841||122.437||117.006||115.867,0.0,0.0,0.0
224,Naunyn_Schmiedebergs_Arch_Pharmacol-3-1-2020506.txt,phosphoinositid||actin cytoskeleton||ra||gtpase||isoform||actin remodel||direct interact||actin organ||receptor||arf||pld||schmidt||stimul||enzym||protein||regul||rho||activ||synthesi||small gtpase||phosphatid acid||plasma membran||membran,phospholipas||phospholipas D1||phospholipas D2||mammalian phospholipas||norepinephrine-induc phospholipas||adp-ribosylation-factor-stimul phospholipas||toxin-b-inhibit phospholipas||rho-control phospholipas||phosphatidylcholine-specif phospholipas||distinct phospholipas||yeast phospholipas||keyword phospholipas||cardiomyocyt phospholipas||phospholipas A2||exton JH phospholipas,246.765||138.943||131.538||127.396||124.759||124.759||124.759||124.759||124.609||123.991||123.943||123.383||123.383||123.383||101.837,0.0,0.0,0.0
225,Eur_J_Appl_Physiol-4-1-2374881.txt,person||muscl||mmc||ambulatori statu||non-domin side||joint||major muscl group||health-rel fit compon||studi||valu||ankl joint||relat||test||larg group||skin-fold||strength||result||mobil||young adult||joint mobil||physic fit||exercis||activ||maxim exercis test||hydrocephalu||differ||muscl strength||adolesc||particip||health-rel physic fit||aerob capac||spina bifida||compon,aerob fit||aerob capac||fit||physic fit||health-rel physic fit||health-rel fit||physic capac||capac||rehabil||aerob power||aerob train||increas aerob capac||aerob perform capac||health-rel physic fit compon||strength,34.494||31.28||28.896||25.9||22.87||22.853||22.687||22.468||21.668||21.357||21.23||20.853||20.853||18.839||18.269,0.6,0.3,0.26666666666666666
226,Eur_Arch_Otorhinolaryngol-4-1-2254466.txt,type||follow-up||case||surgic complic||surgic treatment||facial nerv||studi||recurr||rpa||patient||clinic featur||risk||nerv||multinodular||total||lesion||intervent||signific||multipl lesion||postop radiotherapi||pleomorph adenoma||tumor recurr rate||surgeri||prognost factor||tumor||parotidectomi||malign||previou oper||period,recurr||recurr pleomorph adenoma||pleomorph adenoma||parotid gland||adenoma||gland||recurr lesion||uninodular recurr||recurr tumor||residu pleomorph adenoma||recurr rate||fourth recurr||rpa||recurr benign parotid tumour||parotid surgeri,84.734||73.169||67.387||62.916||61.182||47.673||46.09||45.439||45.053||44.925||43.434||42.896||42.503||41.457||41.052,0.4,0.2,0.2
227,Arch_Sex_Behav-3-1-2042031.txt,sexual behavior||unprotect sex||men||previou std diagnos||past 3 month||studi||oral sex||patient||abus characterist||std||effect||risk||forc||sex||adult||sexual risk behavior||analys||outcom||coercion||demograph||research||penetr||gender||characterist||experi||sexual partner||group||sexual abus||episod||number||abus||limit||partner||addit||hiv||sexual act,sexual abus||abus||adolesc sexual abus sexual||penetr sexual abus||childhood sexual abus||child sexual abus||sexual abus characterist||adolesc sexual abus||sever sexual abus||sexual abus sever||sexual abus experi||non-penetr sexual abus||sexual abus group||sexual abus statu||sexual abus influenc,276.759||247.514||216.51||202.506||194.157||188.712||188.329||186.679||185.523||185.523||185.393||185.391||184.506||184.506||184.506,0.4,0.2,0.13333333333333333
228,Virchows_Arch-4-1-2329727.txt,normal colon||epitheli cell||sdf-1||normal mucosa||carcinoma||adenoma||express||cell||hypoxia||hypox cell||mammalian target||tissu||mtor||surfac epithelium||activ||cytoplasm||pimonidazol||surfac||hif-1||presenc||sdf1||area||colorect carcinogenesi||CA IX||antigen retriev||akt||normal colon tissu||colorect mucosa,hif-1α||hif-1||hif-1α stain||sdf-1||adenocarcinoma hif-1α||hif-1α express||colorect mucosa||colorect adenoma||adenoma||hif-1α presenc||peri-necrot hif-1α||mtor||hif-1α pattern||sdf-1 stain||nuclear hif-1α,86.953||59.891||58.391||57.642||54.511||52.938||51.824||51.109||49.776||47.57||47.566||44.792||44.355||43.736||43.477,0.4,0.4,0.3333333333333333
229,Osteoporos_Int-4-1-2277453.txt,placebo||vertebr fractur||data||studi||bone microarchitectur||osteopenia||patient||effect||risk||risk reduct||femor neck||fractur||postmenopaus women||treatment||advers event||bmd||women||nonvertebr fractur||low bone mass||analysi||popul||risedron||preval vertebr fractur||osteoporosi||fragil fractur||trial||trabecular architectur||fractur risk,fractur||risedron||vertebr fractur||fragil fractur||fragil fractur fragil fractur||nonvertebr fractur||fractur risk||preval fractur||osteoporot fractur||fractur efficaci||leg fractur||subtrochanter fractur||ankl fractur||fractur type||fractur outcom,131.293||93.18||86.519||84.946||84.946||80.119||75.756||71.31||70.453||69.213||68.179||66.887||66.823||65.647||65.647,0.8,0.6,0.4
230,Histochem_Cell_Biol-4-1-2413111.txt,mutant form||cancer||inflamm||endotheli cell||tj||ion select||role||TJ assembl||breast cancer develop||data||tight junction strand||patient||occludin||permeabl||observ||increas||toxin||diabet retinopathi||barrier||express||evid||cell||transmembran protein||integr membran protein||barrier dysfunct||tight junction||protein||brb||factor||paracellular pathway||diseas||claudin||molecular composit||cell polar||function||TJ strand,tight junction||junction||tight junction barrier||tight junction permeabl||tight junction strand||epitheli tight junction||tight junction protein||tight junction claudin-14||tight junction alter||osp-bas tight junction||freeze-cleav tight junction||cation-select tight junction||tight junction dysfunct||discontinu tight junction||tight junction permeabl barrier,154.767||149.0||122.51||113.597||112.132||109.833||106.595||105.013||104.381||104.095||104.095||103.995||103.828||103.178||99.696,0.4,0.2,0.13333333333333333
231,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2292474.txt,measur||endogen insulin level||baselin||studi||somatostatin||healthi subject||ere||optic coher tomographi||hyperglycemia||peripher area||retina||glucos||blood retina barrier||maxim hyperglycemia||subject||chang||retin thick||blood glucos level||refract error||procedur||area||fovea||diabet retinopathi||result,hyperglycemia||thick||retin thick||refract||retin thick measur||macular thick||coher tomographi||optic coher tomographi||diabet||optic||retin thick studi||normo-insulinaem hyperglycemia||retin thick analysi||hypo-insulinaem hyperglycemia||diabet retinopathi,57.265||50.269||46.856||40.271||34.68||33.903||32.625||32.378||32.016||31.884||31.833||31.774||31.237||30.203||30.147,0.4,0.3,0.26666666666666666
232,Matern_Child_Health_J-2-2-1592139.txt,program||case||preconcept||diabet||birth||individu||pregnanc||data||studi||effect||birth defect||invest||investig||intervent||perspect||analys||cost||evalu||preconcept care||women||preconcept visit||servic||care||advers pregnanc outcom||prenat care||public health program||econom evalu||health care provid||case studi||econom burden||financi return||busi case||cost-benefit analysi||health outcom||benefit||health plan||outcom||result,care||preconcept care||preconcept||cost||busi||health care||comprehens preconcept care||preconcept care visit||preconcept care servic||preconcept care intervent||preconcept care group||financi cost||health cost||prenat care||care program,78.049||74.659||71.27||67.315||53.235||53.198||51.706||51.524||50.84||50.714||50.042||48.4||47.831||45.959||45.874,0.8,0.4,0.3333333333333333
233,J_Chem_Ecol-4-1-2292484.txt,mechan damag||level||jasmon acid||terpenoid aldehyd||induct||total foliag||data||studi||comparison||young leav||effect||increas||gland number||higher concentr||signific||herbivori||leav||analys||individu leaf||treatment||damag||control||mechan injuri||leaf||cotton||simul herbivori||accumul||monoterpen||true leav||differ||total terpenoid||anova||number||gland||sesquiterpen||terpenoid||plant,cotton||terpenoid||cotton plant||cotton gossypium||cotton gossypium hirsutum||cotton leav||spodoptera||J.||minor cotton terpenoid||gossypium hirsutum||glandless cotton||plant||cotton plant entomol||gland||cotton leaf gland,96.196||82.716||76.929||73.054||71.183||66.392||65.52||62.631||60.043||58.676||57.878||57.663||57.583||57.202||56.86,0.4,0.2,0.26666666666666666
234,Breast_Cancer_Res_Treat-3-1-2137942.txt,independ predictor||case||mast cell||surviv curv||core||breast cancer||studi||patient||ER score||statist analysi||MC infiltr||tma||invas breast cancer||cell||immun cell||train||prognosi||mc||total number||group||tumor||surviv||presenc||number||good prognosi||stroma||result,mast cell||mc||stromal mast cell||mast cell chymas||chymase-posit mast cell||mast cell secret||stromal mc||stromal mast cell correl||human mast cell chymas||kosma VM mast cell||mast cell diseas leuk||kovanen PT mast cell chymas||mast cell ER kendal ’s||caughey GH mast cell tryptas||cell,43.968||37.177||35.22||33.369||30.326||29.312||27.45||27.385||25.027||22.934||22.46||21.607||21.186||19.926||19.886,0.4,0.2,0.2
235,Matern_Child_Health_J-2-2-1592152.txt,prevent||condit||preconcept||dime birth defect foundat||profession practic guidelin||reproduct awar||health care profession||perinat period||medic condit||pregnanc||histori||patient||folic acid||perinat outcom||health statu||risk||organ||reproduct||specif type||preconcept assess||medic||nurs||unit state||profession||counsel||guidelin||health||health care||women||american colleg||effort||preconcept health||famili physician||standard||main perinat prevent strategi||servic||care||commit||poor pregnanc outcom||genet||committe||import||medicin||screen||preconcept health servic||decad||acog||diseas||nation organ||object||preconcept screen||current statu||fetal alcohol syndrom||outcom,preconcept||preconcept care||pregnanc||preconcept health||preconcept health care||care||preconcept counsel||health care||age-appropri preconcept care||preconcept screen||preconcept visit||preconcept servic||preconcept health servic||preconcept carrier||preconcept health standard,114.722||94.665||88.521||87.907||83.474||74.607||70.193||67.85||64.732||64.243||63.187||63.027||62.382||61.66||61.233,0.6,0.6,0.4666666666666667
236,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2292470.txt,condit||measur||line||asthenopia||fixat cross||prism||artifici view condit||comfort||interv||session||valu||fusion vergenc||observ||test||fixat dispar||heterophoria||stimuli||eye||fusion contour||paramet||natur view condit||phoria paramet||comfort prism||deviat||noniu line||differ||eso||phoria||feedback loop||trial,phoria||prism||comfort prism||dissoci phoria||phoria condit||comfort||phoria paramet||phoria valu||dissoci phoria condit||comfort prism differ||comfort prism 2||prism power||rotari prism||prism dioptr||therapeut prism,169.146||142.225||115.505||113.913||90.733||88.786||85.757||85.482||80.049||77.386||77.004||73.995||73.053||72.628||71.868,0.6,0.5,0.3333333333333333
237,Doc_Ophthalmol-4-1-2235911.txt,array||measur||commerci system||time||iscev guidelin||artifact||element||data||patient||stimulu||mferg respons||reliabl mferg record||region||clinic electrophysiolog||signal||mferg trace||retina||frame||frame frequenc||display||normal||light||report||mferg||electr nois||trace||record||fixat||size||clinic multifoc electroretinographi||procedur||local amplitud||area||waveform||record time||result,mferg||mferg record||stimulu||mferg trace||mferg respons||record||mferg amplitud||stimulu element||mferg signal||reliabl mferg record||clinic mferg||mferg result||mferg trace array||stimulu hexagon||stimulu array,71.627||57.581||48.27||44.922||44.84||43.534||43.368||39.652||39.006||38.767||37.361||35.814||35.773||33.097||32.873,0.8,0.6,0.4
238,Ann_Surg_Oncol-3-1-1914276.txt,van nuy classif||mammographi||tissu microarray||PR express||biolog marker express||studi||patient||van nuy||interv group||PR neg||dci||immunohistochemistri||nonattend||neu express||express||two-year interv||suffici paraffin-embed tissu||screen-detect||multivari analysi||group||differ||woman||interv dci||screen round||screen||patholog||tma group||score||chi-squar analysi,dci||screen-detect dci||interv dci||screen-detect||high-grad dci||low-grad dci||pure dci||dci lesion||screen-detect versu interv dci||situ||screen-detect 95||ductal carcinoma||screen-detect patient||situ carcinoma||interv ductal carcinoma,146.677||115.849||89.415||85.022||76.105||75.537||74.346||73.338||65.963||51.425||45.777||45.478||45.131||42.615||41.037,0.6,0.3,0.2
239,Exp_Brain_Res-4-1-2335293.txt,condit||target||measur||color||time||respons||line||veloc||attribut color||latenc||visual process||lumin||orient||basi||finger||averag||shape||curv||subject||chang||systemat differ||differ||order||refer||posit||attribut||conspicu||particip||movement||hand movement||slope,target||target posit||latenc||target lumin||conspicu target||target size||target locat||respons latenc||target circl||final target posit||posit||veloc||averag respons latenc||movement||target exp brain,69.434||49.799||45.799||44.607||44.161||38.114||37.103||35.803||34.717||33.673||30.164||29.984||28.339||27.495||26.416,0.4,0.2,0.3333333333333333
240,Int_Arch_Occup_Environ_Health-4-1-2254471.txt,elderli employe||depress symptom||men||return||studi||depress||year||social legisl||median||occup health depart||durat||compani||depress episod||compani size||dutch situat||sector||absenc||day||educ||health care||psychiatr disord||sick-leav||age||popul||employe||group||differ||part-tim return||episod||industri sector||number||symptom||work||higher risk||period,absenc||employe||depress employe||depress||absenc durat||employe sick absenc||sick absenc||absenc day||absenc episod||longer absenc||longer absenc durat||depress men||employe return||absenc period||regist absenc,111.797||93.218||90.493||87.769||84.656||77.254||69.273||68.166||67.403||64.786||62.363||60.786||60.214||59.514||57.585,0.6,0.3,0.2
241,Breast_Cancer_Res_Treat-3-1-2001220.txt,cancer||target||letrozol||ER overexpress||breast cancer||combin||studi||tamoxifen||patient||clinic||effect||microarray gene||agent||aromatas inhibitor||express||tool||treatment||cell||growth||therapi||growth factor||gene||adjuv therapi||tumor biolog||trastuzumab||recent advanc||breast tumor||combin therapi||estrogen||resist||tumor||trial||pathway||biomark,letrozol||letrozol breast cancer||breast cancer||breast cancer breast cancer||cancer||metastat breast cancer breast cancer||human breast cancer breast cancer||inhibitor letrozol||breast cancer clin cancer||her2 letrozol||breast cancer cell cancer||mtor letrozol||metastat breast cancer||advanc breast cancer||breast cancer eur,120.862||104.723||96.653||96.653||96.294||78.96||78.191||76.668||74.665||73.217||72.758||67.665||67.165||66.292||66.151,0.6,0.3,0.2
242,Exp_Appl_Acarol-3-1-2039815.txt,variat||dna sequenc||host plant associ||coi||host plant||tetranychid mite||base frequenc homogen||phylogenet analysi||sampl||studi||genu||parasit||dataset||mitochondri coi phylogeni||pattern||dna||gene||phylogeograph pattern||speci delin||analysi||barcod||tetranychida||identif||reproduct parasit||taxa||select sweep||access||spider mite||posit||evolutionari relationship||speci||paup||mite||sequenc||genbank||nuclear||result,tetranychu||tetranychu urtica||spider mite tetranychu urtica||tetranychida||1998 tetranychu tetranychu||tetranychu urtica koch||tetranychu kanzawai||tetranychu cinnabarinu||tetranychu urtica complex||tetranychu T. kanzawai T.||tetranychu speci||T.||tetranychu kanzawai tetranychu truncatu T.||mite||tetranychu turkestani T.,125.606||122.502||94.221||89.699||87.101||85.035||83.392||81.921||81.668||81.491||80.242||79.591||78.911||76.157||75.261,0.2,0.1,0.13333333333333333
243,Calcif_Tissue_Int-3-1-2151961.txt,lifestyl||men||spine||studi popul||data||studi||genotyp||gene||bmd||bodi||analysi||age||associ||polymorph||subject||activ men||popul||low-dens lipoprotein receptor-rel protein 5||peak bone mass||differ||bone||fat mass||signific differ||particip||bodi height||bone miner densiti||bodi mass,NS||lrp5||0.07 NS NS||bone||lrp5 polymorph||7.3 NS||7.0 NS||0.07 NS NS data||1.8 NS||NS 0||16.4 NS||7.9 NS||NS 3||3 NS||0.08 NS,76.661||52.8||52.487||47.502||41.298||40.271||39.948||39.365||39.055||38.947||38.926||38.824||38.339||38.339||38.33,0.2,0.1,0.06666666666666667
244,Matern_Child_Health_J-2-2-1592146.txt,public health concern||risk||obes||women||postpartum||birth outcom||age||prevent studi||activ||pregnanc||intervent||bmi||weight trend||nutrit||overweight,overweight||obes||weight gain||matern overweight||matern obes||pregnanc weight gain||matern weight gain||gestat weight||prepregn weight||gestat weight gain||pregnanc||siega-riz||matern bodi weight||postpartum||obes prevent,38.832||36.161||30.912||30.59||29.255||28.753||28.058||26.766||25.209||24.591||24.434||24.36||23.816||23.599||22.519,0.4,0.2,0.26666666666666666
245,Pediatr_Nephrol-4-1-2413093.txt,podocyt||slit diaphragm||lmx1b,lmx1b||lmx1b lmx1b||lmx1b lox||johnson RL lmx1b lmx1b||lmx1b gene||lmx1b ldb1 e2a||podocyt||lmx1b cre nphs2 bar||lim-homeodomain transcript factor lmx1b||nphs2||knoer nvam gubler m-c lmx1b target||podocyt filtrat||podocyt differenti||glomerular slit||patella syndrom,117.707||117.707||63.657||60.783||60.409||41.345||38.555||36.721||31.699||27.117||23.37||19.965||19.822||16.831||13.506,0.2,0.2,0.13333333333333333
246,Ann_Surg_Oncol-3-1-2039827.txt,delay||dlt||week||maximum-toler dose||phase II studi||studi||patient||endopelv fascia||total||radiotherapi||dose||local recurr rate||day||chemoradi||surgeri||capecitabin||tumor||oxaliplatin||resect||pcr||rectal cancer||treatment cycl||result,oxaliplatin||rectal cancer||preoper oxaliplatin||capecitabin||radiotherapi||rectal perfor||preoper radiotherapi||advanc rectal cancer||rectal cancer patient||poor-risk rectal cancer||irresect rectal cancer||rectal cancer int||T3||rectal cancer Br||weekli oxaliplatin,56.568||47.984||45.315||44.864||37.666||36.196||35.864||35.617||34.85||32.786||32.653||32.623||32.497||31.989||30.778,0.8,0.4,0.26666666666666666
247,Ann_Surg_Oncol-4-1-2277454.txt,grade||fasciotomi||normal tissu||ilp||radiat||surgic resect||studi||patient||perfus||st||major therapeut intervent||medic intervent||treatment procedur||long-term morbid||manag||item||irrevers function damag||extrem||tissu||sever symptom||late effect||tumor||neg impact||limb||sever||ebrt||object||soft tissu sarcoma||daili activ,0 0||object 0 0||atrophi 0 0||toxic 0 1 2 3 4||extrem sarcoma||limb||tissu sarcoma||limb perfus||perfus||soft tissu sarcoma||soft-tissu sarcoma||isol limb perfus||hypertherm isol limb perfus||multipl sarcoma||tissu perfus,270.242||183.405||182.988||59.826||51.042||49.432||46.745||45.934||42.435||41.774||39.622||38.756||34.474||34.293||33.67,0.0,0.3,0.2
248,Anal_Bioanal_Chem-4-1-2287205.txt,FP detect||measur||gradient hplc system||system||affin||hr||concentr||optim||wavelength||assay||coumestrol||on-lin||phytoestrogen||compound||mixtur||meoh||hr system||experi||min||organ modifi||decreas||fia||fluoresc||competit bind curv||test compound||hplc||mode||fluoresc polar||result,erα||erα affin||erα bioaffin||erα lbd||erα concentr||e2-f||erα FP rad||individu erα||erα affin detect||erα affin 6||erα affin 2||erα affin 3||erα FP affin trace||FP||FP erα rad system,107.955||69.143||63.225||61.294||59.901||58.584||56.932||54.931||48.979||46.552||46.189||46.122||46.024||44.796||44.05,0.0,0.0,0.0
249,Photosynth_Res-4-1-2173912.txt,array||structur||red alga||width||phycobilisom||cyanobacteria||project||pbss||psii||pb||electron microscopi||membran,phycobilisom||cyanobacteri phycobilisom||phycobilisom size||phycobilisom diffus||phycobilisom model||phycobilisom method||photosystem||red algal phycobilisom||red alga porphyridium cruentum||discuss porphyridium cruentum||red alga porphyridium||mullineaux CW phycobilisom mobil||psii||cyanobacteria||thylakoid,87.236||50.64||44.359||44.351||43.618||43.618||41.085||37.651||34.999||30.144||29.439||29.091||26.722||25.783||25.365,0.2,0.1,0.2
250,Int_J_Cardiovasc_Imaging-3-1-2121121.txt,heart failur,atrial function||left atrial size||left atrial perform||left atrial volum||atrial contribut||left atrial eject forc||left atrium||atrial systol function||atrial function increas||left atrial function eur heart||left ventricular function||2007 keyword left||heart||toutouza||eject forc,16.986||16.654||15.967||15.967||15.733||15.341||13.457||12.625||12.046||11.927||10.728||7.39||7.065||6.855||6.732,0.0,0.0,0.0
251,J_Magn_Reson-2-1-2323944.txt,equat||human brain||magnet transfer||duti cycl||optim||CW approxim||data||model||acquisit sequenc||excit puls||valu||standard deviat||two-pool model||effect||sensit||test||signal||similar||sled||paramet||solut||estim||experi||simul||flip angl||consist||ramani||CW variant||nois||excit flip angl||magnet||result,RM||RM 0||rfb RM 0||vivo RM 0||0||0 0||1 RM 0||sled||sat||equat||rfb||τ sat||fig. 5 RM 0||fig. 4 RM 0||θ 0 0 1,100.092||80.9||68.086||63.142||61.708||61.708||61.415||50.95||47.182||43.954||42.457||41.673||41.017||40.823||40.75,0.0,0.2,0.13333333333333333
252,J_Med_Internet_Res-4-2-1761933.txt,web site qualiti||time||url||search engin||qualiti||locat||studi||medic topic||internet archiv||specif health-rel topic||site locat||inform||temporari server problem||health claim||site||health inform||address field||content||page||web||web page||uncertain period||item||web content||previou studi||attrit||topic||access||refer||issu||world wide web||viewer||health-rel web site||medic knowledg||result,web||web site||site||web site qualiti||origin web site||web site viewer||health-rel web site||access web site||184 web site||web site sponsor||url||web archiv||web page||qualiti site||site qualiti,113.885||108.162||102.438||77.518||77.488||77.055||76.959||75.389||74.711||72.542||71.004||65.032||61.789||59.334||59.334,0.6,0.4,0.4
253,Behav_Genet-4-1-2226020.txt,social interact effect||measur||find||phenotyp correl||attent problem||instrument||rate||problem||data||model||dsm||zygos||effect||correl||missing||test||variabl||cbcl||present paper||sex||environment influenc||present studi||specif||fit||item||varianc||twin||age||dsm-iv interview||cprs-r||age 12||genet||matern rate||clinic diagnos||factor||statist analys||influenc||statist power||adhd||score||children||result,cbcl||cbcl rate||cbcl score||cprs-r||cbcl question||cbcl measur adhd||genet||cbcl age 7||dsm cbcl age 7||twin||cbcl AP score||adhd||longitudin cbcl score||threshold cbcl age 12||threshold cbcl age 10,190.168||102.492||99.631||95.63||95.084||87.437||74.011||73.667||70.756||70.018||68.101||67.709||67.182||63.776||62.434,0.4,0.4,0.3333333333333333
254,Eur_J_Pediatr-4-1-2292482.txt,epp||photosensit||girl||erythropoiet protoporphyria||symptom||nose||children||cutan manifest||age||porphyria||sever||sun exposur||liver enzym||diagnosi||patient||skin lesion||skin symptom||protoporphyrin,protoporphyria||erythropoiet protoporphyria||erythropoiet protoporphyria Br||erythropoiet protoporphyria eur||domin erythropoiet protoporphyria||epp||porphyria||erythropoiet protoporphyria-report||cutan porphyria||erytropoiet protoporphyria eur||protoporphyria fech ferrochelatas ro||young child-erythropoiet protoporphyria||protoporphyria current problem||erythropoiet protoprophyria-submicroscop event||photosensit,86.591||83.698||56.908||56.684||56.48||47.192||46.887||42.005||34.925||30.817||30.552||29.932||28.864||28.003||25.549,0.2,0.3,0.26666666666666666
255,J_Mol_Biol-2-1-2279256.txt,bind pocket||dtdp||activ site||case||wbmf||cofactor||studi||mutat||protein function||structur||site||gmer||wbmg||antigen||gene||reaction||potenti||triad||product||wbmh||catalyt site||residu||protein||side chain||sdr||blast||phosphat||2||pdb||bind||present time||mutant||posit||substrat||function||ump||deoxythymidin diphosph||lipopolysaccharid,wbmf||wbmf wbmg wbmh||wbmg wbmh wbmf wbmg||wbmh||wbmg wbmh||wbmg||wbmf wbmg wbmh B.||bordetella bronchiseptica||wbmf wbmg wbmh mutant||wbm wbm wbmf wbmg wbmh||wbmf structur||bordetella||wbmf crystal||wbmf rel||incomplet wbmf,118.608||97.384||94.008||89.666||86.772||83.879||78.966||76.501||74.156||73.467||70.053||61.961||60.482||59.304||59.304,0.4,0.3,0.2
256,Childs_Nerv_Syst-3-1-1849423.txt,capillari||intracrani complianc||puls pressur||csf||subarachnoid space||chronic hydrocephalu||ventriculostomi||theori||normal-pressur hydrocephalu||hydrodynam concept||view||etv||systol pressur||systol pressur transmiss||acut hydrocephalu||treatment||etiolog||dandi||cerebrospin fluid||csf pressur||pathophysiolog||hydrocephalu||brain parenchyma||narrow capacit vessel||patent aqueduct||complianc,hydrocephalu||hydrocephalu commun hydrocephalu||chronic hydrocephalu||normal-pressur hydrocephalu||acut hydrocephalu||hydrocephalu research||hydrocephalu classif||intern hydrocephalu||hydrocephalu greitz dan||normal pressur hydrocephalu||csf||greitz||csf pressur||minor pathway hydrocephalu||normal pressur hydrocephalu Br,103.992||72.912||55.04||54.977||52.496||51.996||51.996||51.996||47.613||45.433||42.605||37.085||35.579||34.997||34.075,0.8,0.4,0.4
257,Eur_J_Pediatr-4-1-2254655.txt,mechan ventil||stay||week||case||respiratori distress syndrom||air leak||patient||cpap||air||pneumomediastinum||subcutan emphysema||infect||tissu||age||spontan PM||pneumopericardium||group||intens care unit||neonat||sever||diseas||lung||children,PM||neonat PM||spontan PM||neonat||4 PM||icu PM||idiopath PM||5 PM||2 PM||6 PM||3 PM||13 PM||9 PM||neonat air||5 PM convuls,80.125||61.766||49.951||43.408||42.969||41.696||41.427||40.68||40.063||40.063||40.063||40.063||40.063||29.853||28.9,0.4,0.2,0.13333333333333333
258,Eur_J_Nucl_Med_Mol_Imaging-3-1-1914271.txt,effect||contrast agent||field||studi||imag||clinic arena||promis applic||specif inform||vessel wall||total plaqu burden||molecular imag||cardiovascular molecular imag||patient||therapi||cardiovascular diseas,imag||molecular imag||cardiovascular imag||molecular imag agent||cardiovascular molecular imag||cardiac imag||imag lamb||imag techniqu||magnet reson imag||contrast agent||cardiovascular magnet reson imag||contrast agent cardiovascular||reson imag predict||fibrin-target contrast agent||gadolinium-bas contrast agent,63.209||47.525||44.333||42.266||40.17||33.789||33.702||31.604||29.123||28.445||28.207||27.449||25.385||24.656||22.743,0.6,0.4,0.26666666666666666
259,J_Autism_Dev_Disord-4-1-2226079.txt,permeabl||autism||ratio||hyperserotonemia||blood sampl||platelet||serotonin||test||sat||studi||pdd||urin||intestin permeabl||patient||children,plt||plt 5-ht||curaçao||intestin permeabl||serotonin||permeabl||increas plt 5-ht||increas intestin permeabl||kema||S. intestin permeabl||abnorm intestin permeabl||9 plt||normal intestin permeabl||platelet serotonin||autism,27.954||25.973||25.736||24.975||23.95||23.775||19.315||18.65||18.456||17.836||17.538||16.841||16.65||16.48||16.023,0.4,0.3,0.26666666666666666
260,Skeletal_Radiol-3-1-2042032.txt,prospect studi||find||week||radiograph||incident find||abnorm||non-acut knee symptom||histori||studi||year||patient||bone marrow edema||articular surfac lesion||diagnos||radiologist||convent radiograph||magnet reson imag||non-acut knee problem||knee radiograph||loos bodi||young adult||group||osteoarthr||symptom||enchondroma||knee||signific differ,radiograph||mri||knee radiograph||mri 1 radiograph||patient radiograph||radiograph diagnos||convent radiograph||standard radiograph||unnecessari radiograph||conclus radiograph||recent radiograph||normal radiograph||prior convent radiograph||mri evalu||underw mri,126.201||82.017||80.312||69.968||68.106||66.059||65.243||65.198||63.828||63.568||63.1||63.1||44.29||41.942||41.765,0.4,0.3,0.2
261,Breast_Cancer_Res_Treat-3-1-2137941.txt,tumour||age 50||cancer||breast tumour||cbc||missens variant||women||spectrum||studi||carrier||analysi||variant||age||atm||radiotherapi||ubc||breast cancer||mutat||treatment||patient,atm||atm 2 atm atm||llc 2007 atm atm atm atm||atm atm atm tabl 2 atm||atm atm missens variant||atm mutat||chek2 atm atm genotyp||atm heterozygot||atm function||atm haplotyp||atm atm missens mutat spectrum||atm missens mutat||atm missens variant||mutat analysi atm atm mutat||atm sequenc variant,222.925||167.472||148.938||148.802||136.796||131.202||112.801||112.575||112.156||111.962||110.537||108.243||108.087||105.325||88.232,0.2,0.1,0.06666666666666667
262,Pediatr_Radiol-3-1-1915603.txt,oper find||find||boy||children||viabl abdomin test||studi||patient||test||abdomen||re-examin||testi||npt||testicular posit||udt||laparoscopi||surgeri||surgic procedur||posit||physician||paediatr surgeon||result,npt||inguin testi||nonpalp inguin testi||testi||152 npt||156 npt||30 npt||true’ npt||118 npt||49 npt||presum npt||palpabl testi||inguin canal||undescend testi||inguin explor,85.026||53.429||46.512||46.321||44.744||44.045||43.793||43.636||43.219||43.156||43.107||37.151||36.896||34.197||33.468,0.4,0.2,0.13333333333333333
263,Virchows_Arch-3-1-1888715.txt,respons||partial cribriform prolifer||chi-squar test||reexcis||flat epitheli atypia||studi||patient||question||pathologist||interobserv variabl||criteria||atyp hyperplasia||lesion||adh||ductal intraepitheli neoplasia||signific||high proport||manag||resect margin||respond||number||invas carcinoma||duct||survey||diagnosi||breast||hyperplasia,pathologist||dci||ductal lesion||ductal carcinoma||breast||ductal hyperplasia||breast lesion||reexcis||duct||ductal prolif breast lesion||lesion||invas ductal breast lesion||atyp ductal hyperplasia||expert breast pathologist||keyword breast ductal carcinoma,52.869||47.579||44.006||41.189||39.49||38.818||37.032||36.423||36.198||35.895||34.574||34.169||33.171||32.591||30.467,0.4,0.4,0.3333333333333333
264,Soc_Sci_Med-2-1-2430159.txt,institut consult||find||depart||global economi||salari||practic||research consult||individu||problem||health-rel research||africa||govern depart||limit research capac||academ research||research programm||low univers salari||sub-saharan africa||northern||east africa||overhead||social scientist||research capac||global econom inequ||consult||institut||staff||health||ngo||research||social scienc capac||senior social scientist||contract||senior||report||uganda||agenc||local capac||interviewe||univers staff||donor,research||research consult||consult research||research capac||senior research||research institut consult||institut research consult||northern research||research programm||junior research||develop research||consult||research contract||individu research consult||individu research,116.818||90.202||90.202||82.834||70.199||66.497||66.497||64.975||64.349||64.119||63.8||63.586||62.712||62.545||62.024,0.6,0.4,0.3333333333333333
265,Int_J_Hematol-4-1-2330061.txt,cdna||cocultur||gene||cfc assay||defect||increas||stromal cell||mice||microarray||analysi||express||anim experi||hematopoiet stem cell||cell||hsc,pa6||pa6 cell||pa6 s-2 cell||pa6 subclon cell||pa6 cell line||pa6 cocultur microarray||pa6 subclon cell 3||pa6 s-12 3.2||cell||chimer pa6 10.8||19.9 pa6 s-2 0.60||stromal cell||23.0 pa6 s-2 4||hsc||stem cell,110.181||75.614||62.995||57.53||52.845||45.345||43.147||41.97||41.048||39.444||37.975||37.728||37.402||35.098||32.643,0.0,0.1,0.2
266,Clin_Auton_Res-3-1-1858602.txt,attent||deficit||sampl||duschek||recent research||studi||hypotens individu||blood pressur||test||memori||clinic practic||hypotens||brain||cortic activ||cognit||brain perfus||relationship||eeg studi||lower limit||group||perform||limit||cognit test||cognit deficit||tonic brain perfus||cerebr blood flow||cognit perform||strong evid||addit,hypotens||blood||chronic hypotens||schandri||hypotens 26||40 hypotens||orthostat hypotens||moder hypotens||essenti hypotens||hypotens 25||hypotens group||hypotens individu||hypotens 17||hypotens 32||hypotens 37,115.791||61.14||60.218||59.136||58.905||58.874||58.835||58.687||58.372||58.289||57.902||57.895||57.895||57.895||57.895,0.2,0.1,0.13333333333333333
267,Immunogenetics-3-1-1914291.txt,gene||rhesu macaqu||indian rhesu macaqu||clone||macaqu||evolut||loci||cynomolgu macaqu||vertebr speci||chines origin||polymorph||region configur||haplotyp||sequenc||allel,A1||8822 A1||8765 A1||4053 A1||81 A1||77 A1||80 A1||88 A1||83 A1||A2||0515 3 A1||0513 3 A1||3001 2 A1||0514 4 A1||5801 4 A1,271.516||138.532||137.264||137.114||136.835||136.463||135.758||135.758||135.758||134.107||95.697||94.693||94.639||93.536||93.103,0.0,0.0,0.0
268,Eur_J_Pediatr-4-1-2292480.txt,colchicin||fmf||amyloidosi||attack||famili mediterranean fever||month||patient||treatment||chest pain||anakinra,colchicin||fever||anakinra||famili mediterranean fever||colchicin resist anakinra||fever attack||period fever||famili mediterranean fever protein||famili mediterranean fever patient||recurr fever attack||fmf||springer-verlag 2007 colchicin||keyword famili mediterranean||ozdogan||attack,36.572||35.541||27.219||23.12||22.727||22.585||17.77||17.34||17.34||15.636||14.432||13.558||11.273||10.824||9.63,0.6,0.3,0.3333333333333333
269,Intensive_Care_Med-3-1-2092441.txt,mechan||mortal||control||acut respiratori distress syndrom||criteria||ali||children||studi||ard||acut lung injuri||incid||diseas||cd||patient||unit||admiss||high morbid||syndrom||result,cd||ventil cd||ali||syndrom||24 cd||conclus cd||ard||respiratori||acut respiratori distress syndrom||syndrom bruijn||syndrom neuron||acut respiratori failur||acut lung injuri||syndrom brain||syndrom individu,43.726||31.063||29.616||23.941||22.997||22.339||21.44||18.859||16.762||13.058||12.865||12.393||12.297||11.97||11.97,0.6,0.5,0.4
270,Diabetologia-4-1-2292423.txt,paee||type 2 diabet||follow-up||measur||level||triacylglycerol||diabet||reduct||individu||bodi size||total bodi movement||baselin||data||year||bmi||risk||hdl-cholesterol||increas||systol blood pressur||metabol subcompon||metabol syndrom||variabl||analys||fit||zm||glucos||accelerometri||metabol risk||associ||chang||activ||aerob fit||differ||score||height||physic activ||waist circumfer||particip||statist signific,metabol||metabol risk||metabol syndrom||paee||fit||proactiv β||metabol subcompon||ekelund||metabol score||metabol scienc||metabol rate||proactiv trial||proactiv UK||proactiv cohort||1 proactiv,51.957||32.964||31.73||29.879||27.962||27.56||27.472||26.89||26.559||25.978||25.978||25.862||24.871||24.75||24.185,0.8,0.5,0.3333333333333333
271,Breast_Cancer_Res_Treat-4-1-2217623.txt,effect||risk||gene||entri||differ||case||age||variant||polymorph||popul||meta-analys||data||breast cancer||studi||estrogen receptor||result,pvuii||xbai||2 pvuii xbai pvuii||meta-analysi pvuii xbai||result pvuii xbai||xbai pvuii 13||method pvuii xbai polymorph||eralpha pvuii||pvuii rflp||eralpha xbai polymorph||0.05 pvuii||pvuii restrict||xbai 1||polymorph||tabl 2 pvuii xbai genotyp,71.855||68.586||53.23||48.838||46.814||46.814||43.546||38.803||37.003||36.027||35.927||35.927||34.59||33.743||29.559,0.0,0.0,0.06666666666666667
272,Cancer_Immunol_Immunother-4-1-2253649.txt,cancer||clinic impact||studi||patient||hla||colon||stromal cell||immunohistochemistri||low||analys||impact||prognosi||local recurr||group||tumor||surviv||differ||low express||number||total absenc||rectal cancer||irradi||msi||hla express||result,hla||hla class||class||hla express||down-regul hla class||total hla class||non-class hla class||hla allel||hc10 antibodi hca2 hc10 hla class||affect total hla class||keyword immunolog hla class||tumor||mhc class||hca2||hc10,146.456||127.1||107.745||91.824||87.703||86.388||85.638||73.939||68.553||65.035||63.987||61.644||57.61||51.233||51.233,0.4,0.2,0.2
273,Virchows_Arch-3-1-1888720.txt,cancer||case||icc||data||studi||seri||valu||clinic outcom||patient||neg control||high homogen||immunohistochemistri||express||cell||multivari analysi||liver cirrhosi||immunohistochem||apoptosi||surviv||antibodi demonstr||cholangiocarcinoma||liver fluke infest||tumour cell,cox-2||cox-2 express||cox-2 overexpress||cox-2 moder||cox-2 antibodi||R2 cox-2||0.095 cox-2||cox-2 counteract||cox-2 inhibitor||cox-2 gene||cholangiocarcinoma||cox-2 express 18.7||cox-2 protein express||specif cox-2 immunostain||cyclooxygenase-2,85.885||47.272||45.908||44.883||44.854||44.753||43.845||43.74||43.656||42.943||40.141||31.989||31.514||31.282||28.052,0.0,0.0,0.06666666666666667
274,Matern_Child_Health_J-2-2-1592246.txt,infant||behavior||birth||pregnanc||matern||state||perinat outcom||effect||risk||medicaid||primari care provid||profession organ||matern mortal||unit state||deliveri||intervent||evid||primari care||health||preconcept care||women||age||matern complic||servic||prenat care||american academi||pregnanc outcom,prevent||prevent servic||state||unit state||health unit state||health||servic||preconcept health||obstetrician||gynecologist||prevent control||preconcept servic||preconcept||unit state prevent servic task forc||clinic prevent servic,58.123||46.324||38.717||36.987||36.662||36.012||34.525||34.357||34.016||34.016||33.839||33.614||32.702||32.135||31.945,0.4,0.4,0.26666666666666666
275,J_Mol_Med-4-1-2374880.txt,effect||renin level||tissu angiotensin gener||bind||blockad||prorenin||activ site||renin receptor||renin inhibitor||renin inhibit||enzymat activ||tissu||receptor||site||function||renin||low pH||vitro studi||activ||gener,prorenin||renin||prorenin receptor||prorenin activ||prorenin bind||danser ahj prorenin||high-affin prorenin||plasma prorenin||prorenin disappear||releas prorenin||prorenin molecul||prorenin concentr||renin receptor||renin receptor renin renin angiotensin system||renin inhibit,129.018||104.144||73.28||70.976||69.06||68.865||66.828||65.173||65.128||64.509||64.509||64.509||60.843||59.517||53.856,0.4,0.2,0.26666666666666666
276,Graefes_Arch_Clin_Exp_Ophthalmol-3-1-2082068.txt,eog channel||glaucoma||preval||ocular blood flow||high preval||visual field defect||studi||patient||nerv fiber layer thick||polysomnographi||ahi||apnea-hypopnea index||posit correl||optic nerv perfus defect||control||systol blood veloc||iop||obstruct sleep apnea syndrom||RI increas||factor||group||intracrani pressur increas||ophthalm arteri||sever osa group||oari||risk factor||sever||crari||result,glaucoma||sleep||osa||glaucoma patient||sleep apnea||normal-tens glaucoma||glaucoma preval||normotens glaucoma||open-angl glaucoma||s00417-007-0656-8 glaucoma||apnea||secondari glaucoma||sleep apnea syndrom||obstruct sleep apnea||4 glaucoma patient,86.829||55.574||52.528||51.294||49.798||49.661||46.784||46.449||45.712||44.976||44.022||43.969||38.537||37.761||34.219,0.2,0.1,0.06666666666666667
277,Crit_Care-6-3-137445.txt,cathet||case||complic||femor arteri||pseudoaneurysm||rate||studi||haemodynam monitor||patient||radial arteri||arteri cathet||sepsi||risk||site||radial||infect||axillari arteri||ischaem damag||paper||dorsal pedi||incid||present review||brachial||arteri||temporari occlus||report||arteri cannul||factor||patient popul||risk factor,arteri||arteri cannul||radial arteri||radial arteri cannul||cannul||radial||radial arteri cathet||arteri cathet||percutan radial arteri cannul||long-term radial arteri cannul||radial arteri monitor||arteri cannul site||radial arteri infect||arteri catheter||radial arteri pseudoaneurysm,185.711||163.176||158.659||152.653||140.641||131.607||124.689||121.23||115.891||114.49||113.996||110.65||109.686||109.64||109.09,0.6,0.5,0.3333333333333333
278,Cancer_Causes_Control-2-2-1764594.txt,program||method||feder poverti level||mammographi screen||grante||breast cancer||data||state||breast cancer screen||year||screen rate||mammogram||provid||cervic cancer earli detect program||health insur||ethnic background||percentag||women||estim||poverti level||hispan origin||popul||poverti||servic||famili incom||prevent servic task forc||uninsur women||nation level||number||nation breast||race||elig||ethnic,women||elig women||elig||program elig||screen program||underinsur elig women||250||u.s. women||incom elig||uninsur women||program||underserv women||mammographi screen||low-incom women||poverti,91.599||90.532||89.466||72.083||65.531||63.019||60.113||59.763||56.243||55.542||54.7||52.779||52.33||52.121||50.735,0.4,0.3,0.4
279,Matern_Child_Health_J-2-2-1592147.txt,pregnanc||smoke,tobacco||quitlin||smoke||state quitlin||telephon quitlin||treat tobacco||cigarett smoke||prevent cigarett smoke||prevent||nicotin||state||morb mortal wkli rep 2004||center||morb mortal wkli rep 2005||annual smoke,21.455||20.461||18.958||16.126||15.553||14.971||13.518||13.507||13.487||12.239||11.792||11.716||11.549||11.305||10.777,0.2,0.1,0.06666666666666667
280,Histochem_Cell_Biol-3-1-2137940.txt,antibodi||morpholog||method||dna break||sentinel||apoptot cascad||staurosporin||probe||marker||cytochem techniqu||apoptot cell||tissu section||tunel assay result||light microscopi||necrosi||specif||cell||ssdna antibodi||wide varieti||transmiss electron microscopi||apoptosi||tunel assay||cell death||tissu||protein||electron microscopi||activ||import||caspas||mode||varieti||detect,apoptosi||apoptot cell||apoptosi detect||apoptosi assay||cardiomyocyt apoptosi||apoptosi reagent||apoptosi 1998||nuclear apoptosi||scanti apoptosi||apoptosi occur||term apoptosi||apoptosi exp cell||apoptosi taatj dougla||cell||apoptot cell death,100.846||57.598||56.662||55.811||53.43||52.658||52.1||51.997||51.634||51.434||50.423||49.433||48.253||47.454||46.99,0.4,0.2,0.2
281,Diabetologia-3-1-1781097.txt,pten||key regul||studi||insulin sensit||glucos toler test||primari myocyt||insulin signal||pancreat area||insulin||cell||insulin hypersensit||blood sampl||blood||glucos||insulin inject||mice||protein||activ||blood glucos level||glucos uptak||incub||haploinsuffici||inject||vivo,pten||method pten pten||2 pten pten||interpret pten pten||pten haploinsuffici||18 pten||pten phosphatas||uptak pten||triangl pten||3 pten||pten activ||WT pten||pten level||pten gene||hypothesi pten,353.172||235.724||235.522||235.448||186.328||184.042||181.435||181.038||178.458||178.269||177.916||177.576||177.512||177.252||177.198,0.2,0.1,0.06666666666666667
282,Environ_Health_Perspect-115-3-1849945.txt,author||level||lead||measur||occup||higher level||effect||current||worker||review||relat||stronger predictor||increas||acut effect||test||cognit function||health effect||adult||blood lead||dose||evid||sourc||blood||cognit||analysi||age||associ||current exposur||psychiatr symptom||cumul exposur||report||bone||exposur||consist||symptom||manual dexter||past||chronic effect||neurobehavior test score||cumul lead dose||function||outcom,lead||lead lead||lead exposur||blood lead||tibia lead||lead dose||patella lead||lead smelter||lead worker||bone lead||lead level||lead biomark||inorgan lead||lead toxic||lead oxid,334.973||334.973||206.607||191.379||189.186||187.521||183.137||175.645||174.36||174.29||173.927||172.496||170.044||169.221||168.497,0.4,0.2,0.13333333333333333
283,Appl_Microbiol_Biotechnol-4-1-2266783.txt,metabolit||biodegrad||monooxygenas||final volum||hydroxymucon semialdehyd||strain||organ||carbon||degrad||hydroquinon||batch cultur||energi||solid MM||cell||reaction||enzym||hydroxyquinol||sole sourc||growth substrat||reaction mixtur||activ||high-perform liquid chromatographi||fluorid||cultur||phenol||catechol||benzoquinon||substrat||pathway||tree||peak||cell-fre extract||intermedi||result,4-fp||4-fp degrad||4-fp monooxygenas||4-fp pathway||4-fp metabol||4-fp enrich||4-fp util||hydroquinon||4-fp start||4-fp monooxygenas reaction||0.1 mM 4-fp||4-fp monooxygenas activ||hydroxyquinol||2008 arthrobact arthrobact strain if1||4-fp liquid medium,118.308||70.618||70.065||62.71||61.209||60.944||59.715||59.327||59.154||49.896||47.464||46.71||45.482||44.756||42.722,0.0,0.1,0.13333333333333333
284,Plant_Mol_Biol-4-1-2238787.txt,type||seed||stress toler||level||atipk2β||transgen||relat||increas||test||inositol polyphosph kinas||continu white light||express||treatment||stress||gene||tobacco||transcript level||higher plant||alpha level||wild type||activ||abiot stress||toler||replic||western blot analys||salt||medium||plant||result,atipk2β||ipk2 atipk2β atipk2β||1 atipk2β arabidopsi atipk2β atipk2β||arabidopsi atipk2β||atipk2β arg82 arg82 arg82 atipk2β||atipk2β arg82 arg82||ipk2 atipk2β||atipk2β 2||protein atipk2β||atipk2β protein||method atipk2β||1999 2000 2000 atipk2β atipk2β||plant||atipk2β 6 6 atipk2β 6||atipk2β atipk2β arabidopsi 2 fig. 2,205.884||143.304||135.004||131.623||122.284||112.995||112.014||105.943||104.611||104.611||102.942||83.274||83.251||82.354||80.353,0.2,0.1,0.13333333333333333
285,Knee_Surg_Sports_Traumatol_Arthrosc-4-1-2190783.txt,condit||contour articular prosthet||osteochondr defect||data||studi||contact pressur||experiment studi||test||cartilag||articular compon||flush implant||implant result||sensor||medial femor condyl||ground||devic||implant||test condit||specimen||peak contact pressur||posit||full extens||stanc posit||knee||trial||articular cartilag defect||prosthesi||result,knee||defect||cartilag||knee joint||contact pressur||osteochondr defect||articular cartilag defect||articular cartilag||articular||cartilag contact stress||peak contact pressur||devic peak contact pressur knee biomechan||knee simul||femor articular cartilag||tibiofemor peak contact pressur,41.19||33.511||31.093||31.065||30.893||30.507||30.487||28.975||26.857||25.129||24.781||23.322||22.216||22.133||21.965,0.6,0.5,0.4
286,J_Interv_Card_Electrophysiol-4-1-2262917.txt,cathet||time||system||sheath||accessori pathway||cathet tip||data||studi||patient||tip||artisan control cathet||ablat||human||magnet navig||forc||ablat cathet||cathet ablat||outer sheath||left femor vein||artisan||oper||robot ablat||steerabl guid cathet||map||cardiac arrhythmia||left atrium||radiat exposur||posit||remot cathet ablat||robot navig||procedur||effect remot navig||result twenti patient||laboratori,cathet||cathet ablat||ablat cathet||ablat||remot cathet ablat||robot cathet ablat||cathet ablat procedur||robot remot cathet ablat||artisan cathet||robot cathet||cathet navig||cathet map||cathet ablat journal||remot cathet ablat system||robot ablat,111.174||104.778||104.778||98.381||86.999||81.758||76.829||74.179||73.711||73.447||73.313||71.473||71.17||69.512||67.05,1.0,0.5,0.4
287,Microbes_Infect-2-1-2426737.txt,gene||sequenc||rab||express profil||parasit||apicomplexa||transcript||protein||rab gtpase||function||analysi||intracellular parasit||cluster||upstream region||motif||specif||vesicular traffic||famili,rab||P. falciparum rab rab||theileria plasmodia rab T. parva rab||rab T. parva P. falciparum rab||T. annulata T. parva rab T.||T. parva rab rab1a rab2 rab||T. parva T. parva||T. parva||rab gtpase||theileria||rab famili||abstract rab||9 rab||essenti rab||T. parva T.,161.831||108.674||104.94||100.945||90.461||90.46||85.486||85.486||83.185||82.851||81.728||80.916||80.916||80.916||80.734,0.2,0.2,0.13333333333333333
288,Clin_Rheumatol-3-1-1847465.txt,rheumatoid arthriti||disabl||fibromyalgia,arthriti||arthriti disabl||rheumatoid arthriti||arthriti australia||life rheumatoid arthriti||arthriti care||disabl||FM||life||qualiti||fibromyalgia||II arthriti care||keyword disabl fibromyalgia qualiti||function disabl||health,36.471||27.236||26.533||23.112||22.336||18.235||18.002||14.881||13.94||12.944||12.88||12.511||10.956||10.652||9.768,0.2,0.2,0.2
289,Pflugers_Arch-4-1-2226063.txt,level||integrin stimul||integrin function||ldh||releas||studi||intact ctni||viabl cardiomyocyt||integrin||assay||necrosi||cell||day||ldh activ||control||activ||ctni||incub||cultur||control cardiomyocyt||propidium iodid||chemiluminesc||cardiomyocyt||medium,grgd||ctni||grgd sdgrg grgd||grgd sdgrg||ctni releas||ctni 1 2 grgd grgd||ctni degrad||necrot cardiomyocyt grgd||ctni assay||intact ctni||purifi ctni||3 2 grgd grgd||discuss grgd||nanogram ctni||fragment ctni,109.991||106.933||90.634||80.955||66.698||65.384||61.077||58.593||57.273||56.392||55.25||55.018||54.995||54.843||54.719,0.2,0.2,0.13333333333333333
290,J_Muscle_Res_Cell_Motil-3-1-2045119.txt,iso-osmot ringer||find||increas||nerv fibr||diamet||conduct||osmolar||waveform||skelet muscl||local circuit current||earli surfac||membran potenti||conduct veloc||valu||constant||extracellular osmolar,osm||document||frac||osmolar||theta||muscl||fibr||extracellular osmolar||osm _ 2||rm||2 osm 2||osm vol 5||skelet muscl||sqrt||documentclass,53.903||32.26||31.247||30.584||23.624||23.237||22.798||21.714||21.194||21.032||19.628||19.078||17.729||17.648||17.446,0.2,0.2,0.2
291,Pediatr_Nephrol-3-1-1805045.txt,plasmapheresi||allograft surviv rate||nativ kidney nephrectomi||rate||patient||LD graft||recurr||induct therapi||regimen||risk||subsequ report||cyclosporin||recurr rate||pre-op PP||esrd||remiss||nativ kidney||graft||incid||transplant||factor||report||recipi||fsg||graft surviv||clinic recurr||diseas||pediatr renal allograft recipi,recurr||fsg||fsg keyword recurr||recurr focal segment glomerulosclerosi||recipi||transplant||post-transpl fsg||recurr rate||rapid recurr||posttranspl recurr||subsequ recurr||clinic recurr||recurr diseas||earli recurr||glomerulosclerosi,133.686||100.883||78.19||72.216||71.224||70.341||68.898||68.875||67.985||67.953||67.661||67.171||66.843||66.843||61.658,0.6,0.5,0.4
292,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2292476.txt,prism||vergenc adapt,vergenc||vergenc adapt||prism||keyword prism binocular vergenc adapt||binocular vision||vergenc adapt vergenc eye movement||tonic vergenc||vergenc system||adapt vergenc control||schor CM||binocular vision clinic||heterophoria||vergenc eye movement||binocular dysfunct vergenc eye movement||binocular vision 1964,48.548||34.568||34.129||27.646||27.575||26.685||25.375||24.274||23.045||22.533||22.058||21.618||21.431||21.098||20.907,0.4,0.2,0.13333333333333333
293,Eur_J_Appl_Physiol-3-1-2039775.txt,muscl||level||time||veloc||rate||upper arm-forearm||prolong test||standard deviat||ipl method||lower||effect||mup||lowest forc level||posit task||increas||forc||variabl||motor unit||within-subject standard deviat||dynam||MU activ||present studi||pv||mvc||sd-pv||motor unit potenti||load||dynam contract||paramet||declin||task||higher valu||experi||subject||skew||activ||mup frequenc||lower valu||initi phase||order||prolong dynam test||motor unit discharg||muscl fibr conduct veloc||posit||peak||peak frequenc||shift||load torqu,veloc||mup veloc||mup||peak veloc||conduct veloc||mup propag veloc||muscl conduct veloc||lower mup veloc||muscl||propag veloc||sd-peak veloc||sk-peak veloc||peak veloc shift||muscl fibr conduct veloc||muscl fiber conduct veloc,118.008||105.32||92.631||85.816||74.618||73.768||71.834||71.622||66.265||64.336||60.43||60.43||59.389||57.938||57.509,0.4,0.3,0.26666666666666666
294,Int_Arch_Occup_Environ_Health-4-1-2413126.txt,level||case||atherosclerosi||chd||individu||studi||offic worker||carotid arteri||global stress level||correl||risk||scale||imt||stress||smoke||neg correl||work-rel stress||earli atherosclerosi||ldl||employe||healthi lifestyl||factor||sera||low decis latitud||presenc||work||plaqu||result,stress||work-rel stress||job stress||stress work||work stress||perceiv stress||psychosoci stress||consciou stress||stress situat||relat stress||stress manag||stress respons||high stress||stress modul||atherosclerosi,86.742||66.968||53.467||51.929||51.929||49.171||47.068||44.878||44.007||44.001||43.838||43.741||43.371||43.371||41.086,0.4,0.2,0.2
295,BMC_Genomics-5-_-375527.txt,match||set||measur||concentr||human promot||bind site||refseq||transcript factor||tfb||gene express||correl||human||threshold||z-transform||promot sequenc||regulatori region||promot||statist analysi||chromosom||cluster||signific||gene||cgi||approach||analysi||list||pwm||score||statist signific||matrix||sequenc||result,tfb||start _||pwm||ap2 _ Q6||tfb cluster||cluster tfb||matrix ap2 _ Q6||predict tfb||tfb predict||cluster||01 0.14||01 0.09||01 0.1||01 0.15||01 0.13,135.359||114.733||108.263||106.88||106.836||106.836||81.125||78.658||78.658||78.313||77.142||76.98||76.792||74.44||73.401,0.4,0.3,0.2
296,Bioprocess_Biosyst_Eng-2-2-1705473.txt,condit||lower level||lactat overflow||level||case||lactat product||maxim glutam concentr||ldh||final stoppag||gdh||strategi||step chang||constant control||ferment process||metabol balanc||glutam product||metabol flux||enzym||ferment||glutam ferment||metabol flux analysi||activ||tca metabol flux||lactat||bmc||agit rate||tca cycl||glutam||balanc metabol control||oxygen concentr||result,glutam||glutam metabol||glutam ferment||metabol||metabol flux||glutam product||flux||glutam concentr||glutam synthesi||tca metabol flux||corynebacterium glutamicum||glutam ferment perform||metabol balanc||ferment||metabol control,70.898||61.461||52.693||52.023||46.735||45.35||41.446||39.647||38.989||38.26||37.485||35.129||34.738||34.488||34.426,0.6,0.5,0.4666666666666667
297,Ann_Gen_Hosp_Psychiatry-2-_-162166.txt,attent deficit disord||auditori cortex||respons||auditori deficit||psychoacoust||electrophysiolog test||patient||dyslexia||speech stimulu||test||capd||disord||central auditori deficit||evalu||mental retard||paper||great varieti||central auditori process disord||disabl||mental disord||central auditori system,auditori||central auditori||auditori test||central auditori disord||auditori deficit||auditori deficits'||midlat auditori||auditori cortex||auditori dysfunct||auditori hallucin||auditori abnorm||auditori pattern||auditori inform||auditori process disord||central auditori process,117.433||77.371||65.759||65.231||64.082||61.912||61.912||60.545||60.486||59.965||59.576||59.382||58.717||57.701||56.487,0.2,0.2,0.13333333333333333
298,Int_J_Colorectal_Dis-3-1-2039795.txt,sln procedur||sln||case||number||colon carcinoma||multi-centr studi||studi||ihc||lymph node||aberr lymphat drainag||micrometastas||procedur||result||sentinel lymph node||posit node||patient||multi-centr set||lymph node metastas||tumour cell||group,node||lymph node||sln||lymph node micrometastas||sentinel lymph node||colon||nonsentinel lymph node||lymph node metastas||pericol lymph node||sentinel lymph node map||recov lymph node||lymph node 11||sentinel node map||micrometastas||sentinel node identif,45.682||39.115||36.493||34.273||33.975||31.821||27.659||27.407||27.012||26.957||26.479||26.076||25.093||24.591||24.126,0.6,0.4,0.3333333333333333
299,Obes_Surg-4-1-2226018.txt,person||vertic||follow-up||time||questionnair||neurotic||self-esteem||studi||year||patient||psychopatholog||psycholog variabl||follow-up assess point||bodi imag||norm group||relev norm group||respect||psychosoci function||psychosoci||gastroplasti||surgeri||weight||social anxieti||bariatr surgeri||morbid obes||extrem obes||signific differ||mix result||addit||score||signific improv||gener popul,gastroplasti||psychosoci||bariatr surgeri obe||obes||bariatr surgeri||obe surg obes surgeri||obes surgeri||psychosoci improv||psychosoci function||obe 2003||surgeri||vertic||obe surg 1997||laparoscop bariatr surgeri||patients’ psychosoci function,47.984||41.654||38.804||34.199||32.608||32.504||29.475||26.791||26.514||25.947||24.751||24.379||23.688||22.548||21.817,0.6,0.4,0.4
300,Invest_New_Drugs-3-1-2039853.txt,cancer||administr||studi||patient||mtd||atp||effect||infus||nurs||disord||side effect||dose||pre-termin cancer||chest discomfort||dyspnea||pre-termin cancer patient||medic supervis||cardiac ischemia||maximum dose||reason||home||presenc||lower mtd||day care center||cardiac disord||lung cancer||deep breath,infus||atp infus||1 infus||subsequ infus||infus rate||infus extravas||infus complaint||51 infus||infus arm||hospit infus||99 infus||infus procedur||95 infus||171 infus||13 infus,167.738||110.99||95.342||86.105||85.946||85.787||85.163||84.661||84.569||84.563||84.396||83.869||83.869||83.869||83.869,0.2,0.1,0.06666666666666667
301,Osteoporos_Int-3-1-1820757.txt,vertebr fractur||independ correl||apo polymorph||spine||vertebr bodi||lipid profil||studi||multipl regress model||wrist fractur||risk||observ||fractur||postmenopaus women||acut cardiovascular event||serum triglycerid||lipid||osteoporot fractur||total cholesterol||bmd||bodi composit||women||observ studi||hip||aorta calcif||associ||factor||independ contributor||differ||bone||serum lipid||osteoporosi||signific differ||sever||cardiovascular event||triglycerid||bone loss||apob||bone miner densiti||cardiovascular diseas,fractur||hip fractur||lipid||serum lipid||vertebr fractur||hip||hip bmd||bone||serum||bmd||wrist fractur||women||p-valu hip fractur||osteoporot fractur||non-vertebr fractur,60.99||50.731||47.41||43.186||42.44||40.472||39.683||39.182||38.961||38.894||38.104||36.727||35.472||34.817||33.097,0.8,0.7,0.6666666666666666
302,Diabetologia-4-1-2170456.txt,follow-up||case||diabet||birth||baselin||studi||year||middle-ag women||bmi||baselin recruit||durat||risk||whr||type 2 diabet mellitu||analys||glucos||trend||dietari intak||age||month||associ||breast-feed||weight||parou women||number||physic activ||particip||diabet mellitu||children||in-person interview,breast-feed||breast-feed women||breast-feed durat||trend breast-feed||lifetim breast-feed||breast-feed histori||interpret breast-feed||shanghai||diabet mellitu||diabet||women||shanghai diabet studi||breast-feed durat assess inform||2.99||whr,83.27||54.961||50.548||44.373||42.671||42.26||41.635||38.684||35.714||31.719||26.652||25.295||25.274||23.53||23.296,0.2,0.3,0.26666666666666666
303,Infect_Genet_Evol-1-5-2080692.txt,malaria||south asia||egg||hookworm infect||human hookworm infect||locu||analysi||individu||popul||associ||chitin||data||chitotriosidas||studi||evid||infect||tropic diseas||allel,chit1||al.||chit1 chit1 genotyp||st chit1||abstract chit1 chit1||1997 chit1 chit1 chit1 locu||chit1 brooker||2001 chit1||chit1 chit1 tabl 2||1998 chit1 boot||chitotriosidas||malaguarnera||popul genotyp chit1||2003 chit1 genotyp||wuchereria bancrofti chit1 hise,86.726||68.592||60.929||59.034||57.817||53.204||47.216||44.683||43.365||40.69||38.365||35.317||35.262||34.311||33.508,0.0,0.0,0.06666666666666667
304,Ann_Biomed_Eng-2-2-1705544.txt,mpa||breakdown||level||system||stress level||bioreactor||sampl||studi||densiti||linear bear||PG breakdown||mechanotransduct||compress||displac||strain||test||abil||tissu engin bioreactor||menisc tissu||pressur||cycl||stress||mechan stimuli||load||physiolog load||meniscu||gag||greater PG breakdown||cell death||standard||pressur film||deep zone||displac control||usa||differ||explant||dynam compress||incub||load cell||larg load||actuat||film||meniscectomi||media||result,compress||load||compress strain||explant||compress test||compress rod||explant compress system||menisc explant||strain||dynam compress||mpa||bioreactor compress rod||unconfin compress||compress apparatu||cyclic compress,59.379||47.857||47.459||41.224||40.306||39.091||37.807||36.445||35.54||34.928||34.414||34.117||32.783||30.839||30.671,0.6,0.5,0.4
305,Purinergic_Signal-3-4-2072912.txt,adenin receptor,xylosoxidan||achromobact xylosoxidan||adenin||achromobact||A. xylosoxidan||4 3 achromobact xylosoxidan||3 A. xylosoxidan 3||3 3 A. xylosoxidan||achromobact 50 A. xylosoxidan||3||3 3 3||adenin bind||3 achromobact acinetobact 17 A. xylosoxidan||adenin receptor||achromobact spp,83.939||75.252||68.93||66.566||50.224||48.184||46.226||46.226||45.293||42.227||42.227||41.68||40.578||39.496||38.158,0.0,0.0,0.06666666666666667
306,Environ_Health_Perspect-114-9-1570082.txt,particul air pollut||measur||method||spe||cross-valid||concentr||kriging-bas estim approach||locat||data||studi||valu||model||geocod address||geograph inform system||spatial correl||se||population-bas studi||unit state||site||krige||daili ambient PM||semivariogram paramet||day||averag PE||approach||estim||rmss||rang||location-specif PM||cross-valid paramet||weight least-squar method||address||PM estim||semivariogram||result,krige||ordinari krige||lognorm krige||krige estim||lognorm ordinari krige||univers krige||national-scal krige||log-norm krige||krige model||regular ordinari krige||ordinari krige 10||krige method||log-norm ordinari krige||krige procedur||nation ordinari krige,172.455||125.153||112.08||103.813||100.67||96.544||91.971||90.535||90.271||89.36||89.133||87.181||86.307||86.228||85.831,0.2,0.1,0.06666666666666667
307,Histochem_Cell_Biol-4-1-2413109.txt,actin cytoskeleton||patj||membran asymmetri||junction format||molecul||recent evid||apico-bas polar||par3||complex||jam||aj||signal||adheren junction||specif||cell||protein complex||afadin||local||tight junction||protein||associ||lgl||format||bind||small gtpase||par protein||apkc||interact||major multiprotein complex||claudin||cell polar||membran||function,cell||cell junction||junction||cell polar||epitheli cell||tight junction||cell adheren junction||epitheli junction||cell adhes||epitheli cell polar||epitheli tight junction||cadherin-depend cell junction||epitheli cell exp cell||junction adhes||cell polar protein,178.559||168.839||159.12||134.758||131.593||130.79||123.34||121.874||118.449||118.047||115.403||113.348||110.803||108.73||107.981,0.4,0.3,0.2
308,Exp_Appl_Acarol-3-1-2039800.txt,eriophyida||dgt||slt||infest||phytoseiida||data||predatori mite||densiti||space||coconut||perianth||bulb||coconut palm||adult femal||cultivar||surfac||gap||coconut fruit||size||coconut mite||mite||sri lanka||narrow space,coconut||coconut mite||coconut fruit||mite||infest coconut||coconut predatori||coconut cultivar||coconut mite aceria guerreroni||coconut mite experi||coconut palm||matur coconut||uninfest coconut fruit||coconut fruit sourc||guerreroni||perianth,169.967||135.148||106.816||100.33||99.537||98.548||98.138||96.409||90.099||87.633||85.891||75.966||71.21||70.492||67.286,0.8,0.5,0.4
309,Eur_Radiol-3-1-2039780.txt,case||fat||renal arteri stenosi||mri||imag||higher sensit||studi||patient||renal cell carcinoma||adc||enhanc||lesion||magnet reson imag||renal arteri||renal imag||potenti kidney donor||pseudocapsul||angiomyolipoma||tumor||renal lesion||signal intens||oncocytoma||malign lesion||opposed-phas imag||function||kidney,renal imag||renal angiomyolipoma||renal lesion||renal donor||renal tumor||mri||renal neoplasm||imag||renal vein||renal pyramid||renal cell||renal arteri||renal diseas||renal infect||renal angiomyolipoma ajr,71.007||56.317||54.039||52.851||52.235||50.627||50.369||48.6||48.544||48.395||47.575||47.421||46.717||46.707||44.708,0.4,0.4,0.3333333333333333
310,Diabetologia-4-1-2170455.txt,retin haemodynam||blood flow||level||measur||diabet particip||paramet||good glycaem control||diabet||retin vessel||retinopathi||type 1 diabet||blood glucos||diabet retinopathi||individu||abnorm||retin circul||studi||year||patient||haemodynam measur,diabet||diabet retinopathi||retin haemodynam||retinopathi||nonprolif diabet retinopathi||result 1 1c 1c 1c 1c||diabet control||diabet individu||insulin-depend diabet||retin microangiopathi||retin haemodynam abnorm||diabet 8.8||retin hemodynam||diabet particip||retin vessel,43.435||36.521||31.922||29.606||26.3||25.367||25.107||24.445||23.876||23.869||23.699||23.252||22.963||22.796||22.593,0.8,0.4,0.4
311,J_Headache_Pain-4-1-2386850.txt,european countri||tth||chronic headach||interest||burden||preval||direct cost||data||studi||year||europ||life||patient||neurolog disord||qol||countri||impact||cost||day||headach||estim||public health perspect||social function||popul||methodolog||differ||headach patient||work||migrain||disabl||partner||children,headach||headach headach||migrain headach||migrain||headach impact||non-migrain headach||tension-typ headach||headach suffer||headach disord||headach preval||headach pain||nonmigrain headach||headach worldwid||episod headach||self-report headach,183.369||183.369||153.348||123.326||113.663||96.101||95.491||95.295||95.282||93.909||93.599||93.157||93.076||92.423||92.355,0.4,0.2,0.13333333333333333
312,Exp_Neurol-2-1-2288636.txt,effect||variat||frequenc||tap||stimul||anova||excess synchron||db||perform||side||synchron||variabl||movement||rate||precis frequenc||normal limit||patient||stn||parkinsonian patient||updr motor score,al.||60 μs||130 Hz||130 Hz fog||130 Hz lid||140 Hz||130 Hz tremor||185 Hz||180 Hz||10 Hz||20 Hz||12 Hz||145 Hz||dopa 300 mg||dopa 1800 mg,76.185||72.931||66.865||55.605||48.435||46.701||45.993||45.728||45.67||45.579||45.409||44.874||44.874||35.489||34.716,0.0,0.0,0.0
313,Eur_J_Epidemiol-3-1-2071962.txt,hypertens||data||model||stroke||potassium||mortal||risk||volum||blood pressur||potassium intak||intak||event||posit relationship||creatinin||cohort||all-caus mortal||relationship||sodium||analysi||associ||subject||lower quartil||cvd||dietari data||myocardi infarct||dietari potassium||urinari sodium||salt||cardiovascular event||standard deviat increas||cardiovascular diseas,potassium||sodium||potassium intak||sodium intak||urinari potassium||urinari sodium||intak||dietari potassium intak||dietari potassium||dietari sodium intak||dietari sodium||dietari intak||potassium excret||urinari sodium excret||cvd,71.733||70.832||65.124||64.673||59.986||59.536||58.515||58.091||57.879||57.791||57.429||51.27||48.339||48.005||47.869,0.6,0.6,0.4666666666666667
314,Int_J_Cardiovasc_Imaging-4-1-2373860.txt,volum score||method||cms-index||bpm||scanner||artifici arteri||dual sourc CT||suscept||motion curv||motion||densiti||calcif||effect||electron beam CT||ca-scor||equival mass||agatston score||phantom||heart rate||calcium||slice thick||cardiac motion||mdct||dsct||smaller slice thick||calcium score||triangl||ebt||arteri||physic mass||differ||decreas||circl||64-slice mdct||calcif densiti||score||equival mass score||result,dsct||ca-scor||64-slice mdct||mdct||slice||slice thick||thick||score||calcium score||3.0 mm slice thick||ebt||calcif||absolut ca-scor||calcium||smaller slice thick,76.718||75.856||70.418||69.108||62.169||58.636||55.103||45.512||43.332||43.172||42.835||42.667||41.534||41.153||40.952,0.8,0.7,0.7333333333333333
315,Diabetologia-3-1-2063563.txt,type 2 diabet||insulin secret||insulin sensit||risk||hyperglycaem clamp||gene||glucos||pancreat beta cell||beta cell||glp-1||result||carrier||variant||polymorph||particip||insulin||data||plasma glucos||ogtt||clamp,tcf7l2||tcf7l2 tcf7l2 variant||tcf7l2 tcf7l2 15||tcf7l2 tcf7l2 14||result tcf7l2 tcf7l2||tcf7l2 polymorph||tcf7l2 gene||hypothesi tcf7l2 tcf7l2 polymorph||method tcf7l2||interpret tcf7l2||insulin||glp-1||25 tcf7l2 9 tcf7l2 gene||insulin sensit 4 tcf7l2||tcf7l2 gene variant,163.861||113.443||109.558||109.489||109.24||88.515||85.425||85.222||81.93||81.93||70.848||66.997||66.942||61.599||61.152,0.0,0.0,0.13333333333333333
316,Eur_J_Epidemiol-4-1-2226058.txt,effect||mortal||risk||chd mortal||hdl-cholesterol||lower risk||hr||relat||analys||rotterdam studi||normal weight individu||age||individu||particip||genotyp||studi||year||normal weight||overweight,apo||apo apo||apo apo apo||apo apo apo genotyp||20 apo apo||1 apo apo||apo genotyp||overweight apo||obes apo||apo polymorph||apo epsilon4||apo statu||3 apo||apo 20 22 apo||20 22 apo apo,372.37||372.37||372.37||282.711||248.669||248.247||193.052||191.158||191.104||189.303||188.723||186.977||186.954||186.884||186.884,0.0,0.0,0.0
317,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-2082652.txt,vascular repair||literatur review||embolectomi||occlus||case||arteri embol||aclr||complic||knee||anterior cruciat ligament reconstruct||pseudoaneurysm||graft||poplit arteri occlus||reconstruct||sensori loss||foot||poplit arteri||vascular complic,arteri||poplit arteri||cruciat ligament reconstruct||anterior cruciat ligament||anterior cruciat ligament reconstruct||aclr||anterior cruciat||poplit arteri occlus||proxim poplit arteri||reconstruct||anterior cruciat ligament repair||arteri embol||anterior cruciat ligament reconstruct ann||middl genicular arteri||superior genicular arteri,38.723||38.135||30.581||29.637||28.672||28.364||27.159||26.701||26.248||25.776||23.176||23.052||22.937||21.861||20.36,0.4,0.5,0.4
318,Pediatr_Nephrol-2-2-1764601.txt,proteinuria||case||preval||patient||year||seri||risk||epidemiolog||increas||nephrot syndrom||naprtc||focal segment glomerulosclerosi||renal biopsi||adult||esrd||age||popul||incid||fsg||diagnosi||children,fsg||idiopath fsg||nephrot syndrom||fsg histolog||fsg progress||fsg account||glomerulosclerosi nephrot syndrom||steroid-resist nephrot syndrom||idopath nephrot syndrom||nephrot syndrom predict||primari nephrot syndrom||famili nephrot syndrom||syndrom||fsg caus gene||children,58.017||34.166||32.684||30.495||30.023||29.896||27.521||23.192||22.909||21.789||21.789||21.789||21.74||19.842||18.416,0.4,0.2,0.2
319,Osteoporos_Int-3-1-1766476.txt,prevent||comprehens geriatr assess||convent care||control group||studi||individu care plan||intervent||fractur||treatment||day||fall||multifactori intervent||activ prevent||control||rehabilit||hospit||fall risk factor||multifactori intervent program||surgeri||intervent group||injuri||delirium||group||differ||number||fewer injuri||orthoped||systemat assess||intervent ward||hip fractur||intervent program,fall||fall prevent||fall risk||inpati fall||in-pati fall||fall calcium||recurr fall||fall prevent trial||fall prevent studi||fall prevent measur||geriatr ward||geriatr rehabilit||fall risk factor||patients’ fall risk||fall 18 60,130.162||77.377||70.138||68.16||67.136||65.081||65.081||52.805||52.691||51.584||49.544||48.426||47.551||47.305||43.735,0.2,0.1,0.13333333333333333
320,Arch_Orthop_Trauma_Surg-3-1-2092411.txt,anim||drill time||time||daili practic||rabbit||studi||long time||hind limb||osteocyt||vivo studi||drill||aim||signific||absenc||posit correl||insert forc||tibia||distanc||experi||femur||surgeri||insert time||bone||base plate||kirschner wire||result,drill||osteocyt||drill hole||implant drill||drill time||drill speed||drill tract||k-wire||bone||short drill time||minim drill time||disappear osteocyt||osteocyt lacuna||maximum drill speed||osteocyt apoptosi,107.343||62.752||61.032||60.249||57.705||56.077||53.672||40.896||40.518||39.212||38.47||38.041||38.027||37.384||33.219,0.6,0.4,0.26666666666666666
321,Eur_J_Clin_Pharmacol-3-1-1914266.txt,measur||time||co-trimoxazol||data||studi||patient||pdr||risk||clinic||coumarin||user||antibiot||signific||anticoagul clinic||inr||day||dose adjust||sever overanticoagul||consent||acenocoumarol||overanticoagul||differ||dose reduct||interact||follow-up time||therapeut rang||initi||phenprocoumon||result,pdr||co-trimoxazol pdr||antibiot pdr||co-trimoxazol||antibiot||overanticoagul pdr||inr||co-trimoxazol user||percentag pdr||0.16 pdr||0.55 pdr||pdr approach||conclus pdr||0.24 pdr||0.87 pdr,200.008||179.726||169.102||159.445||138.197||130.814||126.13||103.548||101.615||101.366||100.902||100.644||100.004||100.004||100.004,0.6,0.4,0.26666666666666666
322,J_Med_Internet_Res-7-2-1550646.txt,mass media||mesh||author||notic||ihca||press releas||lexisnexi academ databas||databas||studi||patient||clinic outcom||cochran retract||review||articl||al paper||medic||scientist||page||web||princip conclus||health||retract||citat||pubm||conclus||internet||press report||search||cochran collabor||refer||case studi||public||systemat review||media||queri||result,retract||ihca||ihca review||cochran retract||review||retract public||retract systemat review||cochran review||retract 2005||ihca review author||ihca review conclus||ihca review result||ihca review situat||cochran retract 18||review public,118.435||100.548||89.522||86.312||78.495||75.144||68.436||66.342||62.691||62.645||61.955||60.611||59.681||57.816||55.174,0.8,0.4,0.26666666666666666
323,Biochim_Biophys_Acta-2-1-2258316.txt,tau||tyrosin phosphoryl||tauopathi||syk,tau||tau phosphoryl||blot tau||syk||tau 0n3r||0n3r tau||IP tau||tau y18f||tau y197f||tau y394f||tau pervanad||tau protein||tau splice||fetal tau||control tau,143.156||89.589||82.238||80.276||78.109||78.109||76.116||74.843||74.843||74.843||74.605||72.858||72.229||72.068||71.578,0.4,0.2,0.13333333333333333
324,Clin_Oral_Investig-3-1-1797073.txt,applianc||volunt||sampl||studi||seri||varnish||site||saliva||acquisit||present studi||detect limit||day||applic||enamel sampl||deminer enamel||duraphat||uptak||fluorid||specimen||opposit buccal aspect||transfer||oral caviti||enamel||tooth||respect tooth,fluorid||fluorid varnish||fluorid sampl||koh-solubl fluorid||fluorid dentifric||fluorid uptak||fluorid applic||fluorid site||bound fluorid||fluorid specimen||salivari fluorid||fluorid content||fluorid rins||fluorid retent||topic fluorid,298.414||171.709||164.901||163.159||160.058||159.471||156.548||155.001||154.325||153.565||153.474||152.921||152.374||152.278||152.0,0.2,0.1,0.06666666666666667
325,J_Biol_Inorg_Chem-3-1-1915625.txt,activ site||sampl||model||spectroscop data||wild-typ||water||water molecul||structur||t309v||cytochrom p450 2d6||dft calcul||enzym||experiment observ||heme moieti||supplementari materi||experiment structur||heme||substrat||spin equilibrium||experiment data||rel destabil||result,t309v||t309v mutant||t309v spin equilibrium||cyp2d6||cyp2d6 spin equilibrium||t309v mutat||t309||spin equilibrium||ν Fe||heme spin equilibrium||spin state||heme||spin equilibria||high spin||low spin,55.254||36.876||36.824||30.545||28.587||28.136||27.622||27.609||26.156||25.682||22.195||21.828||20.986||19.691||19.691,0.2,0.2,0.2
326,Clin_Rheumatol-3-1-2071969.txt,large-vessel vascul||test||patholog uptak||pet||wall||cogan||hear loss||involv||white cell||ear pain||syndrom,cogan||cogan ’s||keyword cogan||cogan ’s syndrom||cogan DG syndrom||atyp cogan ’s syndrom||cogan le maladi||cogan ’s syndrom balink||rheumatolog||kita GD cogan||syndrom||large-vessel vascul||CT hear loss large-vessel vascul||takayasu arter||stanson AW ilstrup DM cogan,48.564||28.207||24.282||24.225||22.363||19.716||19.154||19.036||17.42||17.415||16.261||15.781||11.94||11.363||11.183,0.2,0.1,0.2
327,Behav_Genet-4-1-2226021.txt,quantit genet analysi||behavior||linkag analysi||golden retriev||control group||anim model||aggress||studi||allel||effect||frequenc||non-aggress golden retriev||microsatellit marker||loci||dog||genotyp||dna||gene||power||serotonin||dna sampl||estim||analysi||associ||behavior inform||aggress dog||molecular genet studi||strong effect||snp||candid gene||major role||haplotyp||aggress behavior||owner impress,aggress||htr1b||slc6a4||htr1b htr2a slc6a4||htr1a htr1b htr2a slc6a4||htr1a htr2a htr1b slc6a4||htr1a htr1b htr2a||htr1a||htr2a||aggress dog||1 htr1b htr2a slc6a4 htr1b htr2a||dog||aggress dog-direct aggress htr1a||serotonin||4 htr1a htr1b,102.408||101.402||96.96||96.057||94.494||94.494||93.673||89.808||89.808||89.779||79.897||77.15||75.828||70.245||63.739,0.2,0.2,0.26666666666666666
328,J_Comput_Aided_Mol_Des-4-1-2270916.txt,metric||measur||target||enrich||comput||data||model||studi||comparison||properti bia||ligand-bas tool||atom posit||structur||virtual screen||resolut||dataset||compound||purpos||nomin resolut||decoy||simpl molecular properti||properti||applic||paper||crystallograph||atom||decoy set||dpi||predict||rmsd||number||perform||coordin error||robust comparison||area||error||conform reproduct||ligand||engin||pose predict||result,pose||metric||dpi||metric error||decoy||structur||virtual screen||pose predict||error||experiment pose||bioactiv pose||pose reproduct||virtual screen perform||crystal structur||decoy set,37.512||29.375||28.327||26.131||25.517||25.348||24.278||24.115||22.887||20.076||19.467||19.434||18.302||17.993||17.551,0.6,0.7,0.5333333333333333
329,Diabetologia-3-1-2039833.txt,muscl||triacylglycerol||diabet||releas||haart||thiazolidinedion||rate||adipocyt||studi||patient||beta cell damag||atp||insulin secret||develop||risk||organ||adipos tissu||metabol syndrom||lipotox||type 2 diabet mellitu||cell||circul||mitochondria||fatti acid||genet factor||pancreat beta cell||ectop triacylglycerol deposit||insulin resist||result,fatti acid||fatti acid-induc uncoupl||debat fatti||adipocyt||fatti acid releas||fatti acid remov||fatti acid re-esterif||fatti acid esterif||free fatti acid||fatti acid result||fatti acid concentr||fatti acid leakag||satur fatti acid||fatti acid interact||fatti acid-induc uncoupl mitochondri β-oxid,64.905||48.044||47.238||46.578||46.283||45.48||44.173||44.073||43.709||43.705||43.675||43.67||43.648||43.27||39.511,0.4,0.2,0.13333333333333333
330,Histochem_Cell_Biol-3-1-1779629.txt,vector||high level||system||homolog recombin||embryo||primer||element||lacz activ||transgen mice||probe||hypertroph zone||bac||enhanc||offspr||founder||event||newborn||express||transgen copi||cartilag||dna||report gene mous||downstream||specif||cell||chondrocyt||growth factor||gene||bac dna||hypertroph chondrocyt||hypertroph cartilag||activ||long bone||genom context||growth plate||integr site||fvb mice||construct,lacz||bac||bac transgen||chondrocyt||lacz 2004 lacz transgen||hypertroph chondrocyt||col10a1||bac transgen E.||bac transgen line||bac clone||lacz activ||bac dna||bac col10a1 environ||bac line||bac recombin vector,64.988||62.511||51.928||47.304||43.097||38.712||36.757||35.824||35.483||35.301||34.13||33.266||33.09||32.552||30.605,0.4,0.3,0.3333333333333333
331,Eur_J_Appl_Physiol-3-1-2039810.txt,blood flow||condit||time trial perform||valu||perform decrement||effect||increas||muscl temperatur||bodi temperatur||energi flow model||temperatur||present studi||ambient temperatur||power output||higher cardiac output||climat||exercis||differ||decreas||skin||perform||trial||extra blood||hot condit||heat||time trial exercis,2max||sk||GE||text||document||exercis||heat||sk 2000||_{||temperatur||impact GE||lower GE||defin GE||case GE||documentclass,53.794||34.341||28.533||24.865||24.033||22.076||18.05||17.645||16.844||15.828||14.859||14.76||14.267||14.267||13.17,0.0,0.3,0.2
332,Exp_Brain_Res-3-1-2039806.txt,condit||cue||prior||surfac slant||combin||stimulu||orient||head||textur||textur cue||conflict||slant||inform||probe||binocular dispar||motion parallax||cue conflict||weight||surfac||binocular||monocular||posit||trial||rotat screen||particip||movement,cue||binocular cue||textur cue||motion cue||_{||cue conflict||textur cue vision||binocular||dispar cue||textur||cue weight||visual cue||reliability-bas cue||independ cue||outlin cue,112.078||88.671||87.323||75.048||74.204||69.93||65.637||65.263||62.714||62.567||61.543||59.099||57.493||56.55||56.542,0.4,0.5,0.3333333333333333
333,Diabetologia-4-1-2235909.txt,type 2 diabet||hypoglycaemia||target||week||fast plasma glucos||insulin detemir||studi||patient||insulin||event||glycaem control||dose||fpg||analys||present studi||treatment||advers event||basal insulin analogu||ten-point PG profil||glargin||oral glucose-low drug||meal-tim insulin||bodi weight||detemir||oral glucose-low agent||oral agent||insulin glargin||trial||particip||weight gain,insulin||insulin detemir||detemir||insulin glargin||daili insulin detemir||once-daili insulin detemir||twice-daili insulin detemir||insulin detemir result||insulin glargin detemir glargin differ||glargin||nph insulin||insulin dose||insulin glargin event||basal insulin||sulfonylurea insulin,144.337||137.022||129.706||115.895||97.115||93.509||92.965||91.358||89.79||87.453||85.503||82.634||80.256||75.834||74.89,0.8,0.5,0.3333333333333333
334,J_Chem_Ecol-3-1-2039843.txt,time||endogen glucosinol||leaf tissu||sampl||amount||gener linear model||extract||growth rate||instar||infloresc||genotyp||herbivori||natur enemi||glucosinol concentr||leaf||mechan homogen||result||caterpillar||glucosinol||access||flower||lepidoptera||intern standard||pierida||plant||myrosinas,brassica||pieri brassica||P. brassica||plant||M. brassica||brassica napu||pieri||P. brassica pieri rapa||brassica oleracea||brassica juncea||flower||llc 2007 pieri pieri brassica brassica||brassica campestri||plant P.||insect pieri brassica B.,107.468||84.085||74.261||70.07||64.938||64.887||60.702||60.61||60.162||57.094||56.764||56.26||55.671||55.562||55.231,0.2,0.1,0.13333333333333333
335,Histochem_Cell_Biol-3-1-2137947.txt,cancer cell||pnb||cancer||author||mitot phosphoryl||ribosom biogenesi||depend||nucleolar protein||nuclear receptor||norc||studi||process||complex||rdna transcript machineri||nucleolar compon||rdna||dynam||biogenesi||cell||nuclear bodi||nucleolar structur||ribosom||dfc||local||transcript||protein||ribosom protein||nucleolu||upstream bind factor||nuclear export||nucleolar assembl||cell cycl||activ||rrna||bind||factor||nuclear function compartment||compon||nucleolar machineri||assembl||viru||molecul||sequenc||rdna transcript,nucleolu||nucleolar transcript||segreg nucleolu||nucleolu disrupt||nucleolu biochem||nucleolu differ||nucleolu play||nucleolar protein||nucleolar assembl||nucleolar machineri||nucleolar factor||nucleolar local||nucleolar organ||nucleolar retent||nucleolar compon,229.393||139.072||116.339||115.523||115.074||114.705||114.696||113.796||111.681||106.888||103.986||103.138||101.362||100.802||100.674,0.2,0.4,0.3333333333333333
336,Eur_Arch_Otorhinolaryngol-4-1-2358940.txt,posterior part||ventromediocaud part||arytenoid cartilag||level||unilater vocal fold paralysi||arytenoid||cricoarytenoid joint||healthi side||posit||paralysi||movement||procedur||surgeri||patient||phonat||three-dimension comput tomographi||techniqu,vocal fold||paralyz vocal fold||arytenoid||healthi vocal fold||paralyz vocal process||vocal cord||vocal process||vocal fold level||vocal fold relax||unilater vocal fold paralysi||vocal cord paralysi||paralyz side||tomographi unilater vocal||3dct||unilater vocal fold paralysi 7,62.148||56.98||48.416||45.356||44.568||44.417||43.529||42.693||41.785||41.511||38.966||37.429||34.697||34.577||33.407,0.2,0.2,0.13333333333333333
337,Neurosurg_Rev-2-2-1705527.txt,dural arterioven fistula||pulsatil tinnitu||complet obliter||transcondylar approach||patholog vessel||posterior condylar emissari vein||patient||occipit condyl||region||treatment||fistula||pulsatil bruit||occipit arteri||approach||surgeri||hypogloss canal||foramen magnum||intraoss davf||obliter||jugular bulb||transoss arteri feeder||extens boni drill||davf||arteri feeder,dural||dural arterioven fistula||arterioven fistula||dural arterioven malform||intracrani dural arterioven fistula||tentori dural arterioven fistula||dural arteri||complex dural arterioven fistula||dural malform||arterioven malform||intraoss dural arterioven malform||dural avf||fistula||extens dural arterioven malform||spinal dural arterioven malform,123.098||104.992||95.939||92.281||81.06||79.487||79.353||78.744||77.583||76.872||75.573||75.189||70.201||69.799||69.211,0.2,0.1,0.13333333333333333
338,Neurochem_Res-4-1-2270371.txt,antibodi||anim||level||stain||gdnf protein||transect injuri||western blot||spinal cord||rostral stump||dpo||caudal stump||gdnf||present studi||cell||rat||hindlimb||injuri site||neuron||adult rat||rostral||white matter||cord||ventral horn||incub,gdnf||gdnf antibodi||intrins gdnf||gdnf immunoreactivti||gdnf mrna||inflammation-induc gdnf||gdnf express||exogen gdnf||endogen gdnf||gdnf protein||gdnf famili||gdnf deliveri||gdnf antibodi neutral||tabl 2 gdnf||cord,150.95||80.201||77.176||76.962||76.939||76.661||76.133||76.087||75.475||75.475||75.475||75.475||53.467||50.822||45.029,0.2,0.2,0.2
339,Pathol_Oncol_Res-4-1-2413131.txt,oscc||egfr inhibitor||concentr||cisplatin sensit||combin||studi||effect||sensit||oral cancer||cell line||inhibit||treatment||cell||growth||higher express||oscc cell growth||protein||cisplatin resist||cisplatin||egfr||pathway||addit||cancer therapi||oral squamou cell carcinoma,cisplatin||egfr||cisplatin resist||cisplatin sensit||1 cisplatin||egfr inhibitor||cisplatin-resist oscc cell line cisplatin sensit||oscc||epiderm growth||egfr downstream||p-egfr||egfr blockad||growth||oscc cell growth||oscc cell,66.028||51.104||38.493||37.077||33.033||31.396||29.901||29.848||28.372||26.896||26.355||26.206||26.046||25.893||25.817,0.8,0.6,0.5333333333333333
340,Arthritis_Res_Ther-5-3-165040.txt,mechan||type||connect tissu||nutrient||vertebr bodi||studi||disc||patient||nucleu||human||nerv||articular cartilag||back pain||low||cell||therapi||growth||gene||disc degener||spinal canal||tissu||collagen||pain||intervertebr disc||exercis||cartilag end-plat||factor||nutrient suppli||major role||proteoglycan||matrix||loss||annulu||degener,disc||intervertebr disc||disc degener||degener disc||intervertebr disc degener||lumbar intervertebr disc||lumbar disc||intervertebr disc herniat||scoliot intervertebr disc||human intervertebr disc||canin intervertebr disc||bovin intervertebr disc||normal intervertebr disc||intervertebr disc degrad||intervertebr disc properti,345.403||281.408||227.152||227.152||223.906||212.128||209.486||196.984||190.442||190.08||189.482||188.173||188.165||188.118||187.967,0.6,0.3,0.2
341,J_Mol_Med-3-1-1820751.txt,noonan syndrom||gene||costello syndrom||clinic phenotyp||ra||result||protein||ns-like featur||k-ra||ra pathway||disord||jmml||pathway||short statur||mutat||gtp||human cancer||patient||syndrom||germlin,ptpn11||ptpn11 mutat||nf1||noonan||noonan syndrom||syndrom||ptpn11 braf hra||ptpn11 gene||somat ptpn11 mutat||ra||leukemia-associ ptpn11 mutat||32 ptpn11 mutat||noonan syndrom NS noonan syndrom||mutat||neel BG ptpn11,96.273||71.121||64.127||59.406||58.096||56.786||53.522||50.823||50.375||49.989||48.425||47.414||47.147||45.968||42.875,0.2,0.3,0.26666666666666666
342,J_Mol_Model-3-1-2039870.txt,dft||classic electrostat attract||data||combin||lda||densiti||homo-bas stack||refer data||interact energi||base||ccsd||larg basi set||densiti function||π-π stack interact||dna||energi||term||vertic separ||twist angl||hydrogen bond||densiti function theori||function||result,stack||phi chem||π-π stack||π-π stack interact||chem phi 105:8684||chem phi 116:9620||chem phi 116:515||chem phi 107:7921||phi chem 98:3161||phi chem 100:5590||chem phi 119:3015||chem phi 117:11113||stack base||stack benzen||homo-bas stack,83.666||71.813||61.67||49.431||48.819||48.819||48.819||48.819||48.819||48.819||48.819||48.819||48.538||47.099||43.25,0.2,0.1,0.13333333333333333
343,Cardiovasc_Eng-3-1-2137944.txt,myocardi energet output||cardiovascular system||system||myocardi oxygen consumpt||data||patient||valu||stroke||ventricl dysfunct||blood pressur||heart failur||numer simul||myocardi energet||numer model||paramet||cardiac rhythm pace||pulmonari pressur||echocardiographi examin||work||ventricular pace||heart||mode||vvi||aai,pace||ventricular pace||aai pace||dual-chamb pace||cardiac pace||physiolog pace||pace left ventricl||cardiac rhythm pace||perman cardiac pace||text||pacemak||aai||myocardi energet||pacemak mode||aai mode,61.889||42.388||39.965||37.239||35.789||32.266||27.745||25.616||24.604||22.356||18.5||18.041||15.906||15.277||15.047,0.2,0.2,0.26666666666666666
344,Plant_Mol_Biol-3-1-1805041.txt,seed||line||databas||insert||rice gene||import gene||gene function||correl||function analysi||phenotyp data||insert line||gene||mutant panel databas||natur condit||field||mutant||number||phenotyp||experiment data||long leaf||retrotransposon||sequenc||nipponbar||function,tos17||2 tos17 tos17 tos17 tos17 insert||tos17 tos17 1998||tos17 retrotransposon||tos17 http://www.rgrc.dna.affrc.go.jp/||phenotyp||2 tos17 tos17 insert point||tos17 insert mutant popul||mutant phenotyp||rice||dwarf||semi-dwarf phenotyp||leaf||dwarf mutant||mutant,143.284||100.37||95.523||75.243||73.133||64.158||63.131||53.17||51.622||46.514||45.717||44.011||43.254||42.401||39.085,0.0,0.1,0.13333333333333333
345,Biochim_Biophys_Acta-2-1-2225445.txt,antibodi||thymu||phd||panel||mutat||nuclear extract||chromatin||kinas||air||domain||Ku 80||site||phd finger||express||phosphoryl||cell||thymic epitheli cell||gene||protein||activ||posit control||whole-cel extract||apec||immunoprecipit||dna-pk,air||air phosphoryl||dna-pk phosphoryl air||dna-pk||air protein||co-immunoprecipit air||air dimer||air interact||air gene||air phosphoryl site||air phosphoryl level||abstract air||air reveal||air phosphoryl http://scansite.mit.edu/cgi-bin/motifscan_seq||air phosphoryl effici,127.291||93.73||90.187||83.103||75.277||71.996||66.243||65.838||64.239||64.144||63.933||63.645||63.645||63.461||62.812,0.4,0.2,0.13333333333333333
346,Ann_Biomed_Eng-2-2-1705476.txt,antibodi||level||pathogen||time||simpl bar code system||reaction chamber||strain||pathogen detect||test||region||filament||classif||specif||fara||solut||captur||fluoresc||chamber||posit||captur antibodi||laser||peak||viru||decis tree||detect,filament||reoviru||antibodi||filament fluoresc||reoviru t3d||captur antibodi||reoviru t3sa||detect antibodi||reoviru strain||filament posit||wash filament||4f2 antibodi||filament locat||viru||antibodi region,85.424||73.946||63.924||59.767||53.796||49.86||47.678||46.33||45.87||45.259||45.162||44.196||44.189||43.878||43.785,0.4,0.3,0.26666666666666666
347,Ann_Biomed_Eng-2-2-1705503.txt,type||cell cycl analysi||silicon sheet||concentr||studi||effect||pdgf-ab||increas||cultur substrat||cell prolifer||collagen synthesi||express||cell||gelatin||growth factor||two-dimension substrat||prolifer||collagen||ligament tissu engin||tissu regener||synthesi||cultur||substrat||franc||fibroblast||result,ligament||ligament fibroblast||growth||fibroblast||collagen||cruciat ligament fibroblast||collagen synthesi||tgf-β1||fibroblast prolifer||growth factor||collater ligament||M. collagen||anterior cruciat ligament||ligament tissu eng||ligament tissu engin,41.359||35.603||33.251||29.848||29.181||29.16||25.019||24.818||24.196||23.569||23.314||22.885||22.678||22.174||22.118,0.4,0.4,0.3333333333333333
348,J_Gastrointest_Surg-3-1-1852383.txt,case||arteri thrombosi||group||abo-incompat blood group||result||risk factor||chi-squar test||biliari||graft||incid||bc||biliari complic||studi||BC risk factor||neg liver graft||patient||liver transplant||Rh nonident||donor,transplant||Rh||Rh nonident||liver transplant||biliari transplant||Rh graft||liver||BC||nonident Rh group||Rh donor||conclus liver transplant||abo||graft||biliari||rh-nonident liver graft,38.834||37.581||34.689||33.825||29.997||29.422||28.816||25.185||25.061||23.074||22.55||22.256||21.263||21.16||19.872,0.4,0.2,0.26666666666666666
349,Bioinformation-1-3-1891659.txt,program||time||posit||repeat||microsatellit||ssrscanner||motif||ssr||genom||perl,ssrscanner||repeat||softwar ssrscanner||comput program ssrscanner||program||ssr||simpl sequenc repeat||bioinform bioinform bioinform||futur develop ssrscanner||simpl sequenc repeat scanner||anwar||huzzi99@hotmail.com scanner ssr||perl||comput program||execut program,29.954||23.955||15.529||15.099||13.566||13.488||12.136||11.736||10.485||9.932||8.481||8.098||7.763||7.671||7.519,0.6,0.4,0.3333333333333333
350,J_Mol_Med-4-1-2374882.txt,proteinuria||level||nephropathi||glomerulosclerosi||renal angiotensin level||renin receptor||nonproteolyt activ||hypertens||import role||anim model||develop||increas||region||recent||receptor||express||renin receptor express||rat||mitogen-activ protein kinas||intracellular||angiotensin||activ||part||bind||podocyt||prorenin||mrna express||angiotensin II||hypertens condit||addit||kidney||result,renin||prorenin||renin receptor||receptor-bound renin||prorenin receptor||receptor-bound prorenin||pro||rat prorenin||prorenin bind||renin signal||activ prorenin||prorenin proseg||prorenin level||prorenin contribut||human prorenin,134.888||130.273||86.22||84.667||83.913||82.36||72.676||72.33||69.461||68.808||68.552||68.267||67.347||67.057||66.05,0.4,0.2,0.13333333333333333
351,Anal_Bioanal_Chem-4-1-2359830.txt,biota||calcul||methylmercuri biothiol||figur||mehgci||cy||detect condit||extract||direct inject||plant extract||inform||form||organ molecul||electrospray mass spectrometri||complex||methylmercuri||compound||icp-m||mass||signal||ion trap||molecular ion||ammonia group||electrospray mass spectromet||biothiol||solut||es-m paramet||in-sourc fragment||standard||group||analyt method||order||hplc eluent||es-m||fragment||mercuri||fragment pattern||nitrogen atom||proton||molecul||plant,mercuri||mercuri compound||mercuri complex||mercuri speciat||mercuri bound||mercuri intens||mercuri speci||select mercuri||mercuri biomolecul cy||mercuri biothiol complex||2||2 2||2 2 2||mehgci||es-m,84.07||55.548||46.308||44.966||44.246||44.123||43.629||42.035||40.259||39.641||36.901||36.901||36.901||35.08||35.08,0.2,0.1,0.2
352,Urol_Res-3-1-2082064.txt,eswl||va||effect||air||inhal entonox||extracorpor shock wave lithotripsi||pethidin||va score||group||stone||statist analysi||pain||signific differ||procedur||pain relief||entonox||studi||patient||analgesia,entonox||entonox pethidin||air entonox||inhal entonox||eswl||lithotripsi||entonox group||entonox ga||conclus entonox||pethidin||analgesia||pain||shockwav lithotripsi||eswl patient||isfahan,91.992||64.719||52.122||51.264||49.261||49.261||49.15||47.783||45.996||37.446||30.859||30.284||27.913||26.784||26.266,0.6,0.4,0.4
353,J_Abnorm_Child_Psychol-3-1-1915632.txt,find||social maladjust||boy||behavior||problem||aggress||school||peer||problemat social behavior||depend variabl||behavior pattern||social adjust||stabil||bulli||class||pattern||featur||similar||analys||girl||item||social function||gender||nomin||victim||group||report||adjust||dislik||transient||adolesc||score,bulli||victim||childhood bulli||school bulli||olweu bulli||peer victim||stabl bulli||K. bulli||childhood victim||transient bulli||femal bulli||aggress victim||children victim||stabl victim||non-involv children bulli,297.423||219.62||195.33||168.351||165.217||165.053||164.685||158.006||156.429||150.248||148.712||138.494||125.891||125.784||117.197,0.4,0.2,0.13333333333333333
354,Pharm_World_Sci-3-1-1915627.txt,atyp||combin||data||studi||patient||europ||frequenc||medic||clinic practic||polypharmaci||countri||anticholinerg||antipsychot polypharmaci||common practic||belgium||antipsychot agent||number||antipsychot||hospit pharmacist||larg number||daili clinic practic||result,antipsychot||atyp antipsychot||antipsychot polypharmaci||low-pot antipsychot||convent antipsychot||antipsychot properti||antipsychot medic||antipsychot agent||atyp antipsychot 42.1||individu atyp antipsychot||antipsychot polypharmaci 31.7||low-pot convent antipsychot||atyp||median dose antipsychot||convent antipsychot 9.2,225.635||154.781||147.176||129.992||116.587||113.713||113.526||113.391||105.457||103.187||98.718||89.175||83.926||78.399||78.114,0.4,0.3,0.26666666666666666
355,Qual_Life_Res-4-1-2248606.txt,nurs home||qualiti||depress complaint||life||question||alpha||correl||pgcm||scale||oqol||resid||cognit impair||gip-||pilot studi||self-report||gd||valid||na||cognit||item||pa||research||intern consist||group||depress list||posit||neg||cognit test||cognit group||neg affect,scale||life scale||oqol scale||self-report scale||neg scale||cognit||observ scale||self-report oqol scale||posit scale||life-scal scale||self-evalu scale||cornell-brown scale||resid||perform scale||scale 1,114.014||83.948||80.751||69.642||65.382||64.966||62.609||62.258||61.697||61.196||59.213||58.403||57.589||57.009||57.007,0.2,0.2,0.2
356,J_Digit_Imaging-3-1-2039858.txt,method||system||scp emul||net librari||command line version||project||storag||core||imag||session||definit file||valu||dicom||scu||view||dicom file viewer||exampl||test||servic class user||detail||dataset||tool||valid||dicom file||file||class definit file||applic||scp||script||modal||associ||standard||framework||pac||stand-alon tool||import||sut||attribut||sop class||emul||addit||philip||send||messag||dvt||result,dicom||dicom file||dvt||dicom valid||dicom messag||dvt script||file||dicom sniffer||dicom media file||dicom interfac||dicom standard||dicom file viewer||modifi dicom file||dicom object||dicom file stripper,250.478||193.927||177.768||154.437||140.962||139.738||137.376||132.244||131.822||131.325||131.184||131.145||131.119||130.182||129.986,0.6,0.4,0.3333333333333333
357,J_Mol_Med-4-1-2359832.txt,human tumorigenesi||level||variant||sampl||data||studi||mdm4 variant||comparison||ptc||correl||form||western blot||express||signific||tumor properti||thyroid carcinoma||ratio||protein||analysi||p53||papillari thyroid carcinoma||human cancer||group||tumor||method tissu sampl||presenc||histopatholog featur||mdm2||mdm4||mrna||ctrl||addit,mdm4||n.d||mdm4 variant||1 n.d||n.d. n.d||mdm4 mrna||mdm2||1 0.6 wt||full-length mdm4||mdm4 cancer||mdm4 level||1.4 0.8 wt n.d. n.d||mdm4 alter||human mdm4||mdm4 express,116.419||101.744||68.546||67.986||65.593||64.376||61.583||60.799||60.505||60.401||60.298||60.164||59.594||58.907||58.209,0.4,0.3,0.2
358,Eur_J_Epidemiol-3-1-2071967.txt,glaucoma||measur||anxieti disord||method||endocrin diseas||protocol||atherosclerosi||imag||determin||macular degener||studi||depress||stroke||risk||optic disc||heart failur||high risk||disord||updat||dementia||examin||parkinson diseas||gene||amd||blood sampl||blood||research||grief||assess||age||associ||subject||genet factor||myocardi infarct||factor||alzheim diseas||rotterdam studi||osteoporosi||elderli||candid gene||drug||import inform||risk factor||particip||area||urin||diseas||object||larg number,hofman||rotterdam||JR hofman||AK hofman||rotterdam studi||bretel mmb||bretel mmb witteman jcm||witteman jcm bretel mmb||JR bretel MM hofman||swieten JC hofman||tuijl HR hofman||bot ML hofman||PI rotterdam studi||slooter ajc hofman||kuip DA hofman,170.766||122.428||89.126||85.383||84.606||76.281||66.207||66.207||66.014||64.474||61.456||60.817||60.74||60.332||59.673,0.2,0.1,0.06666666666666667
359,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2413123.txt,hartmann-shack aberrometri||measur||endogen insulin level||studi||ocular paramet||increas||equival refract index||hyperglycemia||hyperop shift||refract properti||higher order aberr||eye||glucos||shape||blood glucos||len||subject||chang||ogtt||order||refract error||ocular refract||procedur||precis||healthi human eye||refract index,refract||refract chang||len||ocular refract||refract index||refract properti||refract error||refract indic||object refract||hyperglycemia||refract acta ophthalmol||transient hyperop refract||ocular refract error||equival refract index||hartmann-shack aberrometri refract error len,107.048||68.65||62.83||58.118||55.743||55.499||55.396||53.524||53.524||46.756||44.602||40.07||39.993||38.756||38.082,0.6,0.6,0.4666666666666667
360,Ann_Biomed_Eng-2-2-1705519.txt,respons||center||cat type IV unit||paramet estim||rate||model||sensit analysi||frequenc||gerbil||rm||notch nois respons||spectral notch detector||inhibit||notch||unit||cell||NN stimuli||connect paramet||type iii||physiolog data||paramet||princip cell||sound pressur level||good fit||simul||type IV unit||cat||inhibitori||center frequenc||spontan rate||nois stimuli||experiment data||dcn||nois||sound local,rm||rm BW||rm nsa||model rm||document||documentclass||12pt||amsmath||amsfont||mathrsf||69pt||end||unit||dcn||gerbil dcn,249.622||133.509||133.485||131.591||110.801||58.696||58.696||58.696||58.696||58.696||58.696||48.875||43.468||40.511||35.515,0.2,0.1,0.2
361,Eur_J_Nutr-2-2-1705483.txt,cereal fraction||author||diet supplement||week||microbicid activ||protect effect||studi||effect||immun function||healthi subject||health promot||cereal||periton leukocyt||gssg||macrophag||leukocyt function||healthi mice||immun cell||health||control||antioxid||chronic diseas||oxid stress||mice||total polyphenol||diet||activ||import||redox state||natur product||immun respons||catechin||diseas||supplement||lipid oxid damag||function||polyphenol||result,antioxid||polyphenol antioxid||phenol antioxid||dietari antioxid||polyphenol||antioxid vitamin||antioxid effect||cereal||antioxid statu||antioxid nutrient||antioxid protect||antioxid defenc||antioxid enzym||antioxid signal||antioxid activ,65.276||51.607||41.965||38.198||37.938||37.102||34.347||34.046||33.68||33.622||33.407||33.314||33.27||33.168||33.028,0.4,0.3,0.2
362,Behav_Genet-3-1-1914301.txt,measur||sum||attent problem||respons||varianc decomposit||handl||individu||sum score||data||model||ceil effect||herit||effect||irt||correl||trait||mcmc||underestim||non-shar environment varianc||varianc compon||paramet||item||estim||approach||varianc||twin||latent variabl||analysi||simul||framework||distribut||genet||item respons theori||classic test theori||number||normal distribut||measur error||score||result,irt||item||sum||irt model||item score||sum score||irt estim||sum latent score||score||model||latent score||sum score correl||irt model paramet||sum score approach||varianc,105.713||98.948||95.854||89.341||87.189||85.642||77.117||75.784||75.43||72.97||65.75||65.055||64.7||63.417||63.31,0.6,0.6,0.4666666666666667
363,Sci_Eng_Ethics-4-1-2413105.txt,engin ethic||system||implicit contract||problem||feel||model||self-esteem||pride||view||notion||special oblig||countri||high moral standard||code||virtu||profession integr||approach||social statu||societi||membership-requir view||implicit social contract||contract||occup capac||profess||ethic||sens||high incom||japan||student||social-contract view||posit feel||engin,engin||profession engin||profession||profession pride||pride||engin ethic||engin profess||profession ethic||motiv engin||profession motiv||real-world profession pride||engin societi||japanes engin||profession integr||engin educ,131.135||125.938||120.74||120.534||120.327||94.942||92.959||89.745||88.996||83.798||80.942||79.839||79.227||72.265||71.945,0.4,0.3,0.26666666666666666
364,Eur_J_Pediatr-3-1-2042511.txt,metabol diseas||studi||mutat||patient||platelet||defect||platelet-bas bleed disord||dmd||disord||adhes||adp||gene||gray platelet syndrom||protein||broader clinic phenotyp||platelet function||secret||epstein syndrom||human patholog||pathway||diseas||platelet research||function||result,platelet||platelet defect||platelet adhes||platelet secret||platelet research||platelet function||morpholog platelet||platelet format||platelet 5-ht||giant platelet||platelet aggreg||platelet petechia||platelet activ||patients' platelet||blood platelet,190.222||112.763||100.893||99.234||98.036||97.847||97.343||97.205||97.121||96.697||96.683||96.523||96.416||96.086||95.973,0.4,0.3,0.2
365,Crit_Care-9-3-1175868.txt,cardiac surgeri||author||dopexamin group||enoximon||tachycardia||amrinon||vital organ perfus||signific reduct||data||pulmonari hypertens||studi||patient||clinic outcom||effect||agent||investig||cardiovascular drug||increas||cpb||cowork||dose||signific||levosimendan||signific increas||cabg||low dose||low cardiac output syndrom||map||advers cardiac event||paper||cardiac output||catecholamin||epinephrin||cardiac surgeri patient||min||dobutamin||group||milrinon||clinic research||low cardiac output||literatur search||report||pdi||lco||signific differ||trial||pulmonari arteri pressur||function,milrinon||milrinon milrinon||haemodynam||dobutamin||amrinon||enoximon||enoximon enoximon||kg||cardiac surgeri||μg||cardiopulmonari bypass||kg haemodynam paramet||dopexamin||haemodynam paramet||haemodynam effect,130.119||130.119||120.627||96.881||91.699||90.963||90.963||88.576||84.845||83.891||81.605||81.022||77.38||77.245||74.491,0.6,0.5,0.3333333333333333
366,Eur_J_Nucl_Med_Mol_Imaging-3-1-1998889.txt,locoregion rit||surviv time||resect caviti||mri||high radiat dose||baselin||studi||valu||recurr||patient||tumour-fre statu||fet||fet uptak||effect||sensit tool||intracavitari radioimmunotherapi||clinic deterior||threshold||highest uptak||blood-brain barrier||criterion||normal brain tissu||present studi||treatment||malign glioma||tumour recurr||tumour||ratio||post-therapeut phase||analysi||reliabl indic||residu tumour||initi surgeri||uptak||radiat therapi||pet||peak||contrast||addit||serial fet pet||rit||result,fet||04||fet pet||fet uptak||pet||IV 04||fet pet monitor||serial fet pet||rit||conclus fet pet||max||max max max||patient fet uptak||uptak||glioma,82.191||79.99||72.407||63.128||62.622||54.497||52.797||51.797||50.418||48.271||45.459||45.459||45.1||44.066||43.991,0.6,0.5,0.4
367,Bioinformation-1-6-1891690.txt,databas,databas||databas categori||append databas||dod2006||databas entri||web databas dod2006||databas suit||molecular biolog databas||12. organel databas||5. genom databas||4. structur databas||gene express databas||S. no. databas categori||dod2006 newli||nucleotid sequenc databas citat,47.503||27.305||26.888||26.594||26.219||25.039||24.648||20.194||16.501||16.461||16.235||15.834||14.31||14.162||13.962,0.2,0.1,0.06666666666666667
368,Skeletal_Radiol-4-1-2257990.txt,high intens||advanc imag||case||radiograph||entir marrow space||mri||imag||vertebr bodi||patient||lumbar vertebra||chordoma||bnct||lesion||adipocyte-lik vacuol chordoid cell||metastat diseas||soft tissu mass||pain||benign notochord cell tumor||progress diseas||bone scintigram||tumor||biopsi||surgic procedur||notochord vestig||bone||low signal intens||diagnosi||giant notochord rest,chordoma||classic chordoma||intra-oss chordoma||incipi chordoma||curettag chordoma aliv||biopsi chordoma aliv||notochord vestig||bnct||marten F. chordoma||L5 chordoma die||benign notochord cell tumor||vertebr chordoma yamaguchi takehiko||lesion||benign lesion||vertebr notochord rest,86.352||44.98||44.614||44.375||36.71||34.945||33.125||31.767||31.761||30.836||28.744||28.174||26.883||26.649||26.534,0.2,0.3,0.3333333333333333
369,Histochem_Cell_Biol-4-1-2323029.txt,subsequ studi||type||mechan||organel||viral transmiss||thin||tnt||data||intercellular transfer||tunnel nanotub||membran continu||cell||direct transfer||tissu||virus||similar structur||mitochondria||format||tnt-like structur||nanotub||transfer||bridg||connect||plasma membran,nanotub||cell||membran nanotub||tunnel nanotub||tnt-like connect||connect cell||tnt-like structur||cell protrus||drosophila||f-actin||2004||cell extens||stem cell||immun cell||cell protrus drosophila 2007,41.306||38.701||29.328||26.694||26.615||26.252||25.695||25.196||24.71||23.74||23.236||22.175||21.56||21.557||21.373,0.6,0.4,0.26666666666666666
370,Eur_Arch_Otorhinolaryngol-3-1-2042030.txt,imdd||biopsi||midlin facial structur||complaint||case||local||progress ulcer||lesion||palat||radiotherapi||diseas||radiat ulcer||patient||year||rare diseas||physic examin||treatment||re-irradi||total dose,midlin||re-irradi||idiopath midlin||radiat||destruct||radiat ulcer||recurr midlin||lethal midlin granuloma||destruct diseas radiotherapi midlin granuloma||radiat oncolog||ulcer||neck||irradi area re-irradi||lethal midlin granuloma type||imdd,28.636||24.649||19.96||18.675||16.877||15.471||15.106||14.195||13.67||12.682||12.266||10.727||10.658||10.646||10.562,0.2,0.2,0.2
371,Purinergic_Signal-3-1-2096766.txt,role||respons||cd39||vascular inflammatori||cellular immun respons||data||adenosin||effect||treg||atp||platelet||major defect||dendrit cell||receptor||express||cell||immunoregulatori function||lymphocyt||ecto-enzym||ecto-nucleotidas||function||ecto-atpas||vasculatur||immun respons,cd39||cd39 cd39||cd39 cd39 3 cd39 3||cd39 function||panel cd39||cd39 express||cd39 28 cd39 28||2007 cd39||robson SC cd39||cd39 famili modul||robson SC palmitoyl target cd39||robson||human cd39 transgen mice||s11302-006-9050-i origin paper cd39||cd39 lymphoid cell activ antigen,160.071||160.071||96.431||81.849||81.509||81.161||80.636||80.036||77.009||56.153||46.798||45.275||41.762||40.784||37.717,0.2,0.1,0.06666666666666667
372,J_Med_Internet_Res-5-4-1550572.txt,person||attempt||time||behavior||studi||adolesc searcher||question||school||observ||inform||correct||site||qualit data||adult||content||similar||health educ||page||web||success||result||factor||topic||issu||comput literaci||adolesc||survey||link||answer||internet,search||search question||search engin||success search||search string||unsuccess search||search result||search phrase||search tactic||search behavior||search topic search topic||search simul||search strategi||search term||altern search,180.781||111.733||108.212||105.1||101.219||100.219||97.639||95.556||95.027||94.979||93.731||93.351||92.031||91.669||90.948,0.0,0.0,0.0
373,Support_Care_Cancer-3-1-2092408.txt,sr||cancer||measur||level||time||measur time||distress||studi||year||patient||physic function||chemotherapi||refer group||start||qol||testicular cancer||mental health||spous||coupl||treatment||relationship||social function||stress respons symptom||correspond||differ||partner||diagnosi||function||children,partner||sr||testicular cancer||cancer||testicular cancer patient||testicular cancer survivor||testicular germ-cel cancer||partners’ sr||femal partner||dissemin testicular cancer||testicular cancer treatment||qol||cancer patient cancer||testicular cancer-review||testicular cancer-pati,73.024||63.552||52.781||42.573||41.245||39.53||37.004||36.779||36.512||36.425||35.981||34.773||34.439||32.976||32.976,0.8,0.4,0.3333333333333333
374,J_Mol_Med-3-1-2121656.txt,hypoxia||hif||therapeut||brain||stroke,hif||stroke||prolyl||hif phd||hif phd1||hif prolyl 4 hydroxylas||divert hif||hypoxia||hypoxia-induc stroke toler||stroke therapeut||stroke pathophysiolog||acut stroke||stabl stroke||experiment stroke||hypoxia-induc factor-1,43.787||37.564||27.254||25.522||25.333||23.134||22.804||22.321||22.218||20.97||19.696||19.304||18.782||18.782||18.489,0.4,0.3,0.2
375,J_Gastrointest_Surg-3-1-1915638.txt,follow-up||center||complic||data||studi||year||eea||long-term result||leakag||stent||patient||stent therapi||stenosi||endoscop||treatment||present studi||addit therapi||reconstruct surgeri||bdi||strictur||end-to-end anastomosi||surgeri||injuri||cholecystectomi||bile duct injuri||bile duct||surviv||long-term stricture-fre surviv||data analys||percutan transhepat catheter||duct||procedur||present seri||referr||outcom,eea||duct||bile duct||complic eea||bile duct injuri||eea patient||perop eea||postop bile duct||eea procedur||intrahepat bile duct||primari eea||duct injuri||proxim bile duct||common bile duct||segment bile duct,92.434||74.01||71.954||60.242||56.135||54.356||54.04||51.497||51.082||49.828||49.689||49.253||48.514||48.393||48.365,0.8,0.4,0.26666666666666666
376,Soc_Psychiatry_Psychiatr_Epidemiol-2-2-1764204.txt,popul center||servic util||alcohol abus||rate||tarapaca||data||socio-demograph differ||studi||substanc abus disord||bio bio||region||mental health||disord||countri||interview||chile||drug abus||psychiatr disord||major depress disord||conclus region differ||analysi||lifetim||popul||servic||major depress||region differ||differ||drug||household||mental health servic||span wide geograph area||district,disord||mental disord||psychiatr disord||region disord||panic disord||anxieti disord||dsm-iii-r disord||disord rate||affect disord||schizophreniform disord||delusion disord||schizoaffect disord||psychot disord||cognit disord||substanc abus disord,155.905||96.585||96.306||94.736||92.07||89.951||86.616||82.497||82.429||80.59||80.59||80.168||78.575||77.953||67.218,0.4,0.2,0.2
377,Arch_Orthop_Trauma_Surg-4-1-2225998.txt,measur||reproduc||tradit measur techniqu||radiu fractur||studi||patient||radial length||distal radiu fractur||x-ray||direct measur||observ||AO fractur type||improv||classif||reduct result||techniqu||volar angul||radiu||normal valu||radial inclin||templat||distal radiu||distal radial fractur||side||result,distal radial fractur||fractur||unilater distal radial fractur||distal radiu fractur||radial inclin||distal radial oper||distal radiu||radiu fractur||templat||radial styloid||radial axi||unilater disloc distal radial fractur||distal radial fractur van eerten||radial length||heal distal radiu fractur,52.126||45.477||40.211||39.775||37.993||36.967||36.924||34.848||34.763||33.899||33.276||32.873||32.336||31.82||30.117,0.6,0.6,0.4666666666666667
378,Eur_J_Appl_Physiol-3-1-1914221.txt,level||deficit||studi||patient||year||life||liver transplant||complaint||test||neuromuscular fit||liver transplant recipi||cross-sect studi||norm valu||present studi||fit||ltx||relationship||bodi composit||percentag||rehabilit program||sedentari person||sever||fatigu||isokinet strength||gener popul,2peak||fit||2peak ffm||2peak recr||physic fit||cardiorespiratori fit||liver transplant||transplant||fatigu||liver transplant recipi||neuromuscular fit||fit test||decreas physic fit||fit paramet||3 cardiorespiratori fit,94.221||73.012||62.962||58.286||56.292||52.959||51.145||48.375||43.706||43.282||42.733||38.616||37.528||36.506||35.307,0.2,0.4,0.3333333333333333
379,Diabetologia-3-1-1914285.txt,upregul||lipid content||level||matur adipocyt||thiazolidinedion||adipokin||adipocyt||tzd||prostaglandin metabol||secret protein||lipolysi||rosiglitazon||rosi||adipos tissu||increas||low insulin||insulin||adipos||cell type||treatment||cell||gene||protein||lipid accumul||analysi||fatti acid||chang||metabol||decreas||secret||pathway||result,rosiglitazon||adipocyt||insulin rosiig rosiglitazon||result rosiglitazon||rosiglitazon treatment||3t3-l1 adipocyt||matur adipocyt||pcr rosi rosiglitazon||insulin||matur 3t3-l1 adipocyt||adipocyt differenti||1.52 0.000||1.63 0.000||adipocyt 11beta||1.88 0.000,105.399||74.407||57.268||52.699||52.699||52.502||48.33||43.515||43.165||42.419||41.3||40.185||39.59||38.656||38.648,0.4,0.4,0.26666666666666666
380,Ann_Hematol-4-1-2413090.txt,md||case||ipss||studi||patient||cytogenet find||clinic manag||therapeut strategi||complex abnorm||cell||gene||delet||result||prognosi||month||cytogenet||multicentr studi||group||genet materi||profound||median surviv||prognost relev||monosomi 7||karyotyp||deleteri cytogenet alter||anomali||monosomi,cytogenet||md||imraw cytogenet md||keyword md cytogenet||cytogenet subgroup||poor-risk cytogenet||poor cytogenet||5q||cytogenet profil||cytogenet follow-up||cytogenet featur||cancer cytogenet||cytogenet studi||2 cytogenet||cytogenet find,107.967||66.509||60.074||58.159||57.114||56.468||55.913||55.705||55.676||54.621||54.57||54.289||54.012||53.984||53.984,0.4,0.2,0.2
381,Mol_Genet_Genomics-4-1-2329726.txt,condit||gene||human||strain||absent||gene pool||abu||genom||number||transcript||microarray||hypothet protein||urinari tract infect||urinari tract||environment condit||analysi||upec||up-regul||gene express||asymptomat bacteriuria,83972||escherichia coli||escherichia coli E. coli||strain 83972 E. coli||strain 83972||escherichia coli strain||strain||escherichia coli bacteriuria||2008 escherichia coli strain||escherichia coli isol||abu strain 83972||strain 83972 island||E. coli 2006b||E. coli transcript||strain 83972 descript,138.142||128.54||126.981||124.379||123.336||121.87||108.53||93.145||92.657||89.074||88.534||85.325||84.511||84.015||82.224,0.0,0.1,0.06666666666666667
382,Int_Urogynecol_J_Pelvic_Floor_Dysfunct-4-1-2259253.txt,measur||pregnanc||data||studi||pad test||stress urinari incontin||test||women||self-report symptom||curv||diagnost strength||urinari incontin||group||symptom||clinic relev||sever||childbirth||incontin||weight gain||pad||result,incontin||pad||pad test||urinari incontin||incontin women||self-report incontin||24-h pad test||24-hour pad test||stress incontin||sever incontin||patient-report incontin||self-report urinari incontin||femal incontin||incontin research||transient incontin,102.415||102.412||75.171||72.247||63.921||56.626||55.813||53.732||53.726||53.351||52.404||51.777||51.715||51.208||51.208,0.8,0.4,0.26666666666666666
383,Health_Care_Anal-4-1-2362137.txt,polici develop process||target group||interact polici develop||databas||problem||pam||data||theori||patient||effect||neurologist||develop||criteria||central pre-utilis approv||central committe||nation databas||clinic practic||variabl||clinic trial||guidelin||medic advisor||intervent||hcib||treatment||argument polici analysi||cost||health||workshop||polici||nation registri||clear protocol||interferon-beta||actor||specif recommend||target popul||order||reimburs||long-term effect||multipl sclerosi||drug||interact process||ministri||reimburs request||particip||drug interferon-beta,ifnβ||polici||ifnβ reimburs||reimburs ifnβ||ifnβ prescript||save ifnβ||ifnβ show||polici problem||polici implement||propos polici||polici develop||polici measur||polici maker||public polici||ifnβ user actor,157.106||122.881||97.095||97.095||82.12||79.062||78.553||71.235||70.828||68.332||65.805||64.875||64.396||63.442||62.757,0.2,0.1,0.06666666666666667
384,Eur_J_Clin_Pharmacol-4-1-2254473.txt,find||beta-lactam antibiot||outpati antimicrobi treatment||model||studi||patient||admiss||cap||mortal||pneumonia||antibiot||caus pathogen||treatment||antimicrobi therapi||atyp pathogen||hospit||microbi aetiolog||diagnost workup||antimicrobi drug||predictor||co-morbid||potenti predictor||initi treatment||aetiolog||hospit admiss||diagnosi||bacteria,pneumonia||community-acquir pneumonia||streptococcu pneumonia||viral pneumonia||mycoplasma pneumonia||pneumonia sever||suspect pneumonia||community-acquir pneumonia neth||atyp mycoplasma pneumonia||bt pneumonia guidelin||commun acquir pneumonia||S. pneumonia 19||S. pneumonia H.||pneumonia sever index||danc DA streptococcu pneumonia,144.174||89.228||77.003||76.561||74.838||73.506||72.592||60.157||54.978||52.981||51.104||49.604||49.568||49.507||38.99,0.2,0.1,0.06666666666666667
385,Knee_Surg_Sports_Traumatol_Arthrosc-4-1-2413121.txt,placebo||inflamm||nsaid||cartilag lesion||anterior cruciat ligament||intern knee document committe||studi||patient||joint preserv||function recoveri||effect||chondroprotect||follow-up visit||form||increas||recoveri||articular cartilag||knee pain||cartilag||treatment||i-on||day||control||joint reaction||studi design||sport activ||pemf||arthroscop reconstruct||pain||placebo group||activ||group||ikdc knee examin form||biophys stimul||recoveri time||signific differ||procedur||score||puls electromagnet field||result,i-on||ikdc||cartilag||knee cartilag||knee||i-on group||articular cartilag||acl||setti||electromagnet field||i-on treatment||cadossi||puls electromagnet field||acl reconstruct||ikdc form,37.116||30.928||28.573||28.199||27.825||24.146||24.138||22.703||20.746||20.334||20.056||18.555||17.737||17.705||17.651,0.4,0.3,0.26666666666666666
386,Neurogenetics-4-1-2238789.txt,gene||SI _ figur _||probe||link||biolog associ||lewi bodi||number||drug||interact||microarray||iter analysi||substantia nigra||data||express||studi||neurodegener||complet list||diseas||cell,SI _ figur _||SI _ figur||parkinson||SI _ figur _ 2||SI _ figur _ 1||SI _ tabl||parkinson diseas||1b http://www.morphonom.net/ng/esm/f/si_figure_1b.png SI _ figur||1c http://www.morphonom.net/ng/esm/f/si_figure_1c.png SI _ figur||3 http://www.morphonom.net/ng/esm/t/si_table_3.xl SI _ figur||5 http://www.morphonom.net/ng/esm/f/si_figure_5.png SI _ figur||parkinson ’s||1b http://www.morphonom.net/ng/esm/t/si_table_1b.txt SI _ tabl||1a http://www.morphonom.net/ng/esm/t/si_table_1a.xl SI _ tabl||1g http://www.morphonom.net/ng/esm/t/si_table_1g.rtf SI _ tabl,68.27||60.382||59.229||54.616||54.616||54.254||39.683||37.545||37.255||36.835||36.83||36.429||33.869||33.842||33.695,0.2,0.1,0.06666666666666667
387,Eur_J_Health_Econ-3-1-1913175.txt,copd||cost effect||data||model||patient||valu||year||effect||tiotropium||ipratropium group||ipratropium||spain||qali||util||clinic trial||prefer option||analys||perspect||treatment||cost||diseas state||spanish nation health system||similar declin||month||life year||salmeterol||scenario||gener practition||econom evalu||chronic obstruct pulmonari diseas||differ||scenario analys||trial||sever||probabl||bronchodil||spanish healthcar utilis||ce-plan,tiotropium||copd||cost||exacerb cost||exacerb||salmeterol||sever copd||copd sever||sever exacerb||ipratropium||tiotropium salmeterol ipratropium moder sever||unit cost moder copd sever copd||moder copd||inhal tiotropium||tiotropium pulm,123.659||116.415||113.929||111.144||108.36||84.298||80.468||80.468||76.441||75.865||68.855||68.089||66.173||65.694||65.272,0.6,0.5,0.3333333333333333
388,Ann_Surg_Oncol-4-1-2244700.txt,cancer||studi||prolif activ||prognost signific||correl||section||apoptot cell||perimembran||postop surviv||poor prognosi||overexpress||present studi||nsclc||neg control slide||signific factor||prognosi||surgeri||tumor||cell mitosi||aurora-a||lung cancer||non-small-cel lung cancer||clinic studi||result,aurora-a||aurora-a express||aurora-a statu||aurora-a contribut||perimembran aurora-a express||aurora-a express statu||aurora-a protein express||immunohistochemistri aurora-a express||stk15||conclus perimembran aurora-a statu||aurora-a 22 22||2007 purpos aurora-a||aurora||perimembran||s10434-007-9653-8 thorac oncolog perimembran aurora-a express,117.862||68.815||65.756||58.931||57.144||50.427||45.881||45.877||43.024||41.329||41.106||39.29||34.571||33.802||29.991,0.2,0.1,0.13333333333333333
389,J_Med_Internet_Res-7-3-1550657.txt,cancer||method||interest||search activ||internet user||common cancer||search engin||onlin inform||studi||media coverag||cancer search activ||test||user||health inform||news||buzz index||news media||health||term||month||popul||incid||neoplasm||yahoo||specif cancer type||time period||news coverag||breast||score||internet,yahoo||search||cancer cancer yahoo||search engin yahoo||cancer search||daili yahoo||2003 yahoo||internet search||identifi yahoo||prostat cancer yahoo||search activ||cancer search activ||search term||onlin search||cancer,202.578||154.454||123.379||122.12||119.116||111.125||104.508||101.466||101.289||99.208||95.122||91.341||87.341||84.788||83.779,0.2,0.1,0.26666666666666666
390,Exp_Brain_Res-3-1-2080346.txt,musculoskelet factor||maxim flexion||target||find||present experi||visuo-motor track||extens excurs||flexion||effect||feedback signal||organ||form||region||variabl||point||coordin dynam||harmon||maxim extens||cycl||dynam||present studi||wrist postur||phase space||phase||analysi||direct||musculoskelet underpin||execut||veloc profil||trial||global kinemat||shorter||particip||wrist||stroke patient||experiment trial||movement trajectori||endpoint variabl||global track behavior||anchor||extens||full track trajectori||peak veloc,anchor||wrist||gaze||wrist movement||wrist postur||spatial anchor||tempor anchor||wrist postur gaze direct postur||anchor point||anchor endpoint||gaze direct||movement||track movement||flexion||track,116.731||100.186||89.891||80.629||79.726||75.654||69.857||69.35||68.648||66.027||64.018||61.073||58.631||58.096||56.19,0.6,0.3,0.26666666666666666
391,Bioprocess_Biosyst_Eng-2-2-1705497.txt,optim valu||set||individu||problem||design variabl||amount||bit||multi-object experiment optim||process||mop||multi-object optim||variabl||softwar tool||experiment effort||small popul size||experi||popul||algorithm||experiment design||genet algorithm||gener||object||result,game.opt||mathbf||algorithm||_{||_{ 1||0||multi-object experiment optim||experiment multi-object optim||multi-object optim||experiment design||1 1||1||game.opt perform||method game.opt||genet algorithm,34.873||29.328||27.102||25.467||22.175||21.273||21.237||21.237||19.946||19.672||18.883||18.883||17.863||17.436||17.115,0.2,0.4,0.3333333333333333
392,Apoptosis-4-1-2423418.txt,st||effect||control||hicc||process||electron cell||regulatori volum increas||apoptosi||hela cell||experi||shrunken cell||rvi||avd||hyperton stress||cation channel||cell shrinkag||activ||channel||cell||hypertonicity-induc cation channel,hicc||apoptosi apoptosi||apoptosi||wehner||avd||hicc activ||apoptosi pfluger||cation channel||cell||hypertonicity-induc cation channel||minu minu||minu||sts-induc apoptosi||anti-fas-induc apoptosi||hela cell,41.589||39.371||39.371||36.283||31.989||24.334||24.213||23.059||22.908||22.836||21.893||21.893||21.284||21.284||20.935,0.6,0.6,0.4666666666666667
393,Transgenic_Res-3-1-1829418.txt,tumor latenc||mammari tumor phenotyp||latenc||breast cancer||model||studi||data||fvb||effect||strain||increas||background||metastasi||mice||ino defici||analysi||mammari tumorigenesi||tumor||differ||mous||pymt||phenotyp||molecular pathway||gland||ino||result,mammari gland||mammari tumor||mammari tumorigenesi||gland||mammari epithelium||inguin mammari gland||mammari gland hyperplasia||mammari gland develop||mammari gland initi||mammari develop||mammari line||pymt||transgen mammari tumor||mammari tumor phenotyp||mammari tumor age,47.886||42.382||37.755||33.773||32.872||32.481||32.291||32.268||31.924||31.515||30.999||30.168||29.906||29.049||28.255,0.4,0.2,0.26666666666666666
394,Eur_J_Pediatr-3-1-2039787.txt,neuro-cognit sequela||aspect||intens care treatment||measur tool||psycholog sequela||qualiti||studi||patient||life||effect||health statu||review||qol||outcom||treatment||sequela||health||paediatr intens care unit||lung function||parent||origin ill||post-traumat stress disord||famili||survivor||follow-up research||support||function||children,"picu||picu survivor||survivor||ward picu survivor||3,444 picu survivor||mother picu||diseas picu||picu admiss||52 picu||picu discharg||picu 50||picu 1||picu 10.5||paediatr survivor||pediatr survivor",121.189||98.403||75.617||68.716||67.221||66.847||63.901||62.72||61.341||61.289||61.052||60.603||60.595||51.662||50.565,0.2,0.1,0.06666666666666667
395,J_Gastrointest_Surg-3-1-1915599.txt,anim||reproduc||immun system||laboratori anim||treatment strategi||organ sampl||mucos barrier function||rout||pancreat||model||studi||anim model||biliopancreat duct||effect||experiment studi||human||intestin flora||anim speci||treatment||duoden content||rat||infect||sever acut pancreat||bacteri transloc||fals posit result||earli mortal||sever||acut pancreat||diseas||intestin motil||bacteria||bacteriolog result||immun respons||result,pancreat||acut pancreat||pancreat duct||bacteri pancreat infect||pancreat sepsi||pancreat necrosi||experiment acut pancreat||acut experiment pancreat||pancreat secretagogu||hemorrhagic-necrot pancreat||pancreat morpholog||sever acut pancreat||bile-induc acut pancreat||acut pancreat Br||acut pancreat induct,172.11||124.975||95.712||89.26||89.003||88.92||88.489||88.489||88.096||87.53||86.942||84.98||84.3||83.836||83.64,0.4,0.2,0.2
396,Cardiovasc_Intervent_Radiol-3-1-2062488.txt,esophag varic||cathet||transjugular intrahepat portosystem shunt||patient||tip||intervent radiolog||placement||varic||collater vein||portal vein||avp||varic bleed||devic||liver||closur||portal vein collater||avp devic||amplatz vascular plug||procedur||embol||large-diamet vessel||creation||emerg procedur,avp||avp embol||tip||avp placement||embol||avp devic||varic||vein embol||tip placement||16-mm-diamet avp||avp deliveri||avp ’s||transhepat avp placement||tip creation||tip procedur,71.832||59.15||56.724||46.68||46.468||41.779||41.04||39.423||39.126||37.624||35.916||35.916||35.599||34.857||34.46,0.6,0.5,0.3333333333333333
397,Cancer_Causes_Control-4-1-2323031.txt,program||cancer||categori||mammographi||gp||women||repres sampl||screen||fear||result||rate||subject||nationwid opinion poll||franc||evid||gener practition||reason||crc||gener popul||cancer screen,screen||cancer screen||crc screen||franc||screen test||screen rate||screen program||PC screen||oncogenet screen||screen status||cancer screen test||crc screen test||undergon screen test||cancer screen procedur||undergo screen test,87.408||56.265||52.678||51.675||49.98||47.402||46.698||46.037||45.38||45.229||41.694||39.303||38.318||37.51||35.622,0.6,0.3,0.2
398,Naturwissenschaften-4-1-2270361.txt,condit||anim||hair||infant||mother||bodi angl||problem||primat||gorilla||valu||cling||densiti||mechan properti||bodi hair||human||forc||friction||african ape||infant carri||load||gibbon||human hair||orangutan||result||bodi||curv||biped||adult bodi||scenario||chang||weight||young modulu||skin||ape||posit||limit||area||safeti,hair||ape hair||hair friction||hominoid hair||bodi hair||human hair||ape||mother hair||hair structur||hair densiti||curl hair||hair thick||singl hair||hair keratin||hair pull-out,160.441||122.664||106.13||90.206||86.587||86.098||84.887||83.765||82.553||82.299||82.296||82.067||81.91||81.727||81.647,0.4,0.4,0.26666666666666666
399,Breast_Cancer_Res_Treat-3-1-2092407.txt,shape factor form _ AR||case||nuclear morphometr featur||benign tissu||nuclear size||histori||breast cancer||patient||bbd||multivari analys||risk||breast tumor tissu||case-control studi||nuclear area||famili histori||featur||analys||control||women||form _ AR||associ||longest axi||subject||perimet||nuclear perimet||risk factor||subsequ develop||shape factor||area||benign breast diseas||form _ nci||longest nuclear axi||diagnosi||hyperplasia||morphometri,breast||nuclear axi||nuclear morphometri||nuclear perimet||shortest nuclear axi||breast cancer||longest nuclear axi||nuclear featur||nuclear area||nuclear diamet||nuclear size||nuclear morpholog||bbd||axi||nuclear morphometr featur,70.573||63.876||63.188||55.1||50.522||50.412||50.126||48.035||46.42||46.036||44.693||44.067||43.031||40.83||40.422,0.2,0.4,0.4666666666666667
400,Int_J_Cardiovasc_Imaging-3-1-2121119.txt,LA contractil||ventricular||measur||lav||eject fraction||studi||left atrial volum||patient||aei||la-k||wall thick||aa-sv||mass||lad||control||hypertroph cardiomyopathi||LA size||group||differ||LA conduit||hcm||atrial volum||function,hcm||left||hypertroph cardiomyopathi||non-obstruct hcm||function hypertroph cardiomyopathi left||obstruct hcm||left atrial volum||left atrial enlarg||left atrial size||left atrial angiographi||LA||hcm patient||left atrial pump function||conclus hcm||atrial LA volum,67.243||52.579||45.89||42.697||40.832||39.876||38.001||37.515||37.048||36.605||36.565||36.292||34.39||33.621||32.663,0.4,0.3,0.2
401,Support_Care_Cancer-4-1-2206248.txt,type||cancer||time||total problem||problem||studi||patient||recurr||physic problem||health statu||qol||spous||aim||treatment||cancer patient||relationship||signific relationship||male partner||psychosoci||age||parent||parent cancer||report||group||ill||adolesc||treatment intens||diagnosi||norm||score||function||children,spous||cancer||qol||function||spouses’ qol||cancer patients’||spous ’s qol||parent cancer||spouses’ function||cancer patient cancer||patients’ qol||spous ’s function||parent qol||patients’ function||femal spous,50.548||46.517||42.242||38.278||36.664||36.576||35.624||35.124||34.683||34.629||34.438||34.303||32.986||32.456||32.397,0.8,0.5,0.3333333333333333
402,Intensive_Care_Med-3-1-2039828.txt,serum||GM assay||combin||patient||diagnost process||high tropism||breakthrough infect||ipa||relat||human studi||sign||clinic trial||antifung therapi||treatment||invas diseas||voriconazol||fungal infect||non-invas diagnost test||combin therapi||chronic obstruct pulmonari diseas||invas pulmonari aspergillosi||drug||pcr||risk factor||oral administr||diagnosi,aspergillosi||aspergillu||invas aspergillosi||pulmonari aspergillosi||invas pulmonari aspergillosi||aspergillu aspergillu pcr||aspergillosi non-neutropen||aspergillu niger aspergillu||multiple-triazole-resist aspergillosi||conclus aspergillu aspergillu aspergillu pcr||acut invas pulmonari aspergillosi||lethal pulmonari aspergillosi||aspergillu antigen||scedosporium aspergillu||aspergillu speci,163.818||131.736||120.897||107.699||97.791||92.233||90.491||87.824||83.339||81.687||74.02||72.181||68.398||68.34||66.942,0.2,0.1,0.06666666666666667
403,Bioinformation-1-7-1891696.txt,web databas||inform||enzym||protein interact||cell signal||databas||dcse||hyperlink||tool||blast||biolog commun||sequenc||cell,databas||dcse||web databas databas||web databas||databas pblast||abovement databas||databas interfac||relat databas||blast||enzym||coiled-coil structur||coiled-coil region||sastra||bioinform bioinform bioinform||cell signal enzym,23.174||18.68||17.174||14.175||13.454||12.977||12.327||11.587||11.508||11.193||10.905||10.199||9.459||9.063||8.285,0.6,0.5,0.3333333333333333
404,Behav_Genet-4-1-2257998.txt,case||suffici statist||exact simul||time||effect size||method||mont carlo||data||model||studi||genet design||transform||effect||fals hypothesi||raw data||power||paramet||summari statist||varianc||analysi||qtl||simul||power studi||power calcul||distribut||genotyp valu||group||DZ twin||number||sampl size||probabl||suffici summari statist||design,power||power calcul||Σ||statist power||simul||power comput||keyword simul power||power analysi||power studi||power level||adequ power||power evalu||Σ μ||Σ μ Σ μ Σ μ||exact data simul power calcul,84.941||53.648||51.874||51.239||46.521||44.733||43.821||43.709||42.482||42.473||42.47||42.47||41.54||41.54||39.696,0.6,0.4,0.26666666666666666
405,Breast_Cancer_Res_Treat-4-1-2244694.txt,irregular categori||testosteron||menstrual cycl||cancer||level||find||breast cancer||studi||year||lifetim exposur||risk||menopaus||cycl||breast cancer risk||androgen||androstenedion||menarch||fftp||cumul number||dhea||women||trend||age||characterist||lifetim||sex hormon level||number||physic activ||risk factor||particip||shbg||reproduct characterist||hormon||children||sex hormon,shbg||menstrual cycl||hormon||cycl||shbg level hormon||menstrual characterist||sex hormon||menstrual factor||lifetim menstrual activity-ind||menstrual period||shbg level||menstrual bleed||lifetim||hormon level||irregular cycl,73.74||69.157||68.437||53.173||51.615||48.056||44.449||44.06||43.247||43.231||43.204||42.57||41.969||40.552||40.456,0.8,0.5,0.4
406,J_Neurol-3-1-1915650.txt,follow-up||method||db||reduct||studi||intent tremor||patient||effect||advers effect||tremor amplitud||scale||ataxia||intent||tremor reduct||treatment||function improv||case report||thalamotomi||tremor||isoniazid||limb||multipl sclerosi||trial||placement site||movement||disabl||superior cerebellar peduncl||articl,tremor||intent tremor||bilater tremor||cerebellar tremor||postur tremor||clinic tremor||tremor sever||sever tremor||arm tremor||tremor patient||improv tremor||tremor assess||limb tremor||action tremor||tremor reduct,613.165||354.036||334.464||328.816||319.392||318.463||318.223||318.223||317.971||312.45||310.842||310.757||309.814||309.375||309.089,0.4,0.2,0.2
407,J_Struct_Funct_Genomics-3-1-2140095.txt,crystal||dehydrogenas||target||protein kinas||case||method||structur determin||wide scientif audienc||drug develop||target area||scientif commun||determin||data||sgc||pdz||develop||inform||human||structur||domain||class||reductas||compound||specif||protein structur||inhibitor||approach||enzym||protein||success||metabol enzym||data collect||ligand screen||nmr||oxford||wide structur rang||protein character||gener||famili member||import||number||diseas||purifi protein sampl||ligand,structur||sgc||crystal structur||crystal||protein structur||sgc target||protein||structur genom||annot protein structur||structur determin||final structur||structur annot||protein structur univers||structur data||structur character,66.95||64.606||62.923||58.896||53.545||42.723||40.14||40.094||37.26||36.86||35.97||35.82||35.697||35.693||35.119,0.8,0.6,0.4
408,Skeletal_Radiol-4-1-2335296.txt,find||mri||calcan edema||logist regress||studi||patient||pearson chi-squar analys||calcan spur format||nerv||marker||inferior calcan nerv||achil tendinosi||plantar enthesophyt||abductor digiti minimi atrophi||plantar fasciiti||ptt dysfunct||initi report||analysi||age||calcan spur||format||posterior tibial tendinosi||atrophi||adma||foot||order||presenc,adma||plantar calcan||plantar||calcan spur||plantar fasciiti||plantar nerv||calcan edema||abductor digiti||calcan spur format||atrophi||abductor digiti minimi atrophi||abductor digiti minimi||inferior calcan nerv||plantar nerv entrap||plantar enthesophyt,82.095||76.698||71.733||64.242||60.505||50.918||46.585||44.157||43.948||43.78||43.552||43.475||40.843||40.528||37.444,0.6,0.6,0.6
409,Eur_J_Appl_Physiol-4-1-2267484.txt,muscl||find||modul||data||studi||motor cortex||walk||healthi subject||test||central fatigu||contractil properti||muscl damag||spinal modul||signific recoveri||evok potenti||day||dom||voluntari contract||subject||exercis||intens||mvt||decreas||maxim voluntari torqu||muscl sore||plantar flexor muscl||result,max||exercis||muscl||muscl sore||muscl fatigu||dom||max intens||eccentr exercis||walk exercis||max soleu gastrocnemiu mediali||voluntari muscl drive||human muscl fatigu||fatigu||exercis intens||exercis bout,54.76||46.701||43.187||36.809||34.036||30.426||28.807||28.745||28.144||26.352||26.196||25.199||24.885||24.778||24.42,0.6,0.4,0.26666666666666666
410,Eur_Radiol-3-1-1779628.txt,cancer||neoadjuv therapi||mri||imag||studi||patient||coil system||crm||mesorect fascia||rectal carcinoma||local excis||local stage||fov||import anatom landmark||rectal tumor||import criterion||recent year||accuraci||imag modal||power gradient system||local recurr||mesorect fatti tissu||tumor||eu||rectal cancer||sequenc||stage,rectal cancer||rectal tumor||rectal cancer stage||rectal carcinoma||rectal adenocarcinoma||rectal wall||rectal tumour||rectal distens||resect rectal cancer||T4 rectal cancer||rectal cancer Br||rectal cancer eur||advanc rectal cancer||mri rectal carcinoma||rectal cancer surgeri,101.721||90.043||88.811||88.448||83.98||83.306||82.612||81.949||71.822||69.773||69.079||68.781||68.651||68.481||68.123,0.6,0.3,0.2
411,Pediatr_Nephrol-3-1-1915619.txt,gene||role||marker||vur||result||linkag||locu||sampl||linkag studi||children||famili,reflux||vesicoureter reflux||gdnf||gdnf ret||ret||upk3a||vur||agtr2||linkag||genet||nonsyndrom vesicoureter reflux||upk1a upk3a||primari vesicoureter reflux||slit2||spry1,24.032||23.312||20.435||20.288||20.141||19.509||18.839||18.063||17.966||16.592||16.307||16.257||15.541||15.479||13.005,0.0,0.2,0.13333333333333333
412,Pharm_World_Sci-3-1-2039831.txt,week||questionnair||melatonin||qualiti||patient||year||effect||medic||user||pdd||intervent||discontinu||low dose||daili dose||discontinu rate||gp||bd||gener practic||group||hypnot||differ||trial||particip||placebo control group||primari care||benzodiazepin||period,melatonin||benzodiazepin||benzodiazepin discontinu||melatonin group||melatonin facilit discontinu||melatonin primari||BD||long-term benzodiazepin||benzodiazepin hypnot||BD discontinu||discontinu||anxiolyt benzodiazepin||benzodiazepin investig||benzodiazepin depend||benzodiazepin 1993,92.751||82.851||63.32||47.189||46.404||46.375||45.622||45.405||45.081||44.705||43.788||43.465||42.759||42.757||41.425,0.4,0.2,0.2
413,Clin_Oral_Investig-4-1-2238781.txt,case||indic||problem||studi||eros||wear||teeth||forc||depth||tooth wear||dentin||lesion||dental cari||relev||paramet||tissu||primari||acid||factor||exposur||sever||area||enamel||loss||diagnosi||dentit||score,dentin||eros||eros tooth wear||dentin eros 2||expos dentin||dental eros||wear||dentin exposur||tooth wear||dentin loss||dentin hypersensitivity-ar||remineralis dentin||underli dentin||dentin int||tooth,141.384||124.827||90.921||88.737||82.077||79.182||78.439||75.123||73.968||72.894||72.217||71.795||71.416||71.229||69.496,0.4,0.4,0.26666666666666666
414,Appl_Microbiol_Biotechnol-3-1-2043089.txt,biorefineri||calcul||n-function||advantag||econom||year||agricultur wast stream||arginin||plant compon||polym||amino acid||protamylass||bulk chemic||technic process||cost||raw materi||cyanophycin product||potenti||applic||ton||product||cyanobacteria||protein||ferment||paper||import group||cyanophycin||materi||larg scale||fossil raw materi||amino acid arginin||chemic||biomass||potato||large-scal ferment||organ acid||plant,cyanophycin||cyanophycin product||cyanophycin polym||cyanophycin biopolym||cyanophycin biosynthesi||cyanophycin synthetas||ferment cyanophycin product||cyanophycin deriv||cyanophycin properti||cyanophycin modif||gram-posit cyanophycin||cyanophycin accumul||cyanophycin extract||cyanophycin metabol||cyanophycin elong,235.293||163.473||144.306||126.461||124.669||121.514||121.104||120.192||119.768||119.21||118.658||118.575||118.552||118.541||118.164,0.4,0.2,0.13333333333333333
415,Ann_Surg_Oncol-4-1-2266786.txt,biolog||deceas donor liver graft||liver graft||studi||patient||year||dropout rate||patient surviv||liver transplant||ldlt||criteria||morphology-bas stage system||select bia||favor preliminari surviv result||graft||hcc||olt||past 10 year||transplant||tumor||milan criteria||size||tumor morpholog||ucsf group||ddlt||outcom||result,liver transplant||transplant||donor liver transplant||hcc||living-donor liver transplant||liver transplant recipi||live donor liver transplant||conclus liver transplant||liver graft||criteria||liver resect||pancreat tumor liver transplant||milan criteria||ldlt||transplant stage,82.652||78.486||68.538||67.347||57.156||56.176||56.046||55.101||53.369||51.687||46.919||46.562||46.433||46.242||45.013,0.6,0.5,0.4666666666666667
416,Int_Arch_Occup_Environ_Health-4-1-2413125.txt,measur||regard||determin||studi||year||life||lower regress coeffici||life style||stress life event||multivari model||older age||increas||abil||variabl||mental health||work-rel factor||event||white-collar worker||health||studi popul health promot||higher score||psychosoci factor||lack||age||stress handl||associ||dimens||factor||wai||influenc||work abil||physic activ||work||demand||score||oldest age group||self-develop||result,work||work abil||abil||work teamwork||work abil score||work abil scand||work abil index||perceiv work abil||result work abil||work abil 1998||lower work abil||work demand||work spirit||work 2001||work intens,124.422||110.336||96.25||81.293||77.231||75.549||74.127||74.015||73.557||73.557||73.557||68.89||63.298||62.211||62.211,0.6,0.3,0.2
417,Cogn_Process-4-1-2254470.txt,mechan||attent||role||level||retent||find||time||behavior||modul||represent||pfc||episod buffer||inform||process||sensit||abil||complex||memori||integr||pattern||cognit control||evid||unit||stimuli||cell||neural model||brain||posterior part||control||posterior cortex||task||simul||neuron||neural pattern||recurr loop||mainten||coher||cell assembl||instanc||activ||recurr connect||order||cortex||activ state||relev inform||synchron||input||interact||interdepend function||prefront cortex||area||assembl||automat process||function,memori||pfc||cortex||prefront cortex||memori represent||prefront||memori model||memori inform||memori 1999||memori capac||episod memori||memori function||short-term memori||memori retriev||long-term memori,151.423||117.879||99.523||95.085||94.671||90.647||83.801||81.356||81.089||80.414||80.043||79.877||79.33||78.568||78.473,0.8,0.4,0.26666666666666666
418,Neurochem_Res-4-1-2413118.txt,vector||level||DA level||data||studi||α-synuclein||gene express||ds oligo||express||cell||normal function||specif primer||DA biosynthesi||protein||activ||specif monoclon antibodi||dopamin||min||rna interfer||pcr||PD patholog,alpha-synuclein||α-synuclein||mn9d||alpha-synuclein regul||alpha-synuclein function||alpha-synuclein gene||alpha-synuclein mutat||α-synuclein express||alpha-synuclein display||alpha-synuclein increas||alpha-synuclein share||function α-synuclein||present α-synuclein||dopamin||alpha-synuclein modul dopaminerg,64.686||59.385||40.499||33.486||33.34||33.282||33.223||32.477||32.343||32.343||32.343||30.69||29.693||26.895||26.495,0.2,0.1,0.13333333333333333
419,Diabetologia-3-1-2039867.txt,genet varianc||type 2 diabet||variat||principl||total variat||lipid metabol||metabol characterist||model||studi||chorion||herit||effect||correl||hdl-cholesterol||environment factor||leptin level||east flander prospect twin survey||sex||trait||insulin||random intercept model||young healthi twin popul||varianc compon||total cholesterol||hdl-cholesterol ratio||varianc||twin||high rang||pair||metabol risk factor||genet factor||genet||MZ MC||quantit sex differ||fat mass||covari||MZ DC pair||insulin resist||twin studi,twin||twin twin||MZ twin||DZ twin||AE||twin model||twin correl||women twin||vzw twin||twin int||twin studi||danish twin||countri twin||femal twin||adult twin,104.221||104.221||66.327||57.662||56.324||54.58||54.13||53.884||53.543||52.798||52.782||52.701||52.63||52.559||52.558,0.2,0.1,0.13333333333333333
420,J_Med_Internet_Res-5-4-1550579.txt,pharmaceut compani||method||common convers||studi||consum||difficulti||inform||criteria||process||site||consum search||web site||sourc||variabl qualiti||standard||internet||group||search||medicin||health public||issu||drug||particip||apprais skill||focu group||result,inform||particip||medicin particip||internet-bas inform||medicin||apprais inform||search||credibl inform||inform leaflet||prefer inform||health inform||australian inform||particip 2 medicin||pertin inform||chose inform,162.861||151.082||125.809||104.418||100.537||97.177||96.17||93.916||85.825||84.265||84.189||83.992||83.873||83.867||83.738,0.6,0.4,0.26666666666666666
421,Calcif_Tissue_Int-3-1-1914224.txt,vertebr fractur||follow-up||baselin||studi||year||allel||risk||promot||fractur||bmd||women||analysi||associ||independ effect||chang||osteoporosi||colia1||pcr cycl||femor neck bmd||haplotyp||bone miner densiti||result,colia1||colia1 colia1||colia1 polymorph||llc 2007 colia1 colia1 colia1 colia1||15 colia1||densiti fractur colia1||0.03 colia1 genotyp colia1 3||colia1 sp1 polymorph influenc bmd||polymorph||sp1 polymorph||polymorph sp1||sp1||2 colia1 genotyp||baselin colia1 genotyp 2 colia1 2||ioannidi JP colia1 sp1 polymorph,104.807||104.807||74.176||70.108||52.765||52.485||45.541||44.224||43.545||42.788||42.788||42.032||41.285||41.243||38.734,0.2,0.1,0.06666666666666667
422,Photosynth_Res-3-1-1769344.txt,aps-ito||OG micel||effici energi transfer||photosynthesi||electrod||IR spectra,R. rubrum||palustri||palustri R. rubrum rp||R. rubrum R.||2004 R. rubrum R. rubrum rp||1 R. rubrum R. rubrum rp||palustri rp||palustri 2003 R. rubrum rp||palustri bacterium R. rubrum rp||R. rubrum R. rubrum 1991 λ||4 R. rubrum rp||2002 R. rubrum rp||method R. rubrum rp||rp||2006 rhodospirillum rubrum rhodopseudomona palustri,71.826||67.711||63.022||61.686||55.972||54.79||54.218||51.36||50.825||48.645||46.301||46.094||46.094||40.725||37.883,0.0,0.0,0.0
423,Eur_Radiol-4-1-2373858.txt,follow-up||high tempor resolut imag||time||method||case||tempor resolut||mri||imag||studi||valu||morpholog characterist||clinic inform||malign group||benign||diagnost accuraci||total||reader||lesion||magnet reson imag||breast||imag protocol||initi enhanc||multivari analysi||local imag||evalu||analysi||min||order||auc||divers histolog distribut||perform||pharmacokinet paramet||signific differ||wash-out||lesion size 14 mm||malign lesion||diagnost perform||result,lesion||breast lesion||breast||dynam breast mri||imag||benign lesion||malign breast lesion||fast dynam imag||breast mri||malign lesion||dynam pharmacokinet||smaller breast lesion||suspici breast lesion||small breast lesion||dynam enhanc,50.486||47.177||43.869||41.541||41.007||40.09||38.108||37.121||37.025||35.228||33.451||32.403||31.949||31.759||31.333,0.6,0.4,0.26666666666666666
424,Ann_Surg_Oncol-4-1-2190337.txt,cancer||center||data||studi||patient||hospit volum||mortal||high-volum center||risk adjust||volum||comorbid||treatment||in-hospit mortal||multivari analysi||hospit||case-mix||import determin||lvh||ptnm stage||clinic data||hvh||group||surviv||origin patient file||differ||esophag resect||adjust||resect||tumor stage||procedur||neoadjuv treatment||diseas||high-volum hospit||stage||outcom||result,lvh||hospit||outcom lvh hvh||hospit volum||hospit mortal||volum||mortal||adm||high-volum hospit||hvh||outcom||in-hospit mortal||surgic volum||surgic mortal||low-volum hospit,51.552||39.107||39.036||38.555||38.35||38.003||37.593||34.68||33.926||32.98||32.576||31.732||31.707||31.502||29.109,0.6,0.7,0.6
425,Eur_J_Appl_Physiol-4-1-2225999.txt,food intak||measur||full||respons||cortisol level||level||session||lf-to-hf ratio||sensori rate||human||relat||increas||blood pressur||desir||heart rate||eat||food intak regul||amylas||food||subject||satieti||min||hunger||orosensori stimul||waist-to-hip ratio||hip circumfer||cortisol||oral activ,food||α α||α||satieti||food intak||appetit||food stimul||food consumpt||comfort food||perceiv satieti||food act||subsequ food||food intak regul||satieti quotient||satieti cascad,33.847||31.334||31.334||31.017||24.532||20.912||20.101||17.8||17.463||16.964||16.923||16.923||16.769||16.457||16.093,0.6,0.3,0.26666666666666666
426,Glycoconj_J-4-1-2234449.txt,antibodi||lmwh||gag||biolog characterist||nadroparin||anticoagul||enzymat digest||danaparoid||domain||chemic||sulodexid||enoxaparin||reactiv||heparinas||immunoprofil||sulfat||heparinoid||specif immunoprofil||heparin-induc thrombocytopenia,heparinoid||sulfat||therapeut heparinoid heparinoid||heparin||anticoagul heparinoid||heparinoid batch||complex heparinoid||heparan sulfat||sulfat c5-epimer||sulfat mpb49||heparin heparin 5.0||antibodi||chondroitin sulfat||method heparinoid 1||sulfat glycosaminoglycan curr,91.893||65.326||61.262||55.682||48.888||47.148||45.947||40.958||40.317||37.255||37.122||35.606||34.61||30.913||30.686,0.4,0.2,0.2
427,J_Med_Internet_Res-9-2-1913941.txt,medic research||nlm||interest||inform manag||session||studi||inform||open access||domain||altern medicin practition||user||profession||clinic practic||tool||chiropractor||specif||health||degre||research||pubm||inform retriev||full text||profession develop||abstract||servic||literatur||practition||medicin||access||full-text articl||limit||public||cam||particip||life scienc||articl,pubm||pubm tool||pubm search||bookshelf pubm||pubm ’s||pubm session||research access pubm||pubm resourc||pubm afterward||pubm central||pubm interact||10 pubm tool||search histori pubm||pubm search result||articl,154.503||101.245||98.599||91.77||86.638||86.048||85.052||80.351||78.567||77.252||77.252||67.543||66.603||65.761||60.464,0.2,0.1,0.13333333333333333
428,Ann_Surg_Oncol-3-1-1914247.txt,follow-up||level||complic||ilp||object measur||patient||amput||year||median follow-up||perfus||st||femor PI||treatment||limb salvag treatment strategi||vascular complic||lower limb||ultrasonographi||month||arteri occlus diseas||critic leg ischemia||late vascular morbid||rang||limb||arteri occlus||vascular reconstruct||resect||poplit PI||ebrt||sarcoma||long-term vascular side effect,ebrt||limb||sarcoma||limb perfus||poplit PI||perfus||poplit arteri||primari poplit||amput||ilp||isol limb perfus||upper leg amput||iliac perfus||upper limb||lower limb amput,58.611||53.469||52.018||47.004||43.919||40.539||38.881||38.297||38.271||37.745||37.585||36.995||36.039||35.396||33.939,0.8,0.7,0.4666666666666667
429,Osteoporos_Int-2-2-1705543.txt,method||bisphosphon||data||model||patient||conclus patient||effect||clinic practic||fractur||therapi||cohort||alendron||hip||nonvertebr fractur||month||incid||risedron||differ||osteoporosi||primari analysi||date||risk factor||trial||baselin characterist||hip fractur||health plan||result,fractur||nonvertebr fractur||alendron||risedron||osteoporosi fractur||nonvertebr fractur osteoporosi||hip fractur||fractur incid||nonvertebr fractur incid||nonvertebr fractur risk||fractur risk||vertebr fractur||fractur rate||traumat fractur||fractur outcom,105.412||82.698||79.886||74.42||69.223||66.143||65.832||62.267||61.507||57.169||55.76||55.368||53.99||53.849||53.477,0.8,0.5,0.3333333333333333
430,Clin_Oral_Investig-3-1-2099161.txt,rate||perman molar||studi||year||cari||effect||oral health||altern treatment strategi||teeth||perman dentit||failur||caviti||art||primari dentit||treatment||gross margin defect||oper effect||evalu||restor||dentist||result||primari||high-cari popul||analysi||cox regress analysi||three-year surviv||materi||secondari cari||dental treatment||two-surfac restor||dutch dentist||signific differ||basic oral health care||children||restor treatment,restor||art restor||art||two-surfac art restor||single-surfac art restor||two-surfac restor||glass-ionom restor||one-surfac art restor||multi-surfac art restor||seventy-f art restor||restor treatment||one-surfac restor||restor present||twenty-six restor||amalgam restor,199.133||161.641||124.149||116.761||113.76||113.067||111.567||109.76||108.76||108.66||105.2||102.566||102.531||100.717||100.511,0.4,0.3,0.26666666666666666
431,Childs_Nerv_Syst-3-1-2092440.txt,level||case||mmc||protocol||modern palli care||groningen protocol||prospect||ethic debat||qualiti||studi||deliber termin||life||sever form||decis||criteria||lesion||newborn||palli care||countri||hopeless||treatment||sever physic disabl||intern medic recommend||end-of-lif decis||dutch associ||medic care||pain||babi||experi||parent||care||termin||hydrocephalu||intern legisl||ethic||sever||meningomyelocel||physician||suffer||spina bifida||result,bifida||spina bifida||spina||newborn||untreat spina bifida||spina bifida aperta||open spina bifida||spina bifida int||newborn child||mmc||handicap newborn||life||life termin||spina bifida gothenburg 27||open spina bifida Br,99.531||98.524||97.517||88.431||68.222||68.099||66.139||65.683||57.457||56.844||53.02||51.525||49.977||49.7||49.604,0.4,0.3,0.26666666666666666
432,Childs_Nerv_Syst-4-1-2413122.txt,tumour||meningioma||marker||analysi||mutat||dna||loh||patient||year||radiat therapi||myoepithelioma,ini1||ini1 mutat||conclus ini1||method ini1 mutat||tumour genet predisposit ini1||meningioma||radiation-induc meningioma||s00381-007-0578-0 case report ini1 mutat||radiation-induc tumour||teratoid||tumour||myoepithelioma||atyp teratoid||hulsebo tjm||loh,67.229||37.054||33.615||24.703||23.435||22.28||18.816||15.768||14.327||14.142||13.304||10.606||10.3||10.106||9.9,0.0,0.1,0.26666666666666666
433,Neuropsychologia-2-1-2265793.txt,condit||categori||level||effect size||recognit||individu||data||environment support||studi||comparison||asd||difficulti||process||inform||abil||recal||memori||pattern||evid||relat inform||item||hippocampu||task||list||asd particip||group||word||autism spectrum disord||asd group||perform||relat memori||particip||support,asd||recal||bowler||asd categori||memori||categori||asd individu||item-specif memori process||gardin||relat memori||asd particip||bowler d.m||impair recal||free recal||asd group,99.175||98.146||91.887||84.974||73.967||70.773||65.886||56.702||56.101||54.75||54.716||52.941||52.696||52.486||52.167,0.6,0.5,0.4666666666666667
434,J_Comp_Physiol_A_Neuroethol_Sens_Neural_Behav_Physiol-4-1-2248214.txt,case||diagram||reflect spectra||wavelength||angular reflect||pattern||butterfli||kinoshita||transmiss electron microscopi||scatter||singl scale||singl butterfli scale||butterfli speci||light||structur colour||angular distribut||colour||wing||multilay structur||backscatt light||reflect,butterfli||morpho butterfli||morpho||pierid butterfli||scale||morpho butterfli proc||scale scatter||singl morpho butterfli scale||scatter||butterfli scale giraldo||pierid butterfli wing||singl butterfli scale||wing scale||pierid butterfli proc||iridesc scale,74.795||66.809||58.823||52.099||51.412||48.879||48.707||48.694||46.002||45.81||45.497||45.318||41.852||39.073||38.774,0.2,0.2,0.2
435,Eur_J_Pediatr-3-1-1820762.txt,condit||antibodi||hu||method||plasma||vwf||sampl||mutat||studi||ttp||patient||assay||immunoblot||heterozyg carrier||congenit||thrombot thrombocytopen purpura||polyclon antibodi||normal phenotyp||proteas||normal plasma||von willebrand factor||parent||activ||sds-page||adamts13||normal individu||result,adamts13||adamts13 mutat||adamts13 antigen||adamts13 activ||adamts13 phenotyp||adamts13 band||adamts13 present||adamts13 bioactiv||adamts13 autoantibodi||adamts13 method||adamts13 express||willebrand||purifi plasma adamts13||von willebrand||ttp,205.322||111.478||109.753||106.546||105.394||104.407||104.245||104.207||104.099||103.986||102.661||98.274||90.545||82.03||77.693,0.2,0.1,0.13333333333333333
436,Int_J_Colorectal_Dis-3-1-2134973.txt,abdomin cramp||questionnair||irrig||dynam graciloplasti||defec disord||qualiti||studi||patient||life||amount||water||colon irrig||treatment||addit therapi||dgp||success rate||defec||colostomi||contin||constip||appendico-cecostomi||fecal incontin||result,irrig||colon irrig||colostomi irrig||antegrad irrig||retrograd irrig||rectal irrig||irrig bag||irrig pump||irrig 21.39||irrig method||irrig fluid||conclus colon irrig||fecal incontin||colostomi irrig Br||constip,178.878||123.783||101.764||100.165||93.507||92.058||91.355||91.235||90.846||89.439||89.439||82.918||76.797||70.144||65.094,0.4,0.2,0.26666666666666666
437,J_Gastrointest_Surg-3-1-1852386.txt,linear regress||author||respons||week||time||signific growth inhibit||rate||interv||studi||valu||patient||brdurd-label cell||schedul II||treatment time||clinic down-stag||clinic assess||radiotherapi||spf||signific||treatment||cell||prolifer rate||schedul||earli tumor respons||ratio||brdurdli||prolifer||complet respons||cell death||surgeri||local recurr||tumor||preoper radiotherapi||regress||resect||rectal cancer||cancer cell prolifer,tumor||RT tumor||rectal tumor||RT||prolifer tumor||brdurd||RT brdurdli||preoper RT||RT brdurd LI||prolifer||brdurd LI||respons tumor||tumor respons||tumor down-stag||fast prolifer tumor,76.915||71.838||69.487||66.761||61.073||55.421||54.276||54.195||52.313||45.23||45.089||45.047||45.047||44.427||43.694,0.2,0.2,0.13333333333333333
438,J_Comp_Physiol_A_Neuroethol_Sens_Neural_Behav_Physiol-4-1-2323032.txt,mechan||ear||caudal region||tonotop axi||tympan membran||frequenc||spontan otoacoust emiss||organ||anuran||similar||tonotop organ||narin||round window||tectori curtain||auditori system||s-shape extens||characterist||amphibian||contact membran||mammalian cochlea||nerv fiber||frog||basilar papilla||sacculu||emiss||frequenc select||amphibian auditori system||otoacoust emiss||vertebr||endolymphat space||amphibian papilla||hair cell||speci||spontan emiss||hair bundl||membran||function||singl auditori filter,papilla||amphibian papilla||amphibian||basilar papilla||amphibian papilla caudal||amphibian papilla exhibit||amphibian ear||anuran amphibian||papilla tectorium||basilar papilla ’s||papilla recess||basilar papilla function||respect papilla||small papilla||basilar papilla impli,177.52||159.734||141.948||130.856||112.014||107.686||107.288||93.47||91.571||89.984||89.839||88.834||88.76||88.76||88.434,0.6,0.3,0.2
439,J_Headache_Pain-4-1-2276243.txt,autosom domin||mechan||chronic headach||epigenet||model||studi||mutat||genet repertoir||cluster headach||clinic featur||risk||genet variat||chromosom||typic migrain||headach pathogenesi||disord||featur||behaviour||primari||attack||suscept loci||primari headach||fhm||genet||famili||infanc||migrain||diseas||epigenet mechan,migrain||migrain headach||headach||hemipleg migrain||migrain gene||famili migrain||typic migrain||migrain attack||primari migrain||episod migrain||migrain vertigo||syndrom migrain||matern migrain||migrain featur||mendelian migrain,302.95||242.837||182.723||180.643||171.958||171.373||159.128||156.129||155.255||154.993||154.982||154.539||153.869||153.787||153.37,0.2,0.2,0.13333333333333333
440,Ann_Surg_Oncol-3-1-2039838.txt,anim||mmc||cytoreduct surgeri||model||studi||physic condit||perfus||heat intraperiton chemotherapi||clinic trial||dose||temperatur||treatment||rat||day||adjuv therapi||periton carcinomatosi||result||macroscop tumor||surgeri||group||surviv||surgic procedur||median surviv||rit administr||hipec||procedur||toxic||preclin studi||radioimmunotherapi,hipec||hipec CS||intraperiton||CS||CS CS||rit||adjuv hipec||carcinomatosi||intraperiton radioimmunotherapi||hipec procedur||hipec group||hipec model||periton carcinomatosi||intraperiton chemotherapi||intraperiton mitomycin,91.027||75.566||67.81||60.105||60.105||57.027||54.416||50.206||49.889||47.992||47.543||46.306||43.94||43.063||37.649,0.2,0.1,0.13333333333333333
441,Eur_Radiol-4-1-2220024.txt,data||patient||solid residu||regimen||effect||diagnost accuraci||colonoscopi||total||barium||dose||magnesium citrat||ctc||polyp||residu||fluid||bowel prepar||reason||group||proxim colon||differ||score||statu||patient accept||addit||prone||prepar||diagnost perform,tag||regimen||polyp||100||tag fluid||fluid tag||colon polyp||polyp correl polyp||lax regimen||reduced-lax regimen||fecal tag||tag agent||colonoscopi||tag variabl||6-mm polyp,64.027||57.423||57.016||49.024||41.018||41.018||39.771||38.01||34.757||33.072||33.051||32.736||32.157||32.013||30.755,0.4,0.2,0.2
442,Behav_Genet-4-1-2292426.txt,questionnair||homophobia score||homophobia||individu||sampl||data||model||studi||herit||effect||femal||twin pair correl||threshold||hlq||total||sex||environment influenc||signific||gay men||homosexu||item||estim||varianc||twin||non-heterosexu||pair||genet||differ||contribut||homophobia categori||attitud||influenc||item score||twin studi||score||result,attitud||homosexu||homophobia||homophob attitud||sexual attitud||social attitud||femal homosexu||homophobia score||twin||homosexu person||homosexu men||homosexu individu||miss homosexu||homosexu questionnair||prejudici attitud,92.97||91.874||91.292||57.893||55.263||55.031||54.408||52.995||52.789||52.485||51.647||51.077||50.946||49.598||49.337,0.6,0.5,0.3333333333333333
443,Mol_Imaging_Biol-3-1-1915656.txt,elig studi||imag||data||studi||patient||rel lesion detect||review||sensit||articl||lesion||positron emiss tomographi||attenu correct||AC imag||fdg||specif||nac imag||meta-analysi||fr-pet||index test||oncolog patient||dual-head coincid pet||methodolog qualiti||test accuraci||transmiss||elig||lesion detect||systemat review||tomographi||refer test||result,tw||pet||pet imag||nac||fdg pet||pet emiss imag||nac imag||attenu||nac fr-pet||imag||attenu correct||pet imag interpret||whole-bodi pet||nac FR fdg pet||dual-mod pet,103.514||92.281||71.791||64.95||63.33||59.325||58.125||55.635||53.462||51.301||51.151||50.625||49.817||49.181||48.478,0.0,0.2,0.2
444,Mol_Biochem_Parasitol-1-5-1885993.txt,rdgc||myristoyl||data||motif||phosphatas||ef-hand domain||parasit||amino acid||ef-hand||ppef||specif||gene||conserv||protein phosphatas||protein||analysi||high confid||tbppef||s-gfp||lmppef||result,phosphatas||protein phosphatas||T. brucei||major||T. brucei L.||ppef phosphatas||T. brucei T.||trypanosoma brucei||T. brucei ppef||T. brucei T. cruzi||L.||threonin phosphatas||threonin protein phosphatas||protein||T. brucei T. brucei rna,76.036||62.479||59.341||56.076||56.034||55.7||53.262||52.997||51.349||50.271||49.418||49.292||49.168||48.922||47.473,0.4,0.2,0.2
445,Osteoporos_Int-4-1-2277446.txt,placebo||level||administr||calcium intak||nurs home||baselin||studi||serum 25||effect||secondari hyperparathyroid||increas||bone turnov marker||serum pth||dose||calcium||day||calcium supplement||month||phosphat||pth||nurs staff||home||group||decreas||monthli administr||random clinic trial||particip||daili administr||result,vitamin||weekli vitamin||vitamin D3||daili vitamin||calcium supplement vitamin||oral vitamin||defici vitamin||dietari vitamin||total vitamin||vitamin D2||sever vitamin||optim vitamin||Dd||Dw||Dm,126.811||82.709||77.122||75.733||71.992||65.751||64.666||64.55||64.165||63.938||63.405||63.405||60.079||60.079||58.737,0.0,0.0,0.0
446,Histochem_Cell_Biol-4-1-2228381.txt,patholog gain-of-funct mechan||edem1||earli secretori pathway||ER stress||gl II||golgi apparatu||pathogenesi||nuclear envelop||exampl||complex||edem||chaperon||degrad||oligosaccharid||cell||copii coat||erad||glucosidas II||protein qualiti control||protein||qualiti control||endomannosidas||zuber||chemic chaperon||myocilin-caus open-angl glaucoma||synthet chaperon||protein fold diseas||work||mammalian cell||diseas||result,endoplasm||endoplasm reticulum||reticulum||endoplasm reticulum protein||misfold protein||protein misfold||misfold glycoprotein||protein||degrad protein||protein degrad||degrad||endoplasm reticulum degrad pathway||rough endoplasm reticulum||endoplasm reticulum subdomain||endoplasm reticulum stress,79.12||73.223||67.326||67.295||60.779||60.779||55.503||55.44||53.916||53.916||52.391||51.971||50.371||49.447||49.341,0.0,0.1,0.13333333333333333
447,Neurosci_Lett-1-5-1885995.txt,notch||sub-nuclear bodi||cbf-1,icd||icd icd||icd icd icd||abstract icd icd icd||fig. 2 icd icd icd||fig. 3 icd icd||notch||drosophila notch||receptor notch||sub-nuclear bodi||notch intracellular domain||kopan R. notch||kadesch T. notch signal||keyword notch cbf-1 transcript luciferas||mammalian notch receptor mol,224.15||224.15||224.15||168.112||136.685||114.818||36.283||19.049||18.142||16.13||15.297||14.712||14.122||12.403||10.793,0.0,0.2,0.13333333333333333
448,J_Chem_Ecol-4-1-2239250.txt,insect||level||time||induct||concentr||individu||studi||GS concentr||dri mass determin||effect||femal||parasit||pieri rapa||parasitoid||sex||compound||natur enemi||defens||generalist||caterpillar||mithen||popul||oviposit||glucobrassicin||herbivor||direct defens||surviv||glucosinol||artifici select||speci||total GS concentr||specialist||plant,brassica||brassica oleracea||oleracea||P. xylostella||plant||B. brassica oleracea||brassica B.||P. xylostella B.||J. brassica||brassica D.||D. brassica||P. xylostella B. oleracea B.||P. xylostella brassica α||B. oleracea||brassica rapa,121.985||108.892||95.799||93.752||92.844||92.144||90.317||82.052||81.669||80.255||80.255||80.121||78.17||77.224||76.616,0.2,0.1,0.06666666666666667
449,Eur_J_Pediatr-3-1-2151775.txt,breastf infant||netherland paediatr surveil unit||case||week||administr||infant||birth||data||current dutch guidelin||studi||effect||cholestat liver diseas||netherland||surveil||newborn||dose||late vkdb||age||prophylaxi||incid||current incid||oral||paediatr||report||order||secondari case||vkdb,vitamin||prophylaxi vitamin||bleed||late vitamin||oral vitamin||micellar vitamin||neonat vitamin||intramuscular vitamin||vkdb||defici bleed||prophylact vitamin||nutrit vitamin||TJ vitamin||keyword vitamin||prophylaxi,108.76||76.635||74.293||66.993||59.559||58.777||56.759||56.474||56.392||56.298||55.765||55.105||55.087||54.38||44.51,0.0,0.1,0.13333333333333333
450,Ann_Surg_Oncol-3-1-1914273.txt,follow-up||adjuv radiotherapi||respons||ilp||radiat||patient||year||amput||distant metastas||perfus||radiotherapi||necrosi||patholog examin||treatment||tumor necrosi factor alpha||late morbid||recurr diseas||month||critic leg ischemia||resect margin||isol limb perfus||limb salvag||tumor||surviv||melphalan||limb||skin||time period||resect||diseas||sarcoma||patholog fractur||result,limb||limb perfus||sarcoma||limb salvag||ilp||isol limb perfus||melphalan||perfus||advanc limb||limb perfusion.||involv limb||limb int||limb function||hypertherm isol limb perfus||limb salvag curv,88.495||70.238||65.699||62.884||55.999||54.399||53.565||51.98||49.337||45.763||44.784||44.76||44.248||43.817||43.038,0.8,0.7,0.4666666666666667
451,J_Biol_Inorg_Chem-4-1-2359831.txt,condit||polyacrylamid gel electrophoresi||odn||gel||sampl||copper complex||platinum||copper||close proxim||dna||dna cleavag||odn II||adduct||major groov||sequence-select cleavag||solut||clear sequenc select||band||cleavag||fragment||strand cleavag||nucleobas||smear||result,odn||2||1 2 2||odn II||1 2||free odn||3′-phosphat end 2 2 2 2||1 2 3 2 2 27||cleavag 1 2 1||1 4 2 1 2||odn II adduct||odn II strand||1 2 1 1||1 2 7 2 4 2||cleavag,74.902||53.146||43.661||40.412||38.919||38.032||35.946||33.153||33.138||32.124||32.095||31.949||31.806||31.77||30.021,0.4,0.2,0.2
452,Diabetologia-3-1-2039826.txt,type 2 diabet||insulin level||vascular event||chronic hyperglycaemia||white matter lesion||diabet||mri||histori||data||vascular risk factor||patient||multivari model||cerebr complic||pwml||brain infarct||test||infarct||insulin||type 2 diabet mellitu||macrovascular diseas||present studi||brain||vascular factor||control||regress analys||cognit||sever wml||retinopathi||sever mri abnorm||associ||atrophi||brain mri||group||factor||perform||neuropathi||risk factor||cognit domain||neuropsycholog examin||cognit perform||larg number||score,diabet||diabet mellitu||diabet encephalopathy’||2 diabet||diabet characterist||diabet patient||type 2 diabet||type 1 diabet||2 diabet mellitu||type 2 diabet manschot||type 2 diabet mellitu||type 2 diabet group||cognit||interpret type 2 diabet||non-insulin-depend diabet patient,88.933||47.957||47.39||47.294||46.706||45.503||42.262||40.377||33.856||33.738||33.441||33.359||32.69||31.696||31.679,0.2,0.2,0.26666666666666666
453,J_Mol_Model-4-1-2386531.txt,crystal||type||method||solid||eid||unit cell||higher accuraci||bond length||bond||pm6||artifact||optim||model||valu||distort||ion||densiti||strong bond||partial charg||form||forc||silic||compound||period boundari condit||paramet optim||dabco||fault||unit||energi||net charg||geometri||distanc||train||good accuraci||organ compound||unpair electron||atom||polymorph||gradient||sulfur||ice||turn||charg||hydrogen bond||inter-r distanc||carbon group||solid state||electrostat potenti||miner||survey||speci||error||weak interact||proton||good approxim||organ solid||acet group||molecul||result,pm6||pm6 structur||optim pm6||pm6 sodium||pm6 calcul||nitrat pm6||pm6 valu||pm6 method||pm6 differ||degre pm6||pm6 structur 2||distanc x-ray pm6||optim pm6 structur||optim pm6 geometri||solid,177.437||106.78||98.498||97.426||95.325||92.934||89.46||88.999||88.718||88.718||83.018||82.263||77.707||76.995||72.534,0.2,0.1,0.13333333333333333
454,Neurosurg_Rev-3-1-2077911.txt,occipit bone||case||dura||rate||fmm||import vascular structur||studi||patient||craniocerv junction||head||difficulti||nerv||occipit condyl||surgic strategi||spinal cord||drill||lesion||point||FM area||skull base surgeon||lower cranial nerv||anatomi||VA damag||surgic approach||nerv root||approach||atla||complet resect||VA transposit||literatur||foramen magnum||FM meningioma||tumor||arteri||exposur||meningioma||resect||lower part||branch||vertebr arteri||bone resect,meningioma||foramen||foramen magnum meningioma||foramen magnum||VA meningioma||posterior foramen||anterior meningioma||anterior foramen||VA||extradur meningioma||approach VA||meningioma case||jugular foramen||FM meningioma||meningioma displac,132.699||132.253||131.418||130.778||107.431||84.91||84.225||84.002||82.164||80.095||76.25||74.967||74.696||72.605||70.472,0.4,0.2,0.2
455,Neuroimage-2-1-2225446.txt,method||scanner||imag||data||studi||grey matter||effect||medial tempor lobe||upgrad||test||region volum||multi-scann data-set||signific||calibr||brain||control||varianc||analysi||subject||qualiti control||group||differ||interact||error||diseas||imag intens||thalamu||result,scanner||scanner effect||scanner differ||6 scanner||multipl scanner||oldest scanner||scanner 3||scanner 2||scanner 1||5 scanner||singl scanner||scanner 4||scanner 5||scanner group||greatest scanner effect,158.933||87.808||86.935||80.872||80.675||80.407||79.475||79.468||79.467||79.467||79.467||79.467||79.467||79.467||60.11,0.2,0.1,0.06666666666666667
456,Intensive_Care_Med-3-1-1915613.txt,case||respons||medic condit||disturb||studi||clinic observ||patient||effect||present||criteria||anxieti||hypoact||antipsychot medic||disord||patient descript studi||adult||treatment||picu||diagnost||acut||ill children||approach||pediatr intensivist||haloperidol||parent||routin clinic practic||incid||psychiatr consult||delirium||explan||clinic present||risperidon||intens care unit||design||treatment respons||dsm-iv criteria||pediatr intens care unit||children,delirium||delirium delirium||hyperact delirium||pediatr delirium||delirium catatonia||icu delirium||richtlijn delirium||delirium incid||delirium 2002||subsyndrom delirium||delirium criteria||childhood delirium||haloperidol||keyword delirium critic||yudofski SC delirium textbook,203.648||203.648||117.603||117.3||107.708||104.602||104.527||104.046||103.604||103.295||102.724||102.679||95.127||72.808||57.632,0.2,0.1,0.13333333333333333
457,Cell_Calcium-1-5-1885971.txt,steady-st level||tip||extrus||effect||casm||depth||recoveri||larg snail neuron||diffus coeffici||sequestr||cell||calcium||intracellular calcium||solut||experi||mobil||neuron||cell membran||buffer||time constant||depolaris||appar paramet||diffus||respons time||transient||size||influx||peak||membran||microelectrod||result,Ca||Ca 2||2||2 2||app 2||casm 2||Ca fig. 2||Ca κ||Ca transient||Ca τ casm||app||Ca level||Ca data||Ca fig. 1 2||τ casm 2,160.11||148.967||137.824||137.824||110.759||103.863||103.861||95.186||94.954||85.633||83.693||80.055||80.055||78.994||78.204,0.0,0.0,0.0
458,Matern_Child_Health_J-2-2-1592158.txt,embryo||assist reproduct technolog||birth||fertil||pregnanc||patient||risk||art||cycl||ivf||treatment||lower birth weight||embryo cultur condit||multipl gestat||women||multipl||twin||infertil||factor||addit counsel||singleton||fertil problem,fertil||humrep||infertil||male fertil||vitro fertil||fertil problem||reproduct||vitro fertil assist reproduct technolog||reproduct birth||assist reproduct technolog||art||reproduct technolog||birth||wichita||ivf,41.511||28.107||23.55||23.439||23.131||21.574||20.501||19.256||17.39||16.673||16.633||15.489||14.28||13.53||13.517,0.4,0.4,0.4666666666666667
459,Behav_Genet-4-1-2226023.txt,time||week||gestat age||birth||insert||studi||chorion||herit||effect||environment factor||covari matrix||increas||placenta||growth||cord insert||matern factor||varianc||twin||qtl||umbil cord||weight||birth weight||gestat||regress||order||separ placenta||influenc||covari||placent factor||unadjust model||chanc,twin||covari||twin data twin||twin analysi twin||first-born twin||born twin||beta||herit||live born twin twin||monozygot twin||liveborn twin||8464 twin||body-height twin||gestat||twin pair,109.516||95.481||73.011||73.011||70.48||64.1||61.02||60.491||59.429||58.14||56.997||56.171||56.171||56.103||55.392,0.4,0.3,0.26666666666666666
460,Clin_Oral_Investig-4-1-2238777.txt,condit||consumpt||dental eros||time||soft tissu||protect effect||salivari flow||studi||eros||effect||wear||sport||miner content||clinic examin||increas||dentin||saliva||calcium||enamel surfac||acid drink||eros potenti||eros agent||fluorid||surfac||factor||chemic factor||behaviour factor||phosphat content||import||drink||chemic||enamel||tooth||tooth surfac||progress,eros||dental eros||enamel eros||eros tooth||dental eros cari||enamel eros cari||dental eros monograph||vitro eros||eros potenti||facial eros||eros condit||eros effect||eros agent||eros lesion||induc eros,191.135||139.587||139.283||116.922||110.342||110.139||100.762||98.991||97.696||97.278||97.004||96.883||96.229||96.028||95.568,0.4,0.3,0.26666666666666666
461,J_Med_Internet_Res-4-3-1761945.txt,nation||system||parti||commun||conduct||user guid||relev profession associ||european council||state||criteria||inform||specif tool||medic||user||unit state||provid||guidelin||label||tool||content||avid consum||websit||code||health||eeurop||hon||site provid||bodi||standard||action||rate system||site develop||european||possibl||high qualiti servic||privaci||qualiti initi||order||core set||european union||specif aim||organis||member state||eeurop 2002 action||qualiti criteria||initi||sixti||internet,qualiti||qualiti criteria||criteria||websit||health||organis||code||european||health inform||qualiti criteria access||qualiti criteria simpl code||inform||simpl qualiti criteria||key qualiti criteria||qualiti label,62.856||61.735||60.614||52.249||50.264||49.615||48.752||48.17||47.059||44.712||43.881||43.853||42.258||42.17||42.053,0.8,0.7,0.5333333333333333
462,Eur_J_Epidemiol-4-1-2249618.txt,indic drug||discharg||full multivari model||studi||patient||year||admiss||prescript||non-acut care hospit||medic||intervent||ace inhibitor||day||arb||hospit||health care system||statin||odd||popul||secondari prevent||care||myocardi infarct||acut MI||MI admiss||copay||aspirin||beta-block||sick fund||absolut contraind,infarct||myocardi infarct||copay||acut myocardi infarct||nonfat myocardi infarct||myocardi infarct 2||myocardi infarct 1||waiv copay||drug copay||0.79 copay||acut myocardi infarct care||0.65 copay||acut myocardi infarct trial||myocardi revascularis||keyword myocardi infarct statin beta-block angiotensin,48.83||47.258||42.08||35.057||32.208||31.505||31.505||31.027||29.968||27.451||26.982||26.877||26.293||25.228||24.403,0.4,0.2,0.13333333333333333
463,Chiropr_Osteopat-13-_-1151650.txt,method||search engin||problem||data||studi||year||patient||question||overweight||bmi||risk||obes||review||bodi mass index||evid||evidence-bas practic||research||causal factor||paper||pain||associ||definit answer||literatur||osteoarthr||search||date||risk factor||link,back pain||pain||obes||low||acut low back problem||pain symptomolog||musculoskelet pain||low-back pain||pain syndrom||sciatic pain||knee pain||obes patient||background obes||bmi||chronic low-back pain,83.51||65.323||62.919||56.574||39.989||35.811||35.253||34.832||34.123||33.998||32.662||31.462||31.459||30.22||23.72,0.4,0.2,0.2
464,Appl_Microbiol_Biotechnol-4-1-2243254.txt,petrochem process||metabol pathway||immobil||studi||yield||process||ferment process||organ||agent||fungi||cell||fumar acid||glucos||product||ferment||acid||maleic anhydrid||carboxyl acid||fumar||product recoveri||organ acid,fumar||rhizopu||fumar acid||rhizopu arrhizu||fumar acid product||rhizopu oryza||fumar acid deriv||acid||fumar acid properti||fumar acid ester||fumar acid accumul||fumar acid 1||fumar acid 1998||fumar acid transport||calcium fumar,183.435||150.707||138.434||118.592||115.955||96.587||93.503||93.433||93.019||92.735||92.706||92.696||92.289||92.289||91.717,0.4,0.3,0.2
465,Pflugers_Arch-3-1-2082651.txt,condit||quinidin||data||studi||bcl||arrhythmogenesi||arrhythm activ||flecainid||effect||parallel||point||treatment||heart rate||solut||analysi||ventricl||restitut curv||full agreement||critic DI||br||repolar||drug||pharmacolog condit||extrasystol stimul||heart||arrhythmogen||murin heart,scn5a||Δ scn5a||2 scn5a||42 scn5a||scn5a gene||result scn5a||13 scn5a||anim scn5a||singl scn5a||arrhythmogen 90 scn5a||Δ||Δ heart||8.9 11.8 scn5a||9.0 10.3 scn5a||44.2 9.3 scn5a,260.325||176.522||131.699||130.793||130.172||130.163||130.162||130.162||130.162||108.033||92.72||90.212||88.853||88.752||88.706,0.0,0.0,0.0
466,Dig_Dis_Sci-4-1-2413116.txt,questionnair||sexual offenc||histori||studi||depress||total score||GI symptom||ssf||childhood||anxieti||definit||signific||valid||non-consult||odd ratio||rape||function gastrointestin disord||kind||ib||adulthood||women||sweden||popul||subject||assault||group||hrql||fgid||dyspepsia||abus||signific differ||irrit bowel syndrom||function dyspepsia||gener popul,abus||sexual abus||fgid||emot abus||childhood abus||abus histori||physic abus||adulthood abus||previou abus||abus 3.95||abus questionnair||abus 8.86||past abus||abus 7.59||abus 6.88,162.979||100.373||98.841||97.486||95.398||93.128||90.333||89.817||83.78||83.526||83.064||82.704||82.68||82.554||82.443,0.4,0.2,0.13333333333333333
467,Environ_Manage-2-2-1705511.txt,forag||anim||studi area||meadow||conflict||region||kiang||pastor||war||livestock||nomad||product||changthang||estim||eastern ladakh||kiang densiti||ladakh||hanl valley||livestock popul||survey||herder||area||import habitat||habitat,kiang||ladakh||equu kiang kiang||kiang conflict||gujrat equu kiang kiang||kiang habitat||kiang densiti||kiang popul||kiang count||no. kiang||70 kiang||western kiang||kiang vis-à-vi livestock||ladakh himalaya||ladakh trans-himalaya,159.31||132.826||112.89||90.273||87.754||86.341||83.657||82.846||80.943||79.655||79.655||79.655||75.345||72.237||71.043,0.4,0.3,0.2
468,Int_J_Cardiovasc_Imaging-3-1-2121118.txt,blood pressur data||control||systol||studi||aortic distens||aortic stiff||nccm patient||gender-match control||conclus||noncompact||aortic diamet||wall||diastol heart failur||patient||aortic elast||nccm||result,nccm||nccm noncompact cardiomyopathi||noncompact||aortic stiff||nccm patient||aortic diamet||aortic distens||nccm 3||aortic stiff β||aortic elast||heart failur||aortic complianc||nccm patient nccm patient age||diastol heart failur||aortic area,51.169||33.275||30.264||29.35||28.487||27.006||27.0||26.05||24.396||24.162||24.022||23.982||23.067||21.762||21.444,0.8,0.7,0.5333333333333333
469,Bioinformation-1-1-1891626.txt,gene||est||inform||eukaryot||mrna sequenc||databas||mrna||avatar||gene locat||altern splice||genom,"avatar||avatar avatar||est||est sequenc||est align||5,469,433 est||avatar develop||est score||cluster est||est align inform||web databas avatar||mrna||avatar web site||mrna sequenc||biolog commun avatar",52.652||52.652||50.918||33.822||31.236||29.047||27.574||25.951||25.459||24.05||22.352||20.339||20.132||18.533||17.954,0.4,0.2,0.26666666666666666
470,Photosynth_Res-3-1-1779625.txt,metabolit||time||rate||valu||extract||water||present||incorpor||carbon||mixtur||chloroplast||oxygen electrod||label||dephosphoryl step||glucos||solut||sugar||cylind||analysi||experi||mox-tm deriv||filter membran||intern standard||work-up||apparatu||octulos||photosynthesi||dri nitrogen||membran||sugar phosphat,sugar||13||chloroplast||13 2 13 2 13||sugar phosphat||derivat sugar||mox-tm sugar||13 2||13 2 2 13||dri sugar||13 2 2||13 13 2 1989||4 13 13 2||free sugar||photosynthesi,55.679||49.308||44.291||38.213||37.613||37.402||35.473||35.439||35.439||34.022||30.816||30.67||30.07||28.384||26.976,0.6,0.3,0.26666666666666666
471,Eur_J_Pediatr-3-1-1829442.txt,case||flow||hilar portion||lrv||gross hematuria||data||studi||patient||renal vein||PV ratio||screen examin||renal doppler ultrasound||doppler ultrasound||nutcrack group||asymptomat microscop hematuria||adult||nutcrack syndrom||examin||ratio||doppler angl||hematuria||hypercalciuria||detect||children,hematuria||nutcrack||hematuria renal doppler||gross hematuria||microscop hematuria||isol hematuria||lrv||hematuria persist||total hematuria||doppler||nutcrack syndrom||PV||lrv nutcrack group||nutcrack syndrom nutcrack group||nutcrack group,125.071||92.798||72.924||68.451||67.335||65.702||64.946||63.334||62.536||61.747||58.502||56.215||52.907||52.695||46.887,0.4,0.3,0.3333333333333333
472,Ann_Surg_Oncol-3-1-1914261.txt,primari melanoma site||type||melanoma||re-excis specimen||diagnost biopsi type||import confound||re-excis||studi||patient||incis biopsi||primari melanoma||SN statu||site||posit margin||df||wide excis biopsi group||age||tumor cell||narrow excis biopsi||group||surviv||unknown||influenc||melanoma patient surviv||lymphat invas||breslow thick||invas,biopsi||melanoma||excis biopsi||incision biopsi||diagnost biopsi||excision biopsi||melanoma patient||incis biopsi||narrow excis biopsi||wide excis biopsi||cutan melanoma||excis biopsi group||2.7 excis biopsi||melanoma patient surviv||diagnost biopsi type wide excis biopsi,109.874||91.301||78.406||67.712||64.181||62.242||60.926||58.675||57.12||56.038||53.213||52.547||52.271||51.296||51.276,0.2,0.3,0.26666666666666666
473,Eur_J_Nucl_Med_Mol_Imaging-4-1-2100432.txt,condit||femal group||men||sex differ||auditori||baselin||data||studi||rcbf||region||sex||spm||contrast||male||stimuli||brain||prefront region||auditori process||analysi||gender||subject||auditori stimul||primari auditori cortex||activ||pac||differ||pet||prefront cortex||attent result||music||nois||white nois||result,auditori||auditori cortex||music||pac music||pac||sex||primari auditori cortex||auditori stimuli||human auditori||secondari auditori cortex||prefront cortex||auditori process||auditori affer||auditori stimul||auditori condit,72.161||60.669||48.487||47.051||45.615||44.031||43.345||41.763||40.61||40.446||39.85||37.949||37.312||37.001||36.782,0.6,0.5,0.5333333333333333
474,Purinergic_Signal-2-3-2096647.txt,atp||fura-2 microfluorometri||ach||concentr,ach||atp||ach 8D||ach compon||combin ach||keyword atp ach 2||atp neuron||atp 2||atp 6C||atp 1B||extracellular atp||atp analogu||atp compon||ach fig. 4||p2x atp receptor,320.808||252.982||163.442||160.404||160.404||151.966||143.73||143.529||130.747||127.721||127.411||127.026||126.491||107.308||90.843,0.4,0.2,0.13333333333333333
475,Pediatr_Cardiol-4-1-2267487.txt,subgroup||hla-b locu||ethnic group||taq dna polymeras||studi||comparison||hla||patient||allel||frequenc||increas||dna||signific increas||gene||healthi control group||hla-b||kawasaki diseas||polymorph||associ||korean children||healthi korean adult||diseas||amplif||intern control primer||children,kawasaki diseas||kawasaki syndrom||two-gener kawasaki diseas||recurr kawasaki diseas||kawasaki diseas patient||kawasaki diseas eur||epidem kawasaki syndrom||kawasaki diseas genom dna||0.0||allel||2007 background kawasaki diseas||hla allel||diseas||keyword gene hla kawasaki diseas polymorph||kawasaki diseas 1984 tokyo ministri,106.704||85.083||72.127||71.543||71.538||71.136||57.587||55.218||53.59||53.561||53.365||46.856||46.618||44.304||43.456,0.2,0.2,0.2
476,BMC_Med_Educ-4-_-328087.txt,inform explos||educ activ||knowledg||core||problem||knowledg base||inform manag||medic school||doctor||develop||graduat||learn||knowledg manag||pbl||today||train||trend||factual||web-bas resourc||teach||teacher||challeng||faculti time||opportun cost||student||medic educ,educ||medic educ||teach||problem-bas learn||pbl||learn||medic educ practic||educ reform||in-hous educ||educ activ||pbl teach philosophi||educ util||educ output||educ risk||educ strategi,76.865||59.943||54.785||54.653||54.549||53.321||40.843||40.113||39.32||38.794||38.435||38.432||38.432||38.432||38.432,0.6,0.5,0.3333333333333333
477,Clin_Rheumatol-3-1-2092406.txt,follow-up||situat||studi||profession guidanc||year||patient||durat||sick leav||proport||guidanc||eac||vocat guidanc||aim||tool||chronic arthriti||health profession||workplac adapt||earli arthriti||work disabl||job||gener practition||symptom durat||group||adapt||number||symptom||statu||arthriti||work||studi entri||disabl||diagnosi||diseas||period||gener popul,arthriti||work||work disabl||disabl||sick||sick leav||work disabl pension||rheumatoid arthriti||1.0 work disabl work disabl pension||earli work disabl||partial work disabl||work disabl http://www.cbs.nl||perman work disabl||full work disabl||disabl pension,103.793||94.919||94.177||93.436||86.39||82.583||75.072||70.971||69.732||69.001||66.669||66.055||65.558||65.4||65.149,0.8,0.5,0.3333333333333333
478,Diabetologia-3-1-1794136.txt,type 2 diabet||independ predictor||follow-up||baselin||patient||year||incomplet covari adjust||risk||end||annual assess||variabl||independ contribut||macrovascular diseas||cardiac death||present studi||all-caus mortal||western australian data linkag system||smbg||community-bas cohort||rosso||full adjust||outcom||result,smbg||smbg smbg number||time-depend smbg||baselin smbg||smbg statu||interpret smbg||baselin time-depend smbg||fremantl||diabet||fd||type 2 diabetes’ smbg self-monitor||self-monitor||unadjust analysi||fremantl diabet studi davi||diabet patient,83.507||55.986||47.466||43.257||42.829||41.754||32.647||32.104||31.592||25.682||24.823||24.208||23.129||19.547||17.902,0.2,0.1,0.06666666666666667
479,Mar_Drugs-5-4-2365694.txt,person||system||center||educ materi||studi||marin||inform||major||organ||toxin||public health personnel||pilot studi||caller||blue green alga||health profession||evalu||coastal manag||interview||red tide||cyanobacteria||educ outreach materi||futur hab outreach||hotlin||hab||florida red tide||florida||ciguatera fish poison||brevetoxin||outreach||particip||poison inform specialist||ciguatoxin||healthcar provid,florida||hotlin||poison||caller||florida aquat toxin hotlin||florida marin||aquat toxin hotlin caller||florida red tide||aquat toxin hotlin||educ florida||florida freshwat||florida fish||toxin||tide||hab,131.386||102.695||89.175||89.12||87.417||79.817||76.85||76.607||72.76||70.58||69.917||69.537||68.728||67.896||67.472,0.6,0.4,0.4
480,Surg_Radiol_Anat-3-1-1820760.txt,scapula visibl||muscl||deform||intern||patient||contralater side||superior trunk outlet||view||scapula||rotat||ratio||clavicl||paramet||shoulder||width||sublux||obstetr brachial plexu palsi||brachial plexu||extern rotat||height||acromion||area||angl||children,scapular deform||brachial plexu||scapula||obstetr brachial plexu palsi||scapular hypoplasia||scapular angl||scapular posterior||scapular area||scapular elev||scapular line||scapular plane||scapular spine||conclus scapular deform||obstetr brachial plexu paralysi||deform,61.957||58.761||58.211||47.286||46.449||46.397||46.35||45.557||45.017||44.395||44.154||41.765||41.305||40.996||40.384,0.6,0.3,0.26666666666666666
481,Dig_Dis_Sci-3-1-1914298.txt,superior mesenter arteri||optim diagnost accuraci||measur||target||exercis intens||low level||low cost||studi||patient||consecut period||test||anaerob threshold||optim exercis test||exercis level||exercis tonometri||paramet||roch diagnost||chronic gastrointestin ischemia||tonometri||exercis||rapid serial lactat||lactat||false-neg test||decreas||target HR||exercis test||gastric exercis tonometri||gastric ischemia||diagnosi||period,exercis||exercis tonometri||tonometri exercis||exercis test||RQ||exercis level||submaxim exercis||exercis intens||exercis episod||clinic exercis||exercis int||gastric exercis tonometri||submaxim exercis test||optim exercis test||clinic exercis test,112.176||77.295||77.295||76.371||63.126||62.708||61.985||61.901||58.538||56.952||56.088||55.604||54.846||52.386||51.49,0.6,0.5,0.4666666666666667
482,Neurogenetics-2-2-1513515.txt,caucasian dataset||ethnic group||autism patient||sampl||data||studi||seizur||allel||autism||subunit||dataset||disord||caucasian popul||autism risk||gene||gaba receptor subunit||analysi||associ||popul||signific associ||candid||gaba||group||snp||differ||potenti regulatori region||largest differ||interact||addit||result,gabra4||gabra4 gabra4 gabra4||gabra4 gabrb1||gabra4 gabrb1 gabra4 gabrb1 gabrb1 gabra4||autism||gabrb1||gabrb1 gabra4 4 gabra4 gabrb1 gabrb1||signific valu gabra4 gabrb1 gabra4 gabrb1||gabra4 23 gabrb1||gabra4 gabrb1 gabrb1 utr variat||23 gabra4||44 gabra4||result gabra4||gabrb1 tabl 1 gabra4 gabrb1||5 0.047 discuss gabra4 gabra4 gabrb1,128.656||128.656||112.19||112.19||104.566||95.725||90.748||76.011||75.273||65.364||65.047||64.328||64.328||64.022||59.121,0.2,0.1,0.06666666666666667
483,Plant_Mol_Biol-4-1-2295252.txt,line||rosett||plastochron||juvenil||singl mutant||apic domin||abaxi trichom||day||gene||phase chang||leaf||veget phase chang||averag||arabidopsi||success||leaf initi||light||order||flower||mutant||number||t-dna||signific differ||shoot develop||plant,spl15 spl15 spl15 spl15 spl15||spl15||spl15 spl15 spl9||spl15 spl9 spl15||spl9 spl15||spl15 spl9||spl15 spl9 spl15 spl9 spl15 spl9||spl9||spl9 spl15 spl9 spl15 mir156b||spl9 spl15 spl9 spl15 spl2 spl9||spl9 spl15 spl9 spl15 2003||spl15 1 spl15 spl15||spl9 spl15 pp2a spl9||2008 spl9 spl15 mir156b spl9 spl15||spl9 spl15 mutant,366.263||366.263||361.164||361.164||358.615||358.615||358.615||350.967||319.812||299.601||286.892||274.722||268.896||266.744||241.266,0.0,0.0,0.0
484,Purinergic_Signal-4-2-2377324.txt,atp||membran||jnk||Na||nkcc||usa||cotransport||Cl||intercal cell||purinerg receptor||inhibit||activ||cell||medium||stress-activ protein kinas||kinas,cotransport||na-k-cl cotransport||cotransport intercal cell||sodium-potassium-chlorid cotransport||chlorid cotransport||cell||gekl||orlov SN||kinas||c11-mdck cell||atp||secretori na-k-cl cotransport||grygorczyk||epitheli cell||intercal cell,43.993||26.677||25.839||24.878||22.486||21.854||20.938||19.844||19.37||18.727||18.484||18.476||18.035||16.774||16.762,0.2,0.3,0.3333333333333333
485,Int_J_Hematol-4-1-2276242.txt,c-kit gene||find||case||nasal lymphoma||mutat||studi||patient||malign lymphoma||frequenc||develop||korea||epidemiolog||lymphoma||epidemiolog studi||lmp1||pesticid||cell||gene||nktcl||tumor suppressor gene||china||p53 gene||gene mutat||japan||risk factor||ebv||diseas||latin american countri||western countri,lymphoma||nasal lymphoma||t-cell lymphoma||nasal t-cell lymphoma||sinonas lymphoma||malign lymphoma||nasopharyng lymphoma||nk-cell lymphoma||’s lymphoma||t-cell lymphoma int||peripher t-cell lymphoma||primari lymphoma||cell lymphoma||convent lymphoma||barr,129.563||97.011||95.789||85.346||80.925||68.294||68.273||67.217||67.128||65.988||65.567||64.782||64.782||64.782||64.295,0.4,0.3,0.2
486,Intensive_Care_Med-3-1-2040486.txt,condit||muscl||scherer||lactic acid||patient||demonstr||patholog condit||observ||autopsi||articl||shock||puerper fever||blood||research||johann joseph scherer||carl folwarczni||death||lactat||human blood||leukaemia||result,milchsäur||ueber milchsäur||ueber||die milchsäur||scherer||ueber die bildung von milchsäur||ueber milchsäur im blut||milchsäur bei sauerstoffmangel||lactic acid||milchsäur im blut und harn||und harnanalys bei leukämi||ueber bildung von glycos||vorkommen der milchsäur||milchsäur im thierischen organismu||ueber die verbreitung,66.863||62.085||57.306||54.074||50.936||46.325||45.844||45.786||42.388||39.136||37.532||37.235||36.832||34.912||33.924,0.2,0.2,0.13333333333333333
487,Ann_Surg_Oncol-4-1-2190340.txt,follow-up||case||aspir||false-neg result||melanoma||sampl||locat||studi||patient||cytolog||clinic||difficulti||histopatholog evalu||sensit||diseas statu||needl||test||diagnost accuraci||failur||site||lesion||cell||verif||cytopathologist||fnb||axillari node||lymph node||accuraci||clinic follow-up||malign cell||materi||metastat melanoma||factor||posit||number||primari lesion||fine needl biopsi||clinic materi||procedur||needl pass||patholog||diagnosi||larg number||result,fnb||1.00||melanoma||metastat melanoma||melanoma metastat||suspici fnb||confirm fnb||subcuti fnb||false-neg fnb||fnb procedur||fnb case||fnb stage||739 fnb||fnb attempt||multipl fnb,161.939||128.577||126.77||103.881||103.881||100.51||87.261||86.079||85.874||85.237||84.911||83.081||82.235||81.659||81.51,0.6,0.3,0.2
488,Pain-2-1-2258319.txt,method||respons||questionnair||line||practic||return||studi||vignett||patient||clinic practic||recommend||health care practition||pt||UK gp||behaviour||guidelin recommend||treatment||hcp||advic||gp||clinic behaviour||clinic guidelin||pain||associ||subscal||activ||practition||attitud||lbp||belief||work||random sampl||survey||practic behaviour||score,pain pain||pain||back pain||back pain belief||pain guidelin||pain manag||pain spine||belief||pain disappear||guidelin||pain eur||lbp||pain relat||averag pain||pain predict,82.461||82.461||75.631||65.24||62.432||47.522||46.218||44.457||43.567||42.403||41.683||41.579||41.23||41.23||41.23,0.2,0.2,0.2
489,Exp_Brain_Res-3-1-1914235.txt,condit||muscl||measur||afference-bas interact||time||error correct||peak flexion||bilater muscl activ||kinemat||method||bimanu coordin||left||depend||electromyographi||rel phase||valu||flexion||effect||neural control signal||correct||rhythmic bimanu coordin||pattern||cycl||emg activ||signal||effer signal||control||tempor relat||coordin pattern||instruct||half-cycl||ecr||phase||analysi||emg||phase entrain||activ||coher||rhythmic movement||differ||kinesthet track||limb||time error||antiphas coordin||time correct||emg amplitud||trial||movement||extens||coordin||cycl durat||hand||success half-cycl||result,FC||yy||HC||HC HC||bimanu coordin||xy||coordin||FC Φ||movement||rm FC||rhythmic bimanu coordin||rhythmic bimanu movement||motor-driven movement||HC Φ||antiphas coordin,94.267||84.556||69.519||69.519||68.383||66.09||65.012||63.943||60.932||57.947||56.927||55.566||52.128||51.569||49.534,0.2,0.3,0.3333333333333333
490,J_Med_Internet_Res-6-2-1550592.txt,health servic research||technolog||qualiti expert||project||accur||rate instrument||conduct||search engin||qualiti||studi||patient||common reason||consum||inform||criteria||organ||review||abil||eysenbach||user||site||consum search||health inform||web site||recommend||onlin search||content||tool||code||health||educ||ehealth||research||result||popul||algorithm||stakehold meet||search engin expert||pew||factor||search||access||import variabl||human mediat||particip||health-rel web site||engin||internet,search||consum search||consum||web search||health search||consum health||consum health inform||inform||search mediat search||search engin||onlin consum search||consum search strategi||health inform||web||consum search terminolog,177.203||168.087||158.97||145.243||139.284||130.167||128.529||125.251||119.317||118.419||115.314||113.905||113.308||113.282||112.393,0.6,0.5,0.4
491,Plant_Cell_Rep-4-1-2413081.txt,ornament||transgen||line||ornament plant||root induct||somat embryo||transform||millenium||current studi||poinsettia||pnmv-deriv hprna construct||infect||genet engin||non-fe plant||pnmv||pcp||co-cultiv||somat embryogenesi||resist||explant||poinsettia genom||t-dna||transgen line||area||poinsettia plant||medium||rna,poinsettia||poinsettia plant||plant||plant plant||transform poinsettia plant||transgen poinsettia plant||transgen poinsettia||agrobacterium||eck poinsettia||poinsettia cv||ornament plant||poinsettia industri||poinsettia genom||poinsettia product||poinsettia stem,145.842||124.838||103.835||103.835||103.456||96.393||92.671||81.277||81.021||78.173||77.642||74.625||74.441||73.957||73.414,0.4,0.2,0.26666666666666666
492,BMC_Bioinformatics-4-_-166134.txt,mesh||method||figur||introduct||data||text mine||keyword content||question||section||full text articl||inform||mesh term||articl||context||content||cell||biolog inform||gene||term||relev||inform extract||analysi||subject||abstract||natur text||word||order||number||keyword||biolog concept||scientif articl||result,section||articl section||articl||word||method section||full text articl||discuss section||result section||introduct section||section 4||scientif articl||104 articl||text articl keyword gene||keyword||non-inform word,66.446||64.357||62.268||53.471||36.95||35.313||34.79||34.515||34.355||33.241||32.826||31.677||30.957||29.74||28.271,0.6,0.4,0.4
493,Biotechnol_Lett-3-1-1914260.txt,dextran||gene||starch||result||class||starch granul||kd-ut||foreign polym||asr||alternan||express||tuber juic||potato||starch content||tuber||transform||plant||glucansucras,asr||starch||potato||starch polym||transgen starch||freeze-thaw-st potato starch||potato plant||starch granul||potato tuber starch granul||starch biosynthesi||starch gelatin||potato amyloplast||starch isol potato tuber||starch content||2007 asr leuconostoc,68.37||53.552||44.497||36.995||34.635||33.755||33.588||32.458||31.09||29.325||28.878||28.683||28.513||28.419||28.152,0.6,0.4,0.3333333333333333
494,Cell_Tissue_Res-4-1-2386754.txt,medium||alp activ||studi||surface-mark express profil||assay||frequenc||chondrogen differenti potenti||human||adipos tissu||abdomen||rel target gene express||variabl||fat depot||cell||svf||day||gene||asc||protein||chondrogen differenti||differenti capac||osteogen differenti||differ||order||osteogen lineag||chondrogen||cultur||signific differ||tissue-harvest site||homogen popul||stem cell||gene express||donor,asc||t-l||chondrogen||cultur asc||asc frequenc||adipos tissu||stem cell||adipos differenti||asc nodul||asc prolifer||osteogen differenti||asc 5||cell||chondrogen differenti||abdomen,78.158||52.113||47.962||45.801||42.346||42.038||41.184||40.843||40.513||40.175||40.026||39.115||38.32||37.879||36.977,0.4,0.4,0.5333333333333333
495,World_J_Urol-3-1-1913171.txt,inflamm||bladder tumour||mmc||studi thermo-chemotherapi||transit cell carcinoma||sampl||studi||patient||local microwav||human||chemotherapi||high-grad urotheli cell carcinoma||increas||prolifer activ||temperatur||bladder||treatment||cell||haemorrhag||day||tumour||thermo-chemotherapi||tumour sampl||p53||activ||superfici bladder cancer||group||decreas||hyperthermia||posit||bladder cancer||cystectomi||result,cystectomi||hyperthermia||intraves hyperthermia||cystectomi sampl||microwave-induc hyperthermia||studi hyperthermia||hyperthermia 2||thermo-chemotherapi||mmc||bladder||combin intraves hyperthermia||local microwav hyperthermia||p53||combin local bladder hyperthermia||intraves mmc,83.121||76.511||48.615||43.009||39.842||39.125||38.51||38.087||36.364||35.766||33.843||32.763||30.807||29.964||28.542,0.4,0.5,0.4
496,Nutr_J-2-_-293472.txt,low densiti lipoprotein cholesterol||tablet||isoflavon||studi||cholesterol||effect||form||daidzein||serum TC||phytoestrogen||intervent||mixtur||treatment||lipid||soy protein||meta-analysi||subject||diet||serum cholesterol||serum lipid||genistein||soy||trial||isp,soy||soy isoflavon||isoflavon||purifi soy isoflavon||soy phytoestrogen||isoflavon tablet||soy diet||soy protein||soy capsul||soy biscuit||soy phyto-estrogen||soy compon||soy polysaccharid||soy food||soy product,203.347||196.737||190.126||131.158||121.892||115.009||108.197||107.705||107.527||106.759||104.602||103.272||102.312||101.674||101.674,0.4,0.3,0.2
497,Int_J_Colorectal_Dis-4-1-2386753.txt,follow-up||perian fistula||previou fistula surgeri||seri||recurr||patient||anal fistula plug||rectal advanc flap||cryptoglandular origin||high transsphincter fistula||high success rate||recurr rate||treatment||fistula||sphincter||advanc||anal canal||sphincter complex||surgeri||fibrin glue||group||high transsphincter perian fistula||intern open||consecut seri||altern treatment||closur||advanc flap||procedur||outcom||result,fistula||perian fistula||anal fistula||cryptoglandular fistula||fistula tract||fistula recurr||recurr fistula||high fistula||fistula surgeri||glue||fibrin glue||fibrin||rectovagin fistula||flap||recurr perian fistula,169.618||101.437||96.096||95.877||93.136||92.842||92.842||92.489||90.1||88.451||88.321||88.191||85.803||81.892||72.98,0.4,0.2,0.2
498,Cancer_Causes_Control-2-2-1764867.txt,alcohol consumpt||consumpt||cancer||drink pattern||time||wine intak||ovarian cancer||baselin||breast cancer||year||risk||rel||california||daili glass||alcohol beverag||intak||analys||median famili incom||day||cohort||women||cohort studi||alcohol||decil||age||associ||estrogen||report||liquor||drink||non-drink||wine||censu block group||beer||california teacher studi cohort||daili intak,wine||alcohol||1.00||ovarian cancer alcohol||cancer alcohol||wine intak||ovarian cancer||wine consumpt||alcohol intak||alcohol consumpt||wine drink||alcohol drink||alcohol women||baselin wine intak||ovarian cancer risk,119.985||112.062||106.221||93.586||88.404||85.089||84.347||83.668||81.128||79.707||76.72||72.759||67.127||66.763||65.112,0.4,0.5,0.3333333333333333
499,Histochem_Cell_Biol-4-1-2228382.txt,type||morpholog||cargo||fission||post-golgi transport||process||structur||cisterna||complex||domain||golgi||transport||tubular subdomain||molecular motor||protein||carrier||clem||golgi complex||tgn||format||motor||precursor||tubular network||cell surfac||apic surfac||post-golgi carrier||plasma membran||pgc||target membran||membran||molecular machineri,golgi||pgc||golgi cisterna||tran||tran golgi network||golgi network||golgi complex||golgi stack||golgi apparatu||tgn||yeast golgi||golgi enzym||keyword golgi||golgi area||golgi interfac,102.677||69.81||64.192||62.887||60.664||59.552||57.94||55.332||53.906||53.612||52.151||51.338||51.338||51.338||51.338,0.4,0.4,0.26666666666666666
500,Pediatr_Radiol-3-1-1950216.txt,dwi||time||protocol||spine||mri||imag||abnorm||patient||year||diffusion-weight imag||plane||fat satur||addit sequenc||manufactur||imag protocol||brain||tumour||slice thick||signal-to-nois||age||injuri||contrast||axial||sequenc||children,t1-w||t1-w spin-echo||coron t1-w spin-echo||axial t1-w spin-echo||spin-echo axial t1-w||axial t1-w||sagitt t1-w spin-echo||axial t1-w imag||t2-w spin-echo||sagitt t1-w||sagitt t1-w imag||imag||coron||t2-w imag||sagitt t1-w spin-echo dwi,86.952||79.841||73.145||69.14||69.14||67.344||65.406||65.286||63.363||61.744||61.553||61.17||59.753||57.582||56.317,0.0,0.0,0.06666666666666667
501,J_Membr_Biol-2-2-1764598.txt,mechan||vesicl||synapt bodi||find||system||ribbon||releas||rate||studi||channel||immumoact||exocytosi||synapt transmiss||molecular dissect||increas||evid||auditori nerv fiber||activ zone||cell||calcium||hair cell synaps||protein||synapt ribbon||ribbon synaps||pool||synaps||mous||number||synapt relev||hair cell exocytosi||hair cell||function pool||neurotransmitt||capacit measur||larg number||sound||compon,synaps||synapt ribbon||ribbon synaps||al.||ribbon||synapt vesicl||hair cell ribbon synaps||hair cell synaps||hair cell ribbon||vesicl||synapt exocytosi||hair cell||hair cell affer synaps||affer synaps||synapt vesicl lenzi,110.79||107.546||106.556||105.544||102.321||97.628||91.968||88.517||85.694||82.484||78.73||77.381||76.687||75.993||74.27,0.8,0.6,0.4666666666666667
502,Plant_Cell_Rep-4-1-2413084.txt,respons||anthocyanin accumul||red color||metabol pathway||studi||red pigment||transcript factor||lettuc plant||leaf color||anthocyanin||anthocyanin biosynthesi||express||rt-pcr||repressor||gene||structur protein||myb transcript factor||analysi||regul||atmyb||accumul||factor||lettuc||secondari metabol||plant||result,atmyb60||4 atmyb60 atmyb60 atmyb60 atmyb60 1994||plant||anthocyanin||WT atmyb60||anthocyanin product atmyb60||atmyb60 protein||atmyb60 2005 atmyb60 2005 atmyb60 result||lettuc plant||atmyb||atmyb60 atmyb60-atmyb60 atmyb60 transcript factor||arabidopsi plant||lettuc||atmyb60 transcript factor||anthocyanin biosynthesi,126.885||84.979||71.162||66.394||65.308||65.181||64.401||63.443||60.324||57.066||55.063||53.471||49.487||48.42||46.969,0.4,0.4,0.4
503,Pediatr_Nephrol-3-1-1805050.txt,standard method||case||hypertens||kidney||serum creatinin level||diastol BP||studi||patient||blood pressur||daytim||uak||control||renal mass||renal size sd||renal function||compensatori hypertrophi||abpm||report||ufsk||renal size||group||unp||patient group||solitari kidney||creatinin concentr||size||ura||BP profil||urin microalbumin||renal agenesi||children,Av||av.||24-h sbp||24-h sbp sd||24-h dbp sd||sd||24-h systol||24-h map sd||24-h HR||24-h sbp load sd||24-h map||24-h sbp load||24-h diastol BP||24-h dbp load sd||kidney,49.501||46.371||41.293||38.75||37.228||33.663||33.501||32.221||32.037||32.022||31.499||31.475||30.94||30.881||28.024,0.0,0.0,0.06666666666666667
504,J_Mol_Med-4-1-2262918.txt,hsf1||transfect||yfp||protect effect||studi||hsp||aggreg||effect||western blot||polyglutamin toxic||therapeut agent||treatment||cell||protect||protein||hsp70||hsp gene||experi||polyglutamin||polyglutamin aggreg||number||celastrol||drug||diseas||toxic||result,celastrol||polyglutamin||polyglutamin aggreg||hsf1||polyglutamin toxic||aggreg||celastrol treatment||result celastrol||polyglutamin protein aggreg||polyglutamin diseas||polyglutamin aggreg format||polyglutamin repeat||polyglutamin express||huntingtin aggreg||polyglutamin toxic brain,75.795||68.392||53.801||43.027||40.905||39.209||38.686||38.486||38.325||37.848||37.677||35.928||35.134||27.743||27.27,1.0,0.6,0.4
505,Biogerontology-4-1-2367389.txt,calor restrict||anim||phd||hif-1α||data||diet protocol||restrict||prolyl-4-hydroxylas domain||diet-specif||skelet muscl||express||rat||hypoxia||gene||hif||tissu||protein||age||chang||liver||mif||mous||calor intak||heart,calor restrict||restrict||phd3||calor restrict regimen||calor intak||mif||phd3 express||phd3 mrna||calori restrict||energi restrict||restrict work||phd3 mrna express||phd3 level||mif mrna||phd1,56.1||45.346||41.689||37.4||33.427||29.755||27.806||26.182||24.634||22.673||22.673||22.096||21.68||20.215||19.359,0.6,0.4,0.26666666666666666
506,Arch_Orthop_Trauma_Surg-3-1-1914284.txt,antevers||inaccuraci||safe zone||data||patient||placement||freehand placement||acetabular cup posit||resid||total hip arthroplasti||present studi||free hand||acetabular compon||surgic approach||approach||estim||hip||accuraci||abduct||perop||factor||differ||cup||posit||surgeon||posterolater approach||signific differ||result,antevers||cup antevers||abduct antevers||cup||acetabular cup antevers||abduct||acetabular cup||acetabular abduct||cup placement||acetabular cup posit||cup posit||freehand cup||planar antevers||acetabular cup impactor-position||addit antevers,102.308||97.571||93.33||92.834||85.518||84.352||77.123||72.882||66.889||58.281||56.716||53.617||52.659||52.463||51.154,0.4,0.4,0.26666666666666666
507,Osteoporos_Int-3-1-1820756.txt,follow-up||measur||men||elderli men||spine||roi||larg cohort||rate||baselin||age-rel appar net||studi||periost apposit||periost expans||individu slope||abmd||increas||bone miner content||morpholog basi||femor neck||site||signific||mass||prospect follow-up||hip||bodi||age||chang||areal bone miner densiti||distal forearm||bmc||decreas||bone||periost expans rate||osteoporosi||cross-sect data||distal radiu||area||distal ulna||loss||bone loss,bone||bone loss||endost bone loss||age-rel bone loss||net bone loss||bone miner||appar bone loss||trabecular bone loss||age bone||loss||bone width||longitudin bone loss||cortic bone loss||increas bone loss||bone mass,138.913||107.63||88.296||80.675||80.466||79.919||79.659||77.512||77.336||76.346||75.33||74.984||74.702||72.963||71.783,0.4,0.3,0.2
508,Purinergic_Signal-4-1-2245997.txt,ligand-bas homolog model||molecular model studi||ligand bind||affin||molecular model||structure-act relationship||receptor||side chain||adenosin receptor||deriv||antagonist||ligand||select,spalluto||receptor||adenosin receptor||adenosin||3 adenosin receptor||3 3 receptor||3||moro||adenosin receptor antagonist||3 receptor antagonist||cacciari||adenosin receptor subtyp||3 2A receptor||adenosin A3 receptor||A3 adenosin receptor,50.662||47.731||47.631||47.532||45.289||42.979||40.603||40.437||38.092||35.783||34.899||34.691||33.631||33.439||33.439,0.4,0.2,0.13333333333333333
509,Exp_Cell_Res-1-5-2131725.txt,centromer||polo||polo kinas||anaphas||phosphatas treatment||chromatin||histon modif||kinas||aurora||region||nhk-1||mitosi||phosphoryl||chromosom arm||cell cycl||cyclin||chromosom segreg||histon||loss||centromer region||function,phosphoryl||h2a phosphoryl||h2a||centromer h2a phosphoryl||centromer phosphoryl||h2a t119 phosphoryl||nhk-1||centromer h2a t119 phosphoryl||h2a t119||down-regul h2a phosphoryl||centromer||down-regul h2a t119 phosphoryl||result h2a t119 phosphoryl||polo nhk-1||interphas phosphoryl,82.04||78.291||74.542||69.111||66.396||65.16||61.601||61.558||56.72||54.295||50.752||50.446||48.87||48.363||48.12,0.2,0.2,0.2
510,Intensive_Care_Med-2-2-1315314.txt,hospit stay||icu admiss||sap II||system||project||origin counterpart||northern europ||data||model||studi||patient||europ||sap 3 databas||admiss||sap II paramet||risk adjust||region||variabl||sap 3 studi||intens care||countri||cohort||hospit||chronic condit||intens care unit||vital statu||esm||perform||risk adjust system||icu||outcom,icu||icu admiss||icu coordin||icu outcom||icu patient||307 icu||icu lo||icu stay||303 icu||icu level||26 icu||icu structur||6 icu discharg||11 icu mortal||icu mortal rate,107.958||70.065||59.365||59.195||58.428||56.098||55.219||54.926||54.853||53.979||53.979||53.979||39.343||37.985||37.524,0.4,0.2,0.13333333333333333
511,Antonie_Van_Leeuwenhoek-3-1-2140096.txt,array||complet genom sequenc||studi||present||strain||chromosom||region||dataset||dna||signal||gene||conserv||protein||termin region||analysi||core region||group||linear genom||secondari metabol||speci||sco||sequenc||result,streptomyc||put septum||put regul||put sporulation-rel protein||S. coelicolor streptomyc||protein||hypothet protein sco1044 put||S. avermitili streptomyc maritimu streptomyc||microarray streptomyc||S. coelicolor streptomyc streptomyc cattleya kitasatospora||S. avermitili streptomyc S. coelicolor||ribosom protein||put cell divis||murx streptomyc||streptomyc ambofacien,273.957||211.558||209.873||196.146||174.556||167.001||163.673||161.427||153.744||145.642||145.143||144.097||141.864||141.061||141.061,0.0,0.1,0.06666666666666667
512,Abdom_Imaging-4-1-2386533.txt,follow-up||regard||fat||accur||cross-sect imag||inflammatori bowel diseas||patient prepar||colon||bowel wall enhanc||CD patient||contrast medium||CT enterographi||magnet reson imag||termin ileum||bowel wall||vce||ultrasonographi||accuraci||bowel||contrast administr||specif valu||activ||small bowel||diseas||optim bowel prepar||ibd||sequenc||detect||diagnost perform||techniqu,bowel||diseas bowel||small bowel||bowel ultrasonographi||bowel sonographi||bowel prepar||bowel wall||bowel ultrasound||bowel lumen||bowel assess||bowel purgat||bowel spasm||bowel segment||larg bowel||inflammatori bowel diseas,166.005||110.169||98.347||91.255||88.179||87.873||87.761||85.822||85.562||85.044||84.313||84.115||83.003||83.003||81.846,0.4,0.3,0.26666666666666666
513,Anal_Bioanal_Chem-3-1-1802726.txt,vibrat band||current experi||dmso||corneocyt||molecular structur inform||secondari structur||imag||sampl||solvent||studi||current work||spectra||structur||spectral data||treatment||cell||protein structur||lipid||human SC||relationship||strong band||tissu||factor analysi||II band intens||patholog state||factor||singl cell||band||keratin||skin||epidermi||raman||imag plane||intact tissu||compon,corneocyt||corneocyt spectra||raman||isol corneocyt||raman spectra||individu corneocyt||50 corneocyt||15 corneocyt||raman spectroscopi||spectra||corneocyt epidermi protein||dmso||isol human corneocyt||raman intens||lipid spectra,68.456||47.448||45.366||37.464||35.903||34.228||34.228||34.228||28.547||26.439||26.246||25.495||24.976||24.481||24.301,0.4,0.3,0.26666666666666666
514,Behav_Brain_Res-1-5-2148464.txt,muscimol||cannula||dorsal||place||guid cannula||ap5||studi||ventral hippocampu||effect||infus||food reward||altern||correct||ventral hpc||lesion||dose||present studi||rat||spatial memori||goal arm||hippocampu||result||task||experi||arm||perform||drug||trial||side,hippocampu||dorsal hippocampu||ventral hippocampu||dorsal||muscimol||ventral infus||ventral hippocampu contribut||muscimol infus||spatial memori||infus||dorsal hippocampu tempor inactiv||memori||dorsal hpc infus||rat||ventral hpc,80.429||68.589||66.013||56.748||45.496||45.322||44.846||42.271||39.614||39.047||36.457||35.576||35.201||32.208||30.703,0.8,0.6,0.5333333333333333
515,J_Neurol-3-1-1915612.txt,va||placebo||botulinum toxin||muscl||whiplash||week||baselin||studi||total pain||patient||central nervou system||effect||neck||btx||total||improv||cervic rang||treatment||day||whiplash syndrom||va intens||pain||placebo group||intens||chronic pain||differ||number||central mechan||trial||signific differ||chronic whiplash syndrom||neck pain||placebo-control clinic trial,whiplash||botulinum toxin||pain||neck pain||botulinum toxin-a||chronic whiplash syndrom botulinum toxin||botulinum group||botulinum toxin group||whiplash syndrom||12 week botulinum toxin||neck||conclus botulinum toxin||whiplash injuri||chronic neck pain||chronic pain,89.516||74.654||70.988||60.673||56.075||54.281||53.988||52.434||50.933||50.522||50.359||49.769||47.294||47.192||45.608,0.8,0.5,0.4666666666666667
516,Plant_Cell_Rep-3-1-1824786.txt,seed||level||transgen||respons||line||signific reduct||studi||fhb||fusarium head blight||parent materi||inocul||transgen plant||analys||rt-pcr||fhb sever||percent fhb sever||field condit||greenhous||wheat||chitinas||resist||field||screen||transgen wheat||sever||diseas||transgen wheat line||plant||result,wheat||fusarium||wheat fusarium graminearum||transgen wheat||wheat plant||fusarium graminearum||wheat α-1-purothionin||transgen wheat plant||wheat scab||wheat line||wheat spike||wheat cultivar||transgen wheat line||wheat varieti||wheat head blight,173.026||140.359||134.378||125.749||121.315||115.054||108.221||107.034||103.879||96.818||96.68||93.143||90.703||88.504||88.009,0.4,0.2,0.2
517,FEBS_Lett-1-5-1942071.txt,s6k1||cell develop||embryon stem cell||pkc||mice||pkd||phosphoryl||pdk1||lymphocyt||depend||pathway||agc kinas||loss||activ||present studi||cell||p90rsk||kinas,pdk1||kinas||S6 kinas pdk1||protein kinas||phosphoinositide-depend kinas||pdk1-null||serin kinas protein kinas||pdk1 loss||pdk1 requir||agc kinas||pdk1 result||serin kinas||pdk1 express||kinas 1||kinas domain,80.654||72.446||52.288||46.634||45.973||44.802||43.608||43.005||41.403||41.363||40.687||40.582||40.327||36.467||36.223,0.4,0.3,0.2
518,Int_Ophthalmol-4-1-2359829.txt,donor cornea||method||time||storag||endothelium||studi||risk||hypotherm storag||inspect||antibiot||evalu||corneoscler button||tissu||solut||storag time||donor||cornea||eye bank||mandatori||microbiolog safeti||preserv techniqu||addit||organ cultur||bank||medium||techniqu,cornea||storag||corneal storag||corneal||donor cornea||hypotherm storag||organ cultur corneal||corneal organ cultur||store cornea||donor cornea preserv||cornea tran||cornea 3:219||cornea 4:80||cornea 3:231||human cornea,132.884||113.75||106.716||99.682||93.787||89.213||71.543||71.543||70.986||70.83||68.052||67.947||67.947||67.947||67.663,0.6,0.4,0.26666666666666666
519,Ann_Hematol-3-1-1914243.txt,CR rate||surviv||secondari aml||level||elderli aml patient||aml||studi||wbc count||drug resist||age||mrna||major vault protein||breast cancer resist protein||express||patient||cell||event-fre surviv||ef||result,bcrp||mdr1 bcrp bcrp bcrp mdr1||mdr1 bcrp||mdr1 bcrp mdr1 bcrp||mdr1 mdr1 bcrp mdr1||mdr1||mdr1 mrp1 lrp bcrp||po mdr1 bcrp||1 bcrp mdr1||0.001 mdr1 bcrp||analysi mdr1 bcrp||mrp1 lrp bcrp 1 mdr1 mdr1||1 bcrp mrp1 bcrp lrp||mdr1 mrp1 lrp bcrp 1||2 mdr1 bcrp coexpress,237.504||222.869||219.211||219.211||210.064||200.917||147.499||146.689||146.161||146.14||146.14||131.829||125.329||118.012||110.561,0.0,0.0,0.0
520,J_Mol_Med-3-1-2121654.txt,effect||tat cpp||actin||cpp||protein||primari cell||terminu||concentr||peptid||tat||phase-contrast imag||myosin motor domain||cardiomyocyt||cell||primari adult cardiomyocyt,peptid||vlc-1-tat peptid||cardiomyocyt||trojan peptid||tat||membrane-perm peptid||cell-penetr peptid||arginine-rich peptid||transduc peptid||morano||human vlc-1 peptid||tat-nemo-bind domain peptid||peptid transduct cardiomyocyt drug deliveri||cardoso||rat cardiomyocyt,36.255||24.579||24.332||20.964||20.932||19.74||19.74||19.59||18.845||17.908||17.172||16.03||15.564||14.486||13.739,0.6,0.3,0.2
521,Virchows_Arch-3-1-1888719.txt,grade||ki-67 index||clinic behavior||system||stage iiib||confer||prognost assess||session||patient||digest tumor||foregut||propos||consensu||guidelin||classif||net||neuroendocrin tumor||consensu confer||tumor||tnm||mitot index||particip||pancrea||endocrin||stage||enet guidelin,tumor||depart||endocrin tumor||neuroendocrin tumor||M0||foregut tumor||digest tumor||digest endocrin tumor||endocrin||carcinoid tumor||digest neuroendocrin tumor||stage||net||T1 tumor||N0,64.945||57.112||54.044||47.603||44.918||43.825||43.712||43.522||43.143||39.396||39.228||38.944||38.029||36.93||36.843,0.4,0.4,0.4
522,Theory_Biosci-4-1-2254468.txt,attent||biolog||find||essenti||graduat student||earlier paradigm||evolutionari tree||singl student||question||phylogenet||cladogram||phylogenet relationship||region univers colleg||relationship||remaind||evolutionari biolog||popul||respond||taxon||group||order||import||taxa||text book||stem group||correct answer||linnean categori||speci||tree||systemat||modern evolutionari biolog||draw,tree||student||evolutionari tree||biolog student||evolutionari tree draw||2008 tree||student draw||anthropocentr tree||univers student||tree tip||unbias evolutionari tree||graduat student||cladogram||evolutionari biolog||singl student,54.321||48.559||39.624||36.242||30.159||29.952||29.894||28.691||27.581||27.16||27.004||25.451||24.496||24.425||24.279,0.4,0.2,0.4
523,Diabetologia-4-1-2170457.txt,adipos vein||abdomin subcutan adipos tissu||time||sat||vivo whole-bodi||releas||lipolysi||lipolyt respons||obes||infus||adipos tissu||net uptak||tag||unit||present studi||blood||isotop enrich||insulin concentr||glycerol||glycerol uptak||mainten||abdomin sat||min||obes particip||import||obes individu||beta-adrenerg stimul||particip||neg net flux||result,adipos||obes||sat||adipos tissu||glycerol||sat lipolysi||abdomin sat||adipos vein||abdomin sat lipolysi||obes men||lipolysi||subcutan adipos tissu||abdomin subcutan adipos tissu lipolysi||abdomin subcutan adipos tissu||subcutan abdomin adipos tissu,62.954||57.415||41.932||41.829||38.832||37.178||36.065||35.813||34.851||32.795||32.424||32.364||31.943||31.823||31.823,0.8,0.6,0.5333333333333333
524,Diabetologia-3-1-1914282.txt,insulin sensit||high molecular weight||adiponectin||men||alcohol||concentr||oxid capac||moder alcohol consumpt||studi||activ||hmw||hmw adiponectin||result,adiponectin||hmw adiponectin||lmw adiponectin||mmw adiponectin||adiponectin oligom||adiponectin concentr||hmw adiponectin concentr||hmw||consumpt||whiski||plasma adiponectin oligom||9.4 0.61 adiponectin||alcohol||41.0 0.21 adiponectin||moder alcohol consumpt,49.346||37.289||31.393||31.044||28.221||26.387||26.002||25.231||21.765||20.162||19.633||19.082||17.906||17.527||17.472,0.4,0.3,0.3333333333333333
525,Clin_Oral_Investig-2-2-1544376.txt,titanium||anim||mandibl||week||osseointegr||experiment studi||direct bone||bone format||pilot studi||dog||histolog data||bmp-a||tibia||present studi||rhbmp-2||distanc||BD valu||implant||surfac||differ||germani||biocoat||titanium implant||respect site,implant||titanium implant||implant surfac||rhbmp-2||implant placement||surgic implant||dental implant||implant brush||implant instal||control implant||jennissen HP||rhbmp-2-biocoat titanium implant||dental implant clin oral implant||metal implant materi||bone,106.022||72.658||65.128||61.781||54.757||54.739||54.702||53.86||53.669||53.011||51.844||51.494||45.939||41.742||39.722,0.6,0.3,0.2
526,J_Neurooncol-4-1-2174520.txt,effect||report||agent||dna fragment||apoptosi||non-chemotherapeut agent||lovastatin||trail||dna-depend protein kinas||glioblastoma||combin||synergist effect||studi||strategi||activ||medium||cell||flow cytometri,lovastatin||lovastatin glioblastoma||glioblastoma||glioblastoma cell||cell||trail||human glioblastoma cell||glioblastoma cell line||apoptosi||lovastatin lead||cell death||glioblastoma multiform||apoptot cell||glioblastoma treatment||trail enhanc apoptosi,58.633||55.006||51.378||47.608||43.837||41.396||32.683||32.583||30.68||29.947||29.872||28.821||25.778||25.689||24.525,0.6,0.5,0.3333333333333333
527,Histochem_Cell_Biol-4-1-2413112.txt,morpholog||day 1||uuo||data||control group||studi||Le hir||interstiti space||uranyl acet||cortic interstitium||fibrosi||fibrot kidney||s100a4||cell||rat||day||control||proxim tubul||uret||tubul||resid fibroblast||rer||mitot activ||tubular cell||distal tubul||fsp1||myofibroblast||cortex||interstitium||ligatur||larg popul||uret obstruct||fibroblast||kidney,fibroblast||interstiti fibroblast||myofibroblast||renal myofibroblast||interstiti fibroblast cell||interstiti fibrosi||resid fibroblast||resid peritubular fibroblast||fibrosi||kidney||renal cortic fibroblast||renal fibrosi||renal cortic peritubular fibroblast||keyword kidney fibrosi fibroblast myofibroblast epitheli||renal interstiti myofibroblast popul,66.385||56.784||56.594||46.485||43.785||42.676||42.514||38.804||38.169||38.019||37.636||37.272||36.073||35.501||35.038,0.4,0.5,0.3333333333333333
528,Eur_Arch_Psychiatry_Clin_Neurosci-2-2-1705499.txt,current knowledg||pyromania||behavior||preval||rate||intermitt explos disord||posit result||efficaci||studi||psychiatr||patient||impuls||effect||internet addict||comorbid||evid||icd||treatment||pharmacolog option||specif subtyp||internet||impuls control disord||report||kleptomania||double-blind||skin||double-blind trial||impuls disord||compuls buy||addit||patholog gambl||result,gambl||psychiatri||compuls||compuls disord||impuls gambl||disord||gambl fluvoxamin||obsess compuls disord||patholog gambl||compuls shop disord||trichotillomania||impuls disord||compuls spectrum disord||compuls buy||compuls shop,137.871||134.055||132.664||113.534||102.573||94.405||94.123||88.969||85.868||82.458||81.618||80.84||78.138||76.712||76.485,0.0,0.1,0.2
529,J_Gastrointest_Surg-3-1-1852372.txt,measur||time||biliari reflux||esophagu||upper gastrointestin diseas||studi||valu||refer valu||data||patient||acid reflux||bilirubin absorb||ambulatori pH||bile||age 51 year||reflux||simultan bile||lower esophag sphincter||age||gender-match control||acid||barrett||stomach||meal||group||bile reflux||healthi volunt||intragastr pH||healthi control||esophag manometri||period||result,reflux||bile reflux||esophagu||bile||barrett esophagu||esophag bile||esophag||bile reflux monitor||barrett||duodenogastr reflux||bile acid reflux||24-hour bile reflux||patholog bile reflux||esophag biliari reflux||esophag pH,93.048||81.063||74.842||69.078||67.125||66.414||63.751||63.443||59.408||56.578||56.401||55.525||55.342||54.117||52.346,0.8,0.5,0.3333333333333333
530,J_Gastrointest_Surg-3-1-1852384.txt,pulmonari embol||complic||logist regress||leak||data||patient||year||bmi||roux-en-i gastric bypass||mortal||risk||obes||morbid||comorbid||msof||signific||male||oper||women||age||obstruct sleep apnea||coronari arteri diseas||incid||surgeri||death||cad||bariatr surgeri||report||periop risk||major complic||morbid obes||surgeon||rygb||procedur||postop small bowel obstruct||syndrom,rygb||bariatr surgeri||rygb complic||open rygb||surgeri||cad||primari rygb||bariatr procedur||mortal||conclus rygb||bariatr surgeri program||leak||bmi||0.01 cad||periop mortal,42.16||30.283||27.78||22.878||22.648||22.555||21.763||21.746||21.168||21.08||20.586||20.398||19.453||17.917||17.746,0.6,0.5,0.4666666666666667
531,Virchows_Arch-3-1-1888721.txt,cutan melanoma||morpholog spectrum||case||male breast||carcinoma||data||studi||seri||larg tertiari center||patient||frequenc||femal counterpart||metastas||site||slide||male||lobular||histolog subtyp||distribut||invas carcinoma||breast||period,carcinoma||breast carcinoma||male breast carcinoma||breast||male breast||male||male breast cancer||male breast cancer breast cancer||male breast histolog||male ductal carcinoma||breast cancer||invas carcinoma||keyword male breast carcinoma papillari cancer||lobular carcinoma||duct carcinoma,79.012||76.183||73.779||73.353||71.163||68.973||56.948||54.542||54.391||51.132||50.935||49.621||44.044||43.623||43.508,0.6,0.4,0.3333333333333333
532,Biogerontology-4-1-2174522.txt,glycolysi||condit||level||nad avail||dietari restrict||nadh level||mitochondri||increas||sirtuin activ||cell||sirtuin||control||product||protein||nad||age||format||accumul||activ||dhap||genet||gener||metabol||AL condit||alter protein||lifespan||nadh||pathway||methylglyox||oxid||benefici effect||function,methylglyox||nad||age||nadh||methylglyox induc||methylglyox modif||nad metabol||nad regener||methylglyox impair||methylglyox feb||plasma methylglyox||glycolysi byproduct methylglyox||intracellular nad||nad level||nad unavail,68.636||63.385||45.927||41.946||36.285||36.137||35.578||35.526||35.112||34.318||34.318||33.551||33.411||33.079||32.58,0.8,0.4,0.26666666666666666
533,Crit_Care-8-1-420054.txt,measur||capac||cardiopulmonari resuscit||earlier applic||suboptim care||patient||admiss||risk||develop||team||process||chain||increas||medic||clinic practic||cardiac arrest||acut pain team||intervent||evid||treatment limit decis||treatment||advers event||staff||ward||medic emerg team||hospit||approach||outreach care||earlier recognit||care||servic||literatur||group||report||import||opportun||emerg||outreach||critic ill||error||critic care||icu,care||critic care||outreach care||intens care||crit care critic care||hospit care||critic care outreach||suboptim care||health care||collabor care||multidisciplinari care||clinic care||end-of-lif care||pre-icu care||care resourc,112.896||77.888||71.749||69.477||68.854||65.806||62.126||60.222||59.561||59.434||58.368||58.235||58.123||57.894||57.788,0.6,0.4,0.26666666666666666
534,Med_Biol_Eng_Comput-3-1-1820753.txt,random nois||period signal||modul||sampl||thorax||electrocardiogram||ecg||inform||scale||amplitud||sourc||scale transform||signal||potenti||term||sft||random||multi-modul sourc||phase||spectral analysi||standard||algorithm||heart rate variabl||waveform||compon,τ||kj τ||ε kj τ||x′ τ||ε||1 τ||ij τ||ε kj||min ε kj τ||4 τ||3 τ||kj||1 2 τ||1 ε||2 4 τ,236.823||172.333||159.257||137.529||133.105||132.319||125.118||120.474||119.443||118.881||118.53||107.844||88.429||80.46||79.47,0.0,0.0,0.0
535,Ann_Hematol-4-1-2324127.txt,multipot adult progenitor cell||multi-lineag differenti||protocol||germ layer||differenti capabl||differenti potenti||circumst||marker||isol||mapc||adult||express||msc||differenti||present studi||cell||gene||adult stem cell||basal medium||cultur||passag||stem cell||pluripot||medium,mapc||mapc differenti||differenti mapc||mapc isol||P4 mapc||singl cell-deriv mapc||mapc 4 2||singl cell-deriv mapc transcrib oct4||differenti||stem cell||cell||pluripot stem cell||mapc 6 2 2||mesenchym stem cell||adult stem cell,110.649||72.272||72.272||58.162||57.418||54.138||38.275||38.109||33.896||32.493||31.068||29.189||28.058||26.605||25.908,0.2,0.3,0.3333333333333333
536,J_Gastrointest_Surg-4-1-2231408.txt,biopsi||correl||strain||specif type||pud||lavag fluid||result||studi||analysi||strip||popul||determin||sampl||genotyp||allel type||patient||ppu||perop lavag fluid,vaca||helicobact pylori||vaca vaca vaca caga||H. pylori H. pylori H. pylori||H. pylori H. pylori||H. pylori||vaca caga vaca||caga vaca||caga H. pylori||conclus vaca caga vaca||H. pylori statu||H. pylori infect||vaca genotyp||0.67 H. pylori||keyword H. pylori,113.01||102.176||98.712||96.833||96.833||96.833||93.946||84.414||83.161||70.459||66.813||66.362||65.895||64.919||64.555,0.0,0.0,0.0
537,Mar_Biotechnol_(NY)-3-1-2100433.txt,adhes test||anim||find||studi||marin||tyrosinas||marin mussel||recombin protein||domain||similar||marin mussel adhes||freshwat mussel||plant||cell||adhes||strength||dopa||product||quinon||research||collagen||protein||repetit motif||larg quantiti||byssu||surfac||specif identif||spider silk||natur adhes||adhes research||substrat||repeat||plaqu||marin polychaet||foot organ||attach||mussel||varieti||durabl||thread,mussel||mussel adhes||adhes||mussel adhes protein||eduli||marin mussel adhes||mussel protein||mussel byssal||mussel adhes attach||mussel adhes collagen||blue mussel adhes||natur mussel adhes||mussel adhes research||eduli adhes protein||mussel byssu,270.649||244.52||218.39||190.56||180.443||177.446||176.645||171.145||170.714||167.755||164.672||164.035||163.782||160.491||159.203,0.4,0.3,0.2
538,Cardiovasc_Intervent_Radiol-4-1-2367387.txt,measur||person dosimet||data||studi||lead apron||special holder||intervent procedur||relat||dosimet||radiologist||protect apron||statist analysi||dose||william||present studi||occup exposur||effect dose||singl year||holder||addit dosimet||linear relat||differ||exposur||transmiss||addit inform||procedur||physician||result,apron||dose||lead apron||msv||wrap-around apron||protect apron||wrap-around lead apron||lead equival apron||lead||dose measur||dosimet||averag dose||radiologist||annual dose||dose report,211.783||163.013||156.869||119.239||110.489||107.668||107.644||106.023||101.954||93.866||93.568||90.4||89.437||88.128||85.712,0.4,0.3,0.3333333333333333
539,Sleep_Breath-4-1-2194800.txt,placebo||armodafinil||hypertens||episod secondari memori||residu ES||baselin||clinic global impress||studi||patient||effect||long-term memori||test||cognit function||sleepi||adjunct treatment||treatment||advers event||therapi||day||obstruct sleep apnea syndrom||daili live||wake test||analysi||placebo group||ncpap||wake||visit||fatigu||final visit||signific amount||score||ncpap-adher patient,armodafinil||sleep||adjunct armodafinil||sleep breath sleep||armodafinil group||role armodafinil||nighttim sleep||obstruct sleep apnea||keyword armodafinil fatigu obstruct sleep apnea||sleep apnoea||sleep latenc||sleep disord||sleep stage||persist sleep||sleep medicin,92.656||76.575||54.352||53.932||46.97||46.328||43.727||42.298||41.27||40.953||40.077||39.526||39.155||38.909||38.724,0.2,0.1,0.06666666666666667
540,Pediatr_Radiol-3-1-1891641.txt,vesicoureter junction||uti||veloc||doppler||studi||durat||observ||sphincter muscl||function sphincter||ureter jet||pattern||bladder||physiolog||pregnant women||vur||dual compon||uret||age||action||subject||gener anaesthesia||chang||healthi uret||vuj||neural compon||activ sphincter||group||physiolog condit||signific differ||jet||initi slope||normal subject||children,jet||ureter jet||ureter jet pattern||jet pattern||monophas jet||ureter jet multispik||jet waveform||ureter jet 18||ureter jet direct||ureter jet characterist||ureter jet chang||ureter jet 11||ureter jet length||ureter jet proper||ureter jet effect,270.07||222.974||163.896||157.906||153.893||152.677||149.751||149.41||149.016||148.948||148.902||148.874||148.649||148.649||148.649,0.4,0.2,0.13333333333333333
541,Eur_J_Appl_Physiol-4-1-2226001.txt,measur||obstacl||capac||account||risk||correl||push-off||jump height||abil||high risk||grip strength||lower limb strength||classif||leg press apparatu||strength||daili life||leg||age||subject||faller||muscl strength measur||fall risk||leg extens strength||non-fal||healthi older adult||muscl strength||knee||trial||particip||hand grip strength||result,trip||fall||faller||induc trip||trip trial||simul trip||trip initi||legpress max||older faller||legpress max jump||jump||legpress max legpress rfd||strength||fall risk||max jump,105.297||80.542||55.481||54.252||53.457||53.186||52.649||51.242||51.164||50.025||47.591||46.692||45.699||43.436||43.429,0.2,0.1,0.2
542,Calcif_Tissue_Int-4-1-2268729.txt,anim||measur||time||ovx||bisphosphon||structur paramet||studi||valu||standard deviat||mechan properti||ultim displac||effect||bone structur||test||late zol||singl inject||cortic thick profil||rat||mechan adapt||control||zol||age||late treatment||group||percentag chang||differ||bone||anova||osteoporosi||earli||time point||cortic thick||absolut valu||result,zol||bone||ovx||0.673 0.999||0.265 0.999||3 0.999 0.999 0.579||3 0.999 0.999 0.353||trabecular bone||zol group||zol treatment||late zol||earli zol||bone microstructur||bone structur||cortic bone,103.658||89.338||76.991||68.001||67.525||67.302||67.128||65.962||64.228||62.2||60.506||57.57||56.568||53.818||53.767,0.6,0.3,0.3333333333333333
543,Virchows_Arch-3-1-1888718.txt,case||tcrbcl||infiltr pattern||studi||hepat lymphoma involv||malign lymphoma||frequenc||diagnost algorithm||immunohistochemistri||liver biopsi||infiltr||lymphoma||site||pattern||classif||extranod lymphoma||margin zone lymphoma||lymphoma cell||anaplast larg cell lymphoma||entiti||liver||extranod site||biopsi||differenti diagnosi||pcr||molecular analys||diagnosi||dlbcl||addit biopsi,lymphoma||b-cell lymphoma||t-cell lymphoma||lymphoma infiltr||hepat lymphoma||extranod lymphoma||lymphoma diagnosi||lymphoma entiti||high-grad lymphoma||malign lymphoma||primari lymphoma||burkitt lymphoma||follicular lymphoma||low-grad lymphoma||splenic lymphoma,189.065||115.325||115.203||110.443||109.252||102.767||99.667||98.931||97.39||97.141||97.029||97.019||97.003||96.822||96.218,0.2,0.3,0.2
544,Auton_Neurosci-2-1-2428072.txt,antibodi||import role||somat motoneuron||studi||chat-ir cytoplasm||chat||sympathet preganglion||electroton transmiss||lower cell surfac||spinal cord||rhythmic||slice||express||gap junction||lamina viii||coupl||cell||motoneuron||adult anim||dendrit process||cell bodi||neuron||adult rat||cytoplasm||import||connexin||optic section||room temperatur||vitro studi||close apposit||electr synaps,al.||cx36||motoneuron||cx36 puncta||spinal motoneuron||sympathet preganglion motoneuron||cx36 immunostain||cytoplasm cx36||somat motoneuron||sympathet preganglion||sympathet preganglion motoneuron logan||cx36 protein||preganglion neuron||sympathet preganglion neuron||spinal cord,91.57||84.133||70.094||60.09||59.727||52.733||49.839||48.055||45.292||44.053||43.855||42.067||41.629||41.508||41.018,0.2,0.3,0.26666666666666666
545,Pediatr_Nephrol-3-1-1794138.txt,podocyt||nephrin||podocin||nephrot syndrom||anim model||tubulointerstiti||injuri||pathophysiolog,fsg||glomerulosclerosi||segment glomerulosclerosi||focal segment glomerulosclerosi||alpha-actinin-4-medi fsg||fsg prolifer||primari fsg||question fsg||idiopath focal segment glomerulosclerosi||fsg podocyt loss||podocyt||keyword focal||tubulointerstiti||podocyt injuri||pathogenesi,44.173||34.004||27.857||27.16||25.431||22.864||22.086||22.086||21.943||21.719||19.02||12.883||12.536||11.971||11.918,0.0,0.0,0.13333333333333333
546,Calcif_Tissue_Int-3-1-1914289.txt,endocort osteocyt||shaft||periosteum||studi||rat tibia||endost surfac||section||probe||bone format||increas||express||singl period||tibia||cell||rat||brain||control||bone marrow cell||load||igfbp-2 mrna express||endost side||sham-load tibia||sham||group||hybrid||bone||four-point bend system||mechan load||lamella,igfbp-2||igfbp-2 mrna||igfbp-2 mrna express||load||igfbp-2 mrna-express osteocyt||load tibia||endogen igfbp-2 mrna||tibia||igfbp-2 mrna product||osteocyt||bone||igfbp-2 mrna express level||situ hybrid igfbp-2 mrna express||mrna||mous igfbp-2 cdna,91.206||63.075||48.325||47.198||44.863||44.709||42.662||42.219||42.05||40.31||37.731||36.458||35.982||34.945||30.861,0.4,0.3,0.26666666666666666
547,Sex_Abuse-2-2-1764595.txt,affin self-report rate||categori||affin||VT approach||interest||ppg||femal children||sexual arous||rate||individu||data||offend||studi||devianc index||sexual attract||self-report sexual arous||correl||femal toddler||self-report||adult||view time||male||letourneau||research||assess||age||prepubesc children||intern consist||adult femal||experi||male child victim||victim||group||photograph||auc||sexual interest||intern consist estim||sexual offend||adolesc||procedur||particip||children,sexual offend||sexual arous||self-report sexual arous||sexual abus||sexual interest||adolesc sexual offend arous sexual abus||adolesc sexual offend arous||sexual offens||sexual recidiv||sexual thing||sexual assault||sexual histori||sexual attract||sexual thought||sexual offend journal,207.695||196.269||167.29||159.702||158.961||155.666||153.649||151.852||149.894||149.682||148.561||145.011||144.435||144.294||143.247,0.8,0.4,0.3333333333333333
548,Bioinformation-1-10-1896059.txt,array||aspect||import aspect||level||method||copi number alter||data||valu||effect||boundari||gene express analysi||region||chromosom||gene||term||copi number||analysi||alter||cgh array||group||hybridis||diseas||profil||step||gene express||detect||function,copi number||copi number alter||alter copi number||chromosom copi number alter||copi number estim||copi number variat||similar copi number||copi number measur||copi number gain||copi number alter 14||region||copi number chang detect||region alter||alter||copi number estim problem,47.946||40.278||40.278||34.069||32.822||32.398||32.299||31.964||31.964||30.209||25.746||25.525||25.344||24.941||24.617,0.4,0.2,0.26666666666666666
549,Theor_Appl_Genet-2-2-1544375.txt,seed||match||set||coffe||databas||pericarp||librari||gene famili||similar chromosom architectur||est||annot||tissu||solanacea||protein||blast||famili||cdna||uniqu||tomato||number||speci||stage||unigen set||highli||unigen||sequenc||seed develop||function||result,arabidopsi arabidopsi arabidopsi||arabidopsi||4 arabidopsi arabidopsi arabidopsi arabidopsi||springer-verlag 2005 arabidopsi arabidopsi arabidopsi arabidopsi||arabidopsi arabidopsi 3||coffe||coffe unigen||unigen||coffe arabidopsi materi||tomato coffe||coffe seed||arabidopsi thaliana||8 arabidopsi||method arabidopsi||6 arabidopsi,195.48||195.48||156.386||130.321||130.321||127.62||125.824||124.028||108.73||106.991||104.561||99.706||98.483||98.442||98.238,0.0,0.2,0.13333333333333333
550,Apoptosis-3-1-1914234.txt,antibodi||concentr||nuclear ro product||sampl||studi||effect||atp||heart failur||express||cell||apoptosi||experi||usa||decreas||incub||nuclear nitrotyrosin residu||cardiomyocyt||sah||pb||hci||result,hci||homocystein||hci concentr||mM hci||incub mM hci||s-adenosyl homocystein||homocystein thiolacton||lower hci concentr||high hci concentr||elev hci concentr||homocystein enhanc||homocystein trial||Ψ||cardiomyocyt||nox2,78.639||55.113||43.955||41.935||31.192||30.288||30.288||29.77||29.304||29.304||28.788||27.556||27.081||23.058||22.109,0.2,0.1,0.13333333333333333
551,Eur_J_Epidemiol-3-1-1914270.txt,level||measur||find||method||reproduc||cac||studi||cholesterol||technic variabl||epidemiolog||relat||coronari calcium measur||volum||agatston||measur protocol||mass||ebct||calcium||slice thick||mdct||absolut||calcium score||coronari arteri calcif||subject||scan||differ||cardiovascular risk factor||random select||coronari arteri||risk factor||particip||error||score||result,calcium||coronari calcium||calcium score||coronari calcium measur||score||agatston score||coronari arteri calcium||agatston||coronari calcium quantif||absolut calcium score||low coronari calcium score||inter-scan reproduc||coronari calcif||calcium measur||tomograph coronari calcium scan,58.69||57.058||50.696||43.351||42.703||41.78||40.923||40.857||40.352||40.21||39.44||39.086||37.786||37.313||36.067,0.8,0.5,0.3333333333333333
552,Breast_Cancer_Res_Treat-3-1-2001224.txt,placebo||posit immunohistochem analysi||letrozol||efficaci||breast cancer||data||patient||tamoxifen||median follow-up||year||recurr||post-unblind analysi||risk||placebo-control trial||HR statu||nation cancer institut||tamoxifen therapi||aromatas inhibitor||df||treatment||therapi||adjuv therapi||women||result||analysi||tumor||continu hormon treatment||hormon therapi||clinic benefit||adjuv tamoxifen therapi||trial||ma.17||benefit||hazard ratio||outcom||safeti,letrozol||adjuv letrozol||ma.17||tamoxifen||letrozol therapi||adjuv tamoxifen||letrozol versu tamoxifen||letrozol treatment||letrozol suppress||letrozol improv||ncic ctg ma.17||breast cancer||adjuv tamoxifen therapi||cancer||ma.17 trial,108.721||81.625||74.405||70.765||66.39||62.647||60.808||57.298||54.953||54.925||53.706||52.39||49.784||47.739||47.641,0.6,0.3,0.3333333333333333
553,Sleep_Breath-3-1-1794626.txt,apnea||daytim function||follow-up||oral applianc||measur||author||airway||applianc||reduct||overbit||rate||efficaci||data||studi||patient||benefici respons||upper airway||ess||respons rate||cpap||effect||clinic||abnorm anatomi||polysomnographi||sleep studi||inform||present||investig||common featur||bed partner||continu posit airway pressur||clinic trial||treatment||upper airway resist syndrom||sleep||random||sleep apnea||success||assess||mandibular advanc||group||loud||symptom||subject percept||signific differ||success rate||signific improv||outcom||result,applianc||sleep||maa||sleep apnea||oral applianc||apnea||snore||advanc applianc||obstruct sleep apnea||sleep breath sleep||herbst applianc||mandibular advanc applianc||mandibular protrus applianc||dental applianc||sleep apnea treatment,429.37||343.758||329.515||310.662||294.207||277.566||273.537||250.089||245.507||237.797||235.683||232.676||227.122||225.529||220.611,0.8,0.5,0.3333333333333333
554,Eur_Arch_Otorhinolaryngol-4-1-2279159.txt,subglott||time||peakflow||dilat tracheoscopi||patient||upper airway||femal||present||progress complaint||refer group||tracheal stenosi||stenosi||intervent||treatment||institut||age||number||subglott stenosi||sg||diagnosi||local diseas||tracheoscop,stenosi||subglott stenosi||tracheal stenosi||subglott||WG||sg||TS||DT||stenosi tracheal stenosi dilat tracheoscopi constrict||posttraumat tracheal stenosi||thermal tracheal stenosi||WG patient||congenit stenosi||postintub stenosi||post-intub stenosi,77.535||72.332||67.64||67.129||65.034||64.317||53.284||50.28||45.948||45.582||45.44||42.591||40.728||40.323||40.323,0.8,0.5,0.3333333333333333
555,J_Biomol_NMR-4-1-2268728.txt,structur restraint||residu||nmr structur||nmr data||protein data bank,nmr||nmr structur||nmr structur deposit||wwpdb||nmr data||wwpdb nmr TF||nmr restraint||structur||bmrb||nmr TF||biomolecular nmr||bmrb deposit||nmr spectroscopi||wwpdb nmr TF meet||deposit,62.843||50.6||43.709||42.825||40.549||38.775||38.634||38.358||37.203||36.75||34.55||33.564||32.002||30.267||29.925,0.4,0.2,0.13333333333333333
556,Breast_Cancer_Res_Treat-3-1-2001222.txt,cardioprotect effect||placebo||exemestan||joint symptom||signific decreas||letrozol||breast cancer||studi||year||tamoxifen||patient||endometri cancer||effect||risk||vagin dryness||disadvantag||increas||aromatas inhibitor||ai||life-threaten event||event||fractur||postmenopaus women||treatment||advers event||adjuv therapi||women||result||incid||co-morbid||heart diseas||anastrozol||bone||earli breast cancer||lower incid||trial||signific differ||nation surgic adjuv breast||hot flash||bone loss||safeti,tamoxifen||tamoxifen breast cancer||adjuv tamoxifen||breast cancer||cancer||tamoxifen versu tamoxifen||postmenopaus breast cancer women||adjuv breast cancer trial||breast cancer clin cancer||adjuv tamoxifen therapi||adjuv breast cancer therapi||breast cancer trial||adjuv anastrozol||tamoxifen therapi||earli breast cancer,113.582||98.283||97.723||90.633||83.848||77.997||72.624||72.175||71.336||71.026||70.19||68.945||65.78||65.606||65.474,0.4,0.2,0.2
557,J_Med_Internet_Res-8-2-1550696.txt,electron health inform||document||level||skill||journal articl||case||measur||behavior||understand plagiar||data||studi||question||research librari||higher educ||consum||procedur knowledg||inform||health inform compet||studi particip||articl||actual perform||health inform||consum health inform||idea||sourc||rrsa||one-keyword search||health profession||health educ||secondari sourc||websit||multipl choic||health||nutrit supplement||item||research skill||librarian||assess||health topic||import marker||plagiar||respond||search||compet||particip||area||self-report skill level||score||inform age student||internet,inform||rrsa||health inform||inform compet||health inform compet||health||student||trustworthi health inform||consum health inform||health inform consum||inform consum||health inform evalu||evalu health inform||health inform literaci||compet health inform consum,125.531||109.002||107.233||93.352||91.88||88.934||85.551||81.41||80.836||80.836||76.787||76.541||76.541||76.115||75.92,0.8,0.6,0.4
558,Diabetologia-3-1-1871609.txt,prevent||type 2 diabet||follow-up||level||diabet||weight loss||signific reduct||individu||control group||studi||effect||risk||impair glucos toler||review||cardiovascular fit||multi-compon lifestyl intervent||exercis intervent||moder increas||glucos||analysi||independ effect||physic fit||incid||exercis||igt||plasma glucos||chang||group||physic activ||trial||particip||ifg||relev clinic measur||prediabet||outcom measur,diabet||exercis||physic exercis||glucos||0.1||igt||diabet mellitu||exercis intervent||prediabet||impair glucos toler diabet||glucos igt impair||glucos toler||physic activ||lifestyl||plasma glucos,72.032||60.171||54.663||54.63||50.654||50.289||46.132||44.942||43.351||40.649||40.469||37.037||36.299||33.427||33.39,0.6,0.6,0.5333333333333333
559,Anal_Bioanal_Chem-4-1-2324126.txt,peptid vpp||method||hydrophil fraction||amino acid||compound||complex mixtur||hilic||analys||at-lin assay||separ||column||identif||activ||min||formic acid||fraction||peptid||ace-inhibit||milk hydrolys||larg number||total activ||total run time,n.r||peptid||fraction||hydrophil peptid||hydrophil fraction||hydrophil ace-inhibit peptid||column||n.m||unretain hydrophil fraction||hilic column||n.r. n.m||hydrophil fraction 5||hplc fraction||acei peptid||peptid EW,82.602||58.388||57.634||50.982||50.605||40.917||40.673||40.109||37.992||35.968||34.415||33.737||32.765||32.455||32.423,0.6,0.4,0.26666666666666666
560,Pediatr_Radiol-3-1-2077923.txt,week||project tract||gestat age||infant||anisotropi||roi||imag||refer valu||studi||valu||patient||fraction anisotropi||adc||correl||diffus tensor||brain||white-matt tract||age||standard||direct||white matter||scan||diffus||signific correl||pyramid tract||dti||diffus tensor imag,tract||white-matt tract||FA||roi||adc||diffus||infant||diffus tensor||tract structur FA adc||diffus anisotropi||preterm infant||diffus tensor imag||white matter tract||white-matt injuri||white-matt develop,40.314||40.215||36.366||33.675||30.318||30.195||28.36||27.462||26.75||25.624||24.402||24.36||23.472||22.75||22.399,0.6,0.6,0.4666666666666667
561,Surg_Endosc-4-1-2292804.txt,path length||motion analysi||expert||studi||resid||plane||point||normal path length||object assess||shortest path||method particip||goal-ori movement||train||retract||cylind||mi perform||assess||phase||analysi||experi||task||group||differ||import||basic mi skill||mi||perform||import measur||signific differ||movement||novic||result,mi||phase||retract phase||novic||retract||path length||mi skill||mi perform||experts’ path length||shorter path length||mi instrument||shortest path||movement||shortest path length||basic mi skill,75.119||65.169||59.058||53.602||52.948||52.221||51.652||43.246||41.047||40.565||40.506||39.879||39.593||39.226||37.244,0.8,0.6,0.6
562,Ann_Biomed_Eng-2-2-1705493.txt,outflow decreas||coronari bed||limit number||flow||low ventricular volum||model||isobar beat||strain||cardiac wall||coronari inflow||volum||increas||pressur||radial wall stress||ventricular wall||cycl||stress||bottom||paramet||fiber||nfa||experiment observ||primari interact||chang||resist||ventricular pressur||intramyocardi pump||decreas||normal physiolog condit||minimum||vessel||intramyocardi pressur||primari relat||paramet sensit analysi,"rm||rm m,r||rm lv||rm r0||rm art,c||rm im||rm ven,c||rm s,a0||rm art,c,min||rm m,f||rm ar||rm f0||rm lv0||rm art,c,max||rm max",202.178||129.097||122.428||114.425||114.425||113.689||113.091||109.09||109.09||107.368||105.264||105.09||103.756||103.756||102.673,0.0,0.0,0.0
563,Environ_Health_Perspect-115-3-1849909.txt,mechan||anim||document||set||similar inhal exposur||case||occup||respons||asthma||subsequ inhal challeng||protect cloth||potenti risk||dermal exposur||studi||polyurethan product||clinic||develop||worker||human||sensit||skin absorpt||childhood||import chemic||health administr||workplac||person protect equip||isocyan||health||potenti||respiratori exposur||product||research||host factor||mdi-ig||isocyan asthma||factor||absorpt||import||exposur||skin||mdi||subsequ develop||occup safeti||immun respons||result,isocyan||isocyan exposur||isocyan skin exposur||isocyan asthma||exposur||isocyan sensit||isocyan respiratori exposur||airborn isocyan exposur||environment isocyan exposur||human isocyan exposur||isocyan exposur assess||sensit skin isocyan||isocyan exposur level||isocyan absorpt||isocyan vapor,291.909||231.766||197.611||194.064||171.623||167.529||161.563||157.938||157.023||155.413||154.866||154.786||154.51||152.313||152.258,0.6,0.3,0.2
564,Pediatr_Nephrol-3-1-1994209.txt,anatom defect||ureter bud||children||structur variat||urinari tract||linkag analysi||kidney||studi||mutat||larg multicentr collabor group||clinic classif||develop||human||defect||form||renal||trait||disord||malform||classif||clinic diagnosi||gene||approach||gene map||clinician||congenit anomali||dysplasia||development disord||diseas||renal agenesi||discoveri||signific discoveri||renal parenchyma||syndrom,dysplasia||kidney dysplasia||renal dysplasia||hypoplasia||kidney hypoplasia||kidney||agenesi hypoplasia||kidney agenesi||renal hypoplasia||renal agenesi||renal||syndrom renal dysplasia||syndrom renal agenesi||primari renal hypoplasia||nonsyndrom renal agenesi,89.472||84.073||81.753||79.898||79.286||78.674||78.156||77.544||76.966||75.224||74.034||67.051||62.698||53.001||52.336,0.2,0.3,0.26666666666666666
565,Pediatr_Nephrol-3-1-2064942.txt,mechan||proteinuria||angiotensin type 1 receptor||glomerulosclerosi||ckd||kidney||low nephron number||mutat||renal diseas||patient||glomerulu||aldosteron||effect||human||increas||spironolacton||abil||receptor||macrophag||key role||cell||therapi||growth factor||mice||result||angiotensin||tubulointerstiti fibrosi||action||low birth weight||interstiti fibrosi||angiotensin receptor blocker||injuri||activ||genet factor||experiment model||sclerosi||podocyt||regress||initi injuri||fsg||function||glomerular hypertens||diseas||acei||progress||fibrosi||cardiovascular diseas,kidney||angiotensin||fogo||kidney fibrosi||kidney diseas||fogo AB angiotensin||diabet kidney||fogo AB||keyword angiotensin angiotensin||end-stag kidney||kidney model||kidney function||glomerular diseas||podocyt||kidney int 39,84.574||64.775||63.351||52.665||52.32||51.345||45.973||44.63||43.184||42.287||42.287||42.287||41.474||40.488||39.924,0.4,0.2,0.2
566,Purinergic_Signal-2-2-2096640.txt,oxid stress||cd39||e-ntpdas||bacteri clearanc,airway||airway clearanc||cystic fibrosi airway||boucher||airway e-ntpdas||picher||human airway||lung||airway epithelium||cystic fibrosi||airway calib||airway homeostasi||airway inflamm||boucher RC||fibrosi,66.158||47.797||44.897||43.914||43.592||42.498||37.902||35.145||34.653||34.266||34.124||33.625||33.079||32.673||31.417,0.0,0.0,0.0
567,Clin_Rev_Allergy_Immunol-3-1-2071970.txt,antibodi||infliximab||patient||rituximab||effect||salivari flow rate||infus||va score||improv||biolog agent||clinic trial||treatment||cell||therapi||autoimmun diseas||promis result||baff||pss patient||pss||II studi||trial||score||result,sjogren ’s||sjogren ’s syndrom||primari sjogren ’s||primari sjogren ’s syndrom||rituximab||sjogren ’s syndrom scand||pss||n.r.||sjögren ’s syndrom||ifn-α||primari sjögren ’s syndrom||rituximab treatment||autoimmun diseas arthriti||malt||rheumatoid arthriti,42.434||37.934||32.547||31.643||30.165||28.451||26.05||24.401||22.43||21.481||20.015||19.561||18.274||18.248||18.005,0.2,0.2,0.13333333333333333
568,Oecologia-4-1-2270366.txt,anim||seed||author||bodi size||model||studi||adult size||intercept||correl||mammal||present||reproduct||egg||scale||empir evid||cold-blood vertebr||variabl||fecund||offspr||present paper||mass||reproduct event||averag||annual cycl||heterotherm||reproduct paramet||weight||terrestri habitat||regress||number||allometr scale||speci||expon||plant||slope,0.0001||reproduct||size||0.0001 1978||rp||seed size||0.0001 0||allometri||cdot||offspr||reproduct mass||0.0001 1979||0.0001 1953||seed||0.0001 1968,59.049||53.632||41.988||39.672||38.923||36.85||34.903||34.693||34.604||33.588||33.267||32.81||32.483||31.713||31.681,0.2,0.2,0.2
569,Ann_Surg_Oncol-4-1-2190341.txt,case||center||neoadjuv therapi||re-explor||studi||patient||pancreat cancer||unresect||initi find||oper||day||analysi||surgeri||reoper||group||tumor||resect||initi oper||distal pancreatectomi||diseas||pancreat surgeri||result,unresect||resect||pancreat resect||initi unresect||unresect patient||initi resect||resect patient||unresect tumor||re-explor||reoper||surgic resect||unresect pancreat ductal adenocarcinoma||resect group||resect rate||reoper pancreaticoduodenectomi,63.17||55.93||45.82||42.315||40.658||38.695||37.038||36.239||33.993||32.678||30.562||28.574||27.965||27.965||26.896,0.4,0.4,0.26666666666666666
570,Neuroradiology-2-2-1592467.txt,respons||intraobserv variabl||astrocyt glioma||mri||glioma||oligodendroglioma||data||studi||seri||patient||oligodendrogli tumour||prognost signific||chemotherapi||volum||grade II oligoastrocytoma||genotyp||tumour||rcbv||pcv chemosensit||pcv||pf||primari tumour||factor||chemosensit||loss||outcom,rcbv||tumour rcbv||high rcbv||1p||19q||low rcbv||rcbv data||1 rcbv||rcbv measur||elev rcbv||oligodendrogli tumour||tumour||oligodendroglioma||nr||high rcbv valu,127.81||91.62||70.981||70.497||69.965||64.624||64.287||63.907||63.905||63.905||55.771||55.429||52.546||48.762||47.321,0.2,0.1,0.26666666666666666
571,Matern_Child_Health_J-4-1-2335294.txt,lead||occup||commun||pregnanc||reproduct toxic||patient||water||worker||reproduct risk||wast site||exampl||site||workplac||health||women||fish||clinician||food||diet||home||hobbi||medicin||exposur||chemic||toxic||environment exposur,environment exposur||exposur||occup exposur||occup||environment hazard||environment exposur histori||environment health||environment medicin||environment contamin||workplac exposur||environment histori||environment risk||environment agent||environment contribut||environment pathway,37.936||33.529||31.492||29.455||29.097||27.076||26.159||25.22||24.917||24.322||23.85||22.507||21.72||21.172||21.172,0.6,0.3,0.2
572,Pflugers_Arch-3-1-1839769.txt,condit||action potenti||hypokalemia correl||critic interv||membran potenti||clinic observ||stimulu||hypokalem heart||neg shift||effect||criteria||refractori||experiment result||tdr||hypokalemia||conduct time||map||arrhythmia||repolar||refractori period||verp||heart||arrhythmogen,90||90 90||90 90 90||25 90 90||normokalem heart 90||90 dens||90 5||3 4 90 90||29 90||lidocain||repolar||normokalem heart 90 diverg||heart||normokalem heart||normokalem heart fig. 7 90,71.934||71.934||71.934||47.956||41.465||40.449||36.21||36.006||35.967||35.463||35.127||32.076||31.409||26.23||25.221,0.0,0.0,0.13333333333333333
573,Purinergic_Signal-4-1-2245999.txt,adenylyl cyclas||level||terminu||intern||studi||adenosin||effect||human||amino acid||receptor||arrestin||adenosin receptor||grk||specif||phosphoryl||cell||gpcr||desensit||stimul||protein||lipid raft||agonist exposur||caveola||addit||function||result,2A||2A 2B 2A 2A||2A receptor||2B||2A 2B adenosin receptor||2B receptor||70 2A 2A||receptor||2B 2B 2B 2B 83||2B 2B 2B 2B 86||2A 1 receptor||adenosin receptor||2B 2B 2B 81||62 2A 2A 2A 3 1||adenosin,177.845||167.308||144.322||135.697||130.976||123.248||118.563||110.799||108.557||108.557||107.795||105.181||101.772||100.471||99.564,0.0,0.1,0.2
574,J_Chem_Ecol-4-1-2266969.txt,multi-speci herbivori||volatil||predatori mite||effect||test||plant speci||compound||gc-m||herbivori||natur enemi||treatment||feed||cucumb||volatil blend||min||lima bean||emiss||cold trap||spider mite||speci||thermodesorpt cold trap setup,S. exigua||S. exigua T. urtica S. exigua||spodoptera exigua||S. exigua T.||S. exigua S.||plant||T. urtica||plant volatil||volatil||spodoptera exigua S.||T. urtica S.||T. plant||T.||tetranychu urtica||induc plant volatil,91.535||86.339||80.653||79.731||77.757||76.547||75.949||74.347||72.147||70.503||67.366||66.335||56.124||56.01||54.453,0.0,0.1,0.06666666666666667
575,Mol_Biochem_Parasitol-1-5-1906845.txt,polv,var||var var var var||var var var||var P. falciparum var||var gene||fig. 2 var var||plasmodium falciparum var gene||plasmodium falciparum 3d7 var gene||var gene divers||plasmodium falciparum plasmodium falciparum||plasmodium falciparum||plasmodium falciparum var gene transcript||var gene transcript||fig. 1 var supplementari inform var||plasmodium,121.05||121.05||121.05||72.764||66.442||63.172||56.059||46.118||45.887||45.677||45.677||45.302||45.052||43.782||43.762,0.0,0.0,0.0
576,Pflugers_Arch-3-1-2040175.txt,fiaf||inflamm||level||vegf||adipokin||adipocyt||effect||glut||obes||adipos tissu||normox condit||hypox condit||white adipos tissu||express||differenti||present studi||cell||hypoxia||gene||product||protein||inflammatori respons||mif||leptin||mrna||adiponectin||result,hypoxia||adipocyt||2 2 2||2 2||2||hif-1α||adipokin||adipos factor hif-1α hypoxia||trayhurn||placent hypoxia||hypoxia induc||32 2 2 2 2||human adipocyt||mild hypoxia||adipocyt differenti,47.747||42.824||30.163||30.163||30.163||29.328||28.459||25.807||25.385||25.285||25.131||24.131||24.008||23.873||23.691,0.4,0.3,0.2
577,Doc_Ophthalmol-3-1-1784540.txt,time||grey hexagon||studi||valu||xlr||patient||femal||situ inversu||amplitud||test||retin dysfunct||eye||control||stimulu array||carrier||subject||averag control subject||mferg||hexagon||x-link retinoschisi||implicit time||segment||area,x-link retinoschisi||carrier||xlr carrier||x-link retinoschisi carrier carrier age||hexagon||xlr||x-link retinoschisi Br||juvenil retinoschisi||OU||oblig carrier||x-link retinoschisi kim linda||grey hexagon||carrier state||sex-link juvenil retinoschisi||multifoc erg,46.511||44.535||38.681||36.418||35.379||32.827||31.604||29.418||26.26||23.944||23.736||22.661||22.267||21.54||21.38,0.6,0.4,0.3333333333333333
578,J_Comput_Aided_Mol_Des-4-1-2311385.txt,report||evalu||inform||set||goal||method||binding-mod predict||field||test||paper||requir||practic applic||result||recommend||area||special issu||data||prepar||statist evalu||statist report,ligand||predict ligand||predict||affin||issu predict||pose predict||set||comput method||affin predict test||test ligand||doi||ligand inform||method||binding-mod predict||activ ligand,27.764||25.987||24.21||21.872||18.19||17.44||17.104||17.091||17.073||16.451||16.328||16.311||16.283||15.315||15.249,0.0,0.1,0.2
579,Curr_Genet-4-1-2413079.txt,report||luciferas imag||cultur||bioluminesc||luminesc imag||vivo||express||signal||activ||cell||luminesc||arginin||assay sensit,chlamydomona||chlamydomona chlamydomona||g-luc chlamydomona||g-luc chlamydomona gaussia chlamydomona chlamydomona chlamydomona||g-luc g-luc chlamydomona 5 g-luc||chlamydomona reinhardtii||hsp70a g-luc hsp70a g-luc||chlamydomona gaussia||g-luc chlamydomona strain||chlamydomona g-luc gaussia C.||2008 chlamydomona reinhardtii chlamydomona gaussia||g-luc WT hsp70a r-luc hsp70a g-luc||g-luc C.||chlamydomona sourcebook||chlamydomona mitochondria,205.4||205.4||203.449||182.253||161.978||147.957||140.113||137.911||136.991||121.736||115.215||110.059||105.561||105.072||103.277,0.0,0.0,0.0
580,Pharm_World_Sci-3-1-2082656.txt,treatment regimen||attempt||psycholog reactanc||respons||intervent strategi||freedom||studi||physician behaviour||patient||reactanc theori||reactanc||decis support system||recommend||intervent||evid||behaviour||treatment||clinic care recommend||pharmacist||care||action||factor||sens||medic regimen||medic review||medic practition||physician||decis,reactanc||psycholog reactanc||reactanc theori||reactanc potenti||psycholog reactanc theori||physician||fenton M. reactanc||keyword pharmacist physician psycholog reactanc medic||recommend||pharmacist||hong ’s psycholog reactanc scale||reactanc 20 20 21||physician non-compli||physician behaviour||14. fogarti J. reactanc theori,133.291||80.364||70.587||67.875||56.204||51.777||46.103||45.344||40.95||40.478||34.117||33.323||30.517||29.86||29.708,0.6,0.6,0.4666666666666667
581,Ann_Surg_Oncol-4-1-2277449.txt,retrograd outflow||ihhp||respons||time||isol hepat perfus||hepat toxic||concentr||perfus circuit||hepat arteri||retrograd||studi||simpl procedur||median||leakag||patient||perfus||tumor respons||treatment||oper time||partial respons||portal vein||pharmacokinet||heart-lung machin||progress diseas||month||liver||system melphalan concentr||blood loss||surviv||melphalan||hepat metastas||bile duct necrosi||present seri||stabl diseas||circuit||progress||ihpp procedur,perfus||hepat perfus||melphalan||isol hepat perfus||liver perfus||hypox hepat perfus||perfus retrograd||hepat metastas||perfus circuit||perfus circuit perfus set||ihhp||perfus time||stabl perfus||safe perfus||total perfus,74.828||68.041||56.348||55.481||53.661||49.831||48.639||42.968||42.567||39.991||39.445||39.391||38.643||38.249||37.845,0.6,0.5,0.4
582,Virchows_Arch-3-1-1888717.txt,colorect carcinoma||case||tissu microarray||reactiv cell||core||metastat site||studi||patient||correl||concord egfr statu||section||metastas||tissu section||site||egfr-posit cell||slide||express||tma||epiderm growth factor receptor||egfr statu||crc||tumor||number||primari crc||egfr||result,egfr||egfr pharmdx||egfr express||egfr immunohistochemistri||egfr statu||egfr egfr immunohistochemistri 1||egfr immunostain||egfr immunoreact||crc||metastas||result egfr express||tma||concord egfr statu||tissu section egfr reactiv||primari crc,92.01||53.599||51.892||50.127||49.292||48.205||48.091||47.243||35.319||35.309||34.594||34.586||33.761||33.428||32.35,0.4,0.4,0.4666666666666667
583,J_Chem_Ecol-4-1-2239252.txt,specialist herbivor||insect||plant defens||bar-typ plant||effect||amino acid level||egg||amino acid||bar-typ||leav||glucosinol concentr||leaf||sugar||generalist||chemotyp||experi||oviposit||herbivor||glucosinol||perform||prefer||larva||plant,brassica||M. brassica||J. brassica||pieri brassica||mamestra brassica||M. brassica P.||M. pieri brassica||oviposit P. rapa M. brassica brassica||chemotyp M. brassica||brassica oleracea||M. brassica larva||M.||plasmodiophora brassica||M. brassica P. rapa P.||brassica napu,176.15||134.616||123.499||107.755||107.22||105.799||102.864||102.119||98.015||97.521||94.458||93.083||92.376||90.749||90.7,0.0,0.0,0.0
584,Photosynth_Res-3-1-1779624.txt,method||enzym prepar||reduct PP||rate||octulos phosphat||assay||carbon||phosphotransferas reaction||photosynthet carbon reduct cycl||chloroplast||label||leav||calvin cycl||reaction||reaction sequenc||pga||enzym||PT enzym||phosphat||activ||intact||sep||spinach chloroplast||mg chl||octulos||spinach||sugar phosphat||non-oxid segment||result,14||14 14||2 14 14 14 14||2 14 14 14 14 2||14 1957 14 14 14 14||2 14||2 14 2 14||2 14 14 2||14 2||hbox||dhap 14 14 14||14 14 1 14||2 14 2||2 2 14||2 14 1 14 2 14,146.78||146.78||134.809||126.828||122.692||116.852||116.852||116.852||116.852||115.317||114.204||111.218||106.876||106.876||103.12,0.0,0.0,0.0
585,Pediatr_Nephrol-3-1-1989764.txt,attent||chronic kidney diseas||group deficit||infant||deficit||ckd||mri||data||studi||norm popul||effect||develop||frequenc||cognit function||nervou system||kidney diseas||esrd||kidney transplant||control||cognit||age||popul||literatur||transplant||cognit deficit||dialysi||diseas||function||children,ckd||children||children cognit||IQ||33 children||dialysi||ckd modal||cognit IQ||transplant||kidney transplant||mild-to-moder ckd||8 children||cognit||transplant-depend children||age cognit transplant,36.014||33.18||26.503||25.137||23.374||23.237||22.718||22.481||22.298||21.537||20.239||19.897||19.826||19.731||18.734,0.4,0.5,0.4
586,Osteoporos_Int-3-1-1915640.txt,femor neck width||placebo||synergist effect||studi||year||fractur risk||total||femor neck||clinic trial||dxa-bmd||intak||dose||postmenopaus women||treatment||osteocalcin||non-osteoporot women||day||strength||clinic endpoint||women||age||fnw||menaquinon||bmc||group||bone||osteoporosi||bone loss||vitamin||result,mk-4||bone||bone vitamin||vitamin||bone strength||dxa-bmd||hip bone||fnw||bone miner||bone geometri||strength||mk-4 group||total bone strength||group hip bone strength||bone strength indic,63.252||58.903||53.03||47.158||46.709||45.997||45.659||40.246||39.801||35.629||34.515||34.284||32.822||32.788||32.275,0.4,0.4,0.3333333333333333
587,Transgenic_Res-4-1-2268725.txt,gene||skin||mice||periton lavag||bac||mast cell||eyfp||transgen mice||cre||cell,mast cell||cre||mcpt5-cre||cre mcpt5 cre||skin mast cell||periton mast cell||mast cell lineag||mcpt5 cre||mucos mast cell||mast cell gate||mast cell biolog||mast cell involv||mast cell develop||galli SJ mast cell||mcpt5,77.141||58.662||58.592||54.297||53.816||53.166||52.445||52.114||51.871||51.866||51.842||51.428||51.428||45.964||45.566,0.4,0.2,0.13333333333333333
588,Arch_Dermatol_Res-3-1-2064945.txt,role||find||eosinophil||pathogen effect||mast cell degranul||model||neutrophil||develop||human||neutrophil infiltr||cell||autoimmun diseas||hemidesmosom||mice||lesion skin||extracellular matrix protein||blister fluid||experiment BP||human BP||autoantibodi||diseas||pathogen epitop||inflammatori cell,pemphigoid||bullou pemphigoid||bullou pemphigoid autoantibodi||human bullou pemphigoid||autoimmun bullou pemphigoid||bullou pemphigoid antigen||experiment bullou pemphigoid||bullou pemphigoid autoantigen||bullou pemphigoid cdna||bullou pemphigoid 180||bullou pemphigoid Br||bullou pemphigoid patient||bullou pemphigoid arch dermatol||pemphigoid antigen||pemphigoid antibodi,176.205||173.071||129.603||123.559||119.7||119.508||118.507||118.211||116.687||116.204||115.74||115.391||99.394||94.293||92.438,0.0,0.0,0.0
589,J_Biol_Inorg_Chem-3-1-2099461.txt,formaldehyd oxidoreductas||reaction||high concentr||pre-steady-st data||substrat||ferredoxin||benzyl viologen||visibl spectrum||enzym||concentr||singl broad line||substituted-enzym mechan||data||electron acceptor||valu||wavelength||formaldehyd||pre-steady-st kinet,text||formaldehyd||rightleftharpoon||formaldehyd oxidoreductas||max formaldehyd||prime||total formaldehyd||free formaldehyd||formaldehyd inhibit||P. furiosu formaldehyd oxidoreductas||P. furiosu formaldehyd oxidoreductas R.||oxidoreductas||formaldehyd oxidoreductas tri tri||keyword tungsten formaldehyd oxidoreductas pyrococcu furiosu||ferredoxin,87.308||78.221||55.303||53.804||47.444||46.745||39.111||39.111||39.111||37.685||30.148||29.386||28.461||27.272||26.646,0.4,0.2,0.2
590,Eur_J_Nucl_Med_Mol_Imaging-3-1-2121116.txt,phase histogram||cardiac cycl||substanti LV dyssynchroni||studi||patient||histogram bandwidth||interventricular dyssynchroni||LV dyssynchroni||correl||inform||heart failur||gmp||tdi||gate spect||phase analysi||assess||gate myocardi perfus spect||analysi||higher valu||LV segment||tri-plan tissu doppler imag||crt implant||kurtosi||crt||good correl,dyssynchroni||LV dyssynchroni||LV||substanti LV dyssynchroni||LV dyssynchroni assess||baselin LV dyssynchroni||studi LV dyssynchroni||dyssynchroni assess||LV dyssynchroni paramet||interventricular dyssynchroni||intraventricular dyssynchroni||gmp versu LV dyssynchroni||tri-plan tdi||left ventricular dyssynchroni||tdi,132.588||112.009||91.429||80.461||80.376||75.027||74.951||74.85||74.672||70.063||69.917||68.751||58.31||53.045||50.361,0.4,0.3,0.26666666666666666
591,J_Affect_Disord-1-5-1894757.txt,prospect studi||children||infant||mother||birth||pregnanc||studi||depress||year||earli identif||rural sub-district||life event||difficulti||persist||debt||prolong depress||preval rate||event||countri||psycholog symptom||social support||postnat period||item||women||trimest||persist depress||maximum score||month||subject||depress women||factor||famili||pakistan||infant growth||ladi health worker||depress disord||postnat depress||postnat year||outcom,depress||postnat depress||depress mother||persist depress||postpartum depress||matern depress||depress women||prenat depress||persist postnat depress||depress disord||antenat depress||depress symptom||prolong depress||clinic depress||earli postnat depress,104.33||70.784||68.748||65.948||64.686||57.103||57.003||56.9||56.378||55.289||55.03||54.414||52.965||52.165||47.771,0.6,0.5,0.4
592,Oecologia-3-1-2039789.txt,total biomass product||main stolon||main effect||defens induct||respons||time||measur anova||induct||competit||petiol||competit tray||leaf tissu||studi||effect||leaf area||rel biomass alloc||stolon||adapt plastic hypothesi||dri mass||trait||express||leav||clonal plant||cost||damag||defens||leaf||asymmetr competit||experi||resist||herbivor||leaf area loss||tray||perform||phenotyp||area||leaf dri mass||petiol dri mass||benefit||ramet||plant||result,ramet||plant||stolon||cost||induc ramet||clonal plant||uninduc ramet||induc plant||benefit plant||induc plant defens||uninduc plant||youngest ramet||plant genotyp||petiol||interconnect ramet,84.414||70.197||66.776||58.844||58.26||57.692||52.992||51.152||50.28||48.413||45.883||45.234||44.824||44.722||44.073,0.8,0.5,0.4
593,J_Med_Internet_Res-5-4-1550575.txt,search rank||search engin||search term||studi||correl||search effici||user||site||health inform||web site||page||web||smoke cessat||direct relev||result||link densiti||characterist||internet||teen||search||presenc||posit||number||web-sit characterist checklist||popular search site||googl||posit rank||link||simpl web search||teenag,site||search site||search||web site||web search||popular search site||4 search site||web site search term||search site url||favorit search site||1 search site||web||quit-smok web site||web site url||page-analysi web site,99.254||93.418||87.582||79.549||73.713||67.164||64.37||64.351||63.551||63.007||62.545||59.844||55.051||54.305||54.042,0.6,0.4,0.3333333333333333
594,Int_J_Colorectal_Dis-4-1-2386750.txt,colon cancer||oscc||time||case||radial margin||bloc resect||studi||patient||hemicolectomi||colon||laparoscop surgeri||middl colic vessel||altern||convers||transvers colon||laparoscop resect||middl colic arteri||statist differ||anterior resect||local||lymph node||oncolog qualiti||laparoscopi||proxim resect margin||surgeri||group||tumor||differ||long-term analysi||number||laparoscop approach||splenic flexur||patholog outcom||tcc,laparoscop||colon||transvers colon||colon cancer laparoscop||laparoscop resect||laparoscop transvers colon cancer resect||transvers colon cancer||laparoscop transvers colon cancer surgeri||laparoscop surgeri||colon cancer||colon resect||laparoscop lymph||laparoscop colorect resect||laparoscop versu||laparoscop colecotomi,93.176||84.933||76.862||71.332||63.287||63.237||63.203||62.98||62.645||60.409||59.166||54.05||52.677||48.768||48.184,0.6,0.5,0.3333333333333333
595,Plant_Foods_Hum_Nutr-4-1-2413119.txt,ast activ||placebo||anim||liver damag||noni||placebo pretreat||noni juic||alt||protect effect||experi||liver||rat||group,noni||noni juic||noni fruit||tahitian noni||noni juic pretreat||noni fruit juic||4||4 4||juic||noni compon||noni control||2008 4 4 4 4||4 4 4 exposur||4 4 arrow||vitro 5 4 4 4 4,83.697||63.238||45.552||45.332||44.691||44.627||44.272||44.272||42.779||41.848||41.848||36.056||33.559||30.869||29.515,0.4,0.2,0.13333333333333333
596,J_Med_Internet_Res-4-2-1761932.txt,type||survey research||questionnair||commun||inform consent||databas||studi||patient||site visitor||qualit research||inform||electron public||electron one-to-on interview||exampl||clinic trial||technic issu||web||select bia||research||result||confidenti||data collect||materi||type 2 public||due emphasi||ethic||issu||trial databas||public||survey||particip||peopl||newsgroup||e-mail||internet,research||survey research||internet survey research||internet||internet survey||survey||web survey research||web survey||medic internet research||web||web-bas survey||e-mail survey||health survey research||qualit research||research particip,66.396||63.347||63.26||63.085||61.691||60.298||56.802||52.005||44.816||43.712||43.683||43.634||43.196||40.485||40.183,0.6,0.5,0.4
597,Eur_J_Nucl_Med_Mol_Imaging-3-1-1914225.txt,non-invas detect||target||case||imag||model||patient||strategi||molecular imag||annexin A5||process||vulner plaqu||necrot cell||lesion||apoptot program||apoptot macrophag||cell||apoptosi||environ||death||cell suicid||atherosclerot lesion||cardiovascular diseas||caspas cascad||non-invas imag||pet||caspas||plaqu||clinic studi||detect||vivo||result,apoptosi||99m||apoptosi imag||molecular imag apoptosi||imag||apoptosi detect||macrophag apoptosi||cardiomyocyt apoptosi||apoptosi synaptotagmin||cvd apoptosi||cardiovascular apoptosi||99m 99m 48 99m tc-c2a-gst||apoptosi signal||apoptosi wolter||apoptosi constitut,91.205||76.069||74.583||58.322||57.961||53.281||51.066||50.203||50.139||48.691||47.992||46.429||46.368||46.339||45.603,0.4,0.2,0.13333333333333333
598,Skeletal_Radiol-3-1-1934928.txt,mechan||fat signal||radiograph||spine||CT imag||low signal||imag||mri||vertebr bodi||patient||disc||neural dysfunct||periost apposit||epidur fat||increas||osteoclast activ||signal||cord compress||pain||intervertebr disc||signal characterist||facet||activ||clinic symptom||spinal stenosi||bone||neural||spinal involv||diseas||vertebra,paget||paget diseas||paget facet||paget complic||paget enlarg||paget arthriti||paget t11||paget ’s diseas||paget L3 vertebra||paget spinal stenosi||paget vertebr ankylosi||paget ’s diseas periost||monostot paget ’s diseas||lytic paget ’s diseas||osteolyt paget ’s diseas,261.491||158.53||137.249||134.29||133.451||132.266||132.073||126.063||106.384||102.629||100.304||97.172||96.764||96.378||95.695,0.0,0.0,0.0
599,Environ_Manage-3-1-2094719.txt,swc||project withdraw||soil manag practic||project||knowledg||practic||farmer-bas extens||bolivia||strategi||solid foundat||develop||farmer contest||wide-scal impact||rural develop||rural poverti||sustain||tool||farmer||impact||cl||widespread sustain result||local institut||swc practic||rural villag||approach||train||sustain develop||paper||zimbabw||conserv leader||villag||stone line||mainten||activ||natur resourc manag||famili||group||bolivian mountain valley||contest||ex-post evalu||order||train activ||particip rate||particip||extens||experiment||institut level||farmer group||farmer-to-farm train,swc||swc contest||contest||swc practic||swc extens||swc contest mainten||contest farmer||farmer contest||success swc contest||villag||swc activ||replic swc practic||execut swc practic||improv swc practic||swc practic work,267.692||227.967||188.242||182.985||172.938||157.106||154.913||154.913||152.549||145.394||137.323||128.736||125.43||123.569||122.546,0.6,0.5,0.3333333333333333
600,J_Plant_Res-3-1-2039807.txt,consequ||cell wall||carbohydrate-bind modul||modul||sampl||wall||cellulos||high express||cell wall modif||acid hydrolysi||express||plant develop||cell type||plant||tobacco||control||tobacco cell wall||tissu||cell wall structur||primari||prolong juvenil||polysaccharid||wall loosen||singl cbm||xylem cell||layer||stem||membran||cbm||result,plant||cbm||wall||cellulos||plant cell wall||plant cell||transgen plant||transform plant||plant growth||plant breed||plant height||plant cell wall modif||control plant||plant develop||matur plant,70.046||54.118||48.739||48.218||45.469||43.834||42.389||38.816||37.69||37.38||37.01||36.372||36.166||35.75||35.749,0.8,0.4,0.3333333333333333
601,Exp_Eye_Res-2-1-2394572.txt,anim||onl||intravitr inject||administr||find||time||outer||retin transplant||greater number||studi||photoreceptor||disrupt||effect||section||olm||integr||dose||signific increas||eye||cell||retina||control||adult mous||mice||normal||transplant||subretin space||aaa administr||mous||recipi||number||segment layer||layer||subretin inject||müller cell||cell integr||photoreceptor cell,aaa||al.||olm||photoreceptor||olm disrupt||olm karlsen||olm integr||photoreceptor transplant||transplant photoreceptor||aaa inject||aaa administr||outer||integr photoreceptor||photoreceptor integr maclaren||photoreceptor cell,95.953||95.72||92.306||80.881||70.171||66.053||61.636||59.564||59.564||59.52||56.634||56.123||55.924||51.095||50.668,0.4,0.2,0.3333333333333333
602,Int_J_Hematol-4-1-2276240.txt,multi-centr survey||case||indic||efficaci||favor respons||patient||criteria||investig||clinic evid||clinic trial||treatment||advers event||invas fungal infect||malign hematolog diseas||voriconazol||fungal infect||prophylaxi||activ||diseas||toxic||ifi||antifung,voriconazol||triazol voriconazol||oral voriconazol||voriconazol vehreschild jörg||ifi||fungal infect||averag initi voriconazol dose||oestmann j-w voriconazol versu amphotericin||antifung||amphotericin||ifi 57||invas fungal infect||averag initi voriconazol mg||4 tabl 4 voriconazol dose||liposom amphotericin,90.471||51.444||46.634||31.967||31.046||27.802||24.319||24.113||24.037||23.574||23.251||23.206||23.205||20.746||19.885,0.4,0.4,0.3333333333333333
603,J_Abnorm_Child_Psychol-3-1-1915590.txt,co-occurr||hostil reactiv parent||parent psychopatholog||high level||children||behavior||mother||problem||sampl||physic aggress||model||studi||prenat smoke||impuls||scale||comorbid||matern depress||signific||low||analys||smoke||hyperact||item||age||trajectori||associ||parent||earli childhood||group||famili||tremblay||high||neg parent||adhd||contrast||control variabl,PA||smoke||chi||matern smoke||prenat smoke||matern prenat smoke||matern prenat||E. prenat smoke||PA moder PA high PA||child||PA trajectori||L. matern smoke||high PA||J. matern smoke||2 matern prenat smoke,71.936||67.582||60.083||58.437||57.826||54.981||48.68||47.249||46.159||45.813||45.45||43.838||43.01||42.824||41.254,0.4,0.2,0.13333333333333333
604,Matern_Child_Health_J-2-2-1592150.txt,pregnanc||preconcept care||hiv,hiv||perinat hiv||perinat hiv transmiss||hiv infect||perinat transmiss||transmiss||hiv test||hiv screen||human immunodefici viru||routin hiv||zidovudin||hiv treatment||immunodefici virus-1||perinat human immunodefici viru test||perinat care,40.722||34.518||30.846||26.361||25.909||23.503||23.33||22.045||21.216||20.85||20.721||20.361||20.306||19.58||18.826,0.2,0.1,0.06666666666666667
605,Histochem_Cell_Biol-4-1-2248607.txt,vesicl||role||earli biochem approach||granul||isoform||neuroendocrin tissu||data||hypothesi||msg||molecular tool||isg||prohormon convertas||assay||observ||chromogranin||process||constitutive-lik secret||matur||import issu||secretori granul||cell type||cell||zymogen granul||biochem||neuroendocrin cell||homotyp fusion||protein||mice||golgi complex||experi||tgn||secretori pathway||biochem approach||ph||pc||immatur secretori granul||secret||size||phenotyp||special cell||pathway||addit||hormon process||membran||physiolog pH,secretori||secretori granul||granul||neuroendocrin secretori granul||secretori granul matur||secretori granul biogenesi||immatur secretori granul||pituitari secretori granul||secretori granul protein||secretori granul format||endocrin secretori granul||acth-contain secretori granul||secretori granul malform||secretori cell||secretori vesicl,188.23||177.019||165.807||128.667||128.301||127.202||124.335||122.972||121.118||119.87||119.69||118.978||118.013||111.426||101.126,0.4,0.3,0.2
606,Bioinformation-1-2-1891631.txt,medicin||aromat plant||india||databas||folklor||plant,databas||kashmir||medicin||medicin plant||plant||aromat plant||aromat plant jammu||kashmir india||jammu||web databas||medicin plant speci||folklor||databas interfac||india||folklor background medicin plant,24.817||21.154||20.366||19.724||19.082||18.823||18.376||17.515||17.482||14.384||14.336||14.206||14.147||13.876||13.721,0.6,0.4,0.4
607,Int_J_Legal_Med-3-1-2039830.txt,age interv||socioeconom statu||method||complet fusion||CT scan||individu||data||model||studi||hdi||medial epiphysi||year||effect||femal||variabl||sex||signific||examin||clavicl||slice thick||fusion||age||dri bone specimen||fusion statu||differ||probabl||ethnic||result,text||clavicl||matur clavicl||fuse clavicl||clavicl fusion||medial clavicl||clavicl ossif||clavicl examin||clavicl indian||age||radiolog clavicl examin||matur clavicl model independ||probabl||age 0.000||skelet age,112.913||108.291||67.082||61.596||61.366||60.184||59.712||57.556||55.932||51.381||38.371||35.113||33.804||32.716||28.035,0.2,0.2,0.2
608,Biochim_Biophys_Acta-1-5-2212780.txt,mechan||cx43||IP||glycogen synthas kinas 3||pten||measur||role||diazoxid||connexin43||data||ischaemia||mediat||reactiv oxygen speci||mitochondri permeabl transit pore||kinas||effect||atp||ro format||sensit||mct1||increas||volum||pkc||complex||reperfus||recoveri||abil||gsk3||evid||channel open||phosphoryl||pharmacolog agent||calcium||csa||ro level||cardiac myocyt||cyp||respiratori chain||open||pkg||mitochondri atp-depend potassium channel||apoptosi||product||pore||oxid stress||protein||techniqu||adenin nucleotid||surviv kinas cascad||vdac||cyclophilin||sfa||ant||experi||mitochondria||calcium overload||activ||light||respiratori chain inhibitor||ro product||membran||ampk||decreas||mitok||note||adenin nucleotid translocas||sur||ro||pathway||pharmacolog||heart||mitochondri protein||mptp||ischaem precondit||monocarboxyl transport 1||protect,mitochondri||precondit||mitochondri permeabl||mitochondri k-atp||mitochondri k-atp channel||mitochondri ca2||mitochondri cyclophilin||mitochondri uncoupl||mitochondri matrix||mitochondri oxid||mitochondri permeabl transit||mitochondri cx43||mitochondri membran||mitochondri calcium||mitochondri potassium channel,244.153||180.097||161.406||152.848||135.053||132.313||131.097||130.806||129.025||128.186||127.851||126.079||125.699||125.202||124.102,0.0,0.0,0.0
609,Anal_Bioanal_Chem-4-1-2413088.txt,flow cell||flow||concentr||solut composit||bife||electrochem detect||electrod||increas||maximum respons||signal||adsorpt||potenti||solut||flow system||sensor||analysi||injection-mould electrochem micro-flow cell||cadsv||height||carbon fibr||dimethylglyoxim||film||peak||mercuri film||sampl solut||in-lin,electroanalysi||ogorevc||hočevar SB ogorevc||electroanalysi 15:392||electroanalysi 14:1707||electroanalysi 14:112||electroanalysi 16:1745||electroanalysi 16:1616||electroanalysi 15:1859||electroanalysi 14:1359||electroanalysi 14:192||electroanalysi 13:13||electroanalysi 18:823||electroanalysi 18:223||electroanalysi 18:59,87.229||62.275||45.432||45.097||45.097||45.097||45.097||45.097||45.097||45.097||45.097||45.097||45.097||45.097||45.097,0.0,0.0,0.0
610,Mol_Immunol-1-5-1994210.txt,role||thymu||real-tim pcr||mtec||epitheli cell||air protein||data||studi||thymocyt||microarray data||air||effect||develop||express||signal||antigen||tra||cell||thymic epitheli cell||gene||normal develop||lymph node||autoimmun regul||autoimmun||mous||central toler||result,air||tra||air express||thymic||tra express||thymic express||air induc tra express||al.||air KO||air over-express||air gene||air het||air defici||abstract air||air result,160.803||131.649||116.323||114.251||101.746||93.047||91.46||89.609||87.427||86.976||82.967||81.197||80.925||80.401||80.401,0.4,0.2,0.13333333333333333
611,Plant_Mol_Biol-3-1-1805039.txt,respons||flag||microarray||high-salin stress||cold||studi||rice||motif||full-length cdna sequenc||flag leaf||express pattern||organ||express profil||high-salin||promot||express||leav||rehydr||stress||promot region||gene||salin||genom express||analysi||experi||shoot||panicl||group||regulatori element||drought||bind protein||plant||result,drought||drought stress||stress||high-salin stress||plant drought||high-salin||high-salin stress gene||drought stress 2||drought toler||drought treatment||gene||high-salin stress 2||high-salin stress vari||rice gene||panicl gene,186.765||151.875||116.985||115.243||114.261||113.5||106.485||101.25||95.882||93.382||88.971||76.828||76.828||74.619||71.583,0.6,0.4,0.3333333333333333
612,Matern_Child_Health_J-2-2-1592157.txt,alcohol consumpt||major health risk||preconcept||behavior||indic||infant health||birth||pregnanc||data||state||folic acid||effect||preconcept period||risk||hiv test||inform||hiv transmiss||brfss||unit state||intervent||health||preconcept care||percentag||women||alcohol||insur||advers pregnanc outcom||factor||opportun||risk factor||current smoke||birth defect||hiv||outcom,women||pregnant women||preconcept women||preconcept||2004 women||2004 brfss preconcept women||non-prengn women||million women||individu women||pregnanc||pregnant women mmwr 2001 50||preconcept period||preconcept intervent||brfss||pregnanc statu women 18,66.004||62.068||55.549||45.094||35.604||35.068||34.603||33.555||33.002||28.26||26.612||26.177||25.596||23.969||23.812,0.4,0.3,0.3333333333333333
613,Exp_Brain_Res-3-1-1914290.txt,attent||visual depriv||postur sway||cop||valu||local stabil||amount||effect||sagitt plane||depend variabl||largest lyapunov expon||increas||correl dimens||plane||variabl||surrog data||sampl entropi||analys||dimension||regular cop trajectori||eye||postur control||control||center-of-pressur||cognit dual task||task||dual task||task difficulti||postur stabil||cognit invest||order||decreas||regular||postur||sway-path length||particip||intern focu||expon||dynam structur||result,postur||postur task||postur sway||postur control||postur variabl||postur stabil||upright postur||postur recoveri||human postur||postur sway regular||postur task difficulti||human postur sway||dual-task postur control||postur control brain||ineffect postur control,164.479||106.369||100.945||94.018||89.159||87.051||84.825||82.709||82.639||78.182||73.07||67.563||67.084||65.433||63.688,0.6,0.4,0.26666666666666666
614,Virchows_Arch-3-1-1888722.txt,cancer||case||microsatellit analysi||residu cancer||figur||block||rp||atyp foci||prostat tissu||biopsi core||core||posit biopsi||studi||patient||section||RP specimen||slide||paraffin block||dna||dna specimen analysi||ident||incid||deeper section||specimen||biopsi||vanish cancer||residu prostat cancer||prostatectomi||dna analysi||number||prostat cancer||radic prostatectomi||addit||step,prostatectomi||prostatectomi specimen||radic prostatectomi||pt0 radic prostatectomi||radic prostatectomi specimen||prostat||pt0||prostatectomi tissu||biopsi||specimen||prostat cancer||prostatectomi sampl||prostatectomi area||total prostatectomi||radic retropub prostatectomi,92.263||70.718||67.891||63.822||61.651||61.312||55.684||51.157||49.369||49.172||48.65||48.34||46.59||46.132||46.027,0.4,0.4,0.3333333333333333
615,Neuroradiology-3-1-2082067.txt,avm||onyx||embol agent||flow||pial fistula||detach coil||venou side||shunt||liquid embol agent||high flow||AV shunt,shunt||AV shunt||high-flow AV shunt||high-flow shunt onyx||larg high-flow shunt||larg high-flow AV shunt||high-flow intracrani arterioven shunt||larg AV shunt||fistula||pial fistula||pial fistula avm||high-flow arterioven fistula ajnr||AV||onyx||avm,45.773||30.601||29.027||28.593||24.916||22.544||22.182||21.431||20.93||17.344||16.271||15.741||15.429||14.125||14.125,0.4,0.3,0.3333333333333333
616,J_Comput_Aided_Mol_Des-3-1-2039848.txt,aldosteron synthesi||backbon atom||method||cyp11b1||activ site||isoform||model||cyp11b2||aldosteron||select||substrat bind||helix||hydroxyl||steroid||natur substrat||structur||amino acid||region||similar||protein-inhibitor interact||cell||templat structur||hydroxyl group||protein||inhibitor potenc||molecular dynam||metyrapon||steric fit||carbon atom||fadrazol||crystal structur||substrat||interact||molecular dock||hydroxyl distanc||inhibitor||result,alpha-helix||hcyp11b2||cyp11b2||cyp11b1||hcyp11b1||hcyp11b2 model||cyp101||fadrazol||helix||hcyp11b1 model||cyp11b2 isoform||cyp11b1 isoform||isoform cyp11b1||alpha-helix B′||cyp101 structur,38.106||36.475||35.219||34.455||30.863||29.981||29.784||28.057||27.769||27.175||27.048||26.666||26.666||25.406||24.84,0.4,0.4,0.26666666666666666
617,Virchows_Arch-4-1-2335297.txt,type||cancer||follow-up||case||contralater breast||flat epitheli atypia||carcinoma||studi||atypia||patient||dci||epitheli atypia||descript criteria||lesion||tubular carcinoma||adh||subsequ cancer||classif||fea||ductal carcinoma||median follow-up 160 month||lobular neoplasia||atyp ductal hyperplasia||biopsi||initi diagnosi||high slide rate||microcalcif||diagnosi||malign||breast,atypia||breast||breast biopsi||epitheli atypia||atypia adh||biopsi epitheli atypia||cytolog atypia cytolog atypia||biopsi||breast cancer||cancer breast||keyword breast epitheli atypia lobular||breast core||lobular hyperplasia||stereotact breast biopsi||atyp lobular hyperplasia,106.928||84.395||72.355||71.476||70.751||67.756||62.513||60.315||58.974||58.974||56.998||53.759||52.089||50.44||50.22,0.6,0.4,0.26666666666666666
618,Eur_Arch_Otorhinolaryngol-4-1-2279158.txt,vocal emiss||qualiti||voic||studi||perceptu analysi||patient||life||laser surgeri||inform||radiotherapi||dysphonia||signific||treatment||maximum phonat time||vocal||grab||spectrogram||voic qualiti||fundament frequenc||surgeri||group||laser cordectomi||voic handicap index||differ||laser||score,voic||voic qualiti||voic outcom||voic result||hypofunct voic||voic characterist||voic 1981||voic paramet||voic disord||voic signal||accept voic||voic impair||post-treat voic qualiti||voic qualiti studi||voic handicap index,151.64||91.071||78.004||77.586||77.356||76.621||76.463||76.397||76.375||75.82||75.82||75.82||61.164||60.723||60.612,0.4,0.2,0.2
619,Environ_Health_Perspect-113-12-1314901.txt,document||case||ethylen bisdithiocarbam||meet||compani||human||phosphin||review||mrl||commod industri coalit||pesticid regul||pesticid||methopren||ebdc||coalit||world health organ||tobacco pesticid||public interest||regul||standard||member||note||agenc||epa||industri||case studi||public||philip morri||vettorazzi||regulatori agenc||tobacco industri,access||seckar||tobacco||tobacco industri||industri||2004||u.s. epa||tobacco pesticid||epa||pesticid||coresta||open access articl||tobacco industri document||tobacco industri tactic||tobacco industri interest,143.063||68.786||67.781||65.169||62.556||61.78||60.388||60.301||57.126||52.822||50.836||48.221||46.969||46.043||45.63,0.4,0.5,0.3333333333333333
620,Extremophiles-4-1-2175526.txt,major peak||coval bond||glycerol dibiphytanyl glycerol tetraeth||core lipid||fraction||dcm layer||group||analysi||compound||intact polar lipid analysi||cell||thermoacidophil||gdgt,aciduliprofundum boonei||A. boonei||lipid||gdgt||hydrotherm vent||deep-sea vent||deep-sea||analysi A. boonei||schouten||itoh||deep-sea hydrotherm vent biofilm||core lipid||sinningh damsté JS||keyword aciduliprofundum boonei dhve2 cluster glycerol||intact tetraeth lipid,46.294||33.841||29.261||28.754||26.018||25.284||24.23||23.416||21.433||21.343||19.797||19.393||18.099||17.891||16.601,0.2,0.1,0.13333333333333333
621,Diabetologia-4-1-2292422.txt,atp||type 2 diabet||current||function effect||insulin secret||effect||subunit||beta cell||diabet||neurolog examin||block||sulfonylurea therapi||sur||kir6.2||mutat||channel||patient||mgatp||neonat diabet||atp sensit,atp||atp channel||kcnj11 atp||l164p atp||channel||channel atp sensit||atp channel inhibit||atp sensit||result atp channel||atp 50||kir6.2||atp current||atp inhibit||atp 1||atp conduct,88.54||71.647||64.063||55.111||54.753||50.279||48.401||48.043||47.985||46.672||46.429||46.102||45.224||45.118||45.036,0.4,0.3,0.26666666666666666
622,J_Med_Internet_Res-5-4-1550578.txt,type||cancer||internet user||search engin||cancer type||individu||sampl||cancer queri||data||studi||question||difficulti||inform||nation cancer institut||exampl||natur languag process||user||site||health inform||web site||cancer inform||gener public||treatment||specif||web||term||user question||internet||subcategori||topic||methodolog||search||issu||vocabulari||symptom||specif type||breast||queri||gener inform,queri||cancer queri||categori queri||cancer||cancer type queri||queri cancer type||user queri||internet cancer queri||gener queri||lung cancer queri||neurolog cancer queri||bone cancer queri||specif queri||sampl cancer queri||testi cancer queri,368.864||294.819||224.225||220.774||212.647||212.647||209.815||206.05||200.339||200.257||200.131||199.827||198.198||198.068||197.81,0.6,0.3,0.2
623,Clin_Auton_Res-3-1-1914255.txt,blood flow||measur||method||reproduc||vop||venou occlus pressur||head-up tilt||studi||venou occlus||increas||doppler ultrasound||DU measur||supin posit||leg||superfici femor blood flow||subject||hut||cbf||agreement||posit||strain gaug plethysmographi||superfici femor arteri||venou occlus plethysmographi||angl||blood flow measur||tilt angl||techniqu,hut||vop||hut agreement vop||hut 45||flow||hut posit||hut start||plethysmographi||blood flow||vop measur||blood flow measur||flow measur||leg blood flow||head-up tilt||leg blood flow measur,96.285||57.174||51.793||50.165||49.942||49.731||48.71||45.467||45.158||42.796||39.578||39.181||36.488||35.95||34.471,0.4,0.3,0.3333333333333333
624,Pediatr_Nephrol-3-1-2064946.txt,ccd||Na||capillari||endotheli cell||proteinuria||sodium retent||nephrot patient||renal retent||hydrostat pressur||patient||aldosteron||high blood pressur||effect||increas||nephrot syndrom||edema||glucocorticoid||fluid leakag||cortic collect duct||rat||oncot pressur||pan||sodium||edema format||chang||alter||distal nephron||factor||interstitium||trans-capillari gradient,sodium||sodium retent||nephrot syndrom||retent||nephrot rat||renal sodium retent||sodium reabsorpt||nephrot patient||keyword sodium retent||sodium retent preced||renal sodium||experiment nephrot syndrom||nephrot syndrom scand||sodium excret||nephrot syndrom site,71.488||61.779||57.559||52.07||46.737||44.156||41.985||41.615||41.186||41.186||40.2||39.47||38.91||38.63||38.373,0.6,0.4,0.26666666666666666
625,Skeletal_Radiol-3-1-2141652.txt,blood flow||rheumatoid arthriti||connect tissu||author||measur||ray||small quantiti||flow||joint||mri||imag||studi||patient||eros||disadvantag||space||view||sensit||increas||synov||finger||proxim phalanx||small joint||contrast agent||small field||tendon||ultrasound||proxim recess||fluid||normal||neovascularis||bone||subcutan tissu||dorsal aspect||hand||detect||tendon insert,ultrasound||joint||doppler ultrasound||arthriti||rheumatoid arthriti||keyword ultrasound joint rheumatoid arthriti synov||ultrasound imag||rheumatoid||rheumatoid synov||synov||ultrasound detect synov||rheumatoid hand joint synov||ultrasound examin||metacarpophalang joint||small joint arthriti ultrasound versu,96.224||91.856||71.632||69.92||63.933||62.262||59.092||57.946||57.785||57.625||55.136||54.782||54.298||54.206||54.195,0.6,0.4,0.26666666666666666
626,Cell_Tissue_Res-3-1-2071963.txt,antibodi||cone||outer plexiform layer||goldfish||electron micrograph||cone triad||rod triad||section||process||spinul||pkc||structur||receptor||arrow||cell||retina||rod-driven hc||horizont cell||similar posit||result||dendrit||protein||metabotrop glutam receptor||BC marker||bc||synapt ribbon||electron microscopi||light||rod||posit||mglur||BC dendrit||mglur antibodi||bipolar cell,retina||metabotrop glutam||glutam||goldfish retina||metabotrop glutam receptor||bipolar||zebrafish retina||carp retina||metabotrop glutam receptor mglur7||metabotrop receptor||fish retina||mudpuppi retina||salamand retina||glutam receptor||outer retina,79.9||68.661||63.904||60.974||53.099||52.176||52.117||49.305||48.971||47.696||46.239||44.171||43.4||42.939||42.64,0.4,0.2,0.13333333333333333
627,Dev_Genes_Evol-4-1-2292471.txt,cuticl||gene circuit||class iii||gene||conserv||short germ insect||embryo||normal number||segment polar gene||segment||rnai||express||segment groov||cell,tc-hh||tribolium||tc-hh tc-smo||tribolium drosophila drosophila tribolium||drosophila tribolium drosophila||tc-ci||drosophila||tc-ci tc-hh tc-smo tc-ci tc-ptc tribolium||tc-ci tc-smo tribolium||tc-smo tc-ci||tc-hh tc-smo tribolium 2 drosophila tribolium||tc-smo tc-ci tc-ptc||wg tribolium||tc-smo||tc-hh tc-smo tc-ci rnai,167.716||141.399||139.74||138.06||136.948||136.626||134.722||131.727||129.93||124.196||116.173||114.874||114.156||111.765||107.801,0.0,0.0,0.0
628,Intensive_Care_Med-4-1-2244699.txt,effect||sepsi intervent strategi||level||lp inject||increas||pct||ct-proavp||intervent||prednisolon||human endotoxemia||dose||mr-proanp||studi||patient stratif method||biomark||mr-proadm||corticosteroid||sepsi,struck||morgenthal NG struck||morgenthal NG||sepsi||biomark||joachim struck||ct-proavp||midregion||biomark mr-proadm||endotoxemia||stabl sepsi biomark||prohormon biomark||cc3885 16356231 3. morgenthal NG struck||shk.0b013e318033e5da 17515850 5. morgenthal NG struck||clinchem.2005.051110 16099941 6. morgenthal NG struck,29.973||25.408||23.125||21.932||20.303||17.65||16.935||16.935||16.925||16.42||15.73||15.499||13.833||13.833||13.833,0.4,0.3,0.2
629,Eur_Radiol-4-1-2270358.txt,invas angiographi||find||pulmonari embol||protocol||imag||dose length product||studi||patient||chest pain||simultan evalu||recent CT technolog||respect valu||diagnost accuraci||aortic diseas||neg predict valu||contrast materi||coronari cta||coronari find||diagnost evalu||examin||heart rate||acut chest pain||analysi||diagnost workup||chest pain assess||coronari arteri diseas||coronari arteri segment||cta find||stenos||cta||cardiologist||dual-sourc CT||coronari atherosclerosi||equival dose||heart||insuffici contrast opacif,coronari angiographi||coronari CT angiographi||angiographi||coronari stenos||coronari arteri||noninvas coronari angiographi||coronari cta||coronari angiographi laboratori||coronari angiographi databas||chest||CT||coronari assess||coronari find||coronari angiogram||invas angiographi,54.795||48.698||47.404||42.444||40.219||36.916||36.603||36.53||36.53||36.523||36.503||35.039||34.514||33.121||32.649,0.0,0.1,0.2
630,Histochem_Cell_Biol-4-1-2228376.txt,plc||bax||smooth domain||data||studi||reticulon||subcompart||transit endoplasm reticulum||smooth ER||marker||ER fraction||domain||chaperon||protein complex||cell||lipid||rough||enzym||protein||proteom||analysi||associ||molecular machin||metabol||fraction||ER subcompart||microtubul||membran traffic||rough endoplasm reticulum||pathway||smooth endoplasm reticulum||ER protein||plasma membran||ser||membran||function,ER||endoplasm reticulum||ER protein||protein||endoplasm reticulum membran||rough endoplasm reticulum||ER favor ER||smooth endoplasm reticulum||transit endoplasm reticulum||ER membran||ER subcompart||endoplasm reticulum subdomain||eukaryot endoplasm reticulum||granular endoplasm reticulum||endoplasm reticulum network,92.189||87.506||80.454||68.719||67.253||63.734||61.46||61.093||59.605||59.469||59.125||59.007||58.972||58.849||58.337,0.4,0.5,0.4
631,Virchows_Arch-3-1-2151131.txt,cancer||author||target||mirna express||normal tissu||dna sequenc||case||human protein||role||oligonucleotid||pathogenesi||develop||malign transform||cell prolifer||express||human genom||differenti||cell||gene||human diseas||approach||apoptosi||protein||group||mirna||antisens therapi||microrna||function,microrna||mirna||let-7 microrna||microrna target||microrna express||silenc microrna||microrna polycistron||microrna precursor||microrna sequenc||perspect microrna||microrna compon||bartel DP microrna||mirna express||microrna express profil||microrna target predict,173.9||119.406||117.683||98.54||95.973||90.168||88.175||87.763||87.421||86.95||86.95||71.555||68.726||66.56||66.041,0.4,0.2,0.2
632,Purinergic_Signal-3-4-2072928.txt,mechan||atp||bbg||immunofluoresc||process||posit cell||microglia||gfap||microgli cell||receptor||activ||nac||data||studi||injuri||pakt||agonist||cell||rat||P2 receptor,microglia||7 7||7||7 receptor||receptor||rat microglia||7 7 25 7 7||microgli activ||activ microglia||microglia activ||microglia brain||microgli cell||microgli chemotaxi||59 7 7 receptor||7 receptor activ,48.556||36.362||36.362||33.699||31.037||29.375||29.09||28.802||28.319||28.319||28.148||27.504||27.418||25.94||25.16,0.4,0.2,0.2
633,J_Neurol-2-2-1705488.txt,correct descript||medic emerg||measur||questionnair||knowledg||St john ambul||heart attack||session||studi||stroke awar||stroke||brain attack||inform||sign||acut stroke||brain||educ||train||action||lesson||hands-on measur||teach||topic||healtheduc||symptom||number||aid train||particip||cours||peopl,stroke||stroke lesson||stroke symptom||stroke knowledg||stroke awar||stroke 78.7||acut stroke||stroke patient||stroke progress||stroke initi||stroke manag||stroke care||stroke knowledg emerg||stroke awar campaign||correct stroke symptom,168.067||99.112||90.672||88.901||87.263||86.534||85.988||84.034||84.034||84.034||84.034||84.034||64.407||62.108||61.851,0.4,0.3,0.2
634,Pflugers_Arch-3-1-1915642.txt,find||fat||plasma||glycogen||studi||fat oxid||carbohydr ingest||effect||infus||fiber type||muscl glycogen||lipid-droplet densiti||total||con trial||insulin||imtg||con||plasma ffa oxid||carbohydr||muscl biopsi||glucos||averag||skelet muscl glycogen||insulin concentr||subject||exercis||oxid rate||carbohydr supplement||cho||adipos tissu lipolysi||oxid||cho trial||rest,glycogen||text||carbohydr||muscl glycogen||exercis||glycogen spare||muscl glycogen spare||muscl glycogen oxid||glycogen util||muscl glycogen util||skelet muscl glycogen||glycogen metabol||glycogen content||ingest carbohydr||carbohydr ingest,80.927||66.017||63.701||62.985||61.171||49.298||47.879||47.283||46.09||45.741||45.446||44.176||43.866||43.199||43.199,0.8,0.4,0.4
635,Int_J_Cardiovasc_Imaging-3-1-2048829.txt,measur||method||aortic stenosi||studi||patient||left ventricl||tte||aortic regurgit||ava||signific||axial view||avc||contrast allergi||mild||non-invas method||result||moder||tte measur||cardiac catheter||ebt||valv||aortic valv area||aortic valv||sever||area||signific correl||contrast||aortic valv stenosi||function||techniqu,ava||aortic valv||aortic stenosi||aortic valv stenosi||valv||anatom ava||aortic valv calcif||ava overestim||larger ava||aortic regurgit||aortic valv area||smallest ava||function ava||aortic valv sclerosi||aortic valv diseas,136.347||101.346||88.085||83.438||74.143||71.743||71.322||70.695||70.678||70.657||70.055||70.021||69.227||69.117||67.81,1.0,0.6,0.4666666666666667
636,Diabetologia-3-1-1998885.txt,type 2 diabet||level||gfr||plasma||diabet||hyperglycaemia||concentr||microvascular complic||studi||patient||urinari albumin excret||metabol control||renal dysfunct||marker||type 1 diabet||metabol dysfunct||thiamin||microalbuminuria||adhes molecul||plasma thiamin concentr||erythrocyt||urinari excret||link||diabet complic||vascular dysfunct,thiamin||thiamin thiamin||thiamin thiamin thiamin||thiamin plasma thiamin||plasma thiamin||thiamin transport||thiamin mnl||thiamin clearanc||thiamin effect’||thiamin metabolit||thiamin defici||thiamin transporter-1||thiamin statu||thiamin uptak||thiamin effect,260.152||260.152||260.152||180.333||140.424||135.221||134.704||133.5||132.662||131.874||131.747||131.619||131.305||130.7||130.076,0.2,0.1,0.06666666666666667
637,Neuroradiology-3-1-1786189.txt,mechan||anim||find||secondari deterior||complement||cerebr ischemia||mri||studi||strategi||clinic outcom||rat model||brain damag||patient||disrupt||stroke||effect||temporari mcao||reperfus||platelet||increas||vasogen edema||magnet reson imag||ischem stroke||rat||blood||tissu||reperfus injuri||hypothermia||leukocyt||brain cool||leukocyt infiltr||infarct volum||ischemia||injuri||hyperperfus||bbb||group||blood reperfus||result,reperfus||cerebr reperfus||reperfus injuri||stroke||cerebr reperfus injuri||blood reperfus||postischem reperfus||postischem reperfus injuri||reperfus group||reperfus phase||reperfus area||coronari reperfus||global reperfus injuri||WC reperfus injuri||ischem stroke,154.318||114.187||110.066||98.478||98.062||84.848||84.141||78.031||77.834||77.63||77.159||77.159||73.983||73.92||70.833,0.6,0.4,0.3333333333333333
638,J_Mol_Biol-1-5-1950483.txt,atom forc microscopi||mechan stabil||tnfn3||fibronectin type iii||simul||fnfn10||afm,mechan unfold||unfold forc||fibronectin||mechan forc||forc||mechan stabil||simul||mechan unfold intermedi||afm||fnfn10||unfold pathway||unfold event||molecular mechan||paci E. clark J. mechan unfold||protein stabil,29.981||29.497||27.229||25.596||25.111||23.113||21.196||21.155||20.796||20.031||18.297||16.941||16.764||15.878||15.448,0.0,0.4,0.26666666666666666
639,Histochem_Cell_Biol-4-1-2386530.txt,mechan||flow||ciliari membran||studi||mutat||cilia||ciliopathi||cell biologist||structur||defect||signal||basal bodi||human diseas||tissu||primari cilia||protein||motil||mous||electron microscop studi||diseas||function||ciliogenesi,cilia||primari cilia||sensori cilia||cilia biolog||mammalian cilia||rudimentari cilia||cilia function||renal cilia||adult tissu primari cilia||satir||15889083 wheatley DN cilia||FL wheatley DN cilia||ciliari motil||primari||primari cilium,109.566||69.554||59.506||57.551||57.447||56.352||56.099||54.783||36.814||34.527||31.334||30.549||29.958||29.543||27.984,0.4,0.2,0.13333333333333333
640,Neuroimage-2-1-2330063.txt,left||studi||patient||seizur||tle||white matter tract||correl||medial tempor lobe||volum||test||memori||tractographi analysi||signific interact||memori function||epilepsi||control||voxel||tractographi||parahippocamp gyru||age||hippocamp atrophi||visual cue||hippocamp volum||connect||signific correl||structur connect||side,tle||al.||left tle||epilepsi||unilater tle||refractori tle||tle patient||tempor lobe epilepsi epilepsi||tle 3||tle group||left tle patient||tempor lobe epilepsi||left||tempor lobe epilepsi eichenbaum||medial tempor lobe epilepsi,139.492||112.9||99.654||78.761||71.366||71.301||71.011||70.049||69.82||69.746||67.279||67.144||59.815||53.818||53.01,0.4,0.2,0.2
641,Appl_Microbiol_Biotechnol-3-1-1914237.txt,transcriptom||gene||high-dens oligonucleotid microarray||absent||strain||fragment dna||relationship||discrimin phylogenet relationship||genomotyp||solvent-toler bacteria||microarray||pseudomonad||orf||cog||studi||aflp||absenc||function categori||function||intergen region,P. putida||pseudomona putida||pseudomona monteilii putida P. putida P.||P. putida pseudomona pseudomona||discuss P. putida P. putida P.||pseudomona putida kt2440||P. putida s12||pseudomona putida s12||pseudomona P. monteilii P. putida||P. putida 2002||700801 P. putida||P. putida 1977||P. putida pseudomona strain||proteom pseudomona putida P.||P.,199.174||196.821||158.596||155.952||152.356||145.865||140.799||139.23||134.132||134.109||133.786||133.261||132.041||128.423||117.436,0.0,0.0,0.0
642,Purinergic_Signal-4-2-2377318.txt,mechan||filter||flow||epitheli cell||releas||perfus||atp||assay||signal||cell||stimuli||hypoton challeng||volum addit control||ionomycin||mechan stimul||fluid||atp secret||pool||purinerg||apic surfac||atp releas||transient||monocilium||medium||monolay,monolay||atp||cell monolay||atp releas||releas atp||rescu monolay||mutant monolay||rescu cell monolay||mutant cell monolay||confluent monolay||releas||monolay tight||matur monolay||cilium-compet monolay 2||atp signal,97.534||76.888||64.633||63.333||63.333||62.771||59.851||52.425||50.478||49.872||49.778||49.607||48.767||48.559||48.483,0.6,0.3,0.26666666666666666
643,J_Gastrointest_Surg-3-1-1852380.txt,cha||hepat inflow||major surgeri||major hepatectomi||gastroduoden arteri||hemostasi||case||complet hemostasi||hepat failur||pseudoaneurysm||hepat arteri||patient||pha||tae proxim||angiographi||success outcom||superselect tae distal||rha||hemorrhag||ligat||re-laparotomi||tae||massiv arteri hemorrhag||subphren arteri||surgeri||spa||vascular reconstruct||sma||pancreat head||gda||hilar bile duct cancer||outcom,tae||pseudoaneurysm||arteri pseudoaneurysm||hepat arteri pseudoaneurysm||arteri||rha||hepat arteri||arteri hemorrhag||tae re-laparotomi||splenic arteri pseudoaneurysm||viscer arteri pseudoaneurysm||success tae||tae proxim||select tae||pseudoaneurysm distal,79.371||72.087||64.213||56.35||56.338||53.569||48.482||48.016||47.561||46.369||44.051||43.527||43.205||40.707||40.556,0.4,0.4,0.3333333333333333
644,Support_Care_Cancer-3-1-2092409.txt,attent||cancer||pleasur intens||preval||tempera dimens||problem||studi||analys factor analys||year||question||concept||eatq-r||pearson correl analys||effect||life event||variabl||frustrat||adolesc children||control||relationship||tempera||recurr diseas||age||parent||educ level||dutch||factor||parent cancer||group||report||inter-item correl||socio-demograph||number||daughter||adolesc||illness-rel variabl||children,tempera||tempera dimens||children ’s tempera||children||parent||internalis||externalis problem||internalis problem||problem||import tempera dimens||problem adolesc tempera life event||cohen DJ tempera||adolesc children||earli adolesc tempera questionnair||earli adolesc tempera measur,123.06||66.537||64.041||58.849||52.472||51.826||48.875||48.589||45.351||44.797||43.58||41.459||41.12||40.139||38.575,0.8,0.5,0.4
645,Pharm_World_Sci-3-1-1805038.txt,pharmaci||health care centr||case||system||questionnair||databas||determin||studi||patient||risk||correl||validation-set||netherland||dutch commun pharmaci||drug interact||ratio||analysi||medic surveil system||advers patient outcom||medic surveil||dispens||import||number||drug||euron system||drug combin,pharmaci||dispens||dispens drug||drug||commun pharmaci||pharmaci prepar||dutch pharmaci||sixty-eight pharmaci||256 pharmaci||pharmaci part||swedish pharmaci||74 pharmaci||12 pharmaci||62 pharmaci||drug interact,100.157||99.471||78.327||57.183||53.152||52.653||51.636||51.357||50.996||50.948||50.677||50.079||50.079||50.079||38.256,0.6,0.3,0.26666666666666666
646,J_Chem_Ecol-3-1-1915630.txt,plant defens||van loon||leaf tissu||effect||gl||egg||van poeck||test||total||leaf surfac||leav||natur enemi||butterfli||treatment||pupal weight||cabbag||sixth leav||control||paper||experi||butterfli speci||oviposit||surfac||herbivor||glucosinol||number||perform||leaf surfac extract||plant,oviposit||plant||pieri rapa||pieri||pieri brassica||P. brassica P. rapa||A. pieri||P. brassica||P.||oviposit entomol||P. A.||A.||glucosinol||glucosinol glucosinol||J. A. A.,79.176||77.011||71.336||68.081||63.858||62.713||62.032||58.974||58.313||57.397||57.148||55.983||55.307||55.307||52.595,0.4,0.2,0.2
647,Int_Arch_Occup_Environ_Health-3-1-1915587.txt,pharmaci||level||method||concentr||cytotox drug||hospit pharmaci||sampl||locat||solvent||data||analyt run||effect||variabl physic characterist||threshold||sensit||wipe||platinum||compound||initi amount||icp-m||valid||laf hood||hcl||hospit||dutch hospit pharmaci||clean room||materi||facil||surfac||import||contamin||intern standard||cytotox agent||drug||desorpt solvent||nebulis||procedur||surfac contamin||complianc||result,platinum||platinum contamin||contamin||wipe||platinum surfac contamin||platinum wipe sampl||platinum content platinum||low platinum contamin||5 platinum contamin||platinum recoveri||platinum drug||platinum agent||platinum concentr||platinum level||platinum compound,204.544||180.873||157.201||142.103||138.418||137.615||136.738||120.9||120.614||115.832||115.16||110.638||107.519||105.964||105.724,0.6,0.3,0.2
648,Mol_Genet_Genomics-4-1-2270915.txt,tobacco||defens||fourth leav||level||respons||jasmon acid||pathogen||transcript||acc||express||studi||valu||rice||plant||infect,ospr1||ospr1 ospr1 2 ospr1||ospr1 ospr1 8 ospr1||051 ospr1 ospr1||ospr1 gene ospr1||074 ospr1||071 ospr1||073 ospr1||011 ospr1||072 ospr1||gu ospr1||012 ospr1||022 ospr1||ospr1 gene||121 ospr1,376.247||282.203||282.185||259.08||256.326||239.19||212.874||210.725||209.942||207.659||205.705||205.356||196.68||196.366||194.039,0.0,0.0,0.0
649,Diabetologia-3-1-2039861.txt,contractil dysfunct||basal phosphoryl||triacylglycerol||fat||lcfa uptak||data||substrat uptak||diabetes-rel heart diseas||cd36||basal||high-fat feed||cardiac dysfunct||increas||insulin||hfd||phosphoryl||rat||high-fat diet||vivo cardiac function||diabet cardiomyopathi||diet||lcfa||group||glucos uptak||myocardi triacylglycerol accumul||utilis||sso||lfd||insulin-resist rat||insulin resist||heart||cardiomyocyt,cd36||hfd||cd36 lfd hfd||hfd heart cd36||sarcolemm cd36||lfd||cd36 transloc||cd36 redistribut||cd36 5||hfd heart||cd36 content||cd36 defici||lfd start lfd hfd||hfd cardiomyocyt||hfd rat,102.864||83.01||81.72||68.714||63.932||59.285||54.943||53.654||51.738||51.639||51.432||51.432||50.734||50.007||49.937,0.4,0.3,0.2
650,Pediatr_Nephrol-4-1-2335295.txt,appar diseas onset||follow-up||proteinuria||time||children||studi||year||end-stag renal diseas||patient||corticosteroid||mesangi prolifer degre||late group||signific||focal mesangi prolifer||outcom||treatment||long-term outcom||present studi||multivari analysi||iga-n||studi period||signific factor||sever mesangi cell prolifer||renal surviv||mild iga-n||analysi||japanes children||sever iga-n||group||differ||mesangi prolifer||time period||initi renal biopsi||diseas||diagnosi||baselin characterist||rct||result,iga-n||mesangi prolifer||iga||iga nephropathi||mild iga-n||nephropathi||focal mesangi prolifer||sever iga-n||iga-n patient||prolifer||mesangi prolifer 329||mesangi prolifer degre||focal mesangi prolifer 1976||childhood iga nephropathi||idiopath iga nephropathi,67.989||47.715||45.368||41.164||37.168||36.961||36.746||35.639||34.505||32.259||31.81||31.81||31.628||28.849||27.771,0.6,0.5,0.4
651,Qual_Life_Res-4-1-2358934.txt,level||method||global qualiti||index score||individu||qualiti||patient||life||correl||conjoint analysi||aca||domain||util||valid||iqol||altern method||cancer patient||averag||feasibl||worst option||task||pair||social judgment theori||seiqol||scenario||direct weight||weight||respond||import||largest benefit||agreement||number||individu qualiti||life domain||score||global individu qualiti,aca||aca weight aca||aca weight||domain||weight||iqol domain||aca weight 4||aca task||iqol weight||correl aca||aca method||univers aca||aca survey||life domain||iqol,120.24||103.348||94.902||74.557||69.563||64.86||63.382||62.555||62.363||62.292||61.879||60.494||60.12||57.426||55.163,0.6,0.3,0.3333333333333333
652,Neuropsychol_Rev-3-1-2039835.txt,block||practic motor skill||practic||studi||patient||amount||procedur learn||effect||review||abil||motor-skil learn||cognit function||clinic practic||recommend||dick||train program||control||schmidt||rehabilit||train||research||task||non-pharmacolog intervent||feedback||motor||compon||implicit motor-skil learn||implicit learn||implicit||AD patient||perform||movement||result,learn||AD||motor learn||implicit learn||skill learn||dementia learn||motor-skil learn||learn task||AD patient||learn motor skill||explicit learn||procedur learn||implicit motor-skil learn||AD mild||mild AD,192.909||188.482||135.639||132.474||123.33||120.184||114.705||109.303||108.351||108.343||107.156||100.89||100.483||100.406||100.406,0.2,0.3,0.3333333333333333
653,J_Behav_Med-4-1-2346512.txt,psycholog treatment||condit||time||therapist time||problem||control group||studi||patient||effect||review||disord||intervent||adult||treatment||headach||health condit||chronic diseas||research||cognit behavior therapi||pain||health problem||popul||internet||trial||therapist||systemat review||tradit form||cbt||result,intervent||cbt intervent||cbt||internet-bas cbt intervent||internet-bas intervent||internet intervent||internet-bas cbt||cognitive-behavior intervent||face-to-fac intervent||internet||internet-deliv cbt||face-to-fac cbt||internet-guid intervent||internet-administ cbt||futur internet intervent,66.269||63.844||61.419||56.112||53.459||53.028||51.034||43.117||40.276||39.788||37.895||37.851||37.446||36.108||36.069,0.4,0.3,0.2
654,Clin_Oral_Investig-3-1-2134843.txt,surgic periodont therapi||statist unit||ral-v gain||baselin||studi||patient||greater bone loss||effect||clinic||teeth||aggress periodont||site||baselin ppd||therapi||smoke||single-root teeth||baselin data||paramet||ppd reduct||recent statist method||analysi||nonsurg||ral-v||pli||oral||interproxim groov||srp||factor||influenc||clinic paramet||periodont therapi||doubl contour||bone loss||treatment result||ppd,periodont||periodont therapi||ppd||aggress periodont||periodont re-evalu||smoking-attribut periodont||surgic periodont therapi||non-surg periodont therapi||advanc periodont||baselin ppd||chronic periodont||periodont measur||periodont diseas||ral-v||therapi,80.981||57.985||57.701||43.727||42.291||42.009||41.782||41.259||41.156||40.959||40.491||40.491||40.491||36.438||34.989,0.6,0.5,0.4666666666666667
655,Eur_J_Epidemiol-3-1-2039783.txt,effect intervent||theori||studi||disadvantag||risk||epidemiolog||child||intervent||earli disabl pension||administr databas||evid||countri||health||educ||norway||polici||low parent educ||death||gener||disabl||parent disabl||social polici||low educ,disabl||disabl pension||parent disabl||educ||earli disabl pension||earli disabl||expuls||parent||low parent educ||low educ||irrevers disabl||good educ||gravseth||life||earli expuls,20.139||18.37||16.219||15.979||14.521||13.481||13.029||12.299||11.785||11.528||11.003||10.716||10.295||10.198||9.926,0.8,0.6,0.4
656,Pediatr_Radiol-3-1-1891645.txt,tracheobronchi tree||airway||case||time||protocol||high-resolut imag||imag||mpr||compress||low-dos protocol||inform||CT protocol||congenit||dose||anatom relationship||tracheal||scan||radiat dose||clinic case||lung||children||techniqu,scan||0.75 0.75 0.75 0.75 0.75||CT||airway||tracheobronchi anomali||axial scan||scan combiscan||0.75 mm||bronchoscopi||scan protocol||0.36 0.75 0.75||tracheobronchi strictur||tracheobronchi tree||expiratori scan||tracheobronchi patholog,39.324||33.078||28.307||26.981||26.265||24.959||24.34||24.264||23.996||23.795||23.233||23.025||22.897||21.581||21.445,0.4,0.2,0.2
657,Arch_Dermatol_Res-3-1-1950585.txt,pre-analyt sampl prepar||background intens level||ratio||intens||amplif||array cgh studi||genom dna||fresh tissu||skin dna||tissu||clinic practic||sampl||qualiti||signal||agaros gel||fix||molecular fix||result,dna||genom dna||formalin||fresh sampl||male genom dna||digest dna||skin dna||amplifi dna||dna yield||formalin sampl||hmw dna||dna puriti||dna marker||fresh tissu||sampl,51.389||41.84||30.482||29.828||28.21||28.12||27.939||27.867||27.281||27.08||26.813||26.59||25.695||24.386||23.678,0.2,0.2,0.26666666666666666
658,Surg_Endosc-4-1-2262145.txt,curriculum||level||endoscop surgeri||skill||mandatori part||time||competit element||studi||traine||resid||pgi||train program||train time||surgic resid||train||paramet||task||opinion||virtual realiti||month||simul||endoscop procedur||possibl||perform||particip||virtual realiti simul||surgic curriculum||virtual realiti train||score||result,train||simul train||resid||VR train||realiti train||VR simul train||resid train program||competit train||voluntari train||simul||surgeri train||basic skill train||train time||train program||surgic resid,102.837||79.026||74.189||65.956||65.675||62.376||59.975||56.719||56.689||55.215||55.117||54.642||54.404||52.868||52.576,0.4,0.3,0.4
659,Cancer_Immunol_Immunother-3-1-2150634.txt,respons||figur||serum||protocol||immun monitor||panel||valid practic||cell recoveri||studi||strategi||low background||panel particip||assay||dri ice shipment||criteria||intern site||immun assay||abil||plate||recoveri||harmon||common sourc||guidelin||valid||antigen||cell||intern locat||elispot assay||result||pbmc||immun||central lab||protocol choic||spot||donor||assay outcom||choic||group||report||cmv||elispot||profici panel||perform||repeat||survey||particip||weak respond||laboratori,panel||panel assay||elispot||elispot profici panel||elispot assay||profici panel||panel particip||laboratori||panel median||cimt-monitor panel||panel test||panel result||ongo panel||panel leader||panel leadership,145.304||108.641||105.174||92.629||88.576||86.356||81.838||76.132||76.029||75.398||74.399||74.168||74.135||73.984||73.44,0.6,0.6,0.4
660,Arch_Sex_Behav-3-1-1914258.txt,person||self-efficaci||person norm||measur||find||hiv-posit statu||men||casual sex encount||behavior||subject norm||consequ||import role||msm||determin||neg influenc||unprotect anal intercours||theori||effect||antivir therapi||prosoci behavior||intent||context||sex||variabl||plan behavior||signific||sexual risk behavior||signific increas||present studi||condom||norm-activ theori||moral concern||person characterist||riski sexual behavior||item||varianc||prosoci tendenc||predictor||steadi||predict||neg impact||particip||partner||sexual motiv||peopl||addit||step||emot,condom||sex||casual sex||sex partner||casual sex partner||casual partner||partner||steadi sex partner||sex behavior||steadi partner||casual sex partner variabl||casual sex partner 5||casual sex partner 68||casual sex partner 189||norm,120.309||120.281||113.119||109.195||108.116||102.033||98.11||97.518||90.876||86.137||82.19||81.855||81.591||81.087||78.259,0.4,0.3,0.2
661,Eur_J_Pediatr-3-1-2151778.txt,antibodi||follow-up period||data||studi||year||patient||liver biopsi||fibrosi||low rate||natur histori||adult||hematolog diseas||infect||minim necrosi||nosa||hcv||liver||hgv||group||biopsi||diseas||children,hepat||hcv||hcv infect||viru hcv hepat||antibodi hepat||hepat fibrosi||hcv patient||hepat biopsi||chronic hepat||viral hepat||autoimmun hepat||infect||hepat failur||cholestat hepat||hcv genotyp,88.661||84.944||65.681||64.696||63.659||55.994||54.678||50.76||50.587||50.447||46.445||46.417||45.688||45.342||45.261,0.2,0.1,0.13333333333333333
662,Rev_Endocr_Metab_Disord-3-1-1894828.txt,syndrom||respons||children||cfc||birth||growth hormon||mutat||year||normal rang||patient||short neck||costello syndrom||adult||cardio-facio-cutan syndrom||high incid||treatment||growth||gene||age||hypertroph cardiomyopathi||cytokin||similar cardiac defect||noonan syndrom||height||factor XI||function||leopard syndrom||clinic studi||hormon||short statur,noonan||noonan syndrom||syndrom||noonan JA noonan||noonan ’s syndrom||cardio-facio-cutan syndrom||costello syndrom||growth||cfc syndrom||leopard syndrom||keyword noonan||growth hormon||s11154-006-9021-1 articl noonan syndrom||rare syndrom||hormon,73.338||69.262||65.185||49.634||46.174||45.014||43.484||40.347||39.568||39.024||36.669||36.547||35.407||33.466||32.747,0.4,0.6,0.5333333333333333
663,Anal_Bioanal_Chem-4-1-2287204.txt,anim||gross||concentr||model||studi||sexual differenti||water||develop||effect||femal||observ||neg control||increas||test||exampl||gonad||metamorphosi||tank||treatment||acclim||complet||daili||dilut water||analysi||experi||treatment group||terminolog||biolog variabl||light||water qualiti||frog||group||statist analys||order||exposur||mix sex||procedur||dpf||environment chamber||tadpol||flow-through system||result,gonad||gross gonad||tank||narrow gonad||gonad morpholog||aplasia gonad||complet gonad||gonad tissu||gonad area||gonad femin||thin gonad||gonad 14. transluc gonad||gonad 9-c||sinuat gonad||gonad abnorm,229.852||125.489||123.385||120.143||119.475||119.058||118.894||118.285||117.478||117.117||116.742||116.685||116.315||116.315||116.133,0.4,0.2,0.13333333333333333
664,Biodegradation-3-1-2151777.txt,oxygen consumpt||long-chain alkylamin||nitrogen||depend||micro-organ||octylamin||ammonium||strain||carbon||silica gel||substrat specif||growth||enzym assay||dodecylamin||enzym||strain bert||fatti acid||activ||cell suspens||cultur||substrat||oxid||cell-fre extract||biodegrad pathway||prepar||alkylamin,alkylamin||pseudomona||biodegrad biodegrad||biodegrad||alkylamin dehydrogenas||alkylamin degrad||long-chain alkylamin||growth pseudomona pseudomona pseudomona strain bert||pseudomona sp||long-chain alkylamin dehydrogenas||chain alkylamin||pseudomona ami||anthropogen alkylamin||octylamin||pseudomona pseudomona 12 18,71.145||70.671||50.791||50.791||49.554||44.321||43.224||41.191||38.891||38.137||37.611||36.87||36.766||35.561||35.335,0.2,0.2,0.2
665,Plant_Mol_Biol-4-1-2268730.txt,rice||Zn defici||zn-defici shoot||barley||nicotianamin||transport||iron||ma secret||dma||dma synthesi||analysi||experi||zn-defici rice||shoot||absorpt||Fe defici||secret||zinc||root||dma secret||ma||plant,62||62 Zn||62 62 62 2||62 62 2||62 5 62 62 62 2||phytosiderophor||62 5 62 62 2||5 62 62 62 2||3 62 62 62 2||62 62 1 62 2||mori||Zn||nishizawa||plant||62 2,91.444||72.861||69.639||62.371||61.897||56.58||55.988||55.988||55.83||55.715||55.235||54.277||51.991||51.462||47.835,0.0,0.0,0.06666666666666667
666,J_Behav_Health_Serv_Res-4-1-2214828.txt,case||subclassif||individu||data||studi||state||idb||state agenc||IP SA||medicaid||inform||medicaid enrol||washington state||unit state||opiat||co-occur||mh-onli||day||coeffici||analysi||popul||MH servic||servic||care||group||mental health servic administr||residenti SA servic||window||record||client||addit||diagnosi,servic||medicaid servic||medicaid servic agenc servic||SA servic||agenc servic||MH servic agenc servic||medicaid agenc servic||MH servic||medicaid||medicaid servic 2 agenc servic||SA agenc servic||residenti servic||medicaid enrol agenc servic||medicaid servic 2||medicaid servic group,252.132||203.325||188.819||175.217||174.314||169.686||167.715||165.058||154.519||151.056||148.976||140.958||139.275||135.551||135.55,0.2,0.3,0.2
667,Bioprocess_Biosyst_Eng-2-2-1705514.txt,total biomass||batch-to-batch reproduc||concentr||valu||distort||growth rate||process||recombin protein||pat||manufactur||rel deviat||biomass concentr||cell||control||product||predefin profil||result||ferment||experi||deviat||feedback control||cultur||procedur||biomass||profil||reproduc,μ||μ μ||μ μ profil||process||cultiv process||fed-batch cultiv process||biomass||ferment process||product process||process control||cultiv||μ 4||7 μ||simuti||μ 12,43.811||43.811||32.902||31.436||27.316||26.827||25.62||25.256||25.092||24.093||23.197||22.954||22.329||21.973||21.905,0.2,0.2,0.13333333333333333
668,Biochim_Biophys_Acta-2-1-2323027.txt,oocyt||nano||element||data||translat activ||deadenyl||meiotic matur||translat repress||complex||symplekin||parn||signal||tail||phosphoryl||polyadenyl||cpsf||regul||associ||translat control||activ||cytoplasm||cpeb||bind||factor||synthesi||maskin||polymeras||mrna||gld2||addit||cytoplasm polyadenyl||function,polyadenyl||cytoplasm polyadenyl||polyadenyl mrna||cytoplasm polyadenyl xenopu||mrna cytoplasm polyadenyl||polyadenyl element||polyadenyl complex||cpe-medi polyadenyl||cytoplasm polyadenyl dev||cytoplasm polyadenyl element||earli polyadenyl||maturation-specif polyadenyl||polyadenyl factor||cytoplasm polyadenyl complex||cytoplasm polyadenyl mol,261.037||189.874||186.189||169.248||163.697||141.469||139.088||137.238||136.118||133.883||133.503||133.206||133.01||132.296||132.127,0.4,0.2,0.13333333333333333
669,Anal_Bioanal_Chem-4-1-2324128.txt,stationari phase||larg rang||post-transl modif||proteom level||hydrophil interact liquid chromatographi||retent||scx||separ||chromatographi||proteom||analysi||column||enrich||hydrophil compound||sampl||hilic||neg charg,hilic||proteom||chromatogr||hilic applic||hilic method||common hilic||categori hilic||hilic separ mechan keyword hilic proteom||hilic stationari phase||peptid||proteom applic||hellig||chromatogr 635:19||chromatogr 473:189||proteom group,75.64||43.848||43.366||40.903||38.319||37.82||37.82||35.811||28.478||25.686||25.007||24.527||23.216||23.216||21.924,0.4,0.2,0.13333333333333333
670,Evid_Based_Complement_Alternat_Med-4-2-1876616.txt,condit||non-malign pain||robust support||headach pain||find||week||tension-typ headach||discret pain condit||futur work||patient||depress||rigor studi design||chronic||acupunctur||chronic pain condit||effect||craniosacr therapi||neck||superior||review||colleagu||waitlist control||broad overview||improv||evid||moyer||massag||treatment||therapi||headach||spinal manipul||meta-analysi||broad array||relax||futur studi||pain||follow-up assess||assess||conclus||posit group||chronic pain||group||cochran collabor||fibromyalgia||massag therapi||relev studi||limit||trial||date||preliminari support||support||usual care||migrain||futur clinic trial||outcom||result,massag||pain||MT||massag therapi||acupunctur massag||pain 3 MT||massag treatment||massag group||massag techniqu||swedish massag||swedish-typ massag||cranioscar massag||therapeut massag||convent massag||friction massag,300.269||244.417||240.587||173.91||172.247||161.968||161.783||152.827||152.343||151.904||151.511||151.511||151.481||150.874||150.764,0.6,0.3,0.2
671,Ann_Biomed_Eng-2-2-1705516.txt,bioreactor||mechan forc||leaflet||valv leaflet||cyclic stretch||cell morpholog||imag||elastin||studi||valv failur||effect||section||nativ structur||forc||tissu section||current studi||express||stretch||contractil phenotyp||valv interstiti cell||circumferenti stretch||fiber||dmem||tissu||collagen||cell phenotyp||elastin content||analysi||circumferenti cyclic stretch||sgag||sgag content||aortic valv leaflet||valv||rel motion||aortic valv||stretch bioreactor||avl,leaflet||stretch leaflet||valv leaflet||aortic leaflet||stretch||aortic valv leaflet||fresh leaflet||valv||static leaflet||heart valv leaflet||valv leaflet ann||valv leaflet sampl||leaflet morpholog||leaflet section||aortic heart valv leaflet,184.449||157.892||146.923||131.999||131.336||124.465||112.905||109.396||107.612||99.551||99.523||97.948||97.225||95.957||94.55,0.6,0.5,0.3333333333333333
672,Anal_Bioanal_Chem-4-1-2262919.txt,antibodi||target||recognit||nanoscal sensor||fet||sensit||high sensit||nacl solut||signal||small size||electrochem aptam sensor||detect limit||carbon nanotub||recognit element||deby screen length||protein||sensor||electr signal||bind||electr doubl layer||aptam,aptam||aptam sensor||electrochem aptam sensor||thrombin aptam||aptam handbook||sensor||biotin-label aptam||small aptam||engin aptam||aptam configur||polym aptam||secondari aptam||stabl aptam||mb-tag thrombin aptam||electrochem sensor,115.404||87.479||65.455||62.881||61.855||59.555||58.98||58.667||58.595||58.291||58.254||57.702||57.702||44.027||40.481,0.4,0.3,0.2
673,Arch_Dermatol_Res-3-1-1950346.txt,placebo||chronic plaqu psoriasi||psoriasi||ccr5||baselin||data||patient||pasi||pathogenesi||receptor||lesion||express||treatment||cell||day||pasi 50 respond||analysi||psoriasi patient||placebo group||total number||non-lesion skin||skin||single-stain section||result,ccr5||psoriasi||chemokin||chemokin receptor ccr5||ccr5 express||ccr5 inhibitor||keyword psoriasi ccr5 chemokin inhibitor||ccr5 mrna||ccr5 proport||i.e. ccr5||psoriasi patient||psoriasi area||psoriasi Br||activ psoriasi||psoriasi skin Br,85.228||81.392||51.955||50.049||48.35||47.046||45.488||43.524||42.614||42.614||42.105||41.913||41.747||41.183||40.248,0.4,0.2,0.2
674,Sleep_Breath-3-1-1794625.txt,satisfact||night||studi||patient||c-flex||cpap||effect||va score||pressur||ahi||treatment||therapi||patient prefer||apap||potenti||standard cpap||sleep||expir||airflow||technician||subject||devic||convent cpap||score||central apnea||central event||prefer||complianc,c-flex||cpap||cpap night||rsa c-flex||c-flex cpap pressur||rsa c-flex night||sleep||standard cpap rsa c-flex cpap||night||cpap pressur||rsa||cpap complianc||cpap therapi||standard cpap||sleep breath sleep,102.514||101.937||88.265||81.502||80.273||79.199||76.994||75.122||74.593||69.153||60.49||59.81||59.001||55.334||55.3,0.4,0.4,0.3333333333333333
675,Mol_Cell_Biochem-4-1-2226060.txt,growth medium||level||vascular calcif||atherosclerosi||concentr||amlodipin||combin||studi||atorvastatin||calcif||effect||vitro||ascorb acid||ca||vascular smooth muscl cell||vsmc||dexamethason||cell||calcium||day||calcium deposit||calcif medium||prolifer||apoptosi||statin||immunofluoresc imag||incub||cultur||highest concentr||plaqu||vsmc cultur||calcium antagonist||medium||result,calcif||vsmc calcif||vsmc||aortic vsmc calcif||atorvastatin||vascular calcif||vitro calcif||calcif medium||atherosclerot calcif||arteri calcif||calcif induct||vesicle-medi calcif||affect calcif||aortic vsmc||vitro vsmc calcif 4,97.07||86.805||76.541||64.703||59.05||58.278||55.618||54.574||52.391||50.74||50.071||49.925||49.421||48.519||46.963,0.6,0.5,0.3333333333333333
676,Naunyn_Schmiedebergs_Arch_Pharmacol-3-1-1915621.txt,respons||kcl||olcegep||interest||vehicl||concentr||model||studi||channel||capsaicin||distal coronari arteri||cgrp||relax||concentr respons curv||arteri||bath fluid||porcin||segment||antagonist||human coronari arteri||relax respons,capsaicin||cgrp||50 μM||1 μM||0.1 μM||5 μM||arteri||0.5 μM||100 μM||10 μM||capsaicin-induc relax||porcin arteri||coronari arteri||porcin||capsaicin receptor,50.718||44.624||40.962||38.894||37.956||36.085||36.068||35.877||35.63||35.363||31.994||31.743||30.374||27.419||27.254,0.4,0.3,0.26666666666666666
677,Int_J_Biochem_Cell_Biol-1-5-1906734.txt,cytosol||hsj1||bind surfac||system||vivo assay||substitut||western analysi||data||mutat||conserv qkraa motif||structur||abil||region||domain||loop region||similar||conserv||helix IV||leu||protein||residu||dnaj||bind||bip||iii||interact||basic residu||prj-b vector||function||result,al.||j-domain||hennessi||coli genevaux||E. coli E. coli genevaux||1997 E. coli E. coli hennessi||chimera E. coli E. coli||dnaj||E. coli E. coli pröl||2005a E. coli hennessi||2003 E. coli E. coli genevaux||cbpa E. coli hennessi||2000 E. coli hennessi||interchang E. coli hennessi||E.,146.311||129.663||114.381||112.024||109.567||98.586||98.162||97.087||96.603||93.902||91.864||90.381||89.599||88.394||87.913,0.0,0.1,0.06666666666666667
678,Community_Ment_Health_J-2-2-1705498.txt,level||measur||commun||tradit servic||formal servic||model||substanc abus servic prefer||reserv||effect||SU problem||american indian||mental health||adult||substanc abus||social support||health||higher score||current medic model||research||statement||servic||care||respond||import||cultur||novin||prefer,servic||reserv servic||health servic||mental health servic||tradit servic||indian health servic||formal servic||mental health||reserv||mental health servic whitbeck||servic prefer||mental health servic util||mental health servic administr||J. mental health servic||mental health servic improv,101.062||81.927||78.606||77.416||76.437||73.842||68.362||65.594||62.793||61.735||60.002||59.778||59.074||58.744||58.062,0.4,0.5,0.3333333333333333
679,Breast_Cancer_Res_Treat-3-1-2001216.txt,treatment strategi||letrozol||breast cancer||model||studi||tamoxifen||patient||effect||human||peripher tissu||ai||aminoglutethimid||aromatas||complet inhibit||postmenopaus women||select inhibit||vivo model||estrogen||anastrozol||tumor||random clinic trial||trial||breast||clinic signific||vivo,aromatas||breast||aromatas inhibitor||aromatas inhibitor letrozol||letrozol||breast cancer||breast cancer breast cancer||cancer||postmenopaus breast cancer||breast cancer patient breast cancer||aromatas inhibit||keyword aromatas breast cancer estrogen postmenopaus||human aromatas||aromatas activ||breast cancer clin cancer,135.392||103.136||96.211||94.384||90.73||90.215||90.215||77.295||75.967||72.181||70.522||70.505||69.526||68.835||68.825,0.6,0.4,0.26666666666666666
680,Eur_J_Pediatr-4-1-2190787.txt,prematur children||school outcom||problem||data||studi||year||school||norm score||test||development outcom||neurolog||special assist||follow-up programm||motor skill||development domain||standard test||mild||perinat data||problemat follow-up outcom||school perform||development disturb||development follow-up||age||follow-up assess||assess||parent||low birth weight||group||differ||school outcom group||score||children||result,school||problemat school outcom||problemat development outcom||school outcom normal problemat||school outcom||school outcom school outcom||problemat school outcom follow-up||development outcom||children||school problem||problemat follow-up outcom||development problem||development follow-up||school age||school age outcom,61.041||54.735||53.444||47.43||47.024||47.024||45.737||45.087||44.912||41.584||40.636||39.647||37.956||35.027||34.354,0.4,0.4,0.4
681,Diabetologia-3-1-1914300.txt,type 2 diabet||csf||hypercholesterolaemia||white matter lesion||diabet||wml volum||studi||patient||grey matter||effect||leukoaraiosi||volum||total csf volum||sex||smaller volum||magnet reson imag||control particip||intracrani volum||analys||brain||wml||control||women||cerebrospin fluid||age||associ||cerebr tissu||atrophi||white matter||larger wml volum||segment||particip||white matter volum,white matter||white matter volum||wml||matter hyperintens||wml volum||volum||diabet||white matter hyperintens volum||white matter hyperintens||ventricl volum||grey matter||ventricl||white matter lesion volum||subcort white matter||white matter lesion,51.915||49.781||49.245||48.95||47.38||45.515||45.385||45.026||44.863||42.872||42.291||40.229||38.76||37.506||36.508,0.8,0.6,0.5333333333333333
682,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2206250.txt,suicid bomb||senior surgeon||type||ophthalmologist||ED stay||patient||urgent primari closur||head||lacer||primari repair||eye||open globe||ocular trauma||hospit||terror||attack||ocular injuri||surgeri||emerg facil||medic treatment||injuri||ocular procedur||victim||bomb||primari closur||special attent||surgic procedur||intra-lenticular foreign bodi||mass casualti||surgeon||trauma||vitrectomi,bomb||suicid bomb||suicid bomb injuri||injuri||trauma||suicid bomb attack||globe injuri||terrorist bomb||suicid||globe||ocular injuri||ocular trauma||terrorist bomb attack||suicid attack||eye injuri,72.726||60.24||58.045||53.656||52.313||50.891||50.534||49.876||47.753||47.411||47.286||46.614||43.982||39.973||39.747,0.8,0.4,0.4
683,Invest_New_Drugs-3-1-1915607.txt,mass balanc studi||pseudopharmacokinet paramet||faecal excret||administr||plasma||sampl||studi||patient||radioact||termin elimin phase||typic radio-trac studi||recoveri||long half-lif||dose||tra||epothilon||pharmacokinet||ixabepilon||bile duct||metabol||high concentr||auc||acceler mass spectrometri||total volum||drug||mobil phase||total radioact||urin,ixabepilon||ixabepilon half-lif||ixabepilon Nr ixabepilon radioact||ixabepilon metabolit||unchang ixabepilon||ixabepilon metabol||ixabepilon equiv.||epothilon analog ixabepilon||long ixabepilon half-lif||total urinari ixabepilon||ixabepilon parent drug||anticanc agent ixabepilon||unchang ixabepilon plasma pharmacokinet||normal ixabepilon plasma concentr||excret,133.631||75.167||74.04||70.911||70.684||68.449||68.333||57.487||51.309||49.282||48.006||47.048||46.91||40.761||37.768,0.2,0.1,0.06666666666666667
684,Pediatr_Radiol-4-1-2292494.txt,nephrogen system fibrosi||previou gadolinium exposur||time||chronic kidney diseas||nsf||ckd||gadolinium||patient||year||develop||renal dysfunct||proinflammatori condit||dose||day||renal impair||contrast agent||renal transplant||end-stag renal failur||bodi||age||gadolinium-bas contrast agent||kidney failur||gadodiamid exposur||group||report||contrast-enhanc mri||gadodiamid||risk factor||diseas||children,nephrogen fibros||nephrogen fibros dermopathi||nsf||fibros dermopathi||dermopathi||gadodiamid||gadolinium||keyword nephrogen||nephrogen system fibrosi||nephrogen fibros dermopathi research updat inform||gadodiamide-rel nsf||gadodiamide-rel nephrogen system fibrosi||mra||nsf 2||confirm nsf,95.651||88.591||76.502||74.675||74.473||62.553||58.925||58.213||51.302||44.903||41.229||39.965||38.563||38.255||38.251,0.2,0.4,0.26666666666666666
685,Arch_Orthop_Trauma_Surg-3-1-2111040.txt,time||proxim femor nail||arthroplasti||complic||revis rate||hip screw||multipl regress analysi||total hip replac||studi||year||patient||full weight bear||mortal||risk||comorbid||fractur||primari arthroplasti||outcom||treatment||intern fixat||rel risk||hip||primari||age||treatment group||mortal risk||complic rate||trochanter femor fractur||group||minimum age||influenc||dh||dynam hip screw,fractur||hip fractur||hip||intertrochanter hip fractur||intertrochanter fractur||trochanter fractur||hip arthroplasti||pertrochanter hip fractur||arthroplasti||unstabl fractur||dh||unstabl intertrochanter hip fractur||extracapsular hip fractur||pertrochanter fractur||pfn,90.252||78.995||67.739||65.468||64.332||62.826||62.503||57.734||57.268||56.478||54.778||54.777||53.445||52.732||51.734,0.4,0.3,0.26666666666666666
686,Ann_Hematol-4-1-2324130.txt,gammopathi||follow-up||level||ert||clinic respons||studi||normal rang||patient||mgu||risk||increas||prednison||free light chain||cell||flc||growth factor||gaucher diseas||cohort||protein||age||cytokin||parc||multipl myeloma||rang||decreas||immunoglobulin||serum level||diseas sever||monoclon gammopathi||risk factor||diseas||result,gaucher||gammopathi||gaucher diseas||gaucher ’s||mgu||gaucher type||gaucher cell||monoclon gammopathi||ert||flc||gaucher ’s diseas||gaucher diseas type||adult gaucher diseas||gaucher diseas Br||polyclon gammopathi,154.694||106.653||93.995||82.868||80.7||79.798||77.403||76.78||76.298||72.05||66.344||64.297||62.976||62.663||60.197,0.6,0.6,0.4
687,J_Gastrointest_Surg-3-1-1852388.txt,case||middl pancreatectomi||patient||mortal||neck||risk||exocrin function||benign||exocrin pancreat function||oper||main pancreat duct||long-term endocrin||tumor||distal transect||surgeon||middl segment pancreatectomi||procedur||low-grad malign tumor||segment||gland||median pancreatectomi,pancreatectomi||segment pancreatectomi||middl pancreatectomi||central pancreatectomi||distal pancreatectomi||conserv pancreatectomi||pancreatectomi ann||median pancreatectomi||medial pancreatectomi||multipl pancreatectomi||pancreat neck||pancreat stump||pancreat fistula||middl segment pancreatectomi||pancreat gland,95.438||56.015||54.687||53.249||51.652||48.952||48.903||48.848||48.808||47.719||44.007||43.762||42.381||41.989||41.394,0.2,0.2,0.2
688,Purinergic_Signal-3-4-2072915.txt,adenin deriv||affin||adenosin receptor subtyp||adenosin receptor antagonist||adenosin receptor||deriv||result,2B||2B receptor||2A 3 2B||1 2B 3||conclus 2B||klotz k-n 2B||3||6 3 2B ligand||3 3 receptor||6 2B adenosin receptor subtyp||adenosin receptor||volpini||cristal||6 2A 2B subtyp||receptor,102.222||72.129||60.005||54.741||51.111||49.49||48.949||46.811||46.645||46.554||46.009||44.3||42.479||42.398||42.036,0.0,0.0,0.06666666666666667
689,Mol_Neurobiol-3-1-2039784.txt,neurotox||cell interact||role||cn injuri||releas||model||studi||patholog condit||central nervou system||effect||vitro||synapt transmiss||abil||cn||electrophysiolog properti||receptor||astrocyt||express||cell||brain||microglia||protein||neuron||death||neuroprotect activ||injuri||activ||report||cell function||cultur||interact||cn cell||pathway||chemokin||chemokin express,chemokin||neuron chemokin||cxcr4 chemokin||chemokin fractalkin||chemokin express||chemokin receptor||neuron chemokin express||chemokin cx3cl1||chemokin ccl2||chemokin mcp-1||cxc chemokin||chemokin monocyt||neuron||chemokin sdf-1||chemokin cxcl10,353.169||269.013||211.853||209.821||208.71||201.596||200.759||197.516||188.313||186.856||186.677||186.105||184.858||183.982||180.927,0.4,0.2,0.2
690,J_Struct_Funct_Genomics-3-1-1769342.txt,interfac||genom sequenc||time||figur||databas||year||structur||region||domain||domain interfac||structur genom||amino acid sequenc||famsbas||hydrophob||orf||homolog model||genom||surfac||famili||sequenc ident||solubl protein||templat||number||p-loop||eukaryot protein||function,structur||3D structur||protein structur||protein 3D structur||templat structur||structur genom||3D||model 3D structur||model structur||orf||structur domain||domain structur||3D structur determin||structur determin||structur data,65.395||54.628||44.924||44.57||44.56||44.519||43.861||43.814||43.79||42.592||41.9||41.9||37.036||33.623||32.697,0.2,0.3,0.2
691,Diabetologia-3-1-1914292.txt,ccn famili member||diabet retina||diabet||connect tissu growth factor||protein level||studi||advanc glycat end product||increas||streptozotocin-induc diabet||extracellular matrix||aminoguanidin treatment||express||aminoguanidin||rat||retina||ctgf||ace inhibit||gene express regul||mice||protein||diabet milieu||age||cystein-rich protein 61||microvascular basement membran||famili||differ||extracellular matrix compon||ccn famili||mrna||diabet retinopathi||mrna level,ctgf||result cyr61 ctgf cyr61 ctgf||cyr61||diabet||retin ctgf||lysin ctgf||interpret ctgf||ctgf 19||diabet retina||growth||discuss cyr61 ctgf express||ccn||ctgf 28 ctgf 28 50||ctgf cyr61 48 49||diabet retinopathi,99.728||64.353||61.156||56.608||55.39||52.296||49.864||49.864||44.128||44.042||42.687||41.118||40.489||40.221||39.319,0.4,0.3,0.26666666666666666
692,Histochem_Cell_Biol-4-1-2323030.txt,mechan||antibodi||cancer||role||target||ligand bind||concentr||intern||studi||endosom||year||erbb||cbl||review||complex||receptor||degrad||evid||epiderm growth factor receptor||cell||endosom sort||lysosom degrad||protein||activ||bind||import||ubiquitin||caveola||egfr||pathway||anti-canc therapi||plasma membran||ligand||erbb2||endocytosi,receptor||erbb receptor||egfr||erbb||erbb receptor endocytosi||egfr endocytosi||erbb endocytosi||receptor ubiquitin||receptor downregul||egfr ubiquitin||ubiquitin egfr||egfr downregul||egf receptor||egf receptor endocytosi||receptor degrad,120.771||116.214||113.075||111.658||103.98||96.293||95.584||94.905||93.591||91.057||91.057||89.743||82.713||81.646||80.712,0.6,0.3,0.2
693,Eur_J_Epidemiol-3-1-2071965.txt,discharg||doubl count||hospit mortal||time||case||men||data||studi||patient||admiss||recurr case||mortal||epidemiolog||linkag||acut myocardi infarct||hospit regist||recurr event||event||regist||cohort||ratio||hospit||hospit morbid data||trend||declin||postal code||gender||incid||differ||date||hospit admiss||nation hospit discharg regist||ami||result,regist||regist hospit regist||hospit regist||link regist||nation regist||popul regist||regist men||hospit discharg regist||regist person||hospit regist 7||hospit||link regist 1995 2000 hospit regist||nation ami regist||link regist trend||nation hospit discharg regist,197.05||161.874||144.285||117.155||104.351||103.824||102.557||101.869||101.328||96.212||91.52||89.481||86.968||85.478||79.315,0.4,0.2,0.26666666666666666
694,Eur_Child_Adolesc_Psychiatry-2-2-1705537.txt,attent||fwit||tmt||indic||schizophren patient||interfer task||patient||studi||cognit flexibl||young person||select||first-degre rel||effect||risk||correl||rel||test||correct||cognit function||cognit impair||variabl||control||execut function||cognit adjust||genet risk||task||analysi||correct trial||genet vulner||subject||genet influenc||group||differ||proband||sibl||perform||impair||wcst||speed||schizophrenia||score||gener alert||children||result,schizophrenia||tmt||fwit||schizophrenia schizophr||tmt test||schizophren||cognit||schizophrenia patient||schizophrenia gene||schizophrenia epidemiolog||acut schizophrenia||d2||tmt part||fwit error||wcst,85.317||75.008||71.765||61.042||47.801||46.237||46.146||42.985||42.661||42.659||42.659||40.143||39.85||39.814||39.467,0.6,0.3,0.26666666666666666
695,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2206251.txt,delay||time||case||tertiari care eye hospit||studi||endophthalm||patient||visual loss||remov||nlp||risk||clinic evid||antibiot||treatment||repair||eye||foreign bodi||vision||visual outcom||ocular trauma||iofb||age||associ||final VA||ocular injuri||king khale eye specialist hospit||injuri||factor||eye trauma||risk factor||visual acuiti||decad||trauma||vitrectomi,iofb||eye||endophthalm||retain iofb||iofb studi eye||iofb remov||eye trauma||iofb forcep||iofb extract||eye injuri||intraocular foreign bodi||20 eye||foreign bodi||forty-four eye||589 eye,115.593||92.597||89.486||72.905||70.07||67.108||60.94||58.813||57.797||51.845||48.986||48.237||47.906||47.902||47.708,0.6,0.4,0.3333333333333333
696,J_Biol_Inorg_Chem-3-1-1915633.txt,crystal||ecftna||data||channel||outer entranc||chain ferritin||structur||electron-dens map||Fe atom||site||fourfold channel||side-chain atom||huhf||iron||similar||main-chain||glu||high number||protein||residu||bfr||phase||side chain||ferroxidas center||FC epr signal||monom||refin||afftn||hyperthermophil microorgan||ferritin||hydrogen bond||crystal structur||factor||pfftn||symmetri||result,pfftn||ferritin||pfftn 24-mer||pfftn monom||as-isol pfftn||as-crystal pfftn||pfftn resembl||thermost ferritin||fe-load pfftn crystal||1vlg ferritin||hyperthermophil ferritin||archaeal ferritin||function pfftn 24-mer||chain ferritin||nonsoak pfftn crystal,125.304||97.626||79.731||74.086||72.614||69.768||63.163||58.853||56.369||54.506||54.28||53.525||53.155||52.922||52.574,0.4,0.2,0.2
697,Osteoporos_Int-4-1-2267483.txt,follow-up||poorer complianc||categori||bisphosphon therapi||bisphosphon||data||interv||patient||year||mpr||risk||treatment benefit||medic||user||fractur||low complianc||osteoporot fractur||studi period||women||treatment complianc||analysi||pharmo-rl||osteoporosi||hormon replac therapi||drug||maxim treatment benefit||femal user||complianc||result,bisphosphon||complianc||complianc complianc||fractur||bisphosphon dispens||mpr||non-compli bisphosphon||osteoporot fractur||bisphosphon user||bisphosphon treatment||bisphosphon therapi||introduct bisphosphon||fractur risk||treatment complianc||complianc categori,94.475||78.009||78.009||72.811||60.956||57.11||54.633||52.244||51.451||51.109||50.374||47.238||44.966||42.876||42.536,0.6,0.5,0.4666666666666667
698,J_Gastrointest_Surg-3-1-1852373.txt,cohort||surviv||tumor||node||nodal involv||number||dismal prognosi||studi||lymph node||analysi||patient||impact||lymphadenectomi||patholog stage||stage||outcom,0 0 0 0 0 0||0 0 0||0||0 0||0 0 0 0 2||0 0 1||0 0 3||0 0 10||node||0 0 14||0 0 4||0 0 2||0 0 74||0 2||upper esophagu 0 0 16,81.574||81.574||81.574||81.574||65.677||58.683||57.175||55.866||55.802||55.733||55.311||55.079||54.694||41.832||41.494,0.0,0.1,0.06666666666666667
699,Planta-4-1-2270913.txt,report||SA treatment||author||defens||final extens||induct||pathogen||salicyl acid||promot||element||luc||region iii||ethephon||rice||salicyl acid induct||activ||gfp||plant,ospr10a||ospr10a promot ospr10a ospr10a||ospr10a ospr10a promot||ospr10a ci ospr10a promot||ospr10a promot||ospr10a osactin||ospr10a http://www.dna.affrc.go.jp/cdna/plac||ospr10a cis-bold||result ospr10a||ospr10a Os materi||rt-pcr analysi 16 ospr10a ospr10a||promoter-luc construct ospr10a ospr10a pr10a Os||site ospr10a promot||method bar ospr10a ospr10a promot construct||Os Os,393.287||299.231||267.879||214.405||205.175||199.805||199.805||198.224||196.643||171.858||157.806||153.555||136.783||134.502||120.772,0.0,0.0,0.0
700,World_J_Urol-4-1-2413091.txt,independ predictor||follow-up||diamet||median||studi||patient||median follow-up||mtd||patholog stage||risk||tumor volum||total TV||correl||independ prognost factor||short follow-up||high risk||total||largest diamet||index TV||largest tumor||signific||maximum tumor diamet||month||bcr||prostat||prognost factor||tumor||gleason score||psa failur||high-risk group,mtd||bcr||prostat||conclus mtd||radic prostatectomi||bcr irrespect||psa||gleason||radic prostatectomi specimen||prostat cancer||tumor||tumor diamet||diamet||prostat carcinoma||prostat tumor size,56.227||40.447||33.325||28.113||24.131||22.861||22.398||20.261||19.267||18.862||18.474||18.104||17.734||17.676||17.266,0.6,0.3,0.3333333333333333
701,Ann_Hematol-4-1-2275303.txt,md||risk||order||myelodysplast syndrom||lenalidomid||respons||time||drug||recommend||panel||abnorm||clinic trial||vte||nhae||diseas||patient||neutropenia||treatment||advers event||therapi,lenalidomid||lenalidomid treatment||lenalidomid therapi||polycythemia lenalidomid||lenalidomid dose||2008 lenalidomid||interrupt lenalidomid treatment||lenalidomid treatment digoxin digoxin||md||5q||vte||myelodysplast syndrom||partial respons continu lenalidomid therapi||complet hematolog respons continu lenalidomid therapi||lenalidomid treatment gonad function testosteron,91.434||52.11||51.339||47.89||47.696||46.677||39.441||29.601||27.719||27.719||26.905||26.348||23.018||22.088||21.428,0.2,0.2,0.26666666666666666
702,Mol_Immunol-1-5-2080686.txt,igg||level||Tg||sle||increas||light chain||endogen light chain||mice||genet background||activ||FO||ab||model||autoab||MZ||cell||margin zone,al.||c1qa||2002 c1qa||1998 c1qa||2000 c1qa||weigert||immunol||lpr lpr||lpr||mandik-nayak||botto||method 2.1 mice c1qa||lpr mice||c1q||erikson,134.555||99.049||52.709||51.193||50.988||39.32||38.803||34.046||34.046||33.003||31.993||31.187||29.873||29.106||28.183,0.0,0.0,0.0
703,Appl_Microbiol_Biotechnol-4-1-2279157.txt,imag analysi||method||time||larg number||imag||gel||sampl||data||valu||larg amount||express level||quantiti||express profil||test||background||statist||proteom map||pattern||label||calibr||approach||techniqu||protein||analysi||experi||biolog system||biolog interpret||spot||intens||imag process method||differ||show||express analysi||statist method||softwar||statist test||step||detect||vivo||result,spot||gel spot||gel||two-dimension gel||two-dimension electrophoresi gel||two-dimension gel electrophoresi||protein spot||spot quantit||spot detect||spot pattern||spot match||spot quantiti||gel imag||consensu spot||spot data,215.949||194.838||173.728||129.142||123.046||123.046||120.068||119.643||116.02||115.959||115.433||114.669||114.255||112.342||111.595,0.4,0.2,0.13333333333333333
704,Doc_Ophthalmol-3-1-1896293.txt,clinic perg record||measur||frame rate||respons||amplitud measur||time||amplif system||baselin||patient||lumin||stimulu||electrod||frequenc||pattern electroretinogram||amplitud||clinic electrophysiolog||macula||surfac electrod||perg||perg record||ground||peak time||standard||steady-st perg||compon||transient perg||tempor frequenc||field||refer||checkerboard||implicit time||small signal||waveform||equip||peak||activ electrod||techniqu,perg||perg record||standard perg||perg amplitud||steady-st perg||field perg||transient perg||perg measur||normal perg||perg examin||perg result||monocular perg record||clinic perg record||reproduc perg record||repeat perg record,179.478||115.323||105.098||102.437||97.485||94.158||92.663||92.006||90.621||89.739||89.739||79.705||79.177||78.208||76.882,0.6,0.4,0.3333333333333333
705,J_Autism_Dev_Disord-4-1-2268726.txt,wai iii factor scale||asperg syndrom||wais-iii||level||piq||process speed||problem||studi||hfa group||inform||intellig profil||adult||comprehens||subtest||subtest level||group||differ||hfa||wais-iii profil||perform||diagnost group||speed||peopl||factor scale,asperg||autism asperg||autism||hfa||asperg syndrom||subtest||asperg group||asperg syndrom group subtest||asperg syndrom group||autism handbook||high-funct autism||autism journal||wai iii subtest||hfa group||autism learn,79.922||71.015||62.109||56.368||53.922||53.157||44.336||42.438||38.865||35.123||34.979||34.404||32.718||32.559||32.088,0.4,0.3,0.26666666666666666
706,Pediatr_Nephrol-3-1-1766479.txt,administr||sever side effect||noncompli||concentr||studi||adult patient||increas||guidelin||pediatr periton dialysi patient||iron||adult||erythropoietin||treatment||carnitin supplement||dosag||anemia||iron prepar||carnitin||report||periton dialysi||drug||children,erythropoietin||pediatr||opinion||periton dialysi||iron||perit dial int 21||pediatr nephrol pediatr nephrolog||erythropoietin alpha||erythropoietin therapi||erythropoietin beta||pediatr periton dialysi patient||nephrol dial transplant 14||pediatr periton dialysi patient guidelin||chronic periton dialysi||periton dialysi patient,34.712||24.322||23.814||22.4||21.798||18.939||18.715||18.654||18.033||17.356||17.281||16.311||16.114||15.863||14.934,0.6,0.3,0.26666666666666666
707,Plant_Mol_Biol-4-1-2295253.txt,seed||role||aba insensit||stratif||arrest||germin||studi||seed germin||develop||glucose-arrest seedl||treatment||day||gene||control||sugar||result||analysi||experi||compon||import||abscis acid||mutant||similar time window||phenotyp||seedl develop||media||aba,abi3||abi3 abi5||abi4 abi5 rab18 abi3 abi3||abi4||er abi3||gin abi4||gin||abi3 mutant||abi3 gene||PC abi3||abi3 locu||abi4 abi5||abi3 mutat||3 abi3||abi4 aba2-1 abi4 abi4,371.182||259.748||232.242||225.406||220.399||213.694||201.983||196.904||194.808||194.102||186.924||186.86||186.315||185.591||185.448,0.0,0.0,0.0
708,Matern_Child_Health_J-2-2-1592249.txt,time||knowledg||pregnanc||data||studi||patient||risk||inform||deliveri||famili medicin practic||annual exam||preconcept care||vast major||women||annual well-woman exam||preconcept health||popul||import||primari care practic||risk factor||survey||preconcept healthcar||physician||primari care,preconcept health||preconcept care||preconcept health educ||health||preconcept folic acid||preconcept healthcar||women||preconcept inform||comprehens preconcept health care||health care||physician||periconcept||fetal health||pregnant women||pregnanc,25.204||22.574||19.193||18.299||18.046||17.923||17.321||17.011||15.862||15.669||14.677||14.592||14.389||14.215||13.942,0.4,0.4,0.4
709,Anal_Bioanal_Chem-3-1-1839866.txt,signal enhanc||method||seira||immobil||gold||function studi||studi||metal||electrod||enhanc||potenti||properti||approach||protein||acid||surfac||metal electrod||substrat||interact||self-assembl monolay||film||enhanc factor||membran||techniqu,seira||osawa||ataka||seira substrat||seira spectroscopi||seira result||quantit seira||metal||bcsj.70.2861 osawa||0003702934067478 osawa||heberl||la971110v ataka||metal surfac||metal substrat||surfac,58.619||45.118||41.11||36.125||35.982||29.31||29.31||25.757||24.101||24.101||23.722||22.097||21.888||19.694||18.019,0.2,0.2,0.2
710,Biotechnol_Lett-4-1-2248218.txt,bioactiv||recombin protein||exendin-4||protein determin protein||express||purif||min||vivo||result,exendin-4||recombin exendin-4||exendin-4 reduc||synthet exendin-4||exendin-4 glucagon||exendin-4 dimer||exendin-4 antibodi||exendin-4 facilit||P. pastori||exendin-4 purif purif step total protein||analogu pichia pastori||summari P. pastori P. pastori||j.pep.2004.10.014 15866711 pichia pastori||2007 pichia pastori system||P. pastori E. coli,98.472||58.975||50.879||50.774||50.375||49.943||49.731||49.236||27.99||24.241||23.989||22.768||19.334||18.391||17.619,0.2,0.1,0.06666666666666667
711,Arch_Orthop_Trauma_Surg-4-1-2413128.txt,calcaneu||report||conserv treatment||subtalar arthrodesi||case||subtalar joint||bone graft||complic||pain||nonunion||month||calcan nonunion||fractur||patient||pseudarthrosi||trauma,subtalar||subtalar arthrodesi||arthrodesi||nonunion||subtalar joint arthrodesi||calcan nonunion||subtalar arthrodesi 6||subtalar arthrodesi 3||subtalar joint||subtalar fusion||calcan||calcaneu||calcaneu fractur||subtalar arthrodesi 62 3||femal 61 conserv subtalar arthrodesi,51.889||47.178||42.468||37.847||33.976||32.297||32.2||31.75||29.731||27.235||26.747||25.676||24.16||23.812||22.81,0.4,0.4,0.3333333333333333
712,Curr_Eye_Res-1-1-2430176.txt,visual prognosi||venou thrombosi||laser treatment||case||follow-up period||macular thick||studi||patient||effect||pathogenesi||neovascular||brvo||improv||sheathotomi||signific||ilm||macula||treatment||eye||abnorm hematolog factor||blood||branch retin vein occlus||occlus||hemodilut||month||final VA||small sampl size||group||grid laser photocoagul||random clinic trial||laser photocoagul||risk factor||inject||visual acuiti||short follow-up period||initi VA||hematolog disord||diseas||initi,occlus||retin occlus||vein occlus||retin vein occlus||vein||branch retin vein occlus||branch retin vein||retin branch||central retin vein occlus||retin vein occlus kaohsiung||hemicentr retin vein occlus||retin vein occlus Br||retin vein occlus result||branch retin vein occlus ophthalm||branch retin vein occlus Br,248.929||242.576||238.463||237.717||227.997||216.557||205.766||194.65||180.162||178.944||178.944||178.916||178.316||174.714||173.748,0.2,0.2,0.13333333333333333
713,Photosynth_Res-3-1-1769343.txt,absorpt spectra||band||structur||chl||reconstitut||fluoresc excit||complex||protein||pcp||nativ pcp||room temperatur||peridinin||molecular detail||energi transfer||high effici||energi transfer effici||spectroscop studi||chlorophyl||spectra||fluoresc excit spectra,peridinin||carotenoid peridinin||carotenoid||hiller RG||light-harvest||light-harvest complex||pcp||pcp complex||complex||hiller RG polívka||hiller RG grondel||sharpl FP hiller RG||chl pcp||reconstitut pcp complex pcp||ic2,58.669||53.553||48.438||45.76||44.178||41.584||39.674||39.332||38.989||37.35||36.657||34.582||33.954||33.857||32.263,0.2,0.3,0.2
714,Ann_Hematol-3-1-2040174.txt,follow-up||refractori itp||time||week||respons||long-term complic||studi||patient||rituximab||chronic||rituximab therapi||platelet||immun thrombocytopen purpura||dose||itp||treatment||cell||median time||month||chronic itp||rang||splenectomi||diseas||result,rituximab||thrombocytopen purpura||purpura||itp||Az||refractori itp||idiopath thrombocytopen purpura||immun thrombocytopen purpura||refractori idiopath thrombocytopen purpura||rituximab hematol||rituximab therapi||refractori||chronic idiopath thrombocytopen purpura||thrombot thrombocytopen purpura||rituximab infus,67.346||52.78||51.876||51.756||49.582||43.854||42.358||41.127||40.756||39.439||36.897||35.951||35.642||35.642||35.004,0.4,0.4,0.3333333333333333
715,Eur_J_Clin_Pharmacol-3-1-1779627.txt,categori||system antibiot||respons||questionnair||alspac||databas||data||studi||medicin product||medic||avon longitudin studi||antibiot||cohort||health||product||age||babi||parent||tick box respons option||paracetamol||medicin||number||drug||children,product||medicin product||medicin||alspac||homeopath product||herbal product||dermatolog product||otc product||product categori||prescript product||altern medicin product||children||anti-inflammatori product||no. product||non-therapeut product,48.688||40.585||32.481||32.034||30.857||30.168||28.965||28.58||28.258||27.581||27.056||26.699||26.495||25.869||25.618,0.8,0.4,0.3333333333333333
716,Qual_Life_Res-4-1-2238779.txt,follow-up||measur||respons||time||gener health statu measur||clinic condit||studi||patient||similar symptom||health statu||kccq score||empir evid||heart failur||nyha||clinic trial||valid||analys||similar clinic manifest||assess||intern consist||anemia||kccq||clinic chang||symptom||psychometr properti||statu||reliabl||disease-specif measur||baselin assess||diseas||follow-up interview,kccq||heart||heart failur||anemia||heart failur journal||heart failur questionnair||anemia statu||congest heart failur||decompens heart failur||heart failur popul||chronic heart failur||advanc heart failur||M. anemia||heart failur patient journal||keyword anemia health statu heart failur,63.307||58.748||57.368||56.276||42.975||40.134||39.527||39.192||38.859||38.747||38.611||38.246||36.286||34.936||33.817,0.6,0.3,0.2
717,Cancer_Metastasis_Rev-4-1-2362138.txt,mef||dna damag||cancer||role||target||level||respons||oncogen||depend||target protein||wip1||intrins activ||phosphatas||effect||dna damag respons||tumor suppressor||increas||dephosphoryl||compound||overexpress||cell||phosphoryl||major compon||apoptosi||mice||ppm1d||atm||p53||activ||human cancer||tumor||import||homeostat regul||cancer cell line||amplif||function||result,wip1||49 wip1 wip1 wip1 wip1 wip1||wip1 wip1 wip1 71 wip1||wip1 phosphatas||overexpress wip1||wip1 overexpress||wip1 dephosphoryl||wip1 pathway||human wip1||E. wip1||wip1 journal||wild-typ wip1||wip1 target||wip1 sirna||wip1 gene,392.162||327.174||314.18||227.015||205.473||205.473||204.285||200.593||200.05||199.921||199.672||198.966||198.007||197.565||197.537,0.2,0.1,0.06666666666666667
718,Skeletal_Radiol-4-1-2226078.txt,cancer||nsaid||method||week||complic||spinal metastas||ideal treatment||tumour ablat||combin||studi||patient||electrod||CT guidanc||effect||ablat||opioid||metastas||lesion||pain relief||treatment||cancer patient||net ablat time||pain interfer||local anaesthesia||bpi score||pain||deploy||radiopharmaceut therapi||radiat therapi||radiofrequ ablat||bone metastas||procedur||osseou metastas,ablat||radiofrequ ablat||radiofrequ||radiofrequ ablat session||image-guid radiofrequ ablat||pain||RF ablat||radiofrequ session||saline-infus bipolar radiofrequ ablat||ct-guid radiofrequ||keyword radiofrequ ablat osseou||tumor ablat||tumour ablat||imaging-guid radiofrequ||pain metastas,62.21||60.607||59.004||43.848||43.533||39.689||36.53||34.668||32.66||32.303||32.302||31.864||31.64||30.946||29.183,0.4,0.3,0.26666666666666666
719,Mol_Genet_Metab-2-1-2279742.txt,find||dmso||nativ gel||data||mutat||state||chemic chaperon rescu||amount||rescu||effect||catalyt domain||increas||amino acid||chaperon||compound||osmolyt||mixtur||tmao||growth||yeast||homocystinuria||enzym||protein||enzym activ||mutant cb protein||glycerol||activ||chemic chaperon||tetram||mutant||diseas||addit||missens mutat||cb||media||result,cb||chaperon||i278t cb||i278t||chemic chaperon||fold i278t cb||mutant cb||i278t cb protein||chemic chaperon rescu||cb activ||wild-typ cb||cb protein||WT cb||human cb||cb anti-serum,88.312||85.29||74.461||60.611||59.926||54.763||54.721||51.834||50.708||49.539||49.156||47.446||47.313||45.966||45.67,0.6,0.4,0.26666666666666666
720,J_Med_Internet_Res-2-2-1761853.txt,health||ethic||product||health inform||care||servic||peopl||internet,site||servic||health servic||internet health site||health||e-health site||health inform||user health||site share data||site manag||health internet||site store||health product||onlin health inform||site 2.,55.588||41.692||39.05||37.755||36.409||35.284||32.001||31.389||29.325||29.242||28.839||28.655||28.317||28.083||27.794,0.4,0.3,0.2
721,Anal_Bioanal_Chem-3-1-1764596.txt,author||molecular fragment||method||instrument||injector||higher bromin congen||hrm||studi||review||sensit||on-column inject||pbde||octabd congen||increas||compound||degrad||detector||polybromin diphenyl ether||temperatur||analyt||environment sampl||human sampl||bromin flame retard||HR instrument||instrument method||analyt techniqu||ptv injector||paper||higher bromin compound||analysi||column||standard||mass resolut||min||isobutan||congen||work||molecular weight||inject||inject techniqu||commerci standard||multipl inject||result,pbde||pbde congen||environ||bde congen||pbde degrad||pbde measur||pbde content||bromin||pbde research||pbde level||congen||bde 209||environ sci technol 33:26||major bde congen||higher bromin congen,77.835||57.147||43.535||40.677||40.366||39.537||39.373||39.209||38.923||38.918||36.458||27.453||27.192||27.118||25.951,0.2,0.1,0.2
722,Purinergic_Signal-3-4-2072917.txt,time||concentr||protect effect||experiment condit||effect||caspase-3||guanosin||treatment||cell||mpp||dna fragment||apoptosi||cell death||protein||dopaminerg neuron||activ||bind||cell surviv||molecular mechan||addit||result,post-treat||co-treat post-treat||co-treat||pre-treat||post-treat 1||guanosin||pre-treat co-treat 35 37||parkinson||post-treat 1 materi||post-treat 5 5||post-treat fig. 4||post-treat 38 38||neuroblastoma cell||sh-sy5i neuroblastoma cell||sh-sy5i,82.869||79.154||75.438||66.965||41.454||37.824||35.816||29.998||28.274||28.114||27.858||27.623||26.996||26.549||25.656,0.0,0.1,0.06666666666666667
723,Clin_Rheumatol-4-1-2367388.txt,rheumatoid arthriti||non-signific increas||studi||patient||clinic characterist||open pilot studi||effect||da||marker||intervent||benefici effect||antioxid intervent||treatment||blood||antioxid||oxid stress||stabl non-steroid anti-inflammatori drug||diseas activ score||clinic symptom||number||clinic paramet||step||period,antioxid||antioxid intervent||antioxid statu||antioxid capac||antioxid intak||antioxid supplement||plasma antioxid||antioxid therapi||rheumatoid||blood antioxid statu||rheumatoid arthriti||bioavail natur antioxid||rheumatoid arthriti nutr||rheumatoid arthriti scand||human antioxid defenc system statu,70.912||39.332||37.996||36.466||36.43||36.396||36.233||36.005||29.598||26.037||25.498||24.282||17.336||17.329||15.553,0.4,0.2,0.2
724,Ann_Surg_Oncol-3-1-1914254.txt,cancer||univers hospit||expertis||oper procedur||center||studi||year||patient||univers||hospit volum||effect||mortal||esophag cancer||select referr||outcom||treatment||oper mortal||hospit||data collect||surgeri||death||surviv||tumor||esophag carcinoma||esophag resect||surgeon||diagnosi||referr||stage||region cancer registri,hospit||nonteach hospit||hospit expertis||univers hospit||teach nonunivers hospit||hospit volum||hospit outcom||hospit mortal||esophag cancer||region hospit||low-volum hospit||high-volum hospit||9 hospit||2002 hospit||96 hospit,92.67||68.286||55.15||51.507||51.021||50.558||50.241||49.946||49.598||49.422||48.148||47.993||47.844||46.876||46.843,0.4,0.4,0.26666666666666666
725,Eur_J_Clin_Pharmacol-4-1-2235908.txt,curriculum||medic student||skill||knowledg||practic||core||patient||valid inform||inform||process||nierenberg||clinic practic||lectur||analyt reason||context-learn||undergradu medic curriculum||treatment||consult||essenti skill||educ||term||approach||effect approach||diagnost reason||script||experi||clinic clerkship||therapeut||teach||reason||current theori||clinic pharmacolog||import||undergradu student||pharmacotherapi||compet||student||drug||diseas||futur doctor||object||undergradu teach,student||curriculum||undergradu student||medic student||undergradu medic student||therapeut||therapeut teach||medic curriculum||CP||teach||medic student educ||context-learn curriculum||undergradu medic curriculum||medic student Br||undergradu teach,87.734||62.241||62.075||61.857||53.376||51.72||49.932||49.11||48.523||48.145||47.13||46.002||44.879||42.844||42.28,0.8,0.6,0.5333333333333333
726,Behav_Genet-3-1-2039802.txt,variat||origin||complex phenotyp||epigenet background||rat model||apo-su||epigenet factor||apomorphin suscept||low gnaw score||ap-pcr product||complex disord||topoisomeras II bind site||dna||unsu rat genom||rat||product||hippocampu||genet||wistar rat||unsu genom||genom||differ||high gnaw score||locu||epigenet variat||ap-pcr analysi||thalamu,aph-1b aph-1b aph-1b aph-1b gene||aph-1b aph-1b gene||aph-1b aph-1b copi||apo-su||aph-1b aph-1b 2005 2002||aph-1b mrna||aph-1b express||wistar rat aph-1b||apo-su rat||rat model aph-1b||epigenet||gamma-secretas compon aph-1b||rsa hpa||rat||apo-su sequenc,79.408||66.41||66.303||62.617||50.013||49.452||49.452||49.247||48.577||45.082||37.803||34.808||34.726||34.537||34.183,0.2,0.1,0.13333333333333333
727,Neuroradiology-3-1-2151779.txt,aneurysm||intracrani aneurysm||hour||time||logist regress analysi||diagnost angiograph run||procedur time||vessel||support devic||logist||anterior cerebr arteri||procedur||predictor||angiograph run||devic||patient||occurr||coil||min,aneurysm||coil||coil procedur||procedur||aneurysm procedur time||coil intracrani aneurysm||intracrani aneurysm||procedur time||642 coil procedur||642 aneurysm||321 coil procedur||actual coil procedur||unruptur aneurysm||aneurysm locat||giant aneurysm,90.029||77.574||71.92||66.265||65.411||64.63||58.158||53.103||51.234||49.945||49.3||48.565||47.896||46.97||46.744,0.6,0.5,0.3333333333333333
728,Appl_Microbiol_Biotechnol-4-1-2271084.txt,rel abund||concentr||methanogen popul||acetogen bacteria||studi||sulfat ratio||reactor||srb||probe||dgge||anaerob commun||methanogen||propion||divers||ratio||fish||oligonucleotid probe||complet oxid||sulfat||acet||activ||methanogen archaea||lactat||effluent||total bacteria||mix anaerob commun||acetogen||domin microbi commun||sulfate-reduc bacteria||percentag abund||bacteria||microbi commun||result,text||sulfat||bacteria||anaerob bacteria||methanogen||sulfate-reduc bacteria||sulfat ratio||sulfat reduc||acetogen bacteria||sulfat reduct||cdot||sulfat avail||similar sulfat||sulfat concentr||probe,95.36||52.021||40.03||39.889||37.418||32.032||29.379||29.079||28.778||27.901||26.754||26.01||26.01||26.01||24.351,0.6,0.6,0.4666666666666667
729,Matern_Child_Health_J-2-2-1592142.txt,consumpt||awar||knowledg||birth||pregnanc||year||folic acid||vitamin supplement||increas||folic acid daili||fortif||recommend||dietari supplement||educ||ntd||women||age||folic acid consumpt||health care provid||number||survey||supplement||birth defect,folic||folic acid||folic acid daili||folic acid awar||acid||folic acid supplement||folic acid messag||folic acid recommend||folic acid consumpt||folic acid mandat||suffici folic acid||genet folic acid||lower folic acid knowledg||meaning folic acid messag||nation folic acid campaign,145.818||112.747||83.714||82.743||79.676||79.212||77.671||76.965||76.453||76.426||75.165||75.165||58.694||58.542||57.6,0.4,0.3,0.2
730,Exp_Brain_Res-3-1-2048826.txt,condit||surfac orient||author||cue||surfac slant||slant trapezoid||data||studi||stimulu||orient||depth cue||percept||slant||altern||depth||depth percept||vergenc||perspect||slant rectangl||signal||present studi||eye||saccad||monocular arrow||slant rivalri stimulu||dispar||ambigu||conclus||display||direct||onset||surfac||ambigu stimulu||influenc||perceptu condit||trial||hypothesi||show||result,vergenc||eye vergenc||depth influenc vergenc||vergenc veloc||vergenc data||depth govern vergenc||vergenc differ||depth||vergenc chang||vergenc system||vergenc step||vergenc respons||ocular vergenc||depth percept||depth cue,200.838||108.591||104.819||103.048||102.83||102.125||101.864||101.439||101.143||100.979||100.905||100.419||100.419||91.856||85.906,0.2,0.2,0.26666666666666666
731,Int_J_Biol_Sci-3-3-1802012.txt,transcriptom||broad-coverag array||author||respons||method||microarray||databas||data||gene express||inform||review||serial analysi||increas||filament conceptu||abil||express||porcin sequenc||cell type||cell||infect||gene||pig gene express||est||annot||pig||porcin tissu||transcript||paper||tissu||protein||immun||analysi||qpcr||bioinformat||group||report||differ||snp||number||porcin||pathway||unpublish project||sequenc||librari||result,porcin||pig||pig gene express||gene||porcin affymetrix||gene express||express||pig microarray||porcin sequenc||porcin differenti gene express||porcin gene express data||est||porcin transcriptom analysi porcin||pig genom||pig express bioinformat,105.002||90.159||78.501||73.667||72.677||72.671||71.676||68.853||68.372||67.938||66.75||61.627||58.987||57.545||56.177,0.8,0.7,0.5333333333333333
732,Mech_Dev-2-1-2428104.txt,embryo||shh||breakpoint||region||human disord||site||pattern||express||dna||gene||delet||mice||ihh||limb||mous chromosom 1||anterior||mutant||polydactyli||limb bud||sequenc||posterior||result,dbf||dbf dbf||ihh dbf||shh dbf||2.6 dbf ihh dbf ihh dbf||gli3 dbf||3.3 dbf mutat dbf dbf||ihh ihh dbf||2.4 dbf shh dbf||shh ihh dbf||hand2 dbf||shh ihh shh dbf||dbf hay||3.2 dbf polydactyli dbf||hoxd13 dbf,445.167||445.167||309.039||299.86||280.221||270.83||267.553||263.663||261.222||257.543||247.078||231.795||231.788||228.706||228.706,0.0,0.0,0.0
733,Qual_Life_Res-4-1-2238788.txt,futur||questionnair||satisfact||control group||experiment condit||data||studi||patient||liver transplant||effect||inform||chronic liver diseas||clinic practic||mental hrqol||cld||consult||univari analys||control||chronic diseas||hepatolog||age||gener practic||experiment group||implement||group||hrqol measur||differ||checklist||computer measur||physician||diseas||experiment||score||hrqol||gener popul||result,hrqol||patient hrqol||disease-specif hrqol||patients’ hrqol||hrqol measur||hrqol inform||mental hrqol||hrqol data||hrqol issu||hrqol 24||hrqol topic||disease-specif hrqol questionnair||computer hrqol questionnair||gener hrqol mc||patients’ gener hrqol,121.217||81.938||70.072||68.1||66.124||64.443||61.917||61.829||61.178||60.608||60.608||50.864||48.346||47.478||47.215,0.4,0.3,0.2
734,Eur_J_Epidemiol-3-1-2071968.txt,signific risk factor||case||socioeconom statu||independ variabl||data||model||studi||year||patient||water||inform||variabl||proport||sourc||signific||impact||agricultur||cryptosporidiosi||analysi||popul||associ||water suppli||postcod||water treatment||ill||speci||result,cryptosporidium||cryptosporidium parvum||C. parvum cryptosporidium cryptosporidium C. parvum||cryptosporidium C. homini C. parvum||cryptosporidium C. homini C. parvum C.||C. homini C. parvum||C. parvum C. homini||C. homini||C.||0.001 cryptosporidium||cryptosporidium oocyst||cryptosporidium spp.||cryptosporidium speci||cryptosporidium int||result cryptosporidium 1 cryptosporidium,170.893||152.41||134.419||121.783||117.892||109.505||109.505||102.828||98.438||89.735||89.467||86.402||86.214||86.075||85.694,0.0,0.0,0.0
735,Graefes_Arch_Clin_Exp_Ophthalmol-4-1-2413124.txt,case||ppv||complic||studi||endophthalm||patient||pdr||anti-glaucoma eye drop||retin detach||event||prolif vitreoretinopathi||eye||advers event||final examin||hospit||intra-op complic||analysi||incid||convent ppv group||surgeri||intravitr TA inject||group||factor||differ||order||retin break||sampl size||signific differ||visual acuiti||diseas||diagnosi||addit surgeri,ppv||ta-assist ppv||convent ppv||ppv specialist||pdr||vitrectomi||triamcinolon||convent ppv group||triamcinolon acetonid||acetonid||ta-assist par||success ppv outcom||pdr eye||par||intravitr triamcinolon,101.513||70.476||55.607||50.756||49.159||39.975||39.346||38.828||37.923||36.499||36.013||34.837||33.679||32.586||27.929,0.4,0.3,0.2
736,J_Fluoresc-3-1-2064943.txt,short-liv unwrap state||data||time resolut||valu||blink||process||bulk experi||excit||total||acceptor||event||dna||label||intact nucleosom||dynam||fret pair||nucleosom||fluoresc intens||fret||immobil nucleosom||fret effici||lifetim||experi||fluorophor||spfret measur||trace||fluoresc||subpopul||nois||averag fret effici||donor,nucleosom||fret||blink||acceptor blink||nucleosom dna||immobil nucleosom||keyword fret nucleosom single-molecul blink||nucleosom dynam||dissoci nucleosom||fret effici||effici fret||intact nucleosom||nucleosom core||singl nucleosom||nucleosom construct,89.326||86.153||77.891||60.527||59.29||57.688||56.429||53.866||50.018||49.946||49.946||48.786||47.472||46.217||45.958,0.6,0.5,0.4
737,Pediatr_Radiol-4-1-2292492.txt,delay||tumor||neuroendocrin tumor||present||function imag||carcinoid||pancrea||carcinoid crisi||children||anatom||imag||diseas||diagnosi||patient||imag find||detect||gep-net,net||carcinoid||carcinoid tumor||tumor||neuroendocrin tumor||neuroendocrin||pulmonari net tumor||imag||nonfunct net||nonfunct tumor||pediatr gastroenteropancreat neuroendocrin tumor||carcinoid tumour||metastat gastroenteropancreat neuroendocrin tumor||primari net||primari tumor,38.647||38.168||38.07||37.972||34.401||30.83||26.885||24.874||24.185||23.847||23.599||23.181||22.192||21.654||21.317,0.6,0.4,0.26666666666666666
738,J_Gastrointest_Surg-3-1-1852387.txt,anim||inflammatori tissu infiltr||method||veloc||endothelium interact||model||studi||platelet||intravit microscopi||mild||sever AP||mild AP||microcircul||inflammatori respons||leukocyt||activ||perfus failur||platelet function||thromboxan||platelet activ||sever||acut pancreat||pancrea||tissu damag||inflammatori cell||function||result,platelet||pancreat||intravit||platelet veloc||acut pancreat||platelet adhes||platelet p-selectin||platelet reinject||rhodamine-stain platelet||platelet activ||platelet function||temporari platelet||separ platelet||platelet assess||pancreat microcircul,67.683||57.593||43.927||38.458||38.229||37.763||36.969||36.769||35.425||34.822||34.541||34.526||34.296||34.26||34.14,0.4,0.3,0.26666666666666666
739,J_Mol_Biol-1-5-2291452.txt,role||parent protein||depend||core||side-chain dynam||mutat||tnfn3||stabil||region||domain||exchang||dynam||fold||properti||protein||residu||chimer protein||parent||strand||backbon||loop||surfac||rate constant||fnfn10||fnotnc||fniii||intermedi,fnotnc||tnfn3||fnotnc protein||tnfn3 core||fnfn10||fold||unfold fnotnc||tnfn3 domain||protein fold||wild-typ tnfn3||tnfn3 gdmcl||core||protein||Φ||protein stabil,108.041||93.154||78.024||70.71||68.652||66.402||58.81||57.888||57.205||50.377||49.495||48.266||48.008||45.409||41.388,0.6,0.4,0.4
740,Intensive_Care_Med-2-2-1315315.txt,equat||icu admiss||hospit mortal||time||refer databas||prognost model||databas||logist regress||comput||sampl||data||model||patient||icu level||circumst||sap 3 score||mortal||develop||hospit discharg||variabl||sap 3 system||maximum valu||physiolog data||approach||hospit||region differ||goodness-of-fit||predict||intens care unit||score||refer||ill||check||icu||final estim||outcom||result,admiss||icu admiss||icu||icu admiss data||unplan icu admiss||icu admiss date||icu admiss 8||icu admiss 13||admiss score||icu admiss moreno rui||non-op admiss||icu characterist||icu admiss emerg room||sap 3 admiss score||icu 6,99.125||97.178||95.231||67.542||67.483||65.171||65.08||65.062||57.161||51.35||50.633||49.45||49.011||48.259||47.873,0.4,0.2,0.13333333333333333
741,Liver_Int-1-_-2156150.txt,respons||rate||combin||studi||patient||lamivudin||hbeag clearanc||quantit meta-analys||intent||hbeag-posit patient||treatment||meta-analysi||biochem respons||heterogen||analysi||nonadult popul||treatment safeti||primari efficaci measur||group||monotherapi||interferon||trial||addit,lamivudin||hepat||interferon||lamivudin combin||lamivudin therapi||combin hepat||chronic hepat||pegyl interferon||lamivudin addit||lamivudin reduc||interferon monotherapi||lamivudin combin therapi||lamivudin combin treatment||antigen-posit hepat||hbeag-posit chronic hepat,121.343||96.761||93.887||79.648||68.223||67.357||65.27||62.202||61.434||60.671||59.823||58.133||56.025||54.498||53.71,0.4,0.2,0.13333333333333333
742,J_Neurooncol-4-1-2295256.txt,meg||low-grad glioma||lgg||studi||state||patient||hemispher||correl||higher cognit function||special brain area||increas||rel||region||state brain activ||lower alpha||rel power||neurocognit deficit||delta||gamma band||brain||bilater frontocentr meg region||control||power||frequenc band||neurocognit function||analysi||theta||left pariet region||brain tumor patient||group||differ||tumor||diffus||healthi control||lower alpha band||diseas||left hemispher||result,meg||brain||lgg||band||brain tumor||lgg patient||brain tumor patient||patient||neurocognit function||meg record||meg region||meg registr||meg power analysi||brain activ||power,60.286||50.699||43.945||42.623||40.734||38.992||38.503||34.04||33.719||33.033||32.445||32.033||31.774||31.386||31.343,0.6,0.6,0.4666666666666667
743,Bioprocess_Biosyst_Eng-4-1-2214824.txt,envirocam||condit||measur||imag analysi softwar||imag analysi||shroud||system||broth||diamet||liquid||imag||larger number||ferment broth||scale||increas||abil||resolut||frame||modular camera system||bubbl size||ferment||situ measur devic||standard||agit||ccd camera||led light sourc||distribut||sauter||light||rang||camera||pixel||photograph||number||limit||size||bubbl||agit rate||result,"bubbl||bubbl size||bubbl measur||bubbl imag||bubbl diamet||bubbl distribut||500 bubbl||2,000 bubbl||bubbl break-up||bubbl edg||smaller bubbl||overlap bubbl||circular bubbl||65,000 bubbl||bubbl contrast",313.524||184.969||182.093||166.878||165.885||164.583||164.018||161.999||161.941||160.81||160.153||159.134||158.938||158.144||158.012,0.4,0.2,0.13333333333333333
744,Neuropsychologia-2-1-2394569.txt,addit activ||condit||non-sign||skill||BA 37||superior tempor cortex||hear adult||nativ signer||hear||gyru||individu differ||BA 21||experiment condit||model||studi||deaf nativ signer||perisylvian region||hemispher||deaf||languag||fmri||correl||speech||posterior portion||region||cluster||posit correl||sign languag||stimuli||brain||voxel||hear non-sign||BA 46||frontal cortex||analysi||task||associ||speechread||identif||activ||deaf children||group||deaf peopl||word||score||particip||experiment||middl||deaf particip,speechread||deaf||gyru||hear||deaf speechread proceed||silent speechread||speechread skill||speechread condit||tempor gyru||deaf particip||speechread word||speechread block||individuals’ speechread||al.||speechread materi,124.664||109.958||89.598||81.023||78.207||74.633||73.226||68.479||67.31||65.779||65.648||65.101||63.312||62.769||62.332,0.8,0.5,0.3333333333333333
745,Neuropharmacology-2-1-2194164.txt,effect||glutamaterg transmiss||excitatori postsynapt current||applic||endocannabinoid||solut||hippocampu||glutamaterg synaps||high dose||cannabinoid||concentr||transmitt releas||experi||slice||data||glutam||channel,cannabinoid||al.||hájo||cannabinoid inhibit||cannabinoid receptor||cannabinoid modul||1 hájo||endogen cannabinoid||cannabinoid ligand||cannabinoid effect||cannabinoid compound||freund||cb1 cannabinoid receptor||cannabinoid agonist win||2001 hájo,99.451||95.497||71.53||55.478||55.461||51.472||51.433||51.361||49.725||49.725||49.725||48.235||45.044||41.524||41.516,0.2,0.1,0.06666666666666667
746,Intensive_Care_Med-4-1-2271085.txt,bioimped||measur||svi||stroke volumeindex||studi||bioimped svi||cardiac output||coronari arteri bypass graft||error||data||algorithm||patient||tpco||transpulmonari thermodilut,bioimped||bioimped svi||svi||bioimped algorithm||thermodilut||bioimped devic||bioimped versu thermodilut||thorac bioimped devic||thorac electr bioimped||thorac bioimped cardiographi devic||7 svi||1 loa svi TD||second-gener bioimped devic||transpulmonari thermodilut||13 svi SB 14 svi,50.952||46.764||42.576||34.809||29.882||29.294||26.945||23.173||22.962||22.36||21.288||20.695||20.303||19.92||19.069,0.6,0.3,0.26666666666666666
747,Bioinformation-2-4-2255066.txt,gene||neurolog disord||entri||dnd||drug||databas||disord||diseas||neurodegen disord||sequenc,databas||neurodegen disord databas||neurodegen disord||neurodegen diseas||dnd||relat databas||sourc databas||compil databas||relat neurodegen diseas||comprehens databas||neurodegen diseas mechan||major neurodegen diseas||disord||neurodegen disord gowthaman ragul 1||drug,33.261||27.866||25.169||22.691||21.857||20.114||18.025||17.662||17.45||17.207||15.127||15.127||13.296||12.002||11.968,0.6,0.3,0.3333333333333333
748,BMC_Struct_Biol-4-_-331416.txt,program||method||figur||mlv||murin leukaemia viru||model||structur||probe||eia||region||domain||quest||loop region||sequenc similar||helic||gene||paramet||multipl||protein||molecular model||ident||residu||sequenc align||loop||agreement||signific sequenc similar||viru||sequenc||fv1||result,fv1||fv1 sequenc||sequenc||fv1 align||fv1 model||sequenc align||mlv sequenc||fv1 sub-famili||retrovir sequenc||mous fv1||fv1 NB||fv1 29||fv1 action||abbrevi fv1||htlv-i sequenc,105.55||96.982||88.415||77.216||71.74||68.649||68.005||59.712||56.561||53.598||53.38||52.775||52.775||52.775||51.145,0.4,0.3,0.2
749,Arch_Dermatol_Res-3-1-1800369.txt,prognost classif||cancer||tumour entiti||serum||melanoma||skin cancer pathogenesi||patient||skin cancer||primari melanoma||immunohistochemistri||malign melanoma||express||classif||metastasi||cell||squamou cell carcinoma||molecular marker||prognosi||vascular invas||prognost factor||cancer entiti||primari tumour||cutan malign||tumour size||classif system||invas||diseas||molecul||biomark||gene express,melanoma||melanoma melanoma||melanoma marker melanoma||metastat melanoma melanoma||melanoma progress melanoma||malign melanoma||cutan melanoma||metastat malign melanoma melanoma||metastat melanoma||malign melanoma cutan||cutan malign melanoma||melanoma Br||melanoma correl||melanoma patient||primari melanoma,188.753||188.753||134.411||133.423||128.822||126.409||122.417||116.083||105.758||102.967||102.967||98.271||97.608||96.544||96.437,0.2,0.2,0.2
750,Angiogenesis-4-1-2268731.txt,cancer||role||endotheli cell||nf-κb||mediat||effect||agent||angiogenesi||express||inhibit||treatment||cell||growth||growth factor||direct effect||apoptosi||angiogenesi inhibitor||activ||report||pathway||addit||inhibitor,nf-κb||angiogenesi angiogenesi||angiogenesi||nf-κb activ||nf-kappab||tumor cell nf-κb||tumor angiogenesi||angiogenesi inhibit||mechan nf-κb activ||keyword angiostat nf-κb||endotheli cell||nf-kappab activ||angiogenesi inhibitor||2008 angiogenesi||system nf-κb inhibit,71.336||53.842||53.842||45.382||40.719||34.073||33.67||33.245||31.226||31.107||30.819||30.073||29.056||28.104||27.995,0.4,0.2,0.26666666666666666
751,BMC_Fam_Pract-4-_-169167.txt,elect appoint||measur||time||method||questionnair||compat system||practic||appoint data||data||patient||numer data||primari care organis||develop||appoint||day||routin||term||approach||clinician||survey techniqu||care||literatur||definit problem||search||access||number||organis||broad approach||primari care||demand||mind||articl,appoint||care appoint||urgent appoint||appoint data||routin appoint||appoint system||elect appoint||surgeri appoint||GP appoint||same-day appoint||appoint 21||free appoint||care measur appoint||appoint system data||routin appoint avail,150.393||90.116||86.006||84.537||82.065||80.674||79.355||79.012||78.364||77.896||75.196||75.196||65.877||60.01||57.945,0.4,0.3,0.2
752,J_Chem_Ecol-4-1-2373416.txt,hydrocarbon||type||ppg||individu||strohm||extract||femal||postpharyng gland||sphecida||compound||proport||chemic composit||alken||unsatur||hymenoptera||gc-ftir||femal european beewolv||group||european beewolf||keton||secret||herzner||crabronida||function||polar fraction,strohm||philanthu triangulum||philanthu||E. philanthu triangulum||strohm E. linsenmair||hymenoptera||strohm E. philanthu triangulum fabriciu||hefetz||s002650050652 strohm||j.1365-2311.2001.00300.x strohm||13.1.52 strohm||s004420100702 strohm||j.asd.2006.08.007 strohm||E. philanthu triangulum F.||2008 philanthu triangulum,95.366||69.348||66.458||61.575||57.724||57.543||56.974||52.006||49.127||49.127||49.127||49.127||49.127||47.502||46.979,0.2,0.2,0.13333333333333333
753,Environ_Manage-4-1-2242854.txt,total nitrogen||watersh manag||downstream reach||spatial scale||stream size||nutrient||concentr||sampl||data||studi||effect||correl||ecoregion||total phosphoru||scale||land||total||site||watersh||downstream water qualiti||land cover||analys||relationship||riparian zone||varianc||previou studi||water chemistri||first-ord||high flow||water qualiti||differ||signific predictor||riparian||influenc||stream||annual water volum||surfac water chemistri||entir watersh||result,watersh||watersh land||land||riparian land||watersh land cover||riparian||riparian land cover||land cover||stream||riparian cover||urban land||riparian land cover classif||riparian land cover adjac||agricultur watersh||riparian land cover 2,135.505||131.41||127.314||114.736||111.375||102.159||100.259||99.31||88.568||86.732||78.876||76.58||75.963||75.69||75.207,0.4,0.5,0.3333333333333333
754,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-1779626.txt,membran||type II collagen||method||number||tissu||phenotyp express||cell viabil||articular cartilag||sampl||maci procedur||matrix||tissu engin||implant||distribut||chondrocyt||cell||ultrastructur analys||maci,chondrocyt||autolog chondrocyt||chondrocyt phenotyp||autolog chondrocyt implant||human chondrocyt||chondrocyt transplant||sheep chondrocyt||chondrocyt expans||autolog chondrocyt transplant||autolog chondrocyt implant int||human articular chondrocyt||implant||knee||autolog chondrocyt implant versu mosaicplasti||matrix-support autolog chondrocyt transplant,76.421||52.663||47.749||45.062||40.481||39.457||39.067||38.793||35.939||33.797||31.898||29.861||29.519||27.983||27.771,0.2,0.1,0.13333333333333333
755,Pituitary-3-1-2045692.txt,larg bronchial carcinoid||pancreat polypeptid||ectop ghrh-syndrom||glucos load||case||approxim entropi||ghrh concentr||ghrh||mri||concentr||studi||valu||patient||serum ghrh concentr||remov||increas||test||octreotid||pituitari gland||repeat CT||GH secret||treatment||secretori regular||examin||primari tumor||igf-i||acromegali||normal valu||long-term follow-up||medic therapi||surgeri||normal||report||tumor||decreas||carcinoid||secret||primari pituitari somatotropinoma||clinic find,ghrh||ghrh secret||GH||acromegali||GH secret||patient ghrh||ectop acromegali||ectop ghrh tumor||ghrh concentr||concentr ghrh||ectop ghrh syndrom||ectop||ectop ghrh sourc||dissemin ghrh||ghrh sourc,144.107||107.857||106.854||90.993||89.231||82.658||82.192||80.835||79.943||79.943||74.109||73.391||73.055||73.031||72.886,0.6,0.4,0.26666666666666666
756,Virus_Res-2-1-2194287.txt,bcl-2||vector||replicon vector||alphavirus||protect effect||releas||data||studi||effect||semliki forest viru||high-level express||similar result||vlp||express||cell||infect||egfp||apoptosi||cell death||protein||death||sfv||ire||replicon||viru replic||viru||construct||rna||result,bcl-2||al.||bcl-2 tsujimoto||bcl-2 express||bcl-2 ash||posit bcl-2||bcl-2 embo||bcl-2 faseb||bcl-2 regul||bcl-2 overexpress||bcl-2 famili||liljestrom||semliki||sfv||bcl-2 hcred fig. 2,106.561||70.911||59.921||59.3||56.256||54.245||54.055||53.814||53.281||53.281||53.281||50.622||44.665||41.686||40.408,0.2,0.1,0.13333333333333333
757,Med_Oncol-4-1-2386844.txt,cancer cell||cancer||level||low level||tumor growth||patient||basal express level||hsp||effect||sirna||express||present studi||cell||growth||fir||gene||reaction||heat shock protein||prolifer||protein||brdu incorpor||medic treatment||incub||result,fir||hsp70||hsp70 hsp70||fir incub||fir radiat||fir irradi||fir incub 2||result fir irradi||hsp70 sirna||hsp70a||hsp70 protein||2007 hsp70||endogen hsp70||hsc3||a431 cell hsp70a,123.95||71.553||71.553||68.302||67.46||65.635||46.278||44.097||43.291||41.245||38.561||35.777||35.777||31.214||29.366,0.2,0.1,0.06666666666666667
758,Biochim_Biophys_Acta-2-1-2428106.txt,Na||drug transport||studi||small intestin||effect||amino acid||nhe3||caffein||electrochem gradient||exchang||inhibit||cell||phosphodiesteras||uptak||activ||brush-bord membran||pde||incub||small intestin epithelium||function||monolay,phosphodiesteras||thwait d.t||dipeptid||intestin dipeptid transport||caffein||dipeptid uptak||intestin hpept1||transport||uptak||nhe3||intestin imino||intestin peptid transport||intestin oligopeptid transport||ganapathi V. thwait d.t||small intestin,39.586||37.215||35.485||34.873||31.382||30.285||29.399||26.436||25.086||24.561||24.419||24.255||23.709||23.053||22.898,0.4,0.4,0.3333333333333333
759,J_Occup_Rehabil-3-1-1915628.txt,follow-up||femal comput worker||week||muscl activ||myofeedback train||pain intens||baselin||model||studi||myofeedback||muscl relax||effect||work-rel neck-should complaint||complaint||EC group||va score||netherland||improv||intervent||signific||odd ratio||neck-should region||shoulder||pain||analysi||mfb||subject||factor||group||work-rel musculoskelet complaint||work||cinderella-bas myofeedback train||disabl||result,pain||myofeedback||mfb||ergonom intervent||intervent||shoulder pain||disabl||myofeedback train||pain intens||occup pain||pain disabl index||mfb group||ergonom intervent research||ergonom counsel||intervent group,67.003||66.06||57.441||57.056||55.137||47.101||46.888||45.593||42.519||42.142||40.691||38.177||38.038||37.376||37.025,0.8,0.7,0.4666666666666667
760,Osteoporos_Int-4-1-2358936.txt,grade||measur||low-norm bmd||method||deform||follow-up period||bone resorpt||baselin||data||vertebr deform||studi||year||patient||lumbar spine||risk||increas||sarcoidosi||fractur||suggest||bone turnov||bmd||GC therapi||gc||progress vertebr deform||women||hip||age||popul||subject||multivari logist regress analysi||group||preval deform||bone||ictp||progress deform||diseas||bone miner densiti,deform||vertebr deform||sarcoidosi||vertebr fractur||densiti sarcoidosi vertebr deform||bone||progress vertebr deform||morphometr vertebr deform||incid vertebr deform||fractur||preval vertebr deform||progress deform||bone miner||incid vertebr fractur||progress morphometr vertebr deform,76.759||72.818||71.187||59.733||56.833||53.237||52.636||50.931||50.756||50.591||50.073||44.515||42.705||42.033||41.266,0.6,0.6,0.4666666666666667
761,J_Gastrointest_Surg-3-1-1852378.txt,follow-up||case||imag||hepat aml||hepatocellular carcinoma||surgic resect||studi||year||seri||recurr||patient||hepat angiomyolipoma||conserv treatment||oper||treatment||month||angiomyolipoma||report||tumor||fine needl aspir biopsi||conserv manag||diagnosi,angiomyolipoma||hepat angiomyolipoma||hepat||keyword angiomyolipoma hepat angiomyolipoma liver tumor||hepat angiomyolipoma yang||hepat angiomyolipoma eur||hepat angiomyolipoma exhibit||tumor||malign angiomyolipoma||solitari angiomyolipoma||renal angiomyolipoma||small angiomyolipoma||hepat angiomyolipoma case sex||hepat aml||recurr malign hepat angiomyolipoma,77.893||66.732||55.572||44.678||44.488||44.488||44.488||41.624||39.909||39.713||38.947||38.947||35.705||35.687||35.501,0.4,0.3,0.26666666666666666
762,J_Abnorm_Child_Psychol-4-1-1915634.txt,type||self-report questionnair||homotyp||rcad data||sad||futur soph||gener anxieti disord||sampl||studi||correl||continu||scale||anxieti||disord||ocd||anxieti dimens||soph||girl||varianc||previou studi||taxonomi||social phobia||anxieti construct||gad||obsess compuls disord||commun sampl||symptom||previou work||item score||adolesc||panic disord||young adolesc,anxieti||000||anxieti disord||rcad||soph||anxieti symptom||child anxieti||anxieti problem||anxieti 2001||anxieti dimens||early-adulthood anxieti||anxieti construct||000 boy||earlier anxieti||000 sex,111.789||106.638||77.928||67.36||65.891||64.996||61.942||58.084||57.694||57.409||57.326||57.044||56.872||56.644||56.617,0.4,0.3,0.26666666666666666
763,Ann_Biomed_Eng-3-1-2040176.txt,atd||rollov||measur||acceler||time||crash mode||vehicl||roof deform||roof crush||data||studi||contact||head||far-sid||driver||test||rollov crash||dynam||present studi||human spine||atd neck||probabl column injuri||hybrid iii dummi||load||passeng||spinal injuri||local peak neck forc||dynam rollov test||seat belt||sensor||residu forc magnitud||injuri||camera||onboard clock||lap belt||cervic spine||cadav||load cell||suv||passeng atd||neck load||peak||passeng car||result,roof||rollov||passeng||roof rail||passeng atd||atd||rail||rollov test||sae||driver rail||passeng lap belt||roof rail acceler||driver||rollov crash||driver ’s roof rail,125.904||111.579||109.977||109.389||103.622||97.267||92.874||89.976||87.138||85.526||79.479||78.718||78.178||77.692||76.891,0.6,0.4,0.4
764,Ann_Hematol-4-1-2226003.txt,risk||thrombosi||studi||atherosclerosi||genet marker||serum ferritin concentr||carrier||associ||anemia||coronari heart diseas||coronari arteri diseas||iron||cardiovascular event||patient||thrombocytosi||cardiovascular diseas,iron||iron defici||iron store||iron defici anemia||iron overload||bodi iron||iron hypothesi||iron deplet||iron statu||iron paradigm||iron level||c282i||iron defici anaemia||sever iron defici anemia||bodi iron store,129.428||83.881||73.942||70.051||68.363||67.85||67.359||66.414||66.09||65.218||64.714||62.737||58.466||53.2||51.386,0.2,0.1,0.06666666666666667
765,Ann_Surg_Oncol-4-1-2234441.txt,condit||cancer cell||cancer||level||case||line||import role||hypoxia-resist hcc line||studi||patient||differenti hcc||immunohistochemistri||tumor differenti||hypox condit||statist analysi||express||differenti||liver cirrhosi||result||analysi||immunoblot analysi||hcc||tumor||import||rage||hepat||normal liver||noncancer tissu,rage||rage express||rage mrna||rage transfect||rage level||rage ligand||result rage||hcc||tumor rage express||0.456 rage express||differentiation-associ rage express||enhanc rage express||hypoxia-induc rage express||3. rage express||increas rage express,176.358||100.857||90.903||90.813||90.274||89.871||88.179||85.896||70.51||68.048||68.048||67.887||67.618||67.238||67.238,0.2,0.2,0.13333333333333333
766,Ann_Surg_Oncol-3-1-2077910.txt,follow-up||risk carrier||cancer||prophylact surgeri||find||complic||ovarian cancer||histori||microscop examin||breast cancer||hereditari BC||studi||year||mutat||pbso||data||risk||care histolog examin||fnac||relev data||pm||institut||examin||metastat diseas||standard procedur||women||mastectomi specimen||age||addit investig||prophylact mastectomi||group||famili||hereditari breast cancer||number||malign find||signific differ||primari BC||reconstruct||decis||breast||mastectomi,mastectomi||PM||prophylact mastectomi||breast||breast cancer||prophylact bilater mastectomi||bilater prophylact mastectomi||brca1||breast reconstruct||mastectomi specimen||PM breast cancer 1||PM specimen||hereditari breast||skin-spar mastectomi||PM histori,81.279||74.966||71.223||66.225||52.124||50.493||50.493||50.254||49.52||46.34||44.83||43.184||42.242||42.071||40.837,0.8,0.5,0.3333333333333333
767,Eur_Radiol-3-1-2077918.txt,peripher vascular diseas||level||time||scanner||contrast arriv||imag||data||patient||peripher arteri||review||extens calcif||imag qualiti||enhanc||resolut||peripher CT angiographi||contrast media||acquisit||vessel wall calcif||CT angiographi||bolu||import||diagnost cost||tabl||tomographi||pad||techniqu,angiographi||CT angiographi||peripher CT angiographi||subtract CT angiographi||tomographi angiographi||multi-detector row CT angiographi||multidetector CT angiographi||mdct angiographi||abrams’ angiographi||tomograph angiographi||spiral-ct angiographi||multislice-ct angiographi||3D CT angiographi||helic CT angiographi||dual-energi CT angiographi,163.412||121.878||95.717||93.972||89.354||86.821||86.279||86.092||84.575||83.17||83.14||82.99||82.948||82.671||81.744,0.4,0.2,0.13333333333333333
768,Diabetologia-4-1-2270360.txt,diabet||children||hyperglycaemia||mutat||patient||test||site||guidelin||featur||molecular genet diagnosi||treatment||genet diagnosi||molecular genet||gene||maturity-onset diabet||blood glucos||analysi||report||monogen diabet||diagnosi||modi||interpret||syndrom||result,hnf1a||gck||diabet||gck hnf1a hnf4a mutat||hnf4a||hnf4a mutat||hnf1a mutat hnf1a hnf1a young-onset diabet||mutat||result gck hnf1a hnf4a mutat||maturity-onset diabet||practic gck hnf1a hnf4a maturity-onset diabet||hnf1a mutat hnf4a mutat screen||gck hnf1a tcf1||issu gck hnf1a||modi,91.689||81.018||80.837||80.619||79.907||74.885||71.979||69.863||64.761||63.889||63.729||62.264||59.605||57.569||55.846,0.2,0.3,0.26666666666666666
769,Childs_Nerv_Syst-2-2-1705512.txt,mirna express||method||array result||microarray||sampl||oma||oligonucleotid microarray||human||probe||express profil||organ||human chromosom 13||nervou system develop||express||cluster||signal||nervou system||specif||analysi||cdna||hybrid||mirna||northern blot||microrna||profil,mirna||microrna||mirna express||mirna oligo||mirna probe||mirna oma||mirna biogenesi||neighbor mirna||intron mirna||mirna famili||result mirna||67 mirna||mirna research||mirna express profil||human mirna express,84.906||53.239||49.103||49.06||48.564||48.253||43.899||43.204||43.088||42.914||42.804||42.453||42.453||38.097||36.073,0.6,0.3,0.2
770,Int_J_Med_Sci-4-2-1796947.txt,larg||dna damag||cancer||function effect||method||individu||studi||nucleotid excis repair pathway||allel||effect||risk||drc||human||abil||dna repair||multipl gene||dna repair gene||dna||genotyp||epidemiolog studi||dna repair capac||damag||gene||meta-analysi||heterogen||polymorph||popul||associ||ner pathway||genet polymorph||nucleotid excis repair||lung cancer risk||lung cancer||pathway||statist signific||function,polymorph||xpd polymorph||xpd||dna repair polymorph||ercc2 polymorph||xpd ercc2||dna repair||xpa polymorph||caucasian||ercc2||dna repair gene xpd polymorph||dna||dna repair gene xpd||xpa||xpd gene polymorph,91.907||91.471||91.035||86.612||84.491||84.054||83.964||78.911||77.37||77.074||72.685||70.362||67.88||65.916||65.166,0.2,0.2,0.2
771,Fam_Cancer-3-1-1914241.txt,cancer||method||multipl tumour||fifti year||carcinoma||data||patient||young age||lynch syndrom||criteria||inform||bethesda-guidelin||colorect cancer||famili histori||guidelin||tumour||hospit||clinic genet centr||age||microsatellit instabl||crc||msi-analysi||famili||group||medic specialist||physician||diagnosi||hnpcc,colorect||msi-analysi||colorect cancer||hereditari colorect cancer||hereditari nonpolyposi colorect cancer||hnpcc||famili||famili histori||histori||hereditari colorect cancer syndrom||cancer||colorect carcinoma||hereditari nonpolyposi||hereditari nonpolyposi colorect cancer syndrom||hereditari tumour,49.499||39.242||39.031||37.737||33.396||32.332||29.983||29.836||29.689||29.189||28.562||27.764||27.761||27.425||26.723,0.4,0.5,0.4
772,Eur_J_Appl_Physiol-4-1-2358938.txt,muscl||time||exercis countermeasur||individu||rate||torqu develop||studi||resist exercis||inact control group||bed rest||frequenc||effect||increas||forc||abil||intrins contractil properti||knee extensor||maxim||vibrat train||day||mvc||stimul||foa||torqu||resist vibrat exercis||characterist||subject||exercis||contract||group||rve||isometr knee extens||isometr contract||train session||rest,muscl||bed||bed rest||rest||torqu||bed rest eur||skelet muscl||horizont bed rest||quadricep muscl||muscl unload||faster muscl||assess muscl torqu||slow muscl||vibrat muscl exercis||voluntari muscl function,57.771||55.179||51.692||48.204||39.376||36.586||36.171||35.09||33.997||33.997||33.345||32.382||31.664||31.379||31.287,0.8,0.4,0.26666666666666666
773,J_Biomol_NMR-3-1-1892527.txt,tensor||case||order paramet||system||dipolar coupl||constraint||bond||sampl||data||deriv||valu||princip axi||cholesterol||molecular re-orient||nmr interact||orient||inform||similar result||exampl||site||high degre||experiment error||dynam behaviour||pseudo-forc||quadrupolar interact||averag||molecular properti||nmr investig||nmr interact tensor||analysi||simul||molecular dynam||molecular align||solid state nmr||pgla||segment orient||pyren||membran||order||MD approach||peptid||heat||nmr data||molecul||molecular dynam simul||axi||time averag||compon,vec||nmr||nu||nu }_||alpha||deuterium nmr||beta||nmr constraint||}_||orient||document||simul||simul tensor||tensor||nmr paramet,95.982||80.785||68.9||60.61||60.252||55.137||53.059||52.924||52.32||49.084||48.634||48.59||46.573||44.557||42.99,0.0,0.1,0.2
774,J_Abnorm_Child_Psychol-3-1-1915644.txt,longitudin model||lower level||high level||questionnair||children||behavior||infant||parent-child attach||problem||qualiti||model||studi||year||caregiv||mediat||complet longitudin model||life||strang situat||extern behavior||stress life event||develop||low se||risk||test||se||domain||variabl||signific||cognit abil||present studi||earlier find||tempera||primari caregiv||research||contextu characterist||toddlerhood||assess||high-risk sampl||characterist||parent||path analysi||predictor||effect guidanc||teacher||factor||famili||predict||influenc||interact||earli predictor||ego-resili||score||parent-child interact||attach||result,child||extern behavior||parent-child attach||child develop||child behavior problem||child psycholog||parent-child interact||attach||behavior||child tempera||behavior problem||problem||parent-child attach 1975||child behavior checklist||child neg,86.112||77.217||74.162||66.337||66.165||64.766||64.166||62.858||60.677||56.959||56.192||51.707||50.283||50.035||48.636,0.4,0.5,0.4
775,BMC_Bioinformatics-4-_-521197.txt,model paramet||linear regress||cumul normal distribut||set||method||real gene||random sequenc||hidden markov model||emiss probabl||model||state||glimmer||hmm||fals posit||organ||test||start||signific||similar||gene||stop||train||protein||orf||rb||put gene||distribut||raw genom||challeng||order||score||number||perform||markov model||tabl||codon||length||probabl||statist signific||order markov chain||background state||sequenc,gene||orf||codon||easygen||gene finder||gene start||start codon||sequenc||predict gene||orf length||gene score||orf score||genom||random orf||codon model,75.603||73.124||68.508||64.29||62.762||59.517||55.97||54.257||52.727||50.521||49.85||48.61||47.943||47.092||46.664,0.6,0.4,0.26666666666666666
776,Calcif_Tissue_Int-3-1-2039811.txt,placebo||follow-up||method||raloxifen||baselin||studi||year||postmenopaus osteoporosi||total trabecular bone area||osteocyt||effect||correl||section||immunohistochemistri||test||follow-up biopsi||osteocyt apoptosi||cell||bone remodel||empti lacuna||percentag||women||apoptosi||apoptot osteocyt||placebo group||chang||group||biopsi||differ||number||raloxifen treatment||signific differ||posit osteocyt||averag standard deviat,osteocyt||raloxifen||osteocyt apoptosi||bone||apoptot osteocyt||viabl osteocyt||osteocyt number||dead osteocyt||osteocyt densiti||osteocyt death||total osteocyt||posit osteocyt||osteocyt surviv||osteocyt integr||osteocyt turn,134.033||105.387||86.229||80.681||75.375||69.061||68.468||68.26||68.122||67.668||67.59||67.54||67.456||67.017||67.017,0.8,0.4,0.3333333333333333
777,FEBS_Lett-1-5-1964784.txt,thymu||thymocyt||transcript factor||develop||egr||express||notch||cell||rhoa||transcript||mice||protein||enzym||pre-tcr||ap-1||wild type||cell develop||affymetrix gene||divers biolog function||loss||function,thymocyt||dn3 thymocyt||dn3||rhoa||C3 dn3 thymocyt||thymocyt develop||dn3 cell||C3 dn3||thymocyt differenti||pre-tcr||C3 dn3 cell||gtpase rhoa||3 dn3||thymocyt factor satb1||rhoa function,74.452||67.959||61.465||51.959||50.568||42.484||39.577||38.626||37.77||33.8||31.647||31.207||30.767||29.521||28.411,0.4,0.3,0.2
778,Oecologia-3-1-1915600.txt,pot||top-down control||studi||soil microorgan||microarthropod||effect||inocul||steril||soil biota||hodgkin||microorgan||growth||control||multipl||multitroph interact||plant perform||cook||factor||natur ecosystem||plant commun composit||influenc||biomass||rooij van der||root||nematod||microbi enemi||soil||result,T. ventrali||nematod||T. ventrali T. ventrali T.||T. ventrali T.||T. ventrali T. ventrali A.||T. ventrali A. arenaria T. ventrali||experi T. ventrali||1 T. ventrali||2 T. ventrali||tylenchorhynchu ventrali telotylenchu ventrali 1993 T.||T. ventrali tabl 1 tylenchorhynchu ventrali||soil T. ventrali 1998 T.||T.||ammophila arenaria T. ventrali 1995||root-feed nematod,205.723||196.493||188.672||177.305||165.897||157.211||139.058||138.082||137.36||124.585||124.017||123.112||120.469||118.352||114.058,0.2,0.1,0.06666666666666667
779,J_Interv_Card_Electrophysiol-4-1-2292475.txt,time||line||block||conduct||radiofrequ||pain score||isthmu length||studi||recurr||patient||atrial fibril||ecg||ablat||cathet ablat||atrial flutter||flutter||signific||cryo group||lower requir||bidirect block||recurr rate||cryothermi||applic||cathet curv||success||pain||similar rate||bidirect isthmu block||group||recurr flutter||arrhythmia||isthmu||cryotherapi||procedur||isthmu line||fibril||acut success||isthmu conduct,flutter||ablat||atrial flutter ablat||atrial flutter||atrial isthmu||cathet ablat||radiofrequ ablat||previou flutter ablat||RF ablat||J. atrial flutter||isthmu||atrial cathet||atrial flutter journal||isthmus-depend atrial flutter||typic atrial flutter,133.816||127.985||123.033||120.558||95.97||93.787||92.568||87.578||86.64||85.255||84.64||83.444||83.436||83.06||82.406,0.6,0.4,0.3333333333333333
780,Eur_Arch_Otorhinolaryngol-4-1-2217621.txt,adult form||year||cidofovir||rrp||form||vaccin||papilloma||lesion||treatment||hpv||infect||laryng papilloma||infect host cell||suffici clinic follow-up data||recurr respiratori papillomatosi||prophylact hpv vaccin||low incid||larg multi-centr collabor clinic trial||adequ airway||risk factor||diseas||juvenil onset form,papillomatosi||human papillomaviru||papilloma||recurr respiratori papillomatosi||human papillomaviru E6||glottal papillomatosi||pulmonari papillomatosi||juvenil recurr respiratori papillomatosi||human papillomaviru type||juvenile-onset recurr respiratori papillomatosi||human papilloma||human papillomaviru dna||hpv||human papillomaviru genom||human papillomaviru 6,60.118||41.775||35.433||35.403||32.754||31.64||30.059||30.041||29.8||29.421||28.675||28.468||28.158||27.85||27.85,0.4,0.2,0.2
781,Clin_Oral_Investig-4-1-2238784.txt,measur||dental eros||method||system||indic||data||age group||amount||eros||wear||criteria||epidemiolog||teeth||tooth wear||dentin||epidemiolog studi||occlus||partial record system||hard tissu loss||literatur||surfac||aetiolog||sever||loss||score,wear||tooth wear||tooth||dentin||multifactori tooth wear||eros||dentin 1 dentin||dent||dental eros||wear terminolog||tooth surfac occlus||enamel eros||patholog wear||wear pattern||signific wear,70.936||67.683||64.429||60.297||46.284||45.554||40.21||37.582||37.169||36.91||36.321||36.213||36.081||35.468||35.468,0.6,0.5,0.3333333333333333
782,J_Biol_Inorg_Chem-4-1-2359827.txt,reson||zero-field paramet||iii||electron supplementari materi||line||quadrupol split||citrat||site||fe-protein||superreduc||pattern||cluster||state||epr||activ,buckel||0||0 0||0 0 cluster||0 0 31||0 51 0||0 δ||spectra 0||0 cluster||0 31||3:1 0 5 0||0 1||münck||W. buckel||6 0,54.139||52.46||52.46||39.157||36.88||34.974||34.966||32.541||32.505||29.089||27.528||27.159||27.149||27.069||26.23,0.0,0.0,0.0
783,Ann_Biomed_Eng-2-2-1705490.txt,clinic situat||respons||hypertens||model||anim studi||averag error||increas||heart failur||adapt control||hemodynam||anim experi||dbt||drug interact||acut heart failur||acut||cardiac output||acut disturb||physiolog variat||part||snp-map loop||snp||snp infus||drug||input||setpoint||hemodynam variabl||actual hemodynam,NN||1 NN NN NN||NN mod NN||mod NN||NN mod mod NN||NN mod||NN mod mod||1 mod NN||NN mod mod mod mod||2 NN NN||mod||1 mod mod mod mod||1 mod mod||1 mod||1,254.51||236.49||231.275||219.658||219.658||219.658||208.04||207.249||198.746||190.443||184.805||184.33||184.014||183.618||182.431,0.0,0.0,0.0
784,Ann_Biomed_Eng-2-2-1705524.txt,capillari||consumpt||hepatocyt layer||case||simul result||model||strategi||mat||intern oxygen||hepatocyt distribut||inform||increas||doubl number||mmhg||intern geometri||cell||oxygen||flow field||shear stress||percentag||zone||flow rate||micro model||extern oxygen||flow veloc||cell distribut||shear stress distribut||hepatocyt||maxim shear stress||fraction||fluid flow||outflow zone||ga capillari||effect hepatocyt util ratio||amc-bal||clinic set||medium||result,hepatocyt||oxygen||2 2||2||ratio||mat||hepatocyt distribut 2||hepatocyt distribut||2 ga 2||oxygen ga||2 ga||oxygen capillari||2 2 2 5 2||2 medium||hepatocyt util ratio,109.89||87.589||83.945||83.945||81.439||78.483||78.32||75.507||73.174||69.61||67.788||67.594||67.239||65.571||64.211,0.4,0.4,0.26666666666666666
785,J_Gastrointest_Surg-3-1-1852394.txt,greater omentum||tumor||hemangiopericytoma||case||resect||patient||english literatur||literatur,omentum||hemangiopericytoma||greater omentum||omentum present||greater omentum eur||malign hemangiopericytoma||keyword hemangiopericytoma greater||greater omentum shiba hiroaki||schein CJ hemangiopericytoma||s11605-007-0099-x articl hemangiopericytoma||tumor||resect tumor||peduncul tumor||solitari tumor||vascular tumor,61.279||55.327||45.553||31.117||30.851||30.136||28.385||24.349||19.721||19.671||14.884||9.912||8.983||8.479||8.33,0.4,0.2,0.2
786,Behav_Genet-3-1-1824713.txt,model test||time||marijuana||problem||abnorm||model||year||normal rang||risk||frequenc||inform||present||environment influenc||analys||present studi||twin||age||liabil||parent||longitudin studi||conduct problem||genet||factor||presenc||influenc||substanc||england twin||risk factor||adolesc||initi||progress||environment risk factor||result,marijuana||adolesc marijuana||adolesc||self-report marijuana||2 marijuana||increas marijuana||experiment marijuana||marijuana involv||twin||keyword conduct problem marijuana||barn GE adolesc marijuana||adolesc alcohol||conduct problem||adolesc substanc||adolesc twin sampl,94.978||73.22||51.461||48.168||47.623||47.489||47.489||47.489||42.48||42.336||37.59||37.347||37.184||36.247||33.114,0.4,0.3,0.26666666666666666
787,J_Mol_Evol-3-1-1894752.txt,mechan||translat system||nuclear genom||case||origin trna-il||reassign||modif||cau||stramenopil||mutat||argument||aaa||present||base||cun||abil||amino acid||fungi||ambigu translat||mitochondri genom||uag||trna||code||ucu||gene||aua||delet||met||absent||stop||estim||wobbl posit||gau||pair||codon reassign||ambigu||simul||chang||releas factor||asn||trna gene||small number||uga||fact||posit||disappear||codon||ambigu intermedi mechan||speci||mitochondri genet code||base frequenc||length||origin posit||show,codon||codon reassign||reassign codon||reassign||stop codon reassign||codon disappear reassign||aua codon reassign||mitochondri codon reassign||trna||stop codon||codon reassign knight||sens codon reassign||codon reassign event||codon disappear||sense-to-sens codon reassign,364.979||323.943||323.943||282.907||242.513||239.675||236.451||228.319||224.601||222.317||221.04||220.488||219.723||218.059||217.601,0.6,0.4,0.26666666666666666
788,DNA_Repair_(Amst)-1-5-2077361.txt,telomer||yeast||role||non-permiss temperatur||strain||defect||checkpoint activ||mrc1||telomer dna||dna repair||protein||experi||depend||nucleas||checkpoint pathway||temperatur||accumul||ssdna||activ||dna replic,cdc13-1 cdc13-1 mrc1δ||cdc13-1 mrc1δ||cdc13-1 cdc13-1 rad9δ||cdc13-1 cdc13-1 mrc1δ yku70δ mrc1δ||rad9δ cdc13-1 cdc13-1 mrc1δ||cdc13-1 yku70δ||cdc13-1 mrc1δ yku70δ||mrc1δ||mrc1δ mrc1δ||cdc13-1 mrc1δ exo1||cdc13-1 rad9δ||uncap cdc13-1 cdc13-1 cdc13-1 fig. 5||cdc13-1 mutant||cdc13-1 mrc1δ yku70δ mrc1δ mrc1δ rad9δ||cdc13-1 mre11δ,319.901||293.962||256.975||252.202||246.767||228.473||224.363||216.142||216.142||208.137||199.573||194.149||194.145||188.79||187.41,0.0,0.0,0.0
789,Cell_Tissue_Res-4-1-2295254.txt,ecm||fibronectin||studi||ami phase 2||section||border-zon||adipos tissu||increas||infarct||cell||adhes||asc||prolifer||posit effect||stem cell therapi||ami||myocardi infarct||incub||posit||number||infarct area||area||stem cell||heart||cardiomyocyt||attach,fibronectin||fibronectin deposit||infarct||fibronectin accumul||fibronectin stain||human fibronectin||fibronectin isoform||fibronectin express||fibronectin occur||fibronectin 1||fibronectin serv||fibronectin concentr||fibronectin intens||fibronectin penetr||stem,128.903||74.47||70.967||67.253||67.025||66.35||65.359||65.156||64.989||64.452||64.452||64.452||64.452||64.452||52.915,0.4,0.2,0.13333333333333333
790,J_Behav_Med-4-1-2413087.txt,alcohol consumpt||level||find||higher level||time||wave||regard||mother||problem||parent problem drink||effect||genet suscept||environment factor||test||present studi||control||van der vorst||item||alcohol||father||parent||parent alcohol||longitudin studi||problem drink||famili||factor||drink||behavior control||adolesc||support||addit||children||result,parent||alcohol parent||parent alcohol||alcohol||adolesc alcohol||parent YA T2||U. parent alcohol||parent OA T2||parent YA T3||alcohol problem||parent OA T3||alcohol OA T3||T2||parent problem drink||alcohol psycholog,211.223||208.813||208.813||206.402||153.021||143.509||139.208||135.322||126.533||118.564||118.346||116.739||114.148||112.595||111.752,0.6,0.3,0.26666666666666666
791,Dev_Genes_Evol-4-1-2292478.txt,insect||genom sequenc||embryo||head||develop||observ||region||paralog||tiptop||teashirt||express||gene||conserv||trunk||leg||protein||ident||rnai||hox gene||member||famili member||dsrna||milkwe bug||pcr||segment||ectop express||addit||larval rnai||function||tsh||result,tsh||tc-tiotsh||tc-tiotsh tc-tiotsh tc-tiotsh||tc-tiotsh tc-tiotsh||tc-tiotsh tsh tio tsh||tsh tsh tsh trichoplax||tc-tiotsh tsh tio||tsh drosophila||drosophila tsh 2005 tsh tsh||tc-tiotsh tc-tiotsh tc-tiotsh tc-tiotsh prothoraxless||tribolium tc-tiotsh tribolium tc-tiotsh tsh drosophila||tc-tiotsh 2000 tc-tiotsh||tc-tiotsh tio tio tc-tiotsh drosophila||tribolium tio tsh||tc-tiotsh drosophila tio,341.72||288.962||288.962||288.962||268.23||257.049||243.733||233.585||231.744||231.717||206.732||192.642||180.882||179.962||171.643,0.2,0.1,0.06666666666666667
792,Mol_Syst_Biol-3-_-1800356.txt,set||method||enrich||modul||data||bind site||motif||top||inform||human||test||promot sequenc||background||signific conserv||promot||site||sourc||proxim promot||express||tcat||catalog||cis-regulatori modul||random||tissu||transcript||analysi||liver||balanced-error rate||order||mous||tissue-specif regul||vote||genbank||result,motif||tissue-specif motif||tissue-specif||high-confid tissue-specif motif||tissue-specif transcript||well-known tissue-specif motif||regulatori motif||tissue-specif modul||testi motif||NM||t-rich motif||rfx motif||binding-sit motif||g-rich motif||nuclear-receptor motif,85.713||79.385||73.057||54.562||53.864||53.509||52.954||52.315||51.812||48.898||48.423||47.294||45.814||45.814||44.336,0.2,0.1,0.06666666666666667
793,Behav_Genet-4-1-2226022.txt,uniqu environment factor||sex differ||phobia||twin correl||individu||sampl||data||model||studi||herit||effect||femal||blood-injuri||sex||spous||women||estim||varianc||twin||herit estim||age||genet||ade model||famili member||famili||factor||differ||domin||sibl||influenc||fear||assort mate||broad-sens herit estim||particip||non-addit genet effect||oldest age group||result,fear||blood-injuri fear||agoraphob fear||phobic fear||twin||social fear||fear subtyp||irrat fear||fear score||self-report fear||blood-injury-inject fear||maladapt fear||specif fear||fear dimens||persist fear,188.479||125.749||120.019||115.662||112.167||104.745||97.092||96.714||96.399||95.785||95.671||95.195||95.006||94.824||94.239,0.4,0.2,0.13333333333333333
794,Breast_Cancer_Res_Treat-3-1-2001218.txt,time||letrozol||signific benefit||hormone-sensit breast cancer||breast cancer||patient||tamoxifen||year||recurr||clinic||risk||prior cancer event||event||df||treatment||upfront therapi||distant site||system df||adjuv therapi||big 1-98||women||primari||analysi||monotherapi||trial||addit||primari core analysi||result,hospit||tamoxifen||dunedin hospit waikato hospit||auckland hospit christchurch hospit waikato hospit||canberra hospit||tamoxifen versu tamoxifen||adjuv tamoxifen||ospedal||breast cancer||1-98||tamoxifen group||ginecología hospit privado||big 1-98||tamoxifen therapi||cancer,97.143||67.383||50.438||50.261||49.383||46.849||46.217||45.587||43.117||41.885||38.444||38.076||37.941||37.939||36.181,0.2,0.2,0.2
795,J_Insect_Sci-1-_-355886.txt,lepidopteran||condit||immunodiffus||cecropia||concentr||v-mth||m-mth||sampl||fat bodi||extract||reserv||femal||present||egg||femal pupa||pupa||metamorphosi||yolk format||hemolymph||day||arh||short day condit||protein||whole-bodi extract||long day condit||hexamerin||monarch||mth||support||adult develop||post-eclos egg format,telfer||cecropia||insect||pan||cecropia v-mth||cecropia femal||1988 telfer||1990 telfer||1980 telfer||1983 telfer||hyalophora cecropia tojo||experiment insect hyalophora cecropia||1978 hyalophora cecropia||adult cecropia femal||insect hemolymph,101.403||95.002||68.334||60.233||59.753||55.217||54.418||54.279||54.057||53.756||49.968||48.492||46.423||45.166||44.11,0.2,0.1,0.06666666666666667
796,Domest_Anim_Endocrinol-2-1-2428105.txt,mechan||de||caruncular stroma||involut||caruncular tissu||studi||uterin involut||uteru||uterin horn||uterin igf system||myometrium||deep endometri stroma||se||region||dairi cow||express||similar||postpartum uteru||tissu||igf-ii||sub-epitheli stroma||horn||igf-i mrna||postpartum||mrna||bovin||igf,insulin-lik growth||igf||insulin-lik growth factor||insulin-lik growth factor-i||growth||insulin-lik growth factor-l||uterin insulin-lik growth factor axi||uterin involut||uteru||utero-placent insulin-lik growth factor||insulin-lik growth factor system||insulin-lik growth factor transport||uterin horn||cow||endometri igf,67.241||50.734||50.261||49.912||48.203||45.804||41.012||39.198||38.588||38.428||38.268||37.696||37.058||36.372||35.867,0.2,0.3,0.26666666666666666
797,Breast_Cancer_Res_Treat-4-1-2217620.txt,grade||follow-up||role||cancer||socioeconom statu||time||statist probabl valu||breast cancer||adjuv treatment||studi||year||excess mortal||brca||patient||risk||mortal||node||breast cancer patient||obes||larger tumour||classif||treatment||tumour||women||clinic behaviour||nodal statu||lymph node||age||prognosi||prognost factor||factor||surviv||tumour size||probabl||diagnosi||BC diagnosi||BC patient,surviv||breast||breast cancer surviv||breast cancer||breast cancer breast cancer||cancer||breast cancer specif surviv||primari breast cancer breast cancer||age breast cancer||long-term surviv||breast cancer diagnosi||breast cancer recurr||surviv bmi||breast cancer patient||patient breast cancer,182.584||159.109||156.88||144.028||144.028||128.947||117.924||115.639||112.12||106.131||105.901||101.774||101.58||100.68||100.68,0.4,0.3,0.26666666666666666
798,Health_Care_Anal-4-1-2226192.txt,level||bioethic principl||principl||bioethic||commun||univers principl||intern||social||univers||african countri||social respons||context||guidelin||ethic committe||countri||health||interview||relev||research||paper||polici||south africa||declar||research project||nation level||kenya||ethic||biomed research ethic||nation law||unesco,bioethic||bioethic declar||unesco bioethic declar||unesco||unesco declar||declar||unesco declar univers declar||bioethic principl||ethic||kenya||bioethic polici||bioethic regul||bioethic educ||bioethic tradit||univers declar,92.157||82.077||81.845||81.381||76.69||71.998||61.365||60.695||59.012||49.223||48.508||46.642||46.078||46.078||46.041,0.4,0.6,0.4
799,Appl_Microbiol_Biotechnol-4-1-2270352.txt,lime-tr wheat straw||lactic acid||amount||lime||process||ssf||total||ltw||hydrolysi||wheat straw||monomer sugar||product||glucan||enzym||ferment||phase||supernat||polysaccharid||pretreat||lactic acid product||fed-batch phase||pH control||hydrochlor acid||biomass||addit||mol||medium||calcium hydroxid||organ acid||result,lactic||lactic acid||acid||lactic acid product||lactic acid puriti||coagulan||lactic acid deriv||lactic acid concentr||ferment||decreas lactic acid product||organ acid ferment||acid product||acet acid||hydrochlor acid||B. coagulan,78.59||64.133||49.676||45.895||45.513||45.048||43.182||43.129||40.467||34.757||30.047||29.547||27.469||27.395||27.168,0.4,0.3,0.26666666666666666
800,Int_J_Legal_Med-4-1-2226061.txt,stabl mrna marker||time||method||genom express analysi||rna marker||sampl||stain||vagin secret||test||forens||saliva||express||rna degrad||tissue-specif mrna marker||gene||blood||tissu||analysi||experi||cotton swab||candid||identif||saliva stain||signal intens||mrna||gene express||candid marker,forens||saliva||saliva identif||forens casework||forens medicin||forens scienc||saliva stain||marker||swab||rna marker||rna||human saliva||saliva dataset||saliva detect||blood,67.965||53.158||37.29||35.506||34.632||33.983||31.744||31.257||30.966||30.321||29.386||28.763||27.638||27.313||25.65,0.4,0.4,0.3333333333333333
801,Apoptosis-4-1-2217618.txt,therapeut protein||rgdpeg-avidin||integrin||huvec||subunit||tumor tissu||complex||angiogen endothelium||cell||tumor vasculatur||jurkat cell||approach||product||apoptosi||proapoptot effect||protein||antitumor activ||rgdpeg group||experi||promega||tumor cell||activ||primari amino group||bind||incub||trail||ligand||result,trail||biotinyl trail||trail activ||trail complex||trail bind||unmodifi trail||trail variant||rgd-target trail||trimer trail||trail deriv||clinic trail||trail ’s||trail molecul||trail eur||rgdpeg-avidin,139.452||92.642||78.433||76.419||74.315||71.618||71.496||71.217||70.678||70.226||69.728||69.726||69.726||69.726||62.628,0.2,0.1,0.13333333333333333
802,Bioinformation-2-2-2174421.txt,year 2005||entri||categori||molecular biolog||javascript||access||global search||molecular biolog databas||number||categori list||user||databas||keyword||data||link||list||page,databas||databas link||dod2007||dod2007 dod2007||databas entri||1082 databas||inaccess databas||genom databas||209 databas||patent databas||databas segreg||databas scan||databas home page||specif databas search||molecular biolog databas,104.411||59.384||56.262||56.262||56.008||55.498||54.85||53.915||53.546||53.11||53.048||52.205||41.908||41.747||39.658,0.2,0.1,0.13333333333333333
803,Breast_Cancer_Res_Treat-4-1-2190785.txt,cancer||time||se indic||breast cancer||studi||patient||year||se||socio-econom strata||proport||high particip rate||women||eindhoven cancer registri||social class||socio-econom statu||distribut||group||surviv||vital statu||differ||adequ treatment||multivari rate||screen||diseas||screen programm||period||stage||introduct,se||cancer||op||cancer surviv||surviv||breast cancer surviv||breast cancer||breast cancer screen||breast||screen||socio-econom statu||socio-econom strata||low se||lowest se||high se,45.123||32.695||32.416||32.273||31.852||30.72||30.154||29.228||27.612||27.375||26.523||25.587||24.557||24.39||24.369,0.6,0.5,0.4666666666666667
804,Clin_Rheumatol-4-1-2367392.txt,amyloidosi||tracheobronchomalacia||kidney||patient,amyloidosi||tracheobronchomalacia||AA amyloidosi||amsterdam||keyword amyloidosi kidney rheumatoid arthriti tracheobronchomalacia||amyloidosi chin med||system AA amyloidosi||rheumatolog||amyloid||s10067-008-0836-x case report tracheobronchomalacia||amyloid deposit||VU univers medic center amsterdam||case report 1 fig. 1 amyloidosi||perivascular amyloid deposit||rheumatoid patient,27.076||19.394||14.964||11.457||10.366||10.088||9.976||8.261||8.123||6.846||6.732||6.106||6.021||5.987||5.247,0.4,0.2,0.13333333333333333
805,Clin_Auton_Res-3-1-1797060.txt,hrr||coronari arteri calcium||relationship||presenc||atherosclerosi||slow hrr||cac||young adult||particip||exercis||middl age||heart rate recoveri||year||cac score||heart rate||gxt,hrr||hrr tertil||slow hrr||2-minut hrr||hrr tertil 1||prior hrr studi||conclus slower hrr||exercis||sidney||cardia||recoveri||heart rate recoveri||heart rate||cac||tertil,70.114||43.207||41.347||39.7||28.904||25.223||23.914||22.208||19.841||19.017||18.106||17.514||17.218||17.129||16.301,0.4,0.3,0.4
806,Purinergic_Signal-1-3-2096543.txt,atp||respons||corneal epithelium||imag||migrat||wound repair||cell,2||2 2||figur 2 2||wound||7 2||receptor||migrat||asterisk 2||2 2 7e figur 7 2||egf||nucleotid receptor||2 4 receptor||5 2||red 2||6b 2,47.49||47.49||33.723||32.509||31.229||29.421||28.845||27.943||27.789||26.658||26.157||26.149||25.73||25.247||25.148,0.0,0.1,0.06666666666666667
807,J_Autism_Dev_Disord-4-1-2175022.txt,diagnost protocol||social domain||aq-d||studi||patient||mild asd||asd||diagnos||domain||comorbid||atn||adult||II disord||present studi||high function autism||item||gener outpati clinic||dutch||group||differ||autism spectrum disord||symptom||pddno||clinic experi||score||autism spectrum quotient||result,asd||autism||disord||asd patient||autism spectrum disord||asd group||adult asd||non-asd patient||mild asd||asd symptom||asd expertise-centr||non-asd group||asd diagnosi||sever asd||asd statu,63.116||50.791||45.677||38.78||38.14||37.464||36.532||34.203||33.487||33.284||33.12||32.887||32.505||32.094||31.558,0.4,0.3,0.2
808,J_Mol_Biol-2-1-2267215.txt,fn3||previou peptid studi||Ig||neural cell adhes molecul||bind site||spr||fibroblast growth factor receptor||tris-buff salin||fgfr||structur||tb||domain||fibronectin type 3||cell||conform||protein||ncam||acid box||dissoci constant||immunoglobulin||cell surfac||interact||cam||peptid||weak interact||mammalian cell||pb,ncam||ncam fn3||fn3||ncam fn3 domain||ncam fn3 tandem||ncam tandem||ncam protein||ncam fn3 domain tandem||ncam ig1||ncam region||ncam cdna||recombin ncam||nativ ncam||fn3 domain||fgfr1,99.908||86.278||72.648||65.916||62.023||56.71||53.213||52.815||51.467||51.139||50.782||50.669||49.954||48.92||48.801,0.4,0.2,0.13333333333333333
809,Diabetologia-4-1-2292425.txt,type 2 diabet||variat||insulin secret||gene||snp||childhood||genet variat||region||type 1 diabet||age||birth||variant||associ||popul||genotyp||studi||materi||growth||children,igf1 igf1||igf1 igf1 igf1 igf1||result igf1 igf1 igf1||igf1 8 igf1||hypothesi igf1 igf1||method igf1 igf1||igf1 variant||0.425 igf1||interpret igf1||9 igf1 10 igf1||igf-1 concentr igf1||2 igf1 igf1 6 7||sex discuss igf1 9 igf1||1 diabet igf1||1 igf1 tag-snp,137.559||137.559||103.17||93.029||91.706||91.706||73.553||70.076||68.78||68.78||58.847||56.536||55.024||54.719||52.903,0.0,0.0,0.0
810,Intensive_Care_Med-4-1-2271079.txt,bdi-ii||posttraumat stress disord||follow-up||younger age||ies-r||stay||final model||questionnair||instrument||abdomin sepsi||secondari periton||model||studi||depress||patient||sepsi||multivari model||major comorbid||develop||risk||memori||intens care||event||ptss-10||traumat event||initi emerg laparotomi||previou 3 year||hospit||age||hospit ward||median apache-ii score||factor||predict||nomogram||symptom||ptsd||diseas||icu||periton,ptsd||ptsd symptom||ptsd posttraumat stress disord||posttraumat stress||ptsd symptomatolog||stress||ptsd categori||posttraumat stress disord||posttraumat stress symptom||moderate’ ptsd symptom||ptsd symptom 1||prevent ptsd symptom||posttraumat stress disord symptom||post-traumat stress||stress disord,95.277||62.093||57.591||52.622||50.911||49.412||49.379||45.029||44.718||42.345||41.395||41.395||40.999||39.722||39.627,0.2,0.2,0.13333333333333333
811,Sleep_Breath-4-1-2211364.txt,srbd||oral applianc||sleep-rel breath disord||posit||dgz||posit paper||snore||mandibular advanc devic||obstruct sleep apnea||effect treatment option||treatment||dental sleep medicin||upper airway resist syndrom,sleep||sleep breath sleep||sleep medicin||sleep apnea||sleep physician||sleep research||dental sleep medicin||obstruct sleep apnea||obstruct sleep apnoea||sleep disord dentist||sleep medicin report||intern sleep societi||dgz||oral applianc||sleep medicin practic paramet,52.981||38.311||31.825||31.487||26.49||26.49||25.42||25.192||24.318||21.891||21.216||20.093||17.885||17.396||16.58,0.0,0.2,0.26666666666666666
812,Neurochem_Int-2-1-2194163.txt,effect||control||synapt transmiss||applic||amplitud||capsazepin||drug||glutam releas||data||glutam||studi||wild type||spontan epsc||capsaicin||epsc,al.||vanilloid||capsaicin||caterina||vanilloid receptor||vanilloid receptor trpv1||capsaicin receptor||knockout||marinelli||vanilloid receptor 1||1 caterina||vanilloid receptor-1||kofalvi||hájo||trpv1,63.757||41.071||36.083||27.607||25.804||23.442||23.31||23.06||22.977||22.546||21.818||21.816||20.584||18.948||18.718,0.2,0.1,0.06666666666666667
813,Purinergic_Signal-3-4-2072924.txt,singl channel||model||kinet,channel||cation channel||ion channel||atp-activ channel||p2x receptor||singl channel||7 receptor||4 receptor channel||7 7 receptor||surpren||p2x||atp-gat cation channel||p2x atp receptor||7 7||7,50.398||34.491||33.35||30.712||30.433||30.409||29.885||29.033||28.187||27.831||25.887||25.29||24.798||24.79||24.79,0.0,0.1,0.06666666666666667
814,Eur_Arch_Otorhinolaryngol-3-1-1914238.txt,cancer||troubl||qlq-h||qualiti||studi||patient||tongu||neck cancer||speech||teeth||comorbid||classif||tumor site||function deficit||impact||present studi||treatment||tongu mobil||pain||wors score||function statu||ill||major impact||singl item||oral caviti||oral tumor||score||hrqol||function||gener popul||result,comorbid||comorbid comorbid||speech||neck||head||hrqol||neck qualiti||comorbid condit||tongu||neck cancer||comorbid 32||oral function||speech intellig||neck cancer qualiti||speech therapist,56.861||56.861||46.833||45.424||42.76||33.874||33.844||30.387||29.826||29.419||29.244||28.665||28.076||27.034||24.866,0.4,0.5,0.3333333333333333
815,Eur_J_Pediatr-3-1-1802727.txt,placebo||respons||infant||efficaci||baselin||good clinic practic||studi||data||patient||bodi temperatur||gener state||probiot||trial medic||ecn||treatment||day||health||stool||treatment group||placebo group||nissl 1917||group||present trial||differ||acut diarrhoea||bodi weight||diarrhoea||number||trial||toddler||acut gastroenter||children,ecn||nissl 1917||coli nissl 1917||ecn group||treatment ecn||ecn treatment||investig ecn placebo ecn placebo||diarrhoea||ecn suspens||probiot||nissl 1917 infant probiot toddler||probiot E. coli nissl 1917||coli-stamm nissl 1917||nissl 1917 interfer||nissl 1917 scand,75.012||47.223||41.864||41.827||41.361||41.361||39.393||38.987||38.853||33.291||33.235||33.059||32.523||31.482||31.482,0.4,0.4,0.26666666666666666
816,Purinergic_Signal-3-4-2072925.txt,mechan||subtyp||role||neural stem cell||releas||patholog condit||central nervou system||atp||biolog function||develop||process||synapt transmiss||embryogenesi||cn||astrocyt||cell prolifer||express||calcium wave||differenti||cell||rat||physiolog||prolifer||approach||antisens oligonucleotid||glial cell||hippocampu||neuron||specif agonist||activ||rat hippocampu||earli stage||import||purinerg||knockout anim||purinerg receptor express||pathway||glutam||antagonist||purinerg receptor||result,receptor||purinerg receptor||purinerg||atp receptor||P2 receptor||p2x7 receptor||purinerg signal purinerg||p2y1 purinerg receptor||purinerg receptor cell membran receptor||purinerg receptor subtyp||purinerg receptor express||purinerg receptor activ||purinerg receptor function||p2x3 receptor||neurosci,82.222||73.446||64.67||61.429||56.903||53.405||53.301||52.635||52.528||52.277||51.965||51.572||50.459||49.397||49.391,0.4,0.2,0.2
817,Exp_Brain_Res-4-1-2257995.txt,measur||lowest intens||studi||motor cortex||effect||correl||mep||variabl||interhemispher inhibit||activ condit||motor hotspot||tm||inhibit||transcrani magnet stimul||sici||motor system||corticospin output||age||corticospin excit||subject||chang||fdi||activ||intens||older individu||function imag studi||ihi||pathway||hand,ihi||motor||chang ihi||chang chang chang ihi||rest ihi||motor cortex||mep||chang chang chang rest ihi||activ chang ihi||stronger ihi||ihi measur||long-lat ihi||chang||interhemispher inhibit||amt,63.672||53.985||48.486||40.893||40.374||38.469||37.856||36.13||35.439||34.014||33.473||33.351||33.3||32.081||31.584,0.2,0.3,0.3333333333333333
818,Dig_Dis_Sci-3-1-1914226.txt,tumor||rectal examin||signific medic histori||rectal gist||constip||calculu||gastrointestin stromal tumor||gist||abdomin pain||rectal tumor,gastrointestin||gist||gastrointestin stromal tumor||gastrointestin tumor||rectal gist||tumor||tumor calculu||calculu||malign gastrointestin stromal tumor||rectal tumor||rectal calculu||rectal gist present||gist present||calcifi gist||submucos calculu,32.618||31.695||29.806||28.125||25.304||23.632||23.101||22.57||22.354||21.273||20.742||17.8||17.243||16.836||16.827,0.6,0.6,0.4
819,Crit_Care-9-1-1065098.txt,attent||oper manag||role||regard||protocol||icu director||icu physician||ethic challeng||nurs manag||ethic topic||decis||review||articl||nurs||profession||intens care||manag||paper||polici||clinician||literatur||director||intens care unit||search||ethic||issu||difficult decis||physician||resourc alloc||dilemma||ethic dilemma||critic care||icu||clinic issu,ethic||icu ethic||ethic issu||manag ethic||ethic dilemma||organiz ethic||ethic discuss||ethic role||ethic topic||ethic challeng||icu||busi ethic||ethic concern||ethic import||ethic interest,139.903||106.311||87.155||83.607||76.091||75.649||73.628||73.116||72.901||72.75||72.718||71.845||71.779||71.337||71.233,0.4,0.4,0.3333333333333333
820,Crit_Care-9-1-1065088.txt,administr||case||eh||core temperatur||rate||studi||patient||dantrolen||effect||convent cool||sever case||heat stroke||bodi temperatur||dose||temperatur||treatment||cool||group||hyperthermia||relev studi||exert heat stroke||heat||convent method||result,dantrolen||dantrolen sodium||intraven dantrolen||dantrolen pretreat||dantrolen treatment||dantrolen dose||dantrolen group||dantrolen action||dantrolen exert heat||dantrolen sodium eur||dantrolen 3 mg||dantrolen 23 25||cool||dantrolen inhibit muscl contract||heat,244.474||129.574||128.152||126.094||125.538||124.76||123.172||123.025||107.653||86.672||85.413||81.862||68.98||64.565||56.964,0.2,0.1,0.2
821,J_Mol_Evol-3-1-1915622.txt,method||immun system||hypervari domain||secondari structur||select pressur||model||slr method||select||structur||vaccin||amino acid||region||domain||site||phylogenet relationship||analys||stretch||nonsynonym substitut||potenti||local||protein||recombin||outer membran protein||immun studi||posit||codon||sequenc||immun respons||align,influenza||al||omp-p1||H. influenza||H. influenza H. influenza bolduc||H. influenza bolduc||heamophilu influenza||H. influenza H. influenza meat||haemophilu influenza type||omp-p1 H. influenza thompson||yang||omp-p1 H.||haemophilu||codon||2000 H. influenza H. influenza popul,95.279||88.129||63.335||58.57||53.274||49.744||48.909||48.154||46.271||45.808||43.178||42.598||39.779||39.489||39.418,0.0,0.0,0.06666666666666667
822,Eur_J_Epidemiol-4-1-2270357.txt,signific level||set||method||case||scientif find||microarray||problem||data||model||studi||valu||variabl||confound||statist||signific||marit statu||smoke||independ data set||data split||research||analysi||pain||predictor||part||hypothesi fish||independ parti||two-stag analysi||number||epidemiolog hypothes||epidemiolog survey||case studi||hypothes||procedur||statist signific||population-bas survey,hypothes||hypothes fish||split||epidemiolog hypothes||multipl hypothes||data split||hypothesi||primari hypothes||hypothes effect||data||pain||hypothesi fish||data split method||keyword data split hypothesi fish data||data split procedur,65.92||42.3||41.66||38.264||36.394||35.853||34.824||32.96||32.96||30.046||29.456||26.753||26.043||25.876||25.35,0.4,0.4,0.4
823,Pediatr_Radiol-3-1-1950215.txt,cowperian duct||mullerian duct cyst||embryolog||urethr strictur||patient||intern sphincter||male urethra||present||vcug||congenit||bladder||diverticulum||male||urethra||urogenit diaphragm||anterior urethr diverticula||valv||anterior||dorsal aspect||urorect septum||anomali,urethra||urethr obstruct||urethr duplic||male urethra||urethr strictur||urethra posterior||posterior urethra||congenit urethr strictur||posterior urethr valv||bulbou urethra||prostat urethra||dilat urethra||ventral urethra||membran urethra||anterior urethr diverticula,88.891||58.504||57.672||56.069||55.521||55.293||55.293||50.842||48.464||47.422||47.1||46.333||45.882||44.445||43.372,0.6,0.3,0.26666666666666666
824,Cancer_Immunol_Immunother-4-1-2335290.txt,anim||cancer||case||immun system||respons||complic||carcinoma||studi||high altitud||patient||human patient||effect||massiv liber||section||sensit||system immun||metastas||necrot materi||human cancer patient||local edema||dose||therapeut effect||bladder||local treatment||immunotherapi||cell||therapi||treatment||boscc||day||applic||complet regress||sarcoid||local||mice||immun||month||conclus||nasopharyng carcinoma||interleukin-2||tumor||regress||order||cure||function||inject||sarcoma||immun reaction||median surviv time||result,il-2||local il-2||intratumor il-2||il-2 therapi||il-2 applic||il-2 immunotherapi||intralesion il-2||il-2 treatment||recombin il-2||il-2 instil||il-2 induc||intraves il-2||free il-2||inhal il-2||intraperiton il-2,566.357||345.0||322.97||307.269||299.956||298.62||296.712||294.421||292.907||291.5||290.47||290.328||288.61||288.385||285.417,0.0,0.0,0.0
825,Childs_Nerv_Syst-4-1-2367395.txt,small ventricl||case||tv||small supraorbit craniotomi||patient||altern||etv||routin procedur||shunt||treatment||slit ventricl||headach||mtv||ventricl||supraorbit craniotomi||hydrocephalu||lamina terminali||report||multipl shunt revis||procedur||supraorbit approach,shunt||hydrocephalu||ventriculostomi||sylviu||lamina terminali||tv||aquaduct||obstruct hydrocephalu||etv||shunt malfunct||ventricl||microsurg tv||occlus hydrocephalu||lumboperiton shunt||patient shunt,42.412||40.437||33.788||30.891||26.24||26.167||26.167||25.313||24.475||24.333||23.582||23.416||23.129||22.841||22.835,0.6,0.5,0.4
826,Protein_Expr_Purif-1-5-1885977.txt,gene||vector||tap||yellow fluoresc protein||yfp||tandem affin purif||protein||site||gfp||mc||tag||purif||cell,dictyostelium||abstract dictyostelium dictyostelium dictyostelium arp2||dictyostelium arp2||protein complex dictyostelium discoideum dictyostelium||dictyostelium arp||dictyostelium discodeum||exp5||dictyostelium gene dev||late dictyostelium develop||tap||tap-tag p34-arc dictyostelium D. discoideum||yfp||c-term||discuss clone strategi dictyostelium||conclus dictyostelium bsr gene,79.87||50.789||47.102||43.476||42.036||41.543||38.602||27.134||26.623||25.585||24.98||23.515||21.612||21.319||21.155,0.0,0.1,0.13333333333333333
827,Biotechnol_Lett-3-1-2045120.txt,crystal||cross-link protein crystal||ara||time||transport phenomena||studi||channel||motion||water||pore wall||amino acid||diffus coeffici||transport||lysozym||protein crystal||solut||protein||residu||analysi||orthorhomb lysozym crystal||simul||molecular dynam||order||diffus||free lysozym||molecul||result,crystal||lysozym crystal||lysozym||orthorhomb lysozym crystal||lysozym tetragon crystal||lysozym crystal channel||lysozym crystal matric||protein crystal||cross-link crystal||enzym crystal||β-lactoglobulin crystal||crystal channel||crystal structur||crystallin lysozym||hen lysozym,94.024||85.189||76.354||63.705||58.854||58.46||57.811||56.183||52.867||50.126||49.714||49.513||49.133||46.605||45.103,0.6,0.4,0.26666666666666666
828,Pediatr_Radiol-4-1-2292498.txt,grade||administr||urinari tract||imag||kidney||studi||uca||durat||fundament imag||vcug||increas||fundament mode||harmon||vu||cycl||bladder||urethra||advers event||examin||reflux||intraves administr||evalu||contrast agent||vur||renal pelvi||normal salin||levovist||modal||microbubbl||posterior urethr valv||ultrasound contrast agent||grade II||low diagnost accuraci||reflux diagnosi||procedur||vesicoureter reflux||precontrast||children||result,void||reflux||vesicoureter reflux||vu||reflux diagnosi||reflux detect||microbubbl||vesicoureteroren reflux||reflux sonographi||urosonographi||35 reflux||intraren reflux||1 reflux||reflux pressur||reflux unit,124.045||123.353||105.03||92.218||76.101||66.839||64.893||64.557||63.861||63.391||63.376||62.816||61.676||61.676||61.676,0.8,0.5,0.3333333333333333
829,Bioinformation-2-1-2139994.txt,gene||approach||polar side chain||protein||hypothet protein||databas||sequenc||amino acid residu||function||network,hypothet protein||protein||human hypothet protein||un-annot protein||protein famili||order protein||potenti protein||disord protein||function||protein subunit interact||human protein suravajhala prashanth||protein data bank||india||hypo||unknown function,30.67||28.72||20.951||16.14||15.265||15.173||14.36||14.36||13.406||10.829||10.228||10.055||9.828||8.757||8.515,0.4,0.3,0.2
830,Diabetologia-4-1-2292424.txt,follow-up||diabet foot diseas||diabet||heal||individu||rate||data||model||studi||end-stag renal diseas||year||patient||older age||prospect data||variabl||analys||sensat||eurodial studi||treatment||outcom||infect||esrd||foot ulcer||ulcer||diabet foot ulcer||predict model||characterist||popul||predictor||co-morbid||major amput||peripher arteri diseas||foot||non-heal||presenc||neuropathi||pad||daili clinic practic||result,foot||foot ulcer||diabet foot||diabet foot ulcer||ulcer||diabet||diabet foot ulcer patient||foot ulcer patient||diabet foot ulcer 11||recurr diabet foot ulcer||neuropath foot ulcer||diabet foot infect||diabet foot diabet metab||diabet foot wound||diabet foot diseas,109.58||98.668||89.934||89.208||87.756||70.289||69.727||69.54||66.906||66.906||66.197||65.636||62.82||62.341||61.101,0.8,0.5,0.4
831,Ann_Surg_Oncol-3-1-2077912.txt,time||seer||preval||data||locat||studi||year||patient||distant metastas||head||durat||seer 17 registri||pancreat cancer||epidemiolog||duoden gastrinoma||seer databas||tumor site||small insulinoma||multivari analysi||uncertain malign potenti||seer stage||age||pancreat endocrin tumor||prognost factor||group||islet cell||surviv||seer 9 registri||tumor||neoplasm||registri||islet cell carcinoma||seer program||diseas||diagnosi||pancrea||malign,islet||seer||seer registri||seer stage||seer stage seer stage||islet cell||seer 13||seer program||islet cell tumor||seer 17||seer databas||seer 9||seer 13 registri||seer 17 registri||seer 9 registri,83.605||82.235||56.332||45.077||45.077||44.987||43.11||42.882||42.655||42.429||41.902||41.828||38.883||38.429||38.028,0.4,0.4,0.4666666666666667
832,Eur_Radiol-3-1-1914219.txt,filter||measur||coronari angiographi||msct||imag||studi||valu||standard deviat||lumen||increas||vivo studi||cnr||contrast media||contrast materi||smooth||evalu||tissu compon||coronari plaqu||result||vivo model||oil||intracoronari attenu||specimen||snr||attenu valu||germani||coronari arteri||noncalcifi plaqu||plaqu||attenu||convolut||vivo||plaqu attenu valu,plaqu||coronari plaqu||noncalcifi plaqu||noncalcifi plaqu attenu||calcifi plaqu||calcifi plaqu attenu||attenu||plaqu attenu valu||coronari plaqu attenu valu||coronari attenu||plaqu attenu measur||atherosclerot coronari plaqu||coronari atherosclerot plaqu||noncalcifi plaqu valu||plaqu compon,117.378||86.653||83.591||80.135||77.916||76.352||73.223||70.074||66.538||64.576||64.089||63.488||63.488||62.268||60.942,0.6,0.5,0.3333333333333333
833,Addiction-1-_-2253702.txt,target||measur||effect size||subject norm||tpb||determin||model||studi||expect||ecstasi||review||intent||test||variabl||behaviour||evidence-bas intervent||ancestri approach||control||neg expect||research||associ||theoret framework||attitud||belief||social facilit||drug||posit outcom||public||compound construct,ecstasi||ecstasi user||ecstasi 29||actual ecstasi||ecstasi 11||ecstasi 1 0.40||ecstasi users’ approv||ecstasi 4 7||ecstasi 3 7 perceiv||ecstasi 3 8 perceiv||perceiv||behaviour||e.g. ecstasi enhanc sex||psycholog effect 1 4 ecstasi||1980 public year 4 ecstasi,193.293||100.97||100.132||97.222||96.972||70.432||67.872||66.768||63.697||63.458||55.826||54.294||50.48||45.804||40.845,0.2,0.1,0.13333333333333333
834,Ann_Hematol-4-1-2174523.txt,long travel||author||case||anteced||data||studi||patient||travel||venou thromboembol||vted||relat||plane||variabl||transport||potenti bias||control||meta-analysi||heterogen||associ||bia||factor||episod||methodolog qualiti||hospit patient||systemat review||dvt||result,travel||travel meta-analysi||long travel||air travel||prolong travel||intern travel||lengthi travel||travel Br||vted||vted dvt||long-haul air travel||dvt||prolong travel eur||büller HR travel||bia,119.887||66.999||66.108||62.946||61.994||61.099||61.049||59.944||58.059||50.229||44.0||42.398||41.329||40.88||38.674,0.4,0.3,0.3333333333333333
835,Arch_Dermatol_Res-3-1-1910890.txt,therapeut option||evidence-bas guidelin||unsystemat literatur search||evalu||aspect||psoriasi||psoriasi vulgari||expert||drug||recommend||guidelin||evid||patient||literatur||treatment||therapi||induct therapi||drug interact,psoriasi||psoriasi vulgari||psoriasi therapi||plaqu psoriasi||psoriasi plaqu||plaque-typ psoriasi||psoriasi Br||sever psoriasi||nonscalp psoriasi||moderate-to-sever psoriasi||psoriasi patient||psoriasi lesion||ordinari psoriasi||psoriasi vulgari Br||sever psoriasi vulgari,360.514||219.992||206.11||197.216||197.216||188.203||187.668||185.411||184.057||183.401||180.853||180.257||180.257||151.602||150.097,0.4,0.2,0.13333333333333333
836,Neuroimage-1-5-1971136.txt,quantit histopatholog||measur||visual inspect||protocol||mri||imag||roi||data||studi||valu||patient||volumetr mri data||correl||mtr||patholog block||region||neun||signal||resect tempor lobe||epilepsi||focal epilepsi||paramet||anterior tempor lobe resect||tissu||neuron loss||gray matter||vivo mri||quantit mri||field fraction||analysi||middl tempor gyru||subject||normal||quantit neuropatholog||white matter||neuron tissu||field||neuron densiti||mtr valu||patholog||histopatholog measur,mtr||T2||quantit mtr||histopatholog||quantit histopatholog||mri||quantit mri||epilepsi||T2 correl||roi1||histopatholog correl||roi2||mtr imag||histopatholog eriksson||T2 imag,65.788||63.9||55.918||53.885||49.967||49.814||47.932||47.761||45.677||43.277||40.67||40.391||39.567||38.916||38.623,0.4,0.5,0.3333333333333333
837,Biochim_Biophys_Acta-2-1-2258317.txt,cytosol||calmodulin||neuron calcium sensor||sampl||CN||data||studi||assay||dephosphoryl||nfat||analys||specif||cell||CN activ||calcium||nfat-gfp||control||pierc||gst||bovin brain cytosol||protein||nc||vitro evid||calcineurin activ||activ||bind||sd dissoci buffer||interact||cam||sd||calcineurin||bind buffer||detect||result,nfat||ncs-1||calcineurin||nc||nfat protein||calcium nfat||ncs-1 protein||nc protein||nfat dephosphoryl||nfat signal||nfat activ||calmodulin||ncs-1 signal||calcineurin signal||calcineurin activ,57.821||53.015||52.947||49.153||42.701||41.925||40.298||38.367||37.472||35.411||33.405||33.076||33.009||32.974||30.968,0.6,0.3,0.3333333333333333
838,Ann_Biomed_Eng-2-2-1705526.txt,tempor variat||variat||straight tube model||dynam model||time||oxygen transport||flow||veloc||import role||outer||wall||coronari arteri motion||studi||model||gradual increas||wss||motion||dynam curvatur effect||effect||pulsatil flow effect||region||ldl transport||lad||oxygen||pulsatil||ldl||flux||futur studi||factor||speci transport||medial region||arteri||mass transport pattern||curvatur||wall motion||instantan variat||coronari arteri||mass transport||wss pattern||speci||distal region||result,wall||arteri wall||wall motion||oxygen wall||outer wall||arteri||ldl wall flux||motion||arteri wall shear||pulsatil||dynam wall motion||flow pulsatil||pulsatil flow||wall motion effect||flow,119.23||95.672||95.403||76.924||73.066||72.113||71.731||71.575||68.704||68.606||68.477||68.252||68.252||68.205||67.898,0.4,0.5,0.4
839,Ann_Biomed_Eng-2-2-1705491.txt,flow condit||system||method||flow||studi||ldv||averag number||view||leukocyt adhes||specif||cell||shear stress||averag||hydrogel||leukocyt||surfac||firm adhes||field||number||interact||molecul,hydrogel||A. hydrogel||B. hydrogel||hydrogel scaffold||hydrogel substrat||nonadhes hydrogel||hydrogel system||polyethylen glycol hydrogel||hydrogel leukocyt adhes flow chamber||L. photopolymeriz hydrogel||A. 1986 hydrogel||peg hydrogel 1||cell adhes||leukocyt adhes||adhes ligand,62.11||39.218||33.935||33.919||33.201||32.606||31.441||28.444||27.18||27.113||26.649||26.035||25.975||25.416||24.634,0.2,0.1,0.13333333333333333
840,Eur_Radiol-2-2-1766021.txt,level||case||spatial compound||mammography-dens breast||CM enhanc||mri||imag||combin||studi||patient||harmon imag||calcif||tumour vascularis||breast tumour||speckl reduct imag||fundament mode||lesion||focal breast lesion||breast ultrasound||vascularis||thi||tumour||tissu||small tumour||vacuum biopsi||sri||bolu inject||biopsi||chi||digit imag||malign tumour||malign||contrast||breast||detect||tissu harmon imag,ultrasound||breast ultrasound||doppler ultrasound||breast||harmon imag||breast imag||breast lesion||imag||ultrasound contrast||tissu harmon imag||contrast-enhanc ultrasound||imag lesion||power doppler ultrasound||tissu harmon||3D ultrasound,62.689||54.322||46.522||45.954||45.899||42.627||39.408||39.299||36.895||36.78||36.427||36.08||35.762||35.52||34.9,0.6,0.5,0.3333333333333333
841,Eur_J_Appl_Physiol-3-1-1914240.txt,surfac emg signal||muscl||high level||knee angl||experiment day||data||studi||voluntari activ||neural drive||muscl length||maxim VA||increas||forc||high contract intens||present studi||twitch interpol||mvc||minor influenc||relationship||voluntari torqu||torqu||contract intens||conclus||subject||emg||herzog||contract||differ||triplet||rsemg||subject popul||angl||rest,torqu||voluntari torqu||triplet torqu||superimpos torqu||torqu relationship||interpol twitch torqu||extens torqu||torqu increas||VA||rel voluntari torqu||torqu level||torqu capac||absolut torqu||knee||muscl,120.803||91.316||74.04||69.749||65.833||63.705||63.041||62.532||62.245||61.464||61.022||61.002||60.402||58.923||54.005,0.4,0.2,0.2
842,Biochim_Biophys_Acta-1-5-1906864.txt,cmr||find||particl||lrp||atherosclerosi||studi||cholesterol||effect||increas||receptor||oxid state||top fraction||macrophag||foam cell||lipid||cell||crlp||lactoferrin||ldl||lipid accumul||uptak||apo||accumul||excess ldl||import||decreas||incub||chylomicron remnant||pathway||oxid||phagocytosi||foam cell format||result,chylomicron||chylomicron remnant||crlp||macrophag||oxid||remnant||chylomicron remnant biochim||oxid lipid||fluorescent-label chylomicron remnant||chylomicron biochim||chylomicron remnant model||crlp paramet crlp||chylomicron metabol||remnant lipoprotein||artifici chylomicron,84.08||67.0||66.056||65.306||50.549||49.921||46.869||46.635||45.667||45.343||44.667||44.037||43.588||43.219||43.157,0.8,0.4,0.26666666666666666
843,Matern_Child_Health_J-2-2-1592145.txt,pregnanc||disabl,disabl||disabl issu||physic disabl||disabl statu||disabl woman guid||disabl thierri joann||carlson D. disabl||disabl statist report||women||women women||2006 keyword disabl pregnanc women health||pregnanc||women health||disabl 2004 philadelphia lippincott william||pregnanc welner guid,84.476||47.477||43.988||42.238||32.246||31.078||29.415||29.4||27.243||27.243||24.497||22.634||19.438||18.87||17.659,0.2,0.1,0.13333333333333333
844,Invert_Neurosci-4-1-2413115.txt,crystal||insect||import role||bind site||achbp||subunit||structur||backbon carbonyl||molecular basi||ion channel||neonicotinoid||ctd||vertebr nachr||protein||residu||nitro group||ligand-bind site||hydrogen bond||crystal structur||interact||nicotin acetylcholin receptor||imi||insect nachr,Ls||neonicotinoid Ls||neonicotinoid||neonicotinoid insecticid||3 Ls||Ls 4||1 Ls||0 Ls||nicotin acetylcholin receptor||nicotin receptor||lymnaea stagnali Ls||neonicotinoid Ls 1 2002||sattel DB neonicotinoid||neonicotinoid action||sattel DB neonicotinoid insecticid,128.03||113.134||98.238||69.372||64.065||64.044||64.03||64.025||60.028||59.979||57.004||56.792||54.98||54.364||51.362,0.2,0.2,0.13333333333333333
845,Pediatr_Nephrol-3-1-1784542.txt,long-term cohort studi||proteinuria||respons||children||rate||studi||renal diseas||cholesterol||patient||lower respons rate||corticosteroid||effect||risk||agent||medic||nephrot syndrom||adult||dose||treatment||therapi||sirolimu||esrd||resist||report||urinari protein excret||kidney function||fsg||diseas||kidney||cardiovascular diseas,fsg||glomerulosclerosi||nephrot syndrom||steroid-resist nephrot syndrom||focal glomerulosclerosi||steroid-resist focal segment glomerulosclerosi||segment glomerulosclerosi||focal segment glomerulosclerosi||focal||steroid-resist idiopath nephrot syndrom||nephrot syndrom treatment||nephrot patient||idiopath nephrot syndrom||kidney||sporad steroid-resist nephrot syndrom,43.835||41.755||41.559||38.288||36.534||31.425||31.321||31.319||31.314||30.736||30.618||30.541||30.399||29.202||28.989,0.4,0.2,0.2
846,Dysphagia-3-1-1914227.txt,pharyng residu||volunt||data||studi||amount||head||water||viscos||increas||marker||temperatur||percentag||solut||data collect||analysi||bolu||xanthan||deglutit disord||pharyng||differ||refer||substanc||healthi volunt||oral caviti,pharyng||swallow||pharyng residu||viscos||xanthan||residu||postdeglutit pharyng residu||pharyng mucosa||pharyng paramet||pharyng pressur||volunt||pharyng bolu transit||xanthan solut||bolu||increas bolu viscos,91.376||90.099||72.138||61.264||60.821||52.899||50.225||47.013||46.803||45.688||45.336||42.935||39.093||34.61||33.156,0.8,0.4,0.4
847,Eur_J_Pediatr-4-1-2234440.txt,hypogonadotrop hypogonad||hypogonad||moebiu syndrom||patient,hypogonad||hypogonadotrop hypogonad||moebiu syndrom||hypogonadotroph hypogonad||hypogonadotrop hypogonad lópez||moebiu sequenc||suspect hypogonadotrop hypogonad||moebiu spectrum||poland syndrom hypogonadotrop hypogonad||syndrom||moebius-poland syndrom||ml||baraits||0.7 mU||3.5 mU,28.336||23.099||20.859||17.895||16.308||16.157||15.93||15.599||15.051||11.89||11.536||11.431||11.182||10.087||9.4,0.6,0.3,0.2
848,FEBS_Lett-1-5-1942070.txt,class II histon deacetylas||cell surviv||surviv||role||prolifer||respons||pkc||oxid stress||pkd||regul||pathway||data||express||bcr||present report||activ||cell antigen receptor||cell||essenti role||stress stimuli,kinas||pkd kinas||protein kinas||pkd||threonin kinas||famili kinas||protein kinas D2||c-depend protein kinas||dt40||alpha-depend protein kinas||protein kinas cnu||protein kinas c-alpha||protein kinas D3||protein kinas D1 activ||rozengurt E. cantrel D. protein kinas,99.994||81.86||68.483||63.725||51.633||51.584||48.554||47.401||46.803||46.695||46.594||46.536||46.118||38.299||37.001,0.2,0.1,0.06666666666666667
849,Pediatr_Nephrol-3-1-1805047.txt,crystal||calcium ion||risk||kidney stone||bri||healthi subject||kidney stone diseas||healthi children||statist analysi||age||adolesc||urin||adult||subject||studi||valu||ammonium oxal||bonn risk index||children||result,bri||oxal||bri valu||normal bri||calcium oxal||stone||calcium oxal crystal||calcium||ammonium oxal||bialystok||children||calcium concentr caox calcium oxal 2||laub||urinari calcium oxal satur||calcium oxal urolithiasi world,81.875||45.155||44.659||42.185||36.025||30.975||29.189||26.895||25.476||22.988||22.793||22.033||21.889||21.7||21.613,0.2,0.2,0.2
850,Pediatr_Nephrol-4-1-2335288.txt,gfr||chronic kidney diseas||case||hypertens||ckd||studi||end-stag renal diseas||year||patient||renal diseas||liver transplant||renal insuffici||risk||develop||epidemiolog||cyclosporin||lung transplant||esrd||serum creatinin||hematopoiet stem cell transplant||renal function||liver||transplant||hsct||calcineurin inhibitor||risk factor||diseas||cardiac||cardiac transplant||children,transplant||renal transplant||marrow transplant||lung transplant||heart transplant||liver transplant||transplant pretranspl||cardiac transplant||transplant type||transplant vari||transplant physician||age transplant||bone marrow transplant||renal transplant patient||marrow transplant recipi,290.765||189.181||176.83||163.349||162.017||158.506||153.804||151.717||145.383||145.383||145.383||145.383||127.634||126.252||123.362,0.4,0.4,0.26666666666666666
851,Eur_Radiol-2-2-1766022.txt,earli post-op period||time||case||complic||joint||high resolut||mri||aci||imag||high signal-to-nois ratio||cartilage-cartilag interfac||cartilag defect||smooth contour||studi||patient||autolog chondrocyt implant||cartilag repair surgeri||structur||defect||cartilag repair tissu||complet fill||synov||variabl||articular cartilag||delamin||cartilag||signal||defect fill||repair||evalu||paramet||tissu||cylind||graft||adjac cartilag||joint effus||normal||surfac||earli stage||bone||cartilag repair||osteochondr autograft||signal intens||biomechan statu||sequenc||nativ cartilag||techniqu,cartilag||cartilag repair||articular cartilag||graft cartilag||implant cartilag||cartilag implant||cartilag defect||articular cartilag repair||adjac cartilag||cartilag transplant||cartilag surfac||cartilag integr||hyalin cartilag||cartilag T2||cartilag signal,239.619||165.876||152.165||142.446||138.07||138.07||132.587||132.154||130.289||128.121||126.249||126.043||124.463||122.792||122.398,0.6,0.5,0.3333333333333333
852,Knee_Surg_Sports_Traumatol_Arthrosc-4-1-2358931.txt,measur||intact joint surfac||tekscan sensor||cartilag defect||contact||motion||effect||defect||forc||pressur||cartilag||stress||bottom||plug||surfac measur||osteochondr transplant||earli osteoarthr||flush level||sensor||weight bear motion||stress elev||weight||condyl||transplant||group||mosaicplasti||bone||border contact pressur||surfac congruenc||full-thick cartilag defect||knee||signific differ||articular cartilag defect,mosaicplasti||unbottom mosaicplasti||defect||osteochondr defect||osteochondr cartilag defect||cartilag defect||knee cartilag defect||mosaicplasti donor-sit defect||cartilag||knee||three-plug mosaicplasti||subsequ mosaicplasti||mosaicplasti techniqu||mosaicplasti area||osteochondr plug,90.307||65.415||57.231||55.894||53.712||53.289||51.738||49.959||49.348||48.636||48.27||46.604||46.527||46.453||46.134,0.4,0.5,0.3333333333333333
853,J_Mol_Biol-1-5-2098880.txt,muscl||fast||muscl contract||concentr||isoform||rate||releas||S1||data||studi||rabbit||amount||equilibrium||muscl fibr||actin bind||actin||amplitud||elc||adp||fast phase||essenti light chain||reaction||tca||pig||phase||lifetim||actomyosin complex||mhc||regulatori light chain||light chain||fluoresc||presenc||myosin heavi chain||constant||rlc||myosin||bovin,myosin||BM||BM BM||ob||1 BM||S1 myosin||myosin isoform||αD BM||myosin subfrag||adp||myosin subfrag 1||non-muscl myosin||BM S1||1 BM 13 BM||myosin motor,145.218||117.758||117.758||116.803||96.483||91.805||87.293||84.818||84.707||83.804||81.54||80.832||78.074||77.681||77.517,0.2,0.2,0.13333333333333333
854,J_Neurol-2-2-1705504.txt,genet studi||csf||molecular etiolog||anim model||model||studi||multifactori disord||pathogenesi||human||major||form||congenit||cellular signal pathway||brain||growth factor||molecular genet||gene||molecular||htx rat||genet diseas||cerebrospin fluid||genet loci||cytokin||genet factor||development mechan||hydrocephalu||locu||aqueduct||diseas||cellular prolifer||function,hydrocephalu||congenit hydrocephalu||human hydrocephalu||hereditari hydrocephalu||x-link hydrocephalu||inherit hydrocephalu||infantil hydrocephalu||early-onset hydrocephalu||hydrocephalu gene||normal-pressur hydrocephalu||prenat hydrocephalu||famili hydrocephalu||fgf-2-induc hydrocephalu||obstruct hydrocephalu||murin hydrocephalu,359.304||206.289||186.956||186.838||186.168||183.312||182.366||182.197||182.171||182.111||181.836||181.335||181.076||180.962||180.855,0.2,0.1,0.06666666666666667
855,Plant_Mol_Biol-3-1-1805040.txt,respons||microarray||data||comparison||valu||rice||floral transit||jasmon||express||genotyp||main shoot||present studi||stress||gene||control||salin||tissu||transcript||protein||growth stage||shoot||salt stress||report||toler||salt||agami||root||auxin||stage||plant,rice||salin||rice genotyp||rice plant||salin stress||salin toler||indica||_||japonica||rice growth||california rice||rice gene||rice os.2677.1.s1 _||rice varieti||rice locu,100.264||94.497||71.128||69.53||68.125||64.081||61.935||57.223||57.164||54.058||53.996||53.97||53.453||53.438||52.78,0.4,0.2,0.13333333333333333
856,Immunogenetics-3-1-1914303.txt,host||data||studi||host respons||express profil||express||signific||cell||pmn||infect||gene||mice||transcript||immun||analysi||group||rna qualiti||number||locu||pathway||lung||immun respons,pertussi||B. pertussi||B. pertussi B. pertussi||3 B. pertussi B. pertussi||bordetella pertussi||pertussi 3||B. pertussi infect||B. pertussi inocul||2004 bps-3 B. pertussi B. pertussi||B. pertussi 1949||2 B. pertussi||B.||3 B. pertussi infect||3 B. pertussi inocul||3 B. pertussi 6,244.602||178.517||178.517||143.743||143.214||124.626||124.405||123.161||120.997||120.084||119.301||112.432||94.466||93.534||90.421,0.0,0.0,0.0
857,Matern_Child_Health_J-2-2-1592140.txt,condit||embryo||asthma||mother||individu||pregnanc||studi||folic acid||concept||effect||risk||advers effect||inform||medic||dose||treatment||therapi||health||preconcept care||women||chronic condit||medic supervis||exposur||health care provid||isotretinoin||drug||drug administr||addit inform||fetu||plan,pregnanc||pregnanc registri||pregnanc regist||pregnanc talk||human pregnanc||isotretinoin||effect pregnanc manag||postmarket pregnanc registri||neg pregnanc test||teratogen||medic||pregnanc matern effect 6||matern medic||teratogen exposur||normal human pregnanc Br,103.836||53.518||52.668||52.557||52.293||41.592||38.534||36.509||34.612||34.136||33.282||32.938||27.107||26.508||26.4,0.2,0.2,0.2
858,J_Gastrointest_Surg-3-1-1852390.txt,time||stay||complic||persist dysphagia||studi||dysphagia||seri||patient||convers rate||convers||postop dilat rate||short gastric vessel divis||oper||oper time||cohort||fundopl||short gastric vessel||hospit||dilat||wrap||month||curv||reoper||decreas||laparoscop||seventh cohort||number||surgeon||learn curv||open fundopl||procedur||length||lnf||singl surgeon||laparoscop nissen fundopl||result,fundopl||laparoscop fundopl||laparoscop||laparoscop nissen fundopl||nissen fundopl||underw laparoscop fundopl||laparoscop reoper||redo fundopl||laparoscop nissen fundopl Br||watson fundopl||open fundopl||toupet fundopl||redo nissen fundopl||wrap||dehn tcbd laparoscop fundopl,119.592||106.883||94.174||88.447||85.584||77.337||70.973||68.285||67.465||64.885||64.605||64.402||62.715||59.038||57.523,0.6,0.3,0.3333333333333333
859,Exp_Brain_Res-4-1-2315690.txt,sensorimotor impair||target||obstacl||visual monitor||hemiparet CP||individu||begin||lah||data||studi||prospect control||hypothesi||intermedi fixat||effect||end||visual inform||statist analysi||visuomotor control||respect||control||cerebr palsi||saccad||hemiparesi||task||action||affect hand||experiment group||saccad initi||group||grasp time||number||hand||healthi control||trial||signific differ||particip||movement||object||landmark region||experiment||peak veloc,hand||hand movement||hand coordin||task hand||affect hand||hand veloc||moa||less-impair hand||non-pref hand||hand kinemat||factor hand||prefer hand||hand interact||CP||particip ’s hand,112.39||75.421||70.155||62.715||61.167||60.086||59.094||57.672||57.323||56.761||56.195||56.195||56.195||53.993||52.28,0.4,0.2,0.13333333333333333
860,Evid_Based_Complement_Alternat_Med-5-1-2249747.txt,mechan||condit||chronic smoker||method||emphysema patient||potenti applic||gsh inhal||studi||patient||sulfit||effect||respiratori diseas||review||potenti concern||antioxid protect||minor side effect||side effect||respiratory-rel condit||dose||inhal gsh||treatment||defens||antioxid||gsh||oxid stress||clinic effect||sulfit sensit||report||optim dose||glutathion||inhal||upper||urin||diseas||lung||lower respiratori tract||pulmonari diseas||articl,gsh||inhal gsh||gsh inhal||glutathion||inhal glutathion||glutathion inhal||gsh defici||inhal gsh effect||inhal||gsh replenish||gsh metabol||gsh mechan||gsh level||gsh concentr||regular gsh inhal,183.288||138.802||138.802||103.832||99.074||99.074||94.703||94.367||94.316||93.926||93.429||92.849||92.818||92.786||92.535,0.8,0.5,0.3333333333333333
861,Eur_J_Clin_Pharmacol-3-1-2039832.txt,regress analysi||limit sampl strategi||auc||time||satisfactori predict||ape||lss||popul||tacrolimu||renal transplant recipi||studi||strategi||pharmacokinet profil||literatur||patient||tacrolimu concentr,0||tacrolimu||text||12 0||12 0 12 0||0 4||method 0 12 0||0 23 0 12||transplant||actual 0||23. 0 4 0||tacrolimu pharmacokinet||2 0||nephropathi 0||21. 0 2 0,86.333||72.179||69.122||58.791||58.791||52.876||50.979||50.979||48.474||48.365||48.021||46.176||44.867||44.478||44.017,0.2,0.1,0.06666666666666667
862,Pflugers_Arch-3-1-2137943.txt,respir||anim||cathet||time||trans-diaphragm approach||trans-thorac approach||studi||increas||small amount||netherland||recoveri||mmhg||diaphragm||pressur||mct-induc PH||echocardiographi||rat||control||studi period||pulmonari arteri||cardiac output||ventricl||surgeri||pulmonari circul||respiratori rate||procedur||small burst||heart,anim||pressur||RV pressur||trans-diaphragm||RV||pulmonari arteri pressur||pressur cathet||trans-diaphragm approach||trans-thorac approach||pulmonari arteri||pulmonari embolis||pulmonari circul||recov anim||pulmonari embol||diaphragm,41.691||41.493||36.443||35.746||31.393||30.738||28.833||26.385||26.385||25.36||24.467||24.415||24.147||24.068||23.717,0.4,0.5,0.4666666666666667
863,Qual_Life_Res-3-1-2039864.txt,program||group differ||measur||rate||baselin||session||studi||attend||effect||vitamin supplement||mci||cognit declin||qol||intervent||community-dwel adult||signific interact||analys||outcom||day||percentag||item||random||daili live||age||subject||exercis||pap||physic health||possibl||activ||intens||group||differ||mild cognit impair||random control trial||trial||particip||supplement||moder intens||vitamin||result,vitamin||vitamin b12||b12||vitamin B6||B6||vitamin B6 supplement||d-qol||vitamin supplement||b12 supplement||qol||vitamin B6 mci||vitamin pill||supplement||walk||vitamin b-12,56.403||55.462||54.52||52.123||47.842||46.264||46.02||45.475||44.533||41.518||40.872||34.682||34.547||34.083||32.016,0.2,0.3,0.26666666666666666
864,Environ_Manage-2-2-1705480.txt,variat||lake||spatial scale||boreal lake||deposit variabl||independ variabl||studi||amount||water movement||effect||stepwis rda||water chemic variabl||total phosphoru||water resid time||process||region||variabl||site||alpin||veget||analys||alpin treeless area||largest amount||variat partit||rda||varianc||treeless land cover||toc||arabl land||natur variabl||water chemistri||stream chemistri||local-scal variabl||partial redund analysi||ecosystem||factor||differ||import||geograph posit||uniqu varianc||stream||anc||aquat ecosystem||interact||landscap posit||lake chemistri||total organ carbon||catchment,stream||lake||stream lake geograph||stream catchment||stream chemistri||lake chemistri||stream ecolog||stream water-qu||stream water chemistri||boreal stream||lake ecosystem||stream width||swedish lake||midwestern stream||stream manag,184.872||168.795||137.093||130.407||122.072||114.033||104.594||99.914||99.529||99.194||95.613||95.317||94.743||94.472||94.208,0.6,0.4,0.26666666666666666
865,J_Gastrointest_Surg-3-1-1852376.txt,origin imag find||metastat site||patient||recurr||patholog find||chemotherapi||sensit||metastas||high risk||extens extrahepat diseas||lesion||nonresect diseas||treatment||neoadjuv chemotherapi||bevacizumab||hepat resect||extrahepat diseas||liver||longer follow-up||tumor||colorect liver metastas||resect||neoadjuv treatment||abdomin CT||fdg-pet||detect||result,fdg-pet||fdg-pet neoadjuv chemotherapi||metastas||CT||resect||neoadjuv chemotherapi||hepat metastas||fdg-pet scan||colorect metastas||hepat resect||contrast-enhanc fdg-pet||baselin fdg-pet||follow-up fdg-pet||hepat colorect metastas||colorect hepat metastas,92.557||69.343||65.112||63.65||58.705||57.735||52.463||52.019||50.486||49.26||48.161||47.506||47.203||46.929||46.929,0.6,0.5,0.3333333333333333
866,Neuroradiology-3-1-2039855.txt,follow-up||superior cerebellar arteri||sca||cranial nerv||complic||clinic condit||patient||aneurysm||nerv||treatment||institut||circul||basilar arteri||endovascular treatment||initi angiograph result||complet||occlus||incid||good angiograph||addit||coil||outcom||result,"aneurysm||sca aneurysm||ruptur aneurysm||ruptur sca aneurysm||distal aneurysm||peripher aneurysm||treat aneurysm||2,112 aneurysm||wide-neck aneurysm||distal sca aneurysm||intracrani aneurysm||36 aneurysm||27 aneurysm||28 aneurysm||2 aneurysm",143.561||106.659||78.571||75.632||75.035||74.587||73.422||73.419||73.419||73.275||73.026||72.376||72.213||72.206||71.782,0.2,0.1,0.06666666666666667
867,Oecologia-4-1-2270359.txt,forag||tarangir||low nutrient||constraint||nutrient||larg tree||sampl||qualiti||domin grass speci||studi||savanna tree||savanna||gener linear model||effect||grass||high fibr content||canopi||veget||lower fibr concentr||ludwig||open grassland||energi||bush||dom||protein concentr||percentag||season||posit effect||nutrient requir||protein||veget zone||wildebeest||herbivor||open field||forag qualiti||requir||linear program model||african savanna||canopi edg||speci||tree||eleph||larg herbivor||maximum fibr intak||result,tree||savanna tree||savanna||tree canopi||larg savanna tree||larg tree||neotrop savanna tree||dead tree||tree stem||tree cover||SR tree||small tree||tree remov||tree crown||tree stage,179.426||149.973||120.52||110.16||108.439||102.399||101.52||98.628||93.593||92.548||91.295||90.629||90.6||90.311||90.184,0.6,0.4,0.26666666666666666
868,Naturwissenschaften-3-1-2039849.txt,time||pratt||social carri||model||emigr||strategi||recruit||frank||paramet||late recruit||paper||experi||ant||nest||scout||activ||mallon||rang||revers tandem||fraction||number||tandem||coloni||tandem run,ant||tandem||tandem run||emigr||ant leptothorax albipenni||revers tandem run||revers tandem||nest emigr||ant temnothorax albipenni||house-hunt ant||passiv ant||forward tandem run||house-hunt ant recruit||naïv ant||activ ant,86.318||77.569||65.007||56.081||52.659||52.379||52.345||48.293||47.682||47.637||46.477||46.441||45.735||44.065||43.663,0.8,0.5,0.3333333333333333
869,Eur_J_Pediatr-3-1-1876255.txt,middl ear||acut otiti media||studi||patient||year||aom||effect||tympanostomi tube insert||poor long-term prognosi||vaccin||tympanostomi tube||eustachian tube||antibiot||treatment||infect||day||acut inflamm||recent prospect studi||virus||result||age||month||dysfunct||viral infect||amoxicillin||tube||antibiot treatment||ome||episod||nasopharyng aspir cultur||viral test||bacteria||eustachian tube dysfunct,otiti media||acut otiti||acut otiti media||keyword acut otiti media otiti media||media||infant otiti media||otiti media eur||persist otiti media||chronic otiti media||recurr acut otiti media||acut otiti media eur||acut otiti media int||acut otiti media pathogen||janoski JE otiti media||chronic suppur otiti media,126.831||104.442||98.935||91.744||87.92||87.858||86.014||85.688||84.554||78.426||75.296||74.513||74.201||65.939||64.643,0.2,0.1,0.06666666666666667
870,Virchows_Arch-3-1-2039817.txt,tumor||mix inflammatori cell||pancrea||cystic mass||case||mural nodul||primari retroperiton||borderlin malign||foci||mucin cystadenoma||mass||cyst||retroperitoneum,mucin cystadenoma||cystadenoma||retroperiton cystadenoma||retroperiton||primari retroperiton cystadenoma||ovarian mucin cystadenoma||discuss mucin cystadenoma||mucin cystadenocarcinoma||primari retroperiton||mucin tumor||cystadenoma present||mucin cystic tumor||keyword retroperitoneum mucin||springer-verlag 2007 introduct mucin cystadenoma||retroperiton cyst NR mcabor,88.291||85.367||84.303||83.238||63.793||59.645||58.861||55.193||53.005||48.696||43.119||37.075||36.837||36.02||35.066,0.2,0.2,0.13333333333333333
871,Eur_Radiol-3-1-2077913.txt,time||thorac aorta||bpm||artifact||roi||imag||studi||patient||chest||acut coronari syndrom||ecg-gating-rel artifact||imag qualiti||ecg-gat chest examin||heart rate||excel inter-observ agreement||evalu||contrast media protocol||slice thick||acut chest pain||data acquisit||ventricl||pulmonari trunk||contrast attenu||attenu valu||dual-sourc CT||coronari arteri||independ reader||attenu||heart||nois||lung||aorta||score,chest||imag||aorta||chest pain||coronari arteri||pulmonari arteri||artifact||acut chest pain||imag qualiti||diagnost imag qualiti||thorac aorta||ecg-gat artifact||pulmonari trunk||arteri||rca,50.28||38.426||36.829||35.898||35.209||33.555||32.619||32.087||29.661||29.326||29.231||28.893||28.875||28.147||25.743,0.8,0.7,0.6
872,Purinergic_Signal-3-4-2072910.txt,gene||yeast||pseudogen||posit||evolut||nucleotid||orphan gpcr||receptor||intron||key residu||express||ortholog||specif||analys||agonist||adp||group,12||2007 12 12 12 12 12||12 12 12 12 12 56||receptor 12||12 3 12||conclus 12 12||receptor||12 18 21 12 12||1 12||14 12 12 anoli carolinensi 12||12 0.049||12 gnathostomata||12 33 12 2||0.034 12||12 12 M. m.,140.706||117.446||117.255||116.75||94.073||93.804||92.794||84.424||76.58||73.948||71.947||71.828||71.338||71.093||71.06,0.0,0.1,0.06666666666666667
873,Eur_Radiol-4-1-2270369.txt,signific cad||coronari angiographi||three-dimension imag||origin||variant||intermedi branch||preval||data||studi||patient||anomali||visual||cca||msct-ca||coronari anomali||complex anatomi||popul||anatom variant||diagon branch||number||coronari arteri||variabl number||segment||conu branch arteri,coronari anomali||coronari arteri||coronari arteri anomali||anomali||coronari angiographi||intrins coronari anomali||coronari arteri variant||anomal coronari arteri||coronari segment||congenit coronari arteri||coronari domin||coronari diseas||coronari arteri tree||coronari arteri diseas||arteri,82.831||73.193||71.053||66.771||64.723||55.935||53.407||52.912||51.873||50.394||50.292||49.445||49.312||48.796||47.496,0.8,0.4,0.26666666666666666
874,Virchows_Arch-3-1-1888716.txt,common variant||role||find||microarray||variant||sampl||data||studi||ptc||potenti biomark||lesion||express||cluster||gene||tumour||benign thyroid tissu||metallothionein||transcript||molecular patholog||papillari thyroid carcinoma||express microarray studi||group||follicular variant||rna qualiti||function||biomark||classic morpholog||result,metallothionein||thyroid carcinoma||ptc||thyroid tumour||thyroid lesion||thyroid cancer||human thyroid||thyroid tumor||thyroid carcinogenesi||thyroid neoplasia||papillari thyroid carcinoma||papillari thyroid cancer||malign thyroid carcinoma||fvptc||neoplast thyroid follicular,78.962||75.649||74.644||66.983||66.901||65.922||65.863||65.731||65.038||65.038||64.692||58.208||54.788||53.982||51.434,0.4,0.2,0.2
875,Matern_Child_Health_J-2-2-1592248.txt,ecolog model||program||strateg plan||level||commun||behavior||children||knowledg||panel||pregnanc||individu||focu||model||preconcept period||high risk||action step||clinic practic||recommend||provid||intervent||purpos||sector||health||preconcept care||goal||preconcept intervent||women||research||public polici||preconcept health||action||care||member||famili||lifespan||partner||select panel||step||outcom,preconcept||preconcept health||health||preconcept health care||preconcept care||preconcept health promot||preconcept health program||preconcept health knowledg||women health||preconcept health behavior||preconcept health action step||preconcept intervent||women health care||preconcept health indic||preconcept care intervent,132.051||122.172||112.294||107.185||104.63||90.76||89.804||84.428||83.689||82.834||82.196||81.9||81.529||81.448||80.336,0.6,0.3,0.26666666666666666
876,Mol_Biochem_Parasitol-1-5-1964783.txt,effect||dextran||rna interfer||parasit||defect||pcf||major defect||protein||degrad||rnai||express||arf||lysosom||knockdown||endocytosi,trypanosoma brucei||trypanosoma brucei arf1||T. brucei T. brucei||trypanosoma||trypanosoma brucei embo||tbarf1||arf1||T. brucei lifecycl||lysosom||T. brucei procycl cell||p67||fig. 1 T. brucei||tbarf1 rtf1||tbarf1 rtr1||abstract trypanosoma,55.151||47.506||41.21||39.498||36.768||33.256||32.215||29.43||28.347||24.106||23.277||22.109||19.953||19.953||19.749,0.0,0.1,0.06666666666666667
877,Eur_J_Clin_Pharmacol-3-1-2071959.txt,level||method||time||haart||histori||data||studi||patient||bottl||antiretrovir medic||regimen||period||form||failur||mem cap||thirti patient||self-report||hiv patient||treatment||therapi||feasibl||viral replic||low resourc||pilot-studi||reason||pill intak||monitor||botswana||adher||electron monitor||pill,adher||poor adher adher||antiretrovir adher||medic adher||electron adher monitor||treatment adher||adher measur||adher failur||strict adher||adher level||adher partner||low adher||monitor||medic regimen adher||antiretrovir drug adher,104.2||69.9||68.773||61.412||59.777||55.351||53.878||53.328||52.804||52.779||52.734||52.532||47.628||47.501||47.157,0.2,0.1,0.13333333333333333
878,Histochem_Cell_Biol-4-1-2386529.txt,type||denk||steatohepat||apoptot protein||unpublish data||variant||zatlouk||cytoplasm inclus||omari||mallory-denk bodi||mdb format||studi||patient||aggreg||human||inclus||mdb||degrad||p62||phosphoryl||type II||oxid stress||alcohol||mice||protein||format||liver||hepatocyt||import||ubiquitin||keratin||major constitu||diseas||toxic memori||function,omari||keratin||mallori||omari MB keratin||omari MB||MB keratin||keratin filament||liver||omari MB keratin variant||p62||mallori bodi||keratin cytoskeleton||keratin variant||omari MB fickert||keratin transgen,94.831||94.698||80.641||79.642||72.113||72.047||69.823||68.545||62.48||61.944||60.636||52.904||52.847||51.232||50.242,0.4,0.4,0.26666666666666666
879,Pflugers_Arch-3-1-1915585.txt,role||endotheli cell||glycosaminoglycan chain||endothelium||dermatan sulfat||delic layer||permeabl||mechanotransduct||glycoprotein||plasma-deriv protein||two-photon microscopi||chondroitin sulfat||hyaluronan||vascular diseas||specif||heparan sulfat||endotheli surfac layer||cell||endotheli glycocalyx||glycocalyx||blood||shear stress||vascular endothelium||specif protein bind||part||number||layer||interact||proteoglycan||patholog||molecul||membran||function||compon,glycocalyx||endotheli glycocalyx||endotheli cell glycocalyx||endotheli glycocalyx determin||endotheli glycocalyx protect||cardiac endotheli glycocalyx||glycocalyx composit||venular glycocalyx||glycocalyx thick||glycocalyx structur||glycocalyx perturb||glycocalyx degrad||intact glycocalyx||lumin endotheli cell glycocalyx||endotheli glycocalyx damag coincid,178.631||149.382||105.316||99.588||99.588||99.588||92.966||91.498||90.516||90.472||90.257||90.0||89.97||80.533||75.583,0.4,0.2,0.13333333333333333
880,Mol_Syst_Biol-3-_-2174632.txt,biolog||set||ra||block||databas||data||quantit analysi||mutat||motif||oncogene-sign block||mutat frequenc||node||oncogene-sign collabor||tumorigenesi||event||pattern||regulatori relat||downstream||cell||gene||map||protein||analysi||regulatori loop||neutral hub||alter||cancer signal||tumor||oncogene-sign rout||surviv||gene mutat||number||oncogen stimuli||sequenc||function||network||result,mutat||gene mutat||mutat gene||gene||signal gene mutat||network gene||gene methyl||signal||gene mutat frequenc||network||block||methyl||al||cancer gene||oncogene-sign block,106.296||105.737||105.737||105.177||96.882||88.553||87.922||79.174||72.878||71.929||71.115||70.667||68.171||67.563||66.99,0.6,0.4,0.4
881,Obes_Surg-4-1-2367390.txt,band||case||morbid obes||gastric band||paraesophag hernia||perfor||complic||sever complic||patient||stomach||gastric perfor,intrathorac||intrathorac perfor||perfor||intrathorac stomach||gastric perfor||complic gastric perfor||stomach||gastric band||ischem gastric perfor||underw gastric band||band||gastric band procedur||gastric content||nissen fundopl||complic,32.623||29.613||26.603||25.694||24.845||20.212||18.766||18.002||17.04||12.965||12.917||12.514||11.544||11.193||10.944,0.4,0.4,0.4
882,Mol_Biochem_Parasitol-1-5-1906846.txt,sdx||low level||higher level||intern pH||nutrient||depend||pH gradient||exogen folat transport||effect||pyr||assay||parasit||proton gradient||transport||cell||glucos||2′||npp||uptak||2||folin acid||erythrocyt||buffer||paba||drug||folat||stage||profil||plasma membran||pb||membran||dnp,parasit||folat||plasmodium falciparum||parasit erythrocyt||folat uptak||malaria parasit||folat transport||P. falciparum||parasit membran||human malaria parasit plasmodium falciparum||plasmodium||folat salvag||nake parasit||free parasit||parasit inhibit,108.394||106.259||80.626||79.754||75.42||71.255||67.501||64.749||61.912||61.129||58.732||58.128||57.719||57.447||55.907,0.4,0.2,0.13333333333333333
883,Purinergic_Signal-3-1-2096771.txt,inflamm||human neutrophil||dc||eosinophil||import role||releas||cell damag||studi||neutrophil||atp||receptor||dendrit cell||migrat||recruit||evid||cell||immun cell||intracellular calcium||nucleotid||chemotact activ||lymphocyt||human immun cell||earli recruit||activ||monocyt||function||immatur||chemotaxin||chemokin||immun respons||purinerg receptor,receptor||nucleotid receptor||nucleotid||P2 receptor||human||p2i receptor||human lymphocyt||human eosinophil||purinerg receptor||human neutrophil||p2y14 receptor||extracellular nucleotid||p2x receptor||lymphocyt||human purinerg p2i receptor,62.481||55.044||47.607||47.086||44.081||40.937||40.1||38.209||37.917||37.083||36.424||36.384||36.373||36.12||34.827,0.4,0.4,0.3333333333333333
884,Eur_J_Nutr-2-2-1705489.txt,digest residu||method||sampl||dsc||experiment condit||studi||model||digest||amount||x-ray||small intestin||experiment paramet||digest product||dynam||lower crystallin||glucos||starch||experi||mechan stress||ham||fraction||substrat||batch||crystallin||lower amount||prepar||vivo,starch||starch digest||digest||indigest starch||resist starch||enzyme-resist starch||low-amylopectin starch||starch gelatinis||starch polym||total starch||starch swell||batch digest||vitro digest||dynam digest||indigest starch fraction,149.105||131.761||114.417||88.478||85.531||80.613||77.583||77.583||77.189||75.451||75.171||74.513||72.827||69.336||65.016,0.4,0.2,0.13333333333333333
885,springeropen-4-1-2200676.txt,mechan||biolog||upregul||find||respons||unigen number||studi||hypertrophi||express level||section||increas||hypox condit||differenti||independ experi||oxygen||cardiac myocyt||hypoxia||gene||zebrafish||normox||oxygen level||chronic hypoxia||group||molecular function||decreas||import||adapt||cch||heart||hyperplasia||gene express||chronic constant hypoxia,hypoxia||heart||zebrafish heart||zebrafish||hypox heart||normoxia hypoxia normoxia hypoxia||hypoxia physiol||fish heart||chronic hypoxia||constant hypoxia||high-altitud hypoxia||hypoxia increas||cichlid heart||hypoxia treatment||tissu hypoxia,51.047||43.248||38.503||33.758||30.618||29.917||28.651||28.208||27.16||27.101||26.403||25.939||25.928||25.531||25.524,0.6,0.4,0.26666666666666666
886,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-1950586.txt,follow-up||time||week||return||studi||labral tear||patient||hockey player||fai||joint motion||sport||femor neck||open surgic approach||treatment||adhes||arthroscop approach||structur abnorm||revis arthroscopi||techniqu||hip||microfractur||averag time||profession athlet||imping||femoroacetabular imping||activ||soft tissu patholog||osseou abnorm||order||acetabular rim||arthroscopi||extens OA||atraumat hip injuri||athlet||cam||hip arthroscopi||pincer||patholog||procedur||debrid procedur||proxim femor neck||acetabular retrovers,athlet||profession athlet||fai||hip||high-level athlet||athlet hip injuri||thirty-f athlet||twenty-on athlet||45 athlet||twenty-two athlet||addit athlet||hip arthroscopi||arthroscopi||profession athlet cohort||athlet sport no.,137.004||87.228||79.104||74.772||72.319||71.149||70.93||70.648||69.959||69.559||68.958||66.819||58.866||58.719||58.36,0.8,0.4,0.4
887,J_Mol_Biol-2-1-2279226.txt,nativ page||bromodomain||rsc complex||modif||rsc||depend||rate||mutat||studi||atp-depend chromatin||chromatin||effect||increas||lysin acetyl||complex||amino acid||octam transfer||dna||result gener||tail||nucleosom||hydrolysi||histon acetyl||reaction||control||full-length||acetyl||enzym||protein||activ||octam||snf2||histon||transfer||histon tail||effici||atp hydrolysi||addit||purif,histon||nucleosom||histon acetyl||nucleosom acetyl||histon H4||nucleosom histon modif||acetyl histon H4||histon H3||histon H3 acetyl||histon octam||histon tail||nucleosom reposit||histon H4 tetra-acetyl||acetyl||histon modif,165.968||159.372||128.942||125.644||117.976||114.053||109.29||107.672||102.421||98.276||94.372||92.084||92.019||91.917||91.394,0.6,0.3,0.3333333333333333
888,Int_Urol_Nephrol-4-1-2268719.txt,phosphat control||level||valu||phosphate-bind||serum phosphat level||serum||sever hypermagnesemia||end-stag renal diseas||rang||serum magnesium level||serum phosphat||studi||magnesium||magnesium carbon||patient||hemodialysi||calcium||group,3||3 3||3 3 3||3 3 3 3 3 3||magnesium||3 3 3 3 2||3 3 3 group||2 3 3 3||3 3 3 2||ns 3 3||result 3 3 3||3 3 group||2 3 3||4 3 3||conclus 3 3,106.27||106.27||106.27||106.27||86.315||85.928||81.62||80.842||80.842||80.459||79.703||73.404||72.366||71.721||70.847,0.2,0.1,0.06666666666666667
889,Eur_J_Pediatr-4-1-2413080.txt,syndrom||closur defect||wh||boy||dutch||delet size||age||birth||growth chart||data||studi||weight||sever growth||patient||growth||children,wh||wh growth growth chart||growth chart||growth||standard growth chart||specif growth chart||growth retard||catch-up growth||develop specif growth chart||sever growth||girl fig. 5 growth chart||boy fig. 6 growth chart||girl fig. 3 growth chart||s00431-007-0595-8 origin paper growth chart||wolf-hirschhorn syndrom,50.269||45.897||44.687||43.944||30.457||30.117||24.952||23.377||22.587||21.972||19.778||19.643||19.337||18.592||17.619,0.6,0.4,0.26666666666666666
890,Eur_J_Pediatr-3-1-1829443.txt,age 3 year||episod||symptom||insulinoma||confusion state||month||gtc||diagnosi||state||seizur||patient,insulinoma||seizur||insulinoma present||epilepsi||tonic-clon seizur||epilept seizur||hypoglycem seizur||nguyen DK insulinoma||niedermey||epilepsi myoclonu||intract epilepsi||myoclon jerk||juvenil myoclonu epilepsi||yerevan||jme,36.697||25.014||19.425||18.028||16.074||15.095||13.734||13.203||12.725||12.342||11.542||11.509||10.772||10.701||10.701,0.4,0.2,0.13333333333333333
891,Qual_Life_Res-3-1-2039822.txt,fsq specif||follow-up||life questionnair||respons||method||questionnair||regard||acut otiti media||poor sensit||paediatr condit||caregiv||year||gener questionnair||mcid||aom||effect||clinic||correl||sensit||nr||valid||function health statu||health||estim||om6||function limit||assess||moder||disease-specif||popul||fh||subscal||chang||sem||gener||nr caregiv||taiqol||fsq||otiti media||episod||inter-item correl||clinic relev||reliabl||frequent episod||chang score||sever diseas||hand||construct||score||hrqol||children,questionnair||life questionnair||disease-specif questionnair||fh questionnair||aom||fsq||taiqol||life questionnair qualiti||gener questionnair||hrqol questionnair||gener fh questionnair||questionnair score||life||chang||nr,95.375||75.894||73.508||71.235||68.768||68.03||68.03||67.815||63.5||60.073||58.032||56.872||56.412||52.672||52.238,0.6,0.6,0.5333333333333333
892,Neurochem_Res-4-1-2226019.txt,effect||rat cerebr cortex||vesicular glutam transport||vglut||normal morpholog||incub||cultur||cell cultur||amino acid||peptid||transport||quantit analysi||neuron||glutam||cell||rat,neuron||neuron sat1||neuron cultur||Aβ||sat1||neuron cell||cortic neuron||neuron sat1 contribut||neuron glutamin transport||gabaerg neuron||neuron cell cultur||glutamaterg neuron||cultur cortic neuron||excitatori neuron||neuron marker,71.114||59.499||51.557||48.943||47.884||40.135||40.016||39.666||39.368||37.683||37.424||37.364||37.344||37.076||37.058,0.2,0.1,0.06666666666666667
893,Histochem_Cell_Biol-4-1-2413110.txt,mechan||desmosom||stratifi epithelia||PV pathogenesi||acantholysi||pathogen||desmoglein||specif epiderm layer||desmoglein compens||dsc||cadherin||cell biologist||present||human||desmosom format||rho gtpase||desmoplakin||receptor||dsg||event||adheren junction||cell||junction||intercellular adhes||adhes||gene||pemphigu||plakoglobin||mice||protein||steric hindranc||experi||PV patient||extracellular||tyrosin kinas||bind||keratinocyt||skin||epidermi||PV serum||epiderm split||plakophilin||egfr||desmosom compon||junction complex||autoantibodi||pv-igg||intermedi filament||molecul||compon,desmosom||pemphigu||desmosom cadherin desmosom||desmosom compon desmosom||desmosom cadherin||keratinocyt desmosom||desmosom cell||desmosom adhes||desmosom junction||pemphigu vulgari||desmosom assembl||desmosom plaqu||desmosom glycoprotein||non-epiderm desmosom||desmosom compon,429.737||360.029||317.6||288.905||261.531||253.405||253.279||240.502||239.335||227.945||223.574||222.925||219.448||219.268||218.488,0.4,0.2,0.2
894,Eur_J_Pediatr-3-1-1914296.txt,robot surgeri||convent laparoscopi||robot||case||techniqu||vur||children||surgic treatment||complic||laparoscopi||experi||treatment||laparoscop techniqu||vesicoureter reflux||patient||open surgeri||submucos tunnel||patient laparoscopist||reflux||group,reflux||vesicoureter reflux||laparoscop||reimplant||robot||postpubert vesicoureter reflux||vesicoureter reflux manag||laparoscop techniqu||vesicoureter reflux 32||primari vesicoureter reflux||ureter reimplant||vesico-ureter reflux||low-grad reflux||keyword vesicoureter reflux laparoscopi||laparoscop transves ureter reimplant,47.407||42.119||38.73||33.904||31.853||29.062||28.692||28.548||28.079||28.079||27.569||26.007||24.465||24.325||24.279,0.6,0.4,0.26666666666666666
895,Pediatr_Nephrol-3-1-1766475.txt,renal osteodystrophi||level||sever lesion||growth hormon||patient||normal rang||parathyroidectomi||recommend||hypercalcemia||intak||normal level||dose||growth||calcium||parathyroid hormon||pth level||phosphat||pth||chronic renal failur||group||pediatr patient||dialysi||upper limit||children,phosphat||kidney int||pediatr||nephrol dial transpl||dialysi||phosphat binder||pediatr nephrol pediatr nephrolog||recommend||nephrol dial transplant 15||perit dial int 21:323||hyperparathyroid||pth||phosphat intak||aluminium-contain phosphat binder||kidney di,25.902||24.377||22.248||21.5||20.885||20.51||19.554||18.207||18.089||17.821||16.131||15.44||15.266||14.709||14.701,0.4,0.3,0.26666666666666666
896,Matern_Child_Health_J-2-2-1592243.txt,prevent||prepregn plan||preconcept||practic pattern||knowledg||practic||nation recommend||pregnanc||key word||studi||patient||folic acid||risk||behavior pattern||medic||counsel||recommend||provid||intervent||preconcept survey||guidelin||specif preconcept recommend||preconcept care||ntd||effort||women||approach||age||preconcept counsel||prepregn survey||famili||health care provid||survey||physician||pregnanc outcom||nation summit,preconcept||preconcept care||preconcept care practic||keyword preconcept care preconcept||preconcept counsel||preconcept survey||preconcept care knowledg||preconcept risk||enhanc preconcept||preconcept factor||preconcept behavior||preconcept care innov||practic||preconcept care trial||comprehens preconcept care,94.219||66.736||59.534||56.923||55.063||52.645||49.928||48.531||47.744||47.11||47.11||45.717||45.13||44.491||44.491,0.6,0.4,0.3333333333333333
897,Pharm_World_Sci-4-1-2253652.txt,cancer||complementari treatment option||system||support medic||health care profession||consequ||medic error||system cancer therapi||problem||care process||patient||risk||cancer chemotherapi||oncolog||drug-rel problem||chemotherapi||advers effect||process||specif contribut||prescript||medic||drug regimen||clinic trial||treatment||cancer patient||pharmaceut care||drp||research||analysi||pharmacist||oncolog pharmaci||order||pharmaceut care concept||drug||adr||interact||physician||adher||error||cochran librari,pharm||drug||pharmaceut care||drug interact||chemotherapi pharm||pharmaceut care process||pharmaceut care issu||drug therapi||pharmaceut care concept||cytotox drug||cancer patient pharm||relev drug||drug regimen||non-anticanc drug||commun pharm,45.525||44.19||40.022||30.135||28.944||27.561||27.513||27.082||27.073||25.565||24.013||23.757||23.681||23.615||23.614,0.4,0.3,0.26666666666666666
898,Eur_Arch_Otorhinolaryngol-2-2-1705529.txt,flap||periosteum||volum||mastoidectomi caviti||studi||caviti||open caviti problem||cmof||small meatoplasti||eac||eac volum||neo-osteogenesi||fascioperiost flap||patient||year||meatoplasti||radic mastoidectomi||mastoid obliter,mastoidectomi caviti||eac||radic mastoidectomi||radic mastoidectomi caviti||caviti||mastoid caviti||mastoid||open caviti mastoidectomi||meatoplasti||mastoidectomi elimin||simpl mastoidectomi||cmof||eac reconstruct||mastoid obliter||eac volum,36.85||35.08||28.738||28.734||28.727||28.402||28.077||25.299||24.209||23.067||22.486||20.75||20.642||20.589||20.45,0.8,0.5,0.5333333333333333
899,Matern_Child_Health_J-2-2-1592250.txt,report||risk||health||alcohol consumpt||level||women||high rate||alcohol||screen||assess||alcohol-expos pregnanc||age||individu||pregnanc||intervent||fa||effect contracept||fetal alcohol syndrom||bing drink,alcohol-expos pregnanc||alcohol||pregnanc||cdc alcohol||alcohol syndrom||summari alcohol||alcohol misus||alcohol exposur||prenat alcohol||alcohol consumpt||pregnanc postpon||fetal alcohol syndrom||alcohol-expos pregnanc 7 8 www.preventiveservices.ahrq.gov||pregnanc occur||intervent,35.679||31.804||30.036||18.82||17.842||17.675||17.019||16.659||16.468||16.452||16.146||15.316||15.228||15.018||13.085,0.6,0.4,0.4
900,Int_J_Hematol-4-1-2330060.txt,gene||respons||express||activ||cell type||cell,hox||hox gene||keyword hox||rel express hox hoxa2 hox||hox hox hoxd10 hoxd11 hoxd12||hox gene express||humphri RK hox regul||s12185-008-0057-8 origin articl hox gene||gene||homeobox gene||largman||homeobox gene hoxa9||hoxb gene||hematopoiesi||express,105.93||58.955||52.965||45.436||45.125||42.036||28.978||24.294||11.981||11.612||10.682||10.115||9.551||8.465||8.197,0.0,0.1,0.13333333333333333
901,Gene-2-1-2270349.txt,respir||rate||oligomycin||bioenerget capac||effect||haplogroup||oxid phosphoryl||human popul||cybrid||cell||ident nuclear dna||bioenerget differ||nuclear gene||analysi||mitochondria||differ||intact cybrid||proton leak||atp synthesi||triphenylmethylphosphonium||result,haplogroup||mitochondri haplogroup||ψ||mtdna haplogroup||2007 ψ ψ ψ ψ brand||brand||mitochondri dna haplogroup||1 ψ ψ ψ brand||al.||ineffici mitochondri haplogroup||mitochondri haplogroup oper||haplogroup associ||1990 ψ ψ||human mtdna haplogroup||mitochondri bioenerget,118.819||94.163||84.981||75.776||69.5||68.805||66.945||64.844||64.599||63.39||62.775||60.724||57.196||53.989||53.839,0.2,0.1,0.06666666666666667
902,Pediatr_Radiol-4-1-2292491.txt,pituitari siderosi||method||mri||place||studi||patient||correl||liver biopsi||myocardium||pituitari gland||iron||time domain||signal intens ratio||relax||iron elimin||age||relaxometri||iron overload||organ dysfunct||liver||relaxometri method||ferritin||order||thalassaemia||tissu iron||chelat therapi||multipl echo||liver siderosi,iron||iron overload||iron chelat||liver iron||myocardi iron||liver iron overload||pituitari iron overload||iron content||iron deposit||iron store||tissu iron||transferrin-receptor-independ iron||cellular iron||iron elimin||individu iron,157.914||111.137||91.906||91.841||85.606||82.681||81.868||81.54||81.506||81.25||80.612||80.428||79.716||78.957||78.957,0.4,0.2,0.26666666666666666
903,Int_J_Cardiovasc_Imaging-3-1-2048827.txt,TV leaflet shape||measur||TV anatomi||cross-sect view||TV leaflet||leaflet||imag||studi||patient||normal TV||TV annulu diamet||commissur width||assess||analysi||agreement||commissur||tricuspid annulu shape||qualit assess||area||standard two-dimension echocardiographi||suffici||inadequ,tricuspid||TV||tricuspid valv||valv tricuspid||TV leaflet||TV annulu||tricuspid valv leaflet||tricuspid valv annulu||rt3de imag tricuspid||tricuspid regurgit||TV area||tricuspid valv area||TV leaflet shape||TV anatomi||maxim TV,99.532||94.415||72.671||72.671||71.03||64.538||64.329||60.001||54.317||53.968||53.389||52.568||51.329||51.281||49.593,0.2,0.1,0.2
904,Evid_Based_Complement_Alternat_Med-4-1-1810371.txt,dna damag||anim||consumpt||high level||tobacco smoke||year||regular intak||effect||risk||period||latent period||epidemiolog studi||dose||evid||non-smok||cell||tea||smoke||day||tobacco||carcinogen||mice||long durat||human trial||exposur||cup||smoker||lung cancer||trial||chemoprevent effect||green tea,tea||green tea||tea polyphenol||tea consumpt||green tea polyphenol||tea antioxid||green tea consumpt||black tea||tea 2||green tea exposur||green tea intak||green tea reduc||green tea extract||green tea mutat||green tea eur,203.281||148.473||116.004||110.828||108.558||105.84||105.107||103.384||101.647||101.326||100.932||99.889||99.558||99.342||98.982,0.4,0.2,0.13333333333333333
905,Knee_Surg_Sports_Traumatol_Arthrosc-4-1-2226194.txt,studi||patient||flexion||postop knee kinemat||rotat||stair ascent||signific||dynam stair activ||knee arthroplasti||posterior cruciat||control||stair activ||activ||tibial rotat||group||differ||ligament||knee||knee kinemat||previou report||condylar contact||static knee flexion||averag center||spreader||posterior||anterior femor translat||techniqu,knee||knee arthroplasti||knee kinemat||knee arthroplasti kinemat||arthroplasti||total knee arthroplasti||cruciate-retain knee arthroplasti||mobile-bear knee arthroplasti||knee motion||valgu knee||total knee||varu knee||knee kinemat tka||kinemat||affect knee kinemat,125.107||100.825||95.505||89.184||76.542||70.894||70.16||69.927||69.64||69.082||68.07||66.77||66.385||65.903||65.526,0.6,0.3,0.2
906,Trans_R_Soc_Trop_Med_Hyg-1-5-1950430.txt,unpublish data||preval||pregnanc||aor||sampl||studi||effect||malaria||stool sampl||hiv infect||infect||hookworm infect intens||hookworm||women||estim||analysi||anaemia||associ||moder||intens||import||uganda||epg||helminth||trial||hiv||result,anaemia||helminth||anaemia Hb||helminth infect||pregnanc helminth||mild-to-moder anaemia||sever anaemia||3.6 anaemia||malaria||anaemia strongyloid mansonella mansonella||soil-transmit helminth||soil-transmit helminth infect||al.||intestin helminth infect||hookworm,83.644||68.751||49.234||49.074||48.058||43.778||41.822||41.822||41.696||39.527||37.239||34.625||34.579||33.654||33.456,0.4,0.3,0.26666666666666666
907,J_Gastrointest_Surg-3-1-1852375.txt,gastrointestin symptom||case||genit ulcer||ileocec resect||surgic resect||patient||year||seri||intestin perfor||lesion||reperfor||ocular lesion||ulcer||intestin ulcer||age||intestin involv||oral ulcer||symptom||resect||diseas||diagnosi,behçet||behçet ’s||intestin behçet||ileocec resect||behçet ’s diseas||ileum||behçet ’s syndrom||intestin behçet ’s diseas||keyword behçet ’s||resect||perfor intestin behçet ’s diseas||intestin behçet ’s diseas case||behçet ’s diseas criteria||ileocec resect 4||behçet ’s diseas Br,167.135||108.78||108.082||89.974||81.21||77.951||74.992||73.165||72.52||72.449||66.901||64.534||61.771||61.072||60.908,0.2,0.2,0.13333333333333333
908,Eur_J_Nucl_Med_Mol_Imaging-3-1-1998890.txt,gep tumour||tumour||follow-up||administr||fsh concentr||chi-squar test||side-effect||progress diseas||final dose||dose||uptak||patient||treatment||therapi||octreot,177||177 177 177||1. 177 lu-octreot||tumour||result 177 3 0 3||gep tumour||octreot||3||s00259-002-1050-8 short commun 177 0 3||dose||lutetium-177 gep tumour||neuroendocrin tumour||tumour progress||small tumour||tumour deposit,46.101||46.101||22.027||17.085||15.209||13.023||11.839||11.574||11.315||10.512||9.722||9.297||9.179||9.085||9.081,0.2,0.4,0.26666666666666666
909,Int_J_Colorectal_Dis-4-1-2225995.txt,placebo||certolizumab pegol 400 mg||placebo respons rate||infliximab||efficaci||baselin||studi||patient||life||inflammatori bowel diseas||effect||domain||improv||analys||treatment||certolizumab pegol||offici||crp||symptom||clinic benefit||clinic efficaci||phase iii studi||diseas||hrqol||ibdq||cdai score,certolizumab pegol||certolizumab||crohn diseas||subcutan certolizumab pegol||certolizumab pegol treatment||crohn ’s diseas||certolizumab pegol 400 mg||subcutan certolizumab||crohn ’s diseas patient||earli crohn diseas||activ crohn diseas||ibdq||moderate-to-sever crohn ’s diseas||diseas||certolizumab pegol 400 mg improv hrqol,96.524||96.524||68.26||67.924||65.977||55.699||55.341||53.624||45.793||45.507||45.507||45.231||44.439||43.614||42.644,0.2,0.2,0.26666666666666666
910,Naturwissenschaften-3-1-1829419.txt,behavior||ii||studi||ci||serotonin receptor||bee||marker||region||defens respons||receptor||trait||express||ortholog||pollen||analys||defens behavior||gene||clone||map||qtl||ovariol number||cdna||natur variat||influenc||number||candid gene||coloni||behavior genet||step||sequenc,honeybe||bee||behavior||honeybe forag||honeybe social behavior||api mellifera||qtl||behavior genet||drosophila||behavior trait||honeybe ecotyp||guard bee||honeybe divis||honey bee||defens behavior,78.316||63.369||60.276||55.333||46.665||45.821||45.363||44.919||42.613||42.304||42.065||41.921||41.42||40.876||40.303,0.4,0.4,0.3333333333333333
911,Neuroradiology-3-1-2082066.txt,axial imag||find||rate||studi||patient||aneurysm||middl cerebr arteri||angiographi||risk||inconclus find||unenhanc CT||treatment||rebleed||intern carotid arteri||endovascular treatment||raw date imag||subarachnoid haemorrhag||surgeri||distribut||ia-dsa||cta||diagnost modal||neg||neuroradiologist||sah||vessel loop||posterior||result,aneurysm||cta||intracrani aneurysm||ruptur aneurysm||cerebr aneurysm||asymptomat aneurysm||symptomat aneurysm||aneurysm true||vertebrobasilar aneurysm||proven aneurysm||aneurysm detect||aneurysm surgeri||14 aneurysm||17 aneurysm||15 aneurysm,310.489||236.763||195.318||189.974||165.125||160.834||160.163||159.683||158.976||158.373||158.005||156.42||156.145||156.066||155.897,0.4,0.2,0.13333333333333333
912,Purinergic_Signal-3-4-2072913.txt,atp||ntpdase||swelling-inhibitori effect||A1 receptor||extracellular degrad||enzym||retina||receptor||rat retina||releas||neuron||retin parenchyma||ectonucleotidas||nuclear layer||retin slice||glutam||activ||agonist||cell||extracellular metabol,müller||retin glial müller cell||retin||retin müller cell||müller cell||zimmermann||retin glial cell||retina||glial cell||ectonucleotidas||leipzig||müller CE||swell||glial purinerg signal||pannick,35.784||24.966||24.296||23.403||22.957||22.751||21.36||21.146||19.892||19.681||19.507||19.154||17.401||17.147||16.625,0.0,0.2,0.13333333333333333
913,Exp_Brain_Res-4-1-2190788.txt,asynchron AV stimulu pair||respons||tempor ventriloqu||vroomen||locat||spatial dispar||effect||stimulu gener||short exposur phase||visual task||present studi||gelder||spatial separ||jnd||test stimuli||task||pss||exposur||tempor order judgment||keetel||trial||particip||shift||tempor recalibr||sound||result,sound||exposur sound||test sound||sound locat||tempor percept||tempor recalibr||sound alter||sound observ||sound local||tempor ventriloqu||test stimulu sound||auditori spatial percept||central test sound||exposur||spatial ventriloqu,93.399||67.65||57.743||57.206||51.8||50.377||48.392||47.181||46.699||46.13||42.93||42.161||41.965||41.9||41.563,0.2,0.3,0.26666666666666666
914,Eur_J_Clin_Pharmacol-3-1-1914304.txt,intern databas||case||databas||studi||apd||patient||ror||risk||bodi temperatur||case report||hypothermia||associ||factor||report||literatur search||hypotherm effect||number||drug||adr||risk factor||antipsychot||advers drug reaction||schizophrenia,hypothermia||hypothermia report||accident hypothermia||chlorpromazine-induc hypothermia||neuroleptic-induc hypothermia||hypothermia risk||hypothermia number||extrem hypothermia||mild hypothermia||s00228-007-0294-4 short commun hypothermia||report||interv drug chang detect hypothermia||drug||apd||antipsychot drug,163.645||102.183||85.226||83.399||83.399||82.797||82.675||81.823||81.823||41.7||40.72||39.813||32.638||32.474||31.646,0.2,0.1,0.26666666666666666
915,Int_J_Cardiovasc_Imaging-4-1-2233707.txt,control||LV dysfunct||mad||mitral annulu||studi||nccm patient||laef||noncompact||subject||maa||patient||noncompact cardiomyopathi||LA function||present studi||control subject||nccm||result,nccm||mitral annulu||noncompact||left||3D||3D 3D||echocardiographi 3D||mitral annulu diamet||left atrial function||atrial systol||mitral inflow||noncompact cardiomyopathi||echocardiographi noncompact atrial function||3d-maa||left atrial contract,32.252||32.204||30.989||30.806||30.576||30.576||25.42||25.35||24.751||24.602||24.414||23.887||23.675||23.438||22.901,0.6,0.3,0.26666666666666666
916,J_Headache_Pain-4-1-2245994.txt,level||olcegep||studi||cgrp receptor blocker||effect||human||increas||cgrp||migrain attack||receptor||relief||side effect||treatment||advers event||headach||trigemino-cerebrovascular system||pain||action||arteri||acut attack||trigemin ganglion||cardiovascular side effect||migrain||triptan||addit||mk-0974||coronari blood flow,cgrp||migrain||calcitonin||migrain headach||peptid cgrp||cgrp receptor||migrain attack||acut migrain attack migrain||cgrp antagonist||acut migrain||calcitonin gene-rel peptid||edvinsson||migrain drug||cgrp antibodi||mk-0974,70.144||69.291||49.526||48.172||47.13||45.311||43.846||41.717||41.591||39.589||38.956||38.087||36.468||35.072||34.857,0.4,0.3,0.26666666666666666
917,Neurosci_Lett-2-1-2330064.txt,p2i||adp||spinal cord,1||13 1 1 1 1 receptor||1 fig. 1 1||p2y1||1 receptor||1 1 fig. 2 1 1||adp||fig. 3 1 1||1 12 13||receptor||4 1||13 13 receptor||13||self-ratio||gachet C. evan r.j,15.86||13.09||13.074||12.887||11.918||11.796||11.123||9.109||8.807||7.975||7.93||7.407||7.123||7.08||7.057,0.0,0.1,0.06666666666666667
918,J_Abnorm_Child_Psychol-3-1-1915626.txt,depress symptom||boy||behavior||good learner||problem||data||studi||earli adolesc||depress||school||peer||effect||human||sport||scale||domain||social hierarchi||relev||girl||research||gender||associ||gender differ||nomin||social group||classroom social statu||differ||high||statu||trail||adolesc||achievement-rel domain||area||depress problem||intermedi||children||result,statu||peer statu||depress||peer||low peer statu||social statu||high peer statu||peer statu journal||low statu||statu area||classroom peer statu||high statu||affection-rel statu||peer statu variabl||low affection-rel peer statu,98.336||88.027||81.228||77.718||69.268||68.018||66.828||65.287||65.044||64.781||61.877||61.384||58.961||58.685||56.848,0.6,0.3,0.2
919,Immunogenetics-4-1-2206249.txt,variat||major indel||dbb||databas||data||studi||gene annot||mann||annot data||loci||region||human genom||cluster||haplotyp sequenc||gene||pgf||annot||analysi||popul||popul level||mhc||cox||qbl||european popul||major histocompat complex||popul genet||segment||mcf||founder haplotyp||diseas||haplotyp||sequenc||mhc refer sequenc,haplotyp||hla haplotyp||mcf haplotyp||pgf haplotyp||ssto haplotyp||haplotyp apd||haplotyp sequenc||sequenc haplotyp||mhc haplotyp||mann haplotyp||sequenc hla haplotyp||pgf haplotyp annot||haplotyp haplotyp substitut indel||pgf haplotyp sequenc||haplotyp cluster,143.242||106.065||97.69||96.317||93.573||91.986||90.972||90.972||90.703||85.872||83.611||83.307||80.028||77.113||73.755,0.2,0.2,0.13333333333333333
920,Neurosurg_Rev-2-2-1564192.txt,time||logist regress analysi||radiolog featur||patient||recurr||correl||volum||edema||mib-1||low densiti area||male||cell||growth||potenti||multipl||age||characterist||higher growth rate||tumor||growth potenti||meningioma||independ risk factor||high prolif potenti||index||skull base,meningioma||mib-1||342 meningioma mib-1||incident meningioma||342 meningioma||recurr meningioma||symptomat meningioma||intracrani meningioma||asymptomat meningioma||anaplast meningioma||iii meningioma||multipl meningioma||mib-1 stain||mib-1 index||keyword growth meningioma mib-1,145.091||96.093||85.71||80.842||80.519||78.662||77.58||75.037||74.545||74.537||74.331||74.215||64.932||62.456||62.031,0.4,0.2,0.13333333333333333
921,Purinergic_Signal-4-2-2377323.txt,chlorid channel||releas||data||channel||atp||effect||current||apic solut||treatment||cell||solut||enac||experi||apic||amilorid||activ||atp releas||addit||camp||cftr||monolay,sc||basal-i sc||as-i sc||ds-i sc||sc tg-initi tg-late||physiol renal physiol 275||physiol renal physiol 268||physiol renal physiol 271||physiol renal physiol 277||physiol renal physiol 286:682||physiol renal physiol 254||physiol renal physiol 287||physiol renal physiol 274||physiol renal physiol 280||physiol renal physiol 282,425.475||214.239||214.239||214.239||143.826||59.736||59.595||59.49||59.384||59.232||58.99||58.937||58.895||58.876||58.482,0.0,0.0,0.0
922,Histochem_Cell_Biol-4-1-2386528.txt,cancer||role||centriol||studi||centrosom cycl||katanin||complex||cell divis||mtoc||centrosom||mitosi||cell||sperm||cell cycl regul||aurora kinas||numa||research||protein||duplic||associ||spindl||schatten||cell cycl||accumul||centrosom protein||microtubul||number||scnt||centrosom function||formamid||diseas||plk||result,centrosom||human centrosom centrosom||mitot centrosom||centrosom cycl||centrosom protein||centrosom duplic||centrosom microsc||interphas centrosom||centrosom regul||centrosom anom||centrosom abnorm||abnorm centrosom||mammalian centrosom||centrosom complex||centrosom overdupl,576.678||385.536||317.687||302.94||301.499||297.189||297.18||297.04||296.333||294.533||293.912||293.912||293.621||292.884||292.288,0.6,0.3,0.2
923,Pediatr_Surg_Int-4-1-2248216.txt,time||major ccvd||abnorm||studi||patient||congenit malform||IM patient||mortal||risk||congenit defect||correct||morbid||age||associ||popul||ccvd||high morbid rate||intestin malrot||IM diagnosi||risk factor||IM surgeri||post-op morbid||cardiovascular complic||syndrom,ccvd||ccvd major ccvd minor ccvd||ccvd surgeri||major ccvd||minor ccvd||ccvd sign||co-exist ccvd||ccvd diagnosi||ccvd subgroup||IM||structur ccvd||ccvd group||mild ccvd||malrot||ccvd congenit cardiovascular defect,188.672||119.832||107.537||103.455||101.789||97.298||96.507||95.87||95.226||94.879||94.336||94.336||94.336||72.979||68.607,0.4,0.2,0.13333333333333333
924,J_Interv_Card_Electrophysiol-4-1-2292477.txt,follow-up||chronic success rate||afl||cryoablat||histori||common type afl||data||patient||year||recurr||atrial fibril||atrial flutter||cti||long term follow-up||month||popul||late recurr||long term outcom||cavotricuspid isthmu||procedur||larg popul||acut success,atrial flutter||atrial ablat||atrial fibril||flutter||atrial flutter journal||common atrial flutter||atrial isthmu ablat||atrial flutter ablat journal||lone atrial flutter||S. atrial flutter||typic atrial flutter||atrial flutter pace||atrial fibril AF||isol atrial flutter||atrial flutter trial,146.117||137.902||132.294||105.432||103.656||102.787||101.086||99.992||99.915||99.765||99.732||99.415||98.143||97.411||97.411,0.4,0.2,0.13333333333333333
925,Mol_Immunol-1-5-2075531.txt,amino acid differ||antibodi||igg||condit||respons||glycan||pbs-t||equin||glycosyl||half molecul||ehv-1||chain||fcγr||region||pbl||reactiv||strong respiratori burst||nip||subclass||residu||hors||human serum||potent activ||bind||reqigg||human igg||elisa||molecul,igg||equin igg||igg subclass||equin igg subclass||equin||anti-hors igg||subclass||reqigg subclass||reqigg||equin igg antibodi||equin igg1||al.||igg antibodi||igg7 subclass||hors igg,91.933||85.306||83.785||82.083||78.679||76.19||75.636||73.8||71.965||71.308||70.393||67.814||67.622||66.602||66.188,0.4,0.4,0.26666666666666666
926,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-2082657.txt,attach area||arthroscop view||tunnel placement||line||anterior cruciat ligament||centr||studi||landmark||anatom posit||amb||bundl||anteromedi bundl||plb||double-bundl acl reconstruct||tibia||notch||distanc||arthroscop procedur||tibial attach||acl||femur||attach geometri||notch roof||posterolater bundl||tunnel posit||refer line||posit||intercondylar notch||shallow||knee||area||attach||result,cruciat ligament||ligament||anterior cruciat ligament||anterior cruciat||cruciat ligament reconstruct||anterior cruciat ligament reconstruct||anterior||anterior cruciat ligament attach||anterior cruciat ligament graft||anatom anterior cruciat ligament reconstruct||anterior cruciat ligament instabl||human anterior cruciat ligament||knee ligament||posterior cruciat ligament||arthroscopic-assist anterior cruciat ligament reconstruct,118.024||112.169||111.461||111.107||98.723||98.626||98.335||96.821||88.636||86.362||84.103||83.596||80.879||80.457||79.496,0.2,0.1,0.06666666666666667
927,Eur_J_Clin_Pharmacol-4-1-2329724.txt,train programm||addit train||case||skill||session||classic curriculum||person formulari||studi||patient||univers||gener problem-bas curriculum||effect||posttest||treatment||facilit||train||formulari||ration prescrib||patient case||group||differ||prescrib||student||drug||score||result,formulari||student||person formulari||formulari group||oxford formulari||basic formulari||nation formulari||teach||pharmacolog teach||pharmacolog||person formulari group||medic student||clinic pharmacolog teach||british nation formulari||drug train student,82.515||59.863||49.358||48.775||43.583||42.437||41.258||41.136||40.968||40.801||37.917||37.004||31.165||29.096||27.939,0.6,0.3,0.2
928,J_Comput_Aided_Mol_Des-4-1-2270923.txt,metric||target||set||method||system||popular measur||measur||individu error bar||simpl||studi||valu||question||extens properti||extens quantiti||correl||virtual screen||exampl||intrins properti||test||compound||evid||cost||decoy||independ||properti||goal||approach||varianc||dud||curv||experi||averag properti||experiment design||activ||gener||auc||true posit rare||field||number||perform||screen||bedroc||procedur||extens||design||earli enrich||score||result,text||text TP||decoy||virtual screen||virtual screen metric||drug-lik decoy||metric||virtual screen method||screen||auc||virtual screen metric 26||retrospect virtual screen||protein-bas virtual screen||virtual screen procedur||virtual screen inform,219.933||110.997||62.754||53.124||49.813||44.723||43.189||42.873||40.932||40.367||37.359||36.965||36.147||35.78||35.42,0.4,0.5,0.3333333333333333
929,Semin_Immunopathol-4-1-2315689.txt,endotheli cell||role||inflamm||selectin||endothelium||integrin||inflam venul||local microenviron||bone marrow||leukocyt migrat||site||migrat||recruit||express||cystein molecul||separ anatom site||leukocyt adhes cascad||inflammatori site||rpe||cell||retina||adhes||retin pigment epithelium||inflammatori condit||tissu||tight junction||leukocyt||lymphocyt||brb||immun privileg||bind||monocyt||retin antigen||uveiti||eau||molecul||chemokin||function||barrier,leukocyt||leukocyt migrat||liversidg||barrier||retina barrier||retina||chemokin||forrest JV liversidg||forrest JV||leukocyt adhes||retin barrier||autoimmun||leukocyt traffick||leukocyt integrin||leukocyt diapedesi,78.557||57.333||53.437||52.472||52.413||52.355||52.266||51.783||50.957||49.689||48.954||46.649||46.163||45.106||43.196,0.6,0.5,0.3333333333333333
930,Matern_Child_Health_J-2-2-1592155.txt,program||safe motherhood||infant||pregnanc||intern||matern||reproduct health||inform||health promot||promot||recommend||intervent||countri||safe motherhood initi||health||child surviv||preconcept care||women||polici||care||declar||preconcept counsel||activ||numer factor||famili plan||pregnanc outcom||children,preconcept||preconcept care||preconcept health||preconcept health care||care||health||preconcept care program||preconcept care family-centr matern||preconcept care servic||intern preconcept care program||preconcept care strategi||preconcept care activ||preconcept health educ||preconcept health puzzl||preconcept health initi,72.833||64.561||62.65||60.529||56.289||52.466||49.316||43.821||43.619||43.043||43.041||43.041||42.511||42.49||42.338,0.4,0.3,0.2
931,Int_J_Parasitol-1-5-1885961.txt,method||subolesin||engorg femal||reduct||control group||studi||bm91||femal||egg||total rna||adult||bm86||day||gene||control||larva||analysi||rnai||rel humid||dsrna||group||oligonucleotid primer||tick||inject||rna||result,subolesin||bm86||bm91 subolesin bm86||bm86 bm91||dsrna bm86 bm91 subolesin bm86||bm86 bm91 subolesin bm86 subolesin B.||bm91||bm91 subolesin bm86 bm91 subolesin gene||egg bm86 bm91 subolesin bm86||subolesin dsrna||bm86 bm91 willadsen||boophilu microplu||bm86 subolesin 82||tick||fig. 5 bm86 bm91 bm86 bm91,192.514||180.655||176.703||168.798||160.236||157.076||156.941||147.423||145.163||141.466||126.342||125.834||124.83||113.275||113.0,0.4,0.3,0.26666666666666666
932,Plant_Mol_Biol-3-1-1876254.txt,nerolidol synthas||monoterpen synthas||jasmon acid||petiol||linalool||trichom||amino acid||terpen||herbivori||leav||nerolidol||product||transcript||protein||enzym||min||cdna||tomato||emiss||spider mite||linalool emiss||root||plant,lemts1||lemts1 lemts2 lemts1 lemts2 lemts1 lemts1||lemts1 lemts2 lemts1||lemts1 lemts2||gel lemts1 lemts1 lemts1 9||synthas||lemts1 overexpress||lemts1 express||recombin lemts1||lemts1 function||discuss 2004 lemts1 lemts2 lemts1||result lemts1 lemts2||lemts2||lemts1 wipi-ii rce1||transgen tomato plant lemts1,219.993||180.413||180.413||160.622||132.55||113.933||113.186||112.842||110.592||110.307||109.807||107.098||101.251||94.538||90.22,0.0,0.0,0.0
933,Virchows_Arch-4-1-2329729.txt,follow-up||atyp intraduct epitheli prolifer||mammographi||core||carcinoma||studi||risk lesion||patient||excis||classic lobular neoplasia||core biopsi diagnosi||calcif||risk||diagnost surgic excis||pleomorph lci||dci||site||core biopsi||lesion||lci||surgic biopsi||women||fibrocyst chang||lobular neoplasia||literatur||biopsi||columnar cell chang||radiolog||malign||diagnosi||breast,biopsi||lobular||core biopsi||core||lobular neoplasia||core biopsi forty-nin core biopsi||breast core biopsi||lobular carcinoma||needl core biopsi||neoplasia lobular carcinoma||core biopsi diagnosi||mammotom core biopsi||core biopsi diagnos||adequ core biopsi||benign core biopsi,178.056||176.077||170.498||162.94||144.259||136.976||128.199||124.004||122.36||120.15||116.66||116.55||116.507||115.502||114.842,0.8,0.4,0.3333333333333333
934,Int_J_Colorectal_Dis-4-1-2225996.txt,respect cytokin||role||respons||real-tim pcr||induct||import role||nuclear factor||strong synergist effect||combin||synergist effect||studi||data||inflammatori bowel diseas||effect||express||cell||protein secret||iec||protein||intestin epitheli cell||cytokin||secret||mrna||chemokin,cxcl10||ifn-γ||cxcl10 express||cxcl10 mrna||cxcl10 secret||ifn-γ-induc cxcl10||human cxcl10||cxcl10 gene||cxcl10 promot||il-1β||cxcl10 protect||cxcl10 mrna express||ifn-gamma-induc cxcl10 express||cxcl10 gene express||ifn-γ-induc cxcl10 mrna,128.003||73.88||73.109||70.3||68.62||68.399||67.275||66.864||66.444||64.243||64.002||52.938||51.338||50.648||49.798,0.0,0.0,0.0
935,J_Biol_Inorg_Chem-3-1-2099460.txt,serr||activ site||activ form||studi||state||amount||electrod||spectra||heme iron||electrod surfac||interfaci electr field||Ag electrod||cell||activ enzym||potenti||cyp||solut||enzym||protein||coat electrod||imidazol||potassium phosphat buffer||supplementari materi||intens||buffer||heme||band||presenc||substrat||experiment data||detail structur inform,cyp2d6||hildebrandt||cyp2d6 heme||immobil cyp2d6||ν 4||cyp2d6 substrat||electrod||imidazol||adsorb cyp2d6||heme||heme enzym||thiolat enzym cyp2d6||immobil||immobil enzym||enzym,43.947||36.191||34.838||34.262||33.223||28.978||26.345||26.29||26.275||25.728||25.134||24.666||24.577||24.558||24.54,0.0,0.3,0.26666666666666666
936,Environ_Manage-4-1-2359833.txt,water sector||government regul||provis||infrastructur||capit shortag||financi risk||servic qualiti||water||develop||maanshan||invest||tariff reform||current landscap||energi||public-priv partnership||water govern||urban water govern||manag||bot project||govern||public util||china||mwsl||servic||joint ventur||wastewat treatment||polici paper||contract||local offici||legal system||bcg||capit||macau||environment state||access||privat sector involv||privat||privat sector||public||particip||maswsc||local resid||construct,water||water sector||privat sector||privat||water suppli sector||water sector reform||water govern||chines water sector||public sector||privat water project||water privat fail||privat sector particip||privat sector involv||china water||water suppli,229.158||223.806||204.691||190.927||164.82||160.219||159.995||159.563||145.612||143.802||141.415||140.693||140.124||139.38||138.004,0.8,0.5,0.4
937,Exp_Brain_Res-3-1-1914263.txt,condit||muscl||trial block||magnitud||orient||effect||space||inform||percept||rel||test||limb orient||forearm||mass||line segment 1||pattern||joint angl||signal||kinesthesi||gravit torqu||mass vector||elbow||effort||static torqu||manipul||torqu||line segment||experi||propriocept||vertic plane||upper arm||limb||inerti eigenvector||trial||particip||error||angl||result,CM||CM CM||CM CM CM CM||3 CM CM||arm CM||3 CM 2005 CM CM CM||3 CM||tan CM||curv CM||solid curv CM CM||2 CM||7 CM||CM rel||CM 2007||3 CM CM fig. 6,204.097||204.097||204.097||144.826||142.365||140.547||115.191||103.286||103.093||102.896||102.536||102.048||102.048||102.048||87.046,0.0,0.0,0.0
938,Plant_Mol_Biol-4-1-2268718.txt,anim||categori||system||depend||environment situat||secondari activ transport||rice||membran transport||nucleosid||channel||ion||transport system||biolog activ||organ||increas||amino acid||diverg||transport||transport gene||specif||cell||gene||divers||control||arabidopsi||protein||environment condit||biolog system||prokaryot||pump||gradient||number||substanc||osmot pressur||bacteria||plasma membran||membran||plant,transport||membran transport||transport gene||ion transport||transport system||secondari transport||2||cation transport||water transport||glutam transport||multi-efflux transport||transmembran transport||urea transport||anti||sucros transport,107.414||67.317||65.939||60.622||59.991||59.021||57.518||55.902||55.382||55.168||55.028||55.027||54.669||54.459||54.379,0.8,0.4,0.26666666666666666
939,J_Comp_Physiol_A_Neuroethol_Sens_Neural_Behav_Physiol-3-1-1915583.txt,respons||feed respons||host plant||host||concentr||leaf disc||cold receptor||sensit||receptor||compound||behaviour||cell||stimuli||palp||group||rosacea||record||lepidoptera||evolutionari relict||speci||sensilla||adapt speciat||benzaldehyd||larva,yponomeuta cagnagellu||yponomeuta||yponomeuta Y. cagnagellu||Y. cagnagellu||Y. cagnagellu Y. cagnagellu Y.||Y. cagnagellu Y.||Y.||Y. cagnagellu 1979 Y.||yponomeuta plumbellu||yponomeuta larva||method insect Y. cagnagellu Y.||yponomeuta caterpillar||yponomeuta speci||crataegu yponomeuta||Y. padellu,127.465||117.202||111.336||108.403||102.539||98.629||79.079||75.011||73.244||72.375||70.166||67.938||66.092||60.065||58.577,0.0,0.0,0.0
940,Eur_J_Nutr-2-2-1705523.txt,anim||week||triglycerid level||model||studi||stanol ester||cholesterol||sesamin||effect||human||atherogen diet||intervent||analys||rat||lignan||mice||serum cholesterol||group||pure sesamin epim||cholesterol reduct||result,sesamin||dietari sesamin||sesamin epim||sesamin enterolignan||sesamin prepar||conclus sesamin||pure sesamin epim||sesamin 8 8.01||appelqvist LA sesamin||sesam||sesam lignan||lignan||cholesterol||sugano||sesam seed lignan,129.968||72.59||70.888||66.607||64.984||64.984||48.137||44.483||44.405||43.375||42.79||42.205||36.515||33.859||30.685,0.2,0.2,0.26666666666666666
941,Matern_Child_Health_J-2-2-1592141.txt,risk||cancer||ovarian stimul||chemotherapi||agent||ovarian failur||icsi||women||radiat therapi||ovarian tissu||radiat||fertil||rate||pregnanc||chemotherapi agent||young cancer survivor||treatment,fertil||cancer||ovarian failur||pregnanc||ovarian tissu||vitro fertil||ovarian stimul||fertil preserv option||childhood cancer||fertil rate||fertil issu||ovarian tissu preserv||ovarian product||ovarian surgeri||ovarian function,36.412||29.667||20.33||20.295||19.739||19.417||19.259||19.193||19.164||19.024||18.968||18.609||17.658||17.658||17.658,1.0,0.6,0.4
942,Pediatr_Nephrol-3-1-2100434.txt,igfbp||level||final adult height||ckd||growth hormon||renal failur||patient||end-stag renal diseas||insulin-lik growth factor||effect||ghrelin||rhgh||growth failur||treatment||growth||glomerular filtrat rate||protein||GH resist||renal function||linear growth||transplant||resist||igfbp displac||age 6 year||GH receptor||axi||children,growth||growth hormon||growth failur||insulin-lik growth||growth factor||growth retard||recombin growth hormon||catch-up growth||growth hormon treatment||growth hormon resist||growth disturb||normal growth||serum growth hormon||linear growth||growth abnorm,93.167||68.054||62.889||62.751||50.327||49.986||49.388||49.209||48.682||47.877||47.69||47.683||47.553||47.489||47.081,0.6,0.3,0.26666666666666666
943,J_Biomol_NMR-3-1-2039844.txt,variat||order paramet||bond||data||motion||residu dipolar coupl||ensembl||rdc-probe order paramet||addit motion||dynam||rdc||dma||rdc-probe dynam||liquid crystal nmr spectroscopi||protein||molecular align||charg distribut||direct||intern fluctuat||ubiquitin||net electr dipol moment||dispers||bond fluctuat||molecular align fluctuat||molecul||align,document||vartheta||align||align fluctuat||upomega||langl||rangl||dipolar coupl||fluctuat||documentclass||12pt||amsmath||amsfont||mathrsf||69pt,83.364||79.735||67.96||56.412||50.494||47.453||47.453||46.046||44.864||44.531||44.531||44.531||44.531||44.531||44.531,0.2,0.1,0.06666666666666667
944,Purinergic_Signal-3-4-2072911.txt,antibodi||pma||oocyt||direct pkc-mediat phosphoryl||pkc site||atp||current||final concentr||immunoblot||pkc||receptor||phosphoryl||cell||reaction||p2x receptor||protein||min||sds-page||germani||site-direct elimin||immunoprecipit||result,3||3 3 2||3 2||2 3||2 3 2||2 3 2 3 X.||3 receptor||2||2 3 subunit||p2x receptor 2 3||2 3 X. laevi oocyt||2 receptor||2 3 antibodi||2 fig. 2 2 3 X.||2007 3 2,71.851||65.409||62.188||62.188||58.968||55.915||54.322||52.526||47.128||46.894||46.201||44.659||44.348||43.527||41.459,0.0,0.0,0.0
945,Pflugers_Arch-4-1-2270919.txt,fluoresc imag||order||sscm||pit||membran||method||caveola||fluoresc||endocytosi||high resolut||topograph imag||microscopi||topographi||imag||flotillin||high resolut imag||cell||endocyt pit||surfac||indent,pit||endocyt pit||topograph imag||clathrin-co pit||pit indent||imag||fluoresc imag||fluoresc||139 pit||imag caveola||live imag||nanopipett||fluoresc confoc imag||surfac||singl endocyt pit,58.093||40.429||38.314||36.665||35.98||35.509||34.691||33.874||29.047||28.231||28.173||28.107||27.82||27.269||26.953,0.6,0.6,0.4666666666666667
946,Int_J_Legal_Med-3-1-1794629.txt,y-str||divers||dys643||dys576||loci||tabl||individu||dys481||studi||dys570||intermedi allel||simpl loci||intermediate-s size,y-str||y-str loci||loci||allel||intermediate-s allel||simpl loci||1 loci||ten loci||peak||dys576||individu dys576||intermediate-s allel dys549||allel size||individu||dys481 dys570 dys576 dys643 intermedi allel,27.024||26.82||26.617||19.403||14.466||14.304||13.885||13.804||13.56||13.51||12.231||11.896||11.097||10.952||10.895,0.4,0.4,0.3333333333333333
947,J_Mammary_Gland_Biol_Neoplasia-3-1-1820839.txt,upar||transgen model||cancer cell||cancer||role||person commun||transgen||unpublish data||involut||latent growth factor||breast cancer||mmp||studi||model||defici||heterogen genet background||plasminogen||develop||proteas intervent studi||dci||human||stromal cell||similar express pattern||transgen mous model||express||metastasi||similar||cell||singl transgen||protect role||growth factor||mammari epithelium||mice||proteas||extracellular proteas||gene defici||entir gland||activ||tumor||genet alter||mammari gland||PA system||gland||breast||stroma||mammari cancer,transgen||transgen mammari cancer||mammari gland||mammari cancer||mammari tumor||mammari carcinogenesi||proteas||mammari carcinoma||mmp||transgen mice||mammari epithelium||mammari gland involut||mammari patholog||mammari gland growth||mammari gland hyperplasia,83.408||78.578||77.336||76.163||68.422||62.552||62.307||59.677||58.917||58.102||57.809||57.584||56.408||55.112||53.991,0.6,0.5,0.4
948,Eur_J_Nucl_Med_Mol_Imaging-4-1-2275776.txt,collim||independ predictor||variat||delay||mibg||imag||centr||studi||patient||durat||heart failur||nyha classif||acquisit||present studi||neg correl||ratio||paramet||analysi||prognosi||associ||subject||acquisit paramet||differ||inject||result,123 123||123||123 123 123 123||123 15 123 123||123 123 15 123||conclus 123 123||123 14 123||2.0. 123||analysi 123||123 15 23 123||123 1||method 123||heart||cardiac||cardiac iodin 123 mibg,78.285||78.285||78.285||59.037||59.037||52.19||52.19||40.672||39.766||39.466||39.143||39.142||37.268||35.237||33.054,0.0,0.0,0.0
949,Pituitary-3-1-1915635.txt,cortisol level||week||surgic treatment||data||visual field defect||patient||year||defici||process||defect||pituitari macroadenoma||recoveri||improv||progress improv||non-funct pituitari macroadenoma||nerv compress||treatment||eye||visual outcom||assess||month||surgeri||visual field recoveri||optic chiasm||visual field||initi surgic treatment||visual acuiti||transsphenoid surgeri,visual acuiti||visual field||pituitari pituitari||acuiti||visual improv||visual recoveri||impair visual acuiti||conclus visual acuiti||visual function||visual outcom||visual rehabilit||visual field defect||pituitari macroadenoma||visual field recoveri||transsphenoid surgeri,78.892||63.193||62.662||59.716||56.111||54.343||53.311||52.594||50.35||49.801||49.576||48.833||48.484||45.668||43.719,0.4,0.3,0.4666666666666667
950,Qual_Life_Res-3-1-2039790.txt,hospit anxieti||cancer||measur||endoscopi||time||level||upper GI endoscopi||burden||distress||baselin||patient||depress||cancer surveil test||potenti determin||potenti adapt||anxieti||surveil||pattern||signific||specif distress||lower distress||specif||sedat||gener distress||barrett esophagu||pain||upper gastrointestin||reason||group||differ||symptom||discomfort||procedur||depress score||time point||score||upper gastrointestin endoscopi,endoscopi||endoscopi differ||endoscopi procedur||previou endoscopi||endoscopi result||multipl endoscopi||endoscopi experi||endoscopi 166||endoscopi 320||upper GI endoscopi||patient request endoscopi||upper gastrointestin endoscopi||underw upper GI endoscopi||A. gastrointestin endoscopi||upper GI endoscopi vari,172.526||96.687||91.554||89.52||86.802||86.263||86.263||86.263||86.263||81.139||70.685||70.672||61.657||60.902||60.854,0.2,0.2,0.2
951,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-2042026.txt,follow-up||case||radiograph||bear||studi||year||surviv rate||patient||oper||anteromedi pain||averag||loos femor compon||pain||averag flexion||compon||tibial compon||osteoarthr||surgeon||knee||procedur||revis||score||outcom||result,knee||unicompartment knee||unicompartment knee arthroplasti||bear knee||unicompartment knee replac||knee arthroplasti||unicompartment knee prosthesi||knee prosthesi||unicompartment arthroplasti||mobile-bear unicompartment knee replac||seventeen knee||knee societi||oper knee||primari unicompartment knee replac||marmor knee,83.421||74.287||57.463||57.31||55.728||53.617||51.42||44.553||44.483||43.913||43.73||43.282||43.136||42.664||42.588,0.2,0.1,0.06666666666666667
952,Pediatr_Nephrol-3-1-1766478.txt,blood flow||acut renal failur||cathet||hypoglycemia||expertis||complic||ultrafiltr||rate||patient||dialysi therapi||glucos solut||multi-organ failur||clinic circumst||volum||blood pressur||continu supervis||guidelin||cvvh||arf||therapi||blood||solut||fluid||free flow||dialysi fluid||care||renal function||standard time||hemodialysi||choic||intens care unit||good practic||renal replac therapi||access||prefer therapi||hemofiltr||periton dialysi||blood flow rate||dialysi||extracorpor circuit||buffer-fre solut||extracorpor techniqu||circuit||renal unit||children||techniqu,dialysi||dialysi fluid||dialysi circuit||cvvh||periton dialysi||PD dialysi||ultrafiltr||dialysi therapi||replac||dialysi fluid flow||replac fluid||fluid||arf||cvvh circuit||glucose-contain dialysi fluid,45.393||35.187||31.81||31.321||30.98||28.962||28.367||26.171||25.848||25.64||25.414||24.981||24.902||24.773||24.44,0.8,0.6,0.5333333333333333
953,Purinergic_Signal-1-2-2096532.txt,guanosine-depend neurit outgrowth||cyclic gmp||neurit outgrowth||heme oxygenas||pc12 cell||nitric oxid synthas||ngf||carbon monoxid||guanosin||PC 12 cell,guanosin||ngf||outgrowth ngf||guanosin ho-1 express||guanosin induc||ho-1||neurit outgrowth||outgrowth||guanosin receptor||result guanosin||pc12 cell||ngf-depend neurit outgrowth||pc12 cultur||heme||2.5 ngf,119.671||92.66||77.978||65.976||64.617||64.566||63.782||63.295||60.643||59.839||57.401||51.53||51.252||47.237||46.33,0.4,0.3,0.26666666666666666
954,Matern_Child_Health_J-2-2-1592153.txt,prevent||set||level||behavior||practic set||knowledg||practic||pregnanc||patient||folic acid||preconcept care visit||nonphysician hcp||variabl||provid||hcp||ntd||women||age||correct amount||care||predictor||multivitamin||health care provid||survey||public health servic||particip||physician,hcp||FA||provid||folic||nonphysician hcp||nonphysician provid||physician hcp||hcp knowledg||FA recommend||FA messag||fam||provid age||folic acid||hcp effort||gyn,53.888||52.949||49.021||39.743||38.468||36.035||35.441||32.56||30.96||30.325||29.233||28.841||28.561||28.151||27.574,0.6,0.3,0.26666666666666666
955,Purinergic_Signal-3-3-2096642.txt,wateri diarrhea||larg releas||pathogen||method||uss chamber||host||releas||studi||adenosin||effect||strain||diarrheal diseas||amp||cell||infect||host cell||enzym||experi||phosphat||supernat||activ||host cell death||type iii secret||zinc supplement||revers transcript||secret||cell surfac||minim medium||zinc||addit||inhibitor||rna||epec||phosphat releas,ecto-5′-nucleotidas||epec||escherichia coli||enteropathogen escherichia coli||ecto-5′-nucleotidas rna||enteropathogen escherichia coli infect||espf||enteropathogen E. coli||epec infect||enteropathogen escherichia coli sepz||E. coli||escherichia||escherichia coli strain||enterocyte-adher escherichia coli||enteropathogen E. coli e2348,73.548||44.588||40.95||40.181||37.577||36.318||35.669||34.713||34.66||34.594||32.749||29.411||28.516||28.291||28.264,0.2,0.1,0.06666666666666667
956,Extremophiles-4-1-2262144.txt,bacteri enzym||spite||metabol pathway||arginin||enzym gene||dkfp||archaea||prolin||threonin||pyruv||lipid||gene||complet||glucos||enzym||altern enzym||glycerol||phosphat||compar genom||menaquinon||synthesi||lysin||isoprenoid||folat||haloarcha genom||speci||pathway||isoleucin||bacteria||step||haloarchaea,H. salinarum||halobacterium salinarum||H.||H. marismortui H. walsbyi H. salinarum||H. salinarum 1989||H. salinarum 1986||mete H. salinarum||N. pharaoni H. salinarum||halobacterium||H. marismortui H. salinarum 1988 2006||aspart degrad H. salinarum H. marismortui||3 N. pharaoni H. salinarum||green red H. salinarum||red H. salinarum bold||red border H. salinarum,254.152||226.947||209.839||182.984||170.872||170.868||170.378||162.936||155.429||137.861||137.686||130.349||129.757||129.034||128.997,0.0,0.0,0.0
957,Qual_Life_Res-3-1-2039824.txt,follow-up||high level||measur||time||depress symptom||work absenc||work limit||due||data||return||studi||musculoskelet disord||recurr||baselin||mental||claim statu||health statu||worker||complet recoveri||mental health||disord||rtw||health||wage replac benefit||women||pain||trajectori||intern consist||month||injuri||function statu||multipl outcom measur||rtw statu||limit||statu||particip||disabl||health outcom||score||outcom||result,work||work disabl||work limit||work absenc||return||work injuri||work environ||unpublish work||rtw||worker||sever work disabl||fewer work limit||employee-report work limit||high work limit||multipl work absenc,103.124||61.884||58.372||58.013||55.633||54.491||51.562||51.562||50.625||42.555||42.123||40.434||39.852||39.206||39.163,0.6,0.5,0.3333333333333333
958,Eur_J_Pediatr-4-1-2234442.txt,joint contractur||clinic phenotyp||ert||earli development mileston||complic||joint||enzym replac therapi||hunter syndrom||studi||idursulfas||patient||life||spleen||placebo-control trial||infus||cn involv||involv result||improv||attenu form||disord||treatment||reaction||gene||gag||mucopolysaccharidosi type II||age||sever airway obstruct||death||challeng||infusion-rel reaction||sever||sever diseas||diseas||diagnosi||mp II||progress,mp||hunter||mp II||idursulfas||idursulfas idursulfas||sever mp||hunter syndrom||sever mp II||attenu mp II||II||mucopolysaccharidosi II||mp II spectrum||conclus mp II||mp disord||mp societi,87.942||73.772||67.909||53.777||53.777||53.764||52.648||51.801||48.305||47.876||46.58||46.392||45.273||44.568||44.496,0.4,0.3,0.2
959,Histochem_Cell_Biol-4-1-2248609.txt,mechan||dynamin||role||depend||intern||membran lipid||sandvig||ricin||endocyt mechan||raft||clathrin||actin||complex||toxin||shiga toxin||cell||cholera toxin||rhoa||protein||uptak||flotillin||instanc||caveola||macropinocytosi||plasma membran||membran||endocytosi,endocytosi||clathrin-independ endocytosi||sandvig||apic endocytosi||deur||clathrin-depend endocytosi||receptor-medi endocytosi||caveolar endocytosi||caveolin-1-independ endocytosi||raft-depend endocytosi||apic clathrin-independ endocytosi||endocytosi research||cell||caveola||keyword endocytosi rho,108.832||77.095||68.273||60.587||58.973||58.406||57.273||57.02||55.912||55.912||55.511||54.416||51.388||42.823||37.567,0.4,0.2,0.26666666666666666
960,Evid_Based_Complement_Alternat_Med-2-4-1297501.txt,author||men||practic||data||posit result||studi||patient||chronic||acupunctur||chronic prostat||clinic trial||palmetto||treatment||complementari medicin||random||biofeedback||pain||abstract||altern medicin||hyperthermia||symptom||trial||exploratori studi||supplement||pollen extract||herbal||varieti,prostat||chronic prostat||prostat hyperplasia||prostat decoct||prostat massag||experiment prostat||acut prostat||prostat 1||prostat vari||prostat volum||prostat disord||prostat tissu||prostat secret||chronic prostat world||nonspecif chronic prostat,124.879||86.018||65.991||65.306||63.445||63.035||62.998||62.536||62.44||62.44||62.44||62.44||62.44||58.316||57.904,0.2,0.1,0.06666666666666667
961,Eur_Arch_Otorhinolaryngol-4-1-2217619.txt,specimen||valv||closur||bast||structur||open||utriculo-endolymphat valv||duct||3d-reconstruct||object||lip||wall||opfo||utricular side||endolymph,valv||utriculo-endolymphat valv||bast||bast ’s valv||valv bast ’s||valv lip||one-way valv||valv tip||bast ’s valv 13||rigid valv lip||bast ’s||utricular duct||3d-reconstruct||ar.1090400106 bast||ar.1090680106 bast,75.583||59.494||49.843||43.696||43.696||42.48||38.69||38.371||32.772||31.134||27.752||27.373||26.705||26.59||26.59,0.6,0.3,0.26666666666666666
962,Purinergic_Signal-3-4-2072914.txt,exocytosi||vesicl exocytosi||clone||camp||nucleotid||pc12 cell||protein||nucleotid releas||noradrenalin||receptor||atp releas||sampl||express||p2i receptor||valu||radioact||cell||cyclic amp synthesi,releas||C1||nucleotid releas||depolarization-evok releas||depolarization-evok nucleotid releas||botulinum neurotoxin C1||spontan releas||spontan nucleotid releas||transmitt releas||nucleotid||atp releas||C1 light chain||non-exocytot nucleotid releas||abolish releas||neurotransmitt releas,44.148||43.83||35.24||28.296||27.641||27.326||27.203||26.913||26.491||26.332||25.223||25.032||24.53||23.732||22.71,0.2,0.2,0.2
963,Photosynth_Res-3-1-2117338.txt,light-harvest complex||posit charg||electron||bond||dipol||water||chl||methylacetamid||complex||oxygenas||electrostat bond||chloroplast develop||backbon carbonyl group||feig||protein||dipol moment||plastid||sidechain||charg||group||specif locat||interact||electron densiti||assembl||lhcp||molecul||ligand||membran||chlorophyl,chlorophyl||light-harvest chlorophyl||light-harvest||light-harvest complex||chlorophyl biosynthesi||major chlorophyl||keyword chlorophyl||chlorophyl synthesi||light-harvest complex lhc||hoober JK||light-harvest protein||light-harvest antenna||chlorophyl transit moment||chlorophyl chlorophyl 1991 boca raton||higher-pl light-harvest,82.513||72.057||61.6||42.587||41.994||41.777||41.256||41.256||38.469||37.187||36.049||35.606||34.358||34.111||33.258,0.4,0.2,0.13333333333333333
964,Photosynth_Res-3-1-1769345.txt,edg||electron transfer||iron centr||iron geometri||measur||structur||complex||sampl||data||x-ray absorpt spectroscopi||energi||plastocyanin||spectra||cytochrom,II||II II||iii II||iii||plastocyanin||0.02 II||iii II 3||II complex||II middl||iii panel||xa||díaz-moreno||nostoc||iii sampl||iii 1,49.872||49.872||43.586||37.3||33.525||29.546||29.325||28.434||25.831||23.786||22.535||22.535||20.979||19.272||18.76,0.2,0.1,0.06666666666666667
965,Virchows_Arch-4-1-2329733.txt,valid studi||cancer||case||core||two-class||full section||kappa||marker||slide||paraffin block||express||tma||squamou cell carcinoma||molecular marker||donor block||tissu||escc||analysi||moder||tma core||tumor||agreement||posit,tma||tma slide||tma core||tma technolog||κ κ κ κ κ||total κ tma||total κ tma ck5||esophag cancer tma||tma paraffin block||microarray||tissu microarray||tissu||tissu microarray technolog||ck5||carcinoma,68.006||43.229||42.598||40.849||39.261||37.197||32.966||31.817||26.518||26.077||25.112||24.147||21.305||20.273||19.408,0.4,0.2,0.2
966,Purinergic_Signal-3-4-2072920.txt,atp||microglia||role||nerv||spinal glial cell||neuropath pain||receptor||pain||releas||neuron||p2x||evid||phagocytosi||cell||rat,neuropath pain||pain||neuropath pain sensat||neuropath pain state||neuropath pain model rat||anion||pain mononeuropathi||pain sensat||pain signal||7||pain mononeuropathi brain||microglia||anion gradient||p2x7||microgli activ,42.298||33.575||29.264||28.199||23.105||21.093||20.135||18.385||17.625||14.124||14.064||11.85||11.648||11.511||11.189,0.4,0.2,0.2
967,Purinergic_Signal-3-4-2072926.txt,mechan||function consequ||striatum||blockad||bdnf protein||synapt transmiss||hippocampu||bdnf||receptor||bdnf function||bdnf level||hippocamp slice||normal bdnf tone||experiment model,2A 2A 2A||2A||2A KO mice 2A 2A||2A 4 2A Rs||2A 2A 15 16 2A Rs||17 27 28 2A 2A 2A||bdnf||2A receptor reduc||2A receptor facilit||2A Rs regul||42 43 2A 24||bdnf modul||s11302-007-9066-i origin paper 2A receptor||bdnf avaibl||bdnf level,193.626||193.626||120.152||100.948||99.57||96.951||82.418||71.641||71.39||70.788||49.518||46.998||43.104||42.832||42.823,0.0,0.1,0.13333333333333333
968,Semin_Immunopathol-4-1-2315691.txt,crri||creg||inflamm||low level||anim model||studi||transgen mice||inform||mous model||altern||cfh||treatment||eye||complement system||amd||complement regulatori protein||normal tear||protein||vascular endotheli growth factor||rodent eye||activ||cornea||compon||import||age-rel macular degener||uveiti||diseas||result,complement||complement system complement||ocular complement||complement system||complement factor||complement activ||mous complement||complement inhibit||complement inhibitor||keyword complement system complement||hemolyt complement||recombin complement||intraocular complement||complement compon||complement deplet,199.449||136.003||112.728||104.28||103.222||103.208||102.503||102.161||102.091||102.002||101.918||101.838||101.803||101.259||100.674,0.2,0.1,0.06666666666666667
969,Eur_Radiol-4-1-2292493.txt,match||mammographi||case||sharp margin||brca-mc||rim-enhanc||sporad case||mri||control group||breast cancer||studi||risk||type 3 curv||dci||benign||enhanc kinet||radiologist||lesion||margin||women||carrier||enhanc pattern||age||characterist||brca2||tumor size||group||differ||size||brca1||malign||breast||detect,brca-mc||breast||breast lesion||lesion||breast tumor||breast malign||mammographi||breast cancer||brca-mc case||malign lesion||brca1||breast ultrasound||brca-mc group||breast densiti||lesion size,43.213||41.69||37.468||33.246||28.139||27.69||25.264||25.114||24.699||23.468||23.108||22.786||22.653||22.123||21.849,0.6,0.5,0.4
970,J_Biomol_NMR-3-1-2048825.txt,type||nmr structur ensembl||set||pdb entri||constraint||inter-atom distanc||data||occurr||contact||spectra||inform||sequenc fragment||structur||total||hpc||file||entri||distanc||residu||atom||analysi||distanc inform||nmr||total number||pdb||import||constraint data||number||fragment||noesi spectra||nmr constraint list,constraint||Hβ||distanc constraint||constraint inform||constraint set||nmr distanc constraint||constraint data||deposit constraint||nmr constraint data||constraint list||ambigu constraint||nmr constraint list||constraint file||intra-residu constraint||constraint intra-residu,142.324||89.126||86.751||86.363||82.339||81.666||80.922||77.892||77.781||77.763||76.528||75.675||75.651||75.473||75.473,0.2,0.2,0.2
971,Neurogenetics-3-1-1820748.txt,myokymia||potassium channel||genet studi||function effect||muscl||clinic||electrophysiolog studi||current||epilepsi||oocyt||episod ataxia||transvers||mutat||mutant crna||famili,myokymia||kcna1||ataxia||kcna1 mutat||periorbit myokymia||kv1.1||hereditari myokymia||episod ataxia||episod ataxia mutat||myokymia syndrom||mutat||episod||keyword myokymia potassium channel mutat||potassium channel||episod ataxia type,46.624||29.968||28.768||26.608||26.403||25.683||25.574||25.432||24.704||23.312||23.249||22.096||21.232||18.144||16.955,0.2,0.2,0.26666666666666666
972,Naturwissenschaften-4-1-2270370.txt,non-breed season||coastal||diversif||number||speci diversif||speci||popul||ecolog speciat||sub-speci||non-migr||wader||migratori||studi||environ||area||habitat||migrant||result,inland||migrant inland||migrant||inland wetland||non-migr||partial migrant inland||migrant coastal||inland habitat||whilst inland||winter inland||inland environ||coastal||migrant speci||long-dist migrant||migrant 0.13,456.602||405.274||353.947||312.774||291.945||285.211||282.441||248.363||230.669||230.212||228.851||210.936||188.543||179.152||176.973,0.4,0.2,0.2
973,J_Med_Internet_Res-1-suppl1-1761819.txt,visitor||inform||web site||peopl||telemedicin||internet,web site||ndtm web site||ndtm||telemedicin||site||inform||internet||readership||visitor||200 web page||launch||telemedicin brigg||internet hypermedia readership analysi telemedicin||inform resourc||UK telemedicin project,15.867||15.639||15.184||13.472||13.049||12.052||11.477||10.785||9.789||8.751||8.331||7.953||7.906||7.369||7.329,0.4,0.5,0.3333333333333333
974,J_Digit_Imaging-3-1-2039840.txt,interfac||document||technolog||time||system||phrase||search engin||radiolog report||problem||data||search queri||wildcard||inform||abil||radiologist||user||featur||binari oper||web||queri durat||pac integr||report warehous||solut||medic context||result||user interfac||ri||search interfac||implement||open sourc||report||word||design||index||queri||internet,index||ri||build index||index solut||index system||word||nondistribut index||index project||fuzzi index||index merg||full index||citat index||report||scalabl index solut||ri metadata,74.643||47.718||44.884||41.649||41.474||39.781||38.835||38.38||38.316||38.093||37.941||37.935||31.924||30.853||28.819,0.4,0.3,0.26666666666666666
975,J_Neurooncol-4-1-2174521.txt,transfect||level||data||copi number rel||studi||immunoblot||gain||cell cultur||report plasmid||cell line||overexpress||cell||fish||isochromosom 17q||medulloblastoma||apoptosi||larg cell||chemotherapeut agent||sem||p53||tumor||medulloblastoma growth||amplif||copi gain||result,wip1||wip1 wip1||wip1 wip1 wip1 wip1 locu||i17q wip1 wip1 wip1||24 wip1 wip1 wip1 wip1||wip1 wip1 overexpress||tp53 wip1 tp53 wip1||wild-typ wip1 wip1 5 wip1||wip1 2 2 wip1 wip1||wip1 gain||overexpress wip1||wip1 phosphatas||wip1 rna||wip1 express||excess wip1,307.332||307.332||246.238||245.949||245.866||209.398||194.737||190.314||185.346||166.638||160.431||159.268||155.419||154.812||153.666,0.0,0.0,0.0
976,Qual_Life_Res-3-1-2039860.txt,demograph characterist||dutch colleg||refer popul||practic||qualiti||studi||depress||earli identif||life||patient||physic function||depress group||complaint||domain||chronic consequ||mental health||descript studi||dutch nation survey||consult||health||unexplain complaint||gp||characterist||popul||gener practic||gener practic popul||group||differ||fatigu,unexplain complaint||complaint||unexplain complaint patient||unexplain complaint group||unexplain complaint categori||unexplain fatigu||complaint group||physic complaint||abdomin complaint||musculoskelet complaint||main complaint||unexplain physic symptom||unexplain symptom journal||multipl unexplain symptom||life,100.109||85.853||77.49||69.873||67.268||65.905||47.626||46.788||44.786||44.532||43.818||42.18||41.431||39.605||37.408,0.4,0.2,0.2
977,Eur_Radiol-3-1-2039819.txt,coronari fly-through||mdct||time||imag qualiti||coronari arteri||dual-sourc CT||high qualiti visualis||post-process||virtual angioscopi||major coronari arteri||major branch||patient||min,coronari fly-through||fly-through||coronari angioscopi||coronari arteri||virtual coronari angioscopi||dual-sourc mdct||noninvas coronari angioscopi||keyword virtual angioscopi coronari arteri coronari||dual-sourc CT||autom fly-through||major coronari arteri||coronari arteri tree||coronari arteri diseas||rca||post-process dual-sourc CT,31.661||31.594||26.394||23.122||20.344||19.266||18.126||17.879||17.578||17.253||16.499||15.779||15.415||15.289||15.273,0.4,0.3,0.26666666666666666
978,J_Membr_Biol-3-1-1784061.txt,block||ionic strength depend||concentr||data||low affin||studi||channel||gallamin block||amino acid||outer vestibul||electrostat charg||tea||tetraethylammonium||ionic strength sensit||ionic strength||solut||residu||surfac||lysin||surfac electrostat||vestibul||electrostat potenti||interact||gallamin||quaternari ammonium ion||neg charg||result,channel||kv2.1 channel||shaker shaker channel||shaker||block kv2.1 channel||potassium channel||kv2.1 potassium channel||kv3.1 channel||kv2.1||ion channel||wild-typ kv2.1 channel||mutant kv2.1 channel||channel surfac||kcsa channel||channel subunit,107.93||83.908||83.756||71.67||65.748||65.563||63.671||61.842||59.886||57.949||57.216||57.091||56.793||55.54||55.502,0.2,0.1,0.06666666666666667
979,Int_J_Biochem_Cell_Biol-2-1-2279807.txt,antibodi||role||stabl cell line||bind partner||rasgap||isoform||eef1a1||protein synthesi function||elut protein||complex||sh3 domain||sh2 domain||cell||phosphoryl||shp2||ciap||protein||bead||non-transl function||incub||interact||codon-depend bind||specif antibodi||eef1a2||function,eef1a2||eef1a1||eef1a2 protein||eef1a2 isoform||eef1a2 interact||eef1a2 sampl||eef1a2 molecul||3.4 eef1a2||eef1a2 prepar||eef1a2 isoform budkevich||eef1a2 form complex||protein elong factor eef1a2||purifi eef1a1||translat elong factor eef1a2||his-tag eef1a1,158.713||101.781||87.784||87.273||84.419||81.537||80.095||79.357||79.357||64.166||57.244||55.503||54.925||54.554||54.271,0.4,0.2,0.13333333333333333
980,Eur_J_Pediatr-3-1-2151774.txt,case||alveolar wall ruptur||vomit||patient||chest||alveolar wall||neck||risk||anorexia nervosa||pneumomediastinum||subcutan emphysema||sign||disord||pressur||laryngopharyngoscopi||anorexia patient||literatur||malnutrit||adolesc||spontan pneumomediastinum||secondari pneumomediastinum,pneumomediastinum||spontan pneumomediastinum||anorexia nervosa||keyword pneumomediastinum anorexia||secondari pneumomediastinum||anorexia nervosa predispos||anorexia nervosa int||emphysema||anorexia nervosa postgrad med||bulimia nervosa||anorexia nervosa Br med||anorexia patient||s00431-007-0444-9 origin paper pneumomediastinum||function anorexia Br||subcutan emphysema,77.872||53.908||50.645||42.775||38.936||34.284||33.763||27.507||27.008||26.79||26.361||25.226||20.328||17.557||17.288,0.8,0.4,0.4
981,Soc_Psychiatry_Psychiatr_Epidemiol-3-1-2039804.txt,asylum procedur||lower qualiti||center||preval||qualiti||studi||life||long asylum procedur||psychopatholog||netherland||iraq||physic diseas||iraqi asylum seeker||health||psychiatr disord||post-migr live problem||drug consumpt||servic||care||gener practition||group||factor||visit||import predictor||medic specialist||asylum seeker||physic health problem||disabl||pmlp,"asylum seeker||servic||seeker||iraqi asylum seeker||health servic||keyword asylum seeker servic||22 asylum seeker||asylum procedur||2,352 iraqi asylum seeker||mental health servic||adult iraqi asylum seeker||health||gener healthcar asylum seeker||biggest asylum seeker popul||health care servic",115.567||97.641||94.177||93.57||82.751||82.194||77.045||71.802||70.831||70.795||70.177||67.862||62.243||58.318||57.745,0.6,0.4,0.3333333333333333
982,Purinergic_Signal-4-1-2245998.txt,blood flow||vascular tone||similar import||role||respons||hypertens||releas||studi||atp||effect||human||platelet||increas||angiogenesi||heart failur||purin||receptor||p2i||cell prolifer||ectonucleotidas||clinic import||pyrimidin||growth factor||catecholamin||erythrocyt||pathophysiolog||factor||myocardi infarct||purinerg||aspirin||human skelet muscl||heart||sympathet nerv||antagonist||cardiomyocyt||p2x||blood pressur regul,receptor||atp receptor||atp||burnstock||purinerg receptor||utp atp||P2 receptor||atp circ||nucleotid receptor||atp releas||extracellular atp||receptor mediat||platelet P2 receptor||atp signal||signal atp,78.622||78.535||78.449||62.723||61.232||57.304||54.661||54.048||51.046||50.622||48.878||47.542||47.43||45.963||45.963,0.4,0.2,0.13333333333333333
983,Eur_Radiol-3-1-1820761.txt,prospect studi||cancer||reoxygen||method||flow||imag||studi||human applic||perfus||develop||hypoxia-direct therapi||abil||radiotherapi||hypoxia imag||treatment||cell||therapi||oxygen||invas techniqu||hypoxia||tumour||cancer patient||blood||tissu||chang||chronic hypoxia||cu-atsm-pet||presenc||vessel||clinic translat||vascular||bold-mri||lead contend||function||tumour cell||techniqu,hypoxia||hypoxia imag||tumour hypoxia||tumor hypoxia||hypoxia statu||acut hypoxia||chronic hypoxia||region hypoxia||imag||hypoxia map techniqu||human tumour hypoxia techniqu||kogel AJ tumor hypoxia||prostat gland hypoxia||tumour||farwel DG krohn KA hypoxia,100.898||70.332||67.123||59.239||51.169||50.449||50.449||50.449||39.766||39.148||38.051||33.862||33.633||33.349||27.495,0.4,0.4,0.3333333333333333
984,Eur_J_Appl_Physiol-3-1-1914232.txt,chronic heart failur||recoveri kinet||method||breath||ventilatori threshold||interv||studi||patient||onset kinet||correl||threshold||test||recoveri||coeffici||chf||paramet||function impair||mono-exponenti model||exercis||onset||differ||clinic purpos||exercis test||respons time||kinet||rest||intra-class correl||reproduc,expandaft||ifmmod||fi||document||dot||text||documentclass||12pt||amsmath||amsfont||mathrsf||69pt||end||kinet||exercis,354.469||170.916||168.346||118.511||113.74||69.633||62.741||62.741||62.741||62.741||62.741||62.741||52.184||47.632||37.385,0.0,0.0,0.13333333333333333
985,Qual_Life_Res-4-1-2275305.txt,level||quantit posit||method||system||instrument||descriptor||isoform||direct quantif||eq-5d||studi||vignett||transform||health statu||mild depress||va scale||health||va continuum||extrem||pain||equidist||mobil||respons scale||untransform equidist||level descriptor||five-level version||respond||health state||dimens||indirect method||respons option||methodolog||sever||score,5L||3L||5L descriptor||5L dimens||3L descriptor||descriptor||5L level descriptor||5L score||dimens||5L version||5L mobil||5L respons||5L system||5L answer||5L yield,167.218||141.391||136.978||128.649||124.065||106.738||99.328||95.209||90.08||88.978||86.324||86.006||84.812||84.137||83.609,0.0,0.2,0.13333333333333333
986,Eur_J_Nutr-3-1-1914246.txt,dutch polici||calcul||level||risk manag||afl||maximum level||public health||model||age group||folic acid||nation survey||risk||vitamin||netherland||fortif||intak||adult||exempt||dietari supplement||energi||msfl||dutch model||toler upper intak level||maximum safe amount||product||micronutri||food||popul||risk-assess model||maximum fortif level||sensit group||dutch commod act||group||european union||safe addit||maximum amount||miner||ul||maximum||rasmussen||children||result,msfl||fortif||vitamin||micronutri fortif||food fortif||intak||micronutri intak||0 µg vitamin||100 µg||154 µg vitamin||calcul msfl||fortif level||0 µg||micronutri||lowest msfl,98.658||84.754||68.942||67.89||66.315||66.031||58.528||57.607||57.181||54.836||53.884||52.686||51.94||51.026||50.303,0.6,0.4,0.3333333333333333
987,World_J_Urol-3-1-1913182.txt,cancer||time||case||men||patient||year||strategi||risk assess||mortal||inform||base||earli age||overdiagnosi||treatment||earli detect||popul||incid||random studi||prostat||possibl||invas treatment||biopsi||nomogram||activ surveil||psa||number||overtreat||screen||procedur||prostat cancer||radic prostatectomi||diseas||detect||result,prostat||prostat cancer||prostat cancer screen||screen||indol prostat cancer||prostat biopsi||prostat cancer screen trial||population-bas prostat cancer screen||NS prostat cancer screen||prostat cancer bangma||ml prostat||free-to-tot prostat||prostat test||initi prostat||prostat diseas,173.468||125.495||119.151||106.463||92.965||91.246||90.765||90.404||89.363||88.577||88.517||88.208||87.928||87.324||87.172,0.6,0.3,0.2
988,Int_Arch_Occup_Environ_Health-3-1-1915641.txt,self-report questionnair||time||larg size||psychosoci risk factor||sick||baselin||model||studi||patient||potenti confound||baselin questionnair||effect||neck||risk||style||upper extrem||sick leav||complaint||increas||sex||effect modif||analys||decis author||regress model||pain||popul||upper extrem complaint||turn||musculoskelet co-morbid||heavi physic work||high||cox regress model||symptom||work||risk factor||long period||wildhagen,sick||sick leav||complaint||long-term sick leav||work leav||job||self-report sick||sick absenc||sick day||musculoskelet complaint||outcom measur sick leav||upper extrem complaint||neck||job demand||complaint categor,88.141||81.253||62.084||54.681||51.975||49.244||46.28||46.239||44.071||41.574||40.627||38.031||35.762||33.696||32.427,0.6,0.3,0.3333333333333333
989,Qual_Life_Res-3-1-1915653.txt,cancer||measur||time||respons||studi||self-present||strategi||question||patient||bit||present||discrep group||chemotherapi||qol||treatment||ann||counter-intuit find||interview||respons shift||small-cel lung cancer||discrep||conflict find||explan||fatigu||respons categori||score||answer||result,interview||aloud||interview patient||aloud then-test||interview T1||n’t||self-present||1st interview||interview moment||aloud respons||discrep self-present||previou interview||past interview||fatigu||83 interview,61.972||52.256||37.828||37.595||36.857||36.334||35.341||33.874||33.559||33.543||32.443||31.801||31.653||31.279||30.986,0.2,0.2,0.2
990,J_Mol_Biol-1-5-2082129.txt,condit||time||singl dna-bind cleft||concentr||activ form||plasmid||state||separ molecul||wt||subunit||hexachlorofluorescein||form||sfii||recognit site||complex||site||mixtur||dna||duplex||singl exponenti||fast phase||reaction||enzym||protein||hex||dimer||experi||copi||one-sit plasmid||auc||cleft||substrat||lin||linear product||OC,sfii||sfii endonucleas||dna||endonucleas||sfii restrict endonucleas||restrict endonucleas sfii||figur||dna restrict||mutant sfii endonucleas||sfii restrict endonucleas embo||sfii site||wt sfii||one-sit dna||dna site||dna recognit,95.737||91.972||91.196||88.207||79.959||79.959||77.284||73.565||63.238||60.875||59.325||58.609||57.887||57.055||56.211,0.4,0.2,0.13333333333333333
991,J_Med_Internet_Res-9-2-1913940.txt,hit||immigr||nation||translat||local languag||url||host||search engin||maiz||rate||human migrat||nutrit||turkish||languag||human health||linguist prefer||sourc||countri||indigen group||page||institut||websit||health||higher rate||tuberculosi||term||food agenc||effort||world||estim||result||english||food||food-rel institut||group||order||avian flu||googl search||world wide web||global agenc||french||onlin health inform||googl||diseas||peopl||schizophrenia||spanish||strong prefer||internet,english||english search||languag||languag search||search languag||search||french search||english search rate||googl search||immigr languag||local languag search||non-coloni languag search||french||onlin search||languag translat,132.991||124.392||120.027||117.91||117.91||115.793||97.122||86.023||82.986||80.032||79.649||79.569||78.451||78.44||77.567,0.4,0.3,0.26666666666666666
992,Purinergic_Signal-3-4-2072916.txt,anim||inflamm||respons||spinal cord injuri||data||studi||effect||section||volum||recoveri||spinal cord||potenti mechan||present studi||treatment||guanosin||rat||day||myelin||microglia||apoptosi||potenti clinic import||inflammatori respons||injuri||cord||secondari patholog event||apoptot cell death||secondari injuri||sci||function,cord||spinal cord||spinal cord injuri||injuri||contus spinal cord injuri||spinal cord contus||acut spinal cord injuri||secondari spinal cord injuri||traumat spinal cord injuri||spinal cord injuri micturit||experiment spinal cord injuri||moder spinal cord injuri||spinal cord injuri induct||spinal cord injuri epidemiolog||spinal cord trauma,135.187||134.369||123.415||101.508||97.091||95.618||94.542||94.295||94.14||93.54||93.166||92.562||92.562||92.562||91.029,0.8,0.4,0.26666666666666666
993,Pflugers_Arch-3-1-1950587.txt,target||respons||epi||stretch-activ channel||endo||wall thick||observ||express||stretch||stimuli||transmur differ||rat||cardiac myocyt||gene||myocyt||protein||mechan stimul||ventricl||region differ||rapid||slow inotrop respons||mrna||heart||gene express,endo||epi endo||epi||endo myocyt||endo region||endo strip||endo tissu||epi sampl||epi tissu||0.03 0.015 endo||0.04 0.001 endo||0.22 0.001 endo||myocyt||0.36 0.006 endo||0.42 0.002 endo,48.313||43.964||39.614||32.782||27.957||24.979||24.157||20.705||19.807||17.672||17.585||17.308||17.251||16.973||16.869,0.4,0.2,0.2
994,Intensive_Care_Med-3-1-1915615.txt,complet recoveri||csf||case||week||differenti diagnosi||lyme diseas||coma||protein||mri||lesion||cell count||diseas||full recoveri||treatment||patient,coma||encephalomyel||prolong coma||adem||medic coma||encephalomyel neurol||csf||post-infecti encephalomyel||coma rover jörgen||springer-verlag 2007 keyword coma acut||acut||case||encephalomyel postgrad med||csf pressur||csf cultur,36.566||25.18||19.604||19.417||18.884||17.339||16.265||14.368||14.112||10.033||9.863||9.716||9.177||8.839||8.822,0.2,0.2,0.2
995,J_Med_Internet_Res-6-3-1550604.txt,level||high-school read profici||skill||basic search||grade level||search engin||navig||search term||individu||literaci level||studi||question||effect||read level||difficulti||inform||investig||rectum cancer||abil||site||health inform||web site||method subject||low literaci||health site||health educ||page||health materi||web||health||literaci||term||averag||strong read skill||read abil||experi||subject||text||weak search strategi||materi||group||word||order||search||access||lung cancer||read||particip||think-aloud||googl||answer||health question||internet,internet||subject||subject question||question||low-literaci subject||search||literaci||internet health inform||health question||low-literaci site||internet health web||answer||site||health search||self-direct internet search,101.036||100.492||92.831||85.169||83.487||74.123||71.406||67.492||67.241||65.308||64.824||64.364||64.134||61.718||60.768,0.6,0.6,0.5333333333333333
996,Intensive_Care_Med-4-1-2249616.txt,antimicrobi resist||grade||mechan ventil||acut respiratori distress syndrom||acut renal failur||children||protocol||mortal benefit||recent trial||rate||patient||studi||clinic outcom||strategi||sepsi||effect||mortal||risk||superior clinic outcom||organ||increas||failur||clinic assess||sever sepsi||recommend||pressur||insulin||sepsi bundl||guidelin||steroid therapi||evid||clinic trial||dobutamin inotrop therapi||infect||renal replac||shock||sedat||day||rct||strong||meta-analysi||blood cultur||random||septic patient||cardiac output||blood glucos||fluid challeng||fluid||popul||blood lactat concentr||peep||death||surviv sepsi campaign||literatur||fluid resuscit||group||mortal rate||committe||decreas||fluid administr||report||grade system||entir group||ali||resuscit||shorter intub time||trial||upper GI||critic ill||stress ulcer prophylaxi||support||tidal volum||earli goal-direct resuscit||septic shock||continu analysi||benefit||icu||ill children||outcom||sepsi syndrom,sepsi||septic shock||shock||septic shock recommend||sever sepsi||care||recommend||sepsi campaign||meningococc sepsi||sepsi campaign sepsi bundl||sepsi syndrom||catheter-rel sepsi||sepsi organ||sepsi bundl||sever septic shock,263.494||173.424||168.119||163.574||159.705||144.716||143.874||142.273||138.715||138.311||136.98||136.927||134.459||134.349||134.254,0.8,0.5,0.4666666666666667
997,Matern_Child_Health_J-2-2-1592162.txt,prevent||risk||health||control||preconcept care||health insur||educ||import||women||diabet||commun||complic||age||provid||pregnanc||intervent||barrier||chw||gdm||african american,diabet||diabet women||gestat diabet||diabet prevent||recommend diabet||diabet control||insulin-depend diabet||pre-concept diabet||influenc diabet||non-insulin-depend diabet||undiagnos diabet||diabet translat||futur diabet||main diabet||diabet care 2003,169.244||117.864||94.402||93.852||86.931||86.884||86.432||85.773||85.773||85.623||85.441||85.377||84.622||84.622||73.144,0.2,0.1,0.06666666666666667
998,J_Gastrointest_Surg-3-1-1852379.txt,type||cancer||case||stage IB||center||gastric surgeri||comp||data||studi||year||patient||medic school||hospit volum||mortal||high-volum center||gastric adenocarcinoma||node||gastrectomi||gastric cancer||signific||medic oncolog unit||treatment||institut||diagnost evalu||oper mortal||hospit||nation cancer data base||curv||stage IV diseas||lymphadenectomi||report||surviv||differ||number||ncdb||chcp||hospit type||outcom,cancer||gastric cancer||hospit||thcp hospit||hospit cancer program||cancer program||cancer mortal||cancer stage||thcp||hospit volum||teach hospit cancer program||gastric cancer resect||cancer registri||stomach cancer||gastric cancer patient,59.257||48.639||47.039||41.86||40.636||37.435||37.117||36.735||36.682||36.346||35.675||35.515||34.584||34.523||33.787,0.6,0.4,0.26666666666666666
999,Anal_Bioanal_Chem-3-1-2117337.txt,filter||apoglucos oxidas||applic||glucos||system||solut||apogox||enzym||flow system||acid treatment||flavin adenin dinucleotid||microreactor||fad||detector||low flow rate||devic||glucos oxidas||activ||electrochem detect||prepar,microreactor||korf||enzym||miniatur microreactor||apogox||venema||robust microreactor||gox||expens enzym||enzym characterist||enzym activ||miniatur enzym reactor 1 1||oxidas||specif enzym||enzym enhanc,29.9||26.577||21.589||20.822||16.609||16.455||16.329||13.287||12.383||12.013||11.985||11.424||11.123||10.795||10.795,0.6,0.3,0.2
1000,Anal_Bioanal_Chem-3-1-1592252.txt,metabolit||biolog effect||type||method||biolog fate||data||characterist ion||structur inform||sulfat metabolit||compound||site||mass spectrometri||fragment pathway||rule||product||pharmaceut||carcinogen product||hydroxylamin||neg ion mode||relev properti||sulfat||group||allyl alcohol||bioactiv||structur featur||benzyl alcohol||fragment||drug||sulfat product||vivo,sulfat||sulfat metabolit||sulfat product||sulfat site||vinyl sulfat||sulfat conjug||hydrogen sulfat||unknown sulfat metabolit||relev sulfat site||sulfat site group||potenti sulfat site||3 indoxyl sulfat||sulfat facilit detoxif||100 14 benzyl sulfat||sulfat product group no. chemic,172.486||97.578||94.286||93.355||87.657||86.833||86.243||65.85||63.48||62.877||62.236||60.956||59.722||46.702||38.337,0.6,0.3,0.2
1001,Anal_Bioanal_Chem-4-1-2228378.txt,adduct||dna sequenc||product||electrospray mass spectrometri||guanin||fragment||gutingimycin||oligom||capillari exit voltag||dna||format||higher temperatur||hplc||oligonucleotid||trioxacarcin,4a||5d 4a||2 4a 2||4a 4b 5a||3 4a 2||2 2 2 4a 3||5d||trioxacarcin||5d 2||2||4b 2||discuss 2 4a 4b 5a||materi 4a 4b 5a||4b||1 fig. 2 4a 2,68.583||50.629||44.037||40.577||33.449||32.775||32.675||32.553||32.22||31.764||30.864||30.699||30.432||29.963||29.057,0.0,0.1,0.06666666666666667
1002,Anal_Bioanal_Chem-4-1-2226000.txt,dynam monitor||gold nanoparticl||concentr||wash solut||chip||studi||ser||cell||rang||spectra,"kneipp||23||12 23||verrier||12 23 24||0003702021954557 kneipp||hench LL||9 12 23||1,144 12 23||microfluid chip||1,230 12 23 24||1,482 12 23 24||1,578 12 23 24||1,342 12 23 24||895 12 23 24",21.822||18.697||15.746||14.95||12.588||12.581||12.24||11.919||11.51||10.974||10.275||10.275||10.275||10.156||9.887,0.0,0.0,0.0
1003,Anal_Bioanal_Chem-3-1-1820759.txt,analyt bias||certif||sampl||standard solut||valu||mbt||extract||organotin compound||water||mae||crm||small amount||degrad||methanol||phenyltin analysi||solut||analyt result||uncertainti||materi||tube||upper toluen layer||between-method varianc||dpht||organotin||butyltin||result,118||120 118 118||springer-verlag 2006 118 118 118 118||organotin||120 118||organotin 118 4||organotin impur||clariti fig. 4 118 118 Sn||120 118 4||icp||organotin compound||anal||organotin 4||extract||cdot,106.972||76.621||71.315||67.756||61.445||58.93||44.833||42.301||41.651||39.995||38.006||37.318||34.909||34.614||31.057,0.2,0.1,0.2
1004,Anal_Bioanal_Chem-4-1-2270354.txt,melanin||hair||Cu liver statu||Cu determin||chemometr||princip compon analysi||sampl||studi||inaa||liver biopsi||hepat Cu concentr||dog||nail clip||analysi||Cu concentr||nail||pc||sick dog||thumb nail||hair sampl||Cu liver level||sampl mass||pca||raman||chronic hepat||result,nail||nail clip||Cu||hair||nail sampl||thumb nail||nail analysi||hair melanin||labrador dog nail||hair sampl||x-ray||thumb nail hinder||nail reflect differ||hair color||Cu contamin,85.08||56.083||53.809||53.196||50.402||45.979||44.368||40.165||39.962||34.459||31.868||31.289||29.469||29.182||28.625,0.6,0.5,0.3333333333333333
1005,Anal_Bioanal_Chem-3-1-1914286.txt,protein identif score||sampl||long-capillari monolith column||digest||mass spectromet||peak capac||increas||squar root||linear flow rate||gradient liquid chromatographi||separ||mascot||protein||flow rate||analysi||column||gradient||extern flow cell||min||bsa||score||long column||length||effici||protein identif||similar gradient slope,column||monolith column||750-mm column||trap column||longer column||long column||0.1-mm column||0.2-mm column||column diamet||short column||analysi column||60-cm column||shorter column||long monolith column||long-capillari monolith column,91.422||61.486||55.169||52.332||51.42||50.992||48.864||48.864||47.787||47.365||47.312||47.287||46.262||44.512||42.042,0.2,0.2,0.2
1006,Acta_Neuropathol-4-1-2386160.txt,antibodi||role||dysplast cortex||fcd||normal tempor cortex||case||immunocytochemistri||studi||patient||pyramid neuron||vegfb||patholog condit||observ||vegfa||receptor||dysplast neuron||express||immunoreact||cell||epilepsi||hippocampu||tissu||protein||neuron||vascular endotheli growth factor||intract epilepsi||similar pattern||primari antibodi,fcd||vegf||vegfa||vascular endotheli growth||endotheli growth||vegfb||vascular endotheli growth factor||endotheli growth factor||vascular endotheli growth factor-b||vascular endotheli growth factor express||vascular endotheli growth factor receptor||fcd tissu||endotheli growth factor-b||vascular endotheli growth factor receptors-1||vascular endotheli growth factor administr,76.492||59.828||58.0||56.813||56.122||53.689||49.642||46.791||45.141||42.267||42.18||40.911||40.79||40.278||39.951,0.4,0.4,0.26666666666666666
1007,Acta_Neuropathol-4-1-2386158.txt,human brain||antibodi||low level||AD patholog||brain tissu||imag||insult||reactiv oxygen speci||specif cellular marker||control tissu||form||increas||region||astrocyt||molecular form||evid||specif||cell||control||diffus plaqu||oxid stress||gray matter||enzym||protein||neuron||gray||dens core||report||mous||number||plaqu||minor form||area||peroxiredoxin 6||patholog||peroxiredoxin||tau||goat,peroxiredoxin||peroxiredoxin 6||peroxiredoxin 6 astrocyt||peroxiredoxin isoform||peroxiredoxin famili||AD||peroxiredoxin 6 stain||peroxiredoxin 6 30||stronger peroxiredoxin 6||peroxiredoxin 6 variant||astrocyt||bovin 1-ci peroxiredoxin||AD tissu||springer-verlag 2008 peroxiredoxin 6||pmi AD,131.01||78.394||68.912||66.37||65.505||65.159||56.601||53.036||52.633||52.263||49.947||45.634||42.457||39.702||38.472,0.4,0.2,0.2
1008,Anal_Bioanal_Chem-4-1-2259237.txt,regress tree||leutra river||biofilm sampl||Mg content||method||chemometr||predict abil||sampl||data||model||saal river||water||supervis method||node||discrimin||high sensit||variabl||test set||classif||dpl||biofilm||PC 2||percentag||environment condit||pc||order||munich||number||cart||object||river||result,biofilm||biofilm biofilm grown||biofilm sampl||sampl biofilm||sea biofilm||stand water biofilm||biofilm subgroup||biofilm charact||biofilm structur||15 biofilm||flow water biofilm||biofilm water phase||cart||sea biofilm sampl||water,155.682||111.299||105.173||105.173||80.545||79.954||78.707||78.468||77.841||77.841||76.311||74.907||73.948||71.918||62.761,0.4,0.2,0.26666666666666666
1009,AIDS_Behav-3-1-1847541.txt,pilot intervent||MC servic||men||bailey||mother||practic||circumcis||africa||studi||school||effect||region||clinic trial||non-circumcis commun||accept||cost||lukobo||signific impact||south africa||age||infant circumcis||tradit circumcis||sti||foreskin||non-circumcis ethnic group||unpublish report||male circumcis||medic practition||particip||procedur||submit||addit||hiv||ethnic||protect,circumcis||circumcis men||circumcis accept||male circumcis||tradit circumcis||circumcis prefer||safe circumcis||circumcis servic||undergo circumcis||circumcis peni||circumcis group||pubert circumcis||infant circumcis||circumcis statu||circumcis versu,350.871||207.073||199.682||196.726||182.724||181.609||181.264||179.54||176.59||176.522||176.495||176.246||176.102||175.435||175.435,0.6,0.3,0.26666666666666666
1010,Acta_Neuropathol-4-1-2270355.txt,case||clinic sign||ep||account||studi||region distribut||inclus||dlb||high likelihood categori||braak||dementia||mild||cohort||vulner nuclei||transentorhin region||subject||categor||materi||distribut||dmv||sever||diseas||stage||result,0||0 0 0||0 0||0 0 0 0||2 0 0 0 0||6 0 0 0 0||4 0 0 0||1 0 0 0||2 0 0 0||6 0 0 0||5 0 0 0||0 0 0 0 28 78||2 0 0||3 0 0||1 0,536.158||536.158||536.158||536.158||429.085||429.063||404.428||403.873||402.317||402.289||402.265||358.908||357.704||357.678||271.589,0.0,0.0,0.0
1011,Anal_Bioanal_Chem-4-1-2175028.txt,signific ree content||ree||method||la-mc-icpm analys||isobar interfer||mass bia correct||problem||sampl||data||studi||spot analysi||Sr isotop||mass spectromet||geolog materi||element fraction||high Sr content||carbon||correct||la-mc-icpm||marin carbon||Sr isotop analys||mc-icpm||ratio||dimer||analysi||accuraci||sampl materi||fraction||interfer||Kr correct||laser||Rb correct||precis||instrument mass discrimin||tim analys||Sr isotop ratio||techniqu,Sr||Sr isotop||Sr mass||Sr materi||Sr ratio||Sr isotop mass||Sr concentr||86||21 87 86 Sr||Sr isotop ratio||Sr isotop analys||report Sr isotop||Sr isotop analysi||Sr isotop data||87 86 84 86 Sr ratio,160.164||109.972||91.55||85.48||82.625||80.96||80.082||79.99||78.658||75.011||74.958||74.728||74.488||73.315||71.451,0.2,0.2,0.2
1012,Anal_Bioanal_Chem-3-1-1805043.txt,method||primari clarifi||wastewat||concentr||sampl||biotransform||remov||process||compound||elimin||mbr||treatment||membran bioreactor||ca effluent||diclofenac||hydrochlorothiazid||pharmaceut||hydraul retent time||analysi||effluent concentr||ca process||wastewat treatment||effluent||remov effici||sludg||averag daili flow||intern standard||drug||effici||attenu||membran,mbr||mbr effluent||mbr process||laboratory-scal mbr||mbr system||effluent||sludg||ca effluent||ca||hydrochlorothiazid||wwtp effluent||ofloxacin||bezafibr||ketoprofen||elimin,66.972||49.003||36.298||34.658||33.486||31.033||30.716||27.862||24.69||23.393||22.736||21.303||21.303||20.4||19.547,0.2,0.5,0.4
1013,Acta_Neuropathol-4-1-2270353.txt,antibodi||lewi neurit||section||control||method tissu sampl||case||lewi bodi||overnight||ampa receptor||cell death||protein||tissu section||sporad PD case||express||synapt plastic||dementia||alpha-synuclein||cell,nptx2||narp||nptx2 immunoreact||result nptx2||nptx2 mrna express||narp mrna||nigra||narp hypothesi||neuron pentraxin||worley PF narp||nptx2 label lewi bodi||semi-quantit rate nptx2 IR||nptx2 microarray express data||SN||substantia nigra,76.073||45.635||40.062||38.036||28.764||25.567||23.552||22.817||22.271||22.264||21.283||21.229||20.713||20.214||19.013,0.0,0.0,0.0
1014,Anal_Bioanal_Chem-3-1-2117336.txt,capillari||gold-sensor disk||time||pH optimum||aceton||sampl||surfac modif||immobil||spr||liquid chromatographi||amount||digest||high activ||reactor||water||netherland||on-lin digest||dextran hydrogel||open-tubular reactor||protein||enzym||experi||gentl flow||spr sensor||surfac||order||carry-ov||buffer||high concentr||incub||protein digest||substrat||pda||surfac plasmon reson||fragment||disk||peptid||immobil enzym||complet digest||result,reactor||digest||capillari reactor||capillari||on-lin digest||trypsin||capillari enzym reactor||open-tubular trypsin reactor||spr||open-tubular reactor||fused-silica capillari||enzym reactor||immobil trypsin||immobil||protein digest,41.649||37.101||35.547||29.446||29.004||27.406||27.404||27.012||26.956||26.815||26.705||26.383||26.003||24.6||23.725,0.8,0.6,0.5333333333333333
1015,Am_J_Community_Psychol-2-2-1705531.txt,lifestyl||case||secondari victim||respons||self-blam||neg experi||studi||neg reaction||disclosur||silenc||friend||legal||current studi||sourc||commun system personnel||impact||rape||natali||karen||reaction||interview||effort||neg social reaction||result||social reaction||experi||social class||support provid||assault||commun system||reason||religi commun||medic system||famili||legal system||woman||survivor||posit||rape survivor||fear||support||foster care system||mari||decis||shawna||step||polic||in-person interview,rape||assault||rape survivor||assault disclosur||rape victim||survivors’ assault||disclosur||survivor||rape journal||rape crisi||rape myth||acquaint rape||sexual assault survivor||rape reform||depict rape,205.679||181.199||160.01||149.794||135.209||120.858||118.389||114.34||107.478||106.295||106.105||104.808||104.576||104.165||103.808,0.6,0.5,0.3333333333333333
1016,Anal_Bioanal_Chem-3-1-1914274.txt,condit||measur||present pad system||system||off-lin batch format||concentr||optim||data||pro-oxid||effect||ascorb acid||pad system||ros-produc||increas||resolut||compound||mixtur||hplc separ||on-lin pad system||protein concentr||antioxid||harm effect||paper||flow-rat||flow rate||gradient||flow inject analysi||paraquat||min||organ modifi||fia||bioactiv||flow-rat gradient||individu compound||ro||hplc||mode||detect||result,on-lin pad||pro-oxid||pad system||antioxid||hplc pad system||on-lin pad system||antioxid fia pad system||fia pad system||hplc||on-lin pad assay||ros-produc pro-oxid compound||hplc mode||on-lin gradient hplc mode||compound||ros-produc compound,48.866||46.873||45.71||44.776||43.281||42.709||40.864||39.56||38.421||37.573||36.499||34.43||31.674||31.378||31.312,0.6,0.5,0.4
1017,Anal_Bioanal_Chem-3-1-1797063.txt,import||biofilm||quorum||stabil||signal product||system||commun||signal concentr||aip||endoproteas||growth condit||agr cascad||environ||studi||bacteria||biofilm format||signal diffus||quorum sens||molecul,S. aureu||staphylococcu aureu||S. aureu S.||biofilm S. aureu biofilm||_{||P. aeruginosa S. aureu lifecycl||biofilm||40 65 S. aureu S.||S.||69 fig. 4 S. aureu agr||delta _{||signal||environ||biofilm commun S.||_{ 0,54.689||45.438||44.452||41.089||35.486||29.594||27.489||26.902||23.978||21.33||20.596||20.264||20.061||19.077||18.394,0.0,0.1,0.13333333333333333
1018,Anal_Bioanal_Chem-4-1-2259236.txt,bond||data||marin||ion||spectra||isom||nonrepetit complex materi||meaning molecular-level analysi||complex unknown||current inabl||discret analyt volumetr pixel space||complex mixtur||mass||oxygen||voxel||ratio||properti||separ||chemic structur||structur space||analysi||fticr mass spectra||nmr||complex system||limit bandwidth||materi||chemic bind||number||organ structur spectroscopi||peak||molecul||function,anal chem 70:3853||anal chem 35:2146||anal chem 75:5030||anal chem 66:3849||acc chem||phi chem||anal bioanal chem analyt||chem soc 119:7928||chem soc 120:4763||chem soc 116:7098||chem soc 117:7019||nicholson||molecular-level||chem rev 104:17||bioconjug chem 16:322,46.392||46.392||46.392||46.392||44.227||41.254||35.549||32.546||32.546||32.546||32.546||31.859||30.834||29.625||29.054,0.0,0.0,0.0
1019,Anal_Bioanal_Chem-2-2-1764597.txt,toxic equival quantiti||pcb||sampl type||method||concentr||dioxin-lik pcb||determin||tcdd||sampl||data||seri||toxic effect||pcdd||select||extract||toxic equival factor||discuss||dlpcb||human||review||tempor trend||compound||dioxin||sourc||mixtur||analyt||mass spectrometri||calux||applic||hite||furan||analysi||pcdf||concentr rang||report||order||emiss||number||chemic||congen||polychlorin dibenzofuran||tef||toxic||signific advanc||techniqu,"dioxin||dioxin teq||teq||pcb teq||furan||pcb||dioxin pcdd||2,3,7,8-substitut dioxin||environ||chlorin dioxin||octa-chlorin dioxin||dioxin method||reiner||2,700 pg dioxin||dioxin determin",157.27||148.399||139.529||120.422||104.305||101.316||99.964||94.133||89.36||89.292||86.384||86.319||85.505||85.491||82.092,0.4,0.3,0.2
1020,AIDS_Behav-2-2-1544374.txt,prevent||program||sexual behavior||level||time||campaign||africa||strategi||year||multipl channel||effect||inform||review||sexual activ||hiv preval||countri||health educ||condom||behavior chang||ugandan ministri||health||educ||vision||train||world health organ||iec||hiv||global aid crisi||educ campaign||activ||report||aid||uganda||note||ministri||support||major differ||plan||gpa||district,uganda||uganda program||uganda hiv||uganda aid program||uganda messag||aid||moh uganda||uganda acp||uganda 89||2006 uganda||1 uganda||aid program||uganda hiv preval||program||uganda aid control program 1989,180.159||129.123||123.416||119.596||101.951||100.542||95.207||95.207||90.596||90.085||90.08||89.315||83.305||78.088||77.116,0.2,0.2,0.2
1021,Anal_Bioanal_Chem-3-1-2117333.txt,calcul||compil||set||higher level||method||time||sampl||solvent||polar||full-scan acquisit||retent time shift||amount||solid phase||process||toluen||effici extract||fortif||recoveri||calibr standard||degrad||sourc||methanol||valid||pesticid||mix solut||adsorpt||inject speed||solut||residu||analysi||liner||standard||ethyl acet||clean-up||gpc clean-up||minimum||intern standard||gcb||inject||matrix||step||multi-residu analysi||result,0||102 102 0 0 92 12||api3000||lettuc||api2000||GC||100 0 0 4 sharonfruit||5 GC||5||4||93 93 0 0 88 12||lettuc pesticid||orang||4 102 5 86 2 api2000||99 0 0 9 fennel,259.449||193.403||181.517||167.992||165.428||151.185||149.648||147.262||143.338||142.909||141.996||139.453||134.763||132.354||130.538,0.0,0.0,0.0
1022,Anal_Bioanal_Chem-3-1-1802725.txt,condit||galleri||non-destruct analysi||instrument||mar virgin||analyt challeng||panel||experiment condit||exhibit galleri||larg dimens||investig||raman spectroscopi||museum object||exampl||mobil spectromet||artefact||pigment||indian kalighat||conserv||paint||analysi||spectrum||museum||antiqu egyptian sarcophagi||varnish layer||renaiss||laser||work||lid||area||mobil raman spectroscopi||earli keyboard instrument||object||textil banner||techniqu,museum||paint||raman spectroscopi||raman instrument||raman spectrum||museum galleri||artefact||vandenabeel||raman spectra||museum object||raman spectrosc 35||mobil raman spectroscopi||varnish paint||mobil raman instrument||raman spectrosc 32,56.889||47.26||43.701||43.311||39.565||39.508||38.362||37.723||36.284||34.374||33.884||33.219||32.96||32.959||32.542,0.6,0.5,0.4
1023,Anal_Bioanal_Chem-4-1-2226005.txt,light mass ratio||variat||plasma||instrument||extern precis||element||sampl||data||mc-icp-m||isotop fraction||silic||ion beam||composit||ratio measur||mass spectrometri||ratio||larg variat||standard||intens||extern normal||isotop||high instabl||fraction||interfer||isotop ratio measur||light element||precis||techniqu,earth||isotop||chem geol||Mg isotop||planet sci lett||Li isotop||isotop fraction||isotop composit||chem geol 226:280||lithium isotop||lighter isotop||Mg isotop ratio||Ca isotop ratio||Li isotop fraction||isotop homogen,95.061||83.182||66.18||58.359||57.422||53.946||50.425||46.818||45.029||44.451||43.929||43.459||42.449||41.853||41.591,0.2,0.2,0.13333333333333333
1024,Anal_Bioanal_Chem-3-1-1592466.txt,channel dimens||system||larg molecul||squar capillari||cas-chip||success separ||mix protein sampl||multilay flow||small molecul||capillary-assembl microchip||capillari electrophoresi||solut||protein||squar section channel||CE separ||fluoresc intens profil||microchip||feasibl studi||microchannel||deprotein||pretreat||sampl inject||inject||pdm||molecul||f-bsa||sampl solut,cas-chip||molecul||deprotein||diffusion-bas deprotein||separ capillari||terab||squar capillari||diffusion-bas separ||capillari electrophoresi||small molecul||rhodamine-bas molecul||cas-chip technolog||chemically-function capillari||fluoresc||CE separ,36.264||27.936||26.371||24.271||23.814||22.171||21.279||20.663||20.51||19.007||18.912||18.778||17.532||17.461||16.701,0.6,0.6,0.4666666666666667
1025,Anal_Bioanal_Chem-3-1-1705481.txt,individu congen||program||pcb||method||routin pop analysi||electron supplementari materi||concentr||sampl||low cost||data||solvent||strategi||pop||extract||low environment impact||water||air||GC column||review||analyt laboratori||abil||recoveri||scientist||pesticid||analyt||countri||lipid||field blank||manag||organochlorin||percentag||evapor||analysi||gpc||routin measur||analyt standard||analyt method||sediment||ocp||congen||limit||stockholm pop convent||lab||blank||step||analyt system||environment monitor||detect||techniqu,ocp||pcb||pop||ocp monitor||ocp contamin||pcb congen||ocp recoveri||analyt||ocp analysi||ocp ancillari||15 ocp||routin pcb||ortho-subsitut pcb||pcb number||singl pcb,142.936||138.749||84.828||79.717||77.026||76.54||76.123||75.289||72.941||72.272||71.469||71.299||70.628||69.375||69.375,0.6,0.4,0.26666666666666666
1026,Acta_Neuropathol-3-1-2080348.txt,astrocyt hypertrophi||find||case||pvl||pvl case||infant||perinat period||gray matter lesion||data||studi||neg group||cerebr cortex||dwmg||reactiv astrocyt||necrosi||signific||periventricular leukomalacia||cell||brain||gfap||basal ganglia||periventricular necrosi||gray matter||hippocampu||neuron loss||globu pallidu||white matter gliosi||age||frontal cortex||perinat panencephalopathi||incid||injuri||purkinj cell||group||sever||white matter injuri||gliosi||dwmg group||prematur infant||thalamu,0||1.000 0||0.3273 0||0.495 0||deliveri 0||pvl||dwmg||1.000 occipit cortex 0||1.000 pvl||pvl dwmg neg||NS pvl dwmg||0.629 pvl dwmg||pvl case||posit airway pressur 0||urinari tract infect 0,228.872||134.341||115.818||115.43||114.923||105.464||88.467||73.82||72.637||67.953||67.114||65.881||57.602||57.218||57.218,0.0,0.2,0.2
1027,Osteoporos_Int-4-1-2267485.txt,rheumatoid arthriti||clinic fractur||comput||data||model||studi||year||bmi||risk||continu variabl||increas||exampl||prior histori||fractur probabl||fractur||signific interact||signific||valid||absenc||cohort||osteoporot fractur||bmd||women||hip||assess||age||death||death hazard||osteoporosi||cost-effect||hazard function||clinic risk factor||probabl||clinic spine||fractur risk||hip fractur,fractur||fractur risk||hip fractur||fractur probabl||osteoporot fractur||hip fractur risk||vertebr fractur||fractur hazard||perimenopaus fractur||fragil fractur||clinic fractur||forearm fractur||model fractur||previou fractur||osteoporosis-rel fractur,252.705||177.439||158.009||141.58||140.392||139.397||133.732||132.47||130.12||129.913||129.311||128.973||128.406||127.724||127.265,1.0,0.5,0.4
1028,Sleep_Breath-4-1-2276561.txt,level||time||week||fat||weight loss||hypoxia group||hypox climat||train period||studi||bmi||effect||air||hypox condit||moder hypoxia||oxygen||hypoxia||mild||train||climat||bodi||subject||weight||min||group||normobar hypoxia||room||low intens physic exercis||simul altitud,hypoxia||sham hypoxia||normobar hypoxia||hypoxia train||hypoxia group||moder hypoxia||acut hypoxia||sham hypoxia group||acut hypobar hypoxia||sham hypoxia group 2||sham hypoxia control protocol||subject||normobar sham hypoxia netzer nikolau||sham hypoxia group fig. 5||exercis,105.51||69.862||63.992||62.514||57.392||55.0||54.673||49.666||38.148||37.648||36.258||35.486||33.524||30.086||29.105,0.6,0.4,0.3333333333333333
1029,Purinergic_Signal-3-4-2072919.txt,subtyp||releas||modul||nerv termin||adenosin||pharmacolog profil||channel||patholog situat||atp||effect||synapt transmiss||spinal cord||receptor||excitatori amino acid||p2i receptor||nervou system||brain||p2x receptor||neurotransmitt releas||nucleotid||hippocampu||neuron||termin||activ||extracellular space||neurotransmitt||ligand-g cation channel||sympathet nerv||glutam||neuron activ,receptor||p2x receptor||p2i receptor||releas||atp receptor||P2 receptor||atp p2x receptor||atp releas||p2x||rat||presynapt p2x receptor||presynapt p2i receptor||p2i||facilitatori p2x receptor||ionotrop p2x receptor,165.196||135.287||131.58||131.247||123.718||120.215||117.605||106.743||105.378||104.61||104.549||102.078||97.963||96.177||94.65,0.8,0.4,0.26666666666666666
1030,Intensive_Care_Med-4-1-2228379.txt,refractori shock||septic shock||supplementari materi||product||septic patient||urinari excret||benefici effect||short-term effect||proxim tubul injuri||septic shock patient||kidney damag||clinic paramet||MB treatment||renal tubular injuri marker||renal failur||studi||urin||continu infus||patient||day,methylen||MB||methylen blue||MB excret||MB infus||septic shock||MB treatment MB||nijmegen||excret||nitric oxid||infus||hour MB||refractori septic shock||s00134-007-0867-9||MB treatment,23.103||19.703||19.132||15.432||15.347||13.791||13.135||11.265||11.16||11.151||10.99||10.925||10.734||10.083||9.851,0.0,0.1,0.13333333333333333
1031,Diabetologia-4-1-2362134.txt,vitro techniqu||resorpt||coverslip||control group||rankl||studi||mediat||patient||observ||increas||receptor||opg||diabet control||osteoclast format||osteolysi||excess concentr||osteoclast||m-csf||dentin slice||activ||group||rankl-independ pathway||bone||cultur||presenc||number||healthi control||particip||addit||result,osteoclast||osteoclast resorpt||osteoclast format||osteoclast activ||activ osteoclast||osteoclast cultur||osteoclast precursor||osteoclast differenti||human osteoclast||osteoclast marker||m-csf osteoclast format||0.0001 osteoclast resorpt||osteoclast resorpt 4||opg osteoclast format||srankl osteoclast format,133.556||90.433||73.457||71.068||71.068||70.317||69.294||69.202||68.149||67.363||63.995||61.302||60.302||59.633||56.434,0.4,0.2,0.13333333333333333
1032,BMC_Bioinformatics-4-_-317283.txt,literatur mine||matrix tabl||modifi term||basic pubm search window||simpl||databas||search term||data||larg dataset||keyword term||combin||proteom approach||gene list||tool||term co-occurr||gene||approach||pubm||pair-wis comparison||list||tabl||keyword||queri||pubmatrix||result,pubmatrix||list||term list||term||search term||search||pubm||gene list||chromosomal-band term list||keyword term||annot gene list||mine||simpl search||100 search term||microarray gene list,30.185||26.994||26.408||25.822||25.502||25.182||22.759||20.378||18.723||18.042||17.977||17.431||17.284||17.001||15.956,0.6,0.6,0.4
1033,Dev_Genes_Evol-3-1-1784541.txt,macrostomorpha||anim||organ system||triclad||postembryon develop||polyclad||amput||regener||divers taxa||head||develop||planarian||organ||main function||abil||pharynx||similar||nervou system||ovari||eye||cell||brain||egger||free-liv flatworm||platyhelminth||regener capac||acoela||neoblast||acoel||part||main nerv cord||anterior||flatworm||speci,regener||planarian regener||regener M.||über regener||lignano||regener capac||intercalari regener||posterior regener||regener capabl||brain regener||regener experi||repeat regener||regener studi||regener research||regener potenti,268.161||185.502||145.859||141.393||140.179||138.338||136.828||135.637||135.227||135.101||134.831||134.726||134.128||134.089||134.081,0.2,0.2,0.13333333333333333
1034,Int_J_Cardiovasc_Imaging-4-1-2233708.txt,viabl myocardium||cmr||system||flow||artifact||imag||element cardiac||quantit analysi||studi||cardiovascular magnet reson||imag qualiti||acut myocardi infarct||stent posit||repeat intervent||sequenc paramet||day||dark band artifact||patenc||field strength||acut||feasibl||chronic phase||cine||analysi||cine imag||dark band||scan||repeat catheter||puls sequenc||safeti,3.0||imag||reson 3.0||reson imag||cmr||imag artifact||lge imag||imag 1.5||cine imag||magnet reson imag||imag qualiti||3.0 tesla||lge imag qualiti||stent artifact||cmr scan,63.424||59.154||52.155||50.02||47.661||44.969||44.905||44.359||43.666||43.634||42.77||39.426||38.732||36.483||36.167,0.4,0.3,0.26666666666666666
1035,Osteoporos_Int-3-1-1894753.txt,bone mass||measur||find||method||narrow age rang||boy||studi||periost growth||longitudin growth||humer AR||avon longitudin studi||fractur||analys||present studi||humer dimens||ratio||humeru||girl||width||humer width||age||gender differ||puberti||tanner stage 2||scan||differ||bone||height||dxa||tanner stage||periost||length||area||humer geometri||bone miner densiti||children||result,bone||puberti||humer AR||humer width||humer length||boy||boy girl||girl||humer geometri||humer dimens||greater humer AR||bone length||prepubert boy||gender||bone growth,48.701||47.375||46.356||44.845||44.092||43.356||42.298||41.24||38.876||38.017||33.657||33.047||31.436||30.503||29.908,0.8,0.8,0.5333333333333333
1036,Virchows_Arch-4-1-2329735.txt,cell adhes||type||intestin||high level||find||case||tissu microarray||liver metastasi||carcinoma||studi||patient||patholog characterist||diffus distribut||diffus compon||high stage||muc2||express||classif||diffus part||present studi||mix type||lymph node||emmprin||analysi||lymph node metastasi||genet||group||MT case||invas||gastric carcinoma||statist signific||venou invas||periton||compon,carcinoma||gastric carcinoma||gastric||gastric MT carcinoma||diffuse-typ gastric carcinoma||intestinal-typ gastric carcinoma||carcinoma mixed-typ carcinoma diffuse-typ carcinoma||MT carcinoma||gastric carcinoma anticanc||gastric carcinoma exhibit||gastric carcinoma 3||gastric carcinoma 4||gastric carcinoma Br||human gastric carcinoma||gastric carcinoma progress,94.654||88.525||82.396||67.878||63.863||63.321||63.303||60.619||60.499||60.456||59.049||59.017||59.017||59.017||59.017,0.4,0.2,0.13333333333333333
1037,Neuroimage-2-1-2387200.txt,corpu callosum||group differ||method||mri||abnorm||studi||diffus process||patient||white matter pathway||fraction anisotropi||pdf||genu||pico||threshold||region||multipl linear regress||specif cortic region||first-episod psychosi||interhemispher connect||splenium||voxel||FA||control||psychosi||fiber||age||gender||subject||seed region||white matter||group||differ||cortex||tract||probabl||schizophrenia||focal abnorm||dti||result,al.||schizophrenia||corpu callosum||corpu||corpu callosum abnorm||first-episod schizophrenia||tract||corpu callosum mol||corpu callosum develop||corpu callosum growth||human corpu callosum||schizophrenia schizophr||splenium||genu||genu tract FA,104.821||63.318||61.215||56.916||47.032||46.71||43.013||40.81||40.81||40.81||40.81||37.863||37.265||36.663||34.698,0.4,0.3,0.3333333333333333
1038,Int_J_Cardiovasc_Imaging-3-1-2121120.txt,follow-up||wall motion abnorm||nwma||mri||imag||studi||patient||dobutamin stress cmr||lbbb||dose||examin||stress||wall motion analysi||perfus abnorm||cine||cardiac event||peak-dos dobutamin||coronari arteri diseas||ischemia||peak stress||perfus sequenc||min||cag||dobutamin||addit inform||segment||perfus imag||rest||normal first-pass perfus||perfus deficit,dobutamin||perfus||myocardi perfus||dobutamin stress||nwma||peak-dos dobutamin||myocardi perfus imag||dobutamin stress cmr||perfus abnorm nwma||perfus imag||perfus abnorm||peak-dos dobutamin stress cmr||first-pass myocardi perfus||normal myocardi perfus||myocardi perfus mri,113.915||93.205||83.227||80.62||76.328||75.271||66.406||65.8||65.48||62.984||60.057||58.507||58.203||57.728||57.519,0.4,0.5,0.4
1039,Virchows_Arch-3-1-2082069.txt,tumor||ectop tissu||neoplasia||structur||case||paratesticular structur||mesotheli hyperplasia||pseudotumor||benign mimick||testicular||lesion||diagnosi||cyst||leydig cell||sertoli cell||testi||true neoplasia,testicular||testicular cyst||testi||testicular neoplasia||testicular tumor||testicular hematocel||testicular neoplasm||testicular pseudolymphoma||testicular mass||testicular amyloidosi||testicular vascul||testicular femin||testicular infarct||testicular microlithiasi||testicular polyarter,120.066||81.193||72.146||68.54||65.22||64.475||63.859||62.994||62.777||62.572||62.484||62.407||61.612||61.514||61.514,0.4,0.2,0.13333333333333333
1040,Matern_Child_Health_J-2-2-1592154.txt,preconcept||sara||infant||pregnanc||histori||year postpartum||depress||concept||risk||medic||postpartum period||counsel||mental health||earlier treatment||treatment||melani||women||month||care||famili||perinat||health care provid||episod||mood disord||addit||outcom,depress||postpartum depress||perinat depress||depress episod||matern depress||postnat depress||depress symptom||antenat depress||sever depress||comorbid depress||postpartum||matern depress effect||neonat depress anxieti||postnat depress Br||perinat,114.486||79.723||73.528||62.358||60.574||59.812||59.494||58.213||57.243||57.243||44.961||40.807||40.637||40.232||32.569,0.2,0.1,0.13333333333333333
1041,Ann_Surg_Oncol-3-1-1914262.txt,intern mammari lymph node||time||surgic treatment||rate||breast cancer||patient||node||visual||metastas||visual IM sln||parastern intercost incis||axillari sln||radiotherapi||primari tumor||IM sln||sentinel node||tumor||sln||stage procedur||surgic explor||patient IM sln||inject||lymphoscintigraphi||radiotherapeut treatment,sln||IM sln||IM||IM metastas IM sln||bct||IM sln biopsi||axillari sln||visual IM sln||patient IM sln||retriev IM sln||sln biopsi||IM metastas||visual sln||sentinel IM node||IM sentinel node,148.237||140.746||133.256||116.726||115.744||106.644||101.401||100.765||99.851||96.438||93.338||92.705||84.52||83.91||83.91,0.4,0.5,0.3333333333333333
1042,Support_Care_Cancer-4-1-2413096.txt,day-to-day hands-on caregiv||level||individu||data||model||studi||year||caregiv||patient||concept||inform||abil||proport||valid instrument||palli care||relationship||life-limit ill||south australia||unmet||popul||servic||death||respond||famili member||termin ill||long-term caregiv outcom||survey||health omnibu survey||special palli care servic||support||area||peopl||outcom,caregiv||spc||caregiv respond||end-of-lif caregiv||905 caregiv||famili caregiv||long-term caregiv||caregiv burden||access caregiv||inform caregiv||cancer caregiv||caregiv assess||caregiv characterist||caregiv inabl||caregiv role,202.553||125.456||114.317||105.925||105.129||104.661||103.926||103.569||103.073||103.056||102.455||102.057||101.87||101.845||101.839,0.2,0.1,0.06666666666666667
1043,J_Gastrointest_Surg-3-1-1852391.txt,logist regress analysi||complic||logist regress||rate||studi||patient||effect||obes||anastomosi||variabl||peripher neuropathi||signific||gastric bypass||strictur||age||analysi||odd||surgeri||gerd||bariatr surgeri||group||factor||rygb||oper techniqu||gastrojejunostomi||obes patient||techniqu,strictur||gastrojejunostomi strictur||postop strictur||fewer strictur||strictur group||strictur rate||recurr strictur||predict strictur||JS strictur dilat||bypass||increas strictur rate||roux-en-i||gastric bypass||gastrojejunostomi||strictur group nonstrictur group,108.19||69.699||60.253||56.128||55.764||55.289||54.095||54.095||39.204||37.571||36.86||32.352||32.224||31.207||31.056,0.2,0.1,0.2
1044,J_Mol_Model-3-1-2039871.txt,type||attempt||set||emphasi||method||system||level||bond||pm6||molybdenum||incorrect structur||optim||element||data||valu||spin-fre energi level||orbit||effect||refer data||larg formal charg||water||structur||failur||transit metal complex||complex||parameter||compound||high level calcul||fault||electron state||geometri||group iva||core-cor express||potenti||distanc||main group||paramet||rule||atom||accuraci||rare ga atom||potenti sourc||weight||interatom separ||transit metal||group||hydrogen bond||hydrogen||import||core-cor interact||refer||semiempir method||interact||speci||error||heat||chemic bond||function||approxim||result,element||paramet||_{||pm6||pm6 am1||am1||optim paramet||paramet optim||element pm6 no.||pm3 paramet||no. pm6 am1||core-cor paramet||diatom paramet||pm6 pm5 pm3 am1||atom,85.926||77.086||74.925||68.249||66.56||64.871||64.554||64.554||62.013||61.226||54.994||54.697||53.527||52.924||52.777,0.6,0.3,0.26666666666666666
1045,Eur_J_Clin_Pharmacol-3-1-2071964.txt,type||aspect||ddd||daili dosag||pharmacotherapi audit meet||ptam||method||agreement||result||associ||pharmacist||meet||data||studi||tool||cost||group,ptam||ptam level||ptam meet||prescrib||function ptam||ptam number||84 ptam||ptam 11||includ ptam||drug prescrib||ptam paramet number||total 824 ptam||drug||du90||cost-effect prescrib,159.019||96.868||90.78||85.847||81.272||81.12||80.77||79.863||79.509||69.628||54.08||53.499||53.41||49.848||46.785,0.2,0.1,0.06666666666666667
1046,Purinergic_Signal-3-4-2072921.txt,atp||confoc analysi||striatum||dopamin denerv||rat striatum||presenc||gray matter||rat brain||protein level||protein||receptor||green immunofluoresc||substantia nigra||experiment condit||express||lesion nigro-striat circuit||specif||brain||purinerg receptor,receptor||P2 receptor||purinerg receptor||p2x receptor||p2i receptor||volonté||P2||neuron p2x receptor||P2 receptor subtyp||p2x6 receptor||P2 receptor modul||P2 receptor protein||metabotrop receptor||p2x3 receptor||receptor architectur,48.897||38.447||35.067||33.074||32.328||29.831||27.997||27.977||27.308||27.043||26.845||26.745||26.676||26.563||26.064,0.4,0.2,0.13333333333333333
1047,Eur_Arch_Psychiatry_Clin_Neurosci-3-1-1800370.txt,deficit||control group||fals belief||schizophren||mental state||studi||social cognit task||patient||brain damag||cognit profil||tactic strategi||human||abil||stori||tom||lesion||behaviour||damag||brain||social cognit||item||mental retard||frontal lobe lesion||task||statement||subject||ventromedi frontal lobe damag||group||order||lmpfc||differ||perform||healthi control||prefront cortex||signific correl||medial frontal lobe||peopl||schizophrenia||score||social situat,mind||frontal lesion||frontal lobe||frontal lobe lesion||frontal lobe lesion theori||mind task||lesion||theori||mind impair||medial frontal lobe||exclus frontal lesion||orbit frontal lesion||unilater frontal lobe lesion||mind abil||mind deficit,91.92||79.153||72.609||69.124||66.439||65.257||62.154||58.384||57.15||56.636||53.148||53.144||52.937||51.467||51.008,0.2,0.3,0.2
1048,Knee_Surg_Sports_Traumatol_Arthrosc-3-1-1915597.txt,aitfl imping||fascicl||joint tissu||joint||studi||patient||contact||ankl joint||anterior talofibular ligament||ankl||aitfl||chronic ankl pain||talu||anterior aspect||pain||imping syndrom||imping||dorsiflexion||anterior||arthroscopi||ligament||anterior inferior tibiofibular ligament||talar dome||result,ankl||fascicl||ankl imping||anterior ankl imping||ankl arthroscopi||distal fascicl||ankl joint||imping distal fascicl||imping||ankl sprain||ankl imping syndrom||ankl instabl||keyword ankl imping||ankl injuri||s00167-006-0275-7 ankl,141.478||116.935||109.77||84.741||84.714||80.509||79.709||79.694||78.062||76.421||75.279||74.316||73.18||73.104||72.307,0.4,0.4,0.26666666666666666
1049,J_Headache_Pain-4-1-2386847.txt,placebo||region cerebr blood flow||time||volunt||studi||patient||effect||infus||increas||cgrp||blood pressur||rcbf||mca||signific||treatment||present studi||heart rate||cerebr arteri||chang||min||arteri||decreas||migrain||cerebr blood flow,cgrp||cgrp placebo cgrp placebo cgrp||cgrp infus||cgrp receptor||cgrp antibodi||mca||oral cgrp antagonist||edvinsson||calcitonin||mca territori||cerebr blood flow||blood||olesen||cerebr arteri||mca dilat,66.215||45.942||36.258||33.762||33.108||28.296||23.047||22.254||20.842||18.221||18.015||17.921||17.783||17.643||17.469,0.2,0.2,0.26666666666666666
1050,Surg_Endosc-4-1-2422865.txt,follow-up||week||questionnair||minim invas||randomis trial||complic||studi||patient||health statu||sic||bodi imag||test||total||small-incis cholecystectomi||preoper data||symptomat cholecystolithiasi||analys||method patient||oper||alloc sequenc||health||giqli||alloc conceal||surgeri||subscal||minim invas procedur||cholecystectomi||gener||group||gener short form||differ||order||trial||procedur||score||secondari outcom measur||techniqu,cholecystectomi||sic||laparoscop cholecystectomi||small-incis cholecystectomi||LC||LC versu sic||open cholecystectomi||sic procedur||conv||cholecystectomi rate||cholecystectomi Br||elect cholecystectomi||sic 55.4||sic patient||0.100 sic,97.499||89.275||71.083||68.499||58.658||52.088||51.754||51.074||50.786||49.828||49.608||49.243||46.395||45.617||45.37,0.6,0.3,0.2
1051,Ann_Biomed_Eng-4-1-2413127.txt,csf||time||method||brain tissu||traumat brain injuri||model||studi||brain injuri||cerebr cortex||head||boundari constraint||increas||region||shear modulu||finit element model||injuri criteria||geometri||brain||stress||tbi||numer model||equival stress||gray matter||heterogen||simul||direct||part||cerebrum||injuri||load condit||cortex||influenc||mechan load||comput head model||materi properti||result,document||user2||model||heterogen model||head model||vec||rm||heterogen||documentclass||12pt||amsmath||amsfont||mathrsf||69pt||homogen model,75.097||61.444||56.424||48.997||47.277||45.612||45.563||41.571||40.204||40.204||40.204||40.204||40.204||40.204||39.448,0.2,0.2,0.13333333333333333
1052,Health_Care_Anal-3-1-2045690.txt,reflex consumer||type||social commun||non-profit organ||skill||respons||technolog||commun||internet technolog||practic||individu||state||patient||trust mark||consum||prescript||inform||percept||organ||exampl||user||site||tool||health profession||web||user tool||health||term||hon||non-government organ||reflex||care||activ||special toolbar||literatur||choic||actor||search||medic profession||question reliabl||reliabl||citizen||particip||diseas||polit actor||initi||internet,inform||health inform||inform reliabl||inform consum||medic inform||web-bas inform||pre-select inform||inform seeker||good inform||lth inform||wrong inform||assess inform||inform assess||inform decis||onlin health inform seeker inform,102.268||67.001||61.12||60.789||60.75||56.494||55.819||54.108||53.74||52.385||51.832||51.635||51.635||51.613||51.485,0.2,0.1,0.06666666666666667
1053,Qual_Life_Res-4-1-2238782.txt,isrf||mhm||content domain||lower level||social health||measur||level||case||method||respons||questionnair||msp||polytom item||grade respons model||monoton||locat||model||nonparametr monoton homogen model||valu||monoton homogen model||patient||nonparametr irt analysi||data analysi||scale||parametr model||exampl||domain||point||psycholog well-b||dimension||item||latent variabl||estim||research||paramet||analysi||social limit||mokken model||grm||item respons theori||psycholog||whoqol-bref||patient group||unidimension scale||hrqol||result,item||θ||θ θ||θ θ θ||θ θ 1 θ θ||θ θ θ θ 1||3 θ θ θ||nonparametr item||θ θ area||polytom item||5 6 θ θ θ scale||θ α||item domain||item score||item discrimin,173.176||170.534||170.534||170.534||136.427||136.427||127.942||127.31||113.689||106.765||94.289||92.907||91.901||90.851||89.002,0.2,0.2,0.13333333333333333
1054,Clin_Rheumatol-4-1-2262146.txt,develop||chemotherapi||r-chop||microbiolog test||joint||arthriti||lymphoma||pain||knee||rheumat diseas||synovi fluid||tumor lysi syndrom||wrist||cours||diagnosi||patient||rituximab||treatment||nhl,r-chop||arthriti||rituximab||r-chop chemotherapi||nhl||r-chop administr||rheumatoid arthriti||remitt arthriti||nhl intra-articular||chemotherapi||discuss arthriti||reactiv arthriti||rituximab treatment||joint||joint swell,40.546||31.797||28.656||28.274||28.064||21.053||17.742||17.587||16.996||16.002||15.898||15.898||15.445||12.831||12.617,0.8,0.5,0.4
1055,Pediatr_Nephrol-4-1-2214826.txt,antibodi||proteinuria||sever immunosuppress||clinic respons||patient||year||system lupu erythematosu||rituximab||rituximab therapi||rtx||multipl cours||clinic diseas activ||dose||treatment||therapi||lupu nephriti||age||renal function||hemodialysi||sever sle||sle||clinic remiss||children,lupu nephriti||nephriti||pediatr lupu nephriti||rtx||prolif lupu nephriti||BH lupu nephriti||cyc||class IV lupu nephriti||lupu erythematosu refractori||system lupu erythematosu||rituximab nephriti class||rtx therapi||mmf||rituximab||sle,82.954||82.405||59.955||57.989||55.71||55.647||48.396||44.408||42.402||41.389||40.497||39.178||37.512||37.204||34.754,0.4,0.3,0.3333333333333333
1056,Intensive_Care_Med-3-1-1915647.txt,prematur neonat||subgroup||high-frequ ventil||time||gestat age||respiratori distress syndrom||infant||ventil||studi||rr||year||patient||effect||risk||depend variabl||lpv||protect ventil strategi||high lung volum strategi||cld||rel risk||analysi||death||meta-regress analysi||convent mechan ventil||factor||differ||cmv||import||chronic lung diseas||import variabl||rrr||sensormed ventil||trial||ventil strategi||public||hfv||explanatori variabl||random trial||public bia||outcom||result,ventil||cld||high-frequ ventil||ventil trial||sensormed ventil||convent ventil||ventil strategi||high-frequ oscillatori ventil||hfv||mechan ventil||prolong ventil||pressur ventil||ventil protocol||high-frequ jet ventil||cmv,123.064||88.681||87.325||69.917||69.072||68.521||67.659||66.461||63.357||62.66||62.337||61.532||61.532||58.991||57.633,0.8,0.6,0.4666666666666667
1057,J_Autism_Dev_Disord-4-1-2254472.txt,plaist||effect search strategi||target||fixat cross||stimulu element||stimulu discrimin||control group||enhanc abil||visuo-spati task||effect||search strategi||test||pdd||reaction time data||present studi||search task||control||fixat time||analysi||enhanc stimulu discrimin||subject||high function adult||group||fixat||number||eye movement||size||signific differ||particip||superior perform,pdd||pdd group||pdd excel||autism||fixat||pdd kemner chantal||plaist||task||individu pdd subject adi||eye||search task||autism journal||search||visual search task||eye movement,59.719||33.042||30.429||28.819||25.181||23.797||23.017||21.05||19.298||19.066||18.969||16.998||16.888||16.302||15.462,0.4,0.3,0.3333333333333333
1058,Mcgill_J_Med-11-1-2322926.txt,scaffold||patellar tendon||anterior cruciat ligament||heal||studi||patient||dacron prosthesi||review||acl reconstruct graft||replac||artifici ligament||biolog tissu autograft reconstruct||lad||cell||strength||techniqu||tissu||tissu engin principl||research||collagen||signific progress||graft||acl||surgeri||prosthet replac||implant||acl replac||carbon fibr||ligament||knee||reconstruct||prosthesi||tissu engin||prosthet,ligament||cruciat ligament||anterior cruciat ligament||prosthet ligament||reconstruct anterior cruciat ligament||anterior cruciat ligament reconstruct||cruciat||cruciat ligament prosthesi||leeds-keio ligament||acl||artifici ligament||ligament replac||alloplast ligament||anterior cruciat||acl reconstruct,133.5||106.958||89.822||86.14||82.245||82.245||80.416||80.401||77.675||75.584||73.397||71.989||68.311||67.983||67.548,0.4,0.3,0.26666666666666666
1059,FEMS_Microbiol_Ecol-1-_-2121141.txt,variat||statist packag||set||measur||method||commun||data matric||princip compon analysi||sampl||data||model||ordin||ordin diagram||multivari analys||distanc matric||observ||inform||scale||specif rule||test||complex||variabl||site||statist||cca||pattern||signific||cluster||origin varianc||nmd||ecolog hypothes||rank||distanc||relationship||approach||rda||varianc||multivari||environment condit||gradient||axe||environment gradient||row||instanc||cluster analysi||group||order||divers pattern||pca||tabl||canon correspond analysi||ecolog studi||speci||constrain ordin||object||microbi ecolog||hypothesi||interpret||techniqu,legendr||1998 legendr||anosim legendr||1936 legendr||1988 legendr||1990 legendr||2 legendr||1987 legendr||2002 legendr||1988 manova legendr||2001 manova legendr||regress model legendr||fig. 5 legendr||speci||1973 ward method legendr,207.775||113.147||110.828||105.366||104.925||104.876||103.887||103.887||103.887||72.755||72.091||71.708||69.904||56.435||54.376,0.0,0.0,0.06666666666666667
1060,Behav_Genet-4-1-2257994.txt,person||level||behavior||anxious-depress||discord group||monozygot twin||twin pair||studi||comparison||valu||data||life||psychopatholog||life event||OC symptomatolog||pi-r abbr||environment factor||uniqu life event||OC twin pair||between-pair comparison||ocd||religi obsess||sexual assault||genet similar||alcohol||twin||concord MZ pair||age||pair||futur studi||parent||somat complaint||genet factor||obsessive-compuls symptom||group||factor||differ||uniqu||discord||report||symptom||previou report||concord||concord high pair||score,n.||n. n.||pair||twin pair||twin||OC twin pair||OC twin||OC||discord twin pair||MZ twin pair||n.s. n.||pair discord||discord pair||concord||concord MZ pair,124.222||124.222||112.231||111.209||110.188||108.856||107.169||104.15||98.211||97.402||93.175||92.222||92.222||91.935||91.318,0.6,0.4,0.4
1061,Int_J_Hematol-4-1-2276241.txt,subtyp||categori||aml||data||normal karyotyp||patient||year||clinic featur||advers risk group||cytogenet risk group||classif||mld phenotyp||acut leukemia||mpo||fab||11q23 abnorm||age||analysi||acut myeloid leukemia||prognost factor||genet||mld||surviv||karyotyp||diagnosi||myeloperoxidas||result,leukemia||acut leukemia||acut myeloid leukemia||aml||acut myeloid leukemia classif||adult acut myeloid leukemia||acut myeloid leukemia differ||acut basophil leukemia||leukemia group||leukemia 5 0.8 acut leukemia||leukemia 1 0.2 acut leukemia||myelogen leukemia||acut myeloid leukaemia||leukemia 8 1.3 acut||leukemia 16 2.5 acut,98.998||77.546||72.015||67.695||63.367||55.748||54.011||52.551||51.877||51.404||51.371||50.868||42.951||39.804||39.673,0.6,0.3,0.2
1062,Planta-4-1-2249615.txt,total chlorophyl||carbohydr accumul||carbon export||maiz||doubl mutant||data||callos deposit||leaf tip||carbon||anilin blue||leav||carbohydr||chlorophyl level||sucros||leaf||tissu||starch||lack||mesophyl cell||accumul||sucros export||chlorot||mutant||vein||phenotyp||carbon partit||function||plant,tdy1-r||sxd1-1 tdy1-r||sxd1-1 tdy1-r sxd1-1||tdy1-r sxd1-1 sxd1-1||sxd1-1||sxd1-1 tdy1 tdy1||tdy1-r tdy1 sxd1||tdy1||tdy1-r sxd1-1 arrow||tdy1-r sxd1-1 2||tdy1 tdy1 sxd1 tdy1 sxd1 tdy1||tdy1 sxd1||sxd1 tdy1 sxd1||sxd1-1 plant||sxd1,259.254||245.001||240.249||240.249||230.747||188.545||186.451||167.444||164.623||163.805||155.848||150.049||144.251||138.516||132.655,0.0,0.0,0.0
1063,Aesthetic_Plast_Surg-4-1-2175019.txt,case||liposuct aspir||convent lipoinject||studi||patient||cal||adipos tissu||volum||increas||cosmet breast augment||aspir fat||cell||augment||asc||tissu||postop atrophi||materi||inject||breast augment||breast||lipoinject||result,fat||augment||breast augment||asc||inject fat||graft fat||fat graft||breast||aspir fat||cal||fat tissu||autolog fat||asc-rich fat||lipoinject||asc-poor fat,60.193||45.612||42.574||41.951||41.882||40.163||40.163||39.536||39.48||39.238||37.464||36.814||34.743||34.078||33.194,0.6,0.6,0.4666666666666667
1064,J_Hum_Genet-4-1-2413114.txt,gene||control||japanes||snp||obes||power||test||associ||genotyp rel risk||sever obes||genotyp||sever adult obes||bmi||japanes popul||group,fto||springer 2008 fto fto fto||fto gene||2 fto||obes||fto 2 2 fto gene||andrade-navarro MA fto||fto 2001 2002 2007||s00125-007-0767-0 17657473 fto gene||302114 9867708 fto gene||abecasi GR fto gene||schofield CJ fto gene||2 fto fig. 1||s10038-008-0283-1 origin articl fto gene||sever obes,108.367||68.06||58.611||54.554||47.747||45.415||37.124||32.456||30.808||30.808||30.788||30.054||27.278||25.247||24.692,0.2,0.1,0.13333333333333333
1065,Eur_Arch_Otorhinolaryngol-4-1-2217622.txt,ear||dpoae||perilymph||scala tympani||pressur increas||ear fluid volum||effect||cochlear function||CM potenti||pressur||signal||cmdp||acut||ear pressur||chang||2||decreas||cochlea||guinea pig||inject||diseas||artifici perilymph,ear||ear pressur||ear fluid pressur||pressur||ear pressur recoveri||1||1 1||ear pressur effect||middl ear pressur||ear pressur releas||dpoae||ear function||extern ear||normal ear||inject 1 1,55.689||45.387||35.24||35.085||32.015||31.38||31.38||31.065||30.899||30.258||29.61||29.409||28.779||27.845||27.04,0.6,0.3,0.26666666666666666
1066,Neurochem_Res-3-1-1832150.txt,level||cerebellar ataxia||form||studi||coq10||diseas||patient||defici||skin fibroblast,coenzym||coenzym q10||coenzym q10 defici||10||coenzym q10 supplement||label coenzym q10||muscl coenzym q10 defici||primari coenzym q10 defici||muscl coenzym||dietari coenzym||ubiquinon 10||defici||dietari coenzym q10 biochem biophi||10 coq2 10 27 10 biosynthesi||10 10 coq1 17,85.667||78.843||64.194||58.339||53.134||52.562||48.997||48.493||44.536||43.94||36.303||34.895||32.492||30.679||30.003,0.0,0.0,0.06666666666666667
1067,Clin_Oral_Investig-4-1-2238790.txt,zinc phosphat cement||type||resin cement||retent||time||questionnair||diamet||core||high preval||stainless steel||resin composit||studi||year||amalgam||patient||clinic crown||restor materi||extent||failur||fractur resist||fractur||treatment||lute||post-retain restor||restor||materi||function time||practition||privat practition||factor||root||cement||survey||length||tooth||post,post||endodont post||cement post||fail post||prefabr post||post crown||cast post||post loosen||loosen post||taper post||parallel-sid post||post type||titanium post||post design||post length,245.255||147.827||143.917||141.152||138.392||138.023||135.269||132.431||132.431||131.105||130.038||129.178||127.288||126.68||126.423,0.2,0.1,0.06666666666666667
1068,Eur_J_Pediatr-4-1-2413085.txt,type||gene||role||human||rab||defect||bind||protein||function||transport||diseas||patient||rab protein||activ||griscelli syndrom||membran traffick||brain,rab||rab protein||rab geranylgeranyl||rab gtpase||endocyt rab||rab function||rab interact||rab27a||griscelli||rab escort protein-1||rab gene famili||mammalian rab famili||s00431-008-0740-z review rab protein||mild mental retard rab||keyword rab protein vesicl transport,66.882||42.607||39.449||37.903||35.648||34.636||33.441||30.753||25.434||24.9||24.14||23.213||22.098||19.94||19.9,0.4,0.2,0.13333333333333333
1069,Neurochem_Res-3-1-1794624.txt,arginyl residu||posit charg||import role||data||studi||amount||deimin||process||structur||increas||dna||brain||myelin||apoptosi||protein||neurolog diseas||myelin protein||mbp||citrullin||white matter||methyl||histon||multipl sclerosi||citrullin mbp||up-regul||demyelin||pad||result,myelin||myelin protein||myelin sheath||immatur myelin||citrulline-contain myelin||moscarello||myelin constitu||myelin degrad||myelin breakdown||myelin assembl||basic myelin protein||pad||citrullin||deiminas apoptosi myelin||compact myelin sheath,116.36||65.11||63.857||59.783||59.751||59.716||58.97||58.865||58.831||58.18||52.265||46.887||46.6||46.021||45.141,0.4,0.2,0.26666666666666666
1070,Environ_Health_Perspect-116-2-2235228.txt,endocrin disrupt||de||diethylstilbestrol||summari estim||method||time||uniti||chi-squar test||qualiti||oral contracept||studi||sensit analysi||cryptorchid||risk||prenat exposur||random-effect model||test||testicular cancer||statist||subset||meta-analysi||estim||de exposur||heterogen||associ||hypospadia||environ||estrogen||exposur||pharmaceut estrogen||public||result,hypospadia||al||cryptorchid||estrogen||r-w hypospadia||1977 hypospadia||1981 hypospadia||2005 hypospadia||hypospadia Br||1991 hypospadia||1974 hypospadia||2003 hypospadia||1999 hypospadia||2002 hypospadia||1975 hypospadia,182.28||133.343||110.881||104.665||104.535||94.931||94.848||92.605||92.557||92.274||91.73||91.275||91.169||91.157||91.14,0.6,0.3,0.2
1071,Cancer_Causes_Control-3-1-1914283.txt,prospect cohort studi||follow-up||alcohol consumpt||cancer||data||studi||year||never-smok||bmi||endometri cancer||risk||prospect data||netherland||menopaus||cigarett||smoke||day||cohort||women||cohort studi||alcohol||estim||multivari||age||analysi||associ||endometri cancer risk||exposur||smoker||subcohort member||hrt||cigarett smoke||endometri carcinogenesi,smoke||cigarett smoke||endometri cancer||endometri cancer cancer||cigarett||endometri cancer risk||current cigarett smoke||current smoke||cigarett smoke statu||endometri carcinogenesi||postmenopaus endometri cancer||cigarett smoke featur||smoke frequenc||endometri cancer case||endometri cancer eur,114.499||90.613||88.714||76.949||66.726||66.674||64.695||63.679||62.307||62.006||61.779||60.777||60.768||59.86||59.417,0.8,0.6,0.4
1072,Biol_Psychol-1-5-2075532.txt,attent||attent task||individu||individu differ||rate||data||studi||effect||anxieti||amygdala||facial express||manual respons||face||threat-process||emot intens||cognit||research||eye-mov data||task||bia||direct||intens||present find||similar pattern||attent bia||group||fear||signific differ||emot||result,face||emot face||mogg||emot||bradley||neutral face||emot face locat||fear||anxieti||whalen||al.||gaze||mogg K. bradley b.p||keyword anxieti angri||2001 mogg,81.312||63.948||58.753||46.585||45.406||44.082||43.126||42.414||41.595||37.485||36.38||33.09||32.501||31.383||30.946,0.4,0.4,0.26666666666666666
1073,Virchows_Arch-4-1-2234444.txt,case||rapamycin||aml||tsc||patient||uteru||gynaecolog origin||present||lymphangioleiomyomatosi||actin||site||lesion||featur||sugar tumor||cell||numer case||gene||term||pecoma||angiomyolipoma||mtor||pulmonari lymphangioleiomyomatosi||normal counterpart||tumor||epithelioid||pec||posit||diseas||ccst||clear epithelioid cell||lung||kidney,epithelioid||pecoma||epithelioid angiomyolipoma||perivascular epithelioid||epithelioid aml||malign epithelioid angiomyolipoma||epithelioid cell||angiomyolipoma||renal epithelioid angiomyolipoma||epithelioid sarcoma||epithelioid angiomyolipoma int||hmb-45-posit epithelioid||malign pecoma||kidney pecoma||pecoma lung,275.741||240.36||210.892||186.829||172.37||150.595||149.335||146.043||145.363||142.96||140.961||140.569||135.181||133.579||132.973,0.4,0.3,0.2
1074,Arch_Dermatol_Res-4-1-2254658.txt,psoriasi||moderate-to-sever psoriasi||studi||patient||peripher blood||sever form||mild diseas||increas||lesion||total lymphocyt||subset||present studi||cell||mild||ratio||blood||mild psoriasi||percentag||moderate-to-sever diseas||analysi||lymphocyt||subject||pasi-scor||rel under-represent||differ||skin||diseas||absolut number||normal subject||result,psoriasi||moderate-to-sever psoriasi||lymphocyt||mild psoriasi||cd8||peripher lymphocyt||psoriasi patient||sever psoriasi||psoriasi brit||keyword psoriasi||cd45ro||peripher blood lymphocyt||lymphocyt subset||peripher cd4||cd4,68.973||47.628||45.876||42.112||37.602||37.536||37.042||36.945||36.221||34.487||33.41||32.844||31.015||28.763||28.331,0.8,0.4,0.26666666666666666
1075,Clin_Oral_Investig-4-1-2238791.txt,dental eros||case||shallow defect||studi||diagnost process||eros||wear||current criteria||criteria||epidemiolog||defect||risk group||teeth||tooth wear||lesion||current diagnost criteria||valid||epidemiolog studi||incis||occlus||adjac tooth surfac||shape||characterist||acid||subject||diagnost criteria||tissu loss||surfac||group||exposur||cup||clinic experi||diseas||loss||diagnosi,eros||dental eros||eros tooth||eros lesion||occlus eros||eros drink||eros tooth wear||eros 49||eros 30||eros 5||eros 1||eros 35||dental eros Br dent||eros aust dent||current eros criteria,107.89||83.931||74.887||63.556||62.501||61.973||61.806||54.375||54.351||53.947||53.945||53.945||51.589||47.898||43.343,0.4,0.2,0.13333333333333333
1076,Virchows_Arch-4-1-2233709.txt,antibodi||line||tissu microarray||gastriti||downregul parafibromin express||studi||surviv rate||patient||pathogenesi||parafibromin||section||gastric tumour||adenoma||independ prognost factor||depth||cell line||express||metastasi||multivari analysi||larg tumour||prognosi||tumour tissu||tumour size||invas||gastric carcinoma||progress||parafibromin express,parafibromin||parafibromin express||parafibromin underexpress||parafibromin distinguish||parafibromin immunoreact||parafibromin protein||carcinoma||gastric carcinoma||gastric||downregul parafibromin express||result parafibromin express||1 parafibromin express||higher parafibromin express||distinct parafibromin express||parafibromin tumour suppressor protein,127.262||71.955||65.145||64.464||64.172||63.631||50.966||50.442||49.918||49.212||47.973||47.971||47.97||47.97||41.498,0.4,0.4,0.26666666666666666
1077,J_Hum_Genet-2-2-1705471.txt,logist regress analysi||variant||sampl||data||studi||allel||low statist power||region||upstream region||dopamin D4 receptor||gene||control||synergist interact||polymorph||associ||re-sequenc||haplotyp analysi||snp||genom variant||schizophrenia||linkag disequilibrium||result,drd4||schizophrenia||dopamin||dopamin D4 receptor||drd4 gene||dopamin D4 receptor gene||D4 dopamin receptor gene||dopamin D4 receptor vntr||human dopamin D4 receptor||dopamin D4 receptor gene polymorph||put D4 dopamin receptor||D4 dopamin receptor mrna||multipl dopamin D4 receptor variant||schizophrenia schizophr||D4 dopamin receptor gene map,65.314||47.9||44.504||38.748||38.191||31.828||31.828||29.691||29.398||29.188||29.061||29.061||26.941||26.56||26.03,0.4,0.2,0.13333333333333333
1078,Atherosclerosis-2-1-2292239.txt,aortic distens||atherosclerosi||mri||imag||baselin||patient||effect||atheroma burden||carotid||magnet reson imag||treatment||therapi||unselect coronari arteri diseas patient||statin||chang||small number||crp||regress||larg arteri stiff||plaqu size||coronari arteri||area||plaqu||time point||earli time point||brachial arteri||aorta||ldl-c||function,carotid||statin||carotid atherosclerosi||carotid arteri||cholesterol||atherosclerosi atherosclerosi||atherosclerosi||carotid plaqu||coronari atherosclerosi||simvastatin||reson||statin therapi||atheroma||carotid atheroma progress||brachial arteri,33.981||33.602||29.747||27.118||26.467||25.513||25.513||24.064||20.345||19.461||18.962||18.658||18.061||17.981||17.761,0.4,0.3,0.26666666666666666
1079,J_Headache_Pain-4-1-2386848.txt,week||headach frequenc||reduct||studi||patient||topiram||school||effect||frequenc||follow-up visit||aim||side effect||advers event||day||headach||paper||month||open studi||group||prophylact treatment||drug||prevent treatment||trial||adolesc||pediatr migrain||migrain||disabl||loss||children,topiram||migrain||migrain headach||headach||topiram dosag||migrain disabl||migrain prevent||pediatr migrain||migrain episod||migrain frequenc||migrain prophylaxi||treat migrain||keyword migrain headach children pediatr topiram||chronic migrain||headach frequenc,69.255||60.686||51.886||43.086||37.812||36.739||33.694||33.621||33.564||33.391||32.633||32.419||31.142||30.343||24.591,0.6,0.4,0.3333333333333333
1080,Evid_Based_Complement_Alternat_Med-4-1-1810360.txt,multiple-dos effect||condit||measur||immun system||children||behavior||mood||reduct||sampl||data||studi||depress||session||salivari cortisol||effect||MT research||MT session||child||review||pediatr MT||increas||anxieti||blind||statist||adult||treatment||therapi||research||scientif understand||pain||frequent failur||popul||parent||suffici data||trait anxieti||arthriti pain||report||single-dos effect||field||recipi||massag therapi||statist power||outcom||result,MT||MT effect||pediatr MT||massag||MT studi||MT session||MT benefit||consist MT||MT research||MT style||MT treatment||MT popul MT area||MT grow||MT lower||MT group,146.67||89.367||85.827||84.835||81.873||78.299||77.456||76.236||76.053||74.235||74.08||74.079||73.335||73.335||73.335,0.2,0.3,0.2
1081,Pediatr_Nephrol-4-1-2275777.txt,type||detrusor muscl||follow-up||irrevers renal damag||renal damag||detrusor overact||oxybutynin||intraves pressur||studi||year||intraves instil||detrusor||patient||effect||risk||secondari damag||bladder||earli diagnosi||intermitt catheter||treatment||safe urinari contin||nbsd||long-term outcom||manag||infect||anticholinerg||therapi||evalu||urodynam||renal function||cic||adequ medic treatment||neurogen bladder||standard therapi||upper||contin||long-term experi||nbsd manag||children,bladder||neurogen bladder||bladder dysfunct||dysfunct bladder||neurogen bladder dysfunct||high-risk bladder||low-compli bladder||bladder outlet||bladder affer||bladder capac||bladder function||bladder ultrasound||bladder dynam||bladder wall||bladder neck,132.504||100.587||82.632||82.632||77.978||68.057||67.771||67.653||67.52||67.382||67.032||66.997||66.252||66.252||66.252,0.4,0.2,0.13333333333333333
1082,Oecologia-3-1-2039837.txt,thermal toler||measur||acclimat||respons||clam||rate||data||valu||bay||sensit||temperatur||north sea group||ambient condit||physiolog||genet group||metabol rate||popul||season variat||factor||specimen||taxa||limit||speci||data point||respir rate||mussel,mytilu||mytilu eduli||mytilu M. balthica mytilu||mytilu galloprovinciali||mytilu M.||10 mytilu||5 mytilu||2 mytilu||mussel mytilu eduli||mytilu eduli complex||mytilu eduli mar environ||mytilu galloprovinciali lmk||mediterranean mussel mytilu galloprovinciali||temperatur||mytilu chilensi hupe,208.802||134.233||132.813||124.466||114.139||111.291||104.428||104.401||103.889||89.489||87.339||84.893||74.268||73.565||72.915,0.0,0.0,0.06666666666666667
1083,Eur_J_Pediatr-3-1-2042510.txt,condit||case||logist regress analysi||children||infant||birth order||birth||rsv infect||studi||patient||higher likelihood||major epidem||rsv||respiratori syncyti viru infect||strong autocorrel||gestat age categori||control||hospit||season||age||young children||social characterist||predictor||famili||factor||bivari analysi||number||risk factor||hospit admiss||control-pati||rsv-induc lrti||sever rsv-induc lrti,rsv||rsv infect||respiratori||rsv season||respiratori syncyti viru||rsv epidem||respiratori tract infect rsv respiratori||respiratori syncyti viru infect||syncyti viru infect||respiratori syncyti viru epidem||testpack rsv||rsv surveil||respiratori syncyti viru sever||rsv detect||previou rsv infect,78.431||56.445||55.973||54.826||49.853||48.811||47.157||46.004||42.681||42.187||40.75||40.204||39.839||39.216||38.346,0.4,0.3,0.2
1084,Eur_J_Epidemiol-4-1-2190784.txt,time||men||knot||preval||msm||sexual behaviour||studi||year||hsv transmiss||risk||homosexu contact||calendar year||western blot||increas||amsterdam cohort studi||time trend||blood sampl||age||orogenit contact||associ||sexual partner||sexual activ homosexu men||hsv-2||decreas||independ risk factor||sexual risk behaviour||hsv-1||risk factor||partner||hiv||hsv-infect||result,hsv-2||msm||hsv-2 infect||hsv-1||hiv||hsv-2 preval||hsv-1 infect hsv-1||keyword hsv-1 hsv-2 hiv msm preval||hiv infect||hsv-2 seropreval||hsv-2 elisa||hsv-2 serolog||hsv-2 index||0.81 hsv-2||hsv-2 antibodi,100.248||71.237||71.198||70.443||70.166||62.788||61.011||56.237||56.157||55.187||53.023||52.573||51.835||51.702||50.782,0.8,0.4,0.26666666666666666
1085,Ann_Surg_Oncol-4-1-2277445.txt,patent blue dye||case||liver metastas||figur||ovarian cancer||studi||patient||adopt immunotherapi||expans procedur||pancreat cancer||preoper lymphoscintigraphi||node||transfus||blue||increas||superior surfac||metastas||tumor homogen||malign melanoma||radioact tracer||immunotherapi||cell||antigen||partial right-sid liver resect||squamou cell carcinoma||squamou cellular cancer||averag||lymph node||lymphocyt||surgeri||local recurr||liver||sentinel node||tumor||lymphat vessel||lymphat||posit||success expans||inject||lymphoscintigraphi||diseas||lymphat map,node||lymph node||metinel node||metinel node metinel node po||node PB||drain lymph node||lymph node metastasi||sentinel node||hepat node||pericav node||metastasis-drain lymph node||blue-color node||perihepat metinel node||metastases-drain lymph node||analyz metinel node,167.539||123.415||123.133||103.035||102.699||98.077||96.419||94.173||85.769||85.227||85.192||84.989||84.032||83.248||82.785,0.4,0.3,0.2
1086,Eur_Radiol-3-1-2077917.txt,week||limit bowel prepar||origin raw data||patient||CT colonographi||low-dos protocol||observ||sensit||imag qualiti||colonoscopi||dose-level||rectum||repeat CC||fecal tag||ctc||stool||polyp||experi||simul||bowel prepar||extens cleans||sixty-on patient||larg false-posit lesion||dose reduct||oral contrast agent||stool soften||moder sensit||segment||contrast||prefer||result,ctc||polyp||CC||colorect polyp||ctc bowel prepar||colonoscopi||polyp sensit||ctc examin||miss polyp||30-mm polyp||polyp detect||14-mm polyp||polyp visual||polyp size||larg polyp,103.905||99.273||60.788||57.913||57.572||57.29||53.581||53.053||52.954||52.56||52.226||51.098||50.693||50.565||49.637,0.4,0.3,0.2
1087,J_Mol_Biol-1-5-1885968.txt,order paramet||ligand bind||data||bind site||hsqc||motion||structur||complex||domain||diffus tensor||free energi||dynam||rdc||abp||conform entropi||paramet||heteronuclear singl quantum coher||residu||protein||flexibl||analysi||simul||chang||bind||favour enthalp contribut||protein dynam||differ||entropi||consist||nmr relax||rotat diffus||interact||optimis||experiment data||entrop cost||molecul||molecular dynam simul||ligand||result,dynam||abp||bind||apoabp||backbon dynam||protein dynam||bind entropi||ligand bind||backbon||conform dynam||side-chain dynam||molecular dynam||dynam paramet||apo abp||protein backbon,61.16||60.46||53.296||52.499||50.405||45.45||42.076||40.437||39.651||37.505||36.356||35.621||35.417||34.859||34.696,0.6,0.5,0.3333333333333333
1088,Pediatr_Nephrol-4-1-2259254.txt,condit||muscl||chronic kidney diseas||complic||ckd||caspase-3||metabol acidosi||glucocorticoid||degrad||insulin||muscl wast||cell||kidney diseas||growth||muscl mass||protein||protein degrad||activ||uremia||muscl atrophi||acidosi||insulin resist||loss||result,acidosi||muscl||metabol acidosi||muscl degrad||acidosi proteolysi||non-urem acidosi||acidosi increas||urem acidosi||acidosi stimul||induc acidosi||protein metabol acidosi||acidosi 3||muscl protein||mitch||degrad muscl protein,113.099||77.203||68.234||62.907||62.876||59.478||58.743||58.708||58.484||58.268||57.457||56.572||56.553||56.225||53.905,0.6,0.3,0.2
1089,Doc_Ophthalmol-3-1-1820752.txt,type||standard method||minimum amplitud||method||respons||light adapt||data||valu||eog||electr potenti||electrod||refer data||difficulti||present||clinic eog||total dark||amplitud||test||norm data||dilat pupil||light peak||eye||retina||retin pigment epithelium||ratio||potenti||light rise||saccad||dark||standard||subject||chang||pupil||minimum||clinic electro-oculographi||report||record||eog record||peak||arden ratio||pupil dilat||result,eog||light||eog standard||eog potenti||eog record||fixat light||light trough||light rise||clinic eog||light adapt||adapt light||eog method||light peak||eog respons||light phase,102.538||99.254||72.671||63.764||63.686||59.877||58.768||56.858||56.387||55.146||55.146||54.65||53.171||53.006||52.118,0.4,0.5,0.4
1090,Qual_Life_Res-3-1-2062490.txt,refer point||cancer||measur||method||men||then-test score||studi||vignett||erectil dysfunct||patient||effect||qol||then-test||local prostat cancer||treatment||health||primari treatment||assess||month||respons shift||chang||respond||differ||prostat cancer||diagnosi||origin score||score||result,pre-diagnosi||respons shift||pre-diagnosi health||then-test||prostat cancer||post-diagnosi assess||life respons shift||prostat cancer induc respons shift||respons shift qualiti||respons shift effect||pre-diagnosi assess||sf-36||prostat cancer diagnosi induc respons shift||month post-diagnosi||7-month post-diagnosi,39.891||37.649||31.368||31.015||28.624||28.12||27.579||27.22||26.754||26.706||26.585||25.416||25.388||25.289||24.31,0.6,0.3,0.2
1091,Int_Arch_Occup_Environ_Health-4-1-2175021.txt,conceptu||role||measur||case||sick||emot process||sampl||posit result||strategi||sick absenc measur||durat||avoid||frequenc||effect||present||sick leav||excess risk||ucl||problem-solv||absenc||behaviour||day||social support||item||result||associ||employe||total number||sick absenc||cope||factor||short length||length||health outcom||day absent||stress situat,sick||sick absenc||cope||absenc||sick absenc sick absenc length||sick absenc sick absenc data||sick absenc histori||sick absenc behaviour||futur sick absenc||sick absenc risk||psychiatr sick absenc||sick absenc measur||valu sick absenc||sick absenc pattern||sick absenc record,233.975||208.515||187.032||183.055||178.074||166.813||151.439||143.421||139.982||139.561||139.412||139.322||139.017||139.01||139.01,0.8,0.4,0.3333333333333333
1092,Eur_J_Pediatr-4-1-2254659.txt,organ||chelat||method||liver biopsi||ferritin serum ferritin||bodi||deferasirox||mri||iron overload||magnet reson imag||lic||liver||patient||therapi||day,iron||iron chelat||iron overload||liver iron||iron chelat therapi||cardiac iron||iron burden||excess iron||iron chelat treatment||tissu iron||chelat||iron complex||deferoxamin||hepat iron overload||transfusion iron overload,94.707||71.253||58.639||54.645||50.401||50.38||49.237||48.507||47.949||47.811||47.8||47.353||40.8||40.286||39.99,0.2,0.1,0.13333333333333333
1093,Behav_Genet-4-1-2257997.txt,motor task||measur||find||time||pac interview||famili vulner||deficit||abnorm||compar problem||studi||effect||tendenc||motor output||variabl||disord||genet underpin||motor speed||control||famili resembl||task||age||endophenotyp||accuraci||subject||motor||group||famili||proband||sibl||genet basi||famili suscept||screen||adhd||extern cue||speed||motor time||addit||non-affect sibl||children,motor||motor speed||motor time||sibl||motor speed motor variabl||adhd||motor task||motor output||motor time deficit||non-affect sibl||motor time task||keyword adhd sibl endophenotyp motor||motor process||motor measur||motor function,156.962||110.503||107.367||107.213||105.857||101.462||96.461||94.549||85.834||84.269||83.565||82.931||80.011||79.682||78.481,0.8,0.8,0.5333333333333333
1094,J_Gastrointest_Surg-3-1-1852393.txt,surviv||demograph data||mitogen-activ protein kinas||chemotherapi||radiat therapi||mapk||studi||protein||cd24 express||radiat||month||prognost marker||cholangiocarcinoma||data||express||patient||treatment||cell||patient surviv||multivari analysi,cd24||cd24 express||cd24 overexpress||low cd24||high cd24||cholangiocarcinoma||cd24 overexpressor||cd24 antigen express||cytoplasm cd24 express||keyword cd24 express cholangiocarcinoma surviv||molecular marker cd24||cell-associ antigen cd24||metastasis-associ gene cd24||hilar cholangiocarcinoma||intrahepat cholangiocarcinoma,115.893||64.386||61.83||60.686||59.695||59.109||59.06||44.37||43.858||42.648||41.115||40.861||39.674||37.671||37.198,0.2,0.2,0.13333333333333333
1095,Pediatr_Nephrol-3-1-1766474.txt,ultrafiltr rate||ultrafiltr||session||patient||hemodiafiltr||permeabl||risk||volum||dialysi session||needl||blood volum||blood purif||mmhg||guidelin||dialys||blood||fluid||ultrapur dialys||normal||weight||newer machin||hemodialysi||continu blood volum||import||high flux||access||endotoxin||dialysi||urea||adequ||membran||children||high flux membran,dialysi||dialysi membran||dialysi session||optimum dialysi||enabl dialysi||periton dialysi||dialysi machin||double-pump dialysi||monthli dialysi||single-needl dialysi||dialysi time||dialysi dose||dialysi unit||optim dialysi||dialysi center,98.126||56.796||53.677||53.497||52.8||51.575||50.893||50.499||50.368||50.349||50.313||50.251||50.124||49.668||49.063,0.4,0.2,0.13333333333333333
1096,Cardiovasc_Intervent_Radiol-3-1-2039794.txt,qualiti||baselin||studi||patient||question||bodi imag||sexual||improv||treatment||sexual life||sexual function||women||analysi||fibroid||group||differ||bi||uae||uterin arteri embol||hysterectomi||score,hysterectomi||sexual||hysterectomi sexual function||vagin hysterectomi||fibroid||uterin fibroid||abdomin hysterectomi||laparoscop hysterectomi||subtot hysterectomi||uterin||hysterectomi group||hysterectomi patient||total hysterectomi||embol versu hysterectomi||time uae hysterectomi,126.554||80.335||70.26||69.855||69.821||67.581||66.785||66.4||65.698||65.341||64.843||64.378||63.895||57.665||57.211,0.6,0.3,0.2
1097,Bioprocess_Biosyst_Eng-2-2-1705492.txt,model paramet||primari human liver cell||system||bioreactor||data||model||valu||asp||amino acid||variabl||cell||amino acid metabol||liver cell bioreactor||oxid deamin||activ||part||liver||ly kinet||high||perform||run||princip compon||kinet||differenti equat system||medium,_{||cdot||_{ 0||bioreactor||0||run||liver||zeiling||run H7||liver cell bioreactor||bioreactor system||0 21 0||18 liver cell bioreactor run||3D bioreactor guthk||bioreactor 9,86.264||81.123||61.717||47.24||37.17||36.641||32.216||31.262||27.786||27.567||25.82||25.751||24.784||23.85||23.62,0.2,0.4,0.26666666666666666
1098,Purinergic_Signal-4-2-2377316.txt,guanylyl cyclas||concentr||data||studi||avoid||pkc||western blot||messeng pathway||cell||calcium||behavior assay||tyrosin phosphoryl||control||enzym||protein||chemorepel||tyrosin kinas||purin metabol||buffer||behavior buffer||pharmacolog inhibitor||gtp||inhibitor,tetrahymena||tetrahymena tetrahymena tetrahymena 33 tetrahymena||tetrahymena thermophila||tetrahymena cell||T. thermophila tetrahymena||tetrahymena 50||tetrahymena thermophila eur||tetrahymena cilia||1 2 tetrahymena tetrahymena||result tetrahymena||28 tetrahymena 8 tetrahymena||hennessey TM tetrahymena thermophila||tetrahymena J. biochem||2008 introduct tetrahymena||s11302-007-9052-4 origin paper tetrahymena thermophila,213.061||170.449||163.456||113.233||112.639||110.558||109.488||108.989||106.757||106.541||106.53||88.752||72.966||71.02||66.002,0.0,0.0,0.0
1099,J_Autism_Dev_Disord-4-1-2335292.txt,level||time||play||behavior||control group||qualiti||book||studi||account||autism||durat||asd||develop||disord||play behavior||control||relationship||manipul||age||month||group||differ||daili utensil||opportun||agreement||symbol||development disord||toy||object||attach||children,play||symbol play||play behavior||play behavior play behavior||child play||pretend play||manipul play function play symbol play||manipul play||play develop||H. play||play durat||social’ play||A. play||symbolic’ play||object-direct play,302.57||180.808||179.903||179.903||165.755||164.89||164.534||160.692||157.46||156.541||156.054||153.721||153.508||152.697||152.697,0.4,0.2,0.13333333333333333
1100,Photosynth_Res-3-1-2117334.txt,photosystem II||effect||electron transfer||photosynthesi||level||fluoresc||uv-b radiat||increas||PS II||acceptor side||uv-b irradi||function||uv-b||irradi||chlorophyl||donor side||light||damag||plant,uv-b||fluoresc||chlorophyl fluoresc||uv-b radiat||uv-b light||chlorophyl||non-photochem chlorophyl fluoresc||uv-b irradi||uv-b ultraviolet-b radiat||photosystem II||uv-b stress||chlorophyl fluoresc induct||chlorophyl fluoresc rise||chlorophyl fluoresc nomenclatur||fluoresc rise,67.207||57.347||47.577||46.108||38.336||37.807||37.043||36.534||35.623||34.916||34.643||33.716||33.519||32.712||31.376,0.6,0.6,0.4
1101,Matern_Child_Health_J-2-2-1592144.txt,attent||commun health center||method||pregnanc||problem||data||state||pregnanc plan||counsel||avail||famili plan servic||preconcept care||healthi infant||percentag||women||care||servic||reason||facil||inadequ attent||famili||visit||access||famili plan||underutil,famili plan||plan servic||famili plan servic||famili||pregnanc plan||seek famili plan||famili plan research||famili plan practic||famili plan 1||state-fund famili plan servic||preconcept||preconcept servic||servic||medicaid famili plan demonstr||effect famili plan method,79.257||66.84||66.607||66.14||60.418||55.829||53.458||53.297||52.838||50.777||47.684||44.496||41.308||40.305||39.854,0.8,0.4,0.3333333333333333
1102,Pediatr_Nephrol-3-1-2064944.txt,rrt||chronic kidney diseas||children||ckd||preval||kidney||data||patient||end-stag renal diseas||inform||epidemiolog||major||naprtc||preval rate||unit state||adult||countri||kidney diseas||esrd||renal transplant||earli detect||age||popul||incid||care||congenit renal disord||report||renal replac therapi||registri||dialysi||pediatr ckd,kidney||renal diseas||pediatr||pediatr ckd||ckd||chronic renal failur||end-stag renal diseas||chronic||chronic renal insuffici||renal transplant||chronic kidney diseas||renal insuffici||kidney diseas||children||pediatr nephrol pediatr nephrolog,40.769||38.291||37.946||36.806||35.666||34.957||33.66||32.758||31.666||31.25||31.161||31.121||30.363||29.016||28.326,0.6,0.5,0.5333333333333333
1103,J_Mol_Med-3-1-1820750.txt,dcmi||quantit real-tim pcr analysi||cardiac express profil||microarray analysi||studi||patient||apn||wnt||standard clinic character||biolog function||human||heart failur||dcmi heart||express||molecular virolog analys||human inflammatori cardiomyopathi||cell||gene||local inflamm||dilat cardiomyopathi||gene network||cardiac inflamm||analysi||etiology-rel pathogen pathway||therapeut potenti||genom express profil||heart||cardiac diseas,apn||dcmi||apn network||apn sort1||apn fgf13||synonyma apn||apn adipor1||cyr61||abbrevi apn adiponectin cyr61||local apn express||apn gene downregul||receptor apn pik3r1||1 apn sp3||α apn syncrip||β apn smarca2,117.531||69.057||61.495||60.204||60.204||60.204||60.143||57.556||48.519||45.386||45.128||41.29||41.261||41.01||40.816,0.4,0.2,0.13333333333333333
1104,Glycoconj_J-4-1-2234451.txt,array||antibodi||mab||epitop||glycan||cell wall||sampl||probe||polym||hybridoma supernat||pectic side chain||plant cell wall||hybridoma line||specif||cell||monoclon antibodi||carbohydr microarray||hierarch cluster||analysi||agp||materi||bind||order||plant,mab||pectin||knox||A. thaliana||knox j.p||wall||willat||mab lm13||mab lm14||lime||arabinogalactan-protein||F4 A. thaliana||G8 A. thaliana||8 A. thaliana||H7 A. thaliana,57.228||56.996||53.942||50.85||45.404||42.654||42.619||42.038||39.054||38.676||35.799||35.179||34.794||34.515||34.503,0.2,0.1,0.06666666666666667
1105,Eur_Arch_Otorhinolaryngol-3-1-1914267.txt,split skin graft||questionnair||non-donor site||subject complaint||studi||patient||total score||test||morbid||forearm||lower arm||frff||strength||forearm disabl||subject self-rat||radial forearm flap||donor site morbid||function result||differ||flap||skin||object function test||fasciocutan flap||reconstruct||object||free radial forearm flap||wrist||hand||cosmet||function||donor,flap||forearm flap||forearm||radial forearm flap||radial forearm||fasciocutan radial forearm flap||free radial forearm flap||radial forearm flap donor site||radial forearm flap donor defect||fasciocutan flap||free flap||radial forearm donor site||donor||forearm disabl||radial free flap donor site,94.539||94.38||94.222||84.384||79.306||68.886||68.572||64.59||62.091||58.467||57.838||57.102||51.939||50.953||49.973,0.6,0.5,0.4666666666666667
1106,Mar_Biotechnol_(NY)-4-1-2263118.txt,method||microarray||studi||fish chip||gene express||fluoresc signal||probe||dna||cross-hybridis||gene||singl target hybridis||speci identif||oligonucleotid probe||spot||identif||european sea||fish speci||dna chip||dna microarray||fragment||signal intens||speci||suitabl||design||sequenc||oligonucleotid,marin||microarray||dna microarray||fish||fish speci||dna||speci||hybridis||oligonucleotid microarray||mitochondri dna microarray||microarray probe||marin biolog||marin biotechnolog||marin research||marin organ,72.608||61.41||54.892||52.872||50.416||48.374||47.961||45.211||43.447||41.174||39.061||38.951||37.521||36.304||36.304,0.6,0.5,0.3333333333333333
1107,Clin_Rheumatol-3-1-2039777.txt,function abil||measur||level||jafa||questionnair||final score||studi||patient||median diseas durat||perform test||present studi||individu item||chaq||item||jia||diseas activ||rom||childhood health assess questionnair||intern reliabl||rheumat diseas||spearman correl coeffici||children,jafa||chaq||chaq item||28 patient jafa chaq chaq||disabl jafa||chaq score||ten jafa||total chaq||chaq activ||1 jafa||chaq task||chaq item number||mild disabl jafa||moder disabl jafa||sever disabl jafa,81.696||80.282||49.799||49.533||46.472||44.372||43.282||42.419||41.43||41.292||40.7||33.738||30.981||30.981||30.981,0.4,0.2,0.13333333333333333
1108,Dev_Biol-2-1-2279743.txt,gata||bmp||induct||embryo||earli role||combin||earli express||effect||zebrafish correl||marker||myocardium||express||cardiac marker express||absenc||cell||somit||gene||zebrafish||gata factor||nkx||loop||gata activ||mous||vertebr||evolut||requir||feedback loop||phenotyp||zebrafish embryo||heart||function||network,al.||xenopu||gata4||xenopu xenopu peterkin||gata5||nkx2.5||xenopu peterkin||xenopu gata5 reiter||vivo xenopu xenopu||gata5 nemer||2000 gata6 gata4 xenopu||abstract xenopu xenopu gata5 faust||xenopu gata-4||gata6||zebrafish xenopu peterkin,156.286||130.901||122.862||107.941||107.725||97.481||96.461||90.133||87.268||83.22||82.729||79.9||78.238||73.839||73.106,0.0,0.0,0.0
1109,Bioprocess_Biosyst_Eng-2-2-1705518.txt,method||organel||time||nutrient||concentr||steadi state||rate||model||root mass||growth rate||hairi root growth||independ pathway||amino acid||tool||analys||cell build block||growth||cell||metabol regul||glucos||intracellular ammonium||sugar||primari metabol pathway||flux||plant cell||intracellular concentr||literatur||cultur||medium exchang cultur||secondari metabolit||metabol network||batch||minim medium||experiment data||root||metabol model,hbox||text||ntp||document||nu||C. roseu||frac||Pi||catharanthu roseu||DW C. roseu||ndp||DW C. roseu batch||mmol||0.00254 C. roseu mmol||0.000585 C. roseu mmol,872.911||202.622||175.084||171.118||147.797||146.686||144.355||134.408||132.274||128.114||117.515||102.197||99.431||98.792||98.792,0.0,0.0,0.0
1110,Diabetologia-3-1-1849422.txt,person||futur||diabet||project||preval||individu||burden||data||model||studi||year||II mortal survey||mortal||risk||potenti impact||increas||proport||adult||nhane iii||substanti number||estim||age||popul||total number||nutrit examin survey||decreas||number||older age group||survey||high-risk group||hispan commun||score||result,diabet||diabet diabet burden||diabet preval||diabet estim||diabet burden||undiagnos diabet||diabet risk||diabet mortal||futur diabet||diagnos diabet||diabet 20||total diabet||diabet develop||diabet yield||diabet incid,204.961||144.985||129.517||118.192||114.997||114.026||113.239||111.671||110.606||108.061||105.308||104.994||103.939||103.761||103.568,0.2,0.1,0.06666666666666667
1111,Tuberculosis_(Edinb)-1-5-1913930.txt,glutamin||ammonia||extra-cellular GS||gene||control||strain||level||delet||nitrogen sourc||glutamin synthetas||mutant||protein||cultur filtrat||glnd||virul||nitrogen metabol||macrophag||activ||cell||growth,"glnd||tuberculosi||glnd 7 glnd glnd||glnd M. tuberculosi||mycobacterium tuberculosi||glnd mol||result glnd||glnd result||glnd mutant hyg||mycobacterium tuberculosi isocitr||mycobacterium tuberculosi glutamin synthetas||figur 3 glnd glnd delet region||streptomyc coelicolor M. tuberculosi 8 glnd||figur 4 glnd mutant||M. tuberculosi 4,5",111.086||87.281||83.579||70.361||63.777||56.5||55.543||55.543||44.708||44.427||39.32||38.823||35.651||34.62||34.082,0.2,0.1,0.06666666666666667
1112,Pediatr_Radiol-2-2-1764599.txt,larger bone||databas||roi||low bmd||studi||patient||total bodi bmc||standard deviat||densiti||lumbar spine||norm data||radiologist||clinic pathologist||bmd||bodi composit||bone age||hip||standard deviat score||bodi||age||dxa result||chang||numer result||bmc||factor||import||height||dxa||osteoporosi||pediatr dxa||signific chang||interpret||children||result,bone||dxa||bone miner||lumbar bone||pediatr bone||bodi bone||pediatr dxa||bodi dxa||bone densiti||bone miner densiti||bone age||bone densitometri||absorptiometri||dxa interpret||miner,95.18||94.659||74.782||70.288||61.776||61.596||61.515||61.335||58.68||57.248||55.476||54.966||54.673||54.48||54.383,0.2,0.2,0.2
1113,J_Med_Internet_Res-8-3-2018828.txt,time||effect relaps prevent intervent||cessat||individu||search engin||rate||data||studi||year||inform||quitnet||organ||total||time onlin||onlin||internet searcher||treatment||web||smoke||day||estim||result||popul||servic||reason||readi||search||smoker||survey||particip||peopl||queri||internet,cessat||quit||quit smoke||smoke||cessat inform||smoke cessat websit||cessat servic||cessat treatment||search||cessat inform onlin||encourag cessat||computer-tailor smoke cessat program||smoke cessat inform cobb nathan||evidence-bas smoke cessat treatment||gener cessat inform,102.509||80.627||80.173||79.719||70.699||61.542||54.384||53.506||53.051||51.872||51.255||48.081||48.019||47.568||47.132,0.4,0.3,0.2
1114,Purinergic_Signal-4-2-2377317.txt,mechan||hypoton solut||uridin triphosph||rel abund||concentr||releas mechan||studi||adenosin||perfus||exocytosi||nucleotid speci||udp||uridin nucleotid||nucleotid releas||Ca||cell||intracellular calcium||cell surfac hydrolysi||nucleotid||result||experi||major mechan||fluoresc||hypoton shock||plasma membran||calcium-depend exocytosi,nucleotid||uridin nucleotid||nucleotid releas||uridin nucleotid releas||nucleotid diphosph||uridin nucleotid concentr||nucleotid concentr||nucleotid hydrolysi||nucleotid sugar||nucleotid pyrophosphatas||nucleotid speci||nucleotid content||fm1-43||uridin diphosph||udp,49.509||40.537||35.09||33.915||31.889||29.234||28.069||27.223||26.416||25.789||25.652||25.399||24.768||22.917||21.495,0.6,0.3,0.3333333333333333
1115,Pediatr_Nephrol-3-1-1805046.txt,attent||level||find||chronic kidney diseas||hypertens||ckd||sampl||gener popul||studi||patient||standard deviat||pediatr ckd popul||test||cognit impair||cognit function||memori||neurocognit deficit||mild||esrd||age||analysi||anemia||attent score||onset||clinic variabl||rang||age-bas standard score||memori score||cognit test||risk factor||sever||particip||diseas||cognit perform||IQ score||standard score||function||children,ckd||ckd onset||ckd durat||sever ckd||children||ckd literatur||ckd correl||5 ckd||ckd 69||pediatr ckd patient||pediatr ckd popul||cognit score||memori||cognit dysfunct||cognit test,74.358||42.188||40.114||39.857||38.865||38.518||38.121||37.179||37.179||28.217||28.213||27.924||25.943||23.187||22.59,0.4,0.2,0.3333333333333333
1116,Exp_Brain_Res-3-1-2137946.txt,attent||condit||measur||visual depriv||visual feedback||postur sway||sampl||data||time seri||amount||opposit effect||effect||visual inform||cop trajectori||sampl entropi||concurr visual feedback||present studi||eye||postur control||control||cerebr palsi||posturogram||EC condit||task||analysi||neural control mechan||sway||regular||extern focu||function task||sen||function context||children||result,postur||postur sway||sway||regular postur sway||children||regular sway||sway regular||CP children||postur sway fluctuat||postur control||CP||cop||TD children||cop regular||visual postur sway inform,77.219||72.628||68.038||61.758||57.983||54.028||54.028||52.172||49.218||46.585||46.361||46.237||45.554||43.128||42.586,0.6,0.4,0.26666666666666666
1117,Eur_J_Epidemiol-4-1-2190786.txt,mother||birth||young adulthood||urin sampl||pregnanc||fetal life||studi||develop||process||child||plate||genet determin||dna||medic ethic committe||biobank||blood||research||parent||erasmu medic center||tube||biolog specimen||partner||equal dna concentr||biolog sampl||children||laboratori,rotterdam||sampl||dna sampl||dna||urin sampl||dna mother||erasmu univers rotterdam||urin sampl collect||biolog sampl||blood sampl||urin||stock sampl||90 dna sampl||blood sampl collect||erasmu medic center,32.697||28.274||27.208||26.142||23.733||21.648||20.94||20.676||20.207||19.895||19.193||19.059||18.139||18.117||17.721,0.4,0.3,0.26666666666666666
1118,Diabetologia-4-1-2292420.txt,type 2 diabet||studi||patient||blood pressur||intervent||type 2 diabet mellitu||glycaem control||cardiovascular risk profil||cost||heart rate||exercis intervent||month||physic fit||exercis||medic fit programm||long-term efficaci||min||resist||differ||physic activ||programm||clinic benefit||medic fit||particip||adher||endur type exercis||brisk walk||physic therapist,brisk||brisk walk||brisk walk programm||fit||group-bas brisk walk||brisk walk group||18 brisk walk||group-bas brisk||7.8 0.000 intragroup comparison brisk||3.6 0.000 intragroup comparison brisk||1.8 0.000 intragroup comparison brisk||0.06 0.239 intragroup comparison brisk||0.01 0.070 intragroup comparison brisk||0.01 0.035 intragroup comparison brisk||0.25 0.345 intragroup comparison brisk,144.039||124.082||98.16||89.56||86.511||85.311||82.721||77.705||67.463||67.073||66.766||66.335||66.202||66.126||65.991,0.2,0.1,0.06666666666666667
1119,Eur_Arch_Otorhinolaryngol-4-1-2279156.txt,prospect studi||subject symptom||phpt||parathyroidectomi||asymptomat phpt||questionnair||asymptomat primari hyperparathyroid||symptom||forget||concentr||improv||surgeri||success parathyroidectomi||depress||medic observ||treatment||patient||subject neuropsycholog symptom||result,hyperparathyroid||phpt||parathyroidectomi||asymptomat phpt||symptom||hyperparathyroid subject symptom parathyroidectomi||primari hyperparathyroid||phpt patient||asymptomat primari hyperparathyroid||asymptomat phpt patient||neuropsycholog symptom||mild phpt||patients’ phpt||asymptomat||parathyroidectomi improv,54.255||51.86||42.543||41.377||41.059||37.775||36.862||36.801||34.872||34.832||33.985||31.979||31.933||30.893||30.428,0.8,0.5,0.3333333333333333
1120,Mar_Biotechnol_(NY)-2-2-1475948.txt,tumor necrosi factor||transgen zebrafish||japanes flounder promot||studi||egg||region||promot||site||adult||pattern||induc promot||express||gene||tissu||zebrafish||tnf||liver||gfp||induc activ||keratin||japanes flounder||tissue-specif promot,japanes flounder||japanes flounder promot||transgen japanes flounder||promot||japanes flounder tnf promot||transgen zebrafish||flounder gene||transgen fish||japanes flounder embryo||japanes flounder tnf gene promot||hirono||zebrafish||gfp||tnf promot||fish,68.844||66.504||66.488||61.824||55.572||53.293||52.736||51.57||49.856||48.642||44.851||44.811||44.577||42.3||41.364,0.6,0.4,0.4
1121,Soc_Psychiatry_Psychiatr_Epidemiol-2-2-1764203.txt,voluntari statu||time||non-convert||individu||legal statu||clinic factor||data||model||studi||treatment engag||patient||inv-inv||medic problem||voluntari||criteria||counti hospit||medic||variabl||compulsori||treatment||polytom logist regress model||psychot symptom||hospit||research||assess||analysi||data collect||commit||group||factor||differ||inv-vol||symptom||diagnost characterist||adher||outpati follow-up,discharg||discharg inv-vol||discharg patient||involuntari legal statu||discharg plan||discharg merit||discharg 23||discharg 35||inv-inv||discharg 27||discharg 20||discharg 7||admiss||involuntari statu||legal statu,145.073||95.841||87.186||75.515||73.273||73.231||73.091||73.035||72.837||72.536||72.536||72.536||71.626||71.424||71.233,0.0,0.1,0.13333333333333333
1122,Ann_Hematol-3-1-2082654.txt,case||molecular character||mutat||cml||peripher blood||allogen hematopoiet stem cell transplant||criteria||bone marrow||cel||disord||cytomorpholog||classif||cimf||diagnost||neg cmpd||cytogenet||chronic myelomonocyt leukemia||tyrosin kinas||cmpd||molecular diagnost||diagnosi||detect,jak2||jak2 v617f||jak2 mutat||jak2 35 11 jak2 jak2 bcr||cmpd||jak2 v617f-posit||jak2 11 bcr||jak2 v617f mutat||abl jak2 67||tyrosin kinas jak2||bcr||cmpd fip1l1||jak2 pseudokinas domain||jak2 26 34||abl bcr,149.453||90.857||86.182||84.401||76.272||76.193||69.166||68.209||63.178||60.009||58.046||54.266||50.795||49.818||49.063,0.2,0.1,0.06666666666666667
1123,Biochem_Biophys_Res_Commun-1-5-1899526.txt,anion||sensit||atrial myocyt||solut||myocyt||experi||drug-contain solut||chlorid current||data||heart||valu||human atrial cardiomyocyt||channel||cell,anion||anion background||anion substitut||anion anion atrium atrial myocyt background||cardiac anion conduct||anion background conduct||anion conduct affect action||myocyt||atrial myocyt||chlorid||yamazaki J. horowitz B. anion transport||chlorid current||cardiac myocyt||human atrial myocyt||AB,160.769||82.332||81.68||64.599||59.157||56.927||42.483||34.106||30.177||28.523||27.752||22.973||22.347||22.269||20.0,0.2,0.3,0.26666666666666666
1124,Intensive_Care_Med-3-1-1915596.txt,lo||find||case||reduct||demand cxr||abnorm||clinic indic||data||studi||patient||daili routin cxr||elimin||intervent||day||daili routin chest radiograph||chang||chest radiograph||mortal rate||differ||import||daili routin||number||cxr||icu patient||physician||readmiss rate||icu||result,cxr||routin cxr||demand cxr||cxr practic||formal cxr||daili routin cxr||demand cxr strategi||demand cxr practic||demand cxr increas||demand cxr 5||daili routin cxr strategi||daili routin cxr practic||evid cxr find||icu||demand cxr 2 3,227.905||141.286||132.169||116.074||115.173||112.825||89.702||89.527||88.509||88.113||85.811||85.679||79.497||68.609||66.093,0.4,0.3,0.26666666666666666
1125,Eur_J_Nucl_Med_Mol_Imaging-3-1-1998878.txt,type||delay||normal tissu||time||figur||nuclear medicin||cur treatment||studi||effect||dose rate||receptor||narrow rang||analys||exposur time||low dose||cell||therapi||growth||day||radionuclid therapi||growth delay||radionuclid||low dose rate||dish||rang||irradi chamber||order||slower rate||beta particl||exposur||cultur||chamber||intrins radiosensit||cultur dish||exponenti growth||irradi||tumour cell,cell||dose rate||radiat||u-118mg cell||cell kill||u-373mg cell||tumour dose rate||tumour cell||skbr-3 cell||irradi u-118mg cell||a-431 cell||ht-29 cell||total radiat dose||relev radiat dose||cell line radiat,64.41||55.845||54.735||49.838||49.021||48.369||46.852||46.638||46.379||46.047||45.429||43.134||43.006||42.643||42.448,0.4,0.3,0.2
1126,Pediatr_Nephrol-3-1-1805051.txt,inflamm||chronic kidney diseas||children||studi||patient||end-stag renal diseas||erythropoiesis-stimul agent||effect||ascorb acid||esa therapi||increas||erythropoiet respons||esa||guidelin||iron||advers event||therapi||esrd||acut||oxid stress||absolut||iron storag||anemia||hemoglobin level||hemodialysi||iron supplement||ferritin||parenter iron prepar||kidney function||iron statu||vitro studi||intern recommend||intraven iron,iron||intraven iron||parenter iron||iron sucros||iron therapi||iron defici||iron sacchar||iron supplement||iron administr||serum iron||iron dextran||oral iron||iron statu||iron absorpt||carbonyl iron,274.919||184.855||151.392||148.382||146.437||144.435||141.846||141.564||141.021||140.303||140.093||140.056||139.818||139.72||139.116,0.4,0.3,0.26666666666666666
1127,J_Behav_Med-3-1-2080858.txt,person||aspect||type||attempt||neg feel||awar||level||find||restraint||neg emot||divis||individu||feel||distress||studi||concept||posit aspect||style||tendenc||scale||repression-lik concept||memori||self-decept||definit||denial||empir find||traumat event||non-express||repressor||defens||term||gener approach||suppress||repress memori||research||alexithymia||social phobia||self-imag||other-decept||report||differ||act||repress||self-conceal||peopl||emot control||emot||social situat,repress||repress repress||repress cope||repress cope style repress||repress concept||repress tendenc||repress journal||repress memori||J. repress||repress 1990||W. repress||term repress||repress impli||repress individu||relat repress,298.671||298.671||182.093||178.189||168.073||163.863||163.309||159.94||158.622||158.047||156.0||155.244||154.31||154.11||152.836,0.2,0.2,0.13333333333333333
1128,Neurochem_Res-3-1-1832151.txt,role||bind partner||lrp||beta amyloid||secretas||presenilin||studi||aspartyl proteas activ||gamma secretas||nicastrin||intramembran cleavag||substrat competit||interact protein||complex||evid||molecular clamp||calsenilin||enzym||protein||result||insect cell||activ||gener||amyloid precursor protein||cell surfac||interact||fragment||date||pathway||strong evid||transmembran domain||app||function||compon,presenilin||presenilin protein||presenilin complex||presenilin fragment||presenilin endoproteolysi||presenilin holoprotein||presenilin mutat||presenilin cofactor||presenilin interactor||presenilin 1||presenilin 2||mutant presenilin||presenilin dimer||presenilin origin||gamma-secretas,289.538||174.214||171.434||153.591||150.097||147.433||146.393||145.978||145.863||144.795||144.769||144.769||144.769||144.769||125.126,0.2,0.1,0.06666666666666667
1129,Breast_Cancer_Res_Treat-3-1-2001217.txt,placebo||adjuv||case||neoadjuv therapi||letrozol||individu||hormone-sensit breast cancer||breast cancer||breast cancer continuum||patient||tamoxifen||year||recurr||combin||effect||risk||regimen||chemotherapi||aromatas inhibitor||ai||sexual health||mbc||event||treatment||advers event||adjuv therapi||detriment effect||women||patient awar||long-term survivorship||anastrozol||tumor||trial||decis||benefit,breast cancer||breast cancer breast cancer||cancer||receptor-posit breast cancer breast cancer||II breast cancer breast cancer||primari breast cancer breast||cancer breast cancer group||breast cancer clin||metastat breast cancer||earli breast cancer||advanc breast cancer||receptor-posit breast cancer||node-neg breast cancer||breast cancer patient||perspect breast cancer,161.63||161.63||144.047||130.896||129.304||126.391||117.769||114.63||112.733||111.804||110.753||110.407||110.385||109.375||109.07,0.2,0.1,0.06666666666666667
1130,J_Neurol-3-1-1915648.txt,rand-36||placebo||measur||myoton dystrophi||hypersomnol||modafinil||patient||effect||percept||test||medic||mental health||sleepi||point||dose||present studi||interview||gener health||action||chang||activ||rang||insuffici effect||partner||double-blind placebo-control crossov studi||period,modafinil||modafinil dose||myoton dystrophi||dystrophi modafinil hypersomnol level||hypersomnol||sleepi||400 mg modafinil||housem||daytim sleepi||perceiv hypersomnol||activ||excess sleepi||adult onset myoton dystrophi||excess daytim sleepi||partner,60.721||32.212||28.181||27.901||26.656||25.781||20.648||19.99||18.016||17.4||16.6||16.523||14.637||14.433||12.511,0.6,0.4,0.4
1131,Semin_Immunopathol-3-1-2071951.txt,antibodi||level||renal damag||complement||membran attack complex||glomerulonephr||mpgn type II||hemolyt urem syndrom||model||mutat||patient||defici||deposit||risk||mpgn||complex||inhibit||mbl||cell||damag||therapeut intervent||mice||protein||regul||format||cell membran||renal function||activ||bind||factor||membranoprolif glomerulonephr||diseas||fluid phase||immun complex||ligand||kidney||result,complement||complement deposit||complement activ||complement defici||complement factor||complement protect||complement attack||complement system||complement inhibit||complement cascad||complement inhibitor||complement regul||complement compon||complement scienc||complement analysi,188.545||111.756||102.685||99.812||99.569||98.76||98.616||96.726||95.606||95.25||95.203||95.157||94.921||94.633||94.273,0.2,0.1,0.06666666666666667
1132,Dev_Biol-1-5-2082130.txt,transgen||commun||core||polar||adjac cell||intercellular commun||failur||trichom||complex||polaris||planar polar||rotat||apf||signal||local coordin||cell||localis||clone||tissu||protein||lack||activ||stronger phenotyp||core polar protein||factor||distal cell edg||requir||development||interact||wing||asymmetri||cell polar||function||result,stbm||fz stbm||fz||vang pk stbm||vang fz||pk||dgo pk stbm||stan fz stbm||vang dgo stbm||pk-sple-13 stbm||2002 fz fz fz fz||fz pk-sple stbm||vang||fz stbm 6||2002 fz stbm,475.629||422.697||369.766||361.512||331.573||315.525||309.083||306.827||301.701||298.914||296.611||295.68||293.381||285.944||283.128,0.0,0.0,0.0
1133,Crit_Care-5-4-37409.txt,technolog||system||databas||patient data||comput||data||studi||clinic scenario test||traine||patient||daili note||crossov studi||text entri||inform||process||resid||test||comput commun network||user||staff||palm devic||studi period||care||devic||patient manag||usa||medic refer inform||templat||refer||infrar||pda||handheld devic||physician||handheld comput||softwar||benefit||medic databas,pda||handheld comput||icu||softwar||pda user||handheld technolog||handheld devic||pda patient databas||data||patient-manag softwar||comput||handheld system||palm handheld devic||pda platform||icu round,37.471||27.764||27.337||26.624||25.189||22.836||22.021||21.306||21.221||21.166||19.544||19.375||19.328||19.294||18.516,0.6,0.5,0.4
1134,Int_Urogynecol_J_Pelvic_Floor_Dysfunct-3-1-2062491.txt,questionnair||univari analysi||biomed factor||preval||pregnanc||data||gener popul||studi||depress||year||stress urinari incontin||epidemiolog studi depress scale||urg urinari incontin||ces-d||deliveri||uui||signific increas||analys||over-act bladder syndrom||higher rate||urogenit symptom||women||clinic depress||associ||urinari incontin||oab||factor||sui||healthi nullipar women||symptom||urinari symptom||syndrom,depress||depress symptom||symptom||postnat depress symptom||postpartum depress||major depress symptom||urinari symptom||incontin||oab||depress mood||depress disord||antenat depress||major depress||clinic depress||urinari incontin,87.228||71.285||55.341||48.965||48.124||47.866||47.256||46.185||45.675||44.723||44.663||44.448||44.129||43.614||42.678,0.4,0.4,0.4
1135,Pediatr_Nephrol-4-1-2259258.txt,linkag analysi||chromosom 1||individu||npl||studi||patient||genet linkag||loci||region||linkag||pedigre||complex disord||total||evid||reflux||gene||averag||primari vur||vur||total npl||previou studi||addit marker||famili||lod||maximum lod||genet heterogen||haplotyp||score||children||result,vur||reflux||vesicoureter reflux||lod||famili vesicoureter reflux||famili reflux||primari vesicoureter reflux||nonsyndrom vesicoureter reflux||primari vur||famili||vesico-ureter reflux||nonsyndrom vur||hlod||vur patient||maximum lod,51.548||50.684||45.901||44.666||40.509||40.205||34.774||32.073||32.034||29.725||28.594||27.983||26.863||26.079||24.791,0.6,0.5,0.4
1136,Cell_Tissue_Res-3-1-2039796.txt,soft connect tissu||control group||data||bone regener||section||thrombin peptid||protein express||osteoblast lineag||osteopontin||bsp||adult||osteoblast differenti||bone sialoprotein||cell||osteoblast||tissu sampl||runx2||opn||distract gap||group||gap||bone||distract||area||distract osteogenesi,tp508||tp508 treatment||runx2||distract||thrombin-rel peptid tp508||300 μg tp508 runx2||300 μg tp508||distract osteogenesi||bone||callu distract||ml tp508 discuss 2005a||30 μg tp508 group||0 μg tp508 group||distract gap||osteoblast,104.107||52.053||49.803||49.799||44.717||42.287||39.782||39.773||32.023||30.098||29.626||29.623||29.231||29.001||27.758,0.4,0.4,0.4
1137,Surg_Endosc-3-1-2169269.txt,pneumoperitoneum||ldn||induct||studi||patient||data analysi||infus||anesthesia||kidney extract||overnight infus||crcl||hour||oper||day||urin output||fluid regimen||devic||earli graft function||bolu||group||pre-hydr||periop fluid manag||kidney||donor,nephrectomi||donor nephrectomi||pneumoperitoneum||crcl||donor||laparoscop donor nephrectomi||laparoscop donor||live donor nephrectomi||open donor nephrectomi||group||group group||anesthesia||laparoscop live-donor nephrectomi||crcl preop||laparoscop,50.155||44.173||41.923||40.02||38.191||37.939||31.831||31.271||30.081||29.473||29.473||26.362||26.076||25.816||25.472,0.6,0.4,0.3333333333333333
1138,Calcif_Tissue_Int-3-1-1914229.txt,index date||case||final model||β-blocker||histori||data||studi||patient||effect||risk||gprd||prescript||epidemiolog||variabl||pharmo rl||fractur||cumul dose||antihypertens agent||record||osteoporosi||drug||past||date||dutch pharmo record linkag system,β-blocker||fractur||gprd||β-blocker gprd pharmo rl case||femur fractur||gprd pharmo rl||pharmo rl||femur||rl||femur fractur risk||fractur risk||femur fractur case||osteoporot fractur||hip fractur risk||GD grey AB β-blocker,111.458||51.906||50.334||48.768||43.328||42.323||38.317||34.75||33.567||33.052||32.204||30.691||30.397||29.109||27.864,0.6,0.4,0.26666666666666666
1139,Appl_Microbiol_Biotechnol-4-1-2243256.txt,gene||polyamin||oxidas||putrescin||mutant||putrescin oxidas||plate||amin||enzym||enzym activ||substrat||room temperatur||substrat specif||oxid||spectrum||aromat cage||activ||substrat bind||bind||puo,Rh||Rh Rh||Rh Rh Rh||2 Rh Rh Rh Rh||Rh Rh Rh 1||Rh Rh lane||stabil Rh Rh||1 Rh Rh||2 Rh Rh||2005 Rh Rh||Rh Rh 2 2 Rh||Rh micrococcu||Rh puo Rh R.||Rh lane||Rh 1,340.561||340.561||340.561||272.456||255.759||228.052||227.548||227.491||227.053||227.041||204.351||181.023||179.991||171.798||170.957,0.0,0.0,0.0
1140,Breast_Cancer_Res_Treat-3-1-2045691.txt,optic nerv head||data||breast cancer||studi||year||comparison||tamoxifen||anastrozol user||adjuv endocrin therapi||effect||astrocyt||eye||disk area||regress line||women||eye diseas||optic cup||age||analysi||subject||onh||group||anastrozol||report||predict||cup||hrt||visual acuiti||disk margin||tamoxifen-induc effect||contour line||result,cup||tamoxifen||optic cup||cup volum||tamoxifen user||cup area||cup depth||anastrozol||0.612 cup||small cup||0.431 cup||cup size||cup differ||tamoxifen vision||optic cup size,91.814||78.871||59.689||52.324||52.309||51.109||50.504||47.447||47.13||47.092||46.947||46.545||46.367||41.914||40.218,0.6,0.4,0.26666666666666666
1141,Vision_Res-2-1-2386851.txt,respons||mjm||sensat varianc||paramet valu||data||model||valu||stimulu||finger error||contrast discrimin||observ||threshold||discrimin||increment||visual signal||pedest contrast||intrins uncertainti||fit||ratio||low threshold||estim||varianc||result||sensori threshold||uncertainti||second-respons accuraci||compress transduct||pedest||trial||ja||sigma-to-mean ratio||contrast||nois||detect||function||first-choic accuraci,ja||mjm||Ψ||ja mjm FV MT||swet||ja ’s||mjm ’s||priori Ψ Ψ||1961 swet||MT||FV||Ψ 1||Ψ NP||pedest||pedest pedest,115.627||112.219||83.006||82.321||66.755||60.638||58.934||55.791||55.702||50.814||50.623||50.466||50.393||48.183||48.183,0.4,0.2,0.2
1142,Int_Arch_Occup_Environ_Health-4-1-2175018.txt,emot role function||questionnair||qualiti||studi||patient||year||life||ill percept||percept||complaint||total||upper bodi region||rsi||person control||treatment||respect||work-rel upper extrem musculoskelet disord||health||averag||social function||pain||intens||group||order||differ||ill||treatment control||sick-list chronic rsi patient||work-abl,rsi||sick-list rsi patient||sick-list group||sick-list patient||sick-list chronic rsi patient||sick-list rsi patients’ perspect||rsi patient||rsi measur||sick-list patient group||sick-list chronic rsi patient sluiter judith||work||chronic rsi patient||rsi patients’ associ||umbrella term rsi||ill,75.433||57.163||54.046||48.028||43.852||43.686||41.275||38.512||38.403||31.66||31.013||28.822||28.063||25.849||24.269,0.4,0.2,0.2
1143,J_Med_Internet_Res-4-1-1761926.txt,document||level||technolog||system||diabet||commun||health care profession||lifemast||highest level||data||model||patient||inform||articl||mydiabet||abil||user||site||health inform||web site||criterion||manag||evalu||internet-bas diabet manag||relev||health care||solut||posit effect||internet||framework||more-complet solut||multi-rat kappa||blood glucos level||search||inform deliveri||diseas||result,diabet||100||internet-bas diabet manag||diabet technolog||internet diabet||internet-bas diabet care||diabet care||lifemast||internet-bas diabet system||internet-bas diabet manag system||manag||internet diabet technolog||internet-bas diabet manag solut||diabet manag site||feedback diabet,61.223||47.093||46.56||43.726||43.244||40.33||40.217||40.182||39.022||38.741||37.9||37.573||36.446||35.752||34.56,0.4,0.3,0.26666666666666666
1144,J_Fluoresc-4-1-2266787.txt,sodium carbon solut||method||plasma||concentr||dosag form||determin||spike human plasma||pharmaceut prepar||standard deviat||experiment paramet||dilut time||mixtur||pH 10||fluoresc intens||reaction||solut||oxamniquin||analysi||concentr rang||oxm||drug||precis||dansyl chlorid||result,oxamniquin||oxamniquin enantiom||keyword oxamniquin||oxamniquin conclus||250 mg oxamniquin||dansyl chlorid||belal||reagent oxamniquin pure sampl||electrogener oxamniquin radic anion||propos||dansyl hydroxid||dansyl chlorid effect||fluoresc||determin||capsul,75.237||42.386||37.618||37.618||26.194||25.947||23.417||21.94||21.501||19.044||17.764||17.298||16.963||16.245||15.387,0.2,0.2,0.2
1145,Purinergic_Signal-3-4-2072922.txt,receptor-receptor interact||role||function role||ionotrop receptor||releas||presynapt inhibit||studi||adenosin||channel||neurotransmiss||atp||effect||current||synapt transmiss||receptor||adenosin receptor||cell||brain||gpcr||potenti||hippocampu||nmda||regul||neuron||recent studi||pathophysiolog condit||activ||gaba||famili||interact||receptor interact||antagonist||result,adenosin||adenosin receptor||receptor||adenosin A1 receptor||adenosin a2a receptor||adenosin A3 receptor||A3 adenosin receptor||atp-sensit adenosin receptor||adenosin A1||excitatori adenosin receptor||adenosin receptor Br||inhibitori adenosin receptor||heterodimer adenosin receptor||uniqu adenosin receptor||adenosin modul,188.756||161.811||134.865||118.414||114.533||112.99||112.99||110.719||110.188||109.084||109.0||108.723||108.478||107.874||100.23,0.6,0.3,0.2
1146,Cell_Tissue_Res-4-1-2386751.txt,type||complic||elastin||pregnanc||abnorm||patient||uteru||ehlers-danlo syndrom||uterin tissu||human||present||tenascin-x||day||complet defici||collagen||mice||obstetr complic||ed||age||differ||tnx||skin||vagin plug||elast fiber||signific differ||uterin connect tissu||postpartum hemorrhag||ed patient,tnx||tenascin-x||tnx KO||tnx KO mice||tnx fniii27-32||tnx haploinsuffici||tnx knockout||tnx domain||tnx KO mous||tenascin-x defici||origin tnx KO mice||tnx KO mice show||ehlers-danlo syndrom||tenascin-x defici mice||mous tenascin-x,87.21||62.281||57.494||49.922||49.831||45.627||44.993||44.228||41.143||37.712||37.687||37.442||36.901||36.734||35.362,0.4,0.2,0.2
1147,Neurosurg_Rev-4-1-2279160.txt,case||cranio-vertebr junction||surgic treatment||problem||studi||transor approach||mucosa||remov||compress||muscle-mucos flap||risk||irreduc atlanto-axi disloc||soft palat||nasal caviti||spinal cord||endoscop||endoscop dissect||applic||approach||atla||order||hard palat||anatom studi||clinic applic||endonas approach||endonas||procedur||oral caviti||odontoid process||middl turbin,endonas||endoscop endonas||endonas approach||endoscop endonas approach||endoscop||transor approach||approach||endoscop endonas surgeri||extend endoscop endonas approach||innov endoscop endonas approach||extend endonas approach||endoscop endonas transsphenoid surgeri||endonas techniqu||modifi endonas||endoscop transnas approach,116.461||103.317||96.659||94.497||90.172||77.545||76.858||73.773||72.684||71.122||66.855||60.998||59.122||58.231||56.438,0.6,0.5,0.3333333333333333
1148,J_Med_Internet_Res-8-2-1550702.txt,person||organiz task||author||technolog||organiz level||health care profession||practic||preval||rate||person digit assist||data||studi||year||nation sampl||inform||review||medic refer||articl||resid||clinic practic||profession||usag pattern||patient track||patient care||market research firm||adopt||male||medic resid||health||health care||age||handheld usag rate||characterist||care||present review||group||adopt rate||health care provid||pda||student||survey||handheld devic||physician||handheld comput||specialist||systemat review||specif task||result,pda||survey||survey physician||pda adopt||pda technolog||pda usag||pda devic||profession pda||pda usag rate pda||pda user||administr pda||pda applic||collect pda||futur pda||term pda,250.403||181.71||147.034||141.06||136.401||135.934||134.897||134.861||132.829||129.522||127.886||127.614||126.562||126.557||126.478,0.4,0.2,0.13333333333333333
1149,Dig_Dis_Sci-3-1-1914244.txt,wide local excis||tumor||surviv||case||anu||melanoma||apr||local recurr||margin||wle||diagnosi||patient||abdominoperin resect||treatment,anorect||anorect melanoma||melanoma||metastat anorect melanoma||anorect melanoma int||anu||primari anorect melanoma Br||anal melanoma||apr||anal-rect melanoma||mucos melanoma||excis||benign anorect diseas||atyp anorect lesion||local excis,46.183||42.609||39.034||29.13||28.406||24.25||22.084||21.513||21.441||21.234||21.174||20.231||16.663||16.275||15.528,0.2,0.3,0.2
1150,Mol_Genet_Genomics-2-2-1705487.txt,gene||rna polymeras II||role||level||strain||subunit||cell growth||special role||method strain||cell divis||promot||transcript||presenc||osmot stress||growth||data||express||cell||thiamin||stress condit,rpb4||rpb4 nmt1||nmt1 rpb4 1 rpb4 rpb4||rpb4 nmt1 nmt1 nmt1||rpb4 transcript||rpb4 subunit||cell separ rpb4 rpb4||S. pomb rpb4 rpb4 express||rpb4 fba1||rpb4 strain||subcomplex rpb4||1 rpb4 fig. 1 rpb4 rpb4||nmt1 fba1 rpb4||3 3 rpb4 nmt1 rpb4||600 rpb4 nmt1,257.908||184.827||177.095||148.286||144.405||137.565||136.591||135.48||133.607||131.673||130.156||128.955||126.319||125.554||124.255,0.0,0.0,0.0
1151,Arch_Microbiol-3-1-2111041.txt,isom||fraction||abil||group||compon||earth||speci||glycerol||data||bacteria||diabol acid||alkyl chain||lipid||mass rang||genu,thermotoga||thermotogal thermotoga||thermotoga maritima||thermotoga lettinga||thermotogal||thermotogal T.||T.||T. maritima||thermotoga thermotogal 1986 T.||T. lettinga T.||result thermotogal thermotoga T. maritima T.||276 thermotoga maritima||66 thermotoga||method thermotoga||stetter KO thermotoga maritima,138.295||116.471||108.728||106.22||94.646||88.288||81.929||80.545||79.684||79.334||79.327||73.029||71.066||69.148||68.0,0.0,0.0,0.0
1152,Breast_Cancer_Res_Treat-3-1-2092410.txt,gene||cancer||indonesian popul||amino acid||age||uv||popul||famili||breast cancer||mutat||protein function||brca||breast||specif popul||patient||famili member||group,brca2||brca1 brca2||brca1 brca2 brca1||brca1||mlpa brca1 brca2 brca1 brca2||brca1 brca2 30 brca1||mutat brca1 brca2 21 brca1 brca2||brca2 1 brca2||3 brca1 brca2||brca2 mutat||brca1 brca1 28||brca1 mutat||brca1 brca2 germlin mutat||brca1 breast||brca2 protein,222.967||213.456||210.285||203.945||173.215||157.916||151.779||148.646||142.353||139.91||135.963||130.399||124.677||116.094||111.853,0.0,0.0,0.0
1153,J_Med_Internet_Res-5-4-1550574.txt,clinic event||type||system||medic event||schema||simpl eav schema||databas||convent relat databas system||physic schema||model||patient||valu||clinic inform||larg clinic repositori||form||exampl||complex||domain||class||user||eav||metadata||convent design||medic informat||object-ori approach||web page||applic||gener design||logic schema||electron patient record||approach||flexibl||literatur||phone number||gener||gener eav tabl||field||record||number||attribut||tabl||data type||object||design||physic layout||larg number||eav model||queri||completely-gener physic schema,databas||eav databas||eav||eav tabl||databas schema||eav schema||databas design||eav data||eav design||convent databas||entity-attribute-valu databas||tabl||eav layout||clinic databas||gener databas,169.777||163.387||156.998||129.724||128.295||121.905||116.239||111.553||109.849||106.958||102.649||102.45||98.266||97.59||96.571,0.4,0.2,0.2
1154,Crit_Care-6-5-130146.txt,antithrombin iii||subgroup||atiii||find||indic||congenit defici||italian hospit||heparin||clinic condit||data||studi||patient||sepsi||mortal||inform||dic||evid||treatment||rct||meta-analysi||hospit||italian ministri||observ studi||random||previou rct||intens care unit||dissemin intravascular coagul||drug||trial||septic shock||icu||outcom,atiii||atiii treatment||atiii concentr||abbrevi atiii||women atiii||congenit atiii defici||famili atiii defici||kyrl PA atiii||16.2 atiii level||baselin atiii level||sepsi||antithrombin||intravascular coagul sepsi||antithrombin iii||rct,138.937||70.961||70.364||69.468||69.468||56.372||51.382||47.364||46.792||46.668||34.574||29.93||20.811||20.695||20.458,0.2,0.1,0.26666666666666666
1155,Plant_Mol_Biol-3-1-2039854.txt,goslim||orient group||evolutionari relev||categori||adjac pair||occurr||coexpress domain||coexpress||microsynteni||local microsynteni||well-defin categori||rice||orient||rank number||mpss||local coexpress domain||neighbor||express platform||chromosom||domain||MA data||cluster||MA express data||similar||analys||function categori||gene||distanc||annot||arabidopsi||inparanoid||pair||biolog background||list||import||fraction||coexpress pair||number||intergen distanc||signific fraction||well-defin goslim categori||plant||result,coexpress||coexpress pair||coexpress gene pair||coexpress domain||pair||local coexpress||coexpress tandemli||coexpress adjac pair||singl coexpress pair||coexpress quadruplet||coexpress triplet||coexpress analysi||explain coexpress||tissue-specif coexpress||coexpress relationship,244.827||198.967||161.618||156.186||153.108||141.422||140.86||138.035||132.645||131.189||127.625||123.196||123.119||122.942||122.413,0.8,0.4,0.26666666666666666
1156,Dev_Genes_Evol-4-1-2362136.txt,antibodi||insect||develop||muscl||crustacea||present studi||myogenesi||embryo||western blot||limb||evolut||hoechst||speci||decapoda||adult||pattern||innerv pattern||studi||isopoda||muscl format,crustacean||crustacean limb||muscl||muscl muscl||arthropod muscl||arthropod||crustacean neurobiolog||crayfish muscl crustacean||crustacea||arthropod limb||decapod crustacean||crustacean taxa||crustacean relationship||primit crustacean||crustacean walk,112.813||84.78||72.789||72.789||71.53||70.27||69.018||68.393||68.192||63.509||60.582||58.993||57.454||57.151||57.077,0.2,0.2,0.13333333333333333
1157,Appl_Microbiol_Biotechnol-3-1-2039825.txt,antibodi||method||human vh||advantag||VL domain||single-domain||high stabil||express||antigen||yeast||applic||product||protein||convent antibodi||antibodi fragment||molecular evolut||light chain||function antibodi devoid||egfr||vhh||effici||addit||antigen bind,antibodi||single-domain antibodi||muylderman||llama single-domain antibodi||antibodi fragment||single-domain antibodi fragment||vhh antibodi fragment||llama antibodi fragment||llama single-domain antibodi fragment||single-domain||llama vhh antibodi fragment||camel single-domain antibodi||domain antibodi||vhh||camelid antibodi,94.539||81.395||76.661||74.901||71.432||70.372||69.242||68.259||68.257||68.251||67.41||66.055||65.172||64.863||63.483,0.4,0.3,0.26666666666666666
1158,Dig_Dis_Sci-3-1-2140097.txt,unreli result||studi||valu||medic measur system||diagnost accuraci||stenosi||acid product||chronic mesenter ischemia||diagnost evalu||gold standard||gastric||cgi||chronic gastrointestin ischemia||exercis||ischemia||stomach||meal||gastrointestin ischemia||patient group||gastric exercis tonometri||signific differ||diagnosi||chronic abdomin symptom||splanchnic stenosi||detect||result,ischemia||tonometri||cgi||24-h tonometri||gastrointestin ischemia||gastrointestin tonometri||postprandi tonometri||multi-vessel ischemia||mucos ischemia||hour tonometri||stenosi||suspect cgi||tonometri studi||cgi surgeri||24-h tonometri test,137.858||132.339||124.565||91.253||82.875||80.116||71.628||70.492||69.532||68.932||68.421||67.642||66.741||65.812||62.535,0.6,0.3,0.26666666666666666
1159,Ann_Surg_Oncol-4-1-2190342.txt,cancer||time||respons||tumor regress grade||studi||patient||regimen||mortal||esophag cancer||paclitaxel||transhiat esophag resect||radiotherapi||treatment||patholog complet tumor regress rate||chemoradi||postop complic||surgeri||stage II||tumor||surviv||neoadjuv chemoradi||trial||neoadjuv treatment,neoadjuv chemoradi||esophag||chemoradi||neoadjuv chemoradi regimen||neoadjuv regimen||neoadjuv chemoradiotherapi||esophag cancer||neoadjuv treatment||neoadjuv therapi||paclitaxel-bas neoadjuv chemoradi regimen||chemoradi regimen||resect esophag cancer||esophag carcinoma||esophag adenocarcinoma||neoadjuv treatment regimen,47.444||46.512||39.683||37.761||36.8||35.94||33.061||29.992||29.847||29.084||29.039||26.929||26.404||26.256||26.126,0.4,0.4,0.26666666666666666
1160,Clin_Auton_Res-2-2-1705534.txt,type||measur||method||respons||latenc||studi||contralater side||ipsilater||autonom nervou system||amplitud||stimuli||sympathet skin respons||stimul||electr stimul||reflex||subject||ssr record||ssr||compon||differ||type respons||record||millisecond||peak latenc||area||record site||magnet||side,ssr||electr stimul||magnet||magnet stimul||stimul||sympathet skin||ssr waveform||latenc||ssr onset latenc||ssr onset||electr stimulu||contralater electr stimul||skin latenc||ssr record||electr stimul amplitud,77.491||55.704||50.456||49.315||48.174||48.05||44.512||43.408||43.371||43.353||42.727||42.605||42.293||41.511||40.875,0.8,0.5,0.4
1161,World_J_Urol-4-1-2295251.txt,target||vegf level||g250||vegf||combin||studi||patient||bevacizumab treatment||caix||renal cell carcinoma||effect||clinic trial||antigen||monoclon antibodi||treatment||therapi||partial respons||renal mass||bevacizumab||tumor cell||rcc||tumor||surviv||phase II trial||trial||diseas||result,g250||bevacizumab||rcc||metastat rcc||monoclon antibodi g250||g250 treatment||rcc cell||bevacizumab treatment||low-dos bevacizumab||chimer monoclon antibodi g250||iodine-131-label monoclon antibodi g250||131i-label chimer g250||iodine-131-label chimer monoclon antibodi g250||anti-renal-cel carcinoma chimer antibodi g250||oosterwijk,61.414||59.662||58.297||37.301||37.284||34.652||34.526||33.776||32.047||31.576||29.169||27.379||26.226||25.909||25.882,0.6,0.4,0.26666666666666666
1162,Graefes_Arch_Clin_Exp_Ophthalmol-3-1-2082065.txt,measur||tempor resolut||young control||studi||critic flicker fusion frequenc||stimulu||patient||motion||frequenc||threshold||sensit||color percept||test||region||visual function||motion sensit||contrast sensit||eye||retina||double-puls resolut||eccentr||subject||motion contrast threshold||light||arm||group||visual field||dynam process||peripher motion percept||age-match control||signific differ||visual acuiti||loss||function||result,age-rel maculopathi||flicker||maculopathi vi||vi||age-rel macular degener||earli age-rel maculopathi||strasburg||age-rel macular diseas||flicker sensit||age-rel maculopathi eisenbarth werner||bressler||flicker frequenc||visual percept||macular degener||foveal flicker sensit,48.823||43.092||37.708||35.644||34.923||33.139||29.785||28.479||27.279||26.046||25.797||25.238||24.651||23.447||22.867,0.0,0.0,0.0
1163,Oecologia-4-1-2373415.txt,intermedi depth||water depth||veget commun||swan||speci||fulltofta bay||graze intens||plot||tuber||distribut||treatment||ramet||plant,"P. pectinatu P. perfoliatu||P. perfoliatu P. pectinatu||P. perfoliatu||P. perfoliatu P. pectinatu P.||P.||2 P. pectinatu P. perfoliatu||P. pectinatu 2002||P. pectinatu 2||squar P. perfoliatu||experi P. perfoliatu||1 potamogeton perfoliatu P. pectinatu||potamogeton pectinatu||5 2 P. perfoliatu P.||1,10 NS P. pectinatu||2 potamogeton perfoliatu P. pectinatu shoot",215.671||215.671||215.016||213.484||204.735||172.697||146.983||144.484||144.306||143.344||140.713||136.767||127.113||118.5||117.601,0.0,0.0,0.0
1164,Cancer_Chemother_Pharmacol-4-1-2270367.txt,level||normal tissu||radiat||sampl||studi||AG adduct||patient||dna adduct||correl||infus||tumor tissu||dose||treatment||cell||schedul||adduct||buccal cell||analysi||concurr chemoradiotherapi schedul||format||total number||wbc||cisplatin||tumor||cervic cancer,adduct||cisplatin-dna adduct||platinum-dna adduct||dna adduct||AG adduct||GG adduct||adduct format||adduct level||pt-ag adduct||adduct measur||adduct induct||cisplatin-dna adduct format||cisplatin-dna adduct level||cisplatin-dna adduct measur||cisplatin-dna adduct determin,160.875||107.564||89.478||88.238||87.666||86.304||85.973||85.36||81.944||81.105||80.975||75.4||74.991||72.155||71.976,0.6,0.3,0.2
1165,Diabetologia-4-1-2362135.txt,vascular function||type 2 diabet mellitu,rhdl||rhdl infus||diabet mellitu||infus||apoa-i infus||apoa-i||mellitu||volunt||type 2 diabet mellitu||hdl infus||high-dens lipoprotein||type 2 diabet||0.4||1.2 hdl-cholesterol||1.3,13.937||12.039||11.38||10.14||9.796||9.453||8.952||8.369||8.253||8.253||8.082||8.021||7.886||7.048||6.967,0.0,0.1,0.06666666666666667
1166,Antonie_Van_Leeuwenhoek-3-1-2140093.txt,immunogold||antibodi||igg||high accuraci||cbpp||membran||primari antibodi||host cell||amino acid||domain||immunogold label||lppq||mycoplasma||coverslip||outer surfac||peptid||integr membran domain||electron microscopi||cell||surfac,mycoplasma mycoid mycoid||mycoid M. mycoid||mycoplasma mycoid||2007 mycoplasma mycoid mycoid M. mycoid||M. mycoid||M. mycoid mycoid SC||mycoid SC||M. mycoid mycoid 2000 M. mycoid||mycoid 2000 M. mycoid||mycoid 2002 M. mycoid||mycoid 2005||mycoid 2004||M. mycoid mycoid SC strain||mycoid 2004 2006 M. mycoid||jb.187.19.6824-6831.2005 16166545 mycoplasma mycoid mycoid SC,181.821||166.17||152.352||133.869||128.875||128.562||128.25||127.115||126.235||124.827||120.386||120.38||102.85||99.702||94.602,0.0,0.0,0.0
1167,Emerg_Radiol-3-1-1914302.txt,manual||fast||line||radiograph||indic||spine||imag||pulmonari contus||patient||chest||lumbar spine||primari survey||radiologist||abdomen||convent radiographi||emerg measur||fractur||life-threaten injuri||diagnost imag||treatment||evalu||pelvic radiograph||care||chest radiograph||injuri||physic examin||adjunct||thorac||advanc trauma life support||trauma care||radiolog||pneumothorax||abdomin CT||clinic decis rule||trauma||atl,trauma||atl||trauma patient||blunt trauma||trauma care||torso trauma||trauma victim||trauma suit||trauma set||trauma team||trauma chest pneumothorax||emerg trauma care||atl guidelin||dutch atl||conclus atl,107.033||92.111||57.213||56.884||56.417||55.343||54.912||54.006||53.517||53.517||48.758||46.317||46.055||46.055||46.055,0.6,0.3,0.2
1168,Cancer_Causes_Control-2-2-1764866.txt,risk||calor restrict||cancer||human||cancer risk||transient,restrict||calor restrict||short-term calor restrict||sustain calor restrict||earli calor restrict||calor restrict prevent cancer||dietari restrict||energi restrict||calori restrict||restrict mimet||calor intak||cancer||short-term famin||famin exposur||1945 dutch famin,69.66||68.834||48.839||46.969||46.505||43.234||40.496||39.403||39.263||35.781||34.791||34.047||32.422||31.432||29.992,0.2,0.1,0.13333333333333333
1169,Exp_Brain_Res-3-1-1914280.txt,intersensori||visual toj task||tempor ventriloqu||auditori||locat||effect||frequenc||intersensori interact||av-interv||auditori stream||jnd||experi||rhythm||flanker||light||auditori stimuli||intersensori pair||captur||stream||soa||central loudspeak||tone||sequenc||auditori group||sound,sound||captur sound||flanker sound||sound locat||sound segreg||captur sound locat||sound enhanc||sound sequenc||collision’ sound||26th sound||11th sound||sound burst||sound result||similar sound||40 sound,227.1||162.089||157.985||126.565||125.196||116.736||115.737||115.427||115.055||114.754||114.604||114.202||113.55||113.55||113.55,0.2,0.1,0.06666666666666667
1170,Cancer_Immunol_Immunother-3-1-1914259.txt,control||detect||studi||Hu antibodi||pbmc||individu||cytokin||peptid||patient||nervou system||pn||antigen||cell||hud,paraneoplast encephalomyel||hu-pn||dalmau||paraneoplast neurolog syndrom||hud||paraneoplast encephalomyel antigen hud||paraneoplast neurolog disord||neurolog||paraneoplast cerebellar degener||hu-pn patient||cmv||benyahia||keyword paraneoplast anti-tumour immun||anti-hu-associ paraneoplast encephalomyel acta neuropathol||sfc,27.418||26.061||22.803||22.367||21.247||20.941||20.586||18.221||15.242||14.586||13.972||13.029||12.56||12.529||12.33,0.2,0.1,0.06666666666666667
1171,Mcgill_J_Med-11-1-2322923.txt,report||reaction||wasp sting||acut renal failur||case||direct nephrotox effect||haemolysi||wasp envenom||rhabdomyolysi||interstiti nephriti||direct nephrotox||atn||nepal||acut interstiti nephriti||acut tubular necrosi||intravascular haemolysi||wasp venom||hypersensit reaction||renal failur||patient,wasp||wasp sting||sting||wasp sting case||wasp venom||multipl wasp sting||conclus wasp sting||wasp envenom||multipl wasp||wasp attack||multipl european wasp sting||multipl sting||observ discuss wasp sting||massiv wasp venom||keyword wasp envenom rhabdomyolysi,59.78||56.103||52.426||41.541||40.382||39.113||37.402||35.007||32.456||30.547||29.335||28.779||28.051||27.505||21.955,0.4,0.3,0.2
1172,Pflugers_Arch-3-1-2082653.txt,condit||action potenti||lidocain||restitut||dynam compon||studi||valu||bcl||anti-arrhythm effect||slope||effect||frequenc||hypokalaemia||cycl||baselin cycl length||shortest bcl||hypokalaem langendorff-perfus murin heart||epicardium||map||analysi||experi||alternan||restitut curv||full agreement||critic DI||arrhythmia||record||waveform||heart||arrhythmogen||endocardium,alternan||t-wave alternan||electr alternan||wave alternan||cardiac alternan||TU alternan||durat alternan||restitut||discord alternan||cardiac alternan circ||repolar alternan circ||heart||ventricular arrhythmia||ventricular fibril||electr restitut,87.906||50.844||50.157||49.699||48.104||45.108||44.649||44.509||44.49||37.077||36.803||33.31||32.494||31.007||28.459,0.2,0.2,0.2
1173,Bioprocess_Biosyst_Eng-2-2-1705536.txt,induct||periplasm protein||hydrolas activ||sec pathway||growth rate||polyest||induct phase||hcdc||batch cultiv||cell||glucos||glucos concentr||protein||cultiv||periplasm||rtfh||activ||cytoplasm||extracellular space||solubl protein||mobil phase||batch||extracellular medium||purif||medium||result,rtfh||rtfh dcw||cytoplasm rtfh||rtfh product||rtfh dcw 2||rtfh activ||rtfh releas||dcw||rtfh solut||periplasm||gener rtfh||produc rtfh||rtfh 11||rtfh concentr||rtfh section,105.675||80.002||65.753||57.279||57.264||54.653||54.597||54.33||53.445||53.403||52.838||52.838||52.838||52.838||52.838,0.2,0.2,0.13333333333333333
1174,Antonie_Van_Leeuwenhoek-4-1-2268727.txt,sclerotia||applic||carrot||malt extract agar||cold-act enzym||enzym||mycelium||powder wood||hyalina vel fusca||temperatur||natamycin||activ||growth,F. psychrophila||fibulorhizoctonia psychrophila F. psychrophila||F. psychrophila F.||F. psychrophila athelia arachnoidea F. carota||F. psychrophila F. carota athelia arachnoidea||2 F. psychrophila||F.||F. carota F.||keyword fibulorhizoctonia psychrophila||F. psychrophila aspergillu niger||2 F. psychrophila F. carota A.||rhizoctonia carota||2 F. psychrophila A.||3 3 F. psychrophila||F. psychrophila 2004 2005,114.542||107.625||100.732||78.717||78.717||76.366||73.113||70.817||67.139||66.556||62.524||59.083||58.951||57.854||57.271,0.0,0.0,0.0
1175,Anal_Bioanal_Chem-4-1-2045123.txt,assay||androgen||testosteron||yeast||yegfp||recombin yeast cell||progesteron||paper||primer||antagonist||pcr||compound||cell wall disrupt||yeast androgen bioassay||cell line||yeast cultur||yeast cell||transform||estradiol,β β β||β||β bold β||β lacz lacz||27 27 β β||50 α β||NR NR||androgen||NR NR bde-19 NR NR||yeast androgen||yeast androgen bioassay||yeast||10 β 28||ER agonist NR NR||NR NR dexamethason,117.767||117.767||78.921||60.102||59.893||59.423||55.12||49.086||44.723||44.397||40.267||39.708||39.256||39.04||38.564,0.0,0.1,0.2
1176,Eur_J_Clin_Pharmacol-3-1-2071966.txt,system||problem||patient||effect||inform||clinic practic||sexual problem||side effect||discontinu||patient report||impact||treatment||advers event||hcp||therapi||natur||relev||ineffect||experi||medicin||antidepress||issu||drug||spontan report||previou medic||advers drug reaction,antidepress||report||report side effect||side effect||report experi||antidepress therapi||antidepress treatment||tricycl antidepress||258 report||antidepress user||initi antidepress||patient report||spontan report||multipl report||duplic report,111.459||104.785||80.739||68.715||66.265||57.402||56.938||56.77||56.715||56.464||55.73||55.406||53.809||52.393||52.393,0.4,0.2,0.26666666666666666
1177,Histochem_Cell_Biol-4-1-2413113.txt,cell adhes||hemichannel||form||microtubul||protein||interact||brain tissu||migrat||heart||gap junction||connexon||adheren junction||cell||adhes||brain,junction||gap junction||gap||connexin||connexin43 gap junction||gap junction hemichannel||gap junction connexin 43||connexin 43 gap junction||gap junction channel||gap junction cardiovasc||gap junction nexu||gap junction format||myocardi gap junction||gap junction plaqu||heterolog gap junction,69.853||67.383||64.914||56.033||52.504||51.072||48.721||48.721||46.84||46.282||45.738||45.612||45.583||45.438||45.378,0.2,0.1,0.06666666666666667
1178,Purinergic_Signal-4-2-2377326.txt,atp||ogd||solut||atp releas||maxi-anion channel||astrocyt||arachidon acid||experi||neuron||studi||cell||calibr curv,atp||atp releas||biosensor atp||astrocyt||releas||glial atp||ischemia-induc atp releas||swelling-induc atp releas||atp solut||luciferin-luciferas atp||atp Cl||astrocyte-deriv atp||atp puf||extracellular atp||channel,58.868||47.072||38.665||37.396||35.277||33.133||33.05||32.962||32.481||32.214||31.01||30.773||30.725||30.684||28.756,0.6,0.3,0.2
1179,Ann_Surg_Oncol-4-1-2277442.txt,tumor deposit||case||diamet||breast cancer||studi||patient||SN metastas||breast cancer patient||featur||invas breast cancer||lymph node dissect||lymph node||tumor-posit axillari SN||analysi||SN involv||itc||penetr depth||microanatom locat||sentinel node||ajcc||signific predictor||sn||subcapsular locat||morphometri,non-sn||SN||non-sn metastas||non-sn involv||posit non-sn||SN metastas||non-sn characterist||non-sn 4939||SN involv||node||enlarg non-sn metastas||axillari SN||addit non-sn involv||sentinel node||node metastas,125.642||87.811||84.644||77.062||68.07||65.729||65.418||64.152||58.147||58.01||56.826||52.474||51.792||50.998||50.828,0.0,0.2,0.2
1180,Glycoconj_J-4-1-2413117.txt,calcul||molecular shape||time||na-domain||random coil||isotrop||heparin||sampl||data||model||valu||polym||amid||anisotrop model||oligosaccharid||dynam||coupl||octasaccharid||analysi||experi||simul||nmr||polysaccharid||consist||central residu||nmr relax||diffus||tabl||experiment data||cross-peak||molecul||result,tau||tau _||nmr||document||omega||nmr relax||_||bot||tau _\ parallel||nmr 3J||na-domain||carbohyd||nmr pipe||carbon-13 nmr relax||nmr studi,95.07||67.299||58.462||50.32||45.159||42.241||39.528||34.384||32.28||31.843||31.339||31.339||30.351||29.901||29.253,0.2,0.2,0.2
1181,Soc_Psychiatry_Psychiatr_Epidemiol-2-2-1764202.txt,find||import role||prodrom clinic||studi||patient||year||contact||durat||psychologist||mental health||featur||earli psychosi||health profession||privat psychiatrist||social withdraw||gp||psychosi||assess||prodrom servic||group||health system||symptom||number||posit||reliabl||pathway||schizophrenia||referr||untreat psychosi||help-seek pathway,psychosi||contact||psychosi prodrom||contact symptom||earli psychosi||earli help-seek contact||first-episod psychosi||χ||help-seek pathway||non-affect psychosi||untreat psychosi||psychosi studi||begin psychosi||2006 psychosi||symptom,70.975||50.327||50.011||42.201||41.838||40.381||39.689||38.514||38.258||36.193||35.995||35.894||35.487||35.487||34.074,0.6,0.4,0.4
1182,Clin_Exp_Metastasis-4-1-2413104.txt,antibodi||cancer||find||serum||carcinogenesi||sampl||studi||patient||potenti biomark||differenti express||npc||express||signific||saa||protein marker||maldi-tof-m identif||tissu||protein||confirm elisa||tumor cell||human serum||identif||group||nasopharyng carcinoma||serum level||healthi volunt||elisa||npc patient||biomark,npc||serum||non-lnm npc||lnm npc||npc metastasi||npc stage||npc cell||new-onset npc||npc patient||npc progress||npc research||npc victim||npc group||npc statu||serum hsp70,119.821||70.364||70.141||70.141||69.112||61.897||61.588||61.023||60.71||60.67||60.457||59.91||59.91||59.91||55.099,0.4,0.3,0.2
1183,Planta-4-1-2413075.txt,pme activ||role||pathogen||oxid stress toler||liquid nitrogen||suscept||pme||spore||wild-typ||abiot stress respons||antifung activ||inocul||seedl||pepper||express||leav||growth chamber||treatment||growth||gene||control||protein||molecular mass||hybrid||incub||cotyledon||hybrid signal||inhibitor||plant||result,capmei1||capmei1 capmei1 transcript||arabidopsi capmei1||capmei1 arabidopsi||capmei1 cabpr1||capmei1 arabidopsi capmei1 pr1||capmei1 protein capmei1 E. coli capmei1||capmei1 induct||capmei1 inhibit||capmei1 capmei1 xcv xcv 4||crude capmei1||capmei1 function||capmei1 capmei1 cabpr1 casar82a 32||xcv xcv capmei1 2 capmei1 C.||capmei1 hyaloperonospora parasitica capmei1 arabidopsi H.,423.222||282.148||246.739||246.739||231.07||230.2||214.614||214.425||213.221||212.764||212.1||211.611||180.966||177.375||164.801,0.0,0.0,0.0
1184,Apoptosis-4-1-2257993.txt,mechan||endotheli cell||pten||neg regul||wortmannin||apoptot nuclei||effect||atp||reperfus||jasplakinolid||akt activ||inhibit||treatment||cell||control||rho-kinas||apoptosi||cytochalasind||activ||y-27632||simul ischemia||latrunculina||akt||cytoskeleton,f-actin||f-actin bundl||f-actin cytoskeleton||rho-kinas||f-actin rearrang||f-actin clump||f-actin stain||apoptosi apoptosi||apoptosi||pi3-kinas||akt||a.u.||f-actin cytoskeleton play||rho-kinas inhibit||cell,70.097||48.723||44.263||42.166||39.579||39.237||35.971||35.632||35.632||32.498||31.588||30.221||29.858||27.337||26.022,0.2,0.2,0.26666666666666666
1185,Support_Care_Cancer-3-1-2071950.txt,cancer||set||case||incur cancer||questionnair||problem||qualiti||studi||life||process||extent||rel||netherland||bereav rel||treatment||institut||end-of-lif care||cancer patient||health||interview||hospit||research||care||gener practition||death||medic treatment||home||symptom||number||physician||major differ||major concern,die||home||home care||care||home death||patient||place||bereav rel place||bereav rel||hospital-bas home care||home care set||rel place||home care servic||palli care||0.93 patient ’s die,78.706||51.613||45.44||39.267||36.13||36.042||35.094||33.265||32.35||31.707||30.876||30.502||30.293||29.95||28.687,0.4,0.3,0.2
1186,Mol_Biochem_Parasitol-1-5-2075530.txt,mosquito bite||caspas activ||PS transloc||dna fragment||metacaspas||femal gametocyt||apoptosi||genom dna||cell death||proteas||posit||caspas||mosquito||involv||caspatag||ookinet||stage||result,pbmc1||plasmodium berghei||P. berghei pbmc1||plasmodium P. berghei pbmc1||plasmodium plasmodium||plasmodium||P. berghei||plasmodium metacaspas||P. berghei P. falciparum||4 discuss P. berghei pbmc1 pbmc1||plasmodium falciparum||pbmc1 P. berghei sal hin||vitro P. berghei ookinet||P.||P. berghei P. falciparum P. vivax,66.037||65.509||58.737||58.262||56.836||56.836||55.087||41.62||41.401||40.621||38.137||37.396||36.112||35.993||35.149,0.0,0.0,0.0
1187,Crit_Care-8-2-420020.txt,prone posit||mechan ventil||acut respiratori distress syndrom||high intrathorac pressur||overdistens||model||studi||arteri oxygen||strategi||patient||alveolar flood||effect||human||investig||increas||posit end-expiratori pressur||volum||rm||recruit||cyclic collaps||oxygen||lung injuri||low peep||ard||bacteri transloc||recruit maneuv||peep||injuri||mechan stress||alveolar unit||ali||lung infect||low tidal volum||acut lung injuri||alveolar collaps||lung||benefit||sigh,lung||lung recruit||recruit lung||lung recruit maneuv||maneuv||recruit maneuv||lung injuri||recruit||alveolar recruit maneuv||period lung recruit maneuv||lung mechan||ventil||acut lung injuri||lung volum||optim lung recruit,102.004||85.843||85.843||84.119||80.669||75.176||69.978||69.683||63.149||63.089||61.534||60.846||60.63||59.627||57.532,0.2,0.4,0.3333333333333333
1188,Eur_Radiol-3-1-1797072.txt,treatment regimen||allogen transplant||neoplast cell||imag||patient||small molecular gd-chelat||inform||bone marrow||bone marrow cellular||increas||infiltr||articl||neoplast marrow||high risk||lymphoma||clinic practic||lesion||adult||specif question||treatment||neoplast infiltr||therapi||extracompartment tumor growth||anti-angiogen drug||contrast agent||cellular||uspio||treatment effect||hypercellular marrow||hematopoiet marrow||reconvers||chang||normal||nhl||long bone||tumor||bone||avn||hematolog malign||diffus||signal intens||irradi||addit||contrast||sequenc||clinic signific||techniqu,marrow||bone marrow||bone marrow infiltr||neoplast marrow||hypercellular marrow||bone marrow reconvers||hematopoiet marrow||bone marrow transplant||bone marrow lesion||cellular marrow||hematopoiet bone marrow||bone marrow convers||normal bone marrow||femor marrow||bone marrow cellular,288.262||215.371||153.249||152.477||150.354||150.005||149.141||148.803||147.239||147.057||146.921||146.881||146.461||145.999||145.531,0.6,0.4,0.3333333333333333
1189,J_Gastrointest_Surg-3-1-1852381.txt,biliari ductal system||biliari fistula||hepat arteri thrombosi||approach||anastomosi||skin||tract||oper procedur||biliari surgeri||biliari cutan fistula||fistula tract||procedur||jejun loop||patient||liver||liver transplant||biliari drainag,fistula||biliari fistula||biliari cutan fistula||fistula tract||persist biliari fistula||biliari drainag||long-stand biliari cutan fistula||longstand biliari cutan fistula||chronic biliari cutan fistula||biliary-cutan fistula||transabdomin fistula tract||traumat intrahepatic-cutan biliari fistula||biliari surgeri||cutan bile fistula||biliari tract surgeri,71.707||67.329||51.906||50.802||44.886||39.818||39.558||39.546||39.324||39.272||35.814||35.713||34.69||33.733||33.092,0.6,0.4,0.3333333333333333
1190,Qual_Life_Res-3-1-1915610.txt,level||measur||categori||respons||permut||instrument||system||common dimens||frequenc distribut||problem||health statu||inform||shannon approach||shannon||classif||discriminatori power||hui||health||gener popul survey||gener popul sampl||absolut||popul||rel inform||total number||distribut||respond||health state||formal measur||differ||number||classif system||health classif system||reliabl,hui3||hui2 hui3||shannon||hui2||eq-5d||maui||hui3 cognit||shannon indic||shannon ’s||shannon methodolog||hui2 cognit||shannon approach||17. shannon||24. shannon||hui2 hui3 mobil mobil ambul,67.19||62.616||61.691||58.041||52.103||37.652||36.896||35.951||32.985||32.977||32.321||30.846||30.846||30.846||30.604,0.2,0.1,0.13333333333333333
1191,Arch_Dermatol_Res-2-2-1705535.txt,placebo||chronic plaqu psoriasi||clinic respons||week||psoriasi||respons||long-term studi||data||studi||patient||previou histori||arthropathi ae||risk||open-label extens||increas||proport||psoriat arthriti||clinic trial||event||efalizumab treatment||joint diseas||treatment||ae||arthropathi||analysi||routin clinic practic||placebo group||incid||group||efalizumab group||long-term treatment||efalizumab-tr patient||arthriti||trial||efalizumab||result,efalizumab||arthropathi||arthropathi ae||efalizumab treatment||psoriat arthropathi||efalizumab group||arthropathi AE||efalizumab therapi||efalizumab retreat||arthropathi data||arthropathi event||continu efalizumab treatment||ae||psoriat arthropathi event||efalizumab 1 mg,167.442||162.386||115.05||102.08||94.3||88.913||86.48||85.477||84.753||83.386||82.617||68.927||67.714||63.816||59.666,0.8,0.5,0.4
1192,Histochem_Cell_Biol-4-1-2248610.txt,retrograd traffic||secretori rout||golgi apparatu stack||retrograd transport||endosom||golgi network||earli endosom||golgi apparatu||cisterna||toxin||compart||shiga toxin||ER||golgi cisterna||cell||protein||multipl detail||tgn||secretori pathway||stack||traffic||side||plasma membran||molecul||function||endocytosi,golgi||golgi apparatu||tran golgi||golgi transport||golgi network||golgi cisterna||golgi complex||mammalian golgi||golgi structur||nocodazole-induc golgi||earli golgi||golgi vesicul||golgi ribbon||golgi element||golgi motil,159.635||110.352||100.436||97.3||84.823||83.783||83.628||82.372||81.286||81.244||81.207||81.093||80.406||79.818||79.818,0.4,0.3,0.2
1193,Anal_Bioanal_Chem-3-1-1592253.txt,optic molecular imag||method||fluoresc probe||molecular probe||biomolecul||system||imag||abil||high spatial||oct||fc||power tool||dynam||specif||cell||biolog event||greater tissu penetr||fret||applic||tissu||fluoresc protein||protein||fp||real time||qd||chang||bind||red fluoresc||flim||fluoresc||system biolog||interact||shim||system level||omi||quantum dot||addit||vivo,fluoresc||omi||omi omi||fluoresc protein||fluoresc probe||fp||fluoresc dye||fret fp||fret||red fluoresc||fluoresc lifetim||fluoresc recoveri||decreas fret fluoresc||fluoresc probe aequorea fluoresc protein||fluoresc indic,49.58||44.537||44.537||29.728||28.312||27.244||26.719||26.648||26.053||25.955||25.79||25.27||25.211||24.847||24.79,0.8,0.7,0.4666666666666667
1194,Planta-3-1-2039816.txt,chromatin condens||time||preliminari experi||dna degrad||petal desicc||petal cell||sampl||dehydr||flower open||absciss||develop||petal||increas||floral life span||nuclear area||dna breakdown||lower sequenc||wilt||dna content||treatment||cell||program cell death||dapi||petal senesc||nuclear diamet||chang||agaros gel||flower||ethylen treatment||nuclear condens||nuclei||speci||stage||remark nuclear morpholog||flow cytometri||result,petal||petal absciss||desicc petal||petal desicc||D. belladonna P. yedoensi petal||petal senesc||alstroemeria petal||turgid petal||abscis petal||dianthu petal||younger petal||petal FW||petal wither||petal cell||P. yedoensi,157.138||103.125||94.752||94.752||89.569||88.058||84.86||82.787||82.008||81.714||80.555||80.54||79.603||78.918||75.519,0.4,0.3,0.26666666666666666
1195,Eur_J_Nucl_Med_Mol_Imaging-3-1-1914264.txt,antibodi||target||respons||method||radiat||optim||data||model||studi||patient||amount||gbq||mci||bone marrow||abil||metastas||prospect trial||lymphoma||solid tumour||radiotherapi||whole-bodi||dose||thyroid carcinoma||dosimetri||cell||therapi||maximum toler dose||treatment||tumour||clinic dosimetri||radionuclid therapi||estim||radiat dosimetri||individu patient||phase||radionuclid||activ||abl approach||radiat dose||bone||import||toxic||neuro-endocrin tumour||result,dosimetri||radionuclid therapi dosimetri||radioiodin dosimetri||radiat dosimetri||marrow dosimetri||dose||radionuclid||patient-specif dosimetri||whole-bodi dosimetri||clinic dosimetri||3-dimensional-intern dosimetri||pre-therapi dosimetri||voxel-bas dosimetri||dosimetri techniqu||dosimetri result,121.502||76.682||75.438||73.776||69.561||66.912||65.767||64.404||63.1||62.887||62.135||61.985||61.565||61.435||61.243,0.4,0.5,0.3333333333333333
1196,Exp_Brain_Res-4-1-2373863.txt,condit||level||mechanoreceptor||touch||magnitud||tactil||studi||represent||stimulu||process||explor mode||convex||aftereffect||finger||concav||vogel||shape||experi||subject||curvatur||transfer||singl finger||neural represent||adapt||hand||result,finger||aftereffect||index finger||middl finger||singl finger||human finger||neighbor finger||distant finger||individu finger||curvatur aftereffect||aftereffect transfer||index finger condit||middl finger condit||opposit index finger||singl finger case,112.148||63.682||60.931||60.586||58.439||57.049||56.852||56.651||56.074||50.824||44.011||43.589||43.359||41.001||38.959,0.6,0.3,0.2
1197,Matern_Child_Health_J-2-2-1592161.txt,vlbw||program||follow-up||preconcept||commun assess||commun||infant||birth outcom||poor birth outcom||birth||pregnanc||ipc||magnolia project||pregnanc plan||concept||reproduct age||risk||risk reduct||feto-inf mortal rate||case manag||deliveri||intervent||commun outreach||commun develop||subcontractor||manag||infant mortal||gradi memori hospit||reproduct health outcom||poor nutrit||women||success||month||care||servic||prenat care||activ||poor health||clinic servic||northeast florida healthi start coalit||import||famili plan||initi home visit||particip||previou fetal||outcom,ipc||ipc program||women||gradi ipc program||ipc particip||ipc program enrol||program||initi ipc||ipc intervent||women health||ipc team||ipc program aim||magnolia project||singl ipc||deliveri,113.652||88.639||74.721||74.669||67.17||63.817||63.625||61.531||61.091||60.982||60.862||59.493||58.183||57.468||52.393,0.4,0.3,0.3333333333333333
1198,J_Struct_Biol-1-5-2048824.txt,antibodi||specif region||vesicl||NE assembl||nuclear pore complex||onm||ER membran||oocyt||membran protein||egg extract||sampl||ER tubul||chromatin||nuclear assembl reaction||structur||npc protein||nuclear envelop||npc||larg ER vesicl||larg sac||junction||stage iii oocyt||edg||scan electron microscopi||ultrathin section||protein||tubul||format||curvatur||incub||nuclei||assembl||pb||membran,rtn4a||al.||rtn4a antibodi||rtn4a label||membran||2.1 rtn4a||2.2 rtn4a||2.5 rtn4a||nuclear membran||NE membran||goldberg||NE||voeltz||flatten membran||nuclear envelop,126.189||87.068||72.478||68.668||67.653||63.094||63.094||63.094||62.757||62.267||61.491||56.881||55.424||51.591||49.394,0.2,0.1,0.13333333333333333
1199,Breast_Cancer_Res_Treat-3-1-2001223.txt,cancer||clinic respons||respons||neoadjuv therapi||letrozol||endocrin therapi||breast cancer||studi||tamoxifen||patient||diseas progress||letrozole-tr patient||effect||neoadjuv letrozol||chemotherapi||aromatas inhibitor||express||aromatas||postmenopaus women||treatment||women||surgeri||neoadjuv||tumor||trial||diseas||safeti,breast||breast cancer||cancer||breast cancer clin cancer||postmenopaus breast cancer||oper breast cancer||primari breast cancer||breast cancer biomark||early-stag breast cancer||larg oper breast cancer breast cancer||er-posit breast cancer||breast cancer patient||advanc breast cancer||breast cancer eur||breast cancer proc,88.5||80.211||71.921||63.235||60.082||57.538||56.873||55.774||55.652||55.506||55.409||55.062||54.766||54.141||53.474,0.4,0.2,0.13333333333333333
1200,Clin_Oral_Investig-4-1-2238786.txt,condit||dental eros||case||clinic phenomenon||preval||dental clinician||studi||eros||eros index||wear||oral health||develop||criteria||defect||tooth morpholog||dental practic||tooth wear||lesion||intern basi||current diagnost criteria||valid||occlus||basic eros wear examin||research||age||eros challeng||diagnost criteria||capabl||surfac||factor||exposur||eros tooth wear||loss||diagnosi||tooth||index||lesion characterist||progress||result,wear||eros wear||eros||eros tooth wear||tooth wear||eros tooth||tooth||contemporari eros tooth wear||tooth wear index||eros wear data||dental eros||gradual tooth wear||tooth wear model||eros tooth lesion||eros index,117.802||114.487||111.171||108.175||106.678||103.362||95.553||81.52||79.179||76.623||71.737||71.529||71.118||70.758||67.677,0.8,0.5,0.4666666666666667
1201,Pediatr_Nephrol-3-1-1989763.txt,serum albumin||level||method||fat||infant||eaa||studi||patient||nutrit||ccpd||increas||crf||intak||common practic guidelin||gastrostomi||dietari supplement||energi||growth||htsd||feed||glucos||bodi composit||protein||age||chronic renal failur||report||import||dialysi dose||height||doqi||appetit||fat mass||dialysi||acidosi||diseas||supplement||weight gain||children||result,dialysi||children||nutrit||periton dialysi||chronic dialysi||chronic periton dialysi||failur dialysi growth||dialysi leptin||long-term dialysi||dialysi adequaci||long-term periton dialysi||pediatr dialysi patient||dialysi dose||dialysi clearanc||dialysi solut,128.806||118.754||111.106||95.892||93.893||83.588||72.225||70.334||67.717||67.29||66.137||65.688||65.29||65.186||65.179,0.6,0.3,0.26666666666666666
1202,Eur_Arch_Otorhinolaryngol-3-1-2099165.txt,blood||fossa||case||day||boy||lingual arteri||pseudoaneurysm||embolis||mass||vessel wall||patient||posttonsillectomi haemorrhag||carotid arteri,pseudoaneurysm||posttonsillectomi pseudoaneurysm||posttonsillectomi haemorrhag||haemorrhag||bleed||sever posttonsillectomi haemorrhag||pseudoaneurysm grow||conclus pseudoaneurysm||delay posttonsillectomi haemorrhag||critic posttonsillectomi haemorrhag||postop bleed||tonsillectomi||lingual arteri||sever bleed||massiv bleed,48.0||41.35||32.41||30.118||29.439||24.722||24.589||24.0||22.777||21.607||20.697||19.972||19.426||19.393||16.683,0.4,0.2,0.2
1203,Osteoporos_Int-4-1-2267486.txt,intern refer||data||previou fractur||fractur risk assess tool||lumbar spine||risk||threshold||clinic practic||femor neck||intervent||fractur probabl||fractur||tool||intervent threshold||present studi||therapeut intervent||bmd||women||age||gradient||equival||order||osteoporosis-rel fractur||japan||femor neck bmd||clinic risk factor||probabl||fractur outcom||hip fractur||bone miner densiti,fractur||hip fractur||fractur femor||fractur probabl||fractur risk||osteoporosis-rel fractur||osteoporot fractur||hip fractur probabl||fractur predict||hip fractur risk||fractur number||fractur outcom||previou fractur||japan||japanes,90.565||60.822||57.975||56.749||52.61||50.756||50.432||48.192||47.466||45.433||45.282||45.282||45.282||44.559||44.021,0.6,0.4,0.4666666666666667
1204,Neuroimage-2-1-2278232.txt,syntact process||left pariet lobe||neural system||superior portion||locat||experiment condit||data||phonolog process||bsl task||effect||deaf||languag||region||bsl||sign||phonolog||adult||pariet lobe||phonolog awar||precentr gyru||oral school||hear statu||medial portion||greater extent||primari school||non-n signer||item||neural network||task||analysi||pictur||hear group||english||activ||group||deaf peopl||bsl sign||rhyme||exposur||phonolog represent||left inferior frontal gyru||perform||particip||ifg||left ifg||smg||peopl||network,deaf||languag||phonolog||rhyme||al.||deaf signer||phonolog task||sign phonolog||rhyme task||deaf particip||languag process||phonolog process||semant languag task||deaf nativ signer||task,114.511||106.745||106.038||97.542||93.627||85.083||84.052||80.694||79.805||69.528||65.326||64.973||62.517||62.42||62.067,0.8,0.4,0.4
1205,Rheumatol_Int-3-1-2134974.txt,antibodi||follow-up||case||studi||patient||system lupu erythematosu||rituximab||rituximab therapi||autoimmun disord||thrombocytopen purpura||infus||refractori||cell-direct biolog therapi||pilot studi||small pilot studi||improv||treatment||cell||therapi||autoimmun diseas||vascul||month||autoimmun||potenti util||report||biolog therapi||sle||number||clinic benefit||cell deplet therapi||trial||diseas||clinic remiss||inadequ respons||result,rituximab||rituximab therapi||rituximab treatment||rituximab rheumatolog||rituximab toler||rituximab scand||rituximab group||rituximab 1||optim rituximab||rituximab failur||pt||rituximab infus therapi||success rituximab therapi||final rituximab infus||princ HM rituximab,235.528||129.609||125.19||122.552||119.288||118.696||117.771||117.764||117.764||117.764||114.378||91.052||89.353||83.156||79.234,0.4,0.2,0.13333333333333333
1206,Biotechnol_Lett-3-1-2151841.txt,gene||protein fold||bip||target||heterolog protein||increas||holdas||pdi||substrat||protein||chaperon||chaperon system||molecular chaperon||unfold protein respons||activ||overexpress||cell||upr,upr||protein||chaperon||heterolog protein||overexpress chaperon||heterolog protein overexpress||bip||protein fold||bip overexpress||overexpress||heterolog protein secret||unfold protein respons||upr activ||biotechnol bioeng||protein respons,49.868||45.25||41.112||35.478||35.216||33.426||30.852||30.454||30.086||29.32||28.08||27.054||26.946||26.54||26.132,0.8,0.7,0.5333333333333333
1207,Health_Care_Anal-4-1-2244696.txt,futur||greater orient||individu||studi||valu||social depriv||expect||health inequ||discuss||gain||present orient||egalitarian||aim||impact||welfar||prioritarian||patern||futur orient||evalu||utilitarian||inform choic||autonomi||research||paper||inequ||time orient||uptak||ethic cost||choic||screen uptak||decreas||psycholog||screen||posit outcom||public health approach||particip||dilemma||peopl||greater social depriv||benefit||lower expect||result,screen||choic||inequ||inform choic||screen uptak||choic increas inequ||greater choic||inform choic polici||mammographi screen||health inequ||screen programm||R. screen||inform choic perspect||screen test||choic carri,90.577||90.294||58.252||57.886||53.806||50.153||49.615||48.528||48.339||47.477||46.508||45.989||45.543||45.289||45.147,1.0,0.6,0.4
1208,Doc_Ophthalmol-4-1-2244701.txt,cone-rod dystrophi||cone||case||fmm||data||mutat||patient||retin dystrophi||parafov ring||autofluoresc||retin pigmentosa||visual field preserv||retin dysfunct||rpe||AF abnorm||high densiti autofluoresc||perg||function signific||genotype-phenotyp correl||lipofuscin||ring||field||visual acuiti||high correl||annulu,autofluoresc||fundu autofluoresc||ophthalmol||retin dystrophi||bird AC fundu autofluoresc||rpgr||bird AC holder GE||holder GE bird AC fitzk FW||bird AC holder GE fitzk FW||abnorm fundu autofluoresc||rims1||bird AC||fundu autofluoresc imag||retin pigmentosa||cone-rod dystrophi,73.587||57.598||55.217||51.587||48.568||47.232||43.049||42.496||42.496||41.361||40.933||39.539||39.294||38.464||35.477,0.4,0.2,0.26666666666666666
1209,Arch_Dermatol_Res-3-1-1910889.txt,predefin evalu sheet||evalu||grade||non-allerg advers event||non-steroid anti-inflammatori drug||nsaid||reaction||urticaria||advers reaction||symptom||intoler||studi||drug||coxib||public||patient||advers event||articl,rofecoxib||allergi||rofecoxib toler||celecoxib||rofecoxib allergi eur||intoler||celecoxib toler||rofecoxib administr||high-dos rofecoxib||cox-2 inhibitor rofecoxib||nsaid intoler||cyclooxygenase-2 inhibitor rofecoxib||nsaid||allergi eur||rofecoxib 37.5 mg,180.047||145.668||121.06||119.586||109.901||92.363||90.83||90.71||90.538||88.239||87.276||84.388||82.188||74.829||66.968,0.0,0.1,0.13333333333333333
1210,Clin_Auton_Res-3-1-1797062.txt,chronic mountain sick||respir||level||respons||week||pulmonari vasoconstrict||rate||pulmonari hypertens||high altitud||altitud||densiti||effect||autonom nervou system||sensit||increas||blood pressur||heart failur||baroreflex control||receptor||point||chemoreceptor||heart rate||hypoxia||day||control||acut hypoxia||blood||acut exposur||subject||recent studi||chang||barometr pressur||exposur||high altitud dweller||result,altitud||high altitud||altitud dweller||altitud resid||altitud 1982||extrem altitud||simul altitud||high altitud andean||high altitud dweller||high altitud exposur||high altitud anim||hypoxia||healthi altitud dweller||high altitud research||high altitud commun,160.815||94.776||93.381||81.542||80.896||80.407||80.407||74.163||71.833||66.703||63.804||63.575||63.38||63.184||63.184,0.4,0.3,0.26666666666666666
1211,Clin_Oral_Investig-4-1-2238792.txt,aspect||dental eros||method||instrument||children||indic||fill teeth||non-communic diseas||literatur analysi||world health report||qualiti||studi||eros||oral health||criteria||teeth||health promot||valid||countri||examin||gold standard||result||assess||diseas prevent||cardiovascular diseas||reliabl||diseas||index||qualiti criteria||oral health promot||oral diseas pattern,"eros||dental eros||eros index||dental eros index||dental||eros tooth||oral dental eros index||dental eros 18,555||e.g. dental eros||dental eros process||dental eros 153||dental eros oral health||k03.23 eros||eros 8||population-bas eros index",179.282||151.49||129.099||127.299||123.699||114.186||110.885||101.974||100.993||100.993||100.993||100.774||91.111||89.641||88.9,0.4,0.2,0.13333333333333333
1212,J_Abnorm_Child_Psychol-4-1-2206247.txt,level||measur||parent style||boy||behavior||commun||adolescence-limit delinqu||neglect style||sampl||data||theori||distinct delinqu trajectori||studi||risk||develop||style||child||pittsburgh youth studi||delinqu||demograph variabl||variabl||self-report||pattern||similar||neglect parent||analys||authoritarian||posit parent||childhood delinqu||full model||research||age||trajectori||characterist||parent||famili||famili factor||differ||group||late adolesc||delinqu trajectori,delinqu||delinqu trajectori||delinqu prior delinqu||gener delinqu delinqu||delinqu crime||persist delinqu||offici delinqu||adolesc delinqu trajectori||childhood delinqu||self-report delinqu||adolescence-limit delinqu||delinqu journal||juvenil delinqu||trajectori||minor delinqu trajectori,295.207||223.807||199.567||196.805||165.561||162.038||157.997||157.202||156.129||155.801||154.842||153.878||153.737||152.407||152.158,0.4,0.3,0.3333333333333333
1213,Eur_J_Nucl_Med_Mol_Imaging-3-1-1998881.txt,anim||acut renal failur||technolog||outer medulla||acut tubular necrosi||imag||anim model||model||studi||apoptot cell||atn||cell||rat||apoptosi||analysi||ddc||injuri||experiment model||diagnost imag agent||detect||kidney,aposens aposens aposens aposens aposens aposens||aposens||aposens aposens||aposens aposens aposens aposens imag||interest aposens aposens||aposens aposens 3 aposens 18||result aposens aposens aposens target||aposens aposens aposens 1 2||sampl aposens||aposens synthesi||conclus aposens technolog||discuss aposens technolog||method aposens compound||0.05 result aposens||acut renal failur,133.674||133.674||133.674||109.204||89.116||80.562||80.404||80.206||67.499||66.837||46.416||46.416||44.971||44.564||36.746,0.0,0.0,0.06666666666666667
1214,Eur_J_Pediatr-4-1-2292481.txt,incid rate||case||clinic diagnost criteria||infant||birth||clinic decis||studi||life||torticolli||review||symptomat asymmetri||sign||disord||clinic syndrom||etiolog||current inform||month||literatur||posit prefer||plagiocephali||clinic specialti||craniosynostosi||symptom||differenti diagnosi||screen||movement||asymmetri||diagnosi||young infant||syndrom,torticolli||asymmetri||torticolli plagiocephali||plagiocephali||muscular torticolli||symptomat asymmetri||paroxysm torticolli||ocular torticolli||idiopath asymmetri||congenit muscular torticolli||symptomat asymmetri disord||acquir asymmetri||2008 asymmetri||infant||cranial asymmetri,64.672||53.816||52.161||39.65||38.504||37.55||35.583||34.876||32.969||31.963||28.509||28.261||27.889||27.586||27.486,0.6,0.4,0.3333333333333333
1215,Immunome_Res-1-_-1289288.txt,antibodi||method||epitop||system||immun system||concentr||databas||data||experiment condit||experiment method||valu||search method||vaccin||complex||mhc molecul||protein antigen||databas system||specif allel||cell||blast search||entri||kinet||protein||immun||antijen||peptid interact||quantit specif data||bind||mhc||archiv||major histocompat complex||number||interact||peptid||tcr||link||sequenc,databas||peptid||antijen databas||antijen||mhc||epitop||antigen databas||1745-7580-1-4 databas antijen||6 antijen databas||kinet databas||cell epitop peptid||tap databas||conform epitop peptid||mhc bind||mhc data,89.649||85.726||81.921||74.193||73.507||71.572||56.816||56.592||54.619||54.591||54.309||53.918||53.32||53.2||52.977,0.8,0.5,0.3333333333333333
1216,Purinergic_Signal-3-1-2096770.txt,restenosi||role||atherosclerosi||releas||endothelium||studi||atp||smc||process||intim||receptor||nucleotid receptor||migrat||express||smooth muscl cell||vascular diseas||cell||utp||prolifer||nucleotid||previou studi||activ||earli stage||vascular||extracellular nucleotid||media||function,receptor||P2 receptor||nucleotid receptor||P2 nucleotid receptor||atp receptor||receptor circ||endotheli receptor||2 receptor||P2||receptor mediat||adp receptor||7 receptor||fibroblast P2 receptor||6 receptor||P2 receptor express,77.872||60.82||53.989||50.582||47.928||46.829||44.398||44.109||43.768||43.288||43.2||42.99||41.76||41.743||41.718,0.4,0.2,0.13333333333333333
1217,Ann_Biomed_Eng-2-2-1705502.txt,mit||method||figur||center||case||conduct||border||imag||truncat level||data||model||valu||tsvd||magnet induct tomographi||voltag||increas||resolut||cnr||psf||paramet||regular scheme||radiu||cylind||spatial resolut||chang||imag reconstruct||gener||perturb||snr||regular||regular paramet||VU yield||homogen cylind||contrast||coil,bf||varvec||bf np||bf Gp||bf Ay||bf axa||bf Mp||bf agp||perturb||reconstruct perturb||kappa||document||tsvd||perturb sphere||conduct perturb,183.414||105.481||97.09||95.735||93.049||93.049||92.701||92.628||62.062||47.462||44.911||42.784||40.286||38.805||37.24,0.0,0.1,0.13333333333333333
1218,Ann_Biomed_Eng-2-2-1764593.txt,target||system||steadi state||rate||data||model||nucleu||sensit||increas||complex||dephosphoryl||nfat||calcium concentr||experiment result||nuclear local signal||rise||express||cell||calcium||export||control||averag||low calcium concentr||oscil frequenc||transloc||activ||cytoplasm||bind||factor||gene transcript||ikk||oscil||speci||calcineurin||show||initi||gene express||period||result,hbox||rm||rm ikk||rm dag||rm 7||nfat||kappa||nfat activ||activ nfat||nfat transloc||phosphoryl nfat||nfat model||free nfat||nfat inhibitor||nfat famili,561.471||559.288||309.46||285.375||279.644||243.82||143.519||134.277||134.277||127.189||124.243||123.971||122.731||122.364||121.915,0.0,0.1,0.06666666666666667
1219,Qual_Life_Res-3-1-1832149.txt,random design||subgroup||questionnair||effect size||child health questionnair||sampl||studi||secondari school||effect||scale||form||multi-item scale||test||internet version||valid||onlin questionnair||health||small effect||item||feasibl||chronic condit||paper||result||score differ||chq-cf||differ||standard paper version||chq-cf scale||number||reliabl||adolesc||mode||answer||internet administr||internet,chq-cf||internet||paper||chq-cf administr||chq-cf scale||paper questionnair||questionnair||chq-cf score||internet mode||web-bas chq-cf questionnair||chq-cf item||internet administr||paper mode||internet version||chq-cf scale score,87.159||65.191||56.748||56.413||54.021||53.235||49.723||49.141||48.478||47.547||46.456||45.429||44.256||41.153||39.721,0.8,0.5,0.4666666666666667
1220,Int_J_Parasitol-1-5-1906861.txt,mechan||condit||respons||huvec transcriptom||endothelium||data||studi||icam-1||huvec||signific regul||increas||abil||receptor||express||cluster||cell apoptosi||cell||adhes||gene||ec||term||vascular endothelium||malaria infect||critic factor||chang||tnf||sever malaria||human serum||co-cultur||surfac||EC activ||presenc||prbc||co-cultur experi||biolog process||molecul||up-regul||immun respons||result,al.||prbc||rbc||co-cultur||wautier||malaria||plasmodium||plasmodium falciparum||infect rbc||uninfect rbc||prbc sequestr||icam-1||huvec||rbc chaiyaroj||malaria infect,88.766||65.366||60.097||54.865||48.031||47.98||47.092||40.033||39.029||38.978||38.032||35.483||34.444||34.311||32.97,0.4,0.2,0.3333333333333333
1221,J_Autism_Dev_Disord-4-1-2268724.txt,target||affect state||respons||accur||individu||complex pattern||attention-demand strategi||social cognit task||FR task||pdd-no||autism||process||criteria||anxieti||abil||complex condit||disord||pattern||express||social-cognit function||face recognit||emot recognit||pervas development disord||mcdd||emot||task||signific group differ||accuraci||diagnost criteria||cognit capac||identif||social interact||non-target condit||face process||group||facial express recognit||differ||symptom||speed||diagnosi||hypothesi||facial express||children||result,mcdd||pdd-no||mcdd children||pdd-no versu mcdd children||mcdd criteria||J. mcdd||mcdd group||mcdd symptom||mcdd diagnosi||complet mcdd||children||pure’ mcdd versu pdd-no children||pdd-no criteria||pdd-no journal||pdd-no group,161.265||141.14||120.505||96.153||87.423||86.056||85.79||82.266||81.373||80.632||79.745||78.054||77.36||76.439||75.728,0.4,0.2,0.2
1222,J_Mol_Biol-1-5-1892151.txt,condit||construct||recognit sequenc||OC form||concentr||koac||rate||bpli||plasmid||endonucleas||potassium||test enzym||form||singl polypeptid||site||r-m||double-strand break||dna||bcgi||duplex||SC||reaction||restrict enzym||enzym||individu circl||type iif categori||reaction rate||baei||copi||singl ring||act||fll||restrict endonucleas||catenan||cleavag||substrat||linear product||linear fragment||OC||sequenc,restrict||restrict endonucleas||endonucleas||dna restrict||dna||restrict enzym||sfii restrict endonucleas||restrict endonucleas sgrai||sgrai restrict endonucleas||dna recognit||dna site||bcgi-lik restrict endonucleas||ecorii restrict endonucleas||ecori restrict endonucleas||eco57i restrict endonucleas,93.019||92.683||92.347||86.713||80.406||74.268||65.351||64.475||64.475||64.392||63.756||63.714||63.555||63.555||62.751,0.6,0.4,0.26666666666666666
1223,Diabetologia-4-1-2292421.txt,mitochondria||fatti acid||adipocyt,adipocyt||adipos tissu||fatti||adipos compart||frozen-cut adipos tissu||human adipos tissu||diabetologia diabetologia||diabetologia||tissu||mitochondri uncoupl||fatti acid||sjöström||e444||2008||leiden,15.554||15.534||13.521||11.73||11.605||11.343||9.592||9.592||9.108||8.44||8.331||7.495||7.495||6.917||6.913,0.2,0.1,0.13333333333333333
1224,Eur_J_Clin_Pharmacol-4-1-2426925.txt,administr||amodiaquin||cross-ov studi||haematolog paramet||volunt||artesun||combin||sampl||patient||healthi normal volunt||clinic examin||malaria patient||uncompl falciparum malaria||dose||treatment||advers event||day||ratio||main activ metabolit||phase||pharmacokinet||dihydroartemisinin||group||toler||auc||healthi volunt||drug||pharmacokinet paramet||clinic signific,amodiaquin||artesun||amodiaquin pharmacokinet||amodiaquin monotherapi||oral amodiaquin||amodiaquin AQ||amodiaquin dose||amodiaquin prophylaxi||artesun administr||volunt||artesun tran||keyword amodiaquin artesun pharmacokinet toler healthi||pharmacokinet||quantifi amodiaquin concentr||desethylamodiaquin,168.174||141.599||112.637||89.367||88.241||87.936||86.68||84.087||73.896||73.833||70.8||63.894||57.1||56.95||50.124,0.4,0.3,0.26666666666666666
1225,Bioinformation-2-5-2241933.txt,mesh||vector||set||method||biomed literatur||data||studi||gene annot sentenc||text mine||frequenc||sentenc||inform||process||gene express experi||structur||gene||term||annot||protein||analysi||associ||abstract||list||noun||initi test||keyword||larg number||function,gene||sentenc gene||keyword||sentenc keyword||sentenc||mesh keyword||gene annot sentenc||gene annot||gene annot term||abstract keyword||keyword extract sentenc||gene list||term||inform gene||mesh term,96.951||81.001||75.014||70.032||65.05||63.313||63.299||62.423||59.737||58.0||55.968||55.453||54.365||53.932||52.988,0.6,0.4,0.3333333333333333
1226,Eur_J_Pediatr-3-1-1914295.txt,program||pediatr exclus||adult market||pediatr studi||patent extens||fda||infant||data||studi||pharmaceut prepar||effect||develop||patent||prescript||pediatr popul||clinic pharmacolog review||pediatr||wide age rang||medic||adult||research||age||market exclus||literatur||usa||market||order||medicin||drug||industri||trial||children,drug||drug prescript||off-label drug||system drug||drug util||drug studi||anti-rheumat drug||drug research||label drug||drug sale||drug administr||drug categori||respiratori drug||drug central||cardiovascular drug,120.914||71.266||68.879||68.199||64.968||64.43||64.379||64.361||63.843||62.306||62.256||62.218||62.038||61.924||61.766,0.2,0.1,0.06666666666666667
1227,Cult_Med_Psychiatry-2-2-1705533.txt,person commun||muslim||islam||technolog||infertil husband||regard||sperm donat||fatwa||embryo||middl eastern region||practic||moral||patient||gamet donat||infertil muslim||muslim middl east||egg||infertil father||law||third-parti donat||medic anthropolog||jewish man||debat||adulteri||countri||ivf||coupl||marriag||sperm||ayatollah khamanei||scienc||women||world||recent year||lebanon||global||gamet||lebanes ivf clinic||muslim world||anonym donor||donat||cultur||local moral world||donor gamet||muslim marriag||iran||infertil coupl||ethnograph research||children,donat||muslim||donat islam||gamet donat||sperm donat||infertil muslim||third-parti donat||shi’it muslim||islam||egg donat||third-parti gamet donat||sunni muslim||muslim marriag||embryo donat||shi’it islam,151.365||129.828||123.561||114.115||111.175||100.95||97.57||97.082||95.758||93.974||90.668||90.326||84.482||83.21||80.047,0.8,0.7,0.5333333333333333
1228,Immunome_Res-1-_-1312312.txt,amino acid differ||databas||mous IG||structur approach||data||hla||concept||allel||section||structur||chain||immunogenet||amino acid||domain||web resourc||tool||singl chain fragment variabl||on-lin tool||web||gene||annot||analysi||polymorph||mhc||immunoinformat||imgt||3D structur||immunoglobulin||number||locu||collier de perl,imgt||imgt databas||ligm-db imgt||imgt sequenc databas imgt||imgt repertoir||imgt gene databas imgt||v-quest imgt||junctionanalysi imgt||phylogen imgt||imgt collier||primer-db imgt||allele-align imgt||geneinfo imgt||mhc-db imgt||locusview imgt,517.384||277.827||275.098||273.153||271.575||270.545||267.64||267.64||267.218||266.226||266.149||264.657||264.657||263.166||263.166,0.2,0.1,0.06666666666666667
1229,Neurosci_Lett-1-5-1885960.txt,p53||tau,tau||p53||tau phosphoryl||anti-tot tau||fetal tau||solubl tau||tau protein||p53 ubiquitin||human 2n4r tau||abstract p53||p53 suppress||p53 promot||keyword p53 tau microtubul alzheim diseas||alzheim||alzheim diseas tau protein,44.925||35.763||29.525||25.897||23.75||23.025||22.998||18.549||18.456||17.882||17.882||17.882||17.765||17.329||16.783,0.4,0.2,0.13333333333333333
